data_2kjd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kjd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.159 0.504 . . . . 1.36 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.485 ' HB3' HD23 ' A' ' 113' ' ' LEU . 14.0 ptt180 -129.37 148.97 71.4 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 3.51 110.424 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HB3' HG11 ' A' ' 89' ' ' VAL . 57.2 Cg_endo -70.43 174.5 9.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.787 2.324 . . . . 0.81 112.642 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -134.22 140.47 46.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.793 -0.64 . . . . 2.82 109.961 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.2 110.08 22.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.544 -0.539 . . . . 1.96 109.544 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.414 ' HG ' ' C ' ' A' ' 50' ' ' GLY . 9.0 m -89.78 116.2 27.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.759 -0.655 . . . . 1.17 110.003 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -107.4 118.83 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.444 -0.576 . . . . 1.13 109.444 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.451 ' HE3' HD22 ' A' ' 51' ' ' LEU . 22.7 ptp -137.39 133.26 34.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.89 0.376 . . . . 1.08 111.218 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 87.6 tttt -103.63 147.04 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.65 -0.704 . . . . 3.11 109.298 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 14.4 mtmt -57.33 110.32 0.83 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.893 -0.594 . . . . 1.5 110.747 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.96 -94.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.189 -0.914 . . . . 1.28 113.346 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.62 -72.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.803 2.336 . . . . 2.23 111.971 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -146.19 20.26 1.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.569 0.7 . . . . 3.28 109.753 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 174.5 -156.76 23.73 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.22 -0.9 . . . . 1.93 111.3 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.552 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 83.6 m-85 -112.02 168.17 9.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.337 -0.616 . . . . 1.82 109.337 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.2 70.52 0.45 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.067 -1.063 . . . . 0.96 113.089 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.81 163.1 40.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.01 -0.367 . . . . 0.4 110.01 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.527 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 25.6 t-20 -129.06 129.77 45.7 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.041 -0.527 . . . . 2.23 109.694 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.92 144.1 29.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.692 -0.484 . . . . 2.11 109.692 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.775 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.8 p80 -121.51 130.25 53.43 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.036 -0.666 . . . . 2.02 110.158 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.439 -0.801 . . . . 2.75 109.279 179.262 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 35' ' ' GLN . 4.2 mm100 . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.677 -0.49 . . . . 1.5 109.677 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 75.6 m-85 -112.11 143.71 42.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.301 -0.629 . . . . 0.99 109.301 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.572 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.1 mm -68.39 106.78 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.452 -0.573 . . . . 1.12 109.452 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.775 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.4 ttt180 -75.47 -48.0 24.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 3.48 109.809 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -159.63 143.78 14.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.33 -0.85 . . . . 1.82 109.957 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.79 145.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.724 -0.473 . . . . 1.11 109.724 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 11.0 t70 -87.68 121.92 70.69 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.34 -0.615 . . . . 2.28 109.34 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 24.4 Cg_exo -62.26 -22.54 74.3 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 123.07 2.514 . . . . 1.27 113.339 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -105.39 50.34 0.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.713 0.768 . . . . 2.4 109.418 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 53.5 p -145.28 162.0 39.22 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.454 -0.793 . . . . 0.68 110.035 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 18.9 Cg_endo -60.92 -18.44 57.09 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.045 2.496 . . . . 0.87 112.435 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -67.83 -52.39 37.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 1.17 110.798 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.78 -38.47 91.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.053 0.454 . . . . 2.01 109.865 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.37 94.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.185 -0.461 . . . . 1.15 111.223 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.435 ' OG ' ' HE2' ' A' ' 15' ' ' MET . 85.9 p -70.93 -19.84 62.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.4 111.016 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.414 ' C ' ' HG ' ' A' ' 13' ' ' CYS . . . 105.23 39.12 2.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.962 -0.637 . . . . 0.62 112.813 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.572 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -90.15 95.29 10.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 1.12 109.911 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -85.25 146.24 27.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 5.17 110.26 -176.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -71.03 142.82 50.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 1.44 110.845 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.52 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 2.0 mp0 78.96 -0.02 2.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.146 0.904 . . . . 3.8 111.854 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.7 m-20 -81.71 150.5 27.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.606 -0.516 . . . . 1.02 109.606 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 31.4 ttp-105 -104.64 142.82 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.775 0.321 . . . . 2.26 111.501 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 mm -72.82 123.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.592 -0.731 . . . . 1.37 109.587 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG12 ' HG2' ' A' ' 104' ' ' PRO . 43.5 t -111.92 -48.27 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.439 0.637 . . . . 1.56 109.943 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.5 mt-10 -125.68 146.37 49.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.391 -0.822 . . . . 0.89 110.045 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.69 120.58 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.975 -0.557 . . . . 1.29 109.88 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 62.21 23.06 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.555 -0.748 . . . . 1.17 111.015 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 9.39 62.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.906 -0.664 . . . . 0.66 112.609 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.5 t -114.02 128.04 71.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 1.75 110.446 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.0 p -77.47 129.29 35.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.767 -0.651 . . . . 2.36 110.914 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.71 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.6 mmt -117.15 26.89 9.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.167 0.432 . . . . 1.42 112.167 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.69 114.97 7.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.393 . . . . 3.75 110.253 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.76 62.02 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.866 -0.683 . . . . 1.78 112.913 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.71 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.9 mmtp -92.37 166.98 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.214 -0.291 . . . . 3.73 110.214 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.19 175.62 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.493 -0.321 . . . . 3.61 111.057 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -58.94 -44.09 91.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.786 0.327 . . . . 2.2 110.818 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -39.47 95.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.912 -0.661 . . . . 0.78 112.122 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.75 -47.19 84.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 2.03 111.174 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 77' ' ' ILE . 50.6 t -69.08 -47.52 74.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.71 110.972 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.9 t -64.47 -41.99 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.465 -0.334 . . . . 1.37 111.186 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -63.87 -35.79 81.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.981 -0.378 . . . . 1.12 109.981 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.12 93.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 1.09 110.942 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 73' ' ' VAL . 75.5 mt -60.87 -45.89 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 1.35 110.384 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 52.0 mtp180 -68.18 -28.15 67.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.003 -0.544 . . . . 3.55 110.816 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.24 8.98 16.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.116 -0.493 . . . . 1.28 110.96 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.58 -21.12 58.73 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.85 -0.69 . . . . 0.6 111.752 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -129.71 9.99 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.768 -0.729 . . . . 1.1 111.995 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.443 ' OD2' ' HE3' ' A' ' 16' ' ' LYS . 11.6 p-10 -80.46 -23.94 39.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.748 0.309 . . . . 2.12 111.083 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 2.2 pt-20 -138.26 162.67 33.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.89 0.376 . . . . 2.11 110.815 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -143.79 149.17 36.65 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.815 -0.629 . . . . 1.09 110.1 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -115.1 117.52 30.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.139 -0.482 . . . . 2.25 109.878 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.4 mt -109.05 135.64 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.065 -0.516 . . . . 1.04 110.427 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 44.4 tp -105.72 121.33 43.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.351 -0.611 . . . . 1.22 109.351 175.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.4 m -128.03 156.84 40.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.927 0.394 . . . . 1.09 111.569 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 10' ' ' PRO . 13.6 m -130.63 139.77 50.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.749 . . . . 1.08 110.382 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 173.65 6.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.778 -0.646 . . . . 1.92 110.64 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.601 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.1 ttt-85 -62.41 -49.39 75.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.848 -0.427 . . . . 4.87 109.848 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -39.56 94.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.204 0.526 . . . . 2.68 110.429 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.5 m -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.274 -0.875 . . . . 1.08 111.052 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.12 -37.29 78.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 1.18 111.303 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 31.8 mm-40 -63.54 -36.23 83.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 1.94 109.998 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.514 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 83.5 t80 -63.42 -46.82 84.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.743 -0.662 . . . . 0.83 110.214 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 104' ' ' PRO . 34.6 m-85 -64.26 -38.45 91.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.55 111.401 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -58.85 -50.01 75.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.956 0.407 . . . . 2.5 111.448 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -71.34 -19.04 62.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 2.53 111.663 -172.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -103.3 -2.5 27.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.926 0.393 . . . . 2.19 110.8 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER 57.57 45.3 19.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.595 -0.73 . . . . 4.83 110.895 -177.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.5 t -118.24 134.08 63.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 2.08 110.69 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.6 mm -93.1 120.07 67.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.374 -0.375 . . . . 1.99 110.018 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.472 ' HG2' HG12 ' A' ' 58' ' ' VAL . 32.8 Cg_endo -64.48 142.32 77.76 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.636 2.224 . . . . 0.86 112.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' OE2' ' A' ' 107' ' ' GLU . 9.3 t -153.24 -179.27 7.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.92 109.383 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -57.56 -30.99 65.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.411 0.523 . . . . 1.87 112.411 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.508 ' OE2' ' HB3' ' A' ' 105' ' ' SER . 0.0 OUTLIER -69.34 -28.77 66.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.948 0.404 . . . . 2.82 111.673 -177.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -77.46 -14.6 59.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.442 -0.344 . . . . 0.71 111.425 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 87' ' ' LEU . 96.0 mt -53.31 -58.33 7.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.818 0.342 . . . . 1.47 111.802 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -107.93 14.66 25.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.267 0.556 . . . . 4.09 110.532 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 113' ' ' LEU . . . -92.55 153.68 21.79 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.816 -0.629 . . . . 1.39 111.882 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.76 30.49 0.41 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.429 2.753 . . . . 1.65 113.102 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.485 HD23 ' HB3' ' A' ' 9' ' ' ARG . 70.6 mt . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 115.309 -0.86 . . . . 1.75 113.168 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.063 0.459 . . . . 1.36 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 85.0 mtt-85 -115.72 149.86 43.83 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.07 -0.514 . . . . 3.51 111.447 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' A' ' 109' ' ' LEU . 2.9 Cg_exo -72.7 165.89 31.48 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.512 2.141 . . . . 0.81 109.866 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.63 HH12 ' HB3' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -127.7 131.1 49.81 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.237 -0.438 . . . . 2.82 110.043 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.0 tm? -98.64 112.79 24.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 1.96 109.521 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.4 m -105.74 125.67 51.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.888 -0.596 . . . . 1.17 110.711 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.473 HG21 ' HG2' ' A' ' 85' ' ' LYS . 24.2 m -111.98 117.38 32.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 1.13 109.174 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.6 ptp -126.53 133.6 51.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.178 0.513 . . . . 1.08 110.999 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -111.54 143.24 42.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.158 -0.928 . . . . 3.11 110.146 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 52.6 mttt -62.36 104.59 0.51 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.349 -0.841 . . . . 1.5 111.377 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.82 -80.2 0.93 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.044 -0.98 . . . . 1.28 111.623 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.98 47.5 2.23 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.723 2.282 . . . . 2.23 111.215 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m 61.58 27.6 17.03 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.12 -0.945 . . . . 3.28 110.69 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.521 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -177.09 -178.07 46.52 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.024 -0.608 . . . . 1.93 112.248 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.503 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 29.3 m-85 -106.55 -162.06 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.427 -0.583 . . . . 1.82 109.427 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.67 73.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.115 -1.04 . . . . 0.96 113.043 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -155.1 154.34 32.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.79 0.328 . . . . 0.4 110.287 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -108.75 134.78 50.99 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.383 -0.599 . . . . 2.23 109.383 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 35' ' ' GLN . 23.0 tp -105.24 152.66 22.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.109 -0.496 . . . . 2.11 111.351 -173.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.34 122.49 46.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.745 -0.835 . . . . 2.02 108.745 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.468 0.651 . . . . 2.75 111.198 -174.317 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.456 ' HB3' HD12 ' A' ' 26' ' ' LEU . 21.4 mm-40 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.874 0.368 . . . . 1.5 110.377 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.86 151.33 23.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 0.99 110.557 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.41 106.36 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.276 0.56 . . . . 1.12 110.171 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.25 -54.35 38.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.006 -0.997 . . . . 3.48 110.54 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 p -168.35 137.3 2.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.814 -0.63 . . . . 1.82 109.981 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.38 130.99 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.353 -0.61 . . . . 1.11 109.353 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.53 135.44 72.04 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.511 -0.313 . . . . 2.28 110.246 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.94 139.23 66.81 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.776 2.318 . . . . 1.27 112.406 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.18 48.27 6.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.304 -0.862 . . . . 2.4 110.807 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 98.7 p -120.4 160.45 43.7 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.473 -0.785 . . . . 0.68 109.539 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.503 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.6 Cg_endo -54.46 -29.41 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.167 1.911 . . . . 0.87 111.575 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.23 -50.49 39.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 1.17 110.54 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -65.12 -35.85 82.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.297 -0.41 . . . . 2.01 110.49 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 1.15 111.641 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.7 p -72.99 -18.37 61.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.012 0.434 . . . . 0.4 110.8 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.12 14.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.62 112.547 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.65 114.76 9.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 1.12 110.355 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -97.53 149.65 21.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 5.17 109.906 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.37 151.82 39.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.276 -0.42 . . . . 1.44 110.585 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 70.35 10.7 7.32 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.774 0.671 . . . . 3.8 111.78 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.562 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.7 m-20 -84.6 168.53 15.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.722 -0.473 . . . . 1.02 109.722 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.445 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -131.31 131.26 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.848 -0.427 . . . . 2.26 109.848 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -72.57 130.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.228 0.537 . . . . 1.37 111.203 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.699 HG13 ' HG2' ' A' ' 104' ' ' PRO . 23.6 t -107.22 -48.47 8.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 1.56 110.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.568 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 35.5 mt-10 -133.87 148.34 51.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.89 110.756 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.23 117.78 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.958 -0.565 . . . . 1.29 109.773 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 58.78 31.02 20.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.18 0.514 . . . . 1.17 111.165 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.13 74.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.883 -0.675 . . . . 0.66 112.805 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.04 120.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.279 -0.267 . . . . 1.75 110.279 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 91.9 m -64.61 126.21 27.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.62 . . . . 2.36 111.438 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.576 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.8 mmt -105.14 68.78 0.83 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.923 -0.769 . . . . 1.42 108.923 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 103' ' ' ILE . 27.7 mt-10 -66.7 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.56 -1.2 . . . . 3.75 110.811 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.99 25.93 5.7 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.611 -0.996 . . . . 1.78 110.611 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.576 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 71.9 mmtt -58.2 147.1 31.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.873 -0.663 . . . . 3.73 111.642 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.494 ' HG3' ' H ' ' A' ' 72' ' ' ASP . 12.8 pt20 -77.11 161.36 28.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.092 -0.958 . . . . 3.61 110.29 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.4 -42.57 74.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 2.2 110.446 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.04 92.87 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.78 112.77 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.494 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 8.5 t0 -66.13 -47.09 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 2.03 110.013 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.406 HG23 ' SD ' ' A' ' 65' ' ' MET . 47.7 t -62.62 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.477 -0.783 . . . . 1.71 110.662 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.5 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 1.37 110.883 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -61.97 -39.22 91.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 1.12 110.015 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.18 94.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 1.09 111.012 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.057 0.456 . . . . 1.35 110.629 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -68.93 -24.95 64.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 3.55 111.219 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.63 -10.67 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 1.28 111.093 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -33.31 70.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.702 -0.761 . . . . 0.6 111.904 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.16 -109.38 3.36 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.019 -0.61 . . . . 1.1 112.184 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 11.6 t70 -102.04 -23.97 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.616 -0.513 . . . . 2.12 109.616 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.06 157.3 40.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.028 0.442 . . . . 2.11 110.459 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -146.93 149.32 32.97 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.934 -0.575 . . . . 1.09 109.856 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.473 ' HG2' HG21 ' A' ' 14' ' ' THR . 57.0 mttp -114.36 116.82 29.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.037 0.446 . . . . 2.25 109.896 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -109.54 136.35 49.07 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.838 -0.619 . . . . 1.04 110.574 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.8 tp -104.83 125.12 50.55 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.183 -0.673 . . . . 1.22 109.183 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 11.1 m -135.34 152.08 31.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.185 0.517 . . . . 1.09 111.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 94' ' ' ASP . 16.1 m -130.57 150.97 35.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.354 -0.839 . . . . 1.08 110.145 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.63 ' HB3' HH12 ' A' ' 11' ' ' ARG . 7.6 p-10 -89.97 176.16 6.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.449 -0.575 . . . . 1.92 109.449 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -53.51 -48.93 68.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.211 0.448 . . . . 4.87 112.211 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.2 -43.16 95.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 2.68 111.138 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.0 m -71.25 -41.03 70.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.332 0.587 . . . . 1.08 110.73 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.577 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 22.3 t0 -64.95 -39.31 93.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.528 -0.76 . . . . 1.18 111.072 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.29 -35.73 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 1.94 110.446 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -63.23 -48.03 79.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.83 111.005 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -64.47 -36.04 82.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.29 -0.414 . . . . 0.55 111.701 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 36.2 mttp -58.72 -49.82 76.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.786 0.291 . . . . 2.5 111.786 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 13.1 ptmt -70.85 -23.09 62.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 2.53 110.555 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.87 -7.16 59.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.861 -0.609 . . . . 2.19 110.68 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 57.88 28.94 16.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.423 -0.808 . . . . 4.83 111.299 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.8 p -132.28 147.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.043 -0.526 . . . . 2.08 109.955 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.401 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 70.6 mt -102.1 128.53 28.32 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 121.107 0.48 . . . . 1.99 110.812 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.699 ' HG2' HG13 ' A' ' 58' ' ' VAL . 18.4 Cg_endo -63.71 155.98 60.16 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.655 2.236 . . . . 0.86 112.845 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.593 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 2.1 m -150.12 175.68 11.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.326 -0.99 . . . . 1.92 108.326 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.608 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 22.9 mp0 -59.39 -34.92 73.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.333 0.587 . . . . 1.87 110.122 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.8 pt-20 -62.49 -30.21 71.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 2.82 111.682 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.44 ' HB2' ' H ' ' A' ' 105' ' ' SER . 33.7 m80 -79.29 -24.48 42.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.71 111.322 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.7 pp -91.96 -14.11 30.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.217 -0.447 . . . . 1.47 110.477 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -103.86 -50.91 3.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 4.09 110.785 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.72 -142.6 8.67 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.89 -0.672 . . . . 1.39 112.416 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -84.52 163.21 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.719 2.279 . . . . 1.65 113.236 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.506 -0.77 . . . . 1.75 109.249 175.751 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.477 0.656 . . . . 1.36 109.876 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HB3' HD21 ' A' ' 113' ' ' LEU . 20.4 ptt85 -121.47 150.18 54.09 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.122 -0.945 . . . . 3.51 109.9 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.498 ' HB2' HD13 ' A' ' 87' ' ' LEU . 55.6 Cg_endo -69.16 158.36 58.04 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.46 2.107 . . . . 0.81 111.938 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 11' ' ' ARG . 7.8 ptp180 -118.29 131.59 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.737 -0.665 . . . . 2.82 110.016 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.5 tp -97.33 111.08 23.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 1.96 109.803 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 32.2 m -94.77 117.22 29.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.833 -0.622 . . . . 1.17 110.032 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 m -110.46 117.87 34.74 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.305 -0.628 . . . . 1.13 109.305 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.473 ' HE1' ' HA ' ' A' ' 46' ' ' ALA . 22.5 ptp -128.99 136.35 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.404 -0.362 . . . . 1.08 110.855 -174.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -110.72 139.86 45.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.677 -0.692 . . . . 3.11 109.249 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 11.7 ttmt -61.92 124.4 20.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.329 0.492 . . . . 1.5 112.329 -173.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -149.85 17.91 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.629 -0.714 . . . . 1.28 111.323 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.73 -30.65 17.48 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.037 2.491 . . . . 2.23 112.508 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -109.1 19.93 18.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 3.28 110.573 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.77 2.84 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.569 -0.824 . . . . 1.93 111.959 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.47 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 26.6 m-85 -119.07 -48.46 2.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.753 0.311 . . . . 1.82 110.527 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 70.02 1.23 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.0 -0.619 . . . . 0.96 113.635 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -156.52 156.06 33.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.942 -0.392 . . . . 0.4 109.942 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -101.81 126.48 48.69 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.82 -0.437 . . . . 2.23 109.82 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 tp -100.34 152.74 19.97 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.966 -0.561 . . . . 2.11 110.432 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.415 ' HD2' ' HB2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -106.61 122.7 46.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.305 -0.407 . . . . 2.02 110.108 -176.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.817 -0.628 . . . . 2.75 109.999 -178.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.559 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.823 0.345 . . . . 1.5 111.276 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -118.61 156.79 28.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.99 110.061 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.442 HG13 HD11 ' A' ' 51' ' ' LEU . 44.4 mm -96.37 110.06 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.151 0.5 . . . . 1.12 109.719 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB2' ' HD2' ' A' ' 27' ' ' HIS . 60.8 ttt180 -66.21 -55.15 17.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 3.48 110.371 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 p -169.67 139.24 1.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.812 -0.631 . . . . 1.82 109.599 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -96.41 138.05 22.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.341 -0.391 . . . . 1.11 109.984 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 t70 -71.59 124.0 90.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.178 -0.675 . . . . 2.28 109.178 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 35.1 Cg_exo -56.48 132.85 54.31 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.11 2.54 . . . . 1.27 113.751 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.0 t70 57.44 48.5 14.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.855 -1.066 . . . . 2.4 110.917 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -110.72 169.58 6.17 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.68 109.986 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.2 Cg_endo -55.16 -33.13 83.03 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.89 1.727 . . . . 0.87 111.333 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -60.86 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.439 0.638 . . . . 1.17 110.576 175.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.08 -50.61 73.04 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.276 -0.874 . . . . 2.01 110.067 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -17.5 62.54 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.711 -1.586 . . . . 1.15 111.353 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 51.6 p -84.72 -16.96 39.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.4 110.071 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.22 0.35 35.43 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.754 -0.736 . . . . 0.62 112.697 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 37' ' ' ILE . 37.8 tp -61.62 128.13 34.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.314 . . . . 1.12 110.31 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -117.86 154.21 32.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.251 -0.431 . . . . 5.17 109.915 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -78.88 145.37 34.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.528 -0.305 . . . . 1.44 110.305 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 85.3 mm-40 78.99 3.26 2.42 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.252 0.97 . . . . 3.8 111.202 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 36.4 m-20 -74.13 156.81 36.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 1.02 109.724 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.477 ' NH1' HG21 ' A' ' 58' ' ' VAL . 7.9 tmm_? -123.93 129.21 50.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.721 -0.474 . . . . 2.26 109.721 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.516 ' HA ' HG12 ' A' ' 88' ' ' VAL . 58.2 mt -76.22 130.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.225 0.536 . . . . 1.37 111.416 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.477 HG21 ' NH1' ' A' ' 56' ' ' ARG . 21.8 t -107.5 -51.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.237 -0.892 . . . . 1.56 110.149 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 26.1 mt-10 -130.61 144.35 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.89 111.031 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.31 118.2 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.333 -0.618 . . . . 1.29 109.333 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 61.0 22.41 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.17 110.937 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.98 6.28 63.49 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.66 112.915 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.87 120.73 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 1.75 110.37 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.529 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.2 m -63.51 130.02 42.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 2.36 110.841 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.588 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 25.6 mmt -109.62 18.63 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.406 0.622 . . . . 1.42 110.464 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -61.04 117.78 5.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.069 -0.969 . . . . 3.75 110.731 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.0 -16.76 50.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.833 -0.699 . . . . 1.78 112.951 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.588 ' HD2' ' HA ' ' A' ' 65' ' ' MET . 68.8 mttm -75.6 173.16 11.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.149 0.5 . . . . 3.73 111.808 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -103.36 -175.29 2.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.593 -0.73 . . . . 3.61 111.463 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.402 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 86.3 t60 -63.08 -42.87 99.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.506 . . . . 2.2 110.297 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.36 -39.68 96.49 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.737 -0.665 . . . . 0.78 113.203 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -62.57 -47.47 83.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.046 0.451 . . . . 2.03 110.765 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.33 -46.76 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 1.71 110.968 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.93 -40.08 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.395 . . . . 1.37 111.023 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.7 t -60.28 -42.01 94.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 1.12 110.843 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.72 -43.38 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 1.09 111.35 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.489 HG22 HG21 ' A' ' 84' ' ' THR . 80.6 mt -58.73 -42.38 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.427 0.632 . . . . 1.35 110.407 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 78' ' ' ARG . 31.7 mtp180 -74.29 -31.98 62.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.462 -0.79 . . . . 3.55 111.63 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.79 -7.63 59.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.438 -0.346 . . . . 1.28 111.23 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.31 73.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.182 -0.532 . . . . 0.6 112.186 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.57 -126.96 8.24 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.707 -0.759 . . . . 1.1 111.652 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 8.5 t70 -84.02 -28.37 27.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 2.12 110.017 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -128.85 160.2 33.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.105 0.479 . . . . 2.11 110.618 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 77' ' ' ILE . 10.6 t -146.07 148.74 32.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.56 -0.745 . . . . 1.09 109.647 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -116.42 117.36 29.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 2.25 110.042 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.85 128.34 53.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.946 -0.57 . . . . 1.04 109.75 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' A' ' 10' ' ' PRO . 57.0 tp -103.92 114.76 29.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.679 -0.859 . . . . 1.22 108.679 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.77 162.26 33.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 1.09 110.885 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.22 146.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 1.08 110.473 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.04 166.19 23.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.711 -0.677 . . . . 1.92 109.85 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -53.39 -48.17 68.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.009 0.433 . . . . 4.87 110.862 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -73.39 -28.13 61.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 2.68 109.973 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 m -70.58 -47.82 58.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.371 -0.832 . . . . 1.08 110.695 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -59.36 -45.04 92.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 1.18 110.478 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.8 -36.14 82.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.94 110.984 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.94 -46.09 89.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.83 110.555 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.474 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 48.7 m-85 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.248 -0.433 . . . . 0.55 111.257 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -59.51 -49.72 76.7 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.537 0.199 . . . . 2.5 111.537 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -70.92 -18.74 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 2.53 111.305 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 t -91.43 -19.51 22.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.306 0.574 . . . . 2.19 109.829 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.599 ' NE ' ' HA ' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 67.02 31.75 6.73 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 114.692 -1.14 . . . . 4.83 111.716 176.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.1 p -123.68 141.02 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 2.08 109.852 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 66.7 mt -82.4 129.07 64.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 1.99 110.367 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.474 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 14.5 Cg_exo -66.25 150.8 84.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.79 2.327 . . . . 0.86 111.623 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 t -163.34 178.38 8.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.566 -0.531 . . . . 1.92 109.566 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.412 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 71.1 mt-30 -55.13 -26.86 41.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.584 0.587 . . . . 1.87 112.584 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -55.7 -30.66 61.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.212 0.529 . . . . 2.82 111.389 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -89.77 -12.93 37.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.242 -0.435 . . . . 0.71 111.114 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 106' ' ' GLN . 96.4 mt -64.68 111.33 2.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.024 -0.535 . . . . 1.47 110.43 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 56.34 36.04 26.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 4.09 110.394 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.33 -167.86 11.45 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.605 -0.725 . . . . 1.39 111.843 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.33 150.0 22.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.608 2.205 . . . . 1.65 112.413 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 9' ' ' ARG . 65.3 mt . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 1.75 109.361 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.477 ' HA ' ' HG1' ' A' ' 93' ' ' THR . 81.5 mt . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.366 0.506 . . . . 1.36 112.366 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -110.57 143.09 27.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 120.757 0.313 . . . . 3.51 110.611 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HB3' HG13 ' A' ' 89' ' ' VAL . 64.6 Cg_endo -74.69 177.09 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.637 2.225 . . . . 0.81 111.094 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -146.8 138.27 24.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.897 0.38 . . . . 2.82 111.326 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.23 116.57 29.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.687 -0.688 . . . . 1.96 110.139 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 4.3 m -97.38 115.91 28.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.12 -0.696 . . . . 1.17 109.12 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.42 HG22 ' HG2' ' A' ' 85' ' ' LYS . 27.7 m -110.23 117.42 33.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 1.13 109.334 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.7 ptp -135.06 140.46 45.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.154 -0.475 . . . . 1.08 111.146 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -110.44 153.02 25.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.309 -0.626 . . . . 3.11 109.309 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 5.4 ttmt -69.17 98.89 1.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.493 0.663 . . . . 1.5 111.118 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -106.79 3.15 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.034 -0.985 . . . . 1.28 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HD2' ' HG3' ' A' ' 45' ' ' PRO . 41.4 Cg_endo -70.32 84.11 0.76 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.693 2.262 . . . . 2.23 113.013 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m 63.3 67.38 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.383 0.882 . . . . 3.28 113.383 170.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.39 57.35 6.79 Favored Glycine 0 CA--C 1.517 0.162 0 C-N-CA 121.124 -0.56 . . . . 1.93 114.308 168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 68.08 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.088 0.555 . . . . 1.82 111.56 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.21 70.42 0.73 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.863 -0.684 . . . . 0.96 112.771 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.48 152.4 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.751 -0.463 . . . . 0.4 109.751 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -103.74 135.17 45.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.387 -0.37 . . . . 2.23 110.144 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 HD12 ' H ' ' A' ' 27' ' ' HIS . 0.2 OUTLIER -101.32 151.86 21.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.891 -0.595 . . . . 2.11 109.536 -176.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -106.12 122.02 45.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 2.02 110.065 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.988 -0.551 . . . . 2.75 110.101 179.23 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.735 -0.468 . . . . 1.5 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 68.2 m-85 -103.98 147.56 27.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.135 0.493 . . . . 0.99 110.99 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.497 HG13 HD13 ' A' ' 51' ' ' LEU . 50.6 mm -78.87 106.98 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.469 -0.787 . . . . 1.12 109.149 175.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 39.5 ttt-85 -62.36 -53.25 57.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.37 -0.832 . . . . 3.48 110.113 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 m -161.41 145.25 12.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 1.82 108.91 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.49 131.24 73.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.211 -0.663 . . . . 1.11 109.211 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 t70 -79.13 118.53 72.98 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.298 -0.41 . . . . 2.28 109.895 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 50.2 Cg_exo -56.12 142.15 86.61 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.088 2.526 . . . . 1.27 112.999 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 t70 67.93 47.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.347 -0.842 . . . . 2.4 110.725 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 85.1 p -127.98 164.16 38.88 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.612 -0.722 . . . . 0.68 109.178 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HG3' ' HD2' ' A' ' 19' ' ' PRO . 12.1 Cg_endo -57.43 -33.62 96.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.599 1.532 . . . . 0.87 111.326 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.0 -52.53 34.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.917 -0.583 . . . . 1.17 110.7 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.09 -41.56 97.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 2.01 110.273 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.77 -22.74 63.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 1.15 111.867 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.1 p -72.83 -9.73 59.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.27 0.557 . . . . 0.4 110.359 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.412 ' C ' ' HG ' ' A' ' 13' ' ' CYS . . . 103.12 31.4 5.05 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.559 -0.746 . . . . 0.62 111.792 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 37' ' ' ILE . 30.7 tp -97.13 139.53 32.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.019 -0.363 . . . . 1.12 110.019 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -131.44 148.5 52.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 5.17 109.506 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -73.23 149.87 42.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.093 -0.336 . . . . 1.44 110.093 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 75.2 mt-30 78.89 5.91 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.191 0.932 . . . . 3.8 111.477 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 47.9 m-20 -88.74 148.03 24.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 1.02 109.749 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 24.2 ttt180 -103.73 134.6 46.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 2.26 111.24 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.94 130.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.642 . . . . 1.37 110.031 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.603 HG13 ' HG2' ' A' ' 104' ' ' PRO . 41.3 t -111.24 -42.87 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.029 -0.532 . . . . 1.56 110.878 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.02 143.42 50.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.555 -0.293 . . . . 0.89 110.506 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.7 120.03 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.804 -0.443 . . . . 1.29 109.804 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 62.91 18.31 10.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.346 0.658 . . . . 1.17 111.249 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 0.05 73.09 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.586 -0.816 . . . . 0.66 111.858 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.11 128.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.855 -0.424 . . . . 1.75 109.855 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.454 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 23.1 p -66.68 126.51 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.754 -0.657 . . . . 2.36 111.773 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.3 mmt -133.68 38.81 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 1.42 110.515 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' OE1' ' HB2' ' A' ' 64' ' ' CYS . 41.3 mp0 -61.22 -52.74 63.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 3.75 111.201 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.72 34.78 2.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.674 -0.774 . . . . 1.78 112.472 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.592 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.6 mmtp -79.58 -175.37 4.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.732 0.301 . . . . 3.73 110.603 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -85.07 161.27 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.317 . . . . 3.61 110.658 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -55.84 -42.81 76.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.859 -0.423 . . . . 2.2 109.859 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.71 -39.11 94.82 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.5 -0.773 . . . . 0.78 113.032 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.18 -47.59 79.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.969 0.384 . . . . 2.03 111.354 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' HB3' ' A' ' 65' ' ' MET . 48.7 t -64.55 -43.45 96.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.984 0.421 . . . . 1.71 110.736 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.443 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 97.0 t -65.84 -41.89 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 1.37 110.413 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -62.18 -44.95 95.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 1.12 110.502 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB3' ' HE2' ' A' ' 65' ' ' MET . . . -57.36 -39.56 76.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 1.09 111.332 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.0 mt -57.46 -45.71 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.269 0.557 . . . . 1.35 110.724 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 74' ' ' VAL . 10.2 mpt_? -75.25 -31.99 60.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.703 -0.681 . . . . 3.55 110.983 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -14.75 63.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 1.28 111.874 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.23 -13.83 67.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.824 -0.703 . . . . 0.6 111.872 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.31 -99.82 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.869 -0.682 . . . . 1.1 111.977 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 9.3 t70 -104.72 -21.58 13.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.856 0.36 . . . . 2.12 110.528 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.29 162.29 31.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.844 0.354 . . . . 2.11 110.497 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 t -148.75 148.46 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.978 -0.556 . . . . 1.09 110.238 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HG2' HG22 ' A' ' 14' ' ' THR . 48.2 mttm -112.91 118.36 34.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.202 -0.453 . . . . 2.25 109.954 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.9 mt -105.82 127.66 53.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.976 0.417 . . . . 1.04 109.983 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.9 tp -103.6 118.34 36.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.907 -0.775 . . . . 1.22 108.907 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.2 m -125.52 162.0 29.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.109 -0.496 . . . . 1.09 111.008 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 10' ' ' PRO . 8.3 m -126.95 142.95 41.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 1.08 110.509 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -75.8 172.37 12.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.875 -0.602 . . . . 1.92 109.785 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -59.65 -48.47 81.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.056 0.455 . . . . 4.87 110.793 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.4 mp0 -65.48 -40.28 92.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.87 -0.604 . . . . 2.68 110.273 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.477 ' HG1' ' HA ' ' A' ' 8' ' ' LEU . 7.4 m -63.53 -50.9 67.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.31 -0.859 . . . . 1.08 110.872 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 29.8 t70 -59.08 -41.69 88.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.874 -1.057 . . . . 1.18 111.419 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.76 -36.93 62.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.414 -0.357 . . . . 1.94 111.41 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.13 -47.54 84.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.83 110.75 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -61.62 -38.26 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.55 111.524 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 24.2 mttp -66.32 -50.04 64.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.101 -0.24 . . . . 2.5 111.567 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 16.5 ptmt -72.7 -18.47 61.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 2.53 111.42 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.6 t -89.84 -13.39 36.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.723 -0.843 . . . . 2.19 108.723 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 68.12 33.46 4.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.633 -1.167 . . . . 4.83 110.655 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.3 148.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.869 -1.06 . . . . 2.08 109.987 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.7 mt -97.23 123.22 53.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 110.199 -0.297 . . . . 1.99 110.199 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.603 ' HG2' HG13 ' A' ' 58' ' ' VAL . 36.9 Cg_endo -71.09 145.91 50.7 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.455 2.103 . . . . 0.86 111.499 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.5 p -160.49 170.12 21.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.55 -0.295 . . . . 1.92 110.97 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -55.89 -29.24 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.451 0.469 . . . . 1.87 111.262 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -58.46 -30.83 67.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 2.82 110.972 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -81.39 -15.35 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.71 111.276 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.8 mt -67.42 -55.09 15.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.526 . . . . 1.47 110.349 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -97.58 16.61 19.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 4.09 110.477 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.21 -163.54 11.35 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.907 -0.663 . . . . 1.39 112.329 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -94.38 178.07 0.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.455 2.77 . . . . 1.65 113.0 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 1.75 109.137 175.762 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.548 HD22 ' HG3' ' A' ' 92' ' ' GLU . 26.1 mt . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.237 0.541 . . . . 1.36 111.222 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.945 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 18.3 ptp180 -137.96 141.79 33.73 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.046 -0.525 . . . . 3.51 109.982 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HB2' HD22 ' A' ' 87' ' ' LEU . 30.2 Cg_endo -66.01 160.62 43.49 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.56 2.174 . . . . 0.81 111.588 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.769 -0.65 . . . . 2.82 110.431 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 87' ' ' LEU . 63.0 tp -98.27 111.54 23.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 1.96 109.765 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.8 m -98.8 117.1 32.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 1.17 110.158 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.6 m -104.07 118.45 36.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.539 -0.911 . . . . 1.13 108.539 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.425 ' HE2' HD22 ' A' ' 51' ' ' LEU . 21.4 ptp -131.04 133.6 45.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.101 0.476 . . . . 1.08 111.025 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 13.1 tmtt? -105.23 143.56 33.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 3.11 109.258 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.692 ' HE2' ' HH ' ' A' ' 22' ' ' TYR . 3.4 ttmt -64.43 117.53 7.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.102 0.477 . . . . 1.5 111.371 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.79 -124.03 4.08 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.618 -0.719 . . . . 1.28 111.869 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.15 -67.59 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.762 2.308 . . . . 2.23 113.223 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.2 m -121.18 34.87 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 3.28 111.048 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.14 -141.45 12.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.546 -0.835 . . . . 1.93 111.989 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.692 ' HH ' ' HE2' ' A' ' 17' ' ' LYS . 40.4 m-85 -107.22 -34.38 7.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.151 0.501 . . . . 1.82 110.028 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.47 68.36 0.95 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.153 -0.93 . . . . 0.96 112.91 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -156.88 156.7 33.58 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.802 -0.444 . . . . 0.4 109.802 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -119.74 137.59 53.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.304 -0.407 . . . . 2.23 110.143 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.62 153.88 19.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.456 0.646 . . . . 2.11 112.204 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 2.4 m-70 -105.8 121.57 44.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.005 -0.998 . . . . 2.02 108.352 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.316 -0.88 0 N-CA-C 108.903 -0.777 . . . . 2.75 108.903 178.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.282 0.563 . . . . 1.5 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 50.0 m-85 -124.5 158.04 33.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.233 -0.894 . . . . 0.99 109.096 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.3 mm -87.66 112.39 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.461 -0.57 . . . . 1.12 109.461 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HA ' ' CD2' ' A' ' 27' ' ' HIS . 6.9 tmm_? -69.35 -55.68 9.72 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.097 -0.705 . . . . 3.48 109.097 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -163.15 143.54 9.17 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.485 -0.931 . . . . 1.82 108.485 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.93 122.64 50.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.048 -0.723 . . . . 1.11 109.048 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -62.29 115.29 15.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.499 -0.556 . . . . 2.28 109.499 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.0 150.88 61.58 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.857 2.372 . . . . 1.27 113.003 -174.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 66.66 47.65 1.55 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.039 -0.982 . . . . 2.4 110.33 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 90.2 p -133.6 160.85 66.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.95 -0.568 . . . . 0.68 110.629 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -28.53 83.81 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.443 2.095 . . . . 0.87 111.451 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.42 76.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.265 -0.425 . . . . 1.17 110.409 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -67.49 -41.54 84.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 2.01 110.107 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.62 69.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 1.15 111.975 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.519 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 62.0 p -70.72 -16.58 62.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.038 0.446 . . . . 0.4 110.578 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.07 15.37 22.06 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.73 -0.748 . . . . 0.62 112.975 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 ' HE2' ' A' ' 15' ' ' MET . 31.2 tp -72.02 147.8 46.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.103 -0.332 . . . . 1.12 110.103 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -140.84 157.62 45.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.957 -0.386 . . . . 5.17 109.957 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -80.11 155.12 27.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.42 -0.355 . . . . 1.44 110.831 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 14.1 mm100 75.24 7.45 4.09 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.977 0.798 . . . . 3.8 111.848 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 89.9 m-20 -93.12 154.91 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.946 -0.39 . . . . 1.02 109.946 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.579 HH11 ' HB3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -111.18 133.62 53.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.227 -0.442 . . . . 2.26 109.888 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.533 ' HA ' HG12 ' A' ' 88' ' ' VAL . 71.9 mt -78.25 124.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 1.37 110.849 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.09 -25.78 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.899 -0.591 . . . . 1.56 112.08 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.2 mt-10 -140.24 145.2 37.05 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.32 . . . . 0.89 110.625 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 65' ' ' MET . 96.6 t -131.44 124.83 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 1.29 109.885 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.3 21.64 9.89 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.223 0.609 . . . . 1.17 111.523 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.17 3.56 67.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.538 -0.839 . . . . 0.66 112.665 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.41 ' HB ' ' HE3' ' A' ' 65' ' ' MET . 45.4 t -102.95 128.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.105 -0.331 . . . . 1.75 110.105 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.4 t -63.5 121.16 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 2.36 110.467 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.799 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.9 mmt -108.72 -1.08 19.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 1.42 111.238 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -71.86 84.28 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.47 0.652 . . . . 3.75 109.718 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.18 -8.29 5.09 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.627 -0.715 . . . . 1.78 111.749 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.799 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.8 mmtt -75.97 -172.36 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 3.73 111.09 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -112.83 161.58 16.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 3.61 110.216 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -56.28 -42.88 78.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 2.2 110.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.59 -32.87 79.58 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.563 -0.827 . . . . 0.78 112.503 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.5 -47.32 61.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 2.03 110.432 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.461 HG11 ' SD ' ' A' ' 65' ' ' MET . 33.3 m -67.42 -41.92 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.944 -0.571 . . . . 1.71 111.503 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.35 -40.05 81.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 1.37 110.799 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -66.26 -38.23 87.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 1.12 110.108 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.3 97.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 1.09 111.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.534 HG21 HG21 ' A' ' 84' ' ' THR . 85.0 mt -58.38 -42.15 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.36 0.6 . . . . 1.35 110.591 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -74.74 -35.83 62.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.66 -0.7 . . . . 3.55 110.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.88 7.44 18.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.956 -0.566 . . . . 1.28 111.869 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 -14.59 81.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.6 112.013 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.01 -133.04 9.97 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.942 -0.863 . . . . 1.1 110.942 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 2.9 t70 -103.85 11.17 36.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.524 0.678 . . . . 2.12 109.69 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.539 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -149.2 159.58 44.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.298 -0.865 . . . . 2.11 109.473 174.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.534 HG21 HG21 ' A' ' 77' ' ' ILE . 14.8 t -148.35 149.77 32.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 1.09 110.52 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.48 ' HB3' HD13 ' A' ' 12' ' ' LEU . 76.1 mttt -110.89 117.07 32.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.059 -0.518 . . . . 2.25 110.014 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.0 mt -106.73 118.98 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.703 -0.48 . . . . 1.04 109.703 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 12' ' ' LEU . 4.8 tt -106.79 119.93 40.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.067 -0.716 . . . . 1.22 109.067 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 57' ' ' ILE . 35.5 m -126.59 166.76 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.226 -0.443 . . . . 1.09 110.958 -173.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 m -127.33 136.93 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 1.08 110.72 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 166.37 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.368 -0.833 . . . . 1.92 110.37 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -56.06 -47.5 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.302 . . . . 4.87 110.843 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.548 ' HG3' HD22 ' A' ' 8' ' ' LEU . 11.2 pt-20 -60.57 -38.24 83.92 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.3 0.571 . . . . 2.68 110.314 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.413 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 25.9 m -71.25 -48.35 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.24 -0.891 . . . . 1.08 110.691 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 24.7 t70 -60.55 -49.04 79.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.959 -0.564 . . . . 1.18 110.966 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 36.2 mt-10 -64.83 -27.55 68.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.94 111.141 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.37 -48.52 55.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 0.83 110.034 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HD1' ' O ' ' A' ' 93' ' ' THR . 41.9 m-85 -66.71 -36.74 83.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.377 -0.374 . . . . 0.55 111.82 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.7 mtpp -57.79 -50.14 74.27 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.665 0.246 . . . . 2.5 111.665 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 99' ' ' LYS . 11.2 ptmm? -71.48 -33.96 69.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 2.53 110.757 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -75.55 -11.28 59.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.529 -0.759 . . . . 2.19 111.969 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 55.71 33.49 21.46 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.406 0.682 . . . . 4.83 111.174 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.31 143.74 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 2.08 110.19 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.78 117.26 67.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.059 -0.349 . . . . 1.99 110.059 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.77 140.86 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.349 2.033 . . . . 0.86 111.51 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -157.73 175.07 14.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.427 -0.351 . . . . 1.92 111.195 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.527 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 10.8 mt-30 -53.62 -34.77 59.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.266 0.555 . . . . 1.87 111.127 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -59.3 -30.04 68.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.589 -0.732 . . . . 2.82 111.026 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -87.81 -12.85 43.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.71 112.103 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 77.0 mt -55.0 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.188 0.44 . . . . 1.47 112.188 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.945 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 9.9 t30 72.54 -14.7 0.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.684 -0.689 . . . . 4.09 112.225 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 109' ' ' LEU . . . -83.68 -121.13 0.8 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.725 -0.75 . . . . 1.39 112.669 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.404 ' HD3' ' HA3' ' A' ' 111' ' ' GLY . 52.4 Cg_endo -87.33 110.85 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.868 2.379 . . . . 1.65 112.768 -176.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 9' ' ' ARG . 58.2 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.622 . . . . 1.75 109.447 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 112.555 0.576 . . . . 1.36 112.555 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.552 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 31.4 ptt180 -114.52 160.02 34.68 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.717 -0.846 . . . . 3.51 108.717 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 30.7 Cg_endo -62.55 167.22 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.885 1.723 . . . . 0.81 111.895 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.509 ' HG3' HG23 ' A' ' 88' ' ' VAL . 1.6 ptm180 -128.56 135.96 50.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.971 -0.559 . . . . 2.82 110.347 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HG ' HD13 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -96.51 116.7 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 1.96 110.248 -176.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 82.6 m -101.61 116.81 33.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.579 -0.526 . . . . 1.17 109.579 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -108.79 120.27 41.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.399 -0.593 . . . . 1.13 109.399 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.557 ' HE3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -135.27 133.35 38.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.572 . . . . 1.08 111.548 -175.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -101.87 144.23 30.78 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.375 -0.83 . . . . 3.11 109.649 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.561 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.8 ttmt -65.66 113.01 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.036 0.446 . . . . 1.5 110.562 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.01 -99.72 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.444 -0.798 . . . . 1.28 111.323 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.43 97.97 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.761 2.307 . . . . 2.23 112.327 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 t 71.39 -47.19 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.004 0.922 . . . . 3.28 112.554 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 161.02 81.57 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.375 -0.917 . . . . 1.93 112.83 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' SER . 23.3 m-85 68.13 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.267 0.627 . . . . 1.82 111.601 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.81 69.76 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.896 -0.669 . . . . 0.96 112.817 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.31 154.06 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.705 -0.48 . . . . 0.4 109.705 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -119.27 131.46 55.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.806 0.336 . . . . 2.23 110.99 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.42 133.61 45.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.016 -0.538 . . . . 2.11 110.222 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.1 p80 -120.44 139.38 52.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 2.02 110.601 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 108.998 -0.741 . . . . 2.75 108.998 177.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.5 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.429 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 68.8 m-85 -121.98 148.91 44.21 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.696 -0.853 . . . . 0.99 108.696 175.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 55' ' ' ASP . 38.2 mm -68.32 109.25 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 1.12 109.775 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -65.81 -54.45 26.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.235 -1.024 . . . . 3.48 108.235 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 m -166.34 135.46 3.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 1.82 109.348 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -94.65 121.81 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.386 -0.968 . . . . 1.11 108.386 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -78.22 121.52 84.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.255 -0.43 . . . . 2.28 110.032 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.75 155.98 20.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.513 2.809 . . . . 1.27 112.584 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.7 51.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.998 0.904 . . . . 2.4 109.218 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.2 p -146.94 154.56 47.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.979 -1.009 . . . . 0.68 109.508 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.89 -25.55 78.25 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 0.87 111.705 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.557 ' HA ' ' HE3' ' A' ' 15' ' ' MET . . . -70.52 -43.2 70.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.091 -0.504 . . . . 1.17 110.339 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -67.97 -35.0 77.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.218 0.533 . . . . 2.01 109.808 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -18.97 60.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.566 -0.743 . . . . 1.15 111.58 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 24.2 p -70.42 -18.1 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.138 0.494 . . . . 0.4 109.78 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.31 -0.57 33.01 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.986 -0.626 . . . . 0.62 112.141 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD13 HG13 ' A' ' 37' ' ' ILE . 22.4 tp -61.76 139.39 58.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.541 0.21 . . . . 1.12 110.735 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -124.56 -164.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.459 -0.571 . . . . 5.17 109.459 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.0 140.72 29.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.971 0.415 . . . . 1.44 111.081 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 68.91 26.82 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.952 -1.022 . . . . 3.8 113.013 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.519 ' HB2' HG13 ' A' ' 37' ' ' ILE . 6.2 m-20 -69.7 142.93 53.25 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.377 -0.971 . . . . 1.02 108.377 167.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -108.69 128.44 54.86 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.517 -0.549 . . . . 2.26 109.517 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 88' ' ' VAL . 24.4 mm -71.91 130.1 35.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 1.37 111.257 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.672 HG12 ' HB2' ' A' ' 104' ' ' PRO . 58.2 t -111.79 -51.52 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 1.56 109.959 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.6 mt-10 -136.89 152.49 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.746 -0.661 . . . . 0.89 110.283 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.626 ' HB ' ' HE1' ' A' ' 65' ' ' MET . 87.7 t -129.45 115.7 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.527 . . . . 1.29 109.579 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.21 26.49 15.89 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.478 0.486 . . . . 1.17 111.157 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.54 13.31 67.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.852 -0.69 . . . . 0.66 112.524 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.68 122.77 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.718 -0.475 . . . . 1.75 109.718 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.1 t -65.53 129.77 40.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.037 -0.529 . . . . 2.36 111.338 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.626 ' HE1' ' HB ' ' A' ' 60' ' ' VAL . 26.0 mmt -115.27 14.71 16.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 1.42 111.159 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.713 ' HG3' HG23 ' A' ' 103' ' ' ILE . 56.5 mm-40 -62.31 -31.06 71.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.622 . . . . 3.75 111.489 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.96 20.32 14.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.098 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ASP . 71.9 mmtt -101.45 177.43 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.934 0.397 . . . . 3.73 110.749 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -125.61 -178.39 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.9 -0.591 . . . . 3.61 109.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -54.12 -41.15 68.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.781 0.289 . . . . 2.2 111.781 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.62 93.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.643 -0.789 . . . . 0.78 112.831 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 10.4 m-20 -65.58 -45.99 81.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 2.03 110.972 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 77' ' ' ILE . 98.7 t -62.54 -46.96 95.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 1.71 110.87 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.51 -37.87 78.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.834 0.349 . . . . 1.37 111.444 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.6 t -61.55 -38.79 88.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.74 -0.467 . . . . 1.12 109.74 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.58 78.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 1.09 111.194 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 73' ' ' VAL . 28.7 mm -57.35 -42.46 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.678 0.751 . . . . 1.35 109.378 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -74.81 -37.31 62.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.051 -0.977 . . . . 3.55 111.079 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -6.36 40.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.543 . . . . 1.28 111.988 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.16 -28.18 68.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.6 112.578 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.74 -120.15 4.74 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.768 -0.73 . . . . 1.1 111.442 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 51.4 m-20 -108.74 7.68 26.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 2.12 110.482 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.39 156.73 41.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.75 . . . . 2.11 108.974 171.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.927 0.394 . . . . 1.09 110.076 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -116.89 119.89 36.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 2.25 109.596 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.2 128.26 53.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.979 -0.555 . . . . 1.04 110.092 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 10' ' ' PRO . 23.2 tp -103.66 115.2 30.06 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.288 -1.004 . . . . 1.22 108.288 174.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.1 m -127.58 163.89 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.004 -0.544 . . . . 1.09 111.044 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.38 139.15 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.591 -0.731 . . . . 1.08 110.082 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.79 175.88 9.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.167 -0.469 . . . . 1.92 109.817 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 91' ' ' ARG . 3.3 tpp180 -62.5 -42.04 99.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.708 0.262 . . . . 4.87 111.708 -171.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.32 -42.91 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 2.68 110.715 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.7 m -66.48 -45.83 78.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.856 -0.611 . . . . 1.08 111.451 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 40.7 t0 -58.97 -47.44 85.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 1.18 109.318 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 68.2 mm-40 -59.95 -37.67 80.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 1.94 110.821 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.623 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 84.5 t80 -62.96 -49.34 75.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.512 -0.313 . . . . 0.83 110.973 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -66.64 -38.15 86.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.601 -0.272 . . . . 0.55 111.45 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.1 mtpp -60.28 -48.79 80.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.721 0.296 . . . . 2.5 111.326 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.2 pttt -71.47 -14.55 62.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.277 -0.419 . . . . 2.53 111.295 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.32 -10.62 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 2.19 111.257 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.78 28.23 17.98 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.821 -0.627 . . . . 4.83 111.502 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.1 p -123.82 142.12 41.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.998 0.428 . . . . 2.08 110.848 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.713 HG23 ' HG3' ' A' ' 66' ' ' GLU . 70.5 mt -79.4 128.43 75.36 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.718 -0.674 . . . . 1.99 110.971 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.672 ' HB2' HG12 ' A' ' 58' ' ' VAL . 6.1 Cg_exo -71.9 160.28 48.16 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.069 2.513 . . . . 0.86 111.602 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -165.31 164.96 19.79 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.921 -0.312 . . . . 1.92 110.735 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -59.22 -28.53 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 1.87 110.931 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -58.91 -30.53 67.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.031 0.443 . . . . 2.82 110.892 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -77.52 -15.16 59.44 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.71 111.509 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.411 HD13 ' HG ' ' A' ' 12' ' ' LEU . 60.1 mt -65.01 -61.59 2.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.529 0.68 . . . . 1.47 110.455 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.37 19.72 9.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.127 -0.942 . . . . 4.09 110.36 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.68 -175.81 14.17 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.855 -0.612 . . . . 1.39 112.139 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -87.44 159.83 8.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.354 2.702 . . . . 1.65 112.568 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 9' ' ' ARG . 45.3 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.772 -0.649 . . . . 1.75 109.321 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.443 0.639 . . . . 1.36 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 32.2 ptt180 -119.98 161.4 38.55 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.434 -0.803 . . . . 3.51 109.948 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.544 ' HB2' HD11 ' A' ' 87' ' ' LEU . 6.8 Cg_exo -70.28 169.73 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.463 2.109 . . . . 0.81 111.703 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -128.5 131.37 48.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 2.82 110.505 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.495 HD13 ' HB3' ' A' ' 85' ' ' LYS . 48.7 tp -95.43 110.57 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.009 -0.541 . . . . 1.96 109.623 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.426 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 60.0 m -92.98 117.8 30.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.102 -0.499 . . . . 1.17 110.23 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 m -106.56 118.76 37.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.487 -0.56 . . . . 1.13 109.487 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.585 ' HE3' ' HA ' ' A' ' 46' ' ' ALA . 21.9 ptp -133.79 133.65 41.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.826 -0.624 . . . . 1.08 110.486 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.66 136.73 52.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.046 -0.525 . . . . 3.11 110.016 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.602 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 9.5 ttmt -54.65 119.07 4.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.478 -0.783 . . . . 1.5 111.337 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.43 -107.37 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.568 -0.825 . . . . 1.28 112.678 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.88 -66.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.163 2.575 . . . . 2.23 112.904 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 t -140.86 85.45 1.99 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.375 -0.602 . . . . 3.28 109.375 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.32 -132.1 11.44 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.542 -0.837 . . . . 1.93 111.724 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 44' ' ' SER . 48.7 m-85 -119.99 -31.5 4.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.173 0.511 . . . . 1.82 110.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.42 68.05 1.2 Allowed Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.327 -0.851 . . . . 0.96 113.245 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -156.92 151.89 26.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.753 -0.462 . . . . 0.4 109.753 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.9 m120 -101.45 135.35 43.11 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.194 -0.669 . . . . 2.23 109.194 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -101.29 151.18 22.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.045 0.45 . . . . 2.11 111.352 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -108.9 122.1 46.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.78 -0.646 . . . . 2.02 110.1 -177.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 109.881 -0.414 . . . . 2.75 109.881 176.735 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.491 ' HG3' HG21 ' A' ' 73' ' ' VAL . 23.0 mm-40 . . . . . 0 CA--C 1.517 -0.29 0 N-CA-C 109.466 -0.568 . . . . 1.5 109.466 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.2 m-85 -119.96 157.79 28.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.737 -0.468 . . . . 0.99 109.737 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.498 HG13 HD12 ' A' ' 51' ' ' LEU . 47.5 mm -91.21 109.89 21.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.29 0.566 . . . . 1.12 109.541 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 28.5 ttt180 -63.15 -48.19 79.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.93 -1.032 . . . . 3.48 109.892 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -162.36 160.34 26.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.571 -0.9 . . . . 1.82 108.571 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.58 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.417 -0.586 . . . . 1.11 109.417 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.45 125.84 89.4 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.877 -0.416 . . . . 2.28 109.877 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 141.85 97.92 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.747 2.298 . . . . 1.27 112.069 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 64.59 49.86 2.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.756 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 95.6 p -126.88 158.62 67.89 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.795 -0.639 . . . . 0.68 110.234 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.99 -27.86 80.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.257 1.971 . . . . 0.87 111.147 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' HE3' ' A' ' 15' ' ' MET . . . -64.79 -51.97 59.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.018 -0.537 . . . . 1.17 110.465 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.49 -38.23 90.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.286 -0.415 . . . . 2.01 110.762 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.67 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 1.15 111.415 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 59.5 p -70.68 -14.47 62.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.896 0.379 . . . . 0.4 111.03 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.99 7.07 29.5 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.018 -0.61 . . . . 0.62 112.899 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.498 HD12 HG13 ' A' ' 37' ' ' ILE . 19.7 tp -76.61 130.51 37.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.546 0.212 . . . . 1.12 110.579 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.16 -163.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 5.17 110.951 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.56 140.02 29.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.474 . . . . 1.44 111.207 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 70.34 15.85 7.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.307 -0.86 . . . . 3.8 112.162 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.1 m-20 -69.48 128.39 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.986 -0.376 . . . . 1.02 109.986 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.5 123.79 36.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 2.26 110.583 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.16 124.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 1.37 110.793 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG13 ' HD2' ' A' ' 104' ' ' PRO . 43.1 t -105.29 -45.15 8.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.63 -0.714 . . . . 1.56 110.949 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.5 mt-10 -132.82 153.52 51.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.89 110.479 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -126.77 120.97 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.112 -0.495 . . . . 1.29 109.842 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 63.57 17.77 10.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.192 0.597 . . . . 1.17 111.205 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.501 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.8 4.62 65.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.66 112.528 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.88 128.69 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.66 0.267 . . . . 1.75 110.38 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.548 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.5 m -59.38 118.67 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.724 -0.671 . . . . 2.36 111.558 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.401 ' HE2' ' HB1' ' A' ' 76' ' ' ALA . 22.8 mmt -126.88 70.79 1.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 1.42 111.774 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -135.43 139.42 44.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.968 -0.382 . . . . 3.75 109.968 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.5 -0.46 89.25 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.938 -1.265 . . . . 1.78 109.938 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -74.2 163.56 27.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.15 -1.025 . . . . 3.73 111.724 -178.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.4 177.81 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.594 -0.891 . . . . 3.61 108.594 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -63.0 -37.85 88.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.841 0.353 . . . . 2.2 110.684 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.79 92.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.256 -0.497 . . . . 0.78 113.112 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.96 -47.55 80.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.958 0.409 . . . . 2.03 110.966 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 35' ' ' GLN . 3.4 m -71.81 -41.87 69.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.844 -0.616 . . . . 1.71 111.496 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.6 t -61.99 -48.14 89.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.637 -0.256 . . . . 1.37 110.75 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 t -62.47 -37.67 86.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.552 -0.295 . . . . 1.12 110.303 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' A' ' 65' ' ' MET . . . -62.49 -45.89 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.797 0.332 . . . . 1.09 111.468 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.95 -41.21 90.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 1.35 110.805 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 69.0 mtp180 -74.03 -35.71 64.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 3.55 111.091 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.17 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.458 -0.337 . . . . 1.28 110.938 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.19 -21.06 67.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.021 -0.609 . . . . 0.6 112.1 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -117.99 5.11 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.029 -0.605 . . . . 1.1 111.963 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.602 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 39.6 m-20 -113.97 8.89 17.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 2.12 110.876 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.06 160.22 42.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.11 -0.7 . . . . 2.11 109.11 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.3 t -153.19 148.81 27.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.861 0.362 . . . . 1.09 110.594 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HB3' HD13 ' A' ' 12' ' ' LEU . 6.9 mptt -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.389 -0.597 . . . . 2.25 109.389 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.29 133.77 49.5 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.801 -0.444 . . . . 1.04 109.801 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.3 tp -103.84 115.99 31.48 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.17 -0.678 . . . . 1.22 109.17 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 14.3 m -131.62 155.41 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.019 -0.537 . . . . 1.09 111.209 -173.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.72 146.95 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.411 -0.813 . . . . 1.08 110.331 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.06 176.85 6.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.793 -0.64 . . . . 1.92 109.396 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 ttm105 -56.4 -47.92 78.0 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.786 0.291 . . . . 4.87 111.786 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.72 -40.82 89.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.116 0.484 . . . . 2.68 110.819 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 -48.12 29.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.726 -0.67 . . . . 1.08 111.154 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.583 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 5.5 t0 -60.78 -43.43 98.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 1.18 110.307 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.33 -37.44 77.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.256 -0.429 . . . . 1.94 110.669 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.401 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 91.3 t80 -63.16 -47.39 82.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.83 110.296 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.403 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 64.3 m-85 -67.4 -37.12 82.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.266 -0.425 . . . . 0.55 111.71 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 58.4 mttm -58.56 -50.15 74.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.913 0.387 . . . . 2.5 110.821 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 96' ' ' PHE . 19.3 ptmt -69.7 -22.35 63.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.742 -0.663 . . . . 2.53 110.904 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.37 -16.41 37.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.563 . . . . 2.19 111.072 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.07 37.18 18.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.489 -0.778 . . . . 4.83 111.393 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.54 138.18 50.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.891 0.376 . . . . 2.08 110.688 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 70.0 mt -77.85 131.66 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 1.99 110.748 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 5.9 Cg_exo -70.54 153.43 65.34 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.946 2.431 . . . . 0.86 111.881 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.9 p -158.19 178.39 10.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.592 -0.277 . . . . 1.92 110.398 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.544 ' HA ' ' CD2' ' A' ' 109' ' ' LEU . 2.7 mp0 -55.61 -38.01 68.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 1.87 110.722 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.91 -31.28 69.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.248 0.547 . . . . 2.82 110.965 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -83.04 -25.48 32.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.71 111.584 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 109' ' ' LEU . 4.4 pp -95.34 -28.87 14.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.769 -0.651 . . . . 1.47 110.959 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -93.42 -23.79 18.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 4.09 110.034 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.51 -145.72 9.71 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.923 -0.656 . . . . 1.39 112.299 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.78 169.01 2.51 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.151 2.568 . . . . 1.65 112.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.709 -0.678 . . . . 1.75 110.095 176.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.474 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 88.6 mt . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 121.635 0.731 . . . . 1.36 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 109' ' ' LEU . 14.2 ptt180 -123.78 147.89 54.86 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.022 -0.99 . . . . 3.51 109.025 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HB2' HD11 ' A' ' 87' ' ' LEU . 30.8 Cg_endo -68.52 149.62 74.52 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.586 1.524 . . . . 0.81 110.798 172.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -120.6 135.49 55.08 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.283 -0.417 . . . . 2.82 110.25 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -92.68 111.25 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.957 -0.565 . . . . 1.96 110.159 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.29 117.61 30.37 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.517 -0.765 . . . . 1.17 109.368 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.65 HG22 ' HG2' ' A' ' 85' ' ' LYS . 27.0 m -109.57 119.05 38.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.685 -0.487 . . . . 1.13 109.685 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.449 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 24.4 ptp -131.33 133.59 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.04 0.447 . . . . 1.08 111.003 -174.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -97.9 132.63 43.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.871 -0.604 . . . . 3.11 109.421 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 20.6 ttmt -50.67 129.21 22.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.925 -0.58 . . . . 1.5 111.517 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.97 -158.42 24.36 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.771 -0.728 . . . . 1.28 111.588 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.74 -27.46 44.57 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.06 2.507 . . . . 2.23 112.642 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 p -105.16 13.87 30.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.039 -0.528 . . . . 3.28 110.563 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.06 2.73 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.615 -0.803 . . . . 1.93 111.182 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.409 ' HH ' ' HB2' ' A' ' 17' ' ' LYS . 37.2 m-85 -131.39 159.95 36.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.488 -0.93 . . . . 1.82 108.488 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.78 75.17 0.4 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 119.883 -1.151 . . . . 0.96 113.298 -173.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.03 168.77 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.849 0.357 . . . . 0.4 110.54 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -131.53 143.27 50.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.914 -0.585 . . . . 2.23 110.552 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.56 145.17 30.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.484 0.659 . . . . 2.11 111.835 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.608 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -110.65 129.38 55.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 2.02 109.426 172.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.317 -0.831 0 N-CA-C 108.58 -0.896 . . . . 2.75 108.58 175.018 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.554 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 2.7 mp0 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.961 -0.385 . . . . 1.5 109.961 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.608 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 61.6 m-85 -117.61 157.67 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.551 -0.907 . . . . 0.99 108.551 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.509 HG13 HD11 ' A' ' 51' ' ' LEU . 44.2 mm -90.91 109.43 20.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.598 -0.441 . . . . 1.12 109.834 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -69.12 -54.63 13.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.889 -0.596 . . . . 3.48 110.547 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -152.36 144.1 23.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.709 -0.678 . . . . 1.82 109.912 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.77 137.89 55.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.732 -0.47 . . . . 1.11 109.732 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -82.05 122.96 80.1 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.563 0.22 . . . . 2.28 110.544 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -65.01 -19.68 63.78 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.867 2.378 . . . . 1.27 112.538 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.78 4.51 52.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.913 -0.585 . . . . 2.4 110.633 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 38.8 p -108.86 158.78 33.24 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 122.104 -0.372 . . . . 0.68 110.783 -174.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 28.3 Cg_endo -63.06 -15.97 51.36 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.798 2.332 . . . . 0.87 112.033 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.69 -51.51 48.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.096 -0.502 . . . . 1.17 110.328 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HG3' ' HA ' ' A' ' 42' ' ' PRO . 4.4 tm-20 -64.48 -40.65 96.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.918 -0.771 . . . . 2.01 108.918 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.36 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 1.15 111.966 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 15' ' ' MET . 60.3 p -77.32 -12.54 59.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.4 110.898 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.25 9.44 27.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.783 -0.723 . . . . 0.62 112.734 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.509 HD11 HG13 ' A' ' 37' ' ' ILE . 29.9 tp -78.17 141.58 38.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.727 0.298 . . . . 1.12 110.497 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.8 tpp180 -143.63 164.82 29.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.383 -0.599 . . . . 5.17 109.383 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.57 152.97 40.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.603 -0.271 . . . . 1.44 111.231 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 74.64 11.32 3.92 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.061 0.851 . . . . 3.8 112.135 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 17.9 m-20 -92.08 151.97 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.774 -0.454 . . . . 1.02 109.774 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -105.54 136.61 44.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.51 -0.313 . . . . 2.26 110.666 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.65 130.15 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 1.37 110.151 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.768 HG13 ' HG2' ' A' ' 104' ' ' PRO . 22.7 t -114.37 -47.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 1.56 111.057 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.5 mt-10 -126.29 148.82 49.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.887 0.375 . . . . 0.89 110.928 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.497 ' O ' HG11 ' A' ' 63' ' ' VAL . 61.8 t -129.41 122.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 1.29 109.206 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 62.87 21.09 12.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.785 0.434 . . . . 1.17 111.056 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.3 74.73 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.733 -0.746 . . . . 0.66 113.382 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 60' ' ' VAL . 14.6 p -107.61 138.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.38 0.59 . . . . 1.75 110.111 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 50.9 t -74.5 136.81 42.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 2.36 111.434 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.589 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 25.1 mmt -121.62 68.06 0.9 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.447 -0.797 . . . . 1.42 111.128 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -103.69 -59.15 1.77 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.324 -0.398 . . . . 3.75 110.517 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.62 4.74 Favored Glycine 0 C--N 1.329 0.182 0 N-CA-C 111.548 -0.621 . . . . 1.78 111.548 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.589 ' HG2' ' HB3' ' A' ' 65' ' ' MET . 0.0 OUTLIER -110.94 -172.19 1.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.782 0.801 . . . . 3.73 112.722 -171.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -121.46 150.0 42.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 3.61 108.287 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -56.21 -43.7 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 118.267 0.485 . . . . 2.2 110.162 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.66 88.15 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.696 -0.684 . . . . 0.78 112.668 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.92 -40.03 83.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 2.03 110.362 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 77' ' ' ILE . 63.9 t -65.29 -47.34 87.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.614 . . . . 1.71 110.825 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' HA ' HD13 ' A' ' 77' ' ' ILE . 57.6 t -64.9 -36.78 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.21 0.529 . . . . 1.37 110.071 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 t -61.58 -44.41 97.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.594 -0.73 . . . . 1.12 110.163 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.82 -42.54 93.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.239 -0.437 . . . . 1.09 111.227 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.491 HG21 HG22 ' A' ' 84' ' ' THR . 74.4 mt -58.9 -40.75 81.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 1.35 110.773 177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 mtm-85 -74.18 -39.36 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 3.55 110.976 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.68 10.47 9.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 1.28 111.609 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.74 -33.77 74.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.207 -0.52 . . . . 0.6 112.68 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.68 49.93 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 1.1 111.63 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.619 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 32.2 m-20 67.54 1.57 2.6 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.574 0.749 . . . . 2.12 112.485 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -151.6 154.28 36.13 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.825 -0.805 . . . . 2.11 108.825 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.491 HG22 HG21 ' A' ' 77' ' ' ILE . 12.9 t -141.51 148.11 38.86 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.04 0.448 . . . . 1.09 110.134 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.65 ' HG2' HG22 ' A' ' 14' ' ' THR . 42.2 mttm -118.78 116.92 27.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.511 -0.551 . . . . 2.25 109.511 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.6 mt -106.53 131.27 53.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.434 -0.348 . . . . 1.04 110.128 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 10' ' ' PRO . 16.6 tp -103.79 117.12 33.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.934 -0.765 . . . . 1.22 108.934 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 20.7 m -126.75 151.81 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.142 0.496 . . . . 1.09 111.72 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.56 149.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.082 -0.963 . . . . 1.08 109.717 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.243 -0.651 . . . . 1.92 109.243 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -60.41 -43.89 96.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.89 0.33 . . . . 4.87 111.89 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.08 -35.69 78.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.433 . . . . 2.68 109.83 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 8' ' ' LEU . 89.6 m -69.3 -44.44 71.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 1.08 110.832 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.635 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 33.7 t0 -58.77 -47.71 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.938 -0.393 . . . . 1.18 109.938 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 50.1 mm-40 -61.1 -37.96 84.6 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.058 -0.519 . . . . 1.94 110.823 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.716 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 66.6 t80 -62.11 -48.0 82.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.175 -0.466 . . . . 0.83 110.672 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CD2' HG12 ' A' ' 102' ' ' VAL . 41.8 m-85 -67.34 -37.19 82.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.953 -0.567 . . . . 0.55 111.799 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 66.2 mttm -58.86 -50.82 72.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.051 0.453 . . . . 2.5 111.385 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 18.9 pttp -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 2.53 111.367 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.499 ' HB3' HG13 ' A' ' 102' ' ' VAL . 35.4 t -82.4 -6.61 59.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.862 0.363 . . . . 2.19 111.539 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER 56.68 40.65 29.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.638 -0.71 . . . . 4.83 111.677 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' A' ' 97' ' ' PHE . 5.7 p -126.46 145.12 34.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.357 -0.383 . . . . 2.08 110.492 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.38 121.66 67.21 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-O 120.979 0.419 . . . . 1.99 111.113 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.768 ' HG2' HG13 ' A' ' 58' ' ' VAL . 24.4 Cg_endo -65.71 138.53 54.16 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.537 2.158 . . . . 0.86 111.223 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.432 ' HG ' ' CD ' ' A' ' 59' ' ' GLU . 25.1 t -159.62 178.28 10.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.783 -0.451 . . . . 1.92 109.783 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.52 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 99.3 mt-30 -54.75 -30.46 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.301 0.572 . . . . 1.87 110.859 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.84 -30.39 67.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.616 -0.72 . . . . 2.82 111.465 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -89.02 -14.0 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.482 0.549 . . . . 0.71 112.482 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 95.8 mt -47.74 -54.54 11.9 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.348 0.405 . . . . 1.47 111.492 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -132.36 26.63 4.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.971 0.891 . . . . 4.09 109.442 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.95 165.75 23.22 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.016 -0.993 . . . . 1.39 110.776 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.74 124.9 12.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.221 1.947 . . . . 1.65 112.172 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.197 -0.668 . . . . 1.75 109.197 174.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 54.8 mt . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.29 0.567 . . . . 1.36 110.606 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -119.82 156.26 54.24 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 3.51 108.938 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HB2' HD11 ' A' ' 87' ' ' LEU . 65.6 Cg_endo -71.58 -174.3 1.23 Allowed 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.356 2.038 . . . . 0.81 112.146 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HG3' HG22 ' A' ' 88' ' ' VAL . 15.6 ptt85 -146.65 135.36 22.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.82 110.848 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HG ' HD12 ' A' ' 109' ' ' LEU . 7.3 mt -92.85 121.7 34.49 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.542 . . . . 1.96 110.849 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.0 m -109.1 129.1 55.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.002 -0.544 . . . . 1.17 109.601 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -112.37 118.53 35.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.731 -0.47 . . . . 1.13 109.731 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.475 ' HE2' HD21 ' A' ' 51' ' ' LEU . 25.1 ptp -130.44 142.48 50.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.013 -0.365 . . . . 1.08 110.013 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 14.5 ptpt -121.12 156.52 32.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.003 0.43 . . . . 3.11 110.123 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 8.7 ttmt -61.37 117.17 5.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.797 -1.092 . . . . 1.5 111.651 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.66 -149.29 9.17 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.53 -0.759 . . . . 1.28 112.181 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.83 -33.07 27.98 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.676 2.251 . . . . 2.23 113.258 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -110.27 -21.09 12.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.17 0.509 . . . . 3.28 110.589 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.62 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 144.59 -116.3 0.93 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.131 -0.787 . . . . 1.93 111.131 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.26 160.71 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.72 -0.844 . . . . 1.82 108.72 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.14 71.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.599 -1.286 . . . . 0.96 113.462 -171.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -155.63 150.88 26.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.986 -0.376 . . . . 0.4 109.986 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.15 131.94 54.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 2.23 109.61 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.2 mt -101.3 136.93 40.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.367 -0.379 . . . . 2.11 110.414 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.1 p80 -124.47 125.17 43.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.116 0.484 . . . . 2.02 110.48 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.711 ' HB3' HE22 ' A' ' 35' ' ' GLN . 4.4 p . . . . . 0 C--N 1.32 -0.716 0 CA-C-N 115.338 -0.846 . . . . 2.75 110.692 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.711 HE22 ' HB3' ' A' ' 28' ' ' SER . 26.3 mm-40 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 110.029 -0.36 . . . . 1.5 110.029 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.494 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 41.0 m-85 -122.04 147.58 45.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.979 -0.748 . . . . 0.99 108.979 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.526 HG13 HD13 ' A' ' 51' ' ' LEU . 39.1 mm -77.39 105.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.445 -0.576 . . . . 1.12 109.445 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 49.1 ttt180 -75.12 -45.68 39.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.567 . . . . 3.48 110.027 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -149.19 146.35 27.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 1.82 109.474 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.9 132.37 71.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.805 -0.813 . . . . 1.11 108.805 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.49 126.28 92.23 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.858 -0.61 . . . . 2.28 110.693 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.45 124.03 15.27 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.657 2.238 . . . . 1.27 112.595 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 64.42 36.08 9.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.177 -0.92 . . . . 2.4 111.371 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 94.5 p -97.65 165.67 15.09 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.76 -0.654 . . . . 0.68 109.402 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 12.8 Cg_endo -58.63 -25.6 75.69 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.829 1.686 . . . . 0.87 111.276 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.42 -52.35 22.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.756 -0.656 . . . . 1.17 110.409 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.85 -36.0 82.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.811 0.338 . . . . 2.01 110.457 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.82 65.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 1.15 112.016 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -80.98 -13.45 58.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.966 0.412 . . . . 0.4 110.51 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 26.6 6.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.855 -0.612 . . . . 0.62 112.409 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 37' ' ' ILE . 28.1 tp -94.9 133.25 38.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 1.12 110.473 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 54' ' ' GLN . 13.1 tpp180 -122.49 158.8 29.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.738 -0.467 . . . . 5.17 109.738 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.16 29.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.043 0.386 . . . . 1.44 112.043 -174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 52' ' ' ARG . 12.2 mm100 -132.99 1.17 3.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 3.8 109.707 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 35.7 m-20 -88.29 154.35 20.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.556 -0.747 . . . . 1.02 111.235 -171.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 18.4 ttm180 -116.54 135.04 54.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.407 -0.59 . . . . 2.26 109.407 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.99 123.13 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.65 -0.5 . . . . 1.37 109.65 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.86 -44.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.251 -0.431 . . . . 1.56 110.42 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 34.9 mt-10 -134.48 143.53 47.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.89 110.029 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.96 117.75 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.685 -0.487 . . . . 1.29 109.685 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.59 30.29 19.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.48 0.487 . . . . 1.17 110.945 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 -6.17 79.29 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.068 -0.587 . . . . 0.66 112.974 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -95.88 124.15 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 0.231 . . . . 1.75 110.557 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.54 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.2 t -66.22 136.93 56.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 2.36 111.188 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.438 ' HA ' ' CG ' ' A' ' 68' ' ' LYS . 21.4 mmt -118.09 2.22 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 1.42 111.82 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 97.88 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.357 -0.608 . . . . 3.75 109.357 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.88 12.94 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.78 111.659 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.438 ' CG ' ' HA ' ' A' ' 65' ' ' MET . 34.7 mmtp -84.01 166.78 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 3.73 110.877 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -94.29 174.21 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.645 . . . . 3.61 110.83 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -57.53 -43.06 84.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 2.2 110.359 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.04 96.77 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.78 113.549 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.51 -40.61 76.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.605 0.241 . . . . 2.03 110.897 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.65 -47.26 92.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 1.71 110.552 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.48 -42.31 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 1.37 110.881 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -61.53 -39.94 92.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 1.12 110.941 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.83 94.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 1.09 111.755 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.423 HG21 HG23 ' A' ' 84' ' ' THR . 72.4 mt -60.26 -45.18 96.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.231 0.539 . . . . 1.35 110.075 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -66.0 -30.95 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.608 -0.723 . . . . 3.55 110.895 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.23 -5.53 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.721 -0.672 . . . . 1.28 111.318 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.28 79.17 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.554 -0.831 . . . . 0.6 111.478 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.32 -100.4 2.08 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.106 -0.568 . . . . 1.1 111.9 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.526 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 18.8 m-20 -119.23 -27.66 5.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.648 0.261 . . . . 2.12 110.795 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.6 mt-10 -120.15 139.81 52.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.299 -1.0 . . . . 2.11 108.299 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.423 HG23 HG21 ' A' ' 77' ' ' ILE . 13.8 t -138.02 149.65 46.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.818 0.342 . . . . 1.09 110.954 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 121.08 42.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.149 -0.478 . . . . 2.25 110.477 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.3 mt -107.14 135.65 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.156 -0.475 . . . . 1.04 109.889 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.5 tp -104.24 119.34 38.74 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.202 -0.666 . . . . 1.22 109.202 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.0 m -126.95 163.31 29.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.231 -0.44 . . . . 1.09 111.08 -175.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.99 149.54 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 1.08 111.229 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -90.41 175.57 7.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 1.92 110.117 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 91' ' ' ARG . 25.2 ttm180 -58.48 -48.98 78.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 4.87 111.045 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 5.1 mp0 -63.8 -41.01 97.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 2.68 110.203 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 m -62.04 -51.42 68.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 1.08 110.471 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.23 -43.86 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.137 -0.938 . . . . 1.18 111.708 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 13.6 mm-40 -60.42 -45.68 92.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.207 -0.451 . . . . 1.94 110.738 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -63.09 -47.63 82.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.495 0.497 . . . . 0.83 111.336 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -65.89 -40.45 91.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.487 -0.324 . . . . 0.55 111.613 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -66.17 -44.59 83.62 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.988 -0.285 . . . . 2.5 111.615 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.3 ptmt -70.27 -26.53 63.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.635 0.255 . . . . 2.53 111.087 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.5 t -93.75 -3.56 51.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.345 0.593 . . . . 2.19 110.395 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.54 47.2 13.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.11 -0.95 . . . . 4.83 110.918 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.82 137.9 53.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 2.08 110.204 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 55.5 mt -88.99 125.49 62.24 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.985 -0.376 . . . . 1.99 109.985 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 27.6 Cg_exo -61.9 154.23 62.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.97 2.447 . . . . 0.86 112.07 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.7 p -163.46 167.21 21.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.612 -0.267 . . . . 1.92 111.142 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -57.47 -29.3 64.13 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.732 0.645 . . . . 1.87 111.405 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.44 -34.23 70.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 2.82 110.49 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -75.8 -14.6 60.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.024 -0.989 . . . . 0.71 111.101 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.57 HD12 ' HG ' ' A' ' 12' ' ' LEU . 89.5 mt -73.92 -32.51 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 1.47 110.776 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.14 -36.65 74.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 4.09 111.866 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.44 -80.69 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.558 -1.306 . . . . 1.39 113.863 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.0 132.83 29.21 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.223 2.615 . . . . 1.65 114.386 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 114.846 -1.07 . . . . 1.75 108.912 171.112 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 96' ' ' PHE . 71.6 mt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.96 0.41 . . . . 1.36 111.617 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.512 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 27.5 ptt180 -125.96 154.21 73.78 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.975 -0.38 . . . . 3.51 109.975 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 48.4 Cg_endo -64.73 178.85 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.018 2.479 . . . . 0.81 113.231 -172.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.644 HH12 ' HB3' ' A' ' 90' ' ' ASP . 7.8 ptp85 -137.76 131.98 32.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.988 -0.551 . . . . 2.82 110.304 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HG ' HD11 ' A' ' 109' ' ' LEU . 4.7 mt -93.59 111.01 22.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.96 110.169 176.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 37.2 m -94.68 116.92 29.33 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.489 -0.56 . . . . 1.17 109.489 177.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -105.96 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.675 -0.861 . . . . 1.13 108.675 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.465 ' HE1' HD21 ' A' ' 51' ' ' LEU . 24.9 ptp -135.73 134.92 39.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.953 0.406 . . . . 1.08 110.806 -171.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 23.0 ttpp -92.49 147.09 23.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 3.11 109.209 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 ttmt -59.62 123.46 16.98 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.129 -0.487 . . . . 1.5 111.559 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.51 -157.36 21.51 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.389 -0.684 . . . . 1.28 111.389 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.26 -36.68 27.23 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.159 2.573 . . . . 2.23 113.233 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -93.8 21.29 6.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 3.28 111.595 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.32 69.68 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.597 -0.811 . . . . 1.93 111.273 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 74.89 -50.8 0.67 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.662 0.785 . . . . 1.82 110.739 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 69.66 0.93 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.151 -0.547 . . . . 0.96 113.347 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.33 168.88 25.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.013 -0.365 . . . . 0.4 110.013 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.495 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 20.0 t-20 -133.76 127.19 32.24 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 2.23 109.699 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.31 143.78 30.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.232 -0.44 . . . . 2.11 110.632 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 36' ' ' PHE . 2.6 p80 -125.89 130.7 51.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.8 -0.445 . . . . 2.02 109.8 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 115.618 -0.719 . . . . 2.75 109.844 -177.808 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.778 0.323 . . . . 1.5 110.687 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.544 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 31.1 m-85 -114.27 142.99 45.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.384 -0.599 . . . . 0.99 109.384 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.516 HG13 HD12 ' A' ' 51' ' ' LEU . 32.9 mm -74.32 106.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.43 -0.582 . . . . 1.12 109.43 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 52.0 ttt180 -69.65 -51.85 31.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.75 -0.659 . . . . 3.48 110.382 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -163.32 135.38 5.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.985 -0.552 . . . . 1.82 110.309 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.5 134.29 37.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.43 -0.952 . . . . 1.11 108.43 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.2 m-20 -64.67 128.09 93.15 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.956 -0.387 . . . . 2.28 109.956 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 52.4 Cg_exo -54.54 130.02 37.91 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.171 2.581 . . . . 1.27 113.182 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.61 38.37 12.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.357 -0.838 . . . . 2.4 110.81 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -97.76 164.7 16.94 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.13 -0.486 . . . . 0.68 109.693 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.85 -34.17 90.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.751 1.634 . . . . 0.87 111.125 172.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.84 -46.39 85.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.826 -0.624 . . . . 1.17 110.244 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.27 -43.47 98.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.014 -0.539 . . . . 2.01 110.337 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.85 63.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 1.15 111.988 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.529 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.7 p -76.39 -14.83 60.05 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.4 110.526 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.12 9.07 24.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.782 -0.723 . . . . 0.62 112.333 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 HD12 HG13 ' A' ' 37' ' ' ILE . 37.1 tp -79.79 128.06 32.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.85 0.357 . . . . 1.12 110.115 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -123.42 -170.53 2.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.061 -0.518 . . . . 5.17 110.222 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -95.65 151.65 19.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.673 -0.694 . . . . 1.44 110.29 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 54.7 mt-30 73.02 25.05 2.41 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.825 0.703 . . . . 3.8 110.96 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -95.81 155.25 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.243 -0.651 . . . . 1.02 109.243 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.43 ' NH1' HG21 ' A' ' 58' ' ' VAL . 8.0 tmm_? -124.69 129.55 50.72 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.603 -0.517 . . . . 2.26 109.603 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.519 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.3 mt -73.41 132.06 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.535 . . . . 1.37 111.605 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 104' ' ' PRO . 21.4 t -113.97 -47.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.415 -0.811 . . . . 1.56 110.443 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.1 mt-10 -132.8 149.51 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.89 110.644 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.81 117.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 1.29 109.637 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 57.24 34.21 24.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.986 -0.552 . . . . 1.17 111.041 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.535 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 89.43 -4.63 84.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.925 -0.655 . . . . 0.66 113.084 176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.84 127.21 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.96 -0.385 . . . . 1.75 109.96 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 41.8 t -74.25 135.39 42.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.992 0.425 . . . . 2.36 110.369 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.789 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.5 mmt -116.79 30.15 7.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 1.42 110.415 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 103' ' ' ILE . 21.5 tp10 -70.51 -34.42 72.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 3.75 110.943 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.11 -0.45 28.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.645 -0.788 . . . . 1.78 112.305 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.789 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.3 mmtp -71.95 168.73 17.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.762 0.792 . . . . 3.73 112.791 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -106.12 169.81 8.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.518 -1.219 . . . . 3.61 109.844 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -54.42 -43.93 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 2.2 111.597 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.42 85.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.128 -0.558 . . . . 0.78 113.387 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.97 -42.63 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.021 0.438 . . . . 2.03 110.34 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 65' ' ' MET . 59.0 t -68.26 -47.18 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 1.71 111.174 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.1 -38.55 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 1.37 111.048 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -67.94 -36.69 80.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.408 -0.36 . . . . 1.12 110.497 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.446 -0.343 . . . . 1.09 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.526 HG21 HG21 ' A' ' 84' ' ' THR . 78.6 mt -58.38 -42.06 83.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.446 0.641 . . . . 1.35 110.41 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -74.6 -31.69 62.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 3.55 111.44 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 5.48 18.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 1.28 111.325 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -13.37 83.23 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.682 -0.771 . . . . 0.6 112.009 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -111.43 3.1 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.981 -0.628 . . . . 1.1 111.699 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.431 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 14.0 m-20 -115.03 -6.64 12.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.908 0.385 . . . . 2.12 110.503 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -143.8 157.01 44.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.594 . . . . 2.11 109.622 173.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.526 HG21 HG21 ' A' ' 77' ' ' ILE . 11.9 t -137.57 149.73 46.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 1.09 110.072 -175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -115.63 116.85 28.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.126 -0.488 . . . . 2.25 109.796 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.0 mt -107.85 130.92 54.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.908 -0.587 . . . . 1.04 109.836 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 10' ' ' PRO . 20.8 tp -104.59 115.21 29.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.814 -0.81 . . . . 1.22 108.814 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.5 m -127.54 159.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.191 -0.459 . . . . 1.09 111.377 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.39 150.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.734 . . . . 1.08 110.031 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.644 ' HB3' HH12 ' A' ' 11' ' ' ARG . 4.3 p30 -88.85 176.51 7.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 1.92 109.975 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.5 ttp180 -55.78 -49.99 71.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.755 0.65 . . . . 4.87 112.755 -172.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.532 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 14.2 pt-20 -74.85 -34.35 62.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 2.68 111.139 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.9 m -64.9 -41.92 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.02 -0.537 . . . . 1.08 110.12 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 33.2 t70 -62.49 -38.05 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.608 . . . . 1.18 109.963 177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 48.0 mt-10 -67.2 -35.52 79.79 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.144 -0.48 . . . . 1.94 110.745 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.851 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 59.7 t80 -62.99 -49.62 73.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.896 0.379 . . . . 0.83 110.318 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 27.8 m-85 -68.14 -38.86 82.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.911 -0.586 . . . . 0.55 112.06 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.706 ' HZ1' ' HB3' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -64.61 -48.91 73.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.848 0.314 . . . . 2.5 111.848 -176.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.851 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 22.4 pttp -67.63 -34.18 76.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.113 0.483 . . . . 2.53 110.427 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 67.8 m -75.22 -8.69 57.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.511 -0.768 . . . . 2.19 112.048 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 55.86 32.82 20.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.312 0.645 . . . . 4.83 111.734 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 97' ' ' PHE . 5.8 p -120.36 142.1 37.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.251 -0.431 . . . . 2.08 110.228 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.538 HD12 ' HG2' ' A' ' 66' ' ' GLU . 45.9 mm -86.75 127.28 60.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 1.99 110.625 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.594 ' HB2' HG13 ' A' ' 58' ' ' VAL . 16.9 Cg_exo -65.55 155.13 70.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.824 2.349 . . . . 0.86 111.37 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.7 p -169.06 168.41 10.07 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.554 -0.459 . . . . 1.92 111.807 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.535 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 40.0 mt-30 -57.0 -29.42 63.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 1.87 111.273 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.93 -32.71 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.272 0.558 . . . . 2.82 110.34 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -77.86 -13.7 59.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.71 111.164 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.552 HD11 ' HG ' ' A' ' 12' ' ' LEU . 86.1 mt -75.19 -40.62 59.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 1.47 111.126 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -106.28 13.03 29.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.199 0.523 . . . . 4.09 110.521 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.62 -172.1 12.42 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.827 -0.701 . . . . 1.39 111.82 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -88.97 -179.59 2.16 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.213 2.609 . . . . 1.65 112.258 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 9' ' ' ARG . 53.7 mt . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.09 -0.504 . . . . 1.75 109.761 175.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.264 0.554 . . . . 1.36 110.59 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -126.54 157.02 72.18 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 3.51 109.433 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HB2' HD13 ' A' ' 87' ' ' LEU . 44.4 Cg_endo -70.15 174.73 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.328 2.019 . . . . 0.81 111.782 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HG3' HG22 ' A' ' 88' ' ' VAL . 7.0 ptp85 -132.02 130.6 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.261 -0.427 . . . . 2.82 110.162 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.9 118.1 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 1.96 110.182 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.414 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 12.8 m -108.88 117.49 34.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.215 -0.448 . . . . 1.17 110.305 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -108.9 117.55 34.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.225 -1.028 . . . . 1.13 108.225 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.476 ' HE3' HD21 ' A' ' 51' ' ' LEU . 23.0 ptp -131.15 144.63 51.52 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.744 -0.383 . . . . 1.08 111.164 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HG3' ' HG2' ' A' ' 83' ' ' GLU . 7.5 ttmm -118.89 146.0 45.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.614 -0.721 . . . . 3.11 109.705 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 85.5 mttt -56.32 119.47 6.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.361 -0.836 . . . . 1.5 112.188 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.37 -111.0 3.1 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.575 -1.193 . . . . 1.28 112.282 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.49 -74.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.243 2.629 . . . . 2.23 112.669 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -132.93 83.85 2.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 3.28 110.495 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.97 71.29 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.004 -0.617 . . . . 1.93 112.535 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.543 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 36.2 m-85 67.23 -87.3 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.047 0.539 . . . . 1.82 110.774 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.45 70.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.625 -0.798 . . . . 0.96 112.646 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.94 151.91 26.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.4 109.271 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.24 123.65 45.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.207 -0.664 . . . . 2.23 109.207 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 35' ' ' GLN . 30.3 tp -108.77 146.14 34.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.058 -0.519 . . . . 2.11 109.62 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.45 149.25 27.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.624 -0.43 . . . . 2.02 111.435 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 109.166 -0.679 . . . . 2.75 109.166 174.12 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HB3' HD12 ' A' ' 26' ' ' LEU . 27.6 mm-40 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.13 -0.322 . . . . 1.5 110.13 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -109.92 140.59 43.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.99 110.554 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.509 HG13 HD13 ' A' ' 51' ' ' LEU . 36.9 mm -81.21 105.76 11.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.846 -0.798 . . . . 1.12 108.846 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.02 -55.28 19.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.507 . . . . 3.48 110.106 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 m -157.87 137.77 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.854 -0.612 . . . . 1.82 109.482 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.31 133.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.145 -0.687 . . . . 1.11 109.145 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.82 128.92 92.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.014 -0.539 . . . . 2.28 109.774 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 125.41 19.02 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.753 2.302 . . . . 1.27 113.063 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 63.14 43.46 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.934 -1.03 . . . . 2.4 110.76 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.6 p -102.64 165.3 13.99 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.592 . . . . 0.68 110.639 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 31.6 Cg_exo -56.11 -34.38 92.68 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.888 1.725 . . . . 0.87 111.168 172.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.31 86.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.596 -0.729 . . . . 1.17 110.186 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -61.06 -42.44 98.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 2.01 110.132 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.37 -30.02 68.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.817 -0.629 . . . . 1.15 112.069 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.2 p -70.96 -20.0 62.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.368 . . . . 0.4 110.626 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.19 9.7 15.03 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.792 -0.718 . . . . 0.62 112.803 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.509 HD13 HG13 ' A' ' 37' ' ' ILE . 27.9 tp -69.33 125.17 25.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 1.12 110.685 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 30.5 ttm180 -103.85 147.89 26.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.804 -0.634 . . . . 5.17 109.918 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -74.77 144.21 43.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 1.44 110.092 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 15.4 mm-40 78.87 5.88 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.099 0.875 . . . . 3.8 111.31 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -85.12 149.93 25.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.693 -0.484 . . . . 1.02 109.693 176.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 56' ' ' ARG . 34.9 ttp180 -111.87 137.48 49.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 2.26 110.258 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.42 ' HA ' HG13 ' A' ' 88' ' ' VAL . 65.2 mt -74.56 128.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.985 -0.552 . . . . 1.37 110.627 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.407 HG22 HD23 ' A' ' 87' ' ' LEU . 19.0 m -112.42 -32.89 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 1.56 111.21 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 27.4 mt-10 -134.38 142.85 47.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.89 110.833 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' HB ' ' HE1' ' A' ' 65' ' ' MET . 89.8 t -124.56 120.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 1.29 109.797 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 85' ' ' LYS . 73.8 m-20 58.68 24.57 12.31 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.088 0.555 . . . . 1.17 111.512 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.475 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.61 6.53 63.96 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.66 112.915 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.47 124.18 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 1.75 110.393 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.2 p -64.58 136.94 57.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.636 . . . . 2.36 111.215 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.694 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.1 mmt -123.68 50.99 1.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.968 -0.56 . . . . 1.42 111.074 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -36.11 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.922 -0.311 . . . . 3.75 111.514 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.38 -7.52 54.17 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.842 -0.694 . . . . 1.78 111.857 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.694 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.7 mmtp -70.71 149.16 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.223 0.535 . . . . 3.73 111.436 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -86.45 170.62 11.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.367 -0.833 . . . . 3.61 109.983 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -53.86 -43.52 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.657 0.265 . . . . 2.2 111.241 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.03 99.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.045 -0.598 . . . . 0.78 113.125 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 6.3 t70 -64.78 -43.97 91.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.913 0.387 . . . . 2.03 110.216 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 65' ' ' MET . 46.5 t -63.55 -46.86 93.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 1.71 111.015 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 97.7 t -66.68 -42.5 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.241 -0.436 . . . . 1.37 111.114 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -64.51 -38.27 90.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.46 -0.336 . . . . 1.12 110.387 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.09 93.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 1.09 111.135 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.485 HG21 HG22 ' A' ' 84' ' ' THR . 81.4 mt -61.15 -45.77 97.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.018 0.437 . . . . 1.35 110.621 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 29.6 mtm180 -66.15 -33.2 75.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 3.55 110.366 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.42 -0.36 36.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.952 -0.567 . . . . 1.28 111.501 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.26 85.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.606 -0.807 . . . . 0.6 111.695 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.29 -127.24 9.1 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.208 -0.757 . . . . 1.1 111.208 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 42.1 m-20 -96.73 -12.97 23.04 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.032 -0.267 . . . . 2.12 110.78 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.525 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -130.61 140.82 50.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.989 -0.375 . . . . 2.11 109.989 177.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.485 HG22 HG21 ' A' ' 77' ' ' ILE . 14.4 t -135.09 149.62 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.957 0.408 . . . . 1.09 110.36 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 61' ' ' ASN . 95.0 mttt -106.31 117.81 35.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.248 -0.433 . . . . 2.25 110.289 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.0 mt -111.53 124.91 53.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.145 -0.479 . . . . 1.04 109.815 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 34.8 tp -104.36 122.25 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.029 -0.73 . . . . 1.22 109.029 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 10.5 m -130.15 164.58 32.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.208 -0.451 . . . . 1.09 111.369 -174.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 m -136.72 145.79 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.658 -0.701 . . . . 1.08 110.874 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.72 167.74 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.548 -0.751 . . . . 1.92 109.473 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -56.59 -47.79 78.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.653 0.263 . . . . 4.87 111.22 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -63.45 -31.42 72.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.347 0.594 . . . . 2.68 110.086 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 m -76.54 -50.8 13.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 1.08 111.021 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.7 -47.67 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.865 -0.607 . . . . 1.18 111.656 -174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 31.7 mt-10 -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.721 -0.391 . . . . 1.94 110.767 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.38 -46.09 70.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.937 0.398 . . . . 0.83 110.356 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 102' ' ' VAL . 22.9 m-85 -64.34 -44.24 92.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.55 111.008 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -61.42 -45.33 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.561 0.578 . . . . 2.5 112.561 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 18.1 ptpt -65.47 -25.6 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 2.53 110.955 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.2 t -96.69 0.84 50.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 2.19 110.645 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? 64.63 31.27 12.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.028 -0.533 . . . . 4.83 111.716 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 35.0 t -109.82 139.6 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.491 -0.322 . . . . 2.08 110.416 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.35 125.95 50.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.93 -0.396 . . . . 1.99 109.93 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -65.62 139.53 58.68 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.464 2.11 . . . . 0.86 111.42 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -154.01 166.93 31.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 1.92 110.73 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.475 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 41.2 mt-30 -57.31 -31.98 66.21 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.441 0.463 . . . . 1.87 111.049 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.38 -30.78 70.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.441 -0.345 . . . . 2.82 111.3 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.37 -13.83 61.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.71 111.403 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.31 -25.43 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 1.47 111.2 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -130.4 -14.89 3.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.496 -0.32 . . . . 4.09 111.584 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.35 -177.11 34.44 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.866 -0.683 . . . . 1.39 112.438 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.41 124.26 10.65 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.131 2.554 . . . . 1.65 112.866 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 113' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.444 -0.762 0 CA-C-N 115.96 -0.564 . . . . 1.75 109.825 169.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.948 0.404 . . . . 1.36 110.901 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -119.7 147.02 42.94 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.322 -0.399 . . . . 3.51 109.998 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.578 ' HD2' ' HA ' ' A' ' 109' ' ' LEU . 2.9 Cg_exo -72.26 165.14 33.53 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.899 2.399 . . . . 0.81 111.358 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.771 ' HG3' HG23 ' A' ' 88' ' ' VAL . 5.5 ptt180 -122.9 131.0 53.54 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.663 -0.699 . . . . 2.82 110.627 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.06 113.3 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 1.96 110.03 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 30.5 m -96.87 128.74 44.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.832 -0.622 . . . . 1.17 110.22 -176.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -117.79 117.49 29.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.91 -0.774 . . . . 1.13 108.91 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.554 ' HE3' ' OG ' ' A' ' 49' ' ' SER . 22.5 ptp -142.21 142.55 32.67 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.181 -0.463 . . . . 1.08 110.194 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 43.4 pttt -119.34 152.53 36.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.311 0.577 . . . . 3.11 110.735 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.572 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.1 mtmt -55.55 110.45 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.347 -1.297 . . . . 1.5 112.601 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.09 -129.82 6.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.272 -0.876 . . . . 1.28 112.145 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.29 -75.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.35 2.7 . . . . 2.23 113.616 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -96.91 34.05 1.78 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.891 0.377 . . . . 3.28 111.329 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.572 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 71.77 83.86 0.23 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.585 -0.817 . . . . 1.93 111.755 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.454 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 39.3 m-85 68.07 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.268 0.627 . . . . 1.82 110.638 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.16 68.11 0.38 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.259 -0.496 . . . . 0.96 112.572 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -157.34 153.23 27.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.928 -0.397 . . . . 0.4 109.928 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.36 141.41 40.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 2.23 110.626 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 26' ' ' LEU . 48.6 mt -101.52 154.91 18.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.624 -0.716 . . . . 2.11 111.715 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 2.2 t-80 -105.67 141.81 36.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.188 -0.915 . . . . 2.02 110.459 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.943 -0.571 . . . . 2.75 110.454 -179.343 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.126 0.489 . . . . 1.5 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 38.9 m-85 -102.8 149.92 24.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.99 109.599 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.507 HG13 HD11 ' A' ' 51' ' ' LEU . 48.5 mm -84.45 105.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.645 -0.502 . . . . 1.12 109.645 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 38' ' ' ARG . 22.6 tpt85 -70.13 -39.75 75.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.693 -0.685 . . . . 3.48 110.033 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 p -165.73 152.2 9.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 1.82 109.825 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.08 128.63 74.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 1.11 109.348 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -70.86 135.88 85.41 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.327 -0.397 . . . . 2.28 110.672 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.84 143.1 78.73 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.886 2.391 . . . . 1.27 112.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 61.8 42.13 10.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.502 -0.772 . . . . 2.4 111.202 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.1 p -118.18 159.34 43.62 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 0.68 110.297 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 44.7 Cg_exo -51.15 -39.37 61.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.406 2.071 . . . . 0.87 111.419 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.3 -52.31 64.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.461 -0.791 . . . . 1.17 110.864 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -63.41 -39.63 95.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.171 -0.468 . . . . 2.01 110.601 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.06 77.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 1.15 111.866 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.554 ' OG ' ' HE3' ' A' ' 15' ' ' MET . 71.7 p -70.84 -13.69 62.13 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.982 0.42 . . . . 0.4 110.955 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.1 14.59 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.632 -0.794 . . . . 0.62 113.015 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.507 HD11 HG13 ' A' ' 37' ' ' ILE . 29.2 tp -76.02 123.83 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 1.12 110.297 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 52' ' ' ARG . 21.9 ttt180 -110.28 148.51 31.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.887 -0.597 . . . . 5.17 110.117 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -68.79 148.23 50.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.203 -0.453 . . . . 1.44 110.219 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 78.4 mt-30 78.62 0.7 2.54 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.194 0.934 . . . . 3.8 111.27 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 15.3 m-20 -78.58 143.43 36.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.726 0.298 . . . . 1.02 110.603 177.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttp-105 -104.69 133.52 49.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.824 0.345 . . . . 2.26 110.573 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.84 123.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.991 -0.549 . . . . 1.37 109.735 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.458 HG22 ' HG2' ' A' ' 104' ' ' PRO . 42.2 t -101.86 -46.55 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.268 0.556 . . . . 1.56 110.584 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 32.7 mt-10 -129.92 145.51 51.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.698 . . . . 0.89 110.083 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 77' ' ' ILE . 24.8 t -125.59 130.59 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.606 -0.516 . . . . 1.29 109.606 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.36 8.84 5.97 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.423 0.452 . . . . 1.17 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 9.56 62.99 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.826 -0.702 . . . . 0.66 111.593 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.78 131.03 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.585 0.354 . . . . 1.75 110.171 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 44.1 t -70.1 136.29 50.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.999 -0.546 . . . . 2.36 111.426 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.799 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.5 mmt -119.91 69.43 0.85 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 1.42 110.583 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -98.07 -62.15 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 3.75 110.367 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.26 41.4 2.41 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.618 -0.593 . . . . 1.78 111.618 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.799 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.4 mmtp -107.42 -178.5 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.064 -0.347 . . . . 3.73 110.064 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -125.61 172.28 9.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.605 -0.27 . . . . 3.61 110.972 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -54.68 -44.21 73.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.518 0.511 . . . . 2.2 111.366 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.43 84.45 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.993 -0.622 . . . . 0.78 113.039 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.776 0.322 . . . . 2.03 110.662 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.93 -45.5 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 1.71 110.778 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.65 -36.64 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.294 -0.412 . . . . 1.37 110.905 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -65.87 -36.15 82.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.855 -0.424 . . . . 1.12 109.855 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.1 79.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.584 . . . . 1.09 111.072 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 60' ' ' VAL . 18.8 mm -57.56 -44.49 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.546 0.688 . . . . 1.35 109.464 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.52 -29.22 59.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.001 -1.0 . . . . 3.55 110.936 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.86 44.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 1.28 111.84 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.8 -12.35 83.0 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.448 -0.882 . . . . 0.6 111.867 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 -125.92 8.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.974 -0.851 . . . . 1.1 110.974 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 60.2 m-20 -94.6 -16.85 22.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.943 0.372 . . . . 2.12 110.042 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 7.4 mt-10 -119.55 140.34 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.109 -0.7 . . . . 2.11 109.109 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -129.77 145.52 51.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.026 0.441 . . . . 1.09 110.511 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.5 mttm -113.62 117.77 32.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.913 -0.585 . . . . 2.25 109.825 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.1 mt -109.91 135.86 50.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.861 -0.608 . . . . 1.04 110.159 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' A' ' 10' ' ' PRO . 52.9 tp -104.55 117.09 33.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.09 -0.505 . . . . 1.22 109.884 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.771 HG23 ' HG3' ' A' ' 11' ' ' ARG . 7.2 m -127.95 159.36 39.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 1.09 110.72 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -128.83 148.1 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.0 -0.545 . . . . 1.08 110.747 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.16 172.62 12.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.288 -0.634 . . . . 1.92 109.288 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.0 ttp180 -61.0 -49.1 78.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.612 0.244 . . . . 4.87 110.709 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -35.97 82.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.061 0.458 . . . . 2.68 110.322 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -64.32 -51.44 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 1.08 111.194 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.73 -33.99 76.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.18 111.445 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 12.5 mm-40 -64.17 -41.56 97.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.895 0.379 . . . . 1.94 110.056 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.707 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 70.2 t80 -63.28 -47.83 80.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.83 111.367 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -66.76 -38.82 87.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.514 -0.312 . . . . 0.55 111.776 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.1 -41.82 85.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.376 0.51 . . . . 2.5 112.376 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.707 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 58.6 pttt -68.24 -14.48 63.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 2.53 111.229 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.417 ' HB3' HG11 ' A' ' 102' ' ' VAL . 34.4 t -109.04 -11.4 14.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.274 0.559 . . . . 2.19 109.574 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 65.38 35.29 7.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.761 -1.108 . . . . 4.83 111.371 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 100' ' ' CYS . 3.1 p -118.45 126.93 75.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 2.08 110.124 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -72.15 128.29 89.26 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.99 110.753 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HG2' HG22 ' A' ' 58' ' ' VAL . 34.1 Cg_endo -67.65 143.9 63.98 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.734 2.289 . . . . 0.86 111.355 176.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 m -151.23 174.72 12.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 110.024 -0.362 . . . . 1.92 110.024 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.611 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 43.0 mt-30 -57.59 -40.3 78.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.926 0.393 . . . . 1.87 111.166 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 107' ' ' GLU . 1.5 mp0 -59.22 -35.27 73.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.293 0.568 . . . . 2.82 110.259 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -73.9 -31.52 63.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.564 -0.743 . . . . 0.71 111.525 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.4 pp -88.51 -16.53 32.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 1.47 110.864 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.77 -8.16 59.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.131 -0.486 . . . . 4.09 111.24 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.89 -74.36 0.21 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.03 -1.081 . . . . 1.39 113.723 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.17 116.08 4.54 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.344 2.696 . . . . 1.65 114.12 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.326 -0.852 . . . . 1.75 109.698 171.616 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 121.348 0.594 . . . . 1.36 110.315 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -125.78 147.57 59.15 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.655 -0.702 . . . . 3.51 109.731 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' HD13 ' A' ' 87' ' ' LEU . 38.8 Cg_endo -66.01 159.76 47.68 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.298 1.998 . . . . 0.81 111.183 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.3 ptt85 -121.37 132.55 54.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.037 -0.529 . . . . 2.82 110.396 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -92.72 111.86 23.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.729 -0.669 . . . . 1.96 109.767 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 18.0 m -89.63 117.73 28.72 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.091 -0.707 . . . . 1.17 109.091 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 85' ' ' LYS . 24.4 m -109.85 118.25 36.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.601 -0.518 . . . . 1.13 109.601 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -131.17 132.93 45.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 1.08 110.677 -175.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.8 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 3.4 ttmp? -109.12 128.69 55.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 3.11 109.529 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.4 ttmt -51.59 130.08 27.2 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.041 -0.981 . . . . 1.5 112.768 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.09 -147.57 22.82 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.956 -0.858 . . . . 1.28 110.956 170.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.71 -28.8 6.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.879 2.386 . . . . 2.23 112.841 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -94.28 -27.2 16.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.364 0.505 . . . . 3.28 112.364 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.57 64.79 0.59 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.8 -0.714 . . . . 1.93 112.775 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.529 ' O ' ' HB2' ' A' ' 44' ' ' SER . 26.4 m-85 74.51 -74.58 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.629 0.772 . . . . 1.82 111.013 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.96 69.07 0.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.64 . . . . 0.96 113.007 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -155.71 154.76 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.8 -0.445 . . . . 0.4 109.8 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.77 127.16 55.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.77 0.319 . . . . 2.23 110.586 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.47 137.75 39.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 2.11 110.09 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 11.6 p80 -125.7 138.81 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.46 -0.496 . . . . 2.02 110.705 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 115.265 -0.879 . . . . 2.75 108.891 178.25 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.514 -0.441 0 CA-C-O 121.195 0.521 . . . . 1.5 111.036 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.473 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 52.9 m-85 -125.43 150.55 47.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.715 -0.846 . . . . 0.99 108.715 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.477 HG13 HD11 ' A' ' 51' ' ' LEU . 35.2 mm -75.85 111.17 11.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.839 -0.43 . . . . 1.12 109.839 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 23.3 tpt180 -68.64 -57.05 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 3.48 110.028 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.417 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 49.6 m -160.63 140.57 11.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.47 -0.786 . . . . 1.82 109.041 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.18 132.92 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.6 -0.889 . . . . 1.11 108.6 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 3.2 t70 -83.86 116.24 63.76 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.256 -0.429 . . . . 2.28 109.998 -173.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 9.2 Cg_endo -53.64 150.84 26.89 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.721 2.28 . . . . 1.27 111.904 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 64.36 56.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.051 0.929 . . . . 2.4 109.96 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 87.9 p -145.65 156.27 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.187 -0.915 . . . . 0.68 109.843 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.3 Cg_endo -61.2 -23.9 78.03 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.501 2.134 . . . . 0.87 111.177 172.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.552 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -69.09 -52.1 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.464 . . . . 1.17 110.558 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.761 -0.459 . . . . 2.01 109.761 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.69 -35.31 72.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.794 -0.639 . . . . 1.15 112.064 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.0 p -70.02 -19.44 63.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.861 0.362 . . . . 0.4 111.247 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.33 47.69 1.11 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.751 . . . . 0.62 112.468 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.477 HD11 HG13 ' A' ' 37' ' ' ILE . 34.6 tp -108.01 137.94 45.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.143 -0.317 . . . . 1.12 110.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -118.95 153.09 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.754 -0.462 . . . . 5.17 109.754 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -81.78 34.93 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.519 0.562 . . . . 1.44 112.519 -173.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -152.73 17.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 3.8 110.825 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.562 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.6 m-20 -94.48 159.68 14.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.92 -0.582 . . . . 1.02 110.45 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 56' ' ' ARG . 30.5 ttp180 -115.22 137.62 51.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.418 -0.586 . . . . 2.26 109.418 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.56 126.73 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.98 -0.555 . . . . 1.37 110.887 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.21 -42.01 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 1.56 110.736 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.9 mt-10 -131.82 143.05 49.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.39 -0.368 . . . . 0.89 110.745 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.46 111.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.323 -0.621 . . . . 1.29 109.323 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.67 29.68 19.18 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.374 0.421 . . . . 1.17 111.36 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.421 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.2 -7.44 78.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.66 112.577 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.65 121.4 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.809 -0.441 . . . . 1.75 109.809 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.0 t -80.1 122.66 27.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.156 0.503 . . . . 2.36 110.322 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.576 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.9 mmt -94.75 56.13 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.423 0.63 . . . . 1.42 110.331 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.82 68.79 3.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.25 -0.886 . . . . 3.75 110.958 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.11 27.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 1.78 112.127 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.573 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 75.7 mmtt -69.3 152.92 44.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.312 0.577 . . . . 3.73 111.142 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.52 153.55 24.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.19 -0.914 . . . . 3.61 110.009 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.82 -40.34 66.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.014 -0.994 . . . . 2.2 112.928 -165.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.4 -30.73 68.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.742 -0.742 . . . . 0.78 112.365 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -68.75 -46.81 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.52 . . . . 2.03 110.104 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.576 HG23 ' SD ' ' A' ' 65' ' ' MET . 58.9 t -62.36 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.459 -0.791 . . . . 1.71 110.949 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.434 ' HA ' HD13 ' A' ' 77' ' ' ILE . 97.5 t -64.09 -41.61 92.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.257 -0.428 . . . . 1.37 110.988 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -61.38 -37.56 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 1.12 110.592 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.12 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.09 110.995 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 74' ' ' VAL . 72.6 mt -61.06 -42.1 91.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.151 0.501 . . . . 1.35 110.281 176.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.72 -25.75 63.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.705 -0.68 . . . . 3.55 110.8 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.49 61.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 1.28 111.519 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.28 -20.51 76.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.587 -0.816 . . . . 0.6 111.904 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.43 -84.59 1.33 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.953 -0.641 . . . . 1.1 112.132 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 50.8 m-20 -120.42 1.1 10.67 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.856 -0.202 . . . . 2.12 111.173 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -151.49 161.87 41.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.731 0.301 . . . . 2.11 110.637 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.8 t -140.67 149.56 42.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.568 -0.53 . . . . 1.09 109.568 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HG2' HG22 ' A' ' 14' ' ' THR . 59.7 mttp -119.18 117.22 28.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.802 -0.444 . . . . 2.25 109.802 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -106.48 130.74 54.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.301 -0.409 . . . . 1.04 110.242 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 57.8 tp -104.23 116.08 31.54 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.073 -0.714 . . . . 1.22 109.073 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 18.3 m -127.86 158.27 39.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.227 0.536 . . . . 1.09 111.884 -174.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 10' ' ' PRO . 25.9 m -128.03 147.88 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 1.08 109.916 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.59 176.06 7.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.254 -0.647 . . . . 1.92 109.254 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.6 ttp180 -54.04 -48.78 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.256 0.348 . . . . 4.87 111.469 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.17 -38.05 63.8 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 121.108 -0.237 . . . . 2.68 110.957 -173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.44 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 41.1 m -60.64 -47.62 85.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.886 0.374 . . . . 1.08 110.186 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 28.9 t70 -58.66 -47.83 83.14 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.873 -0.603 . . . . 1.18 110.772 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 48.7 mt-10 -64.77 -28.35 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 1.94 110.823 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.11 -47.72 64.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.83 110.323 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.473 ' CD2' HG12 ' A' ' 102' ' ' VAL . 46.9 m-85 -65.53 -36.8 84.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.446 -0.343 . . . . 0.55 111.278 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 29.1 mtpp -58.77 -49.36 77.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 2.5 111.714 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -71.05 -29.63 65.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.494 . . . . 2.53 111.265 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.424 ' HB3' HG13 ' A' ' 102' ' ' VAL . 36.3 t -85.39 -11.38 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 2.19 111.369 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? 63.16 43.97 6.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.73 -0.668 . . . . 4.83 111.198 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.473 HG12 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -133.39 140.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.172 -0.467 . . . . 2.08 110.29 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.7 mt -86.3 128.28 57.99 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.345 -0.388 . . . . 1.99 110.868 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.98 136.23 55.68 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.497 2.131 . . . . 0.86 111.193 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.9 t -155.8 172.67 17.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.892 -0.41 . . . . 1.92 109.892 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.421 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 60.1 mt-30 -55.68 -31.26 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.581 0.551 . . . . 1.87 111.472 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -59.75 -31.93 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.227 -0.442 . . . . 2.82 111.639 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -80.38 -14.17 58.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.448 -0.342 . . . . 0.71 111.531 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.484 HD23 ' CD1' ' A' ' 87' ' ' LEU . 86.7 mt -59.91 -59.99 4.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.084 0.468 . . . . 1.47 110.848 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -101.98 -12.06 18.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 4.09 111.179 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.42 175.93 38.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.794 -0.717 . . . . 1.39 112.649 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.2 163.16 28.03 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.848 2.365 . . . . 1.65 112.313 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.856 -0.611 . . . . 1.75 109.588 175.727 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.181 0.515 . . . . 1.36 110.105 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.489 ' NH1' ' HA ' ' A' ' 110' ' ' ASN . 49.2 mtm180 -119.67 140.71 29.83 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.828 -0.624 . . . . 3.51 110.127 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.66 ' HB3' HG11 ' A' ' 89' ' ' VAL . 24.6 Cg_exo -65.53 178.54 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.231 2.621 . . . . 0.81 112.141 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 87' ' ' LEU . 7.0 ptp85 -133.19 136.6 45.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.092 -0.504 . . . . 2.82 111.85 -176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.609 ' HG ' ' CD1' ' A' ' 109' ' ' LEU . 4.1 mt -90.92 110.84 22.08 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.027 -0.731 . . . . 1.96 109.027 173.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.8 115.63 27.71 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.117 -0.697 . . . . 1.17 109.117 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.692 HG23 ' HG2' ' A' ' 85' ' ' LYS . 7.3 m -109.34 118.54 36.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.284 -0.636 . . . . 1.13 109.284 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.542 ' HE1' ' HA ' ' A' ' 46' ' ' ALA . 23.1 ptp -128.31 133.13 48.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.161 -0.472 . . . . 1.08 110.294 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.556 ' HE3' ' HB2' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -113.38 137.99 50.72 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.855 -0.795 . . . . 3.11 108.855 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.546 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.9 ttmt -54.6 121.05 7.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.765 -0.652 . . . . 1.5 111.179 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.98 -126.05 5.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.708 -0.758 . . . . 1.28 112.892 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.12 -43.05 45.1 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.221 2.614 . . . . 2.23 113.057 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 m -153.67 86.12 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.87 0.367 . . . . 3.28 110.591 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.546 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 65.99 -136.12 35.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.893 -0.594 . . . . 1.93 112.856 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -124.66 -176.8 3.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.737 -0.838 . . . . 1.82 108.737 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.61 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.963 -1.113 . . . . 0.96 113.243 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.53 146.59 22.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.832 0.348 . . . . 0.4 110.506 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.35 127.35 48.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.424 -0.584 . . . . 2.23 109.424 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 35' ' ' GLN . 18.3 tp -101.71 147.84 25.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.258 0.551 . . . . 2.11 111.582 -169.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 4.8 m-70 -109.56 121.98 46.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.71 . . . . 2.02 110.268 177.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.316 -0.874 0 N-CA-C 107.269 -1.382 . . . . 2.75 107.269 169.687 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 26' ' ' LEU . 26.0 mm-40 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.783 0.325 . . . . 1.5 110.179 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.598 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 30.0 m-85 -109.32 157.73 18.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.413 -0.588 . . . . 0.99 109.413 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.497 HG13 HD13 ' A' ' 51' ' ' LEU . 38.3 mm -98.83 116.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.113 -0.328 . . . . 1.12 110.113 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 59.8 ttt180 -76.87 -44.6 31.43 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.004 0.43 . . . . 3.48 110.549 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 26.2 t -164.48 155.07 14.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.508 -0.769 . . . . 1.82 109.291 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.7 130.06 74.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.56 -0.533 . . . . 1.11 109.56 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.99 119.25 56.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.763 -0.458 . . . . 2.28 109.763 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.3 140.25 81.87 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.648 2.232 . . . . 1.27 112.698 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 12.3 m-20 65.36 39.31 5.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.31 -0.859 . . . . 2.4 111.899 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.619 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 89.6 p -117.95 170.0 6.89 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.737 -0.665 . . . . 0.68 109.365 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 6.3 Cg_endo -51.34 -35.0 52.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.107 1.872 . . . . 0.87 112.015 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -69.92 -47.42 62.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 1.17 110.937 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' HG2' ' H ' ' A' ' 43' ' ' ASP . 5.0 tp10 -62.16 -40.49 96.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.997 0.427 . . . . 2.01 110.232 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.68 -24.32 62.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 1.15 111.763 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -75.93 -13.94 60.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.067 0.461 . . . . 0.4 110.344 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.47 21.65 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.696 -0.764 . . . . 0.62 112.42 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 37' ' ' ILE . 25.9 tp -79.16 132.63 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 1.12 110.277 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 8.0 tpp180 -114.88 156.68 24.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.264 -0.273 . . . . 5.17 110.264 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -87.07 30.24 0.78 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 1.44 111.734 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.79 17.28 1.12 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.377 0.608 . . . . 3.8 109.83 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.7 m-20 -104.6 159.28 15.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.065 -0.97 . . . . 1.02 110.355 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.528 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.8 tmm_? -128.12 130.9 48.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.2 -0.296 . . . . 2.26 110.2 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.473 ' HA ' HG11 ' A' ' 88' ' ' VAL . 56.8 mt -75.58 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 1.37 111.237 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.528 HG22 ' NH1' ' A' ' 56' ' ' ARG . 2.3 t -114.76 -46.32 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.758 -0.656 . . . . 1.56 110.299 177.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.6 mt-10 -123.69 148.13 46.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.89 110.674 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.554 ' O ' HG11 ' A' ' 63' ' ' VAL . 99.6 t -125.53 119.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 1.29 109.371 173.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.23 21.32 10.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 1.17 111.45 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.88 9.38 61.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.669 -0.777 . . . . 0.66 113.782 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.554 HG11 ' O ' ' A' ' 60' ' ' VAL . 11.2 p -115.31 136.25 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.412 0.606 . . . . 1.75 109.816 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.546 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 7.2 p -74.69 136.97 41.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.488 -0.778 . . . . 2.36 111.557 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.562 ' C ' ' HD2' ' A' ' 68' ' ' LYS . 22.4 mmt -108.36 67.45 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.057 -0.519 . . . . 1.42 111.878 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -141.35 131.3 24.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.366 -0.834 . . . . 3.75 109.37 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.38 -0.37 74.65 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.291 -1.123 . . . . 1.78 110.291 -170.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.562 ' HD2' ' C ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -91.0 164.4 13.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.356 -0.922 . . . . 3.73 111.148 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -96.96 172.15 8.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.343 -0.844 . . . . 3.61 109.041 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -62.2 -35.82 80.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.975 0.417 . . . . 2.2 109.953 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.49 -33.73 88.04 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.78 112.829 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.43 -46.76 81.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 2.03 110.551 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.443 HG12 ' HG3' ' A' ' 35' ' ' GLN . 46.4 t -62.4 -46.65 95.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.537 . . . . 1.71 110.559 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.21 -42.85 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 1.37 111.062 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -67.37 -36.55 81.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.445 -0.343 . . . . 1.12 110.747 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.36 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.625 -0.261 . . . . 1.09 111.549 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 HG22 HG23 ' A' ' 84' ' ' THR . 77.9 mt -59.62 -45.34 94.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.283 0.563 . . . . 1.35 110.345 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -72.66 -28.94 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.541 -0.754 . . . . 3.55 110.918 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.53 -14.31 62.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 1.28 111.406 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.61 -19.03 78.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.621 -0.8 . . . . 0.6 112.047 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -104.28 3.14 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.714 -0.755 . . . . 1.1 112.102 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.556 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 7.1 p-10 -98.0 -5.06 34.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.679 0.251 . . . . 2.12 111.679 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -150.47 165.17 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.986 0.422 . . . . 2.11 111.176 178.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.449 HG23 HG22 ' A' ' 77' ' ' ILE . 8.7 t -148.83 148.26 29.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.771 -0.65 . . . . 1.09 109.688 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.692 ' HG2' HG23 ' A' ' 14' ' ' THR . 23.1 mttm -115.31 118.63 33.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.9 -0.407 . . . . 2.25 109.9 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.35 125.87 51.47 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 1.04 109.324 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.558 HD13 HD21 ' A' ' 109' ' ' LEU . 52.0 tp -102.1 115.17 29.98 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.611 -0.885 . . . . 1.22 108.611 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 30.8 m -128.17 168.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.768 -0.651 . . . . 1.09 110.207 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' A' ' 10' ' ' PRO . 28.3 m -127.56 141.76 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.894 -0.594 . . . . 1.08 110.352 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.93 172.08 14.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.145 -0.687 . . . . 1.92 109.145 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 91' ' ' ARG . 19.4 tpt85 -58.13 -46.6 85.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.926 0.394 . . . . 4.87 111.152 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -64.88 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 2.68 111.593 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 m -75.36 -43.8 48.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.185 0.517 . . . . 1.08 110.536 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.413 ' HB2' HG22 ' A' ' 89' ' ' VAL . 24.4 t70 -59.38 -47.9 83.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 1.18 111.618 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.6 -39.67 94.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.726 0.298 . . . . 1.94 111.103 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -62.92 -49.32 75.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.83 110.759 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.225 -0.443 . . . . 0.55 111.24 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -60.43 -49.22 78.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.489 0.551 . . . . 2.5 112.489 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 99' ' ' LYS . 7.2 ptmm? -68.7 -32.82 72.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.294 0.569 . . . . 2.53 110.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.492 ' HB3' HG22 ' A' ' 102' ' ' VAL . 62.0 m -76.47 -13.99 60.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.657 -0.701 . . . . 2.19 111.295 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.5 27.71 15.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.45 -0.795 . . . . 4.83 110.657 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 100' ' ' CYS . 59.5 t -102.71 139.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.805 -0.634 . . . . 2.08 110.676 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.0 mp -84.82 122.66 74.52 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.005 -0.543 . . . . 1.99 109.643 175.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.449 ' HD2' HG12 ' A' ' 58' ' ' VAL . 3.0 Cg_exo -70.47 141.48 42.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.406 2.071 . . . . 0.86 110.891 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -151.44 167.1 29.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.059 -0.256 . . . . 1.92 110.787 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.595 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -52.5 -29.66 26.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.398 0.679 . . . . 1.87 111.778 176.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.26 -30.67 64.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.441 0.639 . . . . 2.82 110.902 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.73 -14.31 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.71 110.704 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.609 ' CD1' ' HG ' ' A' ' 12' ' ' LEU . 74.6 mt -70.03 114.24 8.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 1.47 110.33 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.489 ' HA ' ' NH1' ' A' ' 9' ' ' ARG . 66.2 t30 57.27 28.05 14.59 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.844 0.83 . . . . 4.09 109.965 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.25 -169.05 12.42 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.228 -0.896 . . . . 1.39 111.314 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 147.87 27.05 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.536 2.157 . . . . 1.65 112.694 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 47.6 mt . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.717 -0.674 . . . . 1.75 110.161 175.131 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.5 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.129 0.49 . . . . 1.36 110.772 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -130.54 148.86 71.67 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.758 -0.655 . . . . 3.51 109.413 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HB2' HD13 ' A' ' 87' ' ' LEU . 56.8 Cg_endo -70.38 162.98 40.43 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.566 2.177 . . . . 0.81 111.419 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.418 ' NH1' HH12 ' A' ' 52' ' ' ARG . 6.4 ptp85 -127.65 136.12 51.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.167 -0.47 . . . . 2.82 110.545 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.403 ' HB2' HD11 ' A' ' 109' ' ' LEU . 46.5 tp -94.26 110.36 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.945 -0.57 . . . . 1.96 109.707 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -98.91 116.9 32.2 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.323 -0.621 . . . . 1.17 109.323 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.7 m -111.36 119.3 38.4 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.464 -0.569 . . . . 1.13 109.464 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.426 ' HE3' ' OG ' ' A' ' 49' ' ' SER . 23.1 ptp -127.96 133.24 49.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.014 -0.539 . . . . 1.08 109.971 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -116.79 156.59 26.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.462 -0.79 . . . . 3.11 110.138 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 86.0 mttt -68.55 125.72 27.4 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.264 -1.335 . . . . 1.5 111.778 -172.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.86 -107.58 0.73 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.257 -1.338 . . . . 1.28 110.928 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HG2' ' HD3' ' A' ' 45' ' ' PRO . 33.5 Cg_endo -65.78 104.49 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.597 2.198 . . . . 2.23 111.361 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t 63.48 29.99 15.33 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.31 0.576 . . . . 3.28 110.545 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.91 -97.09 1.11 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.269 -0.732 . . . . 1.93 111.269 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 17.0 m-85 -119.53 -171.17 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.849 -0.797 . . . . 1.82 108.849 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.57 78.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.1 -1.048 . . . . 0.96 112.791 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -155.56 163.15 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.4 110.605 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -128.88 129.22 45.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.939 -0.573 . . . . 2.23 110.285 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.34 134.8 47.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.399 -0.364 . . . . 2.11 110.23 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.0 p80 -125.72 135.29 51.92 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.509 -0.476 . . . . 2.02 110.734 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.408 -0.815 . . . . 2.75 109.533 178.452 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.057 -0.349 . . . . 1.5 110.057 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.429 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 88.1 m-85 -109.11 154.94 21.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 0.99 109.18 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 53' ' ' ALA . 41.3 mm -77.84 107.87 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.002 0.429 . . . . 1.12 110.153 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 30.7 ttt180 -67.92 -43.47 79.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 3.48 109.823 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 p -175.66 140.15 0.44 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.534 -1.212 . . . . 1.82 109.668 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.28 121.37 60.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.0 -0.741 . . . . 1.11 109.0 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -66.05 122.47 81.32 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.669 -0.696 . . . . 2.28 109.957 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.18 149.71 78.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.847 2.365 . . . . 1.27 111.777 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.96 40.55 2.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 2.4 110.905 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 p -130.72 164.44 41.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.61 -0.268 . . . . 0.68 110.696 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD3' ' HG2' ' A' ' 19' ' ' PRO . 23.4 Cg_exo -64.23 -27.33 64.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.494 2.129 . . . . 0.87 111.47 175.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -46.81 71.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.759 -0.655 . . . . 1.17 110.241 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.87 -33.24 75.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.85 -0.614 . . . . 2.01 109.971 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.25 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 1.15 111.753 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.426 ' OG ' ' HE3' ' A' ' 15' ' ' MET . 59.8 p -70.2 -13.51 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.4 110.556 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.58 50.45 1.83 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.62 112.061 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -99.66 149.6 23.13 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.798 -0.445 . . . . 1.12 109.798 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 39.0 ttm180 -147.2 143.36 28.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.683 -0.235 . . . . 5.17 110.575 -173.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -77.22 14.11 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.074 0.768 . . . . 1.44 113.074 -173.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -115.44 -5.49 12.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.208 0.528 . . . . 3.8 109.981 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -91.36 155.06 18.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.152 -0.931 . . . . 1.02 111.273 -172.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -124.85 134.29 52.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 2.26 109.719 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.458 ' HA ' HG13 ' A' ' 88' ' ' VAL . 41.7 mm -63.97 124.41 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.298 -0.41 . . . . 1.37 111.06 -176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.11 -52.01 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.995 -0.548 . . . . 1.56 110.638 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 28.9 mt-10 -133.32 149.37 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.89 110.213 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.33 123.4 66.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.78 -0.452 . . . . 1.29 109.78 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 60.81 20.84 10.97 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.079 0.552 . . . . 1.17 111.153 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.0 1.1 70.52 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.9 -0.667 . . . . 0.66 112.217 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.43 120.66 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.16 -0.311 . . . . 1.75 110.16 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.747 ' HG ' HG22 ' A' ' 103' ' ' ILE . 48.8 t -64.46 136.2 56.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 2.36 111.492 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.519 ' HG3' HG12 ' A' ' 73' ' ' VAL . 26.6 mmt -121.47 73.64 1.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.777 -0.647 . . . . 1.42 109.613 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.78 -57.37 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.22 -0.9 . . . . 3.75 110.667 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.9 13.77 45.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.026 -0.607 . . . . 1.78 111.927 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 30.8 mmtp -86.4 160.26 19.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.856 0.36 . . . . 3.73 110.491 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -90.72 173.11 8.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.0 -0.545 . . . . 3.61 111.429 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -58.48 -36.43 73.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.219 -0.446 . . . . 2.2 110.086 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.1 -38.7 96.56 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.795 -0.717 . . . . 0.78 112.415 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 68' ' ' LYS . 4.3 m-20 -62.57 -48.09 80.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.653 0.263 . . . . 2.03 111.171 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.519 HG12 ' HG3' ' A' ' 65' ' ' MET . 33.4 m -67.42 -40.35 84.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 1.71 111.367 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.44 -45.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.056 0.455 . . . . 1.37 110.672 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -36.59 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 1.12 110.414 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.47 96.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.655 0.264 . . . . 1.09 111.187 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.465 HG22 HG21 ' A' ' 84' ' ' THR . 85.9 mt -60.21 -45.2 96.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.205 0.526 . . . . 1.35 110.274 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.63 -36.04 78.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 3.55 110.913 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 1.28 110.993 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.47 79.59 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 0.6 111.273 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.28 -123.32 7.67 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.004 -0.617 . . . . 1.1 111.659 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 1.3 m-20 -100.22 -4.16 30.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.829 0.347 . . . . 2.12 110.46 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 26.0 mt-10 -135.05 140.05 45.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.357 -0.979 . . . . 2.11 108.357 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.465 HG21 HG22 ' A' ' 77' ' ' ILE . 12.6 t -139.66 148.03 41.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.897 0.38 . . . . 1.09 110.464 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -116.73 123.97 48.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.265 -0.425 . . . . 2.25 110.331 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.48 129.78 55.7 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.736 -0.468 . . . . 1.04 109.736 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 10' ' ' PRO . 16.9 tp -104.75 119.18 38.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.048 -0.723 . . . . 1.22 109.048 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 23.8 m -130.28 165.94 29.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.304 -0.407 . . . . 1.09 111.623 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.43 160.09 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.532 -0.758 . . . . 1.08 110.508 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' CG ' HH12 ' A' ' 11' ' ' ARG . 2.2 m-20 -77.29 175.59 9.58 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.492 0.495 . . . . 1.92 110.418 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -61.89 -47.27 85.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 4.87 110.767 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.41 -35.78 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 2.68 110.093 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -65.89 -41.51 91.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 1.08 110.797 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 20.4 t70 -58.66 -48.54 80.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 1.18 110.194 176.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -62.17 -38.46 89.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 1.94 111.108 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.419 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 77.7 t80 -63.74 -49.19 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.42 -0.354 . . . . 0.83 111.283 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 19.6 m-85 -66.17 -38.27 87.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.476 -0.329 . . . . 0.55 111.212 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 31.3 mtpt -66.72 -43.53 84.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.455 -0.338 . . . . 2.5 111.557 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 96' ' ' PHE . 52.0 pttt -71.75 -14.65 62.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 2.53 110.66 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 54.5 m -94.47 -6.22 44.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.227 0.537 . . . . 2.19 110.566 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.576 ' HD2' ' N ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER 57.96 35.33 25.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.112 -0.949 . . . . 4.83 111.454 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.24 147.33 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.796 -0.638 . . . . 2.08 109.806 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.747 HG22 ' HG ' ' A' ' 64' ' ' CYS . 32.1 mm -87.99 132.19 40.73 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.324 -0.398 . . . . 1.99 111.26 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.486 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 18.7 Cg_exo -65.35 137.4 51.11 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.557 2.171 . . . . 0.86 110.462 173.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.4 p -153.04 174.25 14.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.774 -0.37 . . . . 1.92 111.564 -172.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.442 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 98.3 mt-30 -59.49 -28.36 66.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 1.87 110.298 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.89 -41.34 77.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.616 -0.72 . . . . 2.82 110.429 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -78.95 -14.09 59.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.518 -0.764 . . . . 0.71 111.398 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.442 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.6 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.825 0.345 . . . . 1.47 110.92 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -118.09 -37.64 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 4.09 111.03 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.27 -166.44 36.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.164 -0.541 . . . . 1.39 113.507 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.9 136.77 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.536 2.824 . . . . 1.65 112.636 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' N ' HD21 ' A' ' 113' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 1.75 109.909 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 121.305 0.574 . . . . 1.36 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.519 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 14.1 ptt180 -126.74 160.2 60.0 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.616 -0.72 . . . . 3.51 109.285 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 56.7 Cg_endo -65.79 178.6 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.446 2.097 . . . . 0.81 111.984 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.518 ' HD3' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -137.31 132.5 33.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.108 -0.33 . . . . 2.82 110.108 175.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.464 ' HG ' HD11 ' A' ' 109' ' ' LEU . 3.7 mt -92.82 109.9 21.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.08 -0.509 . . . . 1.96 109.843 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 17.9 m -91.19 116.64 28.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.966 -0.753 . . . . 1.17 108.966 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 116.7 33.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.517 -0.92 . . . . 1.13 108.517 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.466 ' HE2' ' OG ' ' A' ' 49' ' ' SER . 22.9 ptp -140.21 134.13 30.7 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.148 -0.478 . . . . 1.08 110.195 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 17.9 pttp -110.9 156.28 21.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.266 0.555 . . . . 3.11 110.583 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.8 ttmt -59.11 111.85 1.48 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.85 -1.068 . . . . 1.5 112.163 -171.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.53 -107.16 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.414 -0.812 . . . . 1.28 111.256 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.33 95.33 0.14 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.088 2.525 . . . . 2.23 112.126 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.0 t 72.53 -52.17 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.461 0.705 . . . . 3.28 112.139 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -179.69 78.25 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 1.93 111.885 -175.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 71.04 -63.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.342 0.657 . . . . 1.82 110.913 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.12 69.31 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.158 -0.544 . . . . 0.96 112.982 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.43 150.99 25.69 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.783 0.325 . . . . 0.4 110.192 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 45.1 t-20 -102.26 129.33 48.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.894 0.378 . . . . 2.23 109.982 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 35' ' ' GLN . 1.7 tm? -100.84 129.33 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.168 -0.679 . . . . 2.11 109.168 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -153.18 167.04 30.63 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.852 1.797 . . . . 2.02 115.852 -167.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 70.5 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 113.209 -1.814 . . . . 2.75 112.487 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.505 ' HB3' HD13 ' A' ' 26' ' ' LEU . 16.4 mm-40 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.523 -0.547 . . . . 1.5 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 50.3 m-85 -117.53 144.48 45.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.197 -1.001 . . . . 0.99 110.104 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.501 HG13 HD11 ' A' ' 51' ' ' LEU . 45.0 mm -81.56 115.3 23.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.541 -0.54 . . . . 1.12 109.541 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 2.1 tmm_? -77.25 -49.31 15.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.234 -0.654 . . . . 3.48 109.234 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.2 p -159.68 150.47 19.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.057 -0.974 . . . . 1.82 109.824 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.11 122.03 63.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.065 -0.717 . . . . 1.11 109.065 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -67.42 133.02 93.02 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.589 . . . . 2.28 110.436 -174.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 35.5 Cg_exo -59.71 145.2 98.78 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.672 2.248 . . . . 1.27 112.033 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 34.4 m-20 74.54 15.59 3.34 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.997 0.81 . . . . 2.4 111.657 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.5 p -95.09 155.22 39.23 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.752 0.31 . . . . 0.68 110.238 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.68 -27.5 81.27 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.772 2.315 . . . . 0.87 111.182 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.24 -48.81 71.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.732 -0.667 . . . . 1.17 110.114 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 2.01 110.272 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.42 69.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 1.15 111.784 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.466 ' OG ' ' HE2' ' A' ' 15' ' ' MET . 74.6 p -73.68 -12.15 60.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.4 110.875 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.34 51.06 1.36 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.62 112.441 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.501 HD11 HG13 ' A' ' 37' ' ' ILE . 23.1 tp -100.83 142.62 32.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.0 0.429 . . . . 1.12 110.759 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG2' ' H ' ' A' ' 54' ' ' GLN . 32.4 ttm180 -121.63 144.23 48.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 5.17 109.805 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.71 26.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 1.44 111.5 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -139.95 19.75 2.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.641 . . . . 3.8 109.271 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -104.27 157.85 16.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.341 -0.845 . . . . 1.02 111.305 -176.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -115.89 133.08 56.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.604 -0.725 . . . . 2.26 109.874 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' HA ' HG13 ' A' ' 88' ' ' VAL . 65.5 mt -76.63 124.43 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.296 -0.411 . . . . 1.37 110.465 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -106.65 -46.0 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 1.56 110.523 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 43.1 mt-10 -127.07 146.23 50.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.89 110.465 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.54 ' O ' HG11 ' A' ' 63' ' ' VAL . 85.9 t -131.48 118.93 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.22 -0.446 . . . . 1.29 109.841 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 57.23 27.43 13.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.377 -0.374 . . . . 1.17 111.582 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.482 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.6 6.75 63.81 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.66 114.219 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 60' ' ' VAL . 12.1 p -115.41 135.07 56.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.784 0.792 . . . . 1.75 110.092 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.1 t -80.74 136.63 36.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.508 -0.769 . . . . 2.36 111.225 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.478 ' SD ' HG23 ' A' ' 73' ' ' VAL . 23.1 mmt -106.94 53.3 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.695 -0.684 . . . . 1.42 110.479 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.09 -56.77 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 3.75 110.309 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.72 1.47 39.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 1.78 111.794 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.2 146.6 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.178 0.513 . . . . 3.73 110.875 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -98.97 -179.46 4.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.661 -0.699 . . . . 3.61 110.644 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -55.57 -43.87 76.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.401 . . . . 2.2 110.773 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -37.85 95.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.734 -0.746 . . . . 0.78 112.21 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.44 -47.51 75.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.987 0.422 . . . . 2.03 110.876 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.478 HG23 ' SD ' ' A' ' 65' ' ' MET . 25.2 t -70.23 -47.14 68.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 1.71 110.983 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.83 -36.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 1.37 110.636 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -65.31 -47.0 78.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.187 -0.46 . . . . 1.12 110.093 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.59 93.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.218 -0.446 . . . . 1.09 111.651 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.408 HG23 HG22 ' A' ' 84' ' ' THR . 70.3 mt -58.94 -43.26 88.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.288 0.566 . . . . 1.35 110.605 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -74.42 -30.08 61.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.516 -0.765 . . . . 3.55 111.342 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.15 9.94 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 1.28 111.727 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.1 -0.8 86.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.6 111.798 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.37 -101.5 2.49 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.129 -0.788 . . . . 1.1 111.129 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.467 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 6.0 t70 -128.86 -15.96 4.24 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.988 -0.285 . . . . 2.12 110.664 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.2 mt-10 -119.3 144.34 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 2.11 108.481 174.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.408 HG22 HG23 ' A' ' 77' ' ' ILE . 13.3 t -135.34 148.82 49.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.094 0.473 . . . . 1.09 110.395 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HB3' HD21 ' A' ' 12' ' ' LEU . 97.8 mttt -111.67 117.46 32.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 2.25 109.856 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.8 mt -106.68 129.98 54.49 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.16 -0.473 . . . . 1.04 109.797 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 41.5 tp -104.8 115.31 30.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.284 -0.636 . . . . 1.22 109.284 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.0 m -127.48 160.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.107 -0.497 . . . . 1.09 110.861 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.88 138.77 53.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 1.08 110.644 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.22 166.38 23.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.605 . . . . 1.92 110.078 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -56.2 -48.01 77.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 4.87 110.259 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.62 -33.69 76.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 2.68 110.372 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.4 m -70.63 -51.8 25.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.302 -0.863 . . . . 1.08 111.122 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.87 -30.72 68.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 1.18 111.393 -172.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -62.02 -35.27 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.005 0.431 . . . . 1.94 110.126 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -67.83 -45.7 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.83 109.926 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.417 ' CE2' ' HA ' ' A' ' 104' ' ' PRO . 46.6 m-85 -62.54 -36.91 84.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.55 111.498 177.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -59.66 -49.65 76.93 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.54 0.21 . . . . 2.5 111.257 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -71.89 -26.48 62.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.419 -0.355 . . . . 2.53 111.048 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 m -81.19 -8.4 59.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.273 -0.421 . . . . 2.19 111.242 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 58.53 39.63 24.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.338 -0.846 . . . . 4.83 111.046 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.87 145.25 34.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 2.08 110.924 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.9 mt -80.51 131.75 60.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 1.99 110.572 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 22.4 Cg_exo -63.7 136.65 54.8 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.472 2.115 . . . . 0.86 110.619 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.544 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 48.9 m -157.57 163.66 38.11 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.124 -0.23 . . . . 1.92 110.677 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.482 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 50.8 mt-30 -56.89 -28.78 62.32 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.7 0.625 . . . . 1.87 111.983 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.3 pt-20 -57.99 -29.97 65.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.114 0.483 . . . . 2.82 111.061 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -82.97 -13.68 55.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.884 -0.598 . . . . 0.71 110.98 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.464 HD11 ' HG ' ' A' ' 12' ' ' LEU . 66.8 mt -73.73 -53.77 9.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 1.47 110.087 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.51 48.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.454 -0.794 . . . . 4.09 110.258 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.53 38.36 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.755 -0.736 . . . . 1.39 111.959 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.94 174.54 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.048 2.499 . . . . 1.65 112.783 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 9' ' ' ARG . 48.1 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.586 -0.734 . . . . 1.75 109.737 175.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.997 0.904 . . . . 1.36 109.038 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -117.7 146.49 38.86 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.43 -1.259 . . . . 3.51 109.481 -173.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HB2' HD11 ' A' ' 87' ' ' LEU . 48.0 Cg_endo -66.93 159.25 52.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.378 2.052 . . . . 0.81 110.996 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.48 ' HG3' HG22 ' A' ' 88' ' ' VAL . 6.3 ptp85 -114.92 129.55 56.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.209 -0.45 . . . . 2.82 110.304 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.451 -0.574 . . . . 1.96 109.451 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 21.4 m -93.85 116.18 28.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.535 -0.543 . . . . 1.17 109.535 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 85' ' ' LYS . 25.5 m -108.57 116.95 32.94 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.661 -0.866 . . . . 1.13 108.661 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.48 ' HE2' HD22 ' A' ' 51' ' ' LEU . 25.3 ptp -133.55 134.01 42.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.142 0.496 . . . . 1.08 111.201 -172.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -107.07 141.42 38.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.246 -0.888 . . . . 3.11 109.997 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 39.0 mttm -59.79 107.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.695 -0.684 . . . . 1.5 111.427 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.41 -119.64 4.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.922 -1.036 . . . . 1.28 112.366 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -57.52 -58.01 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.079 2.519 . . . . 2.23 113.066 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -121.37 36.4 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 3.28 111.425 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 55.63 84.4 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.249 -0.501 . . . . 1.93 112.736 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 67.32 -149.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.801 -0.444 . . . . 1.82 109.801 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.91 73.34 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.391 -0.909 . . . . 0.96 112.516 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -152.77 158.91 42.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.4 110.539 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -113.91 133.4 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 2.23 109.561 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 35' ' ' GLN . 3.1 tm? -109.23 129.38 55.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.024 -0.362 . . . . 2.11 110.024 -176.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.91 140.13 53.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.123 0.487 . . . . 2.02 110.292 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.972 -0.558 . . . . 2.75 110.066 -178.209 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.411 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.6 mp0 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.805 -0.443 . . . . 1.5 109.805 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.618 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 56.0 m-85 -122.08 142.31 50.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.926 -0.398 . . . . 0.99 109.926 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 51' ' ' LEU . 43.7 mm -72.29 109.41 4.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.199 0.523 . . . . 1.12 110.029 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.793 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.1 tpt180 -66.81 -42.88 85.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.256 -0.883 . . . . 3.48 110.233 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -170.51 158.23 6.28 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.489 -0.778 . . . . 1.82 109.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.05 134.4 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.076 -0.713 . . . . 1.11 109.076 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.44 125.02 91.51 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.104 -0.498 . . . . 2.28 109.932 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 Cg_endo -61.38 134.82 53.92 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.756 2.304 . . . . 1.27 112.771 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.4 m-20 73.16 20.23 3.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.442 -0.799 . . . . 2.4 112.194 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.411 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 97.2 p -97.48 160.4 28.86 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.873 -0.417 . . . . 0.68 109.873 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 19.6 Cg_endo -60.06 -24.25 76.04 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.336 2.024 . . . . 0.87 111.999 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.91 -40.97 75.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 1.17 110.35 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -69.89 -39.38 76.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.201 -0.454 . . . . 2.01 110.249 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 1.15 111.79 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.5 p -75.45 -12.89 60.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.4 110.529 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.83 -1.0 30.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.686 . . . . 0.62 112.29 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 37' ' ' ILE . 30.9 tp -74.82 131.15 40.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.891 0.377 . . . . 1.12 110.466 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -132.77 -172.58 2.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.002 -0.544 . . . . 5.17 110.271 177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.36 154.46 19.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.515 -0.311 . . . . 1.44 111.342 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 69.6 18.82 7.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.694 -0.685 . . . . 3.8 111.235 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -90.57 150.21 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 1.02 109.784 175.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.5 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -120.53 129.1 53.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.534 -0.543 . . . . 2.26 109.534 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.453 ' HA ' HG11 ' A' ' 88' ' ' VAL . 54.9 mt -76.26 136.67 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 1.37 111.406 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG22 ' NH1' ' A' ' 56' ' ' ARG . 3.4 t -115.1 -50.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.481 -0.782 . . . . 1.56 110.098 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 31.2 mt-10 -128.88 149.07 50.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.939 -0.573 . . . . 0.89 110.48 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -130.35 120.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 1.29 110.004 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 60.35 27.61 17.19 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.949 0.5 . . . . 1.17 111.447 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.01 82.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.66 112.32 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.86 121.62 55.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.13 -0.322 . . . . 1.75 110.13 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -70.23 135.27 48.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.421 . . . . 2.36 110.813 -178.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.744 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 23.8 mmt -112.67 64.39 0.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.596 0.712 . . . . 1.42 110.333 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -93.44 99.19 11.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.01 -0.995 . . . . 3.75 110.875 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 4.33 81.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 1.78 112.474 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.744 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.5 mmtp -58.77 156.61 10.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.621 0.724 . . . . 3.73 112.819 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -80.93 162.39 23.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.483 -1.235 . . . . 3.61 109.969 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -59.16 -38.9 80.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.924 0.392 . . . . 2.2 110.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.42 -41.2 91.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.751 -0.738 . . . . 0.78 113.099 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.51 -41.08 89.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.718 0.259 . . . . 2.03 111.215 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.1 m -69.41 -41.89 80.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 1.71 111.383 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.53 -38.09 78.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.973 0.416 . . . . 1.37 110.344 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -66.33 -35.85 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 1.12 110.51 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.49 98.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 1.09 111.567 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.471 HG12 HD23 ' A' ' 86' ' ' LEU . 62.9 mt -59.06 -42.26 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.295 0.569 . . . . 1.35 110.628 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -74.14 -30.28 62.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.682 -0.69 . . . . 3.55 110.706 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 -8.91 57.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.868 -0.605 . . . . 1.28 111.446 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.09 -30.85 78.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.76 -0.734 . . . . 0.6 111.683 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.65 -101.04 1.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.071 -0.585 . . . . 1.1 112.132 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.64 -18.06 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.998 0.428 . . . . 2.12 110.083 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.61 44.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.429 -0.582 . . . . 2.11 109.429 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 77' ' ' ILE . 15.1 t -140.32 149.37 42.67 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.262 -0.426 . . . . 1.09 110.142 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.407 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.9 mttp -116.26 116.89 28.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.185 -0.461 . . . . 2.25 109.989 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 77' ' ' ILE . 87.1 mt -108.3 126.87 53.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.105 -0.498 . . . . 1.04 109.995 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 10' ' ' PRO . 31.0 tp -103.25 115.71 31.09 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.093 -0.706 . . . . 1.22 109.093 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.4 m -127.39 164.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.767 -0.651 . . . . 1.09 110.089 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -127.74 142.06 44.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.086 -0.507 . . . . 1.08 111.14 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.21 168.74 17.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.23 -0.895 . . . . 1.92 109.48 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 91' ' ' ARG . 6.5 ttp180 -56.58 -47.55 79.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.268 0.556 . . . . 4.87 110.155 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.09 -35.92 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.438 -0.801 . . . . 2.68 110.981 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 m -72.16 -49.95 31.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 1.08 111.497 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.63 -46.75 88.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.109 0.48 . . . . 1.18 110.301 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -63.01 -34.63 77.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.913 -0.585 . . . . 1.94 111.269 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.81 -47.37 78.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.83 110.438 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -65.1 -35.9 82.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.1 -0.5 . . . . 0.55 111.393 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -57.9 -49.1 77.88 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.505 0.187 . . . . 2.5 111.505 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -71.01 -22.17 62.19 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.202 0.525 . . . . 2.53 110.812 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.9 m -84.81 -14.45 48.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.018 -0.537 . . . . 2.19 110.817 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 57.63 33.97 23.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.418 -0.81 . . . . 4.83 111.372 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.49 146.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.017 -0.538 . . . . 2.08 109.953 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.2 mt -87.23 132.06 42.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 1.99 111.322 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.04 143.37 84.56 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.783 2.322 . . . . 0.86 110.942 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -156.01 163.04 40.2 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.82 -0.352 . . . . 1.92 110.481 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.446 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 22.7 mt-30 -55.66 -29.01 58.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.679 0.612 . . . . 1.87 110.904 174.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.54 -29.76 66.58 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.939 -0.573 . . . . 2.82 111.839 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -87.24 -13.88 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.361 -0.381 . . . . 0.71 111.798 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 73.2 mt -58.3 106.74 0.41 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.48 -0.327 . . . . 1.47 110.932 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.61 18.25 6.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.153 -0.476 . . . . 4.09 111.638 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.2 179.3 23.01 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.445 -0.662 . . . . 1.39 111.445 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.5 131.9 29.43 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.423 2.082 . . . . 1.65 111.886 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 C--N 1.323 -0.551 0 N-CA-C 109.728 -0.471 . . . . 1.75 109.728 175.754 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.348 0.594 . . . . 1.36 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -112.45 145.98 34.02 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 3.51 109.26 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 87' ' ' LEU . 32.8 Cg_endo -65.06 160.28 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.21 1.94 . . . . 0.81 111.552 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -107.23 130.33 54.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.599 -0.728 . . . . 2.82 109.904 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.6 tp -106.23 109.4 21.32 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.536 -0.542 . . . . 1.96 109.536 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.2 m -96.26 117.5 30.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.743 -0.662 . . . . 1.17 109.841 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -111.06 116.87 31.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.407 -0.961 . . . . 1.13 108.407 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.496 ' HE3' ' OG ' ' A' ' 49' ' ' SER . 22.8 ptp -132.88 133.54 43.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.942 0.401 . . . . 1.08 110.652 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.984 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 6.8 ttmt -108.78 137.38 46.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.233 0.54 . . . . 3.11 110.459 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.608 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.5 ttmt -54.88 125.65 21.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.407 -1.27 . . . . 1.5 112.045 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.91 -153.0 28.68 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.792 -0.64 . . . . 1.28 111.637 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.21 -33.99 58.26 Favored 'Trans proline' 0 CA--C 1.527 0.159 0 C-N-CA 122.912 2.408 . . . . 2.23 112.663 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.9 m -119.49 38.23 3.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.129 0.49 . . . . 3.28 110.868 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.608 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.34 -108.91 2.85 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.325 -0.941 . . . . 1.93 111.869 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -130.82 -155.0 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.835 -0.802 . . . . 1.82 108.835 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.86 73.35 0.22 Allowed Glycine 0 C--O 1.228 -0.265 0 C-N-CA 119.639 -1.267 . . . . 0.96 113.467 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -157.28 152.01 25.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.849 0.325 . . . . 0.4 110.701 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.49 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 3.0 t-20 -112.03 145.42 39.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.462 -0.569 . . . . 2.23 109.462 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.36 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.375 0.607 . . . . 2.11 112.579 -172.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -107.82 121.5 44.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 2.02 110.022 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.32 -0.702 0 N-CA-C 108.792 -0.818 . . . . 2.75 108.792 172.782 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.026 0.441 . . . . 1.5 110.315 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 56' ' ' ARG . 51.6 m-85 -106.55 158.22 17.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 0.99 109.129 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.805 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.8 mm -80.35 110.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.973 -0.751 . . . . 1.12 108.973 175.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.603 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 79.7 ttt180 -67.48 -46.72 72.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.431 0.634 . . . . 3.48 109.905 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.9 p -167.59 131.64 1.79 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.932 -1.031 . . . . 1.82 108.881 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -95.01 127.99 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.314 -0.624 . . . . 1.11 109.314 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.2 115.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.275 -0.639 . . . . 2.28 109.275 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.72 147.53 94.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.591 2.194 . . . . 1.27 111.689 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 63.95 52.87 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.895 0.855 . . . . 2.4 110.031 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.618 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -142.95 167.9 14.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.68 110.113 176.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.3 Cg_endo -54.19 -36.04 84.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.87 111.862 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.52 67.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 1.17 110.757 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.53 -38.54 90.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.254 -0.43 . . . . 2.01 110.152 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.78 79.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 1.15 111.589 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.496 ' OG ' ' HE3' ' A' ' 15' ' ' MET . 87.8 p -72.8 -14.73 61.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.07 0.462 . . . . 0.4 110.933 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.92 38.46 4.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.096 -0.573 . . . . 0.62 113.047 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.805 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -84.25 113.9 21.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 1.12 109.839 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HD2' ' OD1' ' A' ' 55' ' ' ASP . 40.7 ttm105 -94.0 137.95 32.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.74 0.305 . . . . 5.17 110.579 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -82.34 35.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.509 0.559 . . . . 1.44 112.509 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -143.65 -0.98 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 3.8 110.341 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.544 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 29.4 m-20 -98.04 153.78 18.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.184 -0.462 . . . . 1.02 110.957 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 26.5 ttm105 -99.68 133.86 43.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 2.26 110.704 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.5 mt -73.42 122.72 26.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.1 -0.704 . . . . 1.37 109.1 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.4 t -105.69 -46.5 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.0 -0.545 . . . . 1.56 110.431 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.0 mt-10 -128.47 142.44 51.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.329 -0.396 . . . . 0.89 110.627 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.95 118.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 1.29 109.417 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 62.79 19.34 11.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.381 0.426 . . . . 1.17 110.781 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.29 4.55 66.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.837 -0.697 . . . . 0.66 112.425 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.26 115.52 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.037 -0.357 . . . . 1.75 110.037 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.544 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 49.8 t -74.79 130.16 38.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.26 0.552 . . . . 2.36 110.526 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.498 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.4 mmt -97.3 51.14 1.09 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.599 0.714 . . . . 1.42 111.079 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.2 105.67 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.103 -0.953 . . . . 3.75 110.355 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.94 -2.49 87.72 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 1.78 112.712 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.1 mmtp -66.53 160.68 24.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.238 0.542 . . . . 3.73 111.353 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.1 175.51 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.506 -0.77 . . . . 3.61 110.281 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.435 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 8.1 t60 -53.77 -43.4 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.444 0.465 . . . . 2.2 111.516 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.76 -41.84 88.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.78 113.178 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.95 -40.26 97.12 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.964 0.411 . . . . 2.03 110.655 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 77' ' ' ILE . 48.9 t -70.4 -47.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.898 -0.592 . . . . 1.71 110.788 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 77' ' ' ILE . 89.9 t -68.29 -40.69 82.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 1.37 111.369 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -61.49 -38.93 89.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 1.12 110.397 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.9 92.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.497 -0.32 . . . . 1.09 111.138 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 84' ' ' THR . 66.9 mt -58.76 -45.6 91.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.509 0.671 . . . . 1.35 110.162 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.54 -25.42 59.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.257 -0.883 . . . . 3.55 111.306 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.16 3.75 41.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.147 -0.479 . . . . 1.28 111.187 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.87 9.06 54.61 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.985 -0.626 . . . . 0.6 112.315 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.49 -120.13 5.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.772 -0.727 . . . . 1.1 111.517 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 9.3 t70 -107.49 -31.58 8.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 2.12 110.275 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.984 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -121.13 139.66 53.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.242 -0.435 . . . . 2.11 110.273 175.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.494 HG21 HG21 ' A' ' 77' ' ' ILE . 9.1 t -130.66 150.06 52.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.805 -0.634 . . . . 1.09 111.19 -170.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -108.57 118.53 37.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.586 -0.734 . . . . 2.25 110.793 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.488 HD23 HG12 ' A' ' 77' ' ' ILE . 80.2 mt -109.9 131.22 55.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.05 -0.523 . . . . 1.04 109.845 176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 10' ' ' PRO . 32.9 tp -104.19 119.6 39.31 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.604 -0.517 . . . . 1.22 109.604 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.3 m -126.64 153.33 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.173 0.511 . . . . 1.09 111.621 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.44 134.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.759 -0.655 . . . . 1.08 110.288 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.16 171.45 14.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.713 -0.477 . . . . 1.92 109.713 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 91' ' ' ARG . 34.2 ttm180 -52.44 -47.9 66.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.296 0.373 . . . . 4.87 111.615 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.08 -42.32 76.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 2.68 110.622 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.5 m -64.92 -46.59 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.762 -0.653 . . . . 1.08 111.086 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.66 -47.27 84.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 1.18 110.976 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 10.2 mm-40 -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.543 -0.299 . . . . 1.94 110.478 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.782 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 87.8 t80 -63.28 -48.33 78.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.83 110.497 176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.483 ' CD2' ' HB3' ' A' ' 104' ' ' PRO . 34.2 m-85 -66.27 -38.14 87.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.831 0.348 . . . . 0.55 111.47 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -61.91 -48.53 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 2.5 111.618 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.782 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.5 pttt -70.76 -15.56 62.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 2.53 111.445 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.488 ' HB3' HG12 ' A' ' 102' ' ' VAL . 42.4 t -93.19 -7.83 44.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 2.19 110.196 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 59.35 29.45 19.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.281 -0.872 . . . . 4.83 111.21 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 100' ' ' CYS . 12.2 p -115.58 152.41 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 2.08 109.901 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.34 130.97 41.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.858 0.361 . . . . 1.99 110.983 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 47.3 Cg_endo -71.99 135.42 25.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.423 2.082 . . . . 0.86 111.244 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.0 t -158.43 173.92 15.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.295 -0.261 . . . . 1.92 110.295 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.458 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 43.8 mt-30 -55.89 -30.57 61.78 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.322 0.389 . . . . 1.87 111.636 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.79 -29.49 68.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 2.82 110.929 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -86.04 -13.67 46.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.892 -0.594 . . . . 0.71 111.561 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' A' ' 87' ' ' LEU . 86.7 mt -56.66 -73.59 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.885 0.374 . . . . 1.47 111.35 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -101.21 16.83 24.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.249 0.547 . . . . 4.09 110.044 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.51 -175.36 23.25 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.454 -0.793 . . . . 1.39 111.58 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.53 147.94 9.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 1.65 112.466 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.009 -0.542 . . . . 1.75 110.072 176.035 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 121.391 0.615 . . . . 1.36 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -122.0 146.02 45.24 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.617 -0.72 . . . . 3.51 109.801 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' ' CG1' ' A' ' 89' ' ' VAL . 39.9 Cg_endo -68.32 173.57 9.44 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.488 2.125 . . . . 0.81 111.696 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.406 HH22 ' HB3' ' A' ' 52' ' ' ARG . 24.3 ptt-85 -134.3 132.51 39.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.356 . . . . 2.82 110.372 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -95.32 113.22 24.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.928 -0.578 . . . . 1.96 109.879 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.6 m -96.79 118.86 34.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.981 -0.554 . . . . 1.17 109.902 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.854 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.2 m -109.73 117.51 34.09 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.126 -0.694 . . . . 1.13 109.126 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.439 ' HE2' HD21 ' A' ' 51' ' ' LEU . 22.0 ptp -128.89 133.7 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 1.08 111.259 -171.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -107.67 143.6 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.238 -0.892 . . . . 3.11 110.018 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 77.0 mttt -56.8 126.23 26.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.373 -0.831 . . . . 1.5 111.25 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -124.3 1.62 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.451 -1.249 . . . . 1.28 111.011 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.18 -48.32 1.84 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.662 2.241 . . . . 2.23 112.365 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -118.86 -34.19 4.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 3.28 111.491 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -174.61 -143.51 4.47 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.796 -0.716 . . . . 1.93 112.227 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.662 ' O ' ' HB2' ' A' ' 44' ' ' SER . 32.7 m-85 -99.24 -44.35 6.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.649 0.261 . . . . 1.82 110.894 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.68 69.25 0.9 Allowed Glycine 0 C--O 1.227 -0.292 0 C-N-CA 121.105 -0.569 . . . . 0.96 113.213 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -156.89 153.75 28.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.432 -0.581 . . . . 0.4 109.432 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -101.96 126.31 48.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.478 -0.564 . . . . 2.23 109.478 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.489 HD13 ' HG3' ' A' ' 35' ' ' GLN . 2.0 tm? -99.22 123.28 43.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.441 -0.577 . . . . 2.11 109.441 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.676 ' CB ' ' HB2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -126.92 122.52 34.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.524 -0.762 . . . . 2.02 111.256 -171.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.65 -0.704 . . . . 2.75 110.266 179.491 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.489 ' HG3' HD13 ' A' ' 26' ' ' LEU . 1.6 mp0 . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 1.5 109.555 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.31 147.66 37.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.99 110.204 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 HG13 HD13 ' A' ' 51' ' ' LEU . 32.7 mm -81.95 106.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.091 -0.707 . . . . 1.12 109.091 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.676 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 4.3 tmt_? -66.11 -42.39 89.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.941 -0.762 . . . . 3.48 108.941 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 p -174.48 154.87 2.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.736 -1.12 . . . . 1.82 109.56 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -109.93 127.41 66.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.664 -0.495 . . . . 1.11 109.664 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -65.18 128.36 93.71 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.045 -0.525 . . . . 2.28 109.973 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.51 144.9 98.22 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.477 2.118 . . . . 1.27 112.251 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.15 54.49 1.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.466 -0.788 . . . . 2.4 109.628 -177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.662 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.9 p -131.79 150.8 77.24 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.454 -0.794 . . . . 0.68 111.086 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.5 Cg_endo -62.31 -24.14 75.7 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.87 111.629 172.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.87 77.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.146 0.498 . . . . 1.17 109.904 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.63 -32.0 73.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 2.01 110.08 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.32 -32.01 68.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.009 -0.541 . . . . 1.15 111.686 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.2 p -72.65 -13.23 61.32 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.037 0.446 . . . . 0.4 110.697 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.07 26.44 6.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.741 -0.742 . . . . 0.62 112.709 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD21 ' HE2' ' A' ' 15' ' ' MET . 19.7 tp -77.41 158.3 30.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.051 -0.351 . . . . 1.12 110.051 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 39.5 ttm180 -158.04 160.92 37.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.811 -0.811 . . . . 5.17 108.811 -173.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -83.45 152.41 24.99 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.129 -0.228 . . . . 1.44 110.88 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 25.1 mt-30 80.92 1.2 1.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.114 0.884 . . . . 3.8 112.175 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.625 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 33.2 m-20 -84.05 146.34 27.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.868 0.366 . . . . 1.02 110.49 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.4 ttp-105 -106.44 136.88 45.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.501 -0.555 . . . . 2.26 109.501 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.11 123.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.804 -0.443 . . . . 1.37 109.804 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.711 HG11 ' HG2' ' A' ' 104' ' ' PRO . 47.0 t -99.93 -49.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.674 -0.694 . . . . 1.56 110.117 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 23.2 mt-10 -126.45 142.87 51.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.89 110.425 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 118.62 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.103 -0.498 . . . . 1.29 109.711 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.2 30.12 19.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.956 0.408 . . . . 1.17 110.966 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -3.68 73.89 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.891 -0.671 . . . . 0.66 113.96 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HE3' ' A' ' 65' ' ' MET . 7.5 p -113.46 129.26 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.791 0.795 . . . . 1.75 111.237 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.552 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.7 p -71.0 137.15 48.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.004 -0.998 . . . . 2.36 112.028 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 73' ' ' VAL . 24.1 mmt -115.0 11.46 16.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 1.42 111.048 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -59.42 -45.62 91.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 3.75 111.3 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.05 2.0 74.87 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.688 -0.768 . . . . 1.78 112.633 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.6 mmtt -90.72 179.53 5.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.208 -0.293 . . . . 3.73 110.208 -177.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -111.98 174.47 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.666 -0.243 . . . . 3.61 111.537 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.21 -43.93 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 2.2 111.415 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.86 -30.78 76.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.92 -0.657 . . . . 0.78 113.066 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.17 -46.1 62.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.936 0.398 . . . . 2.03 110.808 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 65' ' ' MET . 25.1 t -62.57 -46.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.828 -0.624 . . . . 1.71 111.049 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.05 -39.2 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 1.37 111.183 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 t -68.44 -38.82 81.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.324 -0.398 . . . . 1.12 110.646 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' CB ' ' HE2' ' A' ' 65' ' ' MET . . . -60.52 -38.68 85.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 1.09 111.658 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.95 -43.17 91.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.191 0.519 . . . . 1.35 110.432 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.4 -34.53 70.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 3.55 110.592 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.74 -15.51 63.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 1.28 111.415 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.4 80.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 0.6 111.725 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.23 -111.7 4.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.978 -0.63 . . . . 1.1 112.211 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 -8.34 35.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.664 0.269 . . . . 2.12 110.706 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.44 162.4 40.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.428 -0.351 . . . . 2.11 110.757 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 t -150.35 149.36 29.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.331 -0.395 . . . . 1.09 110.3 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.854 ' HG2' HG23 ' A' ' 14' ' ' THR . 26.9 mttm -115.15 117.46 30.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.713 -0.477 . . . . 2.25 109.713 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -107.89 129.73 55.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.857 0.36 . . . . 1.04 110.302 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.495 HD22 ' HG3' ' A' ' 59' ' ' GLU . 37.5 tp -103.7 116.62 32.67 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.19 -0.67 . . . . 1.22 109.19 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.52 161.83 34.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.005 -0.543 . . . . 1.09 110.756 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 10' ' ' PRO . 8.5 m -133.87 133.35 56.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.746 -0.661 . . . . 1.08 110.78 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.4 154.09 41.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 1.92 109.183 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 70.5 ttt180 -52.72 -41.61 64.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.251 0.463 . . . . 4.87 112.251 -170.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.34 -34.84 72.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.29 0.567 . . . . 2.68 110.72 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -79.45 -41.83 26.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.332 -0.849 . . . . 1.08 110.19 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 25.9 t0 -65.87 -39.01 90.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.206 -0.906 . . . . 1.18 111.689 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 5.1 mm-40 -63.58 -36.34 83.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.992 0.425 . . . . 1.94 110.061 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.16 -41.34 86.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 0.83 110.45 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -65.76 -37.39 86.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.365 -0.38 . . . . 0.55 111.276 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 44.4 mttp -62.95 -49.89 72.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.323 . . . . 2.5 111.266 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.86 -25.82 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 2.53 111.167 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.438 ' HB3' HG13 ' A' ' 102' ' ' VAL . 36.3 t -87.62 -11.87 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.045 0.45 . . . . 2.19 110.676 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 61.96 35.54 16.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.366 -0.834 . . . . 4.83 111.334 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 100' ' ' CYS . 10.0 p -128.56 142.47 43.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.241 -0.436 . . . . 2.08 110.263 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 103' ' ' ILE . 3.0 mp -85.85 126.48 65.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.534 . . . . 1.99 110.734 -176.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.711 ' HG2' HG11 ' A' ' 58' ' ' VAL . 22.8 Cg_endo -63.42 146.4 93.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.75 2.3 . . . . 0.86 111.617 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.5 p -157.67 173.04 17.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.639 -0.255 . . . . 1.92 111.353 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.504 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 51.8 mt-30 -60.12 -28.83 68.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.442 0.464 . . . . 1.87 110.703 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -58.47 -30.08 66.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.24 0.543 . . . . 2.82 111.118 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -85.88 -14.56 44.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.71 111.319 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.2 mt -63.09 107.64 1.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 1.47 110.443 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 60.41 24.79 14.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.96 -0.564 . . . . 4.09 110.494 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.74 174.17 15.13 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.915 -0.66 . . . . 1.39 111.973 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.87 136.39 38.31 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.902 2.401 . . . . 1.65 111.906 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 109.269 -0.641 . . . . 1.75 109.269 176.351 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.828 -0.805 . . . . 1.36 108.828 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -126.61 156.74 72.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.953 -1.022 . . . . 3.51 109.322 -174.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HB2' HD12 ' A' ' 87' ' ' LEU . 38.5 Cg_endo -65.49 165.97 21.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.138 1.892 . . . . 0.81 111.203 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.664 HH12 ' HB3' ' A' ' 90' ' ' ASP . 8.7 ptp85 -121.28 131.95 54.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.872 0.367 . . . . 2.82 110.157 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.5 tp -98.24 111.03 23.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.218 0.533 . . . . 1.96 109.83 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.3 m -98.92 117.59 33.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.544 -0.753 . . . . 1.17 109.799 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -105.75 117.61 34.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.297 -0.631 . . . . 1.13 109.297 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.62 142.49 51.48 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 1.08 111.072 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 37.1 ttpt -114.77 140.18 49.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.817 -0.629 . . . . 3.11 109.622 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.6 ttmt -58.4 105.82 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.779 -0.452 . . . . 1.5 109.779 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.35 -134.37 7.0 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 1.28 113.257 -172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.11 -53.74 2.82 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.291 2.66 . . . . 2.23 112.843 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -116.87 33.31 5.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.091 -0.504 . . . . 3.28 110.663 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.655 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 90.58 -120.07 5.79 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.581 -0.819 . . . . 1.93 111.389 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.493 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 52.7 m-85 -121.08 172.95 7.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.82 109.283 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.28 73.75 0.41 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.159 -1.019 . . . . 0.96 112.816 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -155.43 144.91 21.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.731 0.301 . . . . 0.4 110.203 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 7.2 t-20 -103.57 141.04 36.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.207 -0.664 . . . . 2.23 109.207 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.28 151.3 22.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.09 0.472 . . . . 2.11 111.535 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -108.82 122.27 46.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.645 . . . . 2.02 110.287 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 121.196 0.522 . . . . 2.75 109.862 175.629 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.479 ' HG3' HG23 ' A' ' 73' ' ' VAL . 26.7 mm-40 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.009 0.433 . . . . 1.5 110.448 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.8 m-85 -115.86 158.32 23.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.99 109.492 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.497 HG13 HD11 ' A' ' 51' ' ' LEU . 50.5 mm -87.28 106.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.553 -0.536 . . . . 1.12 109.553 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 25.2 ttt180 -65.24 -50.09 67.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.874 -0.603 . . . . 3.48 110.014 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 p -160.87 133.92 6.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 1.82 109.878 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 p -104.66 132.83 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.356 -0.609 . . . . 1.11 109.356 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.73 134.52 72.19 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.489 -0.56 . . . . 2.28 109.489 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.473 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 52.6 Cg_exo -53.48 136.34 63.46 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.25 2.633 . . . . 1.27 113.126 -177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p30 44.19 38.51 2.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.29 1.036 . . . . 2.4 112.825 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 92.0 p -93.69 165.68 17.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.692 -0.855 . . . . 0.68 108.692 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 10.4 Cg_endo -54.92 -30.31 68.2 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.789 1.659 . . . . 0.87 111.488 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.01 67.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.814 -0.63 . . . . 1.17 110.615 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 34.0 tt0 -70.03 -34.33 73.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.742 0.306 . . . . 2.01 110.384 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -24.89 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 1.15 111.959 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.9 p -75.83 -13.28 60.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.228 0.537 . . . . 0.4 110.718 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.43 37.41 4.04 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.603 -0.726 . . . . 0.62 111.874 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD11 HG13 ' A' ' 37' ' ' ILE . 17.4 tp -83.97 148.26 26.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.197 -0.298 . . . . 1.12 110.197 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.564 ' HD3' ' OD1' ' A' ' 55' ' ' ASP . 62.3 ttt-85 -128.95 151.42 49.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 5.17 110.364 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.6 133.02 44.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.437 -0.347 . . . . 1.44 111.37 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 12.9 mm-40 65.87 29.57 10.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.341 -0.845 . . . . 3.8 111.599 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.564 ' OD1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -88.71 136.17 33.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.105 -0.702 . . . . 1.02 109.105 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.3 129.2 36.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.706 -0.225 . . . . 2.26 110.626 -177.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.442 ' HA ' HG13 ' A' ' 88' ' ' VAL . 52.5 mt -82.87 123.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 1.37 109.779 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.537 HG13 ' HG2' ' A' ' 104' ' ' PRO . 6.5 t -106.05 -35.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.245 -0.434 . . . . 1.56 110.614 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.0 mt-10 -136.48 143.02 43.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.291 -0.413 . . . . 0.89 111.221 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.518 HG12 ' ND2' ' A' ' 61' ' ' ASN . 49.3 t -122.17 109.06 23.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.045 -0.724 . . . . 1.29 109.045 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.518 ' ND2' HG12 ' A' ' 60' ' ' VAL . 10.4 p30 46.47 43.18 11.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.958 0.885 . . . . 1.17 111.579 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 94.26 -4.46 70.49 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.782 -1.099 . . . . 0.66 114.19 174.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.4 t -98.33 119.54 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 117.522 0.661 . . . . 1.75 110.471 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 p -67.92 130.55 43.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.384 -0.825 . . . . 2.36 111.061 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.516 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mmt -117.2 45.28 1.92 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.989 -0.55 . . . . 1.42 111.971 -174.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -90.95 -47.73 7.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.137 0.494 . . . . 3.75 110.62 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.2 18.37 57.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 1.78 112.187 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 72.2 mmtt -100.37 173.83 6.4 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.176 -0.305 . . . . 3.73 110.176 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -112.85 178.49 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.591 -0.277 . . . . 3.61 111.169 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 74' ' ' VAL . 55.2 t-80 -54.88 -43.65 73.36 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.469 -0.332 . . . . 2.2 111.141 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.45 -38.23 95.5 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.013 -0.613 . . . . 0.78 112.831 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.68 -44.26 96.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.952 0.406 . . . . 2.03 110.714 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 77' ' ' ILE . 48.6 t -69.88 -46.81 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.763 -0.653 . . . . 1.71 111.047 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.2 t -63.96 -38.12 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.429 -0.35 . . . . 1.37 110.903 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.1 t -65.65 -36.04 82.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.051 -0.351 . . . . 1.12 110.051 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.39 -34.52 78.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 1.09 110.856 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.519 HG21 HG23 ' A' ' 84' ' ' THR . 29.0 mm -57.47 -45.42 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.7 0.762 . . . . 1.35 109.548 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -75.26 -31.07 60.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.862 -1.063 . . . . 3.55 111.119 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.28 -18.79 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 1.28 111.637 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.03 -17.48 79.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.6 112.252 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.47 -114.74 3.45 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.744 -0.741 . . . . 1.1 111.628 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.622 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 34.3 m-20 -110.04 -9.28 14.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.164 0.507 . . . . 2.12 110.25 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 1.8 pm0 -139.16 142.53 37.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.946 -0.57 . . . . 2.11 110.153 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 77' ' ' ILE . 10.2 t -133.01 151.17 52.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.435 -0.348 . . . . 1.09 110.624 -174.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -111.07 118.0 34.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.257 -0.646 . . . . 2.25 109.257 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.85 135.07 47.94 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.916 0.389 . . . . 1.04 110.1 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 10' ' ' PRO . 26.4 tp -104.92 115.77 30.85 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.915 -0.772 . . . . 1.22 108.915 176.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 13.2 m -127.46 158.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.967 0.413 . . . . 1.09 111.374 -176.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 147.66 30.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.592 -0.731 . . . . 1.08 110.402 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.664 ' HB3' HH12 ' A' ' 11' ' ' ARG . 21.3 p30 -92.47 176.94 6.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.965 -0.561 . . . . 1.92 110.298 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 54.4 ttp180 -54.72 -48.64 72.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.214 0.45 . . . . 4.87 112.214 -174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 1.8 pm0 -65.65 -42.76 91.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.843 0.354 . . . . 2.68 111.675 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -68.36 -44.67 74.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.07 -0.513 . . . . 1.08 110.772 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -60.86 -47.25 87.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.928 -0.578 . . . . 1.18 111.09 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 40.3 mt-10 -64.77 -32.85 74.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.605 -0.27 . . . . 1.94 110.64 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -64.24 -48.43 75.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.83 110.793 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.457 ' CD2' HG13 ' A' ' 102' ' ' VAL . 30.4 m-85 -66.96 -38.74 86.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.642 -0.254 . . . . 0.55 111.495 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -63.85 -47.27 81.39 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.801 0.297 . . . . 2.5 111.801 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.9 ptmt -65.79 -18.96 65.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.375 0.607 . . . . 2.53 110.537 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.442 ' HB2' HG11 ' A' ' 102' ' ' VAL . 92.4 m -94.04 -9.97 35.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.583 -0.735 . . . . 2.19 111.079 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.16 26.92 12.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.346 -0.843 . . . . 4.83 111.39 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.457 HG13 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -109.41 141.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.436 -0.579 . . . . 2.08 109.436 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.3 mm -87.26 123.12 70.43 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.158 -0.474 . . . . 1.99 110.434 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.537 ' HG2' HG13 ' A' ' 58' ' ' VAL . 18.6 Cg_endo -60.49 135.66 62.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.197 1.931 . . . . 0.86 110.678 174.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 m -154.69 166.31 33.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.086 -0.339 . . . . 1.92 110.086 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.436 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 48.3 mt-30 -62.06 -30.37 70.94 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.491 0.494 . . . . 1.87 112.288 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.7 -29.35 70.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 2.82 110.484 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.69 -14.93 60.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.994 -0.548 . . . . 0.71 111.366 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 91.8 mt -62.25 -46.59 88.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.096 0.474 . . . . 1.47 110.362 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -128.61 75.99 1.67 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.619 -0.719 . . . . 4.09 110.1 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.43 176.08 46.75 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.52 -0.764 . . . . 1.39 111.312 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.98 111.08 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.556 2.171 . . . . 1.65 112.642 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 113' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.448 -0.56 0 CA-C-N 116.192 -0.458 . . . . 1.75 110.458 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.222 -0.351 . . . . 12.09 112.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.2 mm -93.97 52.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.91 0.862 . . . . 10.3 109.534 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.564 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 14.1 t70 -92.98 130.78 35.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.262 -0.881 . . . . 7.1 109.759 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.0 -13.42 37.4 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.679 2.253 . . . . 7.27 113.368 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.26 4.42 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.644 0.238 . . . . 8.77 111.644 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 3' ' ' ASP . 6.3 t -77.31 0.27 22.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 4.49 110.952 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptp -89.37 -1.82 58.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 4.32 110.604 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.1 mt -85.53 59.31 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 1.36 110.08 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.485 ' HB3' HD23 ' A' ' 113' ' ' LEU . 14.0 ptt180 -129.37 148.97 71.4 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 3.51 110.424 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HB3' HG11 ' A' ' 89' ' ' VAL . 57.2 Cg_endo -70.43 174.5 9.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.787 2.324 . . . . 0.81 112.642 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -134.22 140.47 46.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.793 -0.64 . . . . 2.82 109.961 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.2 110.08 22.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.544 -0.539 . . . . 1.96 109.544 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.414 ' HG ' ' C ' ' A' ' 50' ' ' GLY . 9.0 m -89.78 116.2 27.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.759 -0.655 . . . . 1.17 110.003 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -107.4 118.83 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.444 -0.576 . . . . 1.13 109.444 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.451 ' HE3' HD22 ' A' ' 51' ' ' LEU . 22.7 ptp -137.39 133.26 34.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.89 0.376 . . . . 1.08 111.218 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 87.6 tttt -103.63 147.04 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.65 -0.704 . . . . 3.11 109.298 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 14.4 mtmt -57.33 110.32 0.83 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.893 -0.594 . . . . 1.5 110.747 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.96 -94.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.189 -0.914 . . . . 1.28 113.346 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.62 -72.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.803 2.336 . . . . 2.23 111.971 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -146.19 20.26 1.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.569 0.7 . . . . 3.28 109.753 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 174.5 -156.76 23.73 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.22 -0.9 . . . . 1.93 111.3 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.552 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 83.6 m-85 -112.02 168.17 9.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.337 -0.616 . . . . 1.82 109.337 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.2 70.52 0.45 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.067 -1.063 . . . . 0.96 113.089 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.81 163.1 40.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.01 -0.367 . . . . 0.4 110.01 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 25.6 t-20 -129.06 129.77 45.7 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.041 -0.527 . . . . 2.23 109.694 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.92 144.1 29.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.692 -0.484 . . . . 2.11 109.692 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.775 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.8 p80 -121.51 130.25 53.43 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.036 -0.666 . . . . 2.02 110.158 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -93.69 124.92 38.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.439 -0.801 . . . . 2.75 109.279 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.9 t70 -86.21 145.42 26.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.897 -0.408 . . . . 3.48 109.897 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 31.7 tptt -91.1 -4.51 56.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.249 -0.432 . . . . 4.89 111.097 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 m -116.32 -48.89 2.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.149 0.5 . . . . 3.79 110.707 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 22.5 pttm -108.02 132.6 20.94 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.982 -0.554 . . . . 3.51 110.505 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 153.98 41.29 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.74 2.293 . . . . 2.55 113.051 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.89 159.7 14.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.536 -0.756 . . . . 1.47 112.11 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 35' ' ' GLN . 4.2 mm100 -97.54 128.32 44.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.677 -0.49 . . . . 1.5 109.677 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 75.6 m-85 -112.11 143.71 42.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.301 -0.629 . . . . 0.99 109.301 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.572 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.1 mm -68.39 106.78 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.452 -0.573 . . . . 1.12 109.452 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.775 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.4 ttt180 -75.47 -48.0 24.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 3.48 109.809 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -159.63 143.78 14.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.33 -0.85 . . . . 1.82 109.957 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.79 145.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.724 -0.473 . . . . 1.11 109.724 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 11.0 t70 -87.68 121.92 70.69 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.34 -0.615 . . . . 2.28 109.34 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 24.4 Cg_exo -62.26 -22.54 74.3 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 123.07 2.514 . . . . 1.27 113.339 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -105.39 50.34 0.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.713 0.768 . . . . 2.4 109.418 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 53.5 p -145.28 162.0 39.22 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.454 -0.793 . . . . 0.68 110.035 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 18.9 Cg_endo -60.92 -18.44 57.09 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.045 2.496 . . . . 0.87 112.435 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -67.83 -52.39 37.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 1.17 110.798 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.78 -38.47 91.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.053 0.454 . . . . 2.01 109.865 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.37 94.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.185 -0.461 . . . . 1.15 111.223 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.435 ' OG ' ' HE2' ' A' ' 15' ' ' MET . 85.9 p -70.93 -19.84 62.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.4 111.016 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' C ' ' HG ' ' A' ' 13' ' ' CYS . . . 105.23 39.12 2.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.962 -0.637 . . . . 0.62 112.813 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.572 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -90.15 95.29 10.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 1.12 109.911 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -85.25 146.24 27.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 5.17 110.26 -176.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -71.03 142.82 50.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 1.44 110.845 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 2.0 mp0 78.96 -0.02 2.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.146 0.904 . . . . 3.8 111.854 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.7 m-20 -81.71 150.5 27.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.606 -0.516 . . . . 1.02 109.606 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 31.4 ttp-105 -104.64 142.82 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.775 0.321 . . . . 2.26 111.501 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 mm -72.82 123.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.592 -0.731 . . . . 1.37 109.587 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG12 ' HG2' ' A' ' 104' ' ' PRO . 43.5 t -111.92 -48.27 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.439 0.637 . . . . 1.56 109.943 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.5 mt-10 -125.68 146.37 49.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.391 -0.822 . . . . 0.89 110.045 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.69 120.58 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.975 -0.557 . . . . 1.29 109.88 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 62.21 23.06 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.555 -0.748 . . . . 1.17 111.015 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 9.39 62.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.906 -0.664 . . . . 0.66 112.609 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.5 t -114.02 128.04 71.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 1.75 110.446 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.0 p -77.47 129.29 35.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.767 -0.651 . . . . 2.36 110.914 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.71 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.6 mmt -117.15 26.89 9.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.167 0.432 . . . . 1.42 112.167 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.69 114.97 7.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.393 . . . . 3.75 110.253 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.76 62.02 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.866 -0.683 . . . . 1.78 112.913 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.71 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.9 mmtp -92.37 166.98 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.214 -0.291 . . . . 3.73 110.214 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.19 175.62 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.493 -0.321 . . . . 3.61 111.057 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -58.94 -44.09 91.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.786 0.327 . . . . 2.2 110.818 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -39.47 95.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.912 -0.661 . . . . 0.78 112.122 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.75 -47.19 84.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 2.03 111.174 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 77' ' ' ILE . 50.6 t -69.08 -47.52 74.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.71 110.972 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.9 t -64.47 -41.99 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.465 -0.334 . . . . 1.37 111.186 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -63.87 -35.79 81.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.981 -0.378 . . . . 1.12 109.981 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.12 93.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 1.09 110.942 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 73' ' ' VAL . 75.5 mt -60.87 -45.89 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 1.35 110.384 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 52.0 mtp180 -68.18 -28.15 67.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.003 -0.544 . . . . 3.55 110.816 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.24 8.98 16.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.116 -0.493 . . . . 1.28 110.96 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.58 -21.12 58.73 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.85 -0.69 . . . . 0.6 111.752 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -129.71 9.99 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.768 -0.729 . . . . 1.1 111.995 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.443 ' OD2' ' HE3' ' A' ' 16' ' ' LYS . 11.6 p-10 -80.46 -23.94 39.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.748 0.309 . . . . 2.12 111.083 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 2.2 pt-20 -138.26 162.67 33.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.89 0.376 . . . . 2.11 110.815 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -143.79 149.17 36.65 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.815 -0.629 . . . . 1.09 110.1 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -115.1 117.52 30.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.139 -0.482 . . . . 2.25 109.878 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.4 mt -109.05 135.64 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.065 -0.516 . . . . 1.04 110.427 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 44.4 tp -105.72 121.33 43.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.351 -0.611 . . . . 1.22 109.351 175.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.4 m -128.03 156.84 40.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.927 0.394 . . . . 1.09 111.569 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 10' ' ' PRO . 13.6 m -130.63 139.77 50.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.749 . . . . 1.08 110.382 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 173.65 6.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.778 -0.646 . . . . 1.92 110.64 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.601 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.1 ttt-85 -62.41 -49.39 75.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.848 -0.427 . . . . 4.87 109.848 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -39.56 94.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.204 0.526 . . . . 2.68 110.429 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.5 m -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.274 -0.875 . . . . 1.08 111.052 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.12 -37.29 78.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 1.18 111.303 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 31.8 mm-40 -63.54 -36.23 83.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 1.94 109.998 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.514 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 83.5 t80 -63.42 -46.82 84.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.743 -0.662 . . . . 0.83 110.214 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 104' ' ' PRO . 34.6 m-85 -64.26 -38.45 91.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.55 111.401 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -58.85 -50.01 75.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.956 0.407 . . . . 2.5 111.448 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -71.34 -19.04 62.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 2.53 111.663 -172.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -103.3 -2.5 27.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.926 0.393 . . . . 2.19 110.8 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER 57.57 45.3 19.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.595 -0.73 . . . . 4.83 110.895 -177.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.5 t -118.24 134.08 63.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 2.08 110.69 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.6 mm -93.1 120.07 67.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.374 -0.375 . . . . 1.99 110.018 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.472 ' HG2' HG12 ' A' ' 58' ' ' VAL . 32.8 Cg_endo -64.48 142.32 77.76 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.636 2.224 . . . . 0.86 112.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' OE2' ' A' ' 107' ' ' GLU . 9.3 t -153.24 -179.27 7.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.92 109.383 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -57.56 -30.99 65.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.411 0.523 . . . . 1.87 112.411 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.508 ' OE2' ' HB3' ' A' ' 105' ' ' SER . 0.0 OUTLIER -69.34 -28.77 66.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.948 0.404 . . . . 2.82 111.673 -177.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -77.46 -14.6 59.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.442 -0.344 . . . . 0.71 111.425 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 87' ' ' LEU . 96.0 mt -53.31 -58.33 7.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.818 0.342 . . . . 1.47 111.802 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -107.93 14.66 25.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.267 0.556 . . . . 4.09 110.532 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 113' ' ' LEU . . . -92.55 153.68 21.79 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.816 -0.629 . . . . 1.39 111.882 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.76 30.49 0.41 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.429 2.753 . . . . 1.65 113.102 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 70.6 mt 59.24 164.18 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.309 -0.86 . . . . 1.75 113.168 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 18.1 Cg_endo -60.16 156.66 38.69 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.805 2.336 . . . . 1.31 112.653 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.3 m -76.2 138.84 68.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.581 -0.736 . . . . 3.47 110.866 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.82 137.85 83.14 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.176 2.584 . . . . 4.93 112.787 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 67.83 8.54 6.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.319 -0.855 . . . . 8.1 112.245 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.9 m 73.58 -58.65 0.59 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.413 0.523 . . . . 9.11 112.413 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -125.02 -81.64 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.068 -0.253 . . . . 9.61 110.42 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -161.61 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.159 -0.543 . . . . 11.55 112.658 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 59.12 87.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.607 0.595 . . . . 13.92 112.607 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 pt -80.25 50.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.251 0.548 . . . . 16.21 110.917 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -69.94 121.75 17.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 18.9 111.243 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp 50.54 66.18 1.23 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.041 0.838 . . . . 20.83 111.575 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -82.39 81.07 8.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.808 -0.633 . . . . 22.5 109.686 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.45 -44.59 9.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.336 -0.393 . . . . 24.29 110.43 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.9 m 48.58 48.24 19.82 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.237 0.458 . . . . 25.0 112.237 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.378 -0.82 . . . . 27.94 109.363 175.46 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.969 -0.453 . . . . 12.09 111.969 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp -92.85 169.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 10.3 110.977 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 13.4 m-20 -92.96 132.6 30.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 7.1 110.391 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 17.0 Cg_exo -67.87 -65.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.568 2.179 . . . . 7.27 111.512 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -132.74 22.82 4.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 8.77 110.029 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 3' ' ' ASP . 9.4 m -98.02 93.71 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 4.49 111.381 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.9 ptp -108.56 18.16 21.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 4.32 110.546 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt -86.72 57.28 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 1.36 109.992 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 85.0 mtt-85 -115.72 149.86 43.83 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.07 -0.514 . . . . 3.51 111.447 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' A' ' 109' ' ' LEU . 2.9 Cg_exo -72.7 165.89 31.48 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.512 2.141 . . . . 0.81 109.866 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.63 HH12 ' HB3' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -127.7 131.1 49.81 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.237 -0.438 . . . . 2.82 110.043 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' HB2' HD23 ' A' ' 109' ' ' LEU . 2.0 tm? -98.64 112.79 24.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 1.96 109.521 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.4 m -105.74 125.67 51.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.888 -0.596 . . . . 1.17 110.711 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.473 HG21 ' HG2' ' A' ' 85' ' ' LYS . 24.2 m -111.98 117.38 32.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 1.13 109.174 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.6 ptp -126.53 133.6 51.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.178 0.513 . . . . 1.08 110.999 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -111.54 143.24 42.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.158 -0.928 . . . . 3.11 110.146 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 52.6 mttt -62.36 104.59 0.51 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.349 -0.841 . . . . 1.5 111.377 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.82 -80.2 0.93 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.044 -0.98 . . . . 1.28 111.623 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.98 47.5 2.23 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.723 2.282 . . . . 2.23 111.215 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m 61.58 27.6 17.03 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.12 -0.945 . . . . 3.28 110.69 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.521 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -177.09 -178.07 46.52 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.024 -0.608 . . . . 1.93 112.248 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.503 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 29.3 m-85 -106.55 -162.06 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.427 -0.583 . . . . 1.82 109.427 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.67 73.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.115 -1.04 . . . . 0.96 113.043 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -155.1 154.34 32.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.79 0.328 . . . . 0.4 110.287 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -108.75 134.78 50.99 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.383 -0.599 . . . . 2.23 109.383 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 35' ' ' GLN . 23.0 tp -105.24 152.66 22.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.109 -0.496 . . . . 2.11 111.351 -173.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.34 122.49 46.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.745 -0.835 . . . . 2.02 108.745 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -132.11 50.9 2.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.468 0.651 . . . . 2.75 111.198 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.32 142.2 28.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.359 -0.837 . . . . 3.48 110.118 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -78.87 -4.54 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.053 0.454 . . . . 4.89 110.566 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -77.42 -25.48 50.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 3.79 110.913 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.27 129.53 21.64 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 3.51 110.893 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.29 151.62 38.47 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.227 1.952 . . . . 2.55 111.399 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.93 155.61 21.55 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.596 -0.812 . . . . 1.47 111.212 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.456 ' HB3' HD12 ' A' ' 26' ' ' LEU . 21.4 mm-40 -102.23 128.81 48.59 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.49 -0.418 . . . . 1.5 110.377 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.86 151.33 23.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 0.99 110.557 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.41 106.36 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.276 0.56 . . . . 1.12 110.171 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.25 -54.35 38.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.006 -0.997 . . . . 3.48 110.54 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 p -168.35 137.3 2.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.814 -0.63 . . . . 1.82 109.981 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.38 130.99 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.353 -0.61 . . . . 1.11 109.353 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.53 135.44 72.04 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.511 -0.313 . . . . 2.28 110.246 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.94 139.23 66.81 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.776 2.318 . . . . 1.27 112.406 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.18 48.27 6.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.304 -0.862 . . . . 2.4 110.807 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 98.7 p -120.4 160.45 43.7 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.473 -0.785 . . . . 0.68 109.539 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.6 Cg_endo -54.46 -29.41 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.167 1.911 . . . . 0.87 111.575 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.23 -50.49 39.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 1.17 110.54 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -65.12 -35.85 82.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.297 -0.41 . . . . 2.01 110.49 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 1.15 111.641 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.7 p -72.99 -18.37 61.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.012 0.434 . . . . 0.4 110.8 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.12 14.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.62 112.547 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.65 114.76 9.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 1.12 110.355 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -97.53 149.65 21.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 5.17 109.906 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.37 151.82 39.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.276 -0.42 . . . . 1.44 110.585 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 70.35 10.7 7.32 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.774 0.671 . . . . 3.8 111.78 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.562 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.7 m-20 -84.6 168.53 15.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.722 -0.473 . . . . 1.02 109.722 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.445 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -131.31 131.26 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.848 -0.427 . . . . 2.26 109.848 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -72.57 130.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.228 0.537 . . . . 1.37 111.203 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.699 HG13 ' HG2' ' A' ' 104' ' ' PRO . 23.6 t -107.22 -48.47 8.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 1.56 110.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.568 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 35.5 mt-10 -133.87 148.34 51.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.89 110.756 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.23 117.78 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.958 -0.565 . . . . 1.29 109.773 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 58.78 31.02 20.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.18 0.514 . . . . 1.17 111.165 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.13 74.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.883 -0.675 . . . . 0.66 112.805 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.04 120.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.279 -0.267 . . . . 1.75 110.279 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 91.9 m -64.61 126.21 27.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.62 . . . . 2.36 111.438 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.576 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.8 mmt -105.14 68.78 0.83 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.923 -0.769 . . . . 1.42 108.923 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 103' ' ' ILE . 27.7 mt-10 -66.7 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.56 -1.2 . . . . 3.75 110.811 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.99 25.93 5.7 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.611 -0.996 . . . . 1.78 110.611 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.576 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 71.9 mmtt -58.2 147.1 31.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.873 -0.663 . . . . 3.73 111.642 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.494 ' HG3' ' H ' ' A' ' 72' ' ' ASP . 12.8 pt20 -77.11 161.36 28.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.092 -0.958 . . . . 3.61 110.29 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -55.4 -42.57 74.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 2.2 110.446 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.04 92.87 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.78 112.77 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.494 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 8.5 t0 -66.13 -47.09 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 2.03 110.013 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.406 HG23 ' SD ' ' A' ' 65' ' ' MET . 47.7 t -62.62 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.477 -0.783 . . . . 1.71 110.662 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.5 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 1.37 110.883 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -61.97 -39.22 91.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 1.12 110.015 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.18 94.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 1.09 111.012 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.057 0.456 . . . . 1.35 110.629 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -68.93 -24.95 64.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 3.55 111.219 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.63 -10.67 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 1.28 111.093 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -33.31 70.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.702 -0.761 . . . . 0.6 111.904 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.16 -109.38 3.36 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.019 -0.61 . . . . 1.1 112.184 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 11.6 t70 -102.04 -23.97 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.616 -0.513 . . . . 2.12 109.616 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.06 157.3 40.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.028 0.442 . . . . 2.11 110.459 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -146.93 149.32 32.97 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.934 -0.575 . . . . 1.09 109.856 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.473 ' HG2' HG21 ' A' ' 14' ' ' THR . 57.0 mttp -114.36 116.82 29.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.037 0.446 . . . . 2.25 109.896 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -109.54 136.35 49.07 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.838 -0.619 . . . . 1.04 110.574 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.8 tp -104.83 125.12 50.55 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.183 -0.673 . . . . 1.22 109.183 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 11.1 m -135.34 152.08 31.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.185 0.517 . . . . 1.09 111.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 94' ' ' ASP . 16.1 m -130.57 150.97 35.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.354 -0.839 . . . . 1.08 110.145 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.63 ' HB3' HH12 ' A' ' 11' ' ' ARG . 7.6 p-10 -89.97 176.16 6.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.449 -0.575 . . . . 1.92 109.449 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -53.51 -48.93 68.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.211 0.448 . . . . 4.87 112.211 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.2 -43.16 95.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 2.68 111.138 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.0 m -71.25 -41.03 70.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.332 0.587 . . . . 1.08 110.73 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.577 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 22.3 t0 -64.95 -39.31 93.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.528 -0.76 . . . . 1.18 111.072 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.29 -35.73 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 1.94 110.446 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -63.23 -48.03 79.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.83 111.005 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -64.47 -36.04 82.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.29 -0.414 . . . . 0.55 111.701 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 36.2 mttp -58.72 -49.82 76.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.786 0.291 . . . . 2.5 111.786 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 13.1 ptmt -70.85 -23.09 62.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 2.53 110.555 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.87 -7.16 59.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.861 -0.609 . . . . 2.19 110.68 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 57.88 28.94 16.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.423 -0.808 . . . . 4.83 111.299 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' A' ' 114' ' ' PRO . 10.8 p -132.28 147.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.043 -0.526 . . . . 2.08 109.955 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.401 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 70.6 mt -102.1 128.53 28.32 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 121.107 0.48 . . . . 1.99 110.812 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.699 ' HG2' HG13 ' A' ' 58' ' ' VAL . 18.4 Cg_endo -63.71 155.98 60.16 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.655 2.236 . . . . 0.86 112.845 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.593 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 2.1 m -150.12 175.68 11.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.326 -0.99 . . . . 1.92 108.326 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.608 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 22.9 mp0 -59.39 -34.92 73.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.333 0.587 . . . . 1.87 110.122 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.8 pt-20 -62.49 -30.21 71.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 2.82 111.682 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.44 ' HB2' ' H ' ' A' ' 105' ' ' SER . 33.7 m80 -79.29 -24.48 42.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.71 111.322 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.7 pp -91.96 -14.11 30.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.217 -0.447 . . . . 1.47 110.477 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -103.86 -50.91 3.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 4.09 110.785 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.72 -142.6 8.67 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.89 -0.672 . . . . 1.39 112.416 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -84.52 163.21 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.719 2.279 . . . . 1.65 113.236 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 39.6 mt -91.85 165.89 19.23 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.506 -0.77 . . . . 1.75 109.249 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 17.9 Cg_endo -60.14 134.29 55.16 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.119 1.88 . . . . 1.31 111.494 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.52 118.94 75.12 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 3.47 110.295 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.15 109.27 0.47 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.965 2.444 . . . . 4.93 112.045 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.46 -58.89 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.619 -0.718 . . . . 8.1 110.008 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.0 m -88.83 107.61 19.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 9.11 109.518 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -91.53 142.43 27.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.069 0.461 . . . . 9.61 111.153 -174.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -130.1 141.25 12.46 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.191 -0.763 . . . . 11.55 111.191 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -86.65 118.73 26.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.914 0.388 . . . . 13.92 110.045 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 54.7 mt -85.87 93.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.945 -0.571 . . . . 16.21 110.889 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -82.85 150.06 26.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.701 -0.682 . . . . 18.9 109.401 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.69 48.96 1.72 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.69 0.626 . . . . 20.83 112.69 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -86.63 60.31 6.15 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.305 -0.628 . . . . 22.5 109.305 170.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -67.06 -71.4 0.2 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.691 -0.686 . . . . 24.29 110.52 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.0 t -169.88 90.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 25.0 110.003 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 128' ' ' ARG . 17.7 ptt85 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 119.187 -0.435 . . . . 27.94 110.065 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.901 -0.48 . . . . 12.09 111.901 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.609 HD11 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -107.21 137.22 39.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.127 0.489 . . . . 10.3 110.918 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -94.54 107.92 33.32 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 7.1 110.083 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 15.19 1.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.741 2.294 . . . . 7.27 112.858 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -99.85 -46.65 5.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.519 -0.309 . . . . 8.77 110.902 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.86 HG22 ' HG ' ' A' ' 8' ' ' LEU . 7.3 m -57.11 111.22 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.534 -0.757 . . . . 4.49 111.258 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -91.21 53.43 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.298 0.57 . . . . 4.32 111.575 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.86 ' HG ' HG22 ' A' ' 6' ' ' THR . 69.5 mt -81.68 50.27 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.477 0.656 . . . . 1.36 109.876 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HB3' HD21 ' A' ' 113' ' ' LEU . 20.4 ptt85 -121.47 150.18 54.09 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.122 -0.945 . . . . 3.51 109.9 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.498 ' HB2' HD13 ' A' ' 87' ' ' LEU . 55.6 Cg_endo -69.16 158.36 58.04 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.46 2.107 . . . . 0.81 111.938 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 11' ' ' ARG . 7.8 ptp180 -118.29 131.59 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.737 -0.665 . . . . 2.82 110.016 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.5 tp -97.33 111.08 23.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 1.96 109.803 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 32.2 m -94.77 117.22 29.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.833 -0.622 . . . . 1.17 110.032 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 m -110.46 117.87 34.74 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.305 -0.628 . . . . 1.13 109.305 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.473 ' HE1' ' HA ' ' A' ' 46' ' ' ALA . 22.5 ptp -128.99 136.35 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.404 -0.362 . . . . 1.08 110.855 -174.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -110.72 139.86 45.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.677 -0.692 . . . . 3.11 109.249 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 11.7 ttmt -61.92 124.4 20.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.329 0.492 . . . . 1.5 112.329 -173.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -149.85 17.91 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.629 -0.714 . . . . 1.28 111.323 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.73 -30.65 17.48 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.037 2.491 . . . . 2.23 112.508 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -109.1 19.93 18.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 3.28 110.573 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.77 2.84 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.569 -0.824 . . . . 1.93 111.959 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.47 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 26.6 m-85 -119.07 -48.46 2.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.753 0.311 . . . . 1.82 110.527 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 70.02 1.23 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.0 -0.619 . . . . 0.96 113.635 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -156.52 156.06 33.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.942 -0.392 . . . . 0.4 109.942 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -101.81 126.48 48.69 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.82 -0.437 . . . . 2.23 109.82 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 tp -100.34 152.74 19.97 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.966 -0.561 . . . . 2.11 110.432 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' HD2' ' HB2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -106.61 122.7 46.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.305 -0.407 . . . . 2.02 110.108 -176.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 t -112.67 81.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.817 -0.628 . . . . 2.75 109.999 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.13 120.87 27.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.623 -0.717 . . . . 3.48 109.484 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -90.34 -16.0 30.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 4.89 110.454 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.9 m -86.84 -16.16 36.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.74 -0.664 . . . . 3.79 111.616 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -155.32 128.11 4.17 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 3.51 110.275 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.35 157.24 62.65 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.051 2.501 . . . . 2.55 112.496 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.61 125.9 5.28 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.135 -0.786 . . . . 1.47 111.135 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.559 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -94.42 139.77 30.69 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.436 -0.449 . . . . 1.5 111.276 -175.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -118.61 156.79 28.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.99 110.061 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.442 HG13 HD11 ' A' ' 51' ' ' LEU . 44.4 mm -96.37 110.06 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.151 0.5 . . . . 1.12 109.719 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB2' ' HD2' ' A' ' 27' ' ' HIS . 60.8 ttt180 -66.21 -55.15 17.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 3.48 110.371 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 p -169.67 139.24 1.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.812 -0.631 . . . . 1.82 109.599 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -96.41 138.05 22.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.341 -0.391 . . . . 1.11 109.984 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 t70 -71.59 124.0 90.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.178 -0.675 . . . . 2.28 109.178 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 35.1 Cg_exo -56.48 132.85 54.31 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.11 2.54 . . . . 1.27 113.751 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.0 t70 57.44 48.5 14.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.855 -1.066 . . . . 2.4 110.917 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -110.72 169.58 6.17 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.68 109.986 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.2 Cg_endo -55.16 -33.13 83.03 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.89 1.727 . . . . 0.87 111.333 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -60.86 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.439 0.638 . . . . 1.17 110.576 175.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.08 -50.61 73.04 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.276 -0.874 . . . . 2.01 110.067 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -17.5 62.54 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.711 -1.586 . . . . 1.15 111.353 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 51.6 p -84.72 -16.96 39.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.4 110.071 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.22 0.35 35.43 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.754 -0.736 . . . . 0.62 112.697 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 37' ' ' ILE . 37.8 tp -61.62 128.13 34.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.314 . . . . 1.12 110.31 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -117.86 154.21 32.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.251 -0.431 . . . . 5.17 109.915 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -78.88 145.37 34.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.528 -0.305 . . . . 1.44 110.305 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 85.3 mm-40 78.99 3.26 2.42 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.252 0.97 . . . . 3.8 111.202 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 36.4 m-20 -74.13 156.81 36.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 1.02 109.724 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.477 ' NH1' HG21 ' A' ' 58' ' ' VAL . 7.9 tmm_? -123.93 129.21 50.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.721 -0.474 . . . . 2.26 109.721 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.516 ' HA ' HG12 ' A' ' 88' ' ' VAL . 58.2 mt -76.22 130.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.225 0.536 . . . . 1.37 111.416 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.477 HG21 ' NH1' ' A' ' 56' ' ' ARG . 21.8 t -107.5 -51.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.237 -0.892 . . . . 1.56 110.149 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 26.1 mt-10 -130.61 144.35 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.89 111.031 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.31 118.2 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.333 -0.618 . . . . 1.29 109.333 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 61.0 22.41 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.17 110.937 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.98 6.28 63.49 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.66 112.915 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.87 120.73 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 1.75 110.37 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.529 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.2 m -63.51 130.02 42.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 2.36 110.841 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.588 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 25.6 mmt -109.62 18.63 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.406 0.622 . . . . 1.42 110.464 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -61.04 117.78 5.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.069 -0.969 . . . . 3.75 110.731 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.0 -16.76 50.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.833 -0.699 . . . . 1.78 112.951 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.588 ' HD2' ' HA ' ' A' ' 65' ' ' MET . 68.8 mttm -75.6 173.16 11.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.149 0.5 . . . . 3.73 111.808 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -103.36 -175.29 2.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.593 -0.73 . . . . 3.61 111.463 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.402 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 86.3 t60 -63.08 -42.87 99.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.506 . . . . 2.2 110.297 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.36 -39.68 96.49 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.737 -0.665 . . . . 0.78 113.203 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -62.57 -47.47 83.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.046 0.451 . . . . 2.03 110.765 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.33 -46.76 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 1.71 110.968 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.93 -40.08 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.395 . . . . 1.37 111.023 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.7 t -60.28 -42.01 94.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 1.12 110.843 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.72 -43.38 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 1.09 111.35 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.489 HG22 HG21 ' A' ' 84' ' ' THR . 80.6 mt -58.73 -42.38 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.427 0.632 . . . . 1.35 110.407 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 78' ' ' ARG . 31.7 mtp180 -74.29 -31.98 62.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.462 -0.79 . . . . 3.55 111.63 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.79 -7.63 59.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.438 -0.346 . . . . 1.28 111.23 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.31 73.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.182 -0.532 . . . . 0.6 112.186 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.57 -126.96 8.24 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.707 -0.759 . . . . 1.1 111.652 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.588 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 8.5 t70 -84.02 -28.37 27.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 2.12 110.017 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -128.85 160.2 33.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.105 0.479 . . . . 2.11 110.618 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 77' ' ' ILE . 10.6 t -146.07 148.74 32.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.56 -0.745 . . . . 1.09 109.647 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -116.42 117.36 29.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 2.25 110.042 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.85 128.34 53.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.946 -0.57 . . . . 1.04 109.75 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' A' ' 10' ' ' PRO . 57.0 tp -103.92 114.76 29.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.679 -0.859 . . . . 1.22 108.679 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.77 162.26 33.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 1.09 110.885 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.22 146.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 1.08 110.473 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.04 166.19 23.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.711 -0.677 . . . . 1.92 109.85 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -53.39 -48.17 68.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.009 0.433 . . . . 4.87 110.862 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -73.39 -28.13 61.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 2.68 109.973 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 m -70.58 -47.82 58.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.371 -0.832 . . . . 1.08 110.695 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -59.36 -45.04 92.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 1.18 110.478 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.8 -36.14 82.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.94 110.984 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.94 -46.09 89.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.83 110.555 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.474 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 48.7 m-85 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.248 -0.433 . . . . 0.55 111.257 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -59.51 -49.72 76.7 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.537 0.199 . . . . 2.5 111.537 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -70.92 -18.74 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 2.53 111.305 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 t -91.43 -19.51 22.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.306 0.574 . . . . 2.19 109.829 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.599 ' NE ' ' HA ' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 67.02 31.75 6.73 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 114.692 -1.14 . . . . 4.83 111.716 176.198 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.1 p -123.68 141.02 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 2.08 109.852 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 66.7 mt -82.4 129.07 64.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 1.99 110.367 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.474 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 14.5 Cg_exo -66.25 150.8 84.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.79 2.327 . . . . 0.86 111.623 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 t -163.34 178.38 8.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.566 -0.531 . . . . 1.92 109.566 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.412 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 71.1 mt-30 -55.13 -26.86 41.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.584 0.587 . . . . 1.87 112.584 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -55.7 -30.66 61.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.212 0.529 . . . . 2.82 111.389 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -89.77 -12.93 37.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.242 -0.435 . . . . 0.71 111.114 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 106' ' ' GLN . 96.4 mt -64.68 111.33 2.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.024 -0.535 . . . . 1.47 110.43 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 56.34 36.04 26.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 4.09 110.394 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.33 -167.86 11.45 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.605 -0.725 . . . . 1.39 111.843 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.33 150.0 22.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.608 2.205 . . . . 1.65 112.413 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 9' ' ' ARG . 65.3 mt -93.8 131.37 32.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 1.75 109.361 175.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.17 123.16 10.01 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.813 2.342 . . . . 1.31 112.797 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.51 87.88 12.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.168 -0.924 . . . . 3.47 110.241 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.63 39.35 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.22 2.613 . . . . 4.93 113.096 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.53 ' CD2' ' HA ' ' A' ' 121' ' ' GLU . 14.7 t80 -157.53 93.08 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.5 . . . . 8.1 109.985 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 119' ' ' ASN . 40.8 p -89.75 177.23 6.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 9.11 110.684 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 118' ' ' THR . 36.6 m-80 68.13 33.46 4.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.18 0.514 . . . . 9.61 110.582 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.19 104.63 1.67 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.591 -0.731 . . . . 11.55 112.846 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -82.38 70.05 9.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.332 -0.988 . . . . 13.92 108.332 174.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.6 pt -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.092 -0.958 . . . . 16.21 111.397 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -139.92 -41.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.927 -0.579 . . . . 18.9 111.493 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -176.08 -28.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.902 -0.136 . . . . 20.83 110.865 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.3 73.04 0.36 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.19 0.441 . . . . 22.5 112.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.65 98.58 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.645 -0.502 . . . . 24.29 109.645 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.3 t -113.43 165.59 12.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.248 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.789 -0.624 . . . . 27.94 109.921 177.754 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.718 -0.553 . . . . 12.09 111.718 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -129.49 113.97 29.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.984 -0.376 . . . . 10.3 109.984 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p-10 -89.36 135.93 30.59 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.005 -0.368 . . . . 7.1 110.005 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 5.8 Cg_endo -87.46 8.47 4.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.903 2.402 . . . . 7.27 112.14 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.417 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 95.9 m-85 -88.46 -19.49 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.03 -0.532 . . . . 8.77 110.369 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.0 t -79.91 -150.62 0.06 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.5 -0.773 . . . . 4.49 110.755 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.43 ' O ' ' HG2' ' A' ' 7' ' ' MET . 20.6 ttt 76.32 13.92 2.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.625 0.77 . . . . 4.32 110.63 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.477 ' HA ' ' HG1' ' A' ' 93' ' ' THR . 81.5 mt 61.68 27.65 17.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.787 -0.642 . . . . 1.36 112.366 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -110.57 143.09 27.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 120.757 0.313 . . . . 3.51 110.611 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HB3' HG13 ' A' ' 89' ' ' VAL . 64.6 Cg_endo -74.69 177.09 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.637 2.225 . . . . 0.81 111.094 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.417 ' NH1' ' HB3' ' A' ' 5' ' ' PHE . 7.8 ptt-85 -146.8 138.27 24.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.897 0.38 . . . . 2.82 111.326 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.23 116.57 29.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.687 -0.688 . . . . 1.96 110.139 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 4.3 m -97.38 115.91 28.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.12 -0.696 . . . . 1.17 109.12 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.42 HG22 ' HG2' ' A' ' 85' ' ' LYS . 27.7 m -110.23 117.42 33.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 1.13 109.334 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.7 ptp -135.06 140.46 45.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.154 -0.475 . . . . 1.08 111.146 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -110.44 153.02 25.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.309 -0.626 . . . . 3.11 109.309 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 5.4 ttmt -69.17 98.89 1.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.493 0.663 . . . . 1.5 111.118 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -106.79 3.15 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.034 -0.985 . . . . 1.28 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HD2' ' HG3' ' A' ' 45' ' ' PRO . 41.4 Cg_endo -70.32 84.11 0.76 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.693 2.262 . . . . 2.23 113.013 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m 63.3 67.38 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.383 0.882 . . . . 3.28 113.383 170.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.39 57.35 6.79 Favored Glycine 0 CA--C 1.517 0.162 0 C-N-CA 121.124 -0.56 . . . . 1.93 114.308 168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 68.08 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.088 0.555 . . . . 1.82 111.56 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.21 70.42 0.73 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.863 -0.684 . . . . 0.96 112.771 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.48 152.4 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.751 -0.463 . . . . 0.4 109.751 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -103.74 135.17 45.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.387 -0.37 . . . . 2.23 110.144 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 HD12 ' H ' ' A' ' 27' ' ' HIS . 0.2 OUTLIER -101.32 151.86 21.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.891 -0.595 . . . . 2.11 109.536 -176.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -106.12 122.02 45.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 2.02 110.065 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -95.56 107.92 20.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.988 -0.551 . . . . 2.75 110.101 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.31 156.66 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.451 -0.341 . . . . 3.48 110.392 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -136.53 10.94 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.687 0.756 . . . . 4.89 109.801 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.1 p -118.49 -39.3 3.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 3.79 111.134 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -111.95 142.07 26.05 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.619 0.247 . . . . 3.51 110.466 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.38 153.53 40.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.823 2.349 . . . . 2.55 112.505 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA3' ' HE ' ' A' ' 56' ' ' ARG . . . 89.89 166.63 41.69 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.864 -0.684 . . . . 1.47 111.59 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -116.21 130.76 56.95 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.735 -0.468 . . . . 1.5 109.735 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 68.2 m-85 -103.98 147.56 27.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.135 0.493 . . . . 0.99 110.99 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.497 HG13 HD13 ' A' ' 51' ' ' LEU . 50.6 mm -78.87 106.98 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.469 -0.787 . . . . 1.12 109.149 175.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 39.5 ttt-85 -62.36 -53.25 57.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.37 -0.832 . . . . 3.48 110.113 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 m -161.41 145.25 12.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 1.82 108.91 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.49 131.24 73.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.211 -0.663 . . . . 1.11 109.211 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 t70 -79.13 118.53 72.98 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.298 -0.41 . . . . 2.28 109.895 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 50.2 Cg_exo -56.12 142.15 86.61 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.088 2.526 . . . . 1.27 112.999 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 t70 67.93 47.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.347 -0.842 . . . . 2.4 110.725 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 85.1 p -127.98 164.16 38.88 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.612 -0.722 . . . . 0.68 109.178 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HG3' ' HD2' ' A' ' 19' ' ' PRO . 12.1 Cg_endo -57.43 -33.62 96.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.599 1.532 . . . . 0.87 111.326 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.0 -52.53 34.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.917 -0.583 . . . . 1.17 110.7 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.09 -41.56 97.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 2.01 110.273 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.77 -22.74 63.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 1.15 111.867 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.1 p -72.83 -9.73 59.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.27 0.557 . . . . 0.4 110.359 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.412 ' C ' ' HG ' ' A' ' 13' ' ' CYS . . . 103.12 31.4 5.05 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.559 -0.746 . . . . 0.62 111.792 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 37' ' ' ILE . 30.7 tp -97.13 139.53 32.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.019 -0.363 . . . . 1.12 110.019 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -131.44 148.5 52.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 5.17 109.506 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -73.23 149.87 42.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.093 -0.336 . . . . 1.44 110.093 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 75.2 mt-30 78.89 5.91 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.191 0.932 . . . . 3.8 111.477 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 47.9 m-20 -88.74 148.03 24.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 1.02 109.749 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 24.2 ttt180 -103.73 134.6 46.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 2.26 111.24 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.94 130.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.642 . . . . 1.37 110.031 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.603 HG13 ' HG2' ' A' ' 104' ' ' PRO . 41.3 t -111.24 -42.87 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.029 -0.532 . . . . 1.56 110.878 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.02 143.42 50.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.555 -0.293 . . . . 0.89 110.506 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.7 120.03 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.804 -0.443 . . . . 1.29 109.804 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 62.91 18.31 10.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.346 0.658 . . . . 1.17 111.249 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 0.05 73.09 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.586 -0.816 . . . . 0.66 111.858 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.11 128.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.855 -0.424 . . . . 1.75 109.855 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.454 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 23.1 p -66.68 126.51 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.754 -0.657 . . . . 2.36 111.773 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.3 mmt -133.68 38.81 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 1.42 110.515 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' OE1' ' HB2' ' A' ' 64' ' ' CYS . 41.3 mp0 -61.22 -52.74 63.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 3.75 111.201 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.72 34.78 2.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.674 -0.774 . . . . 1.78 112.472 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.592 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.6 mmtp -79.58 -175.37 4.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.732 0.301 . . . . 3.73 110.603 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -85.07 161.27 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.317 . . . . 3.61 110.658 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -55.84 -42.81 76.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.859 -0.423 . . . . 2.2 109.859 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.71 -39.11 94.82 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.5 -0.773 . . . . 0.78 113.032 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.18 -47.59 79.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.969 0.384 . . . . 2.03 111.354 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG23 ' HB3' ' A' ' 65' ' ' MET . 48.7 t -64.55 -43.45 96.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.984 0.421 . . . . 1.71 110.736 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.443 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 97.0 t -65.84 -41.89 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 1.37 110.413 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -62.18 -44.95 95.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 1.12 110.502 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB3' ' HE2' ' A' ' 65' ' ' MET . . . -57.36 -39.56 76.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 1.09 111.332 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.0 mt -57.46 -45.71 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.269 0.557 . . . . 1.35 110.724 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 74' ' ' VAL . 10.2 mpt_? -75.25 -31.99 60.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.703 -0.681 . . . . 3.55 110.983 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -14.75 63.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 1.28 111.874 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.23 -13.83 67.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.824 -0.703 . . . . 0.6 111.872 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.31 -99.82 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.869 -0.682 . . . . 1.1 111.977 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 9.3 t70 -104.72 -21.58 13.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.856 0.36 . . . . 2.12 110.528 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.29 162.29 31.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.844 0.354 . . . . 2.11 110.497 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 t -148.75 148.46 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.978 -0.556 . . . . 1.09 110.238 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HG2' HG22 ' A' ' 14' ' ' THR . 48.2 mttm -112.91 118.36 34.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.202 -0.453 . . . . 2.25 109.954 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.9 mt -105.82 127.66 53.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.976 0.417 . . . . 1.04 109.983 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.9 tp -103.6 118.34 36.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.907 -0.775 . . . . 1.22 108.907 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.2 m -125.52 162.0 29.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.109 -0.496 . . . . 1.09 111.008 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 10' ' ' PRO . 8.3 m -126.95 142.95 41.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 1.08 110.509 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -75.8 172.37 12.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.875 -0.602 . . . . 1.92 109.785 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -59.65 -48.47 81.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.056 0.455 . . . . 4.87 110.793 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.4 mp0 -65.48 -40.28 92.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.87 -0.604 . . . . 2.68 110.273 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.477 ' HG1' ' HA ' ' A' ' 8' ' ' LEU . 7.4 m -63.53 -50.9 67.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.31 -0.859 . . . . 1.08 110.872 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 29.8 t70 -59.08 -41.69 88.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.874 -1.057 . . . . 1.18 111.419 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.76 -36.93 62.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.414 -0.357 . . . . 1.94 111.41 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.13 -47.54 84.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.83 110.75 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -61.62 -38.26 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.55 111.524 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 24.2 mttp -66.32 -50.04 64.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.101 -0.24 . . . . 2.5 111.567 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 16.5 ptmt -72.7 -18.47 61.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 2.53 111.42 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.6 t -89.84 -13.39 36.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.723 -0.843 . . . . 2.19 108.723 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 68.12 33.46 4.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.633 -1.167 . . . . 4.83 110.655 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 114' ' ' PRO . 46.2 t -113.3 148.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.869 -1.06 . . . . 2.08 109.987 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.7 mt -97.23 123.22 53.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 110.199 -0.297 . . . . 1.99 110.199 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.603 ' HG2' HG13 ' A' ' 58' ' ' VAL . 36.9 Cg_endo -71.09 145.91 50.7 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.455 2.103 . . . . 0.86 111.499 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.5 p -160.49 170.12 21.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.55 -0.295 . . . . 1.92 110.97 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -55.89 -29.24 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.451 0.469 . . . . 1.87 111.262 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -58.46 -30.83 67.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 2.82 110.972 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -81.39 -15.35 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.71 111.276 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.8 mt -67.42 -55.09 15.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.526 . . . . 1.47 110.349 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -97.58 16.61 19.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 4.09 110.477 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.21 -163.54 11.35 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.907 -0.663 . . . . 1.39 112.329 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -94.38 178.07 0.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.455 2.77 . . . . 1.65 113.0 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.21 129.83 25.06 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 1.75 109.137 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.416 ' HG3' HG13 ' A' ' 102' ' ' VAL . 34.9 Cg_endo -66.22 129.98 22.96 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.705 2.27 . . . . 1.31 112.636 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 5.1 p -105.79 122.95 40.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 3.47 110.96 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.9 Cg_exo -75.34 126.32 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.594 2.196 . . . . 4.93 111.535 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.7 66.5 7.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.499 0.666 . . . . 8.1 110.694 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.6 m -149.07 21.0 0.98 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.213 1.006 . . . . 9.11 108.64 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.21 98.34 9.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.788 -1.096 . . . . 9.61 109.484 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.72 179.33 39.84 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.824 -0.703 . . . . 11.55 111.657 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.8 33.74 21.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.319 0.58 . . . . 13.92 111.048 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 14.7 pt -93.67 81.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.703 0.763 . . . . 16.21 110.808 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -110.21 -63.23 1.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.406 -0.816 . . . . 18.9 109.581 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm 50.08 78.27 0.1 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.291 -0.868 . . . . 20.83 111.474 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.44 -70.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 22.5 109.98 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -169.25 97.59 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.351 -0.84 . . . . 24.29 108.849 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.5 t -139.72 142.06 36.86 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.337 -0.392 . . . . 25.0 110.305 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.277 -0.868 . . . . 27.94 109.308 177.175 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.341 -0.704 . . . . 12.09 111.341 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 pt -88.16 47.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.666 0.746 . . . . 10.3 110.175 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 6' ' ' THR . 10.1 m-20 -68.05 123.51 87.41 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.211 -0.904 . . . . 7.1 111.246 -174.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.48 -6.35 16.31 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.969 2.446 . . . . 7.27 112.892 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -103.28 13.41 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 8.77 111.746 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.616 HG21 ' HG ' ' A' ' 8' ' ' LEU . 10.5 t -114.36 -173.95 2.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.804 -0.443 . . . . 4.49 109.804 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.42 ' HB3' ' HG2' ' A' ' 9' ' ' ARG . 51.6 mtt -77.57 -70.54 0.47 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.663 0.246 . . . . 4.32 111.663 -172.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.616 ' HG ' HG21 ' A' ' 6' ' ' THR . 26.1 mt 52.8 36.55 21.67 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.264 0.977 . . . . 1.36 111.222 -174.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.945 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 18.3 ptp180 -137.96 141.79 33.73 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.046 -0.525 . . . . 3.51 109.982 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HB2' HD22 ' A' ' 87' ' ' LEU . 30.2 Cg_endo -66.01 160.62 43.49 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.56 2.174 . . . . 0.81 111.588 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.769 -0.65 . . . . 2.82 110.431 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 87' ' ' LEU . 63.0 tp -98.27 111.54 23.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 1.96 109.765 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.519 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.8 m -98.8 117.1 32.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 1.17 110.158 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.6 m -104.07 118.45 36.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.539 -0.911 . . . . 1.13 108.539 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.425 ' HE2' HD22 ' A' ' 51' ' ' LEU . 21.4 ptp -131.04 133.6 45.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.101 0.476 . . . . 1.08 111.025 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 13.1 tmtt? -105.23 143.56 33.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 3.11 109.258 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.692 ' HE2' ' HH ' ' A' ' 22' ' ' TYR . 3.4 ttmt -64.43 117.53 7.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.102 0.477 . . . . 1.5 111.371 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.79 -124.03 4.08 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.618 -0.719 . . . . 1.28 111.869 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.15 -67.59 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.762 2.308 . . . . 2.23 113.223 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.2 m -121.18 34.87 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 3.28 111.048 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.14 -141.45 12.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.546 -0.835 . . . . 1.93 111.989 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.692 ' HH ' ' HE2' ' A' ' 17' ' ' LYS . 40.4 m-85 -107.22 -34.38 7.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.151 0.501 . . . . 1.82 110.028 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.47 68.36 0.95 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.153 -0.93 . . . . 0.96 112.91 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -156.88 156.7 33.58 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.802 -0.444 . . . . 0.4 109.802 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -119.74 137.59 53.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.304 -0.407 . . . . 2.23 110.143 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.62 153.88 19.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.456 0.646 . . . . 2.11 112.204 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 2.4 m-70 -105.8 121.57 44.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.005 -0.998 . . . . 2.02 108.352 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -134.84 87.74 2.37 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.903 -0.777 . . . . 2.75 108.903 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.6 t70 -86.76 137.39 32.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.087 -0.96 . . . . 3.48 109.968 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 1.1 57.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 4.89 110.88 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.46 -52.32 3.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.813 -0.81 . . . . 3.79 108.813 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 16.6 pttp -110.78 113.18 55.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.757 . . . . 3.51 110.443 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 163.02 39.88 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.902 2.401 . . . . 2.55 113.192 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.64 145.82 8.94 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.899 -0.667 . . . . 1.47 111.555 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.76 126.95 41.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.282 0.563 . . . . 1.5 110.565 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 50.0 m-85 -124.5 158.04 33.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.233 -0.894 . . . . 0.99 109.096 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.3 mm -87.66 112.39 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.461 -0.57 . . . . 1.12 109.461 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HA ' ' CD2' ' A' ' 27' ' ' HIS . 6.9 tmm_? -69.35 -55.68 9.72 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.097 -0.705 . . . . 3.48 109.097 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -163.15 143.54 9.17 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.485 -0.931 . . . . 1.82 108.485 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.93 122.64 50.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.048 -0.723 . . . . 1.11 109.048 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -62.29 115.29 15.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.499 -0.556 . . . . 2.28 109.499 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.0 150.88 61.58 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.857 2.372 . . . . 1.27 113.003 -174.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 66.66 47.65 1.55 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.039 -0.982 . . . . 2.4 110.33 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 90.2 p -133.6 160.85 66.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.95 -0.568 . . . . 0.68 110.629 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -28.53 83.81 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.443 2.095 . . . . 0.87 111.451 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.42 76.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.265 -0.425 . . . . 1.17 110.409 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -67.49 -41.54 84.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 2.01 110.107 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.62 69.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 1.15 111.975 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.519 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 62.0 p -70.72 -16.58 62.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.038 0.446 . . . . 0.4 110.578 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.07 15.37 22.06 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.73 -0.748 . . . . 0.62 112.975 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 ' HE2' ' A' ' 15' ' ' MET . 31.2 tp -72.02 147.8 46.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.103 -0.332 . . . . 1.12 110.103 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -140.84 157.62 45.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.957 -0.386 . . . . 5.17 109.957 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -80.11 155.12 27.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.42 -0.355 . . . . 1.44 110.831 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 14.1 mm100 75.24 7.45 4.09 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.977 0.798 . . . . 3.8 111.848 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 89.9 m-20 -93.12 154.91 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.946 -0.39 . . . . 1.02 109.946 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.579 HH11 ' HB3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -111.18 133.62 53.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.227 -0.442 . . . . 2.26 109.888 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.533 ' HA ' HG12 ' A' ' 88' ' ' VAL . 71.9 mt -78.25 124.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 1.37 110.849 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.09 -25.78 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.899 -0.591 . . . . 1.56 112.08 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.2 mt-10 -140.24 145.2 37.05 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.32 . . . . 0.89 110.625 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 65' ' ' MET . 96.6 t -131.44 124.83 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 1.29 109.885 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.3 21.64 9.89 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.223 0.609 . . . . 1.17 111.523 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.17 3.56 67.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.538 -0.839 . . . . 0.66 112.665 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.41 ' HB ' ' HE3' ' A' ' 65' ' ' MET . 45.4 t -102.95 128.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.105 -0.331 . . . . 1.75 110.105 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.55 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.4 t -63.5 121.16 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 2.36 110.467 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.799 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.9 mmt -108.72 -1.08 19.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 1.42 111.238 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -71.86 84.28 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.47 0.652 . . . . 3.75 109.718 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.18 -8.29 5.09 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.627 -0.715 . . . . 1.78 111.749 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.799 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.8 mmtt -75.97 -172.36 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 3.73 111.09 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -112.83 161.58 16.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 3.61 110.216 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -56.28 -42.88 78.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 2.2 110.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.59 -32.87 79.58 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.563 -0.827 . . . . 0.78 112.503 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.5 -47.32 61.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 2.03 110.432 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.461 HG11 ' SD ' ' A' ' 65' ' ' MET . 33.3 m -67.42 -41.92 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.944 -0.571 . . . . 1.71 111.503 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.35 -40.05 81.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 1.37 110.799 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -66.26 -38.23 87.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 1.12 110.108 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.3 97.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 1.09 111.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.534 HG21 HG21 ' A' ' 84' ' ' THR . 85.0 mt -58.38 -42.15 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.36 0.6 . . . . 1.35 110.591 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -74.74 -35.83 62.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.66 -0.7 . . . . 3.55 110.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.88 7.44 18.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.956 -0.566 . . . . 1.28 111.869 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 -14.59 81.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.6 112.013 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.01 -133.04 9.97 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.942 -0.863 . . . . 1.1 110.942 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 2.9 t70 -103.85 11.17 36.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.524 0.678 . . . . 2.12 109.69 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.539 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -149.2 159.58 44.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.298 -0.865 . . . . 2.11 109.473 174.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.534 HG21 HG21 ' A' ' 77' ' ' ILE . 14.8 t -148.35 149.77 32.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 1.09 110.52 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.48 ' HB3' HD13 ' A' ' 12' ' ' LEU . 76.1 mttt -110.89 117.07 32.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.059 -0.518 . . . . 2.25 110.014 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.0 mt -106.73 118.98 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.703 -0.48 . . . . 1.04 109.703 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 12' ' ' LEU . 4.8 tt -106.79 119.93 40.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.067 -0.716 . . . . 1.22 109.067 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 57' ' ' ILE . 35.5 m -126.59 166.76 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.226 -0.443 . . . . 1.09 110.958 -173.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 m -127.33 136.93 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 1.08 110.72 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 166.37 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.368 -0.833 . . . . 1.92 110.37 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -56.06 -47.5 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.302 . . . . 4.87 110.843 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.548 ' HG3' HD22 ' A' ' 8' ' ' LEU . 11.2 pt-20 -60.57 -38.24 83.92 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.3 0.571 . . . . 2.68 110.314 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.413 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 25.9 m -71.25 -48.35 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.24 -0.891 . . . . 1.08 110.691 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 24.7 t70 -60.55 -49.04 79.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.959 -0.564 . . . . 1.18 110.966 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 36.2 mt-10 -64.83 -27.55 68.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.94 111.141 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.37 -48.52 55.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 0.83 110.034 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HD1' ' O ' ' A' ' 93' ' ' THR . 41.9 m-85 -66.71 -36.74 83.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.377 -0.374 . . . . 0.55 111.82 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.7 mtpp -57.79 -50.14 74.27 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.665 0.246 . . . . 2.5 111.665 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 99' ' ' LYS . 11.2 ptmm? -71.48 -33.96 69.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 2.53 110.757 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -75.55 -11.28 59.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.529 -0.759 . . . . 2.19 111.969 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 55.71 33.49 21.46 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.406 0.682 . . . . 4.83 111.174 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.31 143.74 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 2.08 110.19 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.78 117.26 67.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.059 -0.349 . . . . 1.99 110.059 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.77 140.86 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.349 2.033 . . . . 0.86 111.51 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -157.73 175.07 14.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.427 -0.351 . . . . 1.92 111.195 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.527 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 10.8 mt-30 -53.62 -34.77 59.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.266 0.555 . . . . 1.87 111.127 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 124' ' ' LYS . 47.5 tt0 -59.3 -30.04 68.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.589 -0.732 . . . . 2.82 111.026 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -87.81 -12.85 43.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.71 112.103 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 77.0 mt -55.0 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.188 0.44 . . . . 1.47 112.188 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.945 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 9.9 t30 72.54 -14.7 0.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.684 -0.689 . . . . 4.09 112.225 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 109' ' ' LEU . . . -83.68 -121.13 0.8 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.725 -0.75 . . . . 1.39 112.669 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.404 ' HD3' ' HA3' ' A' ' 111' ' ' GLY . 52.4 Cg_endo -87.33 110.85 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.868 2.379 . . . . 1.65 112.768 -176.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 58.2 mt -79.01 167.25 36.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.622 . . . . 1.75 109.447 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -44.75 -50.01 8.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.668 2.245 . . . . 1.31 112.877 175.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 96.3 t 68.75 121.13 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.902 -1.045 . . . . 3.47 110.878 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 3.9 Cg_exo -74.23 52.5 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.333 2.689 . . . . 4.93 113.086 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.7 t80 62.85 96.59 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.826 0.851 . . . . 8.1 112.952 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -125.44 -45.83 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.271 -1.011 . . . . 9.11 108.271 168.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -108.43 179.07 4.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.962 -1.017 . . . . 9.61 109.277 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.38 -168.86 39.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.475 -0.869 . . . . 11.55 113.145 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.15 121.74 25.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.917 0.389 . . . . 13.92 110.588 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.0 pt -76.7 -26.51 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.907 -0.588 . . . . 16.21 110.586 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 50.82 74.36 0.24 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.782 0.676 . . . . 18.9 112.75 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -116.35 156.97 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 20.83 110.169 174.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -175.0 -66.4 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 22.5 109.934 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.85 -34.09 57.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 24.29 110.341 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.1 t -145.05 159.7 42.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.716 -0.674 . . . . 25.0 109.968 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 . . . . . 0 C--O 1.25 1.119 0 O-C-N 124.205 0.94 . . . . 27.94 110.636 174.418 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.776 -0.529 . . . . 12.09 111.776 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.4 pt -114.44 138.79 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 10.3 110.764 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.54 141.57 24.82 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.369 -0.604 . . . . 7.1 109.369 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.86 -71.13 0.04 OUTLIER 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.403 2.069 . . . . 7.27 113.175 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -143.72 58.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.31 . . . . 8.77 111.504 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -91.26 99.97 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.501 -0.555 . . . . 4.49 109.501 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.493 ' HG3' ' HG2' ' A' ' 9' ' ' ARG . 22.0 ptp -94.98 -15.0 23.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.641 -0.708 . . . . 4.32 111.763 -168.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.6 mt 62.93 19.37 11.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.613 -0.721 . . . . 1.36 112.555 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.552 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 31.4 ptt180 -114.52 160.02 34.68 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.717 -0.846 . . . . 3.51 108.717 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 30.7 Cg_endo -62.55 167.22 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.885 1.723 . . . . 0.81 111.895 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.509 ' HG3' HG23 ' A' ' 88' ' ' VAL . 1.6 ptm180 -128.56 135.96 50.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.971 -0.559 . . . . 2.82 110.347 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HG ' HD13 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -96.51 116.7 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 1.96 110.248 -176.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 82.6 m -101.61 116.81 33.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.579 -0.526 . . . . 1.17 109.579 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -108.79 120.27 41.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.399 -0.593 . . . . 1.13 109.399 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.557 ' HE3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -135.27 133.35 38.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.572 . . . . 1.08 111.548 -175.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -101.87 144.23 30.78 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.375 -0.83 . . . . 3.11 109.649 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.561 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.8 ttmt -65.66 113.01 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.036 0.446 . . . . 1.5 110.562 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.01 -99.72 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.444 -0.798 . . . . 1.28 111.323 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.43 97.97 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.761 2.307 . . . . 2.23 112.327 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 t 71.39 -47.19 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.004 0.922 . . . . 3.28 112.554 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 161.02 81.57 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.375 -0.917 . . . . 1.93 112.83 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' SER . 23.3 m-85 68.13 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.267 0.627 . . . . 1.82 111.601 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.81 69.76 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.896 -0.669 . . . . 0.96 112.817 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.31 154.06 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.705 -0.48 . . . . 0.4 109.705 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -119.27 131.46 55.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.806 0.336 . . . . 2.23 110.99 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.42 133.61 45.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.016 -0.538 . . . . 2.11 110.222 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.1 p80 -120.44 139.38 52.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 2.02 110.601 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 133.22 52.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.998 -0.741 . . . . 2.75 108.998 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.693 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.6 t70 -87.29 142.33 27.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.115 0.483 . . . . 3.48 110.478 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -77.72 -27.99 50.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.663 -0.699 . . . . 4.89 111.201 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 m -93.24 -43.39 8.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.253 -0.43 . . . . 3.79 110.568 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.693 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 24.1 pttm -116.9 130.52 24.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 3.51 110.399 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.54 156.43 36.22 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.521 2.148 . . . . 2.55 112.735 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.74 159.98 10.84 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.896 -0.669 . . . . 1.47 112.165 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -97.33 128.66 44.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.915 0.388 . . . . 1.5 110.163 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.429 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 68.8 m-85 -121.98 148.91 44.21 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.696 -0.853 . . . . 0.99 108.696 175.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 55' ' ' ASP . 38.2 mm -68.32 109.25 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 1.12 109.775 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -65.81 -54.45 26.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.235 -1.024 . . . . 3.48 108.235 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 m -166.34 135.46 3.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 1.82 109.348 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -94.65 121.81 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.386 -0.968 . . . . 1.11 108.386 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -78.22 121.52 84.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.255 -0.43 . . . . 2.28 110.032 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.75 155.98 20.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.513 2.809 . . . . 1.27 112.584 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.7 51.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.998 0.904 . . . . 2.4 109.218 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.2 p -146.94 154.56 47.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.979 -1.009 . . . . 0.68 109.508 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.89 -25.55 78.25 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 0.87 111.705 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.557 ' HA ' ' HE3' ' A' ' 15' ' ' MET . . . -70.52 -43.2 70.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.091 -0.504 . . . . 1.17 110.339 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -67.97 -35.0 77.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.218 0.533 . . . . 2.01 109.808 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -18.97 60.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.566 -0.743 . . . . 1.15 111.58 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 24.2 p -70.42 -18.1 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.138 0.494 . . . . 0.4 109.78 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.31 -0.57 33.01 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.986 -0.626 . . . . 0.62 112.141 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD13 HG13 ' A' ' 37' ' ' ILE . 22.4 tp -61.76 139.39 58.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.541 0.21 . . . . 1.12 110.735 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -124.56 -164.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.459 -0.571 . . . . 5.17 109.459 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.0 140.72 29.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.971 0.415 . . . . 1.44 111.081 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 68.91 26.82 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.952 -1.022 . . . . 3.8 113.013 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.519 ' HB2' HG13 ' A' ' 37' ' ' ILE . 6.2 m-20 -69.7 142.93 53.25 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.377 -0.971 . . . . 1.02 108.377 167.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -108.69 128.44 54.86 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.517 -0.549 . . . . 2.26 109.517 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 88' ' ' VAL . 24.4 mm -71.91 130.1 35.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 1.37 111.257 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.672 HG12 ' HB2' ' A' ' 104' ' ' PRO . 58.2 t -111.79 -51.52 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 1.56 109.959 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.6 mt-10 -136.89 152.49 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.746 -0.661 . . . . 0.89 110.283 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.626 ' HB ' ' HE1' ' A' ' 65' ' ' MET . 87.7 t -129.45 115.7 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.527 . . . . 1.29 109.579 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.21 26.49 15.89 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.478 0.486 . . . . 1.17 111.157 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.54 13.31 67.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.852 -0.69 . . . . 0.66 112.524 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.68 122.77 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.718 -0.475 . . . . 1.75 109.718 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.1 t -65.53 129.77 40.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.037 -0.529 . . . . 2.36 111.338 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.626 ' HE1' ' HB ' ' A' ' 60' ' ' VAL . 26.0 mmt -115.27 14.71 16.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 1.42 111.159 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.713 ' HG3' HG23 ' A' ' 103' ' ' ILE . 56.5 mm-40 -62.31 -31.06 71.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.622 . . . . 3.75 111.489 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.96 20.32 14.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 1.78 112.098 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 72' ' ' ASP . 71.9 mmtt -101.45 177.43 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.934 0.397 . . . . 3.73 110.749 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -125.61 -178.39 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.9 -0.591 . . . . 3.61 109.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -54.12 -41.15 68.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.781 0.289 . . . . 2.2 111.781 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.62 93.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.643 -0.789 . . . . 0.78 112.831 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 10.4 m-20 -65.58 -45.99 81.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 2.03 110.972 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 77' ' ' ILE . 98.7 t -62.54 -46.96 95.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 1.71 110.87 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.51 -37.87 78.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.834 0.349 . . . . 1.37 111.444 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.6 t -61.55 -38.79 88.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.74 -0.467 . . . . 1.12 109.74 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.58 78.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 1.09 111.194 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 73' ' ' VAL . 28.7 mm -57.35 -42.46 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.678 0.751 . . . . 1.35 109.378 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -74.81 -37.31 62.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.051 -0.977 . . . . 3.55 111.079 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -6.36 40.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.543 . . . . 1.28 111.988 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.16 -28.18 68.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.6 112.578 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.74 -120.15 4.74 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.768 -0.73 . . . . 1.1 111.442 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 51.4 m-20 -108.74 7.68 26.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 2.12 110.482 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.39 156.73 41.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.75 . . . . 2.11 108.974 171.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.927 0.394 . . . . 1.09 110.076 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -116.89 119.89 36.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 2.25 109.596 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.2 128.26 53.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.979 -0.555 . . . . 1.04 110.092 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 10' ' ' PRO . 23.2 tp -103.66 115.2 30.06 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.288 -1.004 . . . . 1.22 108.288 174.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.1 m -127.58 163.89 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.004 -0.544 . . . . 1.09 111.044 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.38 139.15 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.591 -0.731 . . . . 1.08 110.082 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.79 175.88 9.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.167 -0.469 . . . . 1.92 109.817 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 91' ' ' ARG . 3.3 tpp180 -62.5 -42.04 99.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.708 0.262 . . . . 4.87 111.708 -171.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.32 -42.91 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 2.68 110.715 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.7 m -66.48 -45.83 78.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.856 -0.611 . . . . 1.08 111.451 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 40.7 t0 -58.97 -47.44 85.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 1.18 109.318 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 68.2 mm-40 -59.95 -37.67 80.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 1.94 110.821 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.623 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 84.5 t80 -62.96 -49.34 75.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.512 -0.313 . . . . 0.83 110.973 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -66.64 -38.15 86.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.601 -0.272 . . . . 0.55 111.45 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.1 mtpp -60.28 -48.79 80.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.721 0.296 . . . . 2.5 111.326 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.2 pttt -71.47 -14.55 62.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.277 -0.419 . . . . 2.53 111.295 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.32 -10.62 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 2.19 111.257 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.78 28.23 17.98 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.821 -0.627 . . . . 4.83 111.502 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.569 HG11 ' HG3' ' A' ' 114' ' ' PRO . 10.1 p -123.82 142.12 41.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.998 0.428 . . . . 2.08 110.848 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.713 HG23 ' HG3' ' A' ' 66' ' ' GLU . 70.5 mt -79.4 128.43 75.36 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.718 -0.674 . . . . 1.99 110.971 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.672 ' HB2' HG12 ' A' ' 58' ' ' VAL . 6.1 Cg_exo -71.9 160.28 48.16 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.069 2.513 . . . . 0.86 111.602 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -165.31 164.96 19.79 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.921 -0.312 . . . . 1.92 110.735 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -59.22 -28.53 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 1.87 110.931 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -58.91 -30.53 67.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.031 0.443 . . . . 2.82 110.892 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -77.52 -15.16 59.44 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.71 111.509 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.411 HD13 ' HG ' ' A' ' 12' ' ' LEU . 60.1 mt -65.01 -61.59 2.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.529 0.68 . . . . 1.47 110.455 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.37 19.72 9.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.127 -0.942 . . . . 4.09 110.36 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.68 -175.81 14.17 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.855 -0.612 . . . . 1.39 112.139 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -87.44 159.83 8.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.354 2.702 . . . . 1.65 112.568 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 9' ' ' ARG . 45.3 mt -84.74 154.34 61.52 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.772 -0.649 . . . . 1.75 109.321 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.569 ' HG3' HG11 ' A' ' 102' ' ' VAL . 31.4 Cg_endo -64.57 112.52 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.506 2.138 . . . . 1.31 112.717 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 15.5 m -150.22 145.93 19.37 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 114.778 -1.101 . . . . 3.47 109.57 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.9 Cg_exo -78.41 67.31 8.32 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.981 2.454 . . . . 4.93 111.441 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -98.12 99.36 10.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 8.1 110.895 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.2 m 59.09 -85.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.457 0.703 . . . . 9.11 112.209 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -151.33 31.55 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 9.61 109.646 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.15 66.91 2.5 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.553 -0.748 . . . . 11.55 113.214 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.6 105.38 17.33 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.283 -0.636 . . . . 13.92 109.283 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.3 pt -71.62 125.29 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 16.21 111.365 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -81.98 65.66 7.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.04 -0.527 . . . . 18.9 111.141 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -84.09 -6.26 59.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.628 -0.714 . . . . 20.83 109.62 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.01 -55.24 11.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.303 -0.862 . . . . 22.5 110.533 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -100.27 114.55 28.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.925 -0.58 . . . . 24.29 110.523 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m -111.34 44.21 1.36 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 25.0 111.657 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.349 -0.834 . . . . 27.94 110.198 176.132 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.532 -0.627 . . . . 12.09 111.532 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.4 mt 53.0 86.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.375 0.607 . . . . 10.3 111.216 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.12 139.0 95.01 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.71 -0.677 . . . . 7.1 110.75 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.35 46.66 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.115 2.543 . . . . 7.27 111.888 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 62.3 74.33 0.44 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.413 -0.812 . . . . 8.77 110.494 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -89.16 36.02 0.81 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.6 0.714 . . . . 4.49 110.286 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 62.3 mtt -91.86 20.37 5.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.729 -0.669 . . . . 4.32 110.271 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.67 54.84 2.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.542 -0.753 . . . . 1.36 110.078 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 32.2 ptt180 -119.98 161.4 38.55 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.434 -0.803 . . . . 3.51 109.948 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.544 ' HB2' HD11 ' A' ' 87' ' ' LEU . 6.8 Cg_exo -70.28 169.73 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.463 2.109 . . . . 0.81 111.703 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -128.5 131.37 48.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 2.82 110.505 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.495 HD13 ' HB3' ' A' ' 85' ' ' LYS . 48.7 tp -95.43 110.57 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.009 -0.541 . . . . 1.96 109.623 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.426 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 60.0 m -92.98 117.8 30.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.102 -0.499 . . . . 1.17 110.23 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.8 m -106.56 118.76 37.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.487 -0.56 . . . . 1.13 109.487 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.585 ' HE3' ' HA ' ' A' ' 46' ' ' ALA . 21.9 ptp -133.79 133.65 41.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.826 -0.624 . . . . 1.08 110.486 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.66 136.73 52.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.046 -0.525 . . . . 3.11 110.016 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.602 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 9.5 ttmt -54.65 119.07 4.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.478 -0.783 . . . . 1.5 111.337 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.43 -107.37 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.568 -0.825 . . . . 1.28 112.678 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.88 -66.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.163 2.575 . . . . 2.23 112.904 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 t -140.86 85.45 1.99 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.375 -0.602 . . . . 3.28 109.375 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.32 -132.1 11.44 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.542 -0.837 . . . . 1.93 111.724 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 44' ' ' SER . 48.7 m-85 -119.99 -31.5 4.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.173 0.511 . . . . 1.82 110.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.42 68.05 1.2 Allowed Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.327 -0.851 . . . . 0.96 113.245 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -156.92 151.89 26.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.753 -0.462 . . . . 0.4 109.753 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.9 m120 -101.45 135.35 43.11 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.194 -0.669 . . . . 2.23 109.194 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -101.29 151.18 22.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.045 0.45 . . . . 2.11 111.352 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -108.9 122.1 46.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.78 -0.646 . . . . 2.02 110.1 -177.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m -121.53 99.37 6.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.881 -0.414 . . . . 2.75 109.881 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -98.03 122.54 41.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.949 0.405 . . . . 3.48 111.234 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -89.37 48.67 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.305 0.574 . . . . 4.89 109.872 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 t -158.21 -66.78 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.481 -0.781 . . . . 3.79 109.349 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -95.67 119.67 64.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.847 -0.427 . . . . 3.51 109.847 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.64 150.85 69.45 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.871 2.381 . . . . 2.55 112.691 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.8 172.11 13.46 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.267 -0.879 . . . . 1.47 110.981 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.491 ' HG3' HG21 ' A' ' 73' ' ' VAL . 23.0 mm-40 -125.09 128.04 47.85 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.466 -0.568 . . . . 1.5 109.466 175.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.2 m-85 -119.96 157.79 28.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.737 -0.468 . . . . 0.99 109.737 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.498 HG13 HD12 ' A' ' 51' ' ' LEU . 47.5 mm -91.21 109.89 21.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.29 0.566 . . . . 1.12 109.541 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 28.5 ttt180 -63.15 -48.19 79.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.93 -1.032 . . . . 3.48 109.892 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -162.36 160.34 26.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.571 -0.9 . . . . 1.82 108.571 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.58 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.417 -0.586 . . . . 1.11 109.417 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.45 125.84 89.4 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.877 -0.416 . . . . 2.28 109.877 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 141.85 97.92 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.747 2.298 . . . . 1.27 112.069 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 64.59 49.86 2.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.756 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 95.6 p -126.88 158.62 67.89 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.795 -0.639 . . . . 0.68 110.234 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.99 -27.86 80.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.257 1.971 . . . . 0.87 111.147 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' HE3' ' A' ' 15' ' ' MET . . . -64.79 -51.97 59.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.018 -0.537 . . . . 1.17 110.465 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.49 -38.23 90.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.286 -0.415 . . . . 2.01 110.762 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.67 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 1.15 111.415 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 59.5 p -70.68 -14.47 62.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.896 0.379 . . . . 0.4 111.03 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.99 7.07 29.5 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.018 -0.61 . . . . 0.62 112.899 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.498 HD12 HG13 ' A' ' 37' ' ' ILE . 19.7 tp -76.61 130.51 37.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.546 0.212 . . . . 1.12 110.579 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.16 -163.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 5.17 110.951 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.56 140.02 29.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.474 . . . . 1.44 111.207 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 70.34 15.85 7.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.307 -0.86 . . . . 3.8 112.162 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.1 m-20 -69.48 128.39 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.986 -0.376 . . . . 1.02 109.986 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.5 123.79 36.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 2.26 110.583 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.16 124.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 1.37 110.793 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG13 ' HD2' ' A' ' 104' ' ' PRO . 43.1 t -105.29 -45.15 8.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.63 -0.714 . . . . 1.56 110.949 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.5 mt-10 -132.82 153.52 51.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.89 110.479 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -126.77 120.97 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.112 -0.495 . . . . 1.29 109.842 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 63.57 17.77 10.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.192 0.597 . . . . 1.17 111.205 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.501 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.8 4.62 65.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.66 112.528 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.88 128.69 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.66 0.267 . . . . 1.75 110.38 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.548 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.5 m -59.38 118.67 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.724 -0.671 . . . . 2.36 111.558 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.401 ' HE2' ' HB1' ' A' ' 76' ' ' ALA . 22.8 mmt -126.88 70.79 1.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 1.42 111.774 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -135.43 139.42 44.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.968 -0.382 . . . . 3.75 109.968 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.5 -0.46 89.25 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.938 -1.265 . . . . 1.78 109.938 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -74.2 163.56 27.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.15 -1.025 . . . . 3.73 111.724 -178.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.4 177.81 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.594 -0.891 . . . . 3.61 108.594 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -63.0 -37.85 88.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.841 0.353 . . . . 2.2 110.684 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.79 92.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.256 -0.497 . . . . 0.78 113.112 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.96 -47.55 80.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.958 0.409 . . . . 2.03 110.966 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 35' ' ' GLN . 3.4 m -71.81 -41.87 69.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.844 -0.616 . . . . 1.71 111.496 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.6 t -61.99 -48.14 89.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.637 -0.256 . . . . 1.37 110.75 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 t -62.47 -37.67 86.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.552 -0.295 . . . . 1.12 110.303 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' A' ' 65' ' ' MET . . . -62.49 -45.89 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.797 0.332 . . . . 1.09 111.468 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.95 -41.21 90.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 1.35 110.805 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 69.0 mtp180 -74.03 -35.71 64.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 3.55 111.091 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.17 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.458 -0.337 . . . . 1.28 110.938 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.19 -21.06 67.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.021 -0.609 . . . . 0.6 112.1 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -117.99 5.11 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.029 -0.605 . . . . 1.1 111.963 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.602 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 39.6 m-20 -113.97 8.89 17.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 2.12 110.876 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.06 160.22 42.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.11 -0.7 . . . . 2.11 109.11 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.3 t -153.19 148.81 27.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.861 0.362 . . . . 1.09 110.594 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HB3' HD13 ' A' ' 12' ' ' LEU . 6.9 mptt -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.389 -0.597 . . . . 2.25 109.389 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.29 133.77 49.5 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.801 -0.444 . . . . 1.04 109.801 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.3 tp -103.84 115.99 31.48 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.17 -0.678 . . . . 1.22 109.17 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 14.3 m -131.62 155.41 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.019 -0.537 . . . . 1.09 111.209 -173.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.72 146.95 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.411 -0.813 . . . . 1.08 110.331 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.06 176.85 6.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.793 -0.64 . . . . 1.92 109.396 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 ttm105 -56.4 -47.92 78.0 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.786 0.291 . . . . 4.87 111.786 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.72 -40.82 89.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.116 0.484 . . . . 2.68 110.819 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 -48.12 29.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.726 -0.67 . . . . 1.08 111.154 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.583 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 5.5 t0 -60.78 -43.43 98.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 1.18 110.307 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.33 -37.44 77.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.256 -0.429 . . . . 1.94 110.669 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.401 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 91.3 t80 -63.16 -47.39 82.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.83 110.296 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.403 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 64.3 m-85 -67.4 -37.12 82.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.266 -0.425 . . . . 0.55 111.71 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 58.4 mttm -58.56 -50.15 74.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.913 0.387 . . . . 2.5 110.821 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 96' ' ' PHE . 19.3 ptmt -69.7 -22.35 63.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.742 -0.663 . . . . 2.53 110.904 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.37 -16.41 37.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.563 . . . . 2.19 111.072 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.07 37.18 18.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.489 -0.778 . . . . 4.83 111.393 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 114' ' ' PRO . 12.7 p -134.54 138.18 50.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.891 0.376 . . . . 2.08 110.688 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 70.0 mt -77.85 131.66 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 1.99 110.748 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 5.9 Cg_exo -70.54 153.43 65.34 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.946 2.431 . . . . 0.86 111.881 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.9 p -158.19 178.39 10.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.592 -0.277 . . . . 1.92 110.398 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.544 ' HA ' ' CD2' ' A' ' 109' ' ' LEU . 2.7 mp0 -55.61 -38.01 68.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 1.87 110.722 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.91 -31.28 69.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.248 0.547 . . . . 2.82 110.965 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.42 ' HD2' ' HD3' ' A' ' 114' ' ' PRO . 35.7 m80 -83.04 -25.48 32.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.71 111.584 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 109' ' ' LEU . 4.4 pp -95.34 -28.87 14.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.769 -0.651 . . . . 1.47 110.959 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -93.42 -23.79 18.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 4.09 110.034 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.51 -145.72 9.71 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.923 -0.656 . . . . 1.39 112.299 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.78 169.01 2.51 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.151 2.568 . . . . 1.65 112.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -90.53 151.16 43.83 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.709 -0.678 . . . . 1.75 110.095 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.437 ' HG3' HG11 ' A' ' 102' ' ' VAL . 74.1 Cg_endo -73.17 165.21 33.3 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 123.13 2.553 . . . . 1.31 112.351 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.56 124.09 66.67 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.923 -0.581 . . . . 3.47 109.92 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.97 88.17 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.83 2.353 . . . . 4.93 111.77 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -72.52 125.92 28.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.994 -0.548 . . . . 8.1 110.234 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.6 m 62.55 68.83 0.63 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.646 -0.706 . . . . 9.11 110.497 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -124.29 69.32 1.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.774 . . . . 9.61 109.539 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.72 55.82 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.852 -0.69 . . . . 11.55 111.871 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -73.73 95.81 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 13.92 109.423 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.7 pt -84.7 107.46 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.597 0.713 . . . . 16.21 112.496 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -103.82 74.35 1.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.809 -0.812 . . . . 18.9 108.809 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -122.96 71.48 1.05 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.571 -0.529 . . . . 20.83 109.571 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 127' ' ' SER . 44.5 mt-10 -111.63 3.12 17.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 22.5 110.35 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.64 -37.54 0.33 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.679 0.791 . . . . 24.29 111.707 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 125' ' ' GLU . 8.7 t 74.45 -42.81 0.51 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.945 0.898 . . . . 25.0 110.797 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.536 -0.745 . . . . 27.94 109.918 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 111.407 -0.677 . . . . 12.09 111.407 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.43 61.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.475 -0.935 . . . . 10.3 108.475 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' O ' HG22 ' A' ' 6' ' ' THR . 6.1 m-20 -78.19 125.86 84.39 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.156 -0.929 . . . . 7.1 110.521 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.45 -9.99 27.65 Favored 'Trans proline' 0 C--O 1.229 0.074 0 C-N-CA 122.834 2.356 . . . . 7.27 112.462 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -107.14 11.5 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.914 0.339 . . . . 8.77 111.914 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 3' ' ' ASP . 12.9 t -78.38 -35.95 46.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.166 -1.05 . . . . 4.49 108.166 171.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.3 ttm 62.4 11.43 4.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.449 -1.25 . . . . 4.32 112.419 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.474 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 88.6 mt 59.62 34.92 22.39 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.635 0.731 . . . . 1.36 110.57 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 109' ' ' LEU . 14.2 ptt180 -123.78 147.89 54.86 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.022 -0.99 . . . . 3.51 109.025 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HB2' HD11 ' A' ' 87' ' ' LEU . 30.8 Cg_endo -68.52 149.62 74.52 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.586 1.524 . . . . 0.81 110.798 172.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -120.6 135.49 55.08 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.283 -0.417 . . . . 2.82 110.25 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -92.68 111.25 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.957 -0.565 . . . . 1.96 110.159 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.29 117.61 30.37 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.517 -0.765 . . . . 1.17 109.368 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.65 HG22 ' HG2' ' A' ' 85' ' ' LYS . 27.0 m -109.57 119.05 38.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.685 -0.487 . . . . 1.13 109.685 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.449 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 24.4 ptp -131.33 133.59 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.04 0.447 . . . . 1.08 111.003 -174.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -97.9 132.63 43.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.871 -0.604 . . . . 3.11 109.421 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 20.6 ttmt -50.67 129.21 22.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.925 -0.58 . . . . 1.5 111.517 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.97 -158.42 24.36 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.771 -0.728 . . . . 1.28 111.588 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.74 -27.46 44.57 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.06 2.507 . . . . 2.23 112.642 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 p -105.16 13.87 30.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.039 -0.528 . . . . 3.28 110.563 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.06 2.73 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.615 -0.803 . . . . 1.93 111.182 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.409 ' HH ' ' HB2' ' A' ' 17' ' ' LYS . 37.2 m-85 -131.39 159.95 36.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.488 -0.93 . . . . 1.82 108.488 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.78 75.17 0.4 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 119.883 -1.151 . . . . 0.96 113.298 -173.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.03 168.77 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.849 0.357 . . . . 0.4 110.54 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -131.53 143.27 50.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.914 -0.585 . . . . 2.23 110.552 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.56 145.17 30.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.484 0.659 . . . . 2.11 111.835 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.608 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -110.65 129.38 55.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 2.02 109.426 172.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.7 m -151.72 84.03 1.29 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.58 -0.896 . . . . 2.75 108.58 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.0 153.23 21.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.326 -0.852 . . . . 3.48 111.074 -171.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -82.47 49.71 1.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.689 0.756 . . . . 4.89 109.72 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 t -151.33 -38.53 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.641 -1.163 . . . . 3.79 109.261 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -141.45 128.18 11.49 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.795 -0.638 . . . . 3.51 109.979 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.77 158.28 35.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.551 2.167 . . . . 2.55 112.41 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.46 166.26 13.07 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.224 -0.75 . . . . 1.47 111.224 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.554 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 2.7 mp0 -107.85 126.29 52.48 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.961 -0.385 . . . . 1.5 109.961 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.608 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 61.6 m-85 -117.61 157.67 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.551 -0.907 . . . . 0.99 108.551 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.509 HG13 HD11 ' A' ' 51' ' ' LEU . 44.2 mm -90.91 109.43 20.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.598 -0.441 . . . . 1.12 109.834 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -69.12 -54.63 13.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.889 -0.596 . . . . 3.48 110.547 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -152.36 144.1 23.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.709 -0.678 . . . . 1.82 109.912 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.77 137.89 55.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.732 -0.47 . . . . 1.11 109.732 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -82.05 122.96 80.1 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.563 0.22 . . . . 2.28 110.544 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -65.01 -19.68 63.78 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.867 2.378 . . . . 1.27 112.538 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.78 4.51 52.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.913 -0.585 . . . . 2.4 110.633 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 38.8 p -108.86 158.78 33.24 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 122.104 -0.372 . . . . 0.68 110.783 -174.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 28.3 Cg_endo -63.06 -15.97 51.36 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.798 2.332 . . . . 0.87 112.033 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.69 -51.51 48.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.096 -0.502 . . . . 1.17 110.328 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HG3' ' HA ' ' A' ' 42' ' ' PRO . 4.4 tm-20 -64.48 -40.65 96.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.918 -0.771 . . . . 2.01 108.918 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.36 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 1.15 111.966 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 15' ' ' MET . 60.3 p -77.32 -12.54 59.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.4 110.898 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.25 9.44 27.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.783 -0.723 . . . . 0.62 112.734 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.509 HD11 HG13 ' A' ' 37' ' ' ILE . 29.9 tp -78.17 141.58 38.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.727 0.298 . . . . 1.12 110.497 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.8 tpp180 -143.63 164.82 29.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.383 -0.599 . . . . 5.17 109.383 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.57 152.97 40.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.603 -0.271 . . . . 1.44 111.231 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 74.64 11.32 3.92 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.061 0.851 . . . . 3.8 112.135 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 17.9 m-20 -92.08 151.97 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.774 -0.454 . . . . 1.02 109.774 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -105.54 136.61 44.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.51 -0.313 . . . . 2.26 110.666 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.65 130.15 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 1.37 110.151 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.768 HG13 ' HG2' ' A' ' 104' ' ' PRO . 22.7 t -114.37 -47.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 1.56 111.057 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.5 mt-10 -126.29 148.82 49.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.887 0.375 . . . . 0.89 110.928 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.497 ' O ' HG11 ' A' ' 63' ' ' VAL . 61.8 t -129.41 122.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 1.29 109.206 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 62.87 21.09 12.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.785 0.434 . . . . 1.17 111.056 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.3 74.73 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.733 -0.746 . . . . 0.66 113.382 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 60' ' ' VAL . 14.6 p -107.61 138.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.38 0.59 . . . . 1.75 110.111 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 50.9 t -74.5 136.81 42.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 2.36 111.434 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.589 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 25.1 mmt -121.62 68.06 0.9 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.447 -0.797 . . . . 1.42 111.128 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -103.69 -59.15 1.77 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.324 -0.398 . . . . 3.75 110.517 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.62 4.74 Favored Glycine 0 C--N 1.329 0.182 0 N-CA-C 111.548 -0.621 . . . . 1.78 111.548 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.589 ' HG2' ' HB3' ' A' ' 65' ' ' MET . 0.0 OUTLIER -110.94 -172.19 1.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.782 0.801 . . . . 3.73 112.722 -171.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -121.46 150.0 42.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 3.61 108.287 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -56.21 -43.7 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 118.267 0.485 . . . . 2.2 110.162 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.66 88.15 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.696 -0.684 . . . . 0.78 112.668 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.92 -40.03 83.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 2.03 110.362 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 77' ' ' ILE . 63.9 t -65.29 -47.34 87.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.614 . . . . 1.71 110.825 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' HA ' HD13 ' A' ' 77' ' ' ILE . 57.6 t -64.9 -36.78 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.21 0.529 . . . . 1.37 110.071 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 t -61.58 -44.41 97.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.594 -0.73 . . . . 1.12 110.163 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.82 -42.54 93.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.239 -0.437 . . . . 1.09 111.227 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.491 HG21 HG22 ' A' ' 84' ' ' THR . 74.4 mt -58.9 -40.75 81.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 1.35 110.773 177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 mtm-85 -74.18 -39.36 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 3.55 110.976 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.68 10.47 9.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 1.28 111.609 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.74 -33.77 74.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.207 -0.52 . . . . 0.6 112.68 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.68 49.93 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 1.1 111.63 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.619 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 32.2 m-20 67.54 1.57 2.6 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.574 0.749 . . . . 2.12 112.485 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -151.6 154.28 36.13 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.825 -0.805 . . . . 2.11 108.825 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.491 HG22 HG21 ' A' ' 77' ' ' ILE . 12.9 t -141.51 148.11 38.86 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.04 0.448 . . . . 1.09 110.134 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.65 ' HG2' HG22 ' A' ' 14' ' ' THR . 42.2 mttm -118.78 116.92 27.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.511 -0.551 . . . . 2.25 109.511 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.6 mt -106.53 131.27 53.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.434 -0.348 . . . . 1.04 110.128 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 10' ' ' PRO . 16.6 tp -103.79 117.12 33.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.934 -0.765 . . . . 1.22 108.934 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 20.7 m -126.75 151.81 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.142 0.496 . . . . 1.09 111.72 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.56 149.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.082 -0.963 . . . . 1.08 109.717 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.243 -0.651 . . . . 1.92 109.243 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -60.41 -43.89 96.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.89 0.33 . . . . 4.87 111.89 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.08 -35.69 78.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.433 . . . . 2.68 109.83 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 8' ' ' LEU . 89.6 m -69.3 -44.44 71.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 1.08 110.832 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.635 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 33.7 t0 -58.77 -47.71 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.938 -0.393 . . . . 1.18 109.938 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 50.1 mm-40 -61.1 -37.96 84.6 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.058 -0.519 . . . . 1.94 110.823 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.716 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 66.6 t80 -62.11 -48.0 82.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.175 -0.466 . . . . 0.83 110.672 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CD2' HG12 ' A' ' 102' ' ' VAL . 41.8 m-85 -67.34 -37.19 82.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.953 -0.567 . . . . 0.55 111.799 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 66.2 mttm -58.86 -50.82 72.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.051 0.453 . . . . 2.5 111.385 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.716 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 18.9 pttp -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 2.53 111.367 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.499 ' HB3' HG13 ' A' ' 102' ' ' VAL . 35.4 t -82.4 -6.61 59.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.862 0.363 . . . . 2.19 111.539 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER 56.68 40.65 29.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.638 -0.71 . . . . 4.83 111.677 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.52 HG12 ' CD2' ' A' ' 97' ' ' PHE . 5.7 p -126.46 145.12 34.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.357 -0.383 . . . . 2.08 110.492 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.38 121.66 67.21 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-O 120.979 0.419 . . . . 1.99 111.113 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.768 ' HG2' HG13 ' A' ' 58' ' ' VAL . 24.4 Cg_endo -65.71 138.53 54.16 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.537 2.158 . . . . 0.86 111.223 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.432 ' HG ' ' CD ' ' A' ' 59' ' ' GLU . 25.1 t -159.62 178.28 10.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.783 -0.451 . . . . 1.92 109.783 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.52 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 99.3 mt-30 -54.75 -30.46 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.301 0.572 . . . . 1.87 110.859 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.84 -30.39 67.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.616 -0.72 . . . . 2.82 111.465 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -89.02 -14.0 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.482 0.549 . . . . 0.71 112.482 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 95.8 mt -47.74 -54.54 11.9 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.348 0.405 . . . . 1.47 111.492 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -132.36 26.63 4.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.971 0.891 . . . . 4.09 109.442 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.95 165.75 23.22 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.016 -0.993 . . . . 1.39 110.776 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.74 124.9 12.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.221 1.947 . . . . 1.65 112.172 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.14 127.52 93.52 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.197 -0.668 . . . . 1.75 109.197 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.85 146.07 76.83 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 123.079 2.519 . . . . 1.31 112.857 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 4.4 p -98.07 118.38 63.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.489 -0.778 . . . . 3.47 110.757 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.4 Cg_exo -74.56 132.11 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.831 2.354 . . . . 4.93 111.454 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 59.4 -151.35 0.42 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 123.365 0.416 . . . . 8.1 110.167 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.7 m -143.17 106.52 4.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.76 0.315 . . . . 9.11 110.546 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.98 105.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 9.61 110.609 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.1 -94.4 0.55 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.602 -0.809 . . . . 11.55 112.642 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -92.18 72.96 5.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.354 0.597 . . . . 13.92 111.114 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.1 pt -105.82 1.52 10.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.147 -0.686 . . . . 16.21 109.147 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -142.44 104.45 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 18.9 110.159 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.32 118.96 32.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 20.83 110.152 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.13 155.92 29.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.297 -0.26 . . . . 22.5 110.297 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -122.01 76.87 1.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.468 -0.568 . . . . 24.29 109.468 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -145.62 -57.82 0.32 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 25.0 109.964 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.873 -0.584 . . . . 27.94 109.704 177.134 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 111.262 -0.735 . . . . 12.09 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.416 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 39.5 mm 62.71 76.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.41 0.624 . . . . 10.3 110.246 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.79 110.61 42.85 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.626 -0.715 . . . . 7.1 110.864 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 2' ' ' ILE . 14.0 Cg_exo -70.05 -33.86 14.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.827 2.351 . . . . 7.27 111.369 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.12 69.54 0.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.56 -0.745 . . . . 8.77 109.795 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -64.18 121.01 13.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.492 0.663 . . . . 4.49 110.732 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 mtt -127.89 32.62 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.673 -0.694 . . . . 4.32 109.819 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 54.8 mt -92.44 38.88 1.02 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.395 -0.82 . . . . 1.36 110.606 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -119.82 156.26 54.24 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 3.51 108.938 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HB2' HD11 ' A' ' 87' ' ' LEU . 65.6 Cg_endo -71.58 -174.3 1.23 Allowed 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.356 2.038 . . . . 0.81 112.146 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.42 ' HG3' HG22 ' A' ' 88' ' ' VAL . 15.6 ptt85 -146.65 135.36 22.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.82 110.848 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HG ' HD12 ' A' ' 109' ' ' LEU . 7.3 mt -92.85 121.7 34.49 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.542 . . . . 1.96 110.849 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.0 m -109.1 129.1 55.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.002 -0.544 . . . . 1.17 109.601 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -112.37 118.53 35.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.731 -0.47 . . . . 1.13 109.731 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.475 ' HE2' HD21 ' A' ' 51' ' ' LEU . 25.1 ptp -130.44 142.48 50.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.013 -0.365 . . . . 1.08 110.013 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 14.5 ptpt -121.12 156.52 32.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.003 0.43 . . . . 3.11 110.123 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 8.7 ttmt -61.37 117.17 5.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.797 -1.092 . . . . 1.5 111.651 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.66 -149.29 9.17 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.53 -0.759 . . . . 1.28 112.181 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.83 -33.07 27.98 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.676 2.251 . . . . 2.23 113.258 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -110.27 -21.09 12.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.17 0.509 . . . . 3.28 110.589 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.62 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 144.59 -116.3 0.93 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.131 -0.787 . . . . 1.93 111.131 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.26 160.71 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.72 -0.844 . . . . 1.82 108.72 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.14 71.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.599 -1.286 . . . . 0.96 113.462 -171.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -155.63 150.88 26.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.986 -0.376 . . . . 0.4 109.986 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.15 131.94 54.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 2.23 109.61 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.2 mt -101.3 136.93 40.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.367 -0.379 . . . . 2.11 110.414 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.1 p80 -124.47 125.17 43.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.116 0.484 . . . . 2.02 110.48 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.711 ' HB3' HE22 ' A' ' 35' ' ' GLN . 4.4 p -102.13 132.77 47.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.338 -0.846 . . . . 2.75 110.692 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.08 134.1 33.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.024 -0.732 . . . . 3.48 109.024 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -81.79 -14.99 55.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.483 -0.326 . . . . 4.89 110.709 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -91.03 -53.23 4.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 3.79 109.802 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -109.84 104.36 55.31 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.51 110.244 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.07 144.27 80.37 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.997 2.465 . . . . 2.55 113.32 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.86 178.19 22.86 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.838 -1.074 . . . . 1.47 111.568 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.711 HE22 ' HB3' ' A' ' 28' ' ' SER . 26.3 mm-40 -122.93 127.42 48.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.029 -0.36 . . . . 1.5 110.029 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.494 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 41.0 m-85 -122.04 147.58 45.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.979 -0.748 . . . . 0.99 108.979 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.526 HG13 HD13 ' A' ' 51' ' ' LEU . 39.1 mm -77.39 105.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.445 -0.576 . . . . 1.12 109.445 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 49.1 ttt180 -75.12 -45.68 39.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.567 . . . . 3.48 110.027 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -149.19 146.35 27.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 1.82 109.474 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.9 132.37 71.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.805 -0.813 . . . . 1.11 108.805 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.49 126.28 92.23 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.858 -0.61 . . . . 2.28 110.693 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.45 124.03 15.27 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.657 2.238 . . . . 1.27 112.595 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 64.42 36.08 9.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.177 -0.92 . . . . 2.4 111.371 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 94.5 p -97.65 165.67 15.09 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.76 -0.654 . . . . 0.68 109.402 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 12.8 Cg_endo -58.63 -25.6 75.69 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.829 1.686 . . . . 0.87 111.276 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.42 -52.35 22.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.756 -0.656 . . . . 1.17 110.409 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.85 -36.0 82.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.811 0.338 . . . . 2.01 110.457 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.82 65.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 1.15 112.016 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -80.98 -13.45 58.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.966 0.412 . . . . 0.4 110.51 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 26.6 6.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.855 -0.612 . . . . 0.62 112.409 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 37' ' ' ILE . 28.1 tp -94.9 133.25 38.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 1.12 110.473 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 54' ' ' GLN . 13.1 tpp180 -122.49 158.8 29.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.738 -0.467 . . . . 5.17 109.738 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.16 29.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.043 0.386 . . . . 1.44 112.043 -174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 52' ' ' ARG . 12.2 mm100 -132.99 1.17 3.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 3.8 109.707 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 35.7 m-20 -88.29 154.35 20.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.556 -0.747 . . . . 1.02 111.235 -171.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 18.4 ttm180 -116.54 135.04 54.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.407 -0.59 . . . . 2.26 109.407 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.99 123.13 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.65 -0.5 . . . . 1.37 109.65 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.86 -44.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.251 -0.431 . . . . 1.56 110.42 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 34.9 mt-10 -134.48 143.53 47.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.89 110.029 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.96 117.75 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.685 -0.487 . . . . 1.29 109.685 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.59 30.29 19.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.48 0.487 . . . . 1.17 110.945 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 -6.17 79.29 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.068 -0.587 . . . . 0.66 112.974 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -95.88 124.15 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 0.231 . . . . 1.75 110.557 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.54 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.2 t -66.22 136.93 56.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 2.36 111.188 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.438 ' HA ' ' CG ' ' A' ' 68' ' ' LYS . 21.4 mmt -118.09 2.22 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 1.42 111.82 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 97.88 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.357 -0.608 . . . . 3.75 109.357 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.88 12.94 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.78 111.659 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.438 ' CG ' ' HA ' ' A' ' 65' ' ' MET . 34.7 mmtp -84.01 166.78 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 3.73 110.877 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -94.29 174.21 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.645 . . . . 3.61 110.83 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -57.53 -43.06 84.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 2.2 110.359 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.04 96.77 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.78 113.549 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.51 -40.61 76.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.605 0.241 . . . . 2.03 110.897 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.65 -47.26 92.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 1.71 110.552 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.48 -42.31 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 1.37 110.881 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -61.53 -39.94 92.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 1.12 110.941 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.83 94.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 1.09 111.755 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.423 HG21 HG23 ' A' ' 84' ' ' THR . 72.4 mt -60.26 -45.18 96.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.231 0.539 . . . . 1.35 110.075 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -66.0 -30.95 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.608 -0.723 . . . . 3.55 110.895 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.23 -5.53 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.721 -0.672 . . . . 1.28 111.318 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.28 79.17 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.554 -0.831 . . . . 0.6 111.478 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.32 -100.4 2.08 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.106 -0.568 . . . . 1.1 111.9 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.526 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 18.8 m-20 -119.23 -27.66 5.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.648 0.261 . . . . 2.12 110.795 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.6 mt-10 -120.15 139.81 52.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.299 -1.0 . . . . 2.11 108.299 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.423 HG23 HG21 ' A' ' 77' ' ' ILE . 13.8 t -138.02 149.65 46.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.818 0.342 . . . . 1.09 110.954 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 121.08 42.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.149 -0.478 . . . . 2.25 110.477 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.3 mt -107.14 135.65 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.156 -0.475 . . . . 1.04 109.889 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.5 tp -104.24 119.34 38.74 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.202 -0.666 . . . . 1.22 109.202 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.0 m -126.95 163.31 29.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.231 -0.44 . . . . 1.09 111.08 -175.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.99 149.54 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 1.08 111.229 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -90.41 175.57 7.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 1.92 110.117 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 91' ' ' ARG . 25.2 ttm180 -58.48 -48.98 78.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 4.87 111.045 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 5.1 mp0 -63.8 -41.01 97.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 2.68 110.203 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 m -62.04 -51.42 68.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 1.08 110.471 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.23 -43.86 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.137 -0.938 . . . . 1.18 111.708 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 13.6 mm-40 -60.42 -45.68 92.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.207 -0.451 . . . . 1.94 110.738 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -63.09 -47.63 82.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.495 0.497 . . . . 0.83 111.336 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -65.89 -40.45 91.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.487 -0.324 . . . . 0.55 111.613 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -66.17 -44.59 83.62 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.988 -0.285 . . . . 2.5 111.615 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.3 ptmt -70.27 -26.53 63.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.635 0.255 . . . . 2.53 111.087 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.5 t -93.75 -3.56 51.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.345 0.593 . . . . 2.19 110.395 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.54 47.2 13.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.11 -0.95 . . . . 4.83 110.918 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.82 137.9 53.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 2.08 110.204 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 55.5 mt -88.99 125.49 62.24 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.985 -0.376 . . . . 1.99 109.985 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 27.6 Cg_exo -61.9 154.23 62.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.97 2.447 . . . . 0.86 112.07 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.7 p -163.46 167.21 21.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.612 -0.267 . . . . 1.92 111.142 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -57.47 -29.3 64.13 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.732 0.645 . . . . 1.87 111.405 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.44 -34.23 70.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 2.82 110.49 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -75.8 -14.6 60.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.024 -0.989 . . . . 0.71 111.101 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.57 HD12 ' HG ' ' A' ' 12' ' ' LEU . 89.5 mt -73.92 -32.51 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 1.47 110.776 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.14 -36.65 74.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 4.09 111.866 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.44 -80.69 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.558 -1.306 . . . . 1.39 113.863 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.0 132.83 29.21 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.223 2.615 . . . . 1.65 114.386 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.553 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 63.1 mt -95.97 167.79 11.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.846 -1.07 . . . . 1.75 108.912 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 10.8 Cg_endo -56.95 145.98 82.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.074 1.849 . . . . 1.31 112.107 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 95.3 t 73.35 117.74 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 115.58 -0.736 . . . . 3.47 111.384 -177.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 8.1 Cg_exo -71.91 86.11 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.047 2.498 . . . . 4.93 112.027 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.54 -23.95 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.236 0.541 . . . . 8.1 110.416 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -139.01 152.21 47.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.695 -0.684 . . . . 9.11 109.602 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -115.43 86.07 2.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.351 0.596 . . . . 9.61 109.898 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -139.73 164.3 26.07 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.333 -0.849 . . . . 11.55 111.215 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.48 109.65 20.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.369 . . . . 13.92 110.304 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 16.9 pt -72.72 102.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.535 0.684 . . . . 16.21 111.257 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.62 92.32 3.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.543 -0.753 . . . . 18.9 109.16 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -116.85 -71.33 0.74 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 20.83 109.536 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 45.27 50.47 9.74 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 124.013 0.821 . . . . 22.5 111.379 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.79 108.85 13.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.523 -0.917 . . . . 24.29 108.523 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.5 m -76.44 79.38 3.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.841 -0.618 . . . . 25.0 111.729 -173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.411 -0.804 . . . . 27.94 109.325 174.358 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.837 -0.505 . . . . 12.09 111.837 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.34 151.96 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.338 -0.616 . . . . 10.3 109.338 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -91.04 109.73 37.23 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.503 -0.555 . . . . 7.1 109.503 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 -41.32 3.95 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.117 2.545 . . . . 7.27 113.691 -173.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -127.07 22.58 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.763 -0.375 . . . . 8.77 111.788 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.91 177.7 11.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.719 0.295 . . . . 4.49 111.317 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -149.78 31.5 0.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.191 -0.67 . . . . 4.32 109.191 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 96' ' ' PHE . 71.6 mt -86.03 56.59 4.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.471 -0.786 . . . . 1.36 111.617 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.512 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 27.5 ptt180 -125.96 154.21 73.78 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.975 -0.38 . . . . 3.51 109.975 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 48.4 Cg_endo -64.73 178.85 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.018 2.479 . . . . 0.81 113.231 -172.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.644 HH12 ' HB3' ' A' ' 90' ' ' ASP . 7.8 ptp85 -137.76 131.98 32.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.988 -0.551 . . . . 2.82 110.304 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HG ' HD11 ' A' ' 109' ' ' LEU . 4.7 mt -93.59 111.01 22.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.96 110.169 176.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 37.2 m -94.68 116.92 29.33 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.489 -0.56 . . . . 1.17 109.489 177.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -105.96 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.675 -0.861 . . . . 1.13 108.675 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.465 ' HE1' HD21 ' A' ' 51' ' ' LEU . 24.9 ptp -135.73 134.92 39.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.953 0.406 . . . . 1.08 110.806 -171.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 23.0 ttpp -92.49 147.09 23.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 3.11 109.209 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 ttmt -59.62 123.46 16.98 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.129 -0.487 . . . . 1.5 111.559 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.51 -157.36 21.51 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.389 -0.684 . . . . 1.28 111.389 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.26 -36.68 27.23 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.159 2.573 . . . . 2.23 113.233 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -93.8 21.29 6.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 3.28 111.595 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.32 69.68 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.597 -0.811 . . . . 1.93 111.273 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 74.89 -50.8 0.67 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.662 0.785 . . . . 1.82 110.739 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 69.66 0.93 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.151 -0.547 . . . . 0.96 113.347 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.33 168.88 25.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.013 -0.365 . . . . 0.4 110.013 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.495 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 20.0 t-20 -133.76 127.19 32.24 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 2.23 109.699 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.31 143.78 30.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.232 -0.44 . . . . 2.11 110.632 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 36' ' ' PHE . 2.6 p80 -125.89 130.7 51.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.8 -0.445 . . . . 2.02 109.8 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.1 p -122.22 123.79 42.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.618 -0.719 . . . . 2.75 109.844 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -85.71 137.63 32.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.11 0.481 . . . . 3.48 110.451 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -81.94 -6.77 59.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 4.89 109.816 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -87.82 -36.84 17.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.593 -0.731 . . . . 3.79 110.507 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -138.9 128.63 14.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 3.51 110.36 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 159.25 49.67 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 2.55 112.053 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.78 145.19 11.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.636 -0.793 . . . . 1.47 111.783 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.21 133.11 47.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.778 0.323 . . . . 1.5 110.687 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.544 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 31.1 m-85 -114.27 142.99 45.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.384 -0.599 . . . . 0.99 109.384 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.516 HG13 HD12 ' A' ' 51' ' ' LEU . 32.9 mm -74.32 106.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.43 -0.582 . . . . 1.12 109.43 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 52.0 ttt180 -69.65 -51.85 31.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.75 -0.659 . . . . 3.48 110.382 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -163.32 135.38 5.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.985 -0.552 . . . . 1.82 110.309 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.5 134.29 37.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.43 -0.952 . . . . 1.11 108.43 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.2 m-20 -64.67 128.09 93.15 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.956 -0.387 . . . . 2.28 109.956 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 52.4 Cg_exo -54.54 130.02 37.91 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.171 2.581 . . . . 1.27 113.182 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.61 38.37 12.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.357 -0.838 . . . . 2.4 110.81 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -97.76 164.7 16.94 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.13 -0.486 . . . . 0.68 109.693 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.85 -34.17 90.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.751 1.634 . . . . 0.87 111.125 172.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.84 -46.39 85.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.826 -0.624 . . . . 1.17 110.244 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.27 -43.47 98.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.014 -0.539 . . . . 2.01 110.337 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.85 63.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 1.15 111.988 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.529 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.7 p -76.39 -14.83 60.05 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.4 110.526 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.12 9.07 24.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.782 -0.723 . . . . 0.62 112.333 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 HD12 HG13 ' A' ' 37' ' ' ILE . 37.1 tp -79.79 128.06 32.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.85 0.357 . . . . 1.12 110.115 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -123.42 -170.53 2.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.061 -0.518 . . . . 5.17 110.222 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -95.65 151.65 19.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.673 -0.694 . . . . 1.44 110.29 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 54.7 mt-30 73.02 25.05 2.41 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.825 0.703 . . . . 3.8 110.96 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -95.81 155.25 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.243 -0.651 . . . . 1.02 109.243 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.43 ' NH1' HG21 ' A' ' 58' ' ' VAL . 8.0 tmm_? -124.69 129.55 50.72 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.603 -0.517 . . . . 2.26 109.603 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.519 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.3 mt -73.41 132.06 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.535 . . . . 1.37 111.605 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 104' ' ' PRO . 21.4 t -113.97 -47.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.415 -0.811 . . . . 1.56 110.443 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.1 mt-10 -132.8 149.51 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.89 110.644 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.81 117.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 1.29 109.637 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 57.24 34.21 24.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.986 -0.552 . . . . 1.17 111.041 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.535 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 89.43 -4.63 84.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.925 -0.655 . . . . 0.66 113.084 176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.84 127.21 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.96 -0.385 . . . . 1.75 109.96 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 41.8 t -74.25 135.39 42.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.992 0.425 . . . . 2.36 110.369 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.789 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.5 mmt -116.79 30.15 7.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 1.42 110.415 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 103' ' ' ILE . 21.5 tp10 -70.51 -34.42 72.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 3.75 110.943 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.11 -0.45 28.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.645 -0.788 . . . . 1.78 112.305 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.789 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.3 mmtp -71.95 168.73 17.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.762 0.792 . . . . 3.73 112.791 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -106.12 169.81 8.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.518 -1.219 . . . . 3.61 109.844 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -54.42 -43.93 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 2.2 111.597 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.42 85.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.128 -0.558 . . . . 0.78 113.387 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.97 -42.63 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.021 0.438 . . . . 2.03 110.34 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 65' ' ' MET . 59.0 t -68.26 -47.18 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 1.71 111.174 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.1 -38.55 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 1.37 111.048 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -67.94 -36.69 80.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.408 -0.36 . . . . 1.12 110.497 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.446 -0.343 . . . . 1.09 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.526 HG21 HG21 ' A' ' 84' ' ' THR . 78.6 mt -58.38 -42.06 83.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.446 0.641 . . . . 1.35 110.41 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -74.6 -31.69 62.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 3.55 111.44 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 5.48 18.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 1.28 111.325 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -13.37 83.23 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.682 -0.771 . . . . 0.6 112.009 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -111.43 3.1 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.981 -0.628 . . . . 1.1 111.699 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.431 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 14.0 m-20 -115.03 -6.64 12.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.908 0.385 . . . . 2.12 110.503 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -143.8 157.01 44.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.594 . . . . 2.11 109.622 173.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.526 HG21 HG21 ' A' ' 77' ' ' ILE . 11.9 t -137.57 149.73 46.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 1.09 110.072 -175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -115.63 116.85 28.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.126 -0.488 . . . . 2.25 109.796 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.0 mt -107.85 130.92 54.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.908 -0.587 . . . . 1.04 109.836 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 10' ' ' PRO . 20.8 tp -104.59 115.21 29.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.814 -0.81 . . . . 1.22 108.814 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.5 m -127.54 159.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.191 -0.459 . . . . 1.09 111.377 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.39 150.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.734 . . . . 1.08 110.031 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.644 ' HB3' HH12 ' A' ' 11' ' ' ARG . 4.3 p30 -88.85 176.51 7.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 1.92 109.975 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.5 ttp180 -55.78 -49.99 71.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.755 0.65 . . . . 4.87 112.755 -172.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 14.2 pt-20 -74.85 -34.35 62.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 2.68 111.139 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.9 m -64.9 -41.92 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.02 -0.537 . . . . 1.08 110.12 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 33.2 t70 -62.49 -38.05 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.608 . . . . 1.18 109.963 177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 48.0 mt-10 -67.2 -35.52 79.79 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.144 -0.48 . . . . 1.94 110.745 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.851 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 59.7 t80 -62.99 -49.62 73.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.896 0.379 . . . . 0.83 110.318 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 27.8 m-85 -68.14 -38.86 82.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.911 -0.586 . . . . 0.55 112.06 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.706 ' HZ1' ' HB3' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -64.61 -48.91 73.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.848 0.314 . . . . 2.5 111.848 -176.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.851 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 22.4 pttp -67.63 -34.18 76.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.113 0.483 . . . . 2.53 110.427 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 67.8 m -75.22 -8.69 57.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.511 -0.768 . . . . 2.19 112.048 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 55.86 32.82 20.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.312 0.645 . . . . 4.83 111.734 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 97' ' ' PHE . 5.8 p -120.36 142.1 37.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.251 -0.431 . . . . 2.08 110.228 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.538 HD12 ' HG2' ' A' ' 66' ' ' GLU . 45.9 mm -86.75 127.28 60.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 1.99 110.625 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.594 ' HB2' HG13 ' A' ' 58' ' ' VAL . 16.9 Cg_exo -65.55 155.13 70.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.824 2.349 . . . . 0.86 111.37 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.7 p -169.06 168.41 10.07 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.554 -0.459 . . . . 1.92 111.807 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.535 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 40.0 mt-30 -57.0 -29.42 63.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 1.87 111.273 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.93 -32.71 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.272 0.558 . . . . 2.82 110.34 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -77.86 -13.7 59.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.71 111.164 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.552 HD11 ' HG ' ' A' ' 12' ' ' LEU . 86.1 mt -75.19 -40.62 59.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 1.47 111.126 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -106.28 13.03 29.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.199 0.523 . . . . 4.09 110.521 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.62 -172.1 12.42 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.827 -0.701 . . . . 1.39 111.82 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -88.97 -179.59 2.16 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.213 2.609 . . . . 1.65 112.258 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 9' ' ' ARG . 53.7 mt -97.24 148.21 34.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.09 -0.504 . . . . 1.75 109.761 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 113' ' ' LEU . 14.3 Cg_exo -68.35 144.0 60.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.111 2.54 . . . . 1.31 112.045 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.3 m -74.41 155.44 87.68 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.423 -0.808 . . . . 3.47 110.795 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.84 66.54 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.687 2.258 . . . . 4.93 112.066 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -68.14 121.36 16.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.706 -0.679 . . . . 8.1 109.695 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 119' ' ' ASN . 3.2 m 70.4 173.63 0.3 Allowed 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.636 0.585 . . . . 9.11 109.82 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.547 ' H ' HG23 ' A' ' 118' ' ' THR . 9.9 m120 74.21 146.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.869 0.842 . . . . 9.61 112.46 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.12 36.17 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.868 -1.06 . . . . 11.55 110.457 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -118.61 97.18 5.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.162 0.481 . . . . 13.92 110.4 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.5 101.22 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.89 -0.782 . . . . 16.21 108.89 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.12 -8.73 59.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.902 -0.59 . . . . 18.9 110.988 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 58.19 46.36 15.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.955 -1.128 . . . . 20.83 107.955 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -73.35 71.12 1.24 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.922 -1.49 . . . . 22.5 111.128 -177.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -69.48 95.71 0.85 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.979 -1.01 . . . . 24.29 110.021 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.9 t -76.74 -42.08 42.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.673 -0.694 . . . . 27.94 109.676 -178.558 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 112.016 -0.434 . . . . 12.09 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -103.83 134.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.736 0.303 . . . . 10.3 110.221 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.72 135.21 78.09 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 7.1 110.787 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -93.39 7.13 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.075 2.517 . . . . 7.27 112.778 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -155.54 -58.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.958 0.408 . . . . 8.77 110.305 -176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.4 m -151.44 145.62 25.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.496 -0.557 . . . . 4.49 109.496 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.2 ptm -75.02 56.27 0.75 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.238 0.542 . . . . 4.32 111.639 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.4 mt -108.96 59.87 0.6 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.264 0.554 . . . . 1.36 110.59 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -126.54 157.02 72.18 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 3.51 109.433 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HB2' HD13 ' A' ' 87' ' ' LEU . 44.4 Cg_endo -70.15 174.73 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.328 2.019 . . . . 0.81 111.782 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HG3' HG22 ' A' ' 88' ' ' VAL . 7.0 ptp85 -132.02 130.6 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.261 -0.427 . . . . 2.82 110.162 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.9 118.1 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 1.96 110.182 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.414 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 12.8 m -108.88 117.49 34.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.215 -0.448 . . . . 1.17 110.305 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -108.9 117.55 34.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.225 -1.028 . . . . 1.13 108.225 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.476 ' HE3' HD21 ' A' ' 51' ' ' LEU . 23.0 ptp -131.15 144.63 51.52 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.744 -0.383 . . . . 1.08 111.164 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HG3' ' HG2' ' A' ' 83' ' ' GLU . 7.5 ttmm -118.89 146.0 45.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.614 -0.721 . . . . 3.11 109.705 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 85.5 mttt -56.32 119.47 6.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.361 -0.836 . . . . 1.5 112.188 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.37 -111.0 3.1 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.575 -1.193 . . . . 1.28 112.282 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.49 -74.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.243 2.629 . . . . 2.23 112.669 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -132.93 83.85 2.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 3.28 110.495 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.97 71.29 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.004 -0.617 . . . . 1.93 112.535 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.543 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 36.2 m-85 67.23 -87.3 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.047 0.539 . . . . 1.82 110.774 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.45 70.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.625 -0.798 . . . . 0.96 112.646 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.94 151.91 26.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.4 109.271 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.24 123.65 45.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.207 -0.664 . . . . 2.23 109.207 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 35' ' ' GLN . 30.3 tp -108.77 146.14 34.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.058 -0.519 . . . . 2.11 109.62 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.45 149.25 27.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.624 -0.43 . . . . 2.02 111.435 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -94.47 168.71 10.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.166 -0.679 . . . . 2.75 109.166 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -125.93 146.39 49.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.563 -0.532 . . . . 3.48 109.563 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.13 2.61 53.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.349 -0.387 . . . . 4.89 111.371 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.6 t -123.86 -46.5 1.97 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.039 0.447 . . . . 3.79 109.981 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -99.4 126.8 36.36 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.192 -0.458 . . . . 3.51 110.078 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.19 156.65 46.66 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.581 2.187 . . . . 2.55 112.147 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.72 167.38 22.55 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.819 -0.705 . . . . 1.47 111.611 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HB3' HD12 ' A' ' 26' ' ' LEU . 27.6 mm-40 -98.9 128.09 44.99 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.13 -0.322 . . . . 1.5 110.13 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -109.92 140.59 43.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.99 110.554 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.509 HG13 HD13 ' A' ' 51' ' ' LEU . 36.9 mm -81.21 105.76 11.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.846 -0.798 . . . . 1.12 108.846 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.02 -55.28 19.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.507 . . . . 3.48 110.106 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 m -157.87 137.77 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.854 -0.612 . . . . 1.82 109.482 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.31 133.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.145 -0.687 . . . . 1.11 109.145 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.82 128.92 92.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.014 -0.539 . . . . 2.28 109.774 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 125.41 19.02 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.753 2.302 . . . . 1.27 113.063 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 63.14 43.46 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.934 -1.03 . . . . 2.4 110.76 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.6 p -102.64 165.3 13.99 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.592 . . . . 0.68 110.639 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 31.6 Cg_exo -56.11 -34.38 92.68 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.888 1.725 . . . . 0.87 111.168 172.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.31 86.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.596 -0.729 . . . . 1.17 110.186 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -61.06 -42.44 98.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 2.01 110.132 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.37 -30.02 68.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.817 -0.629 . . . . 1.15 112.069 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.2 p -70.96 -20.0 62.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.368 . . . . 0.4 110.626 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.19 9.7 15.03 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.792 -0.718 . . . . 0.62 112.803 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.509 HD13 HG13 ' A' ' 37' ' ' ILE . 27.9 tp -69.33 125.17 25.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 1.12 110.685 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 30.5 ttm180 -103.85 147.89 26.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.804 -0.634 . . . . 5.17 109.918 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -74.77 144.21 43.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 1.44 110.092 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 15.4 mm-40 78.87 5.88 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.099 0.875 . . . . 3.8 111.31 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -85.12 149.93 25.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.693 -0.484 . . . . 1.02 109.693 176.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 56' ' ' ARG . 34.9 ttp180 -111.87 137.48 49.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 2.26 110.258 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.42 ' HA ' HG13 ' A' ' 88' ' ' VAL . 65.2 mt -74.56 128.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.985 -0.552 . . . . 1.37 110.627 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.407 HG22 HD23 ' A' ' 87' ' ' LEU . 19.0 m -112.42 -32.89 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 1.56 111.21 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 27.4 mt-10 -134.38 142.85 47.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.89 110.833 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' HB ' ' HE1' ' A' ' 65' ' ' MET . 89.8 t -124.56 120.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 1.29 109.797 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 85' ' ' LYS . 73.8 m-20 58.68 24.57 12.31 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.088 0.555 . . . . 1.17 111.512 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.61 6.53 63.96 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.66 112.915 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.47 124.18 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 1.75 110.393 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.2 p -64.58 136.94 57.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.636 . . . . 2.36 111.215 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.694 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.1 mmt -123.68 50.99 1.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.968 -0.56 . . . . 1.42 111.074 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -36.11 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.922 -0.311 . . . . 3.75 111.514 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.38 -7.52 54.17 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.842 -0.694 . . . . 1.78 111.857 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.694 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.7 mmtp -70.71 149.16 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.223 0.535 . . . . 3.73 111.436 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -86.45 170.62 11.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.367 -0.833 . . . . 3.61 109.983 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -53.86 -43.52 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.657 0.265 . . . . 2.2 111.241 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.03 99.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.045 -0.598 . . . . 0.78 113.125 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 6.3 t70 -64.78 -43.97 91.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.913 0.387 . . . . 2.03 110.216 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 65' ' ' MET . 46.5 t -63.55 -46.86 93.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 1.71 111.015 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 97.7 t -66.68 -42.5 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.241 -0.436 . . . . 1.37 111.114 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -64.51 -38.27 90.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.46 -0.336 . . . . 1.12 110.387 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.09 93.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 1.09 111.135 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.485 HG21 HG22 ' A' ' 84' ' ' THR . 81.4 mt -61.15 -45.77 97.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.018 0.437 . . . . 1.35 110.621 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 29.6 mtm180 -66.15 -33.2 75.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 3.55 110.366 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.42 -0.36 36.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.952 -0.567 . . . . 1.28 111.501 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.26 85.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.606 -0.807 . . . . 0.6 111.695 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.29 -127.24 9.1 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.208 -0.757 . . . . 1.1 111.208 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 42.1 m-20 -96.73 -12.97 23.04 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.032 -0.267 . . . . 2.12 110.78 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -130.61 140.82 50.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.989 -0.375 . . . . 2.11 109.989 177.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.485 HG22 HG21 ' A' ' 77' ' ' ILE . 14.4 t -135.09 149.62 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.957 0.408 . . . . 1.09 110.36 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 61' ' ' ASN . 95.0 mttt -106.31 117.81 35.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.248 -0.433 . . . . 2.25 110.289 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.0 mt -111.53 124.91 53.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.145 -0.479 . . . . 1.04 109.815 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 34.8 tp -104.36 122.25 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.029 -0.73 . . . . 1.22 109.029 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 10.5 m -130.15 164.58 32.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.208 -0.451 . . . . 1.09 111.369 -174.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 m -136.72 145.79 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.658 -0.701 . . . . 1.08 110.874 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.72 167.74 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.548 -0.751 . . . . 1.92 109.473 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -56.59 -47.79 78.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.653 0.263 . . . . 4.87 111.22 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -63.45 -31.42 72.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.347 0.594 . . . . 2.68 110.086 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 m -76.54 -50.8 13.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 1.08 111.021 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.7 -47.67 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.865 -0.607 . . . . 1.18 111.656 -174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 31.7 mt-10 -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.721 -0.391 . . . . 1.94 110.767 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.38 -46.09 70.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.937 0.398 . . . . 0.83 110.356 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 102' ' ' VAL . 22.9 m-85 -64.34 -44.24 92.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.55 111.008 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -61.42 -45.33 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.561 0.578 . . . . 2.5 112.561 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 18.1 ptpt -65.47 -25.6 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 2.53 110.955 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.2 t -96.69 0.84 50.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 2.19 110.645 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? 64.63 31.27 12.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.028 -0.533 . . . . 4.83 111.716 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 114' ' ' PRO . 35.0 t -109.82 139.6 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.491 -0.322 . . . . 2.08 110.416 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.35 125.95 50.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.93 -0.396 . . . . 1.99 109.93 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -65.62 139.53 58.68 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.464 2.11 . . . . 0.86 111.42 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -154.01 166.93 31.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 1.92 110.73 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.475 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 41.2 mt-30 -57.31 -31.98 66.21 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.441 0.463 . . . . 1.87 111.049 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.38 -30.78 70.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.441 -0.345 . . . . 2.82 111.3 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.37 -13.83 61.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.71 111.403 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.31 -25.43 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 1.47 111.2 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -130.4 -14.89 3.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.496 -0.32 . . . . 4.09 111.584 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.35 -177.11 34.44 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.866 -0.683 . . . . 1.39 112.438 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.41 124.26 10.65 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.131 2.554 . . . . 1.65 112.866 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 113' ' ' LEU . 3.0 mm? -65.67 146.64 98.97 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.96 -0.564 . . . . 1.75 109.825 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.516 ' HB3' HG23 ' A' ' 102' ' ' VAL . 28.4 Cg_endo -62.8 144.6 93.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.785 2.323 . . . . 1.31 112.449 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -159.99 130.18 3.5 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.077 -0.51 . . . . 3.47 110.333 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.52 112.77 2.47 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.816 2.344 . . . . 4.93 111.744 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -81.09 -30.88 34.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.24 -0.437 . . . . 8.1 110.851 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 t -84.02 152.38 24.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.132 -0.486 . . . . 9.11 110.394 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -122.31 111.59 17.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.88 -0.415 . . . . 9.61 109.88 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.21 173.02 42.3 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.993 -0.622 . . . . 11.55 112.665 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.77 160.22 17.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.182 -0.303 . . . . 13.92 110.182 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.41 HD11 ' N ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -126.48 161.33 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.371 -0.377 . . . . 16.21 110.552 179.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -136.11 157.54 46.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.152 -0.476 . . . . 18.9 109.9 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 55.66 64.85 1.62 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.412 0.625 . . . . 20.83 110.224 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 4.1 mp0 -74.65 -30.09 61.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 22.5 110.046 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 66.97 -80.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.056 -0.975 . . . . 24.29 110.512 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -158.47 84.6 0.84 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.204 -0.903 . . . . 27.94 110.479 -176.111 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.394 -0.282 . . . . 12.09 112.394 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.3 pt -87.49 84.62 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 10.3 111.481 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.75 114.06 61.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 7.1 110.012 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -87.27 9.86 3.76 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.911 2.407 . . . . 7.27 113.009 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -106.22 -49.21 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.243 0.544 . . . . 8.77 109.688 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 m -121.17 84.99 2.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.588 -0.733 . . . . 4.49 110.011 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -95.39 19.29 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 4.32 110.592 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.62 41.04 0.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 1.36 110.901 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -119.7 147.02 42.94 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.322 -0.399 . . . . 3.51 109.998 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.578 ' HD2' ' HA ' ' A' ' 109' ' ' LEU . 2.9 Cg_exo -72.26 165.14 33.53 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.899 2.399 . . . . 0.81 111.358 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.771 ' HG3' HG23 ' A' ' 88' ' ' VAL . 5.5 ptt180 -122.9 131.0 53.54 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.663 -0.699 . . . . 2.82 110.627 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.06 113.3 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 1.96 110.03 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 30.5 m -96.87 128.74 44.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.832 -0.622 . . . . 1.17 110.22 -176.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -117.79 117.49 29.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.91 -0.774 . . . . 1.13 108.91 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.554 ' HE3' ' OG ' ' A' ' 49' ' ' SER . 22.5 ptp -142.21 142.55 32.67 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.181 -0.463 . . . . 1.08 110.194 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 43.4 pttt -119.34 152.53 36.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.311 0.577 . . . . 3.11 110.735 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.572 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.1 mtmt -55.55 110.45 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.347 -1.297 . . . . 1.5 112.601 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.09 -129.82 6.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.272 -0.876 . . . . 1.28 112.145 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.29 -75.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.35 2.7 . . . . 2.23 113.616 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -96.91 34.05 1.78 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.891 0.377 . . . . 3.28 111.329 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.572 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 71.77 83.86 0.23 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.585 -0.817 . . . . 1.93 111.755 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.454 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 39.3 m-85 68.07 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.268 0.627 . . . . 1.82 110.638 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.16 68.11 0.38 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.259 -0.496 . . . . 0.96 112.572 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -157.34 153.23 27.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.928 -0.397 . . . . 0.4 109.928 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.36 141.41 40.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 2.23 110.626 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 26' ' ' LEU . 48.6 mt -101.52 154.91 18.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.624 -0.716 . . . . 2.11 111.715 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 2.2 t-80 -105.67 141.81 36.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.188 -0.915 . . . . 2.02 110.459 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -83.95 150.87 25.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.943 -0.571 . . . . 2.75 110.454 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 5.1 p-10 -123.02 164.25 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.932 -0.576 . . . . 3.48 110.335 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -159.89 -49.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.82 -0.627 . . . . 4.89 109.769 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 p -84.41 -23.27 30.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 3.79 111.206 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 23.8 pttm -157.82 140.04 10.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.03 -0.532 . . . . 3.51 110.074 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 14.3 Cg_exo -69.63 171.0 15.12 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.482 2.122 . . . . 2.55 111.68 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 125.01 4.86 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.753 -0.736 . . . . 1.47 111.881 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -93.59 129.06 39.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 1.5 110.911 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 38.9 m-85 -102.8 149.92 24.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.99 109.599 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.507 HG13 HD11 ' A' ' 51' ' ' LEU . 48.5 mm -84.45 105.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.645 -0.502 . . . . 1.12 109.645 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 38' ' ' ARG . 22.6 tpt85 -70.13 -39.75 75.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.693 -0.685 . . . . 3.48 110.033 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 p -165.73 152.2 9.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 1.82 109.825 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.08 128.63 74.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 1.11 109.348 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -70.86 135.88 85.41 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.327 -0.397 . . . . 2.28 110.672 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.84 143.1 78.73 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.886 2.391 . . . . 1.27 112.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 61.8 42.13 10.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.502 -0.772 . . . . 2.4 111.202 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.1 p -118.18 159.34 43.62 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 0.68 110.297 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 44.7 Cg_exo -51.15 -39.37 61.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.406 2.071 . . . . 0.87 111.419 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.3 -52.31 64.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.461 -0.791 . . . . 1.17 110.864 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -63.41 -39.63 95.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.171 -0.468 . . . . 2.01 110.601 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.06 77.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 1.15 111.866 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.554 ' OG ' ' HE3' ' A' ' 15' ' ' MET . 71.7 p -70.84 -13.69 62.13 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.982 0.42 . . . . 0.4 110.955 -178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.1 14.59 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.632 -0.794 . . . . 0.62 113.015 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.507 HD11 HG13 ' A' ' 37' ' ' ILE . 29.2 tp -76.02 123.83 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 1.12 110.297 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 52' ' ' ARG . 21.9 ttt180 -110.28 148.51 31.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.887 -0.597 . . . . 5.17 110.117 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -68.79 148.23 50.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.203 -0.453 . . . . 1.44 110.219 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 78.4 mt-30 78.62 0.7 2.54 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.194 0.934 . . . . 3.8 111.27 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 15.3 m-20 -78.58 143.43 36.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.726 0.298 . . . . 1.02 110.603 177.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttp-105 -104.69 133.52 49.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.824 0.345 . . . . 2.26 110.573 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.84 123.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.991 -0.549 . . . . 1.37 109.735 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG22 ' HG2' ' A' ' 104' ' ' PRO . 42.2 t -101.86 -46.55 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.268 0.556 . . . . 1.56 110.584 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 32.7 mt-10 -129.92 145.51 51.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.698 . . . . 0.89 110.083 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 77' ' ' ILE . 24.8 t -125.59 130.59 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.606 -0.516 . . . . 1.29 109.606 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.36 8.84 5.97 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.423 0.452 . . . . 1.17 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 9.56 62.99 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.826 -0.702 . . . . 0.66 111.593 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.78 131.03 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.585 0.354 . . . . 1.75 110.171 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 44.1 t -70.1 136.29 50.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.999 -0.546 . . . . 2.36 111.426 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.799 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.5 mmt -119.91 69.43 0.85 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 1.42 110.583 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -98.07 -62.15 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 3.75 110.367 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.26 41.4 2.41 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.618 -0.593 . . . . 1.78 111.618 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.799 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.4 mmtp -107.42 -178.5 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.064 -0.347 . . . . 3.73 110.064 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -125.61 172.28 9.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.605 -0.27 . . . . 3.61 110.972 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -54.68 -44.21 73.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.518 0.511 . . . . 2.2 111.366 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.43 84.45 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.993 -0.622 . . . . 0.78 113.039 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.776 0.322 . . . . 2.03 110.662 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.93 -45.5 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 1.71 110.778 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.65 -36.64 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.294 -0.412 . . . . 1.37 110.905 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -65.87 -36.15 82.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.855 -0.424 . . . . 1.12 109.855 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.1 79.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.584 . . . . 1.09 111.072 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 60' ' ' VAL . 18.8 mm -57.56 -44.49 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.546 0.688 . . . . 1.35 109.464 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.52 -29.22 59.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.001 -1.0 . . . . 3.55 110.936 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.86 44.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 1.28 111.84 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.8 -12.35 83.0 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.448 -0.882 . . . . 0.6 111.867 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 -125.92 8.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.974 -0.851 . . . . 1.1 110.974 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 60.2 m-20 -94.6 -16.85 22.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.943 0.372 . . . . 2.12 110.042 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.609 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 7.4 mt-10 -119.55 140.34 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.109 -0.7 . . . . 2.11 109.109 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -129.77 145.52 51.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.026 0.441 . . . . 1.09 110.511 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.5 mttm -113.62 117.77 32.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.913 -0.585 . . . . 2.25 109.825 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.1 mt -109.91 135.86 50.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.861 -0.608 . . . . 1.04 110.159 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' A' ' 10' ' ' PRO . 52.9 tp -104.55 117.09 33.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.09 -0.505 . . . . 1.22 109.884 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.771 HG23 ' HG3' ' A' ' 11' ' ' ARG . 7.2 m -127.95 159.36 39.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 1.09 110.72 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -128.83 148.1 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.0 -0.545 . . . . 1.08 110.747 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.16 172.62 12.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.288 -0.634 . . . . 1.92 109.288 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.0 ttp180 -61.0 -49.1 78.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.612 0.244 . . . . 4.87 110.709 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -35.97 82.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.061 0.458 . . . . 2.68 110.322 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -64.32 -51.44 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 1.08 111.194 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.73 -33.99 76.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.18 111.445 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 12.5 mm-40 -64.17 -41.56 97.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.895 0.379 . . . . 1.94 110.056 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.707 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 70.2 t80 -63.28 -47.83 80.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.83 111.367 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -66.76 -38.82 87.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.514 -0.312 . . . . 0.55 111.776 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.1 -41.82 85.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.376 0.51 . . . . 2.5 112.376 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.707 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 58.6 pttt -68.24 -14.48 63.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 2.53 111.229 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.417 ' HB3' HG11 ' A' ' 102' ' ' VAL . 34.4 t -109.04 -11.4 14.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.274 0.559 . . . . 2.19 109.574 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 65.38 35.29 7.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.761 -1.108 . . . . 4.83 111.371 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 100' ' ' CYS . 3.1 p -118.45 126.93 75.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 2.08 110.124 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -72.15 128.29 89.26 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.99 110.753 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HG2' HG22 ' A' ' 58' ' ' VAL . 34.1 Cg_endo -67.65 143.9 63.98 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.734 2.289 . . . . 0.86 111.355 176.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 m -151.23 174.72 12.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 110.024 -0.362 . . . . 1.92 110.024 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.611 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 43.0 mt-30 -57.59 -40.3 78.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.926 0.393 . . . . 1.87 111.166 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 107' ' ' GLU . 1.5 mp0 -59.22 -35.27 73.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.293 0.568 . . . . 2.82 110.259 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.557 ' CD2' ' HD3' ' A' ' 114' ' ' PRO . 28.2 m80 -73.9 -31.52 63.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.564 -0.743 . . . . 0.71 111.525 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.4 pp -88.51 -16.53 32.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 1.47 110.864 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.77 -8.16 59.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.131 -0.486 . . . . 4.09 111.24 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.89 -74.36 0.21 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.03 -1.081 . . . . 1.39 113.723 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.17 116.08 4.54 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.344 2.696 . . . . 1.65 114.12 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 mt -87.0 152.9 54.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.326 -0.852 . . . . 1.75 109.698 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 108' ' ' HIS . 56.8 Cg_endo -69.48 138.14 38.01 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.993 2.462 . . . . 1.31 112.547 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 27.2 m -84.94 144.76 42.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.835 -0.62 . . . . 3.47 110.546 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 6.3 Cg_exo -75.19 28.73 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.178 2.585 . . . . 4.93 112.645 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 115' ' ' VAL . 97.6 m-85 -124.78 48.2 2.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 8.1 109.97 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -135.59 9.1 3.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 9.11 110.214 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -95.6 38.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 9.61 110.999 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.81 3.75 19.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.604 -0.808 . . . . 11.55 112.431 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.25 140.07 32.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 13.92 111.175 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.69 98.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 16.21 109.994 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -114.55 95.33 5.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.362 -0.381 . . . . 18.9 110.212 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.557 ' HZ1' ' HB2' ' A' ' 124' ' ' LYS . 10.1 mtmp? -81.45 64.07 6.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.443 . . . . 20.83 110.091 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -141.13 -56.88 0.5 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.877 -0.601 . . . . 22.5 109.535 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -84.45 43.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.541 0.686 . . . . 24.29 109.89 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 p -77.33 -24.92 50.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 25.0 110.773 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 18.0 tpt180 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.688 -0.672 . . . . 27.94 109.883 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.814 -0.514 . . . . 12.09 111.814 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 tt -99.93 141.66 16.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.756 -0.461 . . . . 10.3 109.756 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.41 130.04 60.76 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.553 -0.536 . . . . 7.1 109.553 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.19 -18.21 63.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.09 2.527 . . . . 7.27 112.259 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.74 -157.47 0.74 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.272 -1.01 . . . . 8.77 108.272 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m 65.51 -0.59 1.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.406 0.521 . . . . 4.49 112.406 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 70.3 mtm -83.28 -12.49 56.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.411 . . . . 4.32 111.052 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -93.54 54.66 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 1.36 110.315 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -125.78 147.57 59.15 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.655 -0.702 . . . . 3.51 109.731 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' HD13 ' A' ' 87' ' ' LEU . 38.8 Cg_endo -66.01 159.76 47.68 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.298 1.998 . . . . 0.81 111.183 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.3 ptt85 -121.37 132.55 54.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.037 -0.529 . . . . 2.82 110.396 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -92.72 111.86 23.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.729 -0.669 . . . . 1.96 109.767 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 18.0 m -89.63 117.73 28.72 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.091 -0.707 . . . . 1.17 109.091 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 85' ' ' LYS . 24.4 m -109.85 118.25 36.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.601 -0.518 . . . . 1.13 109.601 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -131.17 132.93 45.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 1.08 110.677 -175.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.8 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 3.4 ttmp? -109.12 128.69 55.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 3.11 109.529 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.4 ttmt -51.59 130.08 27.2 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.041 -0.981 . . . . 1.5 112.768 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.09 -147.57 22.82 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.956 -0.858 . . . . 1.28 110.956 170.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.71 -28.8 6.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.879 2.386 . . . . 2.23 112.841 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -94.28 -27.2 16.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.364 0.505 . . . . 3.28 112.364 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.57 64.79 0.59 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.8 -0.714 . . . . 1.93 112.775 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.529 ' O ' ' HB2' ' A' ' 44' ' ' SER . 26.4 m-85 74.51 -74.58 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.629 0.772 . . . . 1.82 111.013 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.96 69.07 0.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.64 . . . . 0.96 113.007 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -155.71 154.76 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.8 -0.445 . . . . 0.4 109.8 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.77 127.16 55.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.77 0.319 . . . . 2.23 110.586 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.47 137.75 39.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 2.11 110.09 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 11.6 p80 -125.7 138.81 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.46 -0.496 . . . . 2.02 110.705 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -120.33 139.03 53.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.265 -0.879 . . . . 2.75 108.891 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.627 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 10.9 t70 -86.31 134.48 33.74 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.975 -0.75 . . . . 3.48 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -82.71 -6.73 59.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.305 -0.407 . . . . 4.89 111.707 -173.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.4 m -107.78 -39.45 5.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.114 0.483 . . . . 3.79 109.99 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.627 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 23.8 pttm -120.68 102.03 45.17 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.929 -0.578 . . . . 3.51 109.734 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.2 155.99 58.13 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.583 2.189 . . . . 2.55 113.042 -174.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.78 149.03 5.48 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.325 -0.852 . . . . 1.47 111.101 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.88 127.37 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.253 0.526 . . . . 1.5 111.036 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.473 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 52.9 m-85 -125.43 150.55 47.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.715 -0.846 . . . . 0.99 108.715 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.477 HG13 HD11 ' A' ' 51' ' ' LEU . 35.2 mm -75.85 111.17 11.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.839 -0.43 . . . . 1.12 109.839 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 23.3 tpt180 -68.64 -57.05 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 3.48 110.028 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.417 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 49.6 m -160.63 140.57 11.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.47 -0.786 . . . . 1.82 109.041 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.18 132.92 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.6 -0.889 . . . . 1.11 108.6 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 3.2 t70 -83.86 116.24 63.76 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.256 -0.429 . . . . 2.28 109.998 -173.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 9.2 Cg_endo -53.64 150.84 26.89 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.721 2.28 . . . . 1.27 111.904 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 64.36 56.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.051 0.929 . . . . 2.4 109.96 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 87.9 p -145.65 156.27 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.187 -0.915 . . . . 0.68 109.843 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.3 Cg_endo -61.2 -23.9 78.03 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.501 2.134 . . . . 0.87 111.177 172.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.552 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -69.09 -52.1 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.464 . . . . 1.17 110.558 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.761 -0.459 . . . . 2.01 109.761 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.69 -35.31 72.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.794 -0.639 . . . . 1.15 112.064 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.0 p -70.02 -19.44 63.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.861 0.362 . . . . 0.4 111.247 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.33 47.69 1.11 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.751 . . . . 0.62 112.468 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD11 HG13 ' A' ' 37' ' ' ILE . 34.6 tp -108.01 137.94 45.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.143 -0.317 . . . . 1.12 110.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -118.95 153.09 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.754 -0.462 . . . . 5.17 109.754 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -81.78 34.93 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.519 0.562 . . . . 1.44 112.519 -173.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -152.73 17.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 3.8 110.825 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.562 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.6 m-20 -94.48 159.68 14.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.92 -0.582 . . . . 1.02 110.45 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 56' ' ' ARG . 30.5 ttp180 -115.22 137.62 51.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.418 -0.586 . . . . 2.26 109.418 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.56 126.73 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.98 -0.555 . . . . 1.37 110.887 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.21 -42.01 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 1.56 110.736 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.9 mt-10 -131.82 143.05 49.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.39 -0.368 . . . . 0.89 110.745 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.46 111.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.323 -0.621 . . . . 1.29 109.323 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.67 29.68 19.18 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.374 0.421 . . . . 1.17 111.36 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.421 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.2 -7.44 78.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.66 112.577 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.65 121.4 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.809 -0.441 . . . . 1.75 109.809 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.0 t -80.1 122.66 27.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.156 0.503 . . . . 2.36 110.322 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.576 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.9 mmt -94.75 56.13 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.423 0.63 . . . . 1.42 110.331 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.82 68.79 3.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.25 -0.886 . . . . 3.75 110.958 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.11 27.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 1.78 112.127 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.573 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 75.7 mmtt -69.3 152.92 44.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.312 0.577 . . . . 3.73 111.142 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.52 153.55 24.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.19 -0.914 . . . . 3.61 110.009 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.82 -40.34 66.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.014 -0.994 . . . . 2.2 112.928 -165.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.4 -30.73 68.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.742 -0.742 . . . . 0.78 112.365 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -68.75 -46.81 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.52 . . . . 2.03 110.104 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.576 HG23 ' SD ' ' A' ' 65' ' ' MET . 58.9 t -62.36 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.459 -0.791 . . . . 1.71 110.949 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.434 ' HA ' HD13 ' A' ' 77' ' ' ILE . 97.5 t -64.09 -41.61 92.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.257 -0.428 . . . . 1.37 110.988 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -61.38 -37.56 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 1.12 110.592 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.12 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.09 110.995 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 74' ' ' VAL . 72.6 mt -61.06 -42.1 91.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.151 0.501 . . . . 1.35 110.281 176.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.72 -25.75 63.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.705 -0.68 . . . . 3.55 110.8 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.49 61.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 1.28 111.519 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.28 -20.51 76.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.587 -0.816 . . . . 0.6 111.904 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.43 -84.59 1.33 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.953 -0.641 . . . . 1.1 112.132 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 50.8 m-20 -120.42 1.1 10.67 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.856 -0.202 . . . . 2.12 111.173 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -151.49 161.87 41.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.731 0.301 . . . . 2.11 110.637 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.8 t -140.67 149.56 42.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.568 -0.53 . . . . 1.09 109.568 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HG2' HG22 ' A' ' 14' ' ' THR . 59.7 mttp -119.18 117.22 28.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.802 -0.444 . . . . 2.25 109.802 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -106.48 130.74 54.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.301 -0.409 . . . . 1.04 110.242 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 57.8 tp -104.23 116.08 31.54 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.073 -0.714 . . . . 1.22 109.073 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 18.3 m -127.86 158.27 39.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.227 0.536 . . . . 1.09 111.884 -174.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 10' ' ' PRO . 25.9 m -128.03 147.88 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 1.08 109.916 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.59 176.06 7.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.254 -0.647 . . . . 1.92 109.254 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.6 ttp180 -54.04 -48.78 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.256 0.348 . . . . 4.87 111.469 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.17 -38.05 63.8 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 121.108 -0.237 . . . . 2.68 110.957 -173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.44 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 41.1 m -60.64 -47.62 85.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.886 0.374 . . . . 1.08 110.186 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 28.9 t70 -58.66 -47.83 83.14 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.873 -0.603 . . . . 1.18 110.772 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 48.7 mt-10 -64.77 -28.35 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 1.94 110.823 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.11 -47.72 64.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.83 110.323 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.473 ' CD2' HG12 ' A' ' 102' ' ' VAL . 46.9 m-85 -65.53 -36.8 84.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.446 -0.343 . . . . 0.55 111.278 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 29.1 mtpp -58.77 -49.36 77.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 2.5 111.714 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -71.05 -29.63 65.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.494 . . . . 2.53 111.265 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.528 ' HG ' HG21 ' A' ' 115' ' ' VAL . 36.3 t -85.39 -11.38 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 2.19 111.369 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? 63.16 43.97 6.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.73 -0.668 . . . . 4.83 111.198 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.489 HG11 ' HG3' ' A' ' 114' ' ' PRO . 7.7 p -133.39 140.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.172 -0.467 . . . . 2.08 110.29 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.7 mt -86.3 128.28 57.99 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.345 -0.388 . . . . 1.99 110.868 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.98 136.23 55.68 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.497 2.131 . . . . 0.86 111.193 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.9 t -155.8 172.67 17.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.892 -0.41 . . . . 1.92 109.892 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.421 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 60.1 mt-30 -55.68 -31.26 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.581 0.551 . . . . 1.87 111.472 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -59.75 -31.93 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.227 -0.442 . . . . 2.82 111.639 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -80.38 -14.17 58.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.448 -0.342 . . . . 0.71 111.531 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.484 HD23 ' CD1' ' A' ' 87' ' ' LEU . 86.7 mt -59.91 -59.99 4.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.084 0.468 . . . . 1.47 110.848 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -101.98 -12.06 18.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 4.09 111.179 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.42 175.93 38.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.794 -0.717 . . . . 1.39 112.649 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.2 163.16 28.03 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.848 2.365 . . . . 1.65 112.313 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.45 150.23 44.12 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.856 -0.611 . . . . 1.75 109.588 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.489 ' HG3' HG11 ' A' ' 102' ' ' VAL . 38.9 Cg_endo -68.06 166.56 24.47 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.692 2.262 . . . . 1.31 112.147 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.528 HG21 ' HG ' ' A' ' 100' ' ' CYS . 89.6 t 76.37 114.6 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 123.948 0.78 . . . . 3.47 110.614 -176.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 14.8 Cg_exo -68.37 100.29 0.65 Allowed 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.397 2.732 . . . . 4.93 112.702 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -82.22 127.34 33.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.093 -0.503 . . . . 8.1 110.203 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.6 m 62.16 57.0 2.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.554 0.692 . . . . 9.11 110.834 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -96.06 -47.41 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.008 -0.542 . . . . 9.61 110.253 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.81 -26.68 16.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.705 -0.76 . . . . 11.55 111.78 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.83 52.8 1.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.152 0.501 . . . . 13.92 110.994 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 -41.37 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.908 -0.587 . . . . 16.21 110.069 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -78.15 98.52 5.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.63 . . . . 18.9 109.507 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' A' ' 124' ' ' LYS . 16.9 pttp -63.69 102.44 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.48 -0.782 . . . . 20.83 111.179 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.3 -37.32 77.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.963 -1.017 . . . . 22.5 111.082 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.555 HD22 ' HB3' ' A' ' 128' ' ' ARG . 9.7 t30 -128.56 110.69 12.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.851 -0.613 . . . . 24.29 110.354 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -82.81 54.96 2.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.171 0.51 . . . . 25.0 111.557 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.555 ' HB3' HD22 ' A' ' 126' ' ' ASN . 26.0 tpt180 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 27.94 109.471 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.668 -0.573 . . . . 12.09 111.668 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.6 tt -86.42 93.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.572 0.701 . . . . 10.3 111.179 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.87 133.53 69.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.112 -0.699 . . . . 7.1 109.112 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.23 36.09 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 123.098 2.532 . . . . 7.27 113.857 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 50.58 45.39 26.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.034 0.445 . . . . 8.77 110.687 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -58.2 150.95 20.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.374 -0.83 . . . . 4.49 111.974 -172.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.2 ptp -102.63 52.7 0.79 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.962 -1.017 . . . . 4.32 110.995 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.92 58.86 2.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 1.36 110.105 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.489 ' NH1' ' HA ' ' A' ' 110' ' ' ASN . 49.2 mtm180 -119.67 140.71 29.83 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.828 -0.624 . . . . 3.51 110.127 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.66 ' HB3' HG11 ' A' ' 89' ' ' VAL . 24.6 Cg_exo -65.53 178.54 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.231 2.621 . . . . 0.81 112.141 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 87' ' ' LEU . 7.0 ptp85 -133.19 136.6 45.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.092 -0.504 . . . . 2.82 111.85 -176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.609 ' HG ' ' CD1' ' A' ' 109' ' ' LEU . 4.1 mt -90.92 110.84 22.08 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.027 -0.731 . . . . 1.96 109.027 173.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.8 115.63 27.71 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.117 -0.697 . . . . 1.17 109.117 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.692 HG23 ' HG2' ' A' ' 85' ' ' LYS . 7.3 m -109.34 118.54 36.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.284 -0.636 . . . . 1.13 109.284 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.542 ' HE1' ' HA ' ' A' ' 46' ' ' ALA . 23.1 ptp -128.31 133.13 48.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.161 -0.472 . . . . 1.08 110.294 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' HE3' ' HB2' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -113.38 137.99 50.72 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.855 -0.795 . . . . 3.11 108.855 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.546 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.9 ttmt -54.6 121.05 7.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.765 -0.652 . . . . 1.5 111.179 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.98 -126.05 5.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.708 -0.758 . . . . 1.28 112.892 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.12 -43.05 45.1 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.221 2.614 . . . . 2.23 113.057 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 m -153.67 86.12 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.87 0.367 . . . . 3.28 110.591 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.546 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 65.99 -136.12 35.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.893 -0.594 . . . . 1.93 112.856 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -124.66 -176.8 3.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.737 -0.838 . . . . 1.82 108.737 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.61 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.963 -1.113 . . . . 0.96 113.243 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.53 146.59 22.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.832 0.348 . . . . 0.4 110.506 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.35 127.35 48.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.424 -0.584 . . . . 2.23 109.424 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 35' ' ' GLN . 18.3 tp -101.71 147.84 25.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.258 0.551 . . . . 2.11 111.582 -169.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 4.8 m-70 -109.56 121.98 46.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.71 . . . . 2.02 110.268 177.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -117.32 101.73 8.66 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.269 -1.382 . . . . 2.75 107.269 169.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 2.6 t70 -85.65 158.06 20.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.204 0.526 . . . . 3.48 111.739 -165.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 31' ' ' SER . 59.1 tttp -85.6 115.95 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.249 -0.887 . . . . 4.89 109.619 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 24.4 m 79.96 -18.47 0.5 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.013 0.82 . . . . 3.79 112.158 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 62.8 mttp -98.4 112.97 63.57 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.82 -0.437 . . . . 3.51 109.82 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.1 150.18 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.394 2.062 . . . . 2.55 112.238 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.88 173.57 19.98 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.932 -0.867 . . . . 1.47 110.932 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 26' ' ' LEU . 26.0 mm-40 -121.53 128.73 52.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.783 0.325 . . . . 1.5 110.179 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.598 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 30.0 m-85 -109.32 157.73 18.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.413 -0.588 . . . . 0.99 109.413 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.497 HG13 HD13 ' A' ' 51' ' ' LEU . 38.3 mm -98.83 116.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.113 -0.328 . . . . 1.12 110.113 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 59.8 ttt180 -76.87 -44.6 31.43 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.004 0.43 . . . . 3.48 110.549 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.442 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 26.2 t -164.48 155.07 14.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.508 -0.769 . . . . 1.82 109.291 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.7 130.06 74.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.56 -0.533 . . . . 1.11 109.56 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.99 119.25 56.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.763 -0.458 . . . . 2.28 109.763 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.3 140.25 81.87 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.648 2.232 . . . . 1.27 112.698 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 12.3 m-20 65.36 39.31 5.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.31 -0.859 . . . . 2.4 111.899 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.619 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 89.6 p -117.95 170.0 6.89 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.737 -0.665 . . . . 0.68 109.365 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 6.3 Cg_endo -51.34 -35.0 52.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.107 1.872 . . . . 0.87 112.015 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -69.92 -47.42 62.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 1.17 110.937 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.537 ' HG2' ' H ' ' A' ' 43' ' ' ASP . 5.0 tp10 -62.16 -40.49 96.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.997 0.427 . . . . 2.01 110.232 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.68 -24.32 62.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 1.15 111.763 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -75.93 -13.94 60.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.067 0.461 . . . . 0.4 110.344 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.47 21.65 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.696 -0.764 . . . . 0.62 112.42 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 37' ' ' ILE . 25.9 tp -79.16 132.63 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 1.12 110.277 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.421 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 8.0 tpp180 -114.88 156.68 24.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.264 -0.273 . . . . 5.17 110.264 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -87.07 30.24 0.78 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 1.44 111.734 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.79 17.28 1.12 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.377 0.608 . . . . 3.8 109.83 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.7 m-20 -104.6 159.28 15.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.065 -0.97 . . . . 1.02 110.355 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.528 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.8 tmm_? -128.12 130.9 48.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.2 -0.296 . . . . 2.26 110.2 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.473 ' HA ' HG11 ' A' ' 88' ' ' VAL . 56.8 mt -75.58 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 1.37 111.237 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.528 HG22 ' NH1' ' A' ' 56' ' ' ARG . 2.3 t -114.76 -46.32 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.758 -0.656 . . . . 1.56 110.299 177.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.6 mt-10 -123.69 148.13 46.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.89 110.674 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.554 ' O ' HG11 ' A' ' 63' ' ' VAL . 99.6 t -125.53 119.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 1.29 109.371 173.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.23 21.32 10.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 1.17 111.45 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.88 9.38 61.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.669 -0.777 . . . . 0.66 113.782 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.554 HG11 ' O ' ' A' ' 60' ' ' VAL . 11.2 p -115.31 136.25 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.412 0.606 . . . . 1.75 109.816 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.546 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 7.2 p -74.69 136.97 41.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.488 -0.778 . . . . 2.36 111.557 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.562 ' C ' ' HD2' ' A' ' 68' ' ' LYS . 22.4 mmt -108.36 67.45 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.057 -0.519 . . . . 1.42 111.878 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -141.35 131.3 24.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.366 -0.834 . . . . 3.75 109.37 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.38 -0.37 74.65 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.291 -1.123 . . . . 1.78 110.291 -170.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.562 ' HD2' ' C ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -91.0 164.4 13.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.356 -0.922 . . . . 3.73 111.148 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -96.96 172.15 8.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.343 -0.844 . . . . 3.61 109.041 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -62.2 -35.82 80.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.975 0.417 . . . . 2.2 109.953 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.49 -33.73 88.04 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.78 112.829 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.43 -46.76 81.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 2.03 110.551 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG12 ' HG3' ' A' ' 35' ' ' GLN . 46.4 t -62.4 -46.65 95.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.537 . . . . 1.71 110.559 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.21 -42.85 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 1.37 111.062 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -67.37 -36.55 81.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.445 -0.343 . . . . 1.12 110.747 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.36 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.625 -0.261 . . . . 1.09 111.549 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 HG22 HG23 ' A' ' 84' ' ' THR . 77.9 mt -59.62 -45.34 94.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.283 0.563 . . . . 1.35 110.345 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -72.66 -28.94 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.541 -0.754 . . . . 3.55 110.918 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.53 -14.31 62.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 1.28 111.406 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.61 -19.03 78.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.621 -0.8 . . . . 0.6 112.047 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -104.28 3.14 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.714 -0.755 . . . . 1.1 112.102 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.556 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 7.1 p-10 -98.0 -5.06 34.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.679 0.251 . . . . 2.12 111.679 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -150.47 165.17 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.986 0.422 . . . . 2.11 111.176 178.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.449 HG23 HG22 ' A' ' 77' ' ' ILE . 8.7 t -148.83 148.26 29.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.771 -0.65 . . . . 1.09 109.688 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.692 ' HG2' HG23 ' A' ' 14' ' ' THR . 23.1 mttm -115.31 118.63 33.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.9 -0.407 . . . . 2.25 109.9 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.35 125.87 51.47 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 1.04 109.324 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.558 HD13 HD21 ' A' ' 109' ' ' LEU . 52.0 tp -102.1 115.17 29.98 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.611 -0.885 . . . . 1.22 108.611 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 30.8 m -128.17 168.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.768 -0.651 . . . . 1.09 110.207 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' A' ' 10' ' ' PRO . 28.3 m -127.56 141.76 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.894 -0.594 . . . . 1.08 110.352 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.93 172.08 14.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.145 -0.687 . . . . 1.92 109.145 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 91' ' ' ARG . 19.4 tpt85 -58.13 -46.6 85.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.926 0.394 . . . . 4.87 111.152 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -64.88 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 2.68 111.593 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 m -75.36 -43.8 48.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.185 0.517 . . . . 1.08 110.536 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.413 ' HB2' HG22 ' A' ' 89' ' ' VAL . 24.4 t70 -59.38 -47.9 83.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 1.18 111.618 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.6 -39.67 94.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.726 0.298 . . . . 1.94 111.103 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -62.92 -49.32 75.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.83 110.759 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.225 -0.443 . . . . 0.55 111.24 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -60.43 -49.22 78.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.489 0.551 . . . . 2.5 112.489 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 99' ' ' LYS . 7.2 ptmm? -68.7 -32.82 72.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.294 0.569 . . . . 2.53 110.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.492 ' HB3' HG22 ' A' ' 102' ' ' VAL . 62.0 m -76.47 -13.99 60.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.657 -0.701 . . . . 2.19 111.295 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.5 27.71 15.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.45 -0.795 . . . . 4.83 110.657 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 100' ' ' CYS . 59.5 t -102.71 139.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.805 -0.634 . . . . 2.08 110.676 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.0 mp -84.82 122.66 74.52 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.005 -0.543 . . . . 1.99 109.643 175.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.449 ' HD2' HG12 ' A' ' 58' ' ' VAL . 3.0 Cg_exo -70.47 141.48 42.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.406 2.071 . . . . 0.86 110.891 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -151.44 167.1 29.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.059 -0.256 . . . . 1.92 110.787 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.595 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -52.5 -29.66 26.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.398 0.679 . . . . 1.87 111.778 176.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.26 -30.67 64.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.441 0.639 . . . . 2.82 110.902 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.73 -14.31 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.71 110.704 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.609 ' CD1' ' HG ' ' A' ' 12' ' ' LEU . 74.6 mt -70.03 114.24 8.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 1.47 110.33 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.489 ' HA ' ' NH1' ' A' ' 9' ' ' ARG . 66.2 t30 57.27 28.05 14.59 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.844 0.83 . . . . 4.09 109.965 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.25 -169.05 12.42 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.228 -0.896 . . . . 1.39 111.314 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 147.87 27.05 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.536 2.157 . . . . 1.65 112.694 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 47.6 mt -89.7 145.63 33.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.717 -0.674 . . . . 1.75 110.161 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.418 ' HG3' HG11 ' A' ' 102' ' ' VAL . 36.5 Cg_endo -65.0 147.47 89.06 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.842 2.361 . . . . 1.31 111.826 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 7.6 p -55.96 129.2 72.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 3.47 110.903 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 33.6 Cg_exo -58.8 89.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.071 2.514 . . . . 4.93 112.045 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.605 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 3.8 t80 -70.36 124.6 24.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 8.1 110.268 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -101.06 39.96 1.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.816 -0.629 . . . . 9.11 111.415 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.605 ' HB3' ' CE2' ' A' ' 117' ' ' PHE . 4.1 t-20 -133.78 108.49 8.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.946 -0.57 . . . . 9.61 110.064 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.42 53.86 0.48 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.175 -0.77 . . . . 11.55 111.175 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.16 99.46 7.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 13.92 110.538 -174.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.6 mt -77.25 -46.33 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.906 -0.588 . . . . 16.21 110.932 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 60.3 91.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.577 0.704 . . . . 18.9 110.942 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -79.3 -6.01 55.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.109 -0.95 . . . . 20.83 109.944 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.94 -44.94 71.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.167 -0.924 . . . . 22.5 111.449 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -102.86 28.91 5.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.157 -0.474 . . . . 24.29 111.694 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.9 p -71.01 -66.49 0.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.19 -0.3 . . . . 25.0 110.19 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 109.177 -0.675 . . . . 27.94 109.177 174.068 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.737 -0.545 . . . . 12.09 111.737 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.0 mp -107.07 122.89 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.758 -0.46 . . . . 10.3 109.758 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -91.34 109.53 36.48 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.244 -0.434 . . . . 7.1 109.847 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.02 -10.85 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.369 2.046 . . . . 7.27 112.921 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.31 -79.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.648 0.261 . . . . 8.77 110.633 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m 60.5 82.64 0.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.534 0.683 . . . . 4.49 110.948 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptm -84.87 23.32 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 4.32 110.561 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.5 mt -84.12 61.47 6.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 1.36 110.772 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -130.54 148.86 71.67 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.758 -0.655 . . . . 3.51 109.413 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HB2' HD13 ' A' ' 87' ' ' LEU . 56.8 Cg_endo -70.38 162.98 40.43 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.566 2.177 . . . . 0.81 111.419 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.418 ' NH1' HH12 ' A' ' 52' ' ' ARG . 6.4 ptp85 -127.65 136.12 51.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.167 -0.47 . . . . 2.82 110.545 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.403 ' HB2' HD11 ' A' ' 109' ' ' LEU . 46.5 tp -94.26 110.36 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.945 -0.57 . . . . 1.96 109.707 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -98.91 116.9 32.2 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.323 -0.621 . . . . 1.17 109.323 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.7 m -111.36 119.3 38.4 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.464 -0.569 . . . . 1.13 109.464 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.426 ' HE3' ' OG ' ' A' ' 49' ' ' SER . 23.1 ptp -127.96 133.24 49.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.014 -0.539 . . . . 1.08 109.971 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -116.79 156.59 26.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.462 -0.79 . . . . 3.11 110.138 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 86.0 mttt -68.55 125.72 27.4 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.264 -1.335 . . . . 1.5 111.778 -172.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.86 -107.58 0.73 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.257 -1.338 . . . . 1.28 110.928 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HG2' ' HD3' ' A' ' 45' ' ' PRO . 33.5 Cg_endo -65.78 104.49 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.597 2.198 . . . . 2.23 111.361 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t 63.48 29.99 15.33 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.31 0.576 . . . . 3.28 110.545 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.91 -97.09 1.11 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.269 -0.732 . . . . 1.93 111.269 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 17.0 m-85 -119.53 -171.17 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.849 -0.797 . . . . 1.82 108.849 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.57 78.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.1 -1.048 . . . . 0.96 112.791 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -155.56 163.15 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.4 110.605 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -128.88 129.22 45.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.939 -0.573 . . . . 2.23 110.285 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.34 134.8 47.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.399 -0.364 . . . . 2.11 110.23 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.0 p80 -125.72 135.29 51.92 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.509 -0.476 . . . . 2.02 110.734 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -102.31 122.39 44.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.408 -0.815 . . . . 2.75 109.533 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.9 152.71 22.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.556 -0.535 . . . . 3.48 109.556 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -85.86 -24.62 26.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.829 -0.623 . . . . 4.89 110.56 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -101.49 -42.16 6.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.841 -0.618 . . . . 3.79 109.99 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -94.34 117.74 67.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 3.51 110.407 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 154.22 58.66 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.502 2.134 . . . . 2.55 112.231 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.0 161.52 30.76 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.9 -0.667 . . . . 1.47 111.961 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.87 128.76 40.32 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.057 -0.349 . . . . 1.5 110.057 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.429 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 88.1 m-85 -109.11 154.94 21.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 0.99 109.18 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 53' ' ' ALA . 41.3 mm -77.84 107.87 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.002 0.429 . . . . 1.12 110.153 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 30.7 ttt180 -67.92 -43.47 79.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 3.48 109.823 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 p -175.66 140.15 0.44 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.534 -1.212 . . . . 1.82 109.668 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.28 121.37 60.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.0 -0.741 . . . . 1.11 109.0 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -66.05 122.47 81.32 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.669 -0.696 . . . . 2.28 109.957 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.18 149.71 78.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.847 2.365 . . . . 1.27 111.777 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.96 40.55 2.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 2.4 110.905 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 p -130.72 164.44 41.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.61 -0.268 . . . . 0.68 110.696 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD3' ' HG2' ' A' ' 19' ' ' PRO . 23.4 Cg_exo -64.23 -27.33 64.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.494 2.129 . . . . 0.87 111.47 175.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -46.81 71.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.759 -0.655 . . . . 1.17 110.241 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.87 -33.24 75.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.85 -0.614 . . . . 2.01 109.971 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.25 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 1.15 111.753 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.426 ' OG ' ' HE3' ' A' ' 15' ' ' MET . 59.8 p -70.2 -13.51 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.4 110.556 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.58 50.45 1.83 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.62 112.061 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -99.66 149.6 23.13 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.798 -0.445 . . . . 1.12 109.798 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 39.0 ttm180 -147.2 143.36 28.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.683 -0.235 . . . . 5.17 110.575 -173.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -77.22 14.11 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.074 0.768 . . . . 1.44 113.074 -173.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -115.44 -5.49 12.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.208 0.528 . . . . 3.8 109.981 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -91.36 155.06 18.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.152 -0.931 . . . . 1.02 111.273 -172.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -124.85 134.29 52.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 2.26 109.719 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.458 ' HA ' HG13 ' A' ' 88' ' ' VAL . 41.7 mm -63.97 124.41 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.298 -0.41 . . . . 1.37 111.06 -176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.11 -52.01 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.995 -0.548 . . . . 1.56 110.638 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 28.9 mt-10 -133.32 149.37 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.89 110.213 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.33 123.4 66.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.78 -0.452 . . . . 1.29 109.78 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 60.81 20.84 10.97 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.079 0.552 . . . . 1.17 111.153 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.0 1.1 70.52 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.9 -0.667 . . . . 0.66 112.217 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.43 120.66 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.16 -0.311 . . . . 1.75 110.16 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.747 ' HG ' HG22 ' A' ' 103' ' ' ILE . 48.8 t -64.46 136.2 56.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 2.36 111.492 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.519 ' HG3' HG12 ' A' ' 73' ' ' VAL . 26.6 mmt -121.47 73.64 1.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.777 -0.647 . . . . 1.42 109.613 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.78 -57.37 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.22 -0.9 . . . . 3.75 110.667 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.9 13.77 45.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.026 -0.607 . . . . 1.78 111.927 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 68' ' ' LYS . 30.8 mmtp -86.4 160.26 19.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.856 0.36 . . . . 3.73 110.491 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -90.72 173.11 8.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.0 -0.545 . . . . 3.61 111.429 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -58.48 -36.43 73.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.219 -0.446 . . . . 2.2 110.086 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.1 -38.7 96.56 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.795 -0.717 . . . . 0.78 112.415 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 68' ' ' LYS . 4.3 m-20 -62.57 -48.09 80.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.653 0.263 . . . . 2.03 111.171 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.519 HG12 ' HG3' ' A' ' 65' ' ' MET . 33.4 m -67.42 -40.35 84.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 1.71 111.367 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.44 -45.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.056 0.455 . . . . 1.37 110.672 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -36.59 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 1.12 110.414 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.47 96.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.655 0.264 . . . . 1.09 111.187 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.465 HG22 HG21 ' A' ' 84' ' ' THR . 85.9 mt -60.21 -45.2 96.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.205 0.526 . . . . 1.35 110.274 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.63 -36.04 78.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 3.55 110.913 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 1.28 110.993 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.47 79.59 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 0.6 111.273 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.28 -123.32 7.67 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.004 -0.617 . . . . 1.1 111.659 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 1.3 m-20 -100.22 -4.16 30.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.829 0.347 . . . . 2.12 110.46 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 26.0 mt-10 -135.05 140.05 45.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.357 -0.979 . . . . 2.11 108.357 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.465 HG21 HG22 ' A' ' 77' ' ' ILE . 12.6 t -139.66 148.03 41.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.897 0.38 . . . . 1.09 110.464 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -116.73 123.97 48.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.265 -0.425 . . . . 2.25 110.331 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.48 129.78 55.7 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.736 -0.468 . . . . 1.04 109.736 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 10' ' ' PRO . 16.9 tp -104.75 119.18 38.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.048 -0.723 . . . . 1.22 109.048 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 23.8 m -130.28 165.94 29.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.304 -0.407 . . . . 1.09 111.623 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.43 160.09 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.532 -0.758 . . . . 1.08 110.508 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.414 ' CG ' HH12 ' A' ' 11' ' ' ARG . 2.2 m-20 -77.29 175.59 9.58 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.492 0.495 . . . . 1.92 110.418 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -61.89 -47.27 85.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 4.87 110.767 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.41 -35.78 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 2.68 110.093 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -65.89 -41.51 91.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 1.08 110.797 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 20.4 t70 -58.66 -48.54 80.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 1.18 110.194 176.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -62.17 -38.46 89.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 1.94 111.108 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.419 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 77.7 t80 -63.74 -49.19 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.42 -0.354 . . . . 0.83 111.283 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 19.6 m-85 -66.17 -38.27 87.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.476 -0.329 . . . . 0.55 111.212 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 31.3 mtpt -66.72 -43.53 84.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.455 -0.338 . . . . 2.5 111.557 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 96' ' ' PHE . 52.0 pttt -71.75 -14.65 62.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 2.53 110.66 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 54.5 m -94.47 -6.22 44.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.227 0.537 . . . . 2.19 110.566 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.576 ' HD2' ' N ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER 57.96 35.33 25.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.112 -0.949 . . . . 4.83 111.454 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 114' ' ' PRO . 10.9 p -132.24 147.33 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.796 -0.638 . . . . 2.08 109.806 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.747 HG22 ' HG ' ' A' ' 64' ' ' CYS . 32.1 mm -87.99 132.19 40.73 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.324 -0.398 . . . . 1.99 111.26 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.486 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 18.7 Cg_exo -65.35 137.4 51.11 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.557 2.171 . . . . 0.86 110.462 173.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.4 p -153.04 174.25 14.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.774 -0.37 . . . . 1.92 111.564 -172.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.442 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 98.3 mt-30 -59.49 -28.36 66.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 1.87 110.298 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.89 -41.34 77.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.616 -0.72 . . . . 2.82 110.429 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -78.95 -14.09 59.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.518 -0.764 . . . . 0.71 111.398 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.442 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.6 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.825 0.345 . . . . 1.47 110.92 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -118.09 -37.64 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 4.09 111.03 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.27 -166.44 36.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.164 -0.541 . . . . 1.39 113.507 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.9 136.77 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.536 2.824 . . . . 1.65 112.636 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 2.8 mm? -63.11 154.86 76.0 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 1.75 109.909 171.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.537 ' HB3' HG13 ' A' ' 102' ' ' VAL . 7.1 Cg_endo -48.4 -31.27 17.31 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.312 3.341 . . . . 1.31 115.015 -168.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.8 m -66.33 119.45 62.35 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.678 -0.692 . . . . 3.47 111.012 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.659 ' HB2' ' HB3' ' A' ' 119' ' ' ASN . 34.6 Cg_endo -66.24 92.32 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.582 2.188 . . . . 4.93 111.542 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -52.9 109.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.576 -0.738 . . . . 8.1 111.603 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.3 p 59.64 23.05 11.8 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.085 0.954 . . . . 9.11 112.047 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 116' ' ' PRO . 9.8 t30 -116.62 121.74 42.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.172 -0.467 . . . . 9.61 110.209 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.32 -96.37 0.7 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.656 -0.783 . . . . 11.55 112.213 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 57.02 40.2 28.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.553 0.692 . . . . 13.92 110.731 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 pt -98.95 122.14 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.236 -0.893 . . . . 16.21 110.575 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -145.54 -85.14 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.332 -0.394 . . . . 18.9 110.126 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -112.59 0.91 15.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.996 0.427 . . . . 20.83 110.158 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.78 141.16 4.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 22.5 110.064 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -174.85 132.17 0.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 24.29 109.379 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.1 m 52.99 41.46 32.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.173 0.511 . . . . 25.0 110.795 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.656 -0.688 . . . . 27.94 109.988 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.834 -0.506 . . . . 12.09 111.834 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.527 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 23.6 pt -76.65 140.21 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.773 0.32 . . . . 10.3 110.47 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.92 114.98 60.91 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.341 0.591 . . . . 7.1 112.212 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 2' ' ' ILE . 18.8 Cg_endo -90.83 -51.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.943 2.429 . . . . 7.27 111.564 169.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -154.59 57.96 0.69 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.644 -0.707 . . . . 8.77 110.079 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.519 HG23 ' HG ' ' A' ' 8' ' ' LEU . 3.3 m -81.23 73.5 8.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.496 0.665 . . . . 4.49 110.585 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptm -84.33 51.94 2.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.314 -0.857 . . . . 4.32 111.168 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.519 ' HG ' HG23 ' A' ' 6' ' ' THR . 81.1 mt -80.97 60.38 4.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.305 0.574 . . . . 1.36 110.436 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.519 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 14.1 ptt180 -126.74 160.2 60.0 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.616 -0.72 . . . . 3.51 109.285 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 56.7 Cg_endo -65.79 178.6 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.446 2.097 . . . . 0.81 111.984 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.518 ' HD3' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -137.31 132.5 33.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.108 -0.33 . . . . 2.82 110.108 175.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.464 ' HG ' HD11 ' A' ' 109' ' ' LEU . 3.7 mt -92.82 109.9 21.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.08 -0.509 . . . . 1.96 109.843 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 17.9 m -91.19 116.64 28.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.966 -0.753 . . . . 1.17 108.966 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 116.7 33.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.517 -0.92 . . . . 1.13 108.517 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.466 ' HE2' ' OG ' ' A' ' 49' ' ' SER . 22.9 ptp -140.21 134.13 30.7 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.148 -0.478 . . . . 1.08 110.195 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 17.9 pttp -110.9 156.28 21.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.266 0.555 . . . . 3.11 110.583 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.8 ttmt -59.11 111.85 1.48 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.85 -1.068 . . . . 1.5 112.163 -171.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.53 -107.16 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.414 -0.812 . . . . 1.28 111.256 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.33 95.33 0.14 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.088 2.525 . . . . 2.23 112.126 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.0 t 72.53 -52.17 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.461 0.705 . . . . 3.28 112.139 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -179.69 78.25 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 1.93 111.885 -175.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 71.04 -63.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.342 0.657 . . . . 1.82 110.913 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.12 69.31 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.158 -0.544 . . . . 0.96 112.982 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.43 150.99 25.69 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.783 0.325 . . . . 0.4 110.192 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 45.1 t-20 -102.26 129.33 48.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.894 0.378 . . . . 2.23 109.982 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 35' ' ' GLN . 1.7 tm? -100.84 129.33 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.168 -0.679 . . . . 2.11 109.168 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -153.18 167.04 30.63 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.852 1.797 . . . . 2.02 115.852 -167.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 70.5 m 87.39 12.61 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 113.209 -1.814 . . . . 2.75 112.487 169.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.555 ' OD2' ' HB2' ' A' ' 70' ' ' HIS . 1.7 p-10 -129.67 163.26 26.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.173 0.511 . . . . 3.48 110.928 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -166.26 -25.75 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.945 -1.025 . . . . 4.89 109.054 170.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -150.04 19.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.645 -0.707 . . . . 3.79 110.281 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -126.18 135.4 27.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.932 -0.396 . . . . 3.51 109.932 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 154.08 68.44 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.408 2.072 . . . . 2.55 111.003 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 105.88 2.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.429 -0.891 . . . . 1.47 110.984 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.505 ' HB3' HD13 ' A' ' 26' ' ' LEU . 16.4 mm-40 -100.4 140.51 34.55 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 1.5 109.523 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 50.3 m-85 -117.53 144.48 45.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.197 -1.001 . . . . 0.99 110.104 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.501 HG13 HD11 ' A' ' 51' ' ' LEU . 45.0 mm -81.56 115.3 23.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.541 -0.54 . . . . 1.12 109.541 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 2.1 tmm_? -77.25 -49.31 15.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.234 -0.654 . . . . 3.48 109.234 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.2 p -159.68 150.47 19.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.057 -0.974 . . . . 1.82 109.824 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.11 122.03 63.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.065 -0.717 . . . . 1.11 109.065 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -67.42 133.02 93.02 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.589 . . . . 2.28 110.436 -174.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 35.5 Cg_exo -59.71 145.2 98.78 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.672 2.248 . . . . 1.27 112.033 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 34.4 m-20 74.54 15.59 3.34 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.997 0.81 . . . . 2.4 111.657 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.5 p -95.09 155.22 39.23 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.752 0.31 . . . . 0.68 110.238 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.68 -27.5 81.27 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.772 2.315 . . . . 0.87 111.182 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.24 -48.81 71.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.732 -0.667 . . . . 1.17 110.114 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 2.01 110.272 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.42 69.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 1.15 111.784 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.466 ' OG ' ' HE2' ' A' ' 15' ' ' MET . 74.6 p -73.68 -12.15 60.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.4 110.875 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.34 51.06 1.36 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.62 112.441 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.501 HD11 HG13 ' A' ' 37' ' ' ILE . 23.1 tp -100.83 142.62 32.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.0 0.429 . . . . 1.12 110.759 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG2' ' H ' ' A' ' 54' ' ' GLN . 32.4 ttm180 -121.63 144.23 48.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 5.17 109.805 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.71 26.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 1.44 111.5 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -139.95 19.75 2.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.641 . . . . 3.8 109.271 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -104.27 157.85 16.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.341 -0.845 . . . . 1.02 111.305 -176.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -115.89 133.08 56.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.604 -0.725 . . . . 2.26 109.874 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' HA ' HG13 ' A' ' 88' ' ' VAL . 65.5 mt -76.63 124.43 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.296 -0.411 . . . . 1.37 110.465 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -106.65 -46.0 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 1.56 110.523 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 43.1 mt-10 -127.07 146.23 50.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.89 110.465 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.54 ' O ' HG11 ' A' ' 63' ' ' VAL . 85.9 t -131.48 118.93 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.22 -0.446 . . . . 1.29 109.841 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 57.23 27.43 13.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.377 -0.374 . . . . 1.17 111.582 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.482 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.6 6.75 63.81 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.66 114.219 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 60' ' ' VAL . 12.1 p -115.41 135.07 56.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.784 0.792 . . . . 1.75 110.092 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.1 t -80.74 136.63 36.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.508 -0.769 . . . . 2.36 111.225 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.478 ' SD ' HG23 ' A' ' 73' ' ' VAL . 23.1 mmt -106.94 53.3 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.695 -0.684 . . . . 1.42 110.479 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.09 -56.77 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 3.75 110.309 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.72 1.47 39.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 1.78 111.794 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.2 146.6 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.178 0.513 . . . . 3.73 110.875 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -98.97 -179.46 4.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.661 -0.699 . . . . 3.61 110.644 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.555 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 40.7 t60 -55.57 -43.87 76.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.401 . . . . 2.2 110.773 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -37.85 95.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.734 -0.746 . . . . 0.78 112.21 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.44 -47.51 75.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.987 0.422 . . . . 2.03 110.876 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.478 HG23 ' SD ' ' A' ' 65' ' ' MET . 25.2 t -70.23 -47.14 68.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 1.71 110.983 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.83 -36.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 1.37 110.636 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -65.31 -47.0 78.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.187 -0.46 . . . . 1.12 110.093 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.59 93.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.218 -0.446 . . . . 1.09 111.651 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.408 HG23 HG22 ' A' ' 84' ' ' THR . 70.3 mt -58.94 -43.26 88.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.288 0.566 . . . . 1.35 110.605 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -74.42 -30.08 61.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.516 -0.765 . . . . 3.55 111.342 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.15 9.94 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 1.28 111.727 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.1 -0.8 86.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.6 111.798 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.37 -101.5 2.49 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.129 -0.788 . . . . 1.1 111.129 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.467 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 6.0 t70 -128.86 -15.96 4.24 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.988 -0.285 . . . . 2.12 110.664 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.2 mt-10 -119.3 144.34 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 2.11 108.481 174.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.408 HG22 HG23 ' A' ' 77' ' ' ILE . 13.3 t -135.34 148.82 49.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.094 0.473 . . . . 1.09 110.395 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HB3' HD21 ' A' ' 12' ' ' LEU . 97.8 mttt -111.67 117.46 32.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 2.25 109.856 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.8 mt -106.68 129.98 54.49 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.16 -0.473 . . . . 1.04 109.797 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 41.5 tp -104.8 115.31 30.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.284 -0.636 . . . . 1.22 109.284 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.0 m -127.48 160.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.107 -0.497 . . . . 1.09 110.861 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.88 138.77 53.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 1.08 110.644 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.22 166.38 23.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.605 . . . . 1.92 110.078 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -56.2 -48.01 77.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 4.87 110.259 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.62 -33.69 76.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 2.68 110.372 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.4 m -70.63 -51.8 25.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.302 -0.863 . . . . 1.08 111.122 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.87 -30.72 68.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 1.18 111.393 -172.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -62.02 -35.27 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.005 0.431 . . . . 1.94 110.126 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -67.83 -45.7 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.83 109.926 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.417 ' CE2' ' HA ' ' A' ' 104' ' ' PRO . 46.6 m-85 -62.54 -36.91 84.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.55 111.498 177.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -59.66 -49.65 76.93 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.54 0.21 . . . . 2.5 111.257 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -71.89 -26.48 62.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.419 -0.355 . . . . 2.53 111.048 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 m -81.19 -8.4 59.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.273 -0.421 . . . . 2.19 111.242 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 58.53 39.63 24.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.338 -0.846 . . . . 4.83 111.046 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG12 ' CG ' ' A' ' 114' ' ' PRO . 7.3 p -132.87 145.25 34.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 2.08 110.924 -176.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.9 mt -80.51 131.75 60.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 1.99 110.572 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 22.4 Cg_exo -63.7 136.65 54.8 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.472 2.115 . . . . 0.86 110.619 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.544 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 48.9 m -157.57 163.66 38.11 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.124 -0.23 . . . . 1.92 110.677 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.482 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 50.8 mt-30 -56.89 -28.78 62.32 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.7 0.625 . . . . 1.87 111.983 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.3 pt-20 -57.99 -29.97 65.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.114 0.483 . . . . 2.82 111.061 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.416 ' CD2' ' HD3' ' A' ' 114' ' ' PRO . 35.9 m80 -82.97 -13.68 55.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.884 -0.598 . . . . 0.71 110.98 -177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.464 HD11 ' HG ' ' A' ' 12' ' ' LEU . 66.8 mt -73.73 -53.77 9.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 1.47 110.087 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.51 48.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.454 -0.794 . . . . 4.09 110.258 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.53 38.36 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.755 -0.736 . . . . 1.39 111.959 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.94 174.54 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.048 2.499 . . . . 1.65 112.783 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 9' ' ' ARG . 48.1 mt -88.43 138.23 30.3 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.586 -0.734 . . . . 1.75 109.737 175.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' CG ' HG12 ' A' ' 102' ' ' VAL . 48.0 Cg_endo -68.23 127.41 15.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.808 2.338 . . . . 1.31 112.578 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 27.3 m -125.96 144.97 50.39 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 3.47 109.662 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 13.3 Cg_exo -70.4 72.64 1.74 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.922 2.415 . . . . 4.93 112.038 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.92 142.17 28.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.785 -0.45 . . . . 8.1 109.785 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.0 p -72.88 89.22 1.38 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 9.11 111.652 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.97 156.21 22.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.769 -0.65 . . . . 9.61 110.385 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.57 157.16 49.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.078 -0.582 . . . . 11.55 112.392 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.72 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.106 0.479 . . . . 13.92 111.46 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 57.8 mt -84.55 86.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.686 -0.857 . . . . 16.21 108.686 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -73.54 122.66 22.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 18.9 110.978 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -118.58 57.12 0.87 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.172 -0.922 . . . . 20.83 109.655 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -61.93 -59.31 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.773 -1.103 . . . . 22.5 110.669 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -102.53 106.17 16.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 24.29 110.113 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.2 t -130.78 120.71 24.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.829 -0.623 . . . . 25.0 109.919 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.708 -0.663 . . . . 27.94 109.465 179.471 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 112.035 -0.426 . . . . 12.09 112.035 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.9 mt 71.17 110.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.329 0.585 . . . . 10.3 110.75 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 16.2 t70 -85.51 135.63 38.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.828 -0.624 . . . . 7.1 109.567 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 32.5 Cg_exo -59.62 -16.87 38.93 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.391 2.727 . . . . 7.27 112.784 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.509 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 18.6 p90 -136.38 -152.76 0.46 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.917 -1.142 . . . . 8.77 107.917 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.518 HG23 ' HG3' ' A' ' 7' ' ' MET . 23.1 m 71.73 129.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 4.49 111.661 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.518 ' HG3' HG23 ' A' ' 6' ' ' THR . 85.1 mtp 66.58 11.82 8.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.8 . . . . 4.32 111.415 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.509 ' CD1' ' HA ' ' A' ' 5' ' ' PHE . 65.9 mt -93.63 64.38 3.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.997 0.904 . . . . 1.36 109.038 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -117.7 146.49 38.86 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.43 -1.259 . . . . 3.51 109.481 -173.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HB2' HD11 ' A' ' 87' ' ' LEU . 48.0 Cg_endo -66.93 159.25 52.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.378 2.052 . . . . 0.81 110.996 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.48 ' HG3' HG22 ' A' ' 88' ' ' VAL . 6.3 ptp85 -114.92 129.55 56.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.209 -0.45 . . . . 2.82 110.304 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.451 -0.574 . . . . 1.96 109.451 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 21.4 m -93.85 116.18 28.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.535 -0.543 . . . . 1.17 109.535 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 85' ' ' LYS . 25.5 m -108.57 116.95 32.94 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.661 -0.866 . . . . 1.13 108.661 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.48 ' HE2' HD22 ' A' ' 51' ' ' LEU . 25.3 ptp -133.55 134.01 42.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.142 0.496 . . . . 1.08 111.201 -172.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -107.07 141.42 38.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.246 -0.888 . . . . 3.11 109.997 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 39.0 mttm -59.79 107.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.695 -0.684 . . . . 1.5 111.427 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.41 -119.64 4.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.922 -1.036 . . . . 1.28 112.366 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -57.52 -58.01 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.079 2.519 . . . . 2.23 113.066 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -121.37 36.4 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 3.28 111.425 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 55.63 84.4 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.249 -0.501 . . . . 1.93 112.736 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 67.32 -149.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.801 -0.444 . . . . 1.82 109.801 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.91 73.34 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.391 -0.909 . . . . 0.96 112.516 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -152.77 158.91 42.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.4 110.539 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -113.91 133.4 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 2.23 109.561 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 35' ' ' GLN . 3.1 tm? -109.23 129.38 55.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.024 -0.362 . . . . 2.11 110.024 -176.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.91 140.13 53.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.123 0.487 . . . . 2.02 110.292 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -126.36 142.57 51.48 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.972 -0.558 . . . . 2.75 110.066 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 8.6 t70 -92.26 141.27 28.74 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.67 -0.863 . . . . 3.48 108.67 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.36 -9.79 23.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 4.89 110.965 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 t -97.53 -44.02 6.99 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.186 -0.672 . . . . 3.79 109.186 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 22.2 pttm -117.43 114.22 38.37 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.636 . . . . 3.51 109.889 176.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.7 140.23 84.11 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.012 2.475 . . . . 2.55 113.193 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.82 135.47 2.9 Favored Glycine 0 C--N 1.312 -0.752 0 CA-C-N 114.618 -1.174 . . . . 1.47 112.115 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.411 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.6 mp0 -101.28 128.3 47.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.805 -0.443 . . . . 1.5 109.805 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.618 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 56.0 m-85 -122.08 142.31 50.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.926 -0.398 . . . . 0.99 109.926 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 51' ' ' LEU . 43.7 mm -72.29 109.41 4.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.199 0.523 . . . . 1.12 110.029 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.793 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.1 tpt180 -66.81 -42.88 85.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.256 -0.883 . . . . 3.48 110.233 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -170.51 158.23 6.28 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.489 -0.778 . . . . 1.82 109.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.05 134.4 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.076 -0.713 . . . . 1.11 109.076 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.44 125.02 91.51 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.104 -0.498 . . . . 2.28 109.932 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 Cg_endo -61.38 134.82 53.92 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.756 2.304 . . . . 1.27 112.771 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.4 m-20 73.16 20.23 3.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.442 -0.799 . . . . 2.4 112.194 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.411 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 97.2 p -97.48 160.4 28.86 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.873 -0.417 . . . . 0.68 109.873 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 19.6 Cg_endo -60.06 -24.25 76.04 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.336 2.024 . . . . 0.87 111.999 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.91 -40.97 75.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 1.17 110.35 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -69.89 -39.38 76.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.201 -0.454 . . . . 2.01 110.249 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 1.15 111.79 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.5 p -75.45 -12.89 60.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.4 110.529 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.83 -1.0 30.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.686 . . . . 0.62 112.29 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 37' ' ' ILE . 30.9 tp -74.82 131.15 40.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.891 0.377 . . . . 1.12 110.466 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -132.77 -172.58 2.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.002 -0.544 . . . . 5.17 110.271 177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.36 154.46 19.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.515 -0.311 . . . . 1.44 111.342 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 69.6 18.82 7.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.694 -0.685 . . . . 3.8 111.235 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -90.57 150.21 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 1.02 109.784 175.135 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.5 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -120.53 129.1 53.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.534 -0.543 . . . . 2.26 109.534 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.453 ' HA ' HG11 ' A' ' 88' ' ' VAL . 54.9 mt -76.26 136.67 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 1.37 111.406 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.5 HG22 ' NH1' ' A' ' 56' ' ' ARG . 3.4 t -115.1 -50.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.481 -0.782 . . . . 1.56 110.098 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 31.2 mt-10 -128.88 149.07 50.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.939 -0.573 . . . . 0.89 110.48 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -130.35 120.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 1.29 110.004 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 60.35 27.61 17.19 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.949 0.5 . . . . 1.17 111.447 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.01 82.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.66 112.32 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.86 121.62 55.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.13 -0.322 . . . . 1.75 110.13 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -70.23 135.27 48.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.421 . . . . 2.36 110.813 -178.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.744 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 23.8 mmt -112.67 64.39 0.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.596 0.712 . . . . 1.42 110.333 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -93.44 99.19 11.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.01 -0.995 . . . . 3.75 110.875 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 4.33 81.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 1.78 112.474 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.744 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.5 mmtp -58.77 156.61 10.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.621 0.724 . . . . 3.73 112.819 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -80.93 162.39 23.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.483 -1.235 . . . . 3.61 109.969 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -59.16 -38.9 80.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.924 0.392 . . . . 2.2 110.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.42 -41.2 91.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.751 -0.738 . . . . 0.78 113.099 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.51 -41.08 89.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.718 0.259 . . . . 2.03 111.215 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.1 m -69.41 -41.89 80.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 1.71 111.383 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.53 -38.09 78.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.973 0.416 . . . . 1.37 110.344 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -66.33 -35.85 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 1.12 110.51 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.49 98.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 1.09 111.567 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.471 HG12 HD23 ' A' ' 86' ' ' LEU . 62.9 mt -59.06 -42.26 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.295 0.569 . . . . 1.35 110.628 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -74.14 -30.28 62.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.682 -0.69 . . . . 3.55 110.706 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 -8.91 57.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.868 -0.605 . . . . 1.28 111.446 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.09 -30.85 78.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.76 -0.734 . . . . 0.6 111.683 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.65 -101.04 1.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.071 -0.585 . . . . 1.1 112.132 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.64 -18.06 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.998 0.428 . . . . 2.12 110.083 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.61 44.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.429 -0.582 . . . . 2.11 109.429 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 77' ' ' ILE . 15.1 t -140.32 149.37 42.67 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.262 -0.426 . . . . 1.09 110.142 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.407 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.9 mttp -116.26 116.89 28.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.185 -0.461 . . . . 2.25 109.989 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 77' ' ' ILE . 87.1 mt -108.3 126.87 53.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.105 -0.498 . . . . 1.04 109.995 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 10' ' ' PRO . 31.0 tp -103.25 115.71 31.09 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.093 -0.706 . . . . 1.22 109.093 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.4 m -127.39 164.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.767 -0.651 . . . . 1.09 110.089 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -127.74 142.06 44.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.086 -0.507 . . . . 1.08 111.14 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.21 168.74 17.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.23 -0.895 . . . . 1.92 109.48 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 91' ' ' ARG . 6.5 ttp180 -56.58 -47.55 79.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.268 0.556 . . . . 4.87 110.155 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.09 -35.92 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.438 -0.801 . . . . 2.68 110.981 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 m -72.16 -49.95 31.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 1.08 111.497 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.63 -46.75 88.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.109 0.48 . . . . 1.18 110.301 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -63.01 -34.63 77.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.913 -0.585 . . . . 1.94 111.269 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.81 -47.37 78.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.83 110.438 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -65.1 -35.9 82.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.1 -0.5 . . . . 0.55 111.393 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -57.9 -49.1 77.88 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.505 0.187 . . . . 2.5 111.505 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -71.01 -22.17 62.19 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.202 0.525 . . . . 2.53 110.812 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 116' ' ' PRO . 85.9 m -84.81 -14.45 48.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.018 -0.537 . . . . 2.19 110.817 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 57.63 33.97 23.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.418 -0.81 . . . . 4.83 111.372 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.4 HG11 ' HG2' ' A' ' 114' ' ' PRO . 11.4 p -128.49 146.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.017 -0.538 . . . . 2.08 109.953 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.2 mt -87.23 132.06 42.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 1.99 111.322 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.04 143.37 84.56 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.783 2.322 . . . . 0.86 110.942 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -156.01 163.04 40.2 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.82 -0.352 . . . . 1.92 110.481 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.446 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 22.7 mt-30 -55.66 -29.01 58.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.679 0.612 . . . . 1.87 110.904 174.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.54 -29.76 66.58 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.939 -0.573 . . . . 2.82 111.839 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -87.24 -13.88 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.361 -0.381 . . . . 0.71 111.798 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 73.2 mt -58.3 106.74 0.41 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.48 -0.327 . . . . 1.47 110.932 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.61 18.25 6.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.153 -0.476 . . . . 4.09 111.638 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.2 179.3 23.01 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.445 -0.662 . . . . 1.39 111.445 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.5 131.9 29.43 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.423 2.082 . . . . 1.65 111.886 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.3 mt -78.88 132.34 64.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.728 -0.471 . . . . 1.75 109.728 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HG2' HG11 ' A' ' 102' ' ' VAL . 30.4 Cg_endo -64.47 149.45 89.97 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.416 2.744 . . . . 1.31 113.02 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 p -128.77 83.29 66.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 122.002 0.906 . . . . 3.47 109.969 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HG2' ' O ' ' A' ' 100' ' ' CYS . 3.0 Cg_endo -87.58 5.65 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.445 2.763 . . . . 4.93 112.068 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 63.88 -69.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.596 -1.184 . . . . 8.1 112.01 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 m 58.95 59.61 2.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.876 0.846 . . . . 9.11 110.213 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -94.78 -21.15 18.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.428 -0.806 . . . . 9.61 109.593 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.74 149.55 28.6 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.87 -0.681 . . . . 11.55 111.969 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -73.52 106.69 5.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.804 0.335 . . . . 13.92 110.339 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.73 109.12 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 16.21 110.446 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -126.89 87.71 2.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.445 . . . . 18.9 110.343 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.217 0.532 . . . . 20.83 110.737 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.11 155.55 18.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.696 -0.684 . . . . 22.5 110.756 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -115.22 66.61 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.941 -0.572 . . . . 24.29 110.417 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 p -81.34 90.77 6.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.381 0.61 . . . . 25.0 109.86 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.537 -0.756 . . . . 27.94 110.808 -175.16 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.952 0 N-CA-C 111.816 -0.513 . . . . 12.09 111.816 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.6 pt -114.61 36.36 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 10.3 109.637 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.56 116.53 65.03 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.193 -0.912 . . . . 7.1 110.636 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.06 -26.46 30.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.838 2.359 . . . . 7.27 111.622 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -95.64 71.49 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 8.77 110.271 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -124.95 160.29 29.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 4.49 111.117 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 ptm -92.14 21.39 5.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 4.32 111.596 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.8 mt -109.25 41.05 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.348 0.594 . . . . 1.36 110.62 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -112.45 145.98 34.02 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 3.51 109.26 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 87' ' ' LEU . 32.8 Cg_endo -65.06 160.28 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.21 1.94 . . . . 0.81 111.552 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -107.23 130.33 54.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.599 -0.728 . . . . 2.82 109.904 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.6 tp -106.23 109.4 21.32 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.536 -0.542 . . . . 1.96 109.536 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.2 m -96.26 117.5 30.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.743 -0.662 . . . . 1.17 109.841 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -111.06 116.87 31.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.407 -0.961 . . . . 1.13 108.407 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.496 ' HE3' ' OG ' ' A' ' 49' ' ' SER . 22.8 ptp -132.88 133.54 43.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.942 0.401 . . . . 1.08 110.652 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.984 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 6.8 ttmt -108.78 137.38 46.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.233 0.54 . . . . 3.11 110.459 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.608 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.5 ttmt -54.88 125.65 21.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.407 -1.27 . . . . 1.5 112.045 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.91 -153.0 28.68 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.792 -0.64 . . . . 1.28 111.637 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.21 -33.99 58.26 Favored 'Trans proline' 0 CA--C 1.527 0.159 0 C-N-CA 122.912 2.408 . . . . 2.23 112.663 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.9 m -119.49 38.23 3.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.129 0.49 . . . . 3.28 110.868 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.608 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.34 -108.91 2.85 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.325 -0.941 . . . . 1.93 111.869 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -130.82 -155.0 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.835 -0.802 . . . . 1.82 108.835 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.86 73.35 0.22 Allowed Glycine 0 C--O 1.228 -0.265 0 C-N-CA 119.639 -1.267 . . . . 0.96 113.467 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -157.28 152.01 25.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.849 0.325 . . . . 0.4 110.701 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.49 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 3.0 t-20 -112.03 145.42 39.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.462 -0.569 . . . . 2.23 109.462 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.36 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.375 0.607 . . . . 2.11 112.579 -172.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -107.82 121.5 44.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 2.02 110.022 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -105.76 92.45 4.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.792 -0.818 . . . . 2.75 108.792 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.69 131.97 34.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.562 0.696 . . . . 3.48 111.982 -170.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -96.46 44.81 1.06 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.941 -1.027 . . . . 4.89 111.032 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.7 p -162.59 -57.54 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.321 -0.854 . . . . 3.79 109.804 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -101.57 131.11 23.36 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 3.51 110.162 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.95 155.04 30.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.668 2.245 . . . . 2.55 113.233 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.24 158.25 24.06 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.235 -0.893 . . . . 1.47 111.848 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -93.21 127.37 38.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.026 0.441 . . . . 1.5 110.315 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 56' ' ' ARG . 51.6 m-85 -106.55 158.22 17.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 0.99 109.129 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.805 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.8 mm -80.35 110.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.973 -0.751 . . . . 1.12 108.973 175.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.603 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 79.7 ttt180 -67.48 -46.72 72.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.431 0.634 . . . . 3.48 109.905 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.9 p -167.59 131.64 1.79 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.932 -1.031 . . . . 1.82 108.881 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -95.01 127.99 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.314 -0.624 . . . . 1.11 109.314 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.2 115.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.275 -0.639 . . . . 2.28 109.275 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.72 147.53 94.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.591 2.194 . . . . 1.27 111.689 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 63.95 52.87 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.895 0.855 . . . . 2.4 110.031 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.618 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -142.95 167.9 14.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.68 110.113 176.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.3 Cg_endo -54.19 -36.04 84.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.87 111.862 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.52 67.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 1.17 110.757 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.53 -38.54 90.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.254 -0.43 . . . . 2.01 110.152 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.78 79.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 1.15 111.589 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.496 ' OG ' ' HE3' ' A' ' 15' ' ' MET . 87.8 p -72.8 -14.73 61.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.07 0.462 . . . . 0.4 110.933 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.92 38.46 4.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.096 -0.573 . . . . 0.62 113.047 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.805 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -84.25 113.9 21.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 1.12 109.839 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HD2' ' OD1' ' A' ' 55' ' ' ASP . 40.7 ttm105 -94.0 137.95 32.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.74 0.305 . . . . 5.17 110.579 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -82.34 35.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.509 0.559 . . . . 1.44 112.509 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -143.65 -0.98 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 3.8 110.341 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.544 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 29.4 m-20 -98.04 153.78 18.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.184 -0.462 . . . . 1.02 110.957 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 26.5 ttm105 -99.68 133.86 43.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 2.26 110.704 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.5 mt -73.42 122.72 26.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.1 -0.704 . . . . 1.37 109.1 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.4 t -105.69 -46.5 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.0 -0.545 . . . . 1.56 110.431 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.0 mt-10 -128.47 142.44 51.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.329 -0.396 . . . . 0.89 110.627 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.95 118.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 1.29 109.417 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 62.79 19.34 11.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.381 0.426 . . . . 1.17 110.781 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.29 4.55 66.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.837 -0.697 . . . . 0.66 112.425 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.26 115.52 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.037 -0.357 . . . . 1.75 110.037 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.544 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 49.8 t -74.79 130.16 38.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.26 0.552 . . . . 2.36 110.526 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.498 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.4 mmt -97.3 51.14 1.09 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.599 0.714 . . . . 1.42 111.079 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.2 105.67 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.103 -0.953 . . . . 3.75 110.355 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.94 -2.49 87.72 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 1.78 112.712 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.1 mmtp -66.53 160.68 24.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.238 0.542 . . . . 3.73 111.353 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.1 175.51 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.506 -0.77 . . . . 3.61 110.281 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.435 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 8.1 t60 -53.77 -43.4 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.444 0.465 . . . . 2.2 111.516 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.76 -41.84 88.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.78 113.178 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.95 -40.26 97.12 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.964 0.411 . . . . 2.03 110.655 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 77' ' ' ILE . 48.9 t -70.4 -47.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.898 -0.592 . . . . 1.71 110.788 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 77' ' ' ILE . 89.9 t -68.29 -40.69 82.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 1.37 111.369 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -61.49 -38.93 89.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 1.12 110.397 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.9 92.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.497 -0.32 . . . . 1.09 111.138 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.494 HG21 HG21 ' A' ' 84' ' ' THR . 66.9 mt -58.76 -45.6 91.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.509 0.671 . . . . 1.35 110.162 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.54 -25.42 59.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.257 -0.883 . . . . 3.55 111.306 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.16 3.75 41.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.147 -0.479 . . . . 1.28 111.187 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.87 9.06 54.61 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.985 -0.626 . . . . 0.6 112.315 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.49 -120.13 5.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.772 -0.727 . . . . 1.1 111.517 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 9.3 t70 -107.49 -31.58 8.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 2.12 110.275 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.984 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -121.13 139.66 53.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.242 -0.435 . . . . 2.11 110.273 175.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.494 HG21 HG21 ' A' ' 77' ' ' ILE . 9.1 t -130.66 150.06 52.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.805 -0.634 . . . . 1.09 111.19 -170.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -108.57 118.53 37.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.586 -0.734 . . . . 2.25 110.793 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.488 HD23 HG12 ' A' ' 77' ' ' ILE . 80.2 mt -109.9 131.22 55.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.05 -0.523 . . . . 1.04 109.845 176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 10' ' ' PRO . 32.9 tp -104.19 119.6 39.31 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.604 -0.517 . . . . 1.22 109.604 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.3 m -126.64 153.33 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.173 0.511 . . . . 1.09 111.621 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.44 134.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.759 -0.655 . . . . 1.08 110.288 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.16 171.45 14.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.713 -0.477 . . . . 1.92 109.713 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 91' ' ' ARG . 34.2 ttm180 -52.44 -47.9 66.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.296 0.373 . . . . 4.87 111.615 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.08 -42.32 76.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 2.68 110.622 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.5 m -64.92 -46.59 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.762 -0.653 . . . . 1.08 111.086 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.66 -47.27 84.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 1.18 110.976 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 10.2 mm-40 -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.543 -0.299 . . . . 1.94 110.478 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.782 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 87.8 t80 -63.28 -48.33 78.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.83 110.497 176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.483 ' CD2' ' HB3' ' A' ' 104' ' ' PRO . 34.2 m-85 -66.27 -38.14 87.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.831 0.348 . . . . 0.55 111.47 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -61.91 -48.53 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 2.5 111.618 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.782 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.5 pttt -70.76 -15.56 62.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 2.53 111.445 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.488 ' HB3' HG12 ' A' ' 102' ' ' VAL . 42.4 t -93.19 -7.83 44.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 2.19 110.196 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 59.35 29.45 19.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.281 -0.872 . . . . 4.83 111.21 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 100' ' ' CYS . 12.2 p -115.58 152.41 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 2.08 109.901 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.34 130.97 41.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.858 0.361 . . . . 1.99 110.983 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 47.3 Cg_endo -71.99 135.42 25.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.423 2.082 . . . . 0.86 111.244 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.0 t -158.43 173.92 15.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.295 -0.261 . . . . 1.92 110.295 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.458 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 43.8 mt-30 -55.89 -30.57 61.78 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.322 0.389 . . . . 1.87 111.636 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.79 -29.49 68.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 2.82 110.929 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.41 ' CD2' ' HD3' ' A' ' 114' ' ' PRO . 42.5 m80 -86.04 -13.67 46.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.892 -0.594 . . . . 0.71 111.561 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' A' ' 87' ' ' LEU . 86.7 mt -56.66 -73.59 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.885 0.374 . . . . 1.47 111.35 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -101.21 16.83 24.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.249 0.547 . . . . 4.09 110.044 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.51 -175.36 23.25 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.454 -0.793 . . . . 1.39 111.58 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.53 147.94 9.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 1.65 112.466 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 mt -79.37 135.15 57.63 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.009 -0.542 . . . . 1.75 110.072 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.41 ' HD3' ' CD2' ' A' ' 108' ' ' HIS . 59.5 Cg_endo -71.07 160.81 48.08 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.239 2.626 . . . . 1.31 113.238 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 15.4 m -91.39 140.45 25.52 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.209 -0.905 . . . . 3.47 108.802 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 25.3 Cg_exo -64.66 65.48 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.477 2.785 . . . . 4.93 114.326 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -96.76 93.89 6.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.584 -0.895 . . . . 8.1 108.584 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 t -59.18 112.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.351 0.596 . . . . 9.11 111.426 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -143.94 134.3 24.58 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.162 -0.681 . . . . 9.61 109.162 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 122' ' ' ILE . . . -102.88 117.4 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.643 -0.789 . . . . 11.55 112.259 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.83 34.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.363 0.601 . . . . 13.92 110.618 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.43 ' H ' ' C ' ' A' ' 120' ' ' GLY . 43.0 mm -98.41 -15.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 16.21 110.628 -175.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -67.19 -24.47 65.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.056 0.455 . . . . 18.9 110.549 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.49 -0.11 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 20.83 110.712 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.71 -0.48 57.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.647 0.737 . . . . 22.5 109.226 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -116.41 -173.17 2.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.198 -0.91 . . . . 24.29 109.548 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.5 m -63.66 -53.32 53.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.819 0.342 . . . . 25.0 110.131 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.778 -0.63 . . . . 27.94 109.445 176.822 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.29 -0.324 . . . . 12.09 112.29 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 tp -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.058 0.456 . . . . 10.3 110.386 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' OD2' ' HB ' ' A' ' 6' ' ' THR . 3.6 p-10 -91.91 111.82 51.71 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.923 -0.58 . . . . 7.1 109.451 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.13 -41.5 76.08 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.114 3.209 . . . . 7.27 113.703 -170.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.08 102.6 8.43 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.686 -0.487 . . . . 8.77 109.686 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.477 ' HB ' ' OD2' ' A' ' 3' ' ' ASP . 14.8 t -127.07 163.45 23.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.617 -0.72 . . . . 4.49 110.877 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -108.96 29.1 7.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.062 -0.517 . . . . 4.32 110.766 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' OG1' ' A' ' 6' ' ' THR . 90.0 mt -76.48 71.97 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.391 0.615 . . . . 1.36 111.091 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -122.0 146.02 45.24 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.617 -0.72 . . . . 3.51 109.801 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' ' CG1' ' A' ' 89' ' ' VAL . 39.9 Cg_endo -68.32 173.57 9.44 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.488 2.125 . . . . 0.81 111.696 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.406 HH22 ' HB3' ' A' ' 52' ' ' ARG . 24.3 ptt-85 -134.3 132.51 39.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.356 . . . . 2.82 110.372 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -95.32 113.22 24.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.928 -0.578 . . . . 1.96 109.879 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.6 m -96.79 118.86 34.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.981 -0.554 . . . . 1.17 109.902 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.854 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.2 m -109.73 117.51 34.09 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.126 -0.694 . . . . 1.13 109.126 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.439 ' HE2' HD21 ' A' ' 51' ' ' LEU . 22.0 ptp -128.89 133.7 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 1.08 111.259 -171.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -107.67 143.6 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.238 -0.892 . . . . 3.11 110.018 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 77.0 mttt -56.8 126.23 26.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.373 -0.831 . . . . 1.5 111.25 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -124.3 1.62 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.451 -1.249 . . . . 1.28 111.011 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.18 -48.32 1.84 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.662 2.241 . . . . 2.23 112.365 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -118.86 -34.19 4.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 3.28 111.491 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -174.61 -143.51 4.47 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.796 -0.716 . . . . 1.93 112.227 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.662 ' O ' ' HB2' ' A' ' 44' ' ' SER . 32.7 m-85 -99.24 -44.35 6.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.649 0.261 . . . . 1.82 110.894 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.68 69.25 0.9 Allowed Glycine 0 C--O 1.227 -0.292 0 C-N-CA 121.105 -0.569 . . . . 0.96 113.213 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -156.89 153.75 28.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.432 -0.581 . . . . 0.4 109.432 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -101.96 126.31 48.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.478 -0.564 . . . . 2.23 109.478 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.489 HD13 ' HG3' ' A' ' 35' ' ' GLN . 2.0 tm? -99.22 123.28 43.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.441 -0.577 . . . . 2.11 109.441 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.676 ' CB ' ' HB2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -126.92 122.52 34.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.524 -0.762 . . . . 2.02 111.256 -171.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -112.05 170.91 7.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.65 -0.704 . . . . 2.75 110.266 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.1 t70 -121.21 152.88 38.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.214 -0.662 . . . . 3.48 109.214 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.14 -7.09 40.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.258 -0.428 . . . . 4.89 111.121 -174.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 m -116.39 -45.89 2.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 3.79 110.645 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 24.8 pttm -105.32 127.8 27.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.431 . . . . 3.51 110.354 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 16.9 Cg_exo -68.62 169.24 17.81 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.931 2.421 . . . . 2.55 112.602 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.23 136.94 9.25 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.374 -0.83 . . . . 1.47 112.18 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.489 ' HG3' HD13 ' A' ' 26' ' ' LEU . 1.6 mp0 -93.72 128.43 39.92 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.555 -0.535 . . . . 1.5 109.555 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.31 147.66 37.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.99 110.204 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 HG13 HD13 ' A' ' 51' ' ' LEU . 32.7 mm -81.95 106.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.091 -0.707 . . . . 1.12 109.091 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.676 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 4.3 tmt_? -66.11 -42.39 89.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.941 -0.762 . . . . 3.48 108.941 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 p -174.48 154.87 2.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.736 -1.12 . . . . 1.82 109.56 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -109.93 127.41 66.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.664 -0.495 . . . . 1.11 109.664 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -65.18 128.36 93.71 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.045 -0.525 . . . . 2.28 109.973 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.51 144.9 98.22 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.477 2.118 . . . . 1.27 112.251 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.15 54.49 1.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.466 -0.788 . . . . 2.4 109.628 -177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.662 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.9 p -131.79 150.8 77.24 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.454 -0.794 . . . . 0.68 111.086 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.5 Cg_endo -62.31 -24.14 75.7 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.87 111.629 172.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.87 77.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.146 0.498 . . . . 1.17 109.904 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.63 -32.0 73.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 2.01 110.08 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.32 -32.01 68.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.009 -0.541 . . . . 1.15 111.686 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.2 p -72.65 -13.23 61.32 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.037 0.446 . . . . 0.4 110.697 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.07 26.44 6.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.741 -0.742 . . . . 0.62 112.709 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD21 ' HE2' ' A' ' 15' ' ' MET . 19.7 tp -77.41 158.3 30.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.051 -0.351 . . . . 1.12 110.051 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 39.5 ttm180 -158.04 160.92 37.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.811 -0.811 . . . . 5.17 108.811 -173.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -83.45 152.41 24.99 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.129 -0.228 . . . . 1.44 110.88 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 25.1 mt-30 80.92 1.2 1.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.114 0.884 . . . . 3.8 112.175 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.625 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 33.2 m-20 -84.05 146.34 27.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.868 0.366 . . . . 1.02 110.49 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.4 ttp-105 -106.44 136.88 45.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.501 -0.555 . . . . 2.26 109.501 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.11 123.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.804 -0.443 . . . . 1.37 109.804 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.711 HG11 ' HG2' ' A' ' 104' ' ' PRO . 47.0 t -99.93 -49.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.674 -0.694 . . . . 1.56 110.117 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 23.2 mt-10 -126.45 142.87 51.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.89 110.425 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 118.62 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.103 -0.498 . . . . 1.29 109.711 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.2 30.12 19.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.956 0.408 . . . . 1.17 110.966 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -3.68 73.89 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.891 -0.671 . . . . 0.66 113.96 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HE3' ' A' ' 65' ' ' MET . 7.5 p -113.46 129.26 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.791 0.795 . . . . 1.75 111.237 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.552 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.7 p -71.0 137.15 48.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.004 -0.998 . . . . 2.36 112.028 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 73' ' ' VAL . 24.1 mmt -115.0 11.46 16.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 1.42 111.048 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -59.42 -45.62 91.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 3.75 111.3 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.05 2.0 74.87 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.688 -0.768 . . . . 1.78 112.633 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.6 mmtt -90.72 179.53 5.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.208 -0.293 . . . . 3.73 110.208 -177.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -111.98 174.47 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.666 -0.243 . . . . 3.61 111.537 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.21 -43.93 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 2.2 111.415 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.86 -30.78 76.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.92 -0.657 . . . . 0.78 113.066 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.17 -46.1 62.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.936 0.398 . . . . 2.03 110.808 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 65' ' ' MET . 25.1 t -62.57 -46.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.828 -0.624 . . . . 1.71 111.049 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.05 -39.2 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 1.37 111.183 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 t -68.44 -38.82 81.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.324 -0.398 . . . . 1.12 110.646 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' CB ' ' HE2' ' A' ' 65' ' ' MET . . . -60.52 -38.68 85.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 1.09 111.658 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.95 -43.17 91.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.191 0.519 . . . . 1.35 110.432 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.4 -34.53 70.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 3.55 110.592 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.74 -15.51 63.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 1.28 111.415 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.4 80.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 0.6 111.725 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.23 -111.7 4.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.978 -0.63 . . . . 1.1 112.211 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 -8.34 35.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.664 0.269 . . . . 2.12 110.706 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.44 162.4 40.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.428 -0.351 . . . . 2.11 110.757 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 t -150.35 149.36 29.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.331 -0.395 . . . . 1.09 110.3 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.854 ' HG2' HG23 ' A' ' 14' ' ' THR . 26.9 mttm -115.15 117.46 30.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.713 -0.477 . . . . 2.25 109.713 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -107.89 129.73 55.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.857 0.36 . . . . 1.04 110.302 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.495 HD22 ' HG3' ' A' ' 59' ' ' GLU . 37.5 tp -103.7 116.62 32.67 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.19 -0.67 . . . . 1.22 109.19 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.52 161.83 34.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.005 -0.543 . . . . 1.09 110.756 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 10' ' ' PRO . 8.5 m -133.87 133.35 56.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.746 -0.661 . . . . 1.08 110.78 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.4 154.09 41.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 1.92 109.183 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 70.5 ttt180 -52.72 -41.61 64.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.251 0.463 . . . . 4.87 112.251 -170.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.34 -34.84 72.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.29 0.567 . . . . 2.68 110.72 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -79.45 -41.83 26.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.332 -0.849 . . . . 1.08 110.19 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 25.9 t0 -65.87 -39.01 90.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.206 -0.906 . . . . 1.18 111.689 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 5.1 mm-40 -63.58 -36.34 83.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.992 0.425 . . . . 1.94 110.061 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.16 -41.34 86.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 0.83 110.45 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -65.76 -37.39 86.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.365 -0.38 . . . . 0.55 111.276 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 44.4 mttp -62.95 -49.89 72.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.323 . . . . 2.5 111.266 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.86 -25.82 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 2.53 111.167 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.438 ' HB3' HG13 ' A' ' 102' ' ' VAL . 36.3 t -87.62 -11.87 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.045 0.45 . . . . 2.19 110.676 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 61.96 35.54 16.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.366 -0.834 . . . . 4.83 111.334 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 100' ' ' CYS . 10.0 p -128.56 142.47 43.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.241 -0.436 . . . . 2.08 110.263 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 103' ' ' ILE . 3.0 mp -85.85 126.48 65.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.534 . . . . 1.99 110.734 -176.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.711 ' HG2' HG11 ' A' ' 58' ' ' VAL . 22.8 Cg_endo -63.42 146.4 93.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.75 2.3 . . . . 0.86 111.617 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.5 p -157.67 173.04 17.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.639 -0.255 . . . . 1.92 111.353 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.504 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 51.8 mt-30 -60.12 -28.83 68.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.442 0.464 . . . . 1.87 110.703 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -58.47 -30.08 66.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.24 0.543 . . . . 2.82 111.118 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -85.88 -14.56 44.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.71 111.319 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.2 mt -63.09 107.64 1.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 1.47 110.443 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 60.41 24.79 14.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.96 -0.564 . . . . 4.09 110.494 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.74 174.17 15.13 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.915 -0.66 . . . . 1.39 111.973 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.87 136.39 38.31 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.902 2.401 . . . . 1.65 111.906 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 37.5 mt -80.96 161.3 63.76 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 109.269 -0.641 . . . . 1.75 109.269 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 77.7 Cg_exo -45.59 154.64 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.75 2.967 . . . . 1.31 114.446 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 114' ' ' PRO . 90.1 t 79.28 123.06 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 114.645 -1.161 . . . . 3.47 111.386 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 6.8 Cg_exo -73.62 89.44 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.127 2.551 . . . . 4.93 111.235 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -73.63 -18.39 61.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 8.1 110.871 -175.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.4 t -140.79 31.78 1.82 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.135 0.493 . . . . 9.11 110.154 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 65.87 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.359 -0.837 . . . . 9.61 110.782 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.87 -63.67 4.21 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.08 -0.581 . . . . 11.55 112.832 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -81.57 74.19 8.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 13.92 110.865 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 11.1 pt -141.24 101.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.255 -0.884 . . . . 16.21 109.515 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -128.1 -73.01 0.6 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.228 -0.442 . . . . 18.9 110.649 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 28.2 mtpp -105.49 68.38 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.083 0.468 . . . . 20.83 110.793 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.19 137.41 32.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.634 -0.712 . . . . 22.5 109.845 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.22 -32.56 26.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.641 . . . . 24.29 110.37 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.1 t -170.2 -67.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 25.0 109.36 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.827 -0.606 . . . . 27.94 109.638 177.546 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.084 -0.806 . . . . 12.09 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.5 tt -84.05 78.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.564 1.173 . . . . 10.3 108.752 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.97 139.39 90.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.107 -1.406 . . . . 7.1 111.373 -170.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.74 -31.64 92.14 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.279 2.653 . . . . 7.27 112.096 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.475 ' C ' ' H ' ' A' ' 7' ' ' MET . 25.9 p90 -117.82 -152.09 0.5 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.558 -1.275 . . . . 8.77 107.558 171.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.464 HG22 HH21 ' A' ' 9' ' ' ARG . 27.1 m 71.61 -12.65 0.62 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.577 0.703 . . . . 4.49 111.192 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 5' ' ' PHE . 91.8 mmm -92.96 -3.22 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 4.32 110.277 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -80.04 68.52 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.828 -0.805 . . . . 1.36 108.828 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.464 HH21 HG22 ' A' ' 6' ' ' THR . 10.5 ptp180 -126.61 156.74 72.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.953 -1.022 . . . . 3.51 109.322 -174.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HB2' HD12 ' A' ' 87' ' ' LEU . 38.5 Cg_endo -65.49 165.97 21.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.138 1.892 . . . . 0.81 111.203 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.664 HH12 ' HB3' ' A' ' 90' ' ' ASP . 8.7 ptp85 -121.28 131.95 54.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.872 0.367 . . . . 2.82 110.157 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.5 tp -98.24 111.03 23.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.218 0.533 . . . . 1.96 109.83 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.3 m -98.92 117.59 33.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.544 -0.753 . . . . 1.17 109.799 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -105.75 117.61 34.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.297 -0.631 . . . . 1.13 109.297 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.62 142.49 51.48 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 1.08 111.072 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 37.1 ttpt -114.77 140.18 49.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.817 -0.629 . . . . 3.11 109.622 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.6 ttmt -58.4 105.82 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.779 -0.452 . . . . 1.5 109.779 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.35 -134.37 7.0 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 1.28 113.257 -172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.11 -53.74 2.82 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.291 2.66 . . . . 2.23 112.843 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -116.87 33.31 5.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.091 -0.504 . . . . 3.28 110.663 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.655 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 90.58 -120.07 5.79 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.581 -0.819 . . . . 1.93 111.389 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.493 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 52.7 m-85 -121.08 172.95 7.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.82 109.283 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.28 73.75 0.41 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.159 -1.019 . . . . 0.96 112.816 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -155.43 144.91 21.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.731 0.301 . . . . 0.4 110.203 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 7.2 t-20 -103.57 141.04 36.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.207 -0.664 . . . . 2.23 109.207 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.28 151.3 22.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.09 0.472 . . . . 2.11 111.535 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -108.82 122.27 46.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.645 . . . . 2.02 110.287 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 p -135.31 92.92 2.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.196 0.522 . . . . 2.75 109.862 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.66 150.41 24.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 3.48 110.902 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.07 8.73 38.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 4.89 109.46 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 m -107.93 -47.89 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.269 -0.878 . . . . 3.79 110.507 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -126.78 134.77 26.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 3.51 110.675 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 159.87 46.07 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.79 2.327 . . . . 2.55 112.304 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 157.88 17.83 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.116 -0.794 . . . . 1.47 111.116 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.479 ' HG3' HG23 ' A' ' 73' ' ' VAL . 26.7 mm-40 -111.32 128.85 56.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.009 0.433 . . . . 1.5 110.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.8 m-85 -115.86 158.32 23.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.99 109.492 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.497 HG13 HD11 ' A' ' 51' ' ' LEU . 50.5 mm -87.28 106.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.553 -0.536 . . . . 1.12 109.553 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 25.2 ttt180 -65.24 -50.09 67.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.874 -0.603 . . . . 3.48 110.014 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 p -160.87 133.92 6.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 1.82 109.878 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 p -104.66 132.83 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.356 -0.609 . . . . 1.11 109.356 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.73 134.52 72.19 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.489 -0.56 . . . . 2.28 109.489 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.473 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 52.6 Cg_exo -53.48 136.34 63.46 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.25 2.633 . . . . 1.27 113.126 -177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p30 44.19 38.51 2.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.29 1.036 . . . . 2.4 112.825 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 92.0 p -93.69 165.68 17.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.692 -0.855 . . . . 0.68 108.692 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 10.4 Cg_endo -54.92 -30.31 68.2 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.789 1.659 . . . . 0.87 111.488 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.01 67.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.814 -0.63 . . . . 1.17 110.615 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 34.0 tt0 -70.03 -34.33 73.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.742 0.306 . . . . 2.01 110.384 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -24.89 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 1.15 111.959 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.9 p -75.83 -13.28 60.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.228 0.537 . . . . 0.4 110.718 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.43 37.41 4.04 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.603 -0.726 . . . . 0.62 111.874 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD11 HG13 ' A' ' 37' ' ' ILE . 17.4 tp -83.97 148.26 26.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.197 -0.298 . . . . 1.12 110.197 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.564 ' HD3' ' OD1' ' A' ' 55' ' ' ASP . 62.3 ttt-85 -128.95 151.42 49.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 5.17 110.364 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.6 133.02 44.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.437 -0.347 . . . . 1.44 111.37 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 12.9 mm-40 65.87 29.57 10.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.341 -0.845 . . . . 3.8 111.599 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.564 ' OD1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -88.71 136.17 33.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.105 -0.702 . . . . 1.02 109.105 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.3 129.2 36.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.706 -0.225 . . . . 2.26 110.626 -177.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.442 ' HA ' HG13 ' A' ' 88' ' ' VAL . 52.5 mt -82.87 123.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 1.37 109.779 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.537 HG13 ' HG2' ' A' ' 104' ' ' PRO . 6.5 t -106.05 -35.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.245 -0.434 . . . . 1.56 110.614 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.0 mt-10 -136.48 143.02 43.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.291 -0.413 . . . . 0.89 111.221 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.518 HG12 ' ND2' ' A' ' 61' ' ' ASN . 49.3 t -122.17 109.06 23.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.045 -0.724 . . . . 1.29 109.045 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.518 ' ND2' HG12 ' A' ' 60' ' ' VAL . 10.4 p30 46.47 43.18 11.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.958 0.885 . . . . 1.17 111.579 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 94.26 -4.46 70.49 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.782 -1.099 . . . . 0.66 114.19 174.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.4 t -98.33 119.54 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 117.522 0.661 . . . . 1.75 110.471 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 p -67.92 130.55 43.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.384 -0.825 . . . . 2.36 111.061 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.516 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mmt -117.2 45.28 1.92 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.989 -0.55 . . . . 1.42 111.971 -174.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -90.95 -47.73 7.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.137 0.494 . . . . 3.75 110.62 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.2 18.37 57.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 1.78 112.187 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 72.2 mmtt -100.37 173.83 6.4 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.176 -0.305 . . . . 3.73 110.176 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -112.85 178.49 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.591 -0.277 . . . . 3.61 111.169 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 74' ' ' VAL . 55.2 t-80 -54.88 -43.65 73.36 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.469 -0.332 . . . . 2.2 111.141 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.45 -38.23 95.5 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.013 -0.613 . . . . 0.78 112.831 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.68 -44.26 96.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.952 0.406 . . . . 2.03 110.714 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 77' ' ' ILE . 48.6 t -69.88 -46.81 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.763 -0.653 . . . . 1.71 111.047 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.2 t -63.96 -38.12 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.429 -0.35 . . . . 1.37 110.903 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.1 t -65.65 -36.04 82.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.051 -0.351 . . . . 1.12 110.051 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.39 -34.52 78.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 1.09 110.856 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.519 HG21 HG23 ' A' ' 84' ' ' THR . 29.0 mm -57.47 -45.42 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.7 0.762 . . . . 1.35 109.548 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -75.26 -31.07 60.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.862 -1.063 . . . . 3.55 111.119 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.28 -18.79 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 1.28 111.637 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.03 -17.48 79.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.6 112.252 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.47 -114.74 3.45 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.744 -0.741 . . . . 1.1 111.628 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.622 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 34.3 m-20 -110.04 -9.28 14.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.164 0.507 . . . . 2.12 110.25 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 1.8 pm0 -139.16 142.53 37.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.946 -0.57 . . . . 2.11 110.153 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 77' ' ' ILE . 10.2 t -133.01 151.17 52.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.435 -0.348 . . . . 1.09 110.624 -174.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -111.07 118.0 34.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.257 -0.646 . . . . 2.25 109.257 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.85 135.07 47.94 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.916 0.389 . . . . 1.04 110.1 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 10' ' ' PRO . 26.4 tp -104.92 115.77 30.85 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.915 -0.772 . . . . 1.22 108.915 176.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 13.2 m -127.46 158.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.967 0.413 . . . . 1.09 111.374 -176.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 147.66 30.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.592 -0.731 . . . . 1.08 110.402 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.664 ' HB3' HH12 ' A' ' 11' ' ' ARG . 21.3 p30 -92.47 176.94 6.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.965 -0.561 . . . . 1.92 110.298 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 54.4 ttp180 -54.72 -48.64 72.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.214 0.45 . . . . 4.87 112.214 -174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 1.8 pm0 -65.65 -42.76 91.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.843 0.354 . . . . 2.68 111.675 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -68.36 -44.67 74.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.07 -0.513 . . . . 1.08 110.772 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -60.86 -47.25 87.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.928 -0.578 . . . . 1.18 111.09 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 40.3 mt-10 -64.77 -32.85 74.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.605 -0.27 . . . . 1.94 110.64 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -64.24 -48.43 75.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.83 110.793 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.457 ' CD2' HG13 ' A' ' 102' ' ' VAL . 30.4 m-85 -66.96 -38.74 86.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.642 -0.254 . . . . 0.55 111.495 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -63.85 -47.27 81.39 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.801 0.297 . . . . 2.5 111.801 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.9 ptmt -65.79 -18.96 65.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.375 0.607 . . . . 2.53 110.537 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.442 ' HB2' HG11 ' A' ' 102' ' ' VAL . 92.4 m -94.04 -9.97 35.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.583 -0.735 . . . . 2.19 111.079 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.16 26.92 12.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.346 -0.843 . . . . 4.83 111.39 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.457 HG13 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -109.41 141.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.436 -0.579 . . . . 2.08 109.436 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.3 mm -87.26 123.12 70.43 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.158 -0.474 . . . . 1.99 110.434 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.537 ' HG2' HG13 ' A' ' 58' ' ' VAL . 18.6 Cg_endo -60.49 135.66 62.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.197 1.931 . . . . 0.86 110.678 174.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 m -154.69 166.31 33.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.086 -0.339 . . . . 1.92 110.086 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.436 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 48.3 mt-30 -62.06 -30.37 70.94 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.491 0.494 . . . . 1.87 112.288 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.7 -29.35 70.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 2.82 110.484 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.69 -14.93 60.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.994 -0.548 . . . . 0.71 111.366 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 91.8 mt -62.25 -46.59 88.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.096 0.474 . . . . 1.47 110.362 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -128.61 75.99 1.67 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.619 -0.719 . . . . 4.09 110.1 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.43 176.08 46.75 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.52 -0.764 . . . . 1.39 111.312 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.98 111.08 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.556 2.171 . . . . 1.65 112.642 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 113' ' ' LEU . 2.4 mm? -58.53 135.89 85.88 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 116.192 -0.458 . . . . 1.75 110.458 174.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.93 136.58 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.611 2.208 . . . . 1.31 112.444 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.04 125.21 2.02 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.649 -0.705 . . . . 3.47 110.526 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -84.04 118.52 2.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.585 2.19 . . . . 4.93 111.969 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -103.35 -46.59 4.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.061 0.458 . . . . 8.1 109.79 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.9 m -80.12 115.0 19.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.692 -0.686 . . . . 9.11 110.515 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.35 48.72 1.44 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 9.61 110.998 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.5 -41.08 5.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.909 -0.662 . . . . 11.55 113.018 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.36 8.02 35.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.285 0.564 . . . . 13.92 111.104 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 47.1 mt -108.55 82.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.502 -0.925 . . . . 16.21 108.502 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -97.78 61.93 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.95 -0.568 . . . . 18.9 112.237 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.03 -3.02 20.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.471 -0.937 . . . . 20.83 108.471 167.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -71.89 148.5 46.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.547 -1.206 . . . . 22.5 110.638 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -128.7 -59.51 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 24.29 110.202 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.2 t -178.29 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 . . . . . 0 C--O 1.245 0.851 0 CA-C-N 114.846 -1.07 . . . . 27.94 109.16 175.796 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.159 0.504 . . . . 0.80000000000000004 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HB3' HD21 ' A' ' 113' ' ' LEU . 14.0 ptt180 -129.37 148.97 71.4 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 3.0899999999999999 110.424 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HB3' HG12 ' A' ' 89' ' ' VAL . 57.2 Cg_endo -70.43 174.5 9.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.787 2.324 . . . . 0.46999999999999997 112.642 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -134.22 140.47 46.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.793 -0.64 . . . . 2.3700000000000001 109.961 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.2 110.08 22.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.544 -0.539 . . . . 1.3200000000000001 109.544 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -89.78 116.2 27.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.759 -0.655 . . . . 0.40000000000000002 110.003 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -107.4 118.83 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.444 -0.576 . . . . 0.34999999999999998 109.444 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.788 ' HE1' ' HA ' ' A' ' 46' ' ' ALA . 22.7 ptp -137.39 133.26 34.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.89 0.376 . . . . 0.88 111.218 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 87.6 tttt -103.63 147.04 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.65 -0.704 . . . . 2.5800000000000001 109.298 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 14.4 mtmt -57.33 110.32 0.83 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.893 -0.594 . . . . 0.92000000000000004 110.747 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.96 -94.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.189 -0.914 . . . . 1.28 113.346 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.62 -72.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.803 2.336 . . . . 2.23 111.971 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -146.19 20.26 1.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.569 0.7 . . . . 2.8700000000000001 109.753 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 174.5 -156.76 23.73 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.22 -0.9 . . . . 1.9299999999999999 111.3 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 83.6 m-85 -112.02 168.17 9.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.337 -0.616 . . . . 1.8200000000000001 109.337 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.2 70.52 0.45 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.067 -1.063 . . . . 0.42999999999999999 113.089 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.81 163.1 40.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.01 -0.367 . . . . 0.40000000000000002 110.01 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 25.6 t-20 -129.06 129.77 45.7 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.041 -0.527 . . . . 2.1800000000000002 109.694 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.92 144.1 29.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.692 -0.484 . . . . 1.52 109.692 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.8 p80 -121.51 130.25 53.43 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.036 -0.666 . . . . 1.3400000000000001 110.158 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.439 -0.801 . . . . 2.2999999999999998 109.279 179.262 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.449 ' NE2' ' HA ' ' A' ' 70' ' ' HIS . 21.1 mm-40 . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.677 -0.49 . . . . 1.5 109.677 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 75.6 m-85 -112.11 143.71 42.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.301 -0.629 . . . . 0.87 109.301 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.56 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.1 mm -68.39 106.78 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.452 -0.573 . . . . 0.39000000000000001 109.452 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.4 ttt180 -75.47 -48.0 24.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 2.8300000000000001 109.809 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -159.63 143.78 14.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.33 -0.85 . . . . 1.26 109.957 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.79 145.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.724 -0.473 . . . . 0.37 109.724 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 11.0 t70 -87.68 121.92 70.69 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.34 -0.615 . . . . 2.2799999999999998 109.34 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 24.4 Cg_exo -62.26 -22.54 74.3 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 123.07 2.514 . . . . 1.1699999999999999 113.339 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -105.39 50.34 0.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.713 0.768 . . . . 2.3999999999999999 109.418 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 53.5 p -145.28 162.0 39.22 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.454 -0.793 . . . . 0.56999999999999995 110.035 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 18.9 Cg_endo -60.92 -18.44 57.09 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.045 2.496 . . . . 0.65000000000000002 112.435 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.788 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -67.83 -52.39 37.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 0.35999999999999999 110.798 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.78 -38.47 91.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.053 0.454 . . . . 2.0099999999999998 109.865 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.37 94.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.46999999999999997 111.223 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -70.93 -19.84 62.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.40000000000000002 111.016 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.23 39.12 2.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.962 -0.637 . . . . 0.62 112.813 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -90.15 95.29 10.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.65000000000000002 109.911 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -85.25 146.24 27.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 4.3799999999999999 110.26 -176.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -71.03 142.82 50.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 1.4399999999999999 110.845 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 2.0 mp0 78.96 -0.02 2.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.146 0.904 . . . . 3.0600000000000001 111.854 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.7 m-20 -81.71 150.5 27.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.606 -0.516 . . . . 1.02 109.606 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 31.4 ttp-105 -104.64 142.82 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.775 0.321 . . . . 1.5700000000000001 111.501 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 mm -72.82 123.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.592 -0.731 . . . . 0.68000000000000005 109.587 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 104' ' ' PRO . 43.5 t -111.92 -48.27 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.439 0.637 . . . . 0.87 109.943 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.5 mt-10 -125.68 146.37 49.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.391 -0.822 . . . . 0.89000000000000001 110.045 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.69 120.58 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.975 -0.557 . . . . 0.66000000000000003 109.88 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 62.21 23.06 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.555 -0.748 . . . . 1.1699999999999999 111.015 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 9.39 62.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.906 -0.664 . . . . 0.66000000000000003 112.609 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.5 t -114.02 128.04 71.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 1.1699999999999999 110.446 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.0 p -77.47 129.29 35.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.767 -0.651 . . . . 1.6799999999999999 110.914 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.716 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.6 mmt -117.15 26.89 9.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.167 0.432 . . . . 0.81000000000000005 112.167 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.69 114.97 7.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.393 . . . . 3.75 110.253 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.76 62.02 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.866 -0.683 . . . . 1.47 112.913 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.9 mmtp -92.37 166.98 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.214 -0.291 . . . . 3.3599999999999999 110.214 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.19 175.62 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.493 -0.321 . . . . 2.8900000000000001 111.057 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.449 ' HA ' ' NE2' ' A' ' 35' ' ' GLN . 20.8 t60 -58.94 -44.09 91.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.786 0.327 . . . . 1.4199999999999999 110.818 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -39.47 95.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.912 -0.661 . . . . 0.71999999999999997 112.122 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.75 -47.19 84.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 2.0299999999999998 111.174 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 77' ' ' ILE . 50.6 t -69.08 -47.52 74.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.0800000000000001 110.972 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.9 t -64.47 -41.99 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.465 -0.334 . . . . 0.71999999999999997 111.186 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -63.87 -35.79 81.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.981 -0.378 . . . . 0.66000000000000003 109.981 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.12 93.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.41999999999999998 110.942 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 73' ' ' VAL . 75.5 mt -60.87 -45.89 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.68999999999999995 110.384 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 52.0 mtp180 -68.18 -28.15 67.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.003 -0.544 . . . . 3.0899999999999999 110.816 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.24 8.98 16.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.116 -0.493 . . . . 0.65000000000000002 110.96 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.58 -21.12 58.73 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.85 -0.69 . . . . 0.59999999999999998 111.752 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -129.71 9.99 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.768 -0.729 . . . . 1.1000000000000001 111.995 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD2' ' HE3' ' A' ' 16' ' ' LYS . 11.6 p-10 -80.46 -23.94 39.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.748 0.309 . . . . 2.1200000000000001 111.083 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 2.2 pt-20 -138.26 162.67 33.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.89 0.376 . . . . 2.1099999999999999 110.815 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -143.79 149.17 36.65 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.815 -0.629 . . . . 0.32000000000000001 110.1 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -115.1 117.52 30.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.139 -0.482 . . . . 1.6299999999999999 109.878 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.463 HD12 ' HE3' ' A' ' 15' ' ' MET . 96.4 mt -109.05 135.64 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.065 -0.516 . . . . 0.28000000000000003 110.427 -177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 44.4 tp -105.72 121.33 43.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.351 -0.611 . . . . 0.51000000000000001 109.351 175.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.617 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.4 m -128.03 156.84 40.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.927 0.394 . . . . 0.33000000000000002 111.569 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 10' ' ' PRO . 13.6 m -130.63 139.77 50.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.749 . . . . 0.41999999999999998 110.382 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 173.65 6.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.778 -0.646 . . . . 1.9199999999999999 110.64 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.612 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.1 ttt-85 -62.41 -49.39 75.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.848 -0.427 . . . . 4.1600000000000001 109.848 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -39.56 94.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.204 0.526 . . . . 2.6800000000000002 110.429 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.5 m -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.274 -0.875 . . . . 0.46999999999999997 111.052 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.12 -37.29 78.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 1.1799999999999999 111.303 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 31.8 mm-40 -63.54 -36.23 83.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 1.9399999999999999 109.998 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 83.5 t80 -63.42 -46.82 84.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.743 -0.662 . . . . 0.72999999999999998 110.214 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 104' ' ' PRO . 34.6 m-85 -64.26 -38.45 91.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.401 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -58.85 -50.01 75.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.956 0.407 . . . . 1.9199999999999999 111.448 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -71.34 -19.04 62.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 2.04 111.663 -172.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -103.3 -2.5 27.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.926 0.393 . . . . 1.3899999999999999 110.8 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.57 45.3 19.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.595 -0.73 . . . . 4.0899999999999999 110.895 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.5 t -118.24 134.08 63.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 1.4199999999999999 110.69 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.6 mm -93.1 120.07 67.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.374 -0.375 . . . . 1.3300000000000001 110.018 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.485 ' HG2' HG11 ' A' ' 58' ' ' VAL . 32.8 Cg_endo -64.48 142.32 77.76 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.636 2.224 . . . . 0.53000000000000003 112.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.519 ' HB3' ' OE2' ' A' ' 107' ' ' GLU . 9.3 t -153.24 -179.27 7.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.4199999999999999 109.383 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -57.56 -30.99 65.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.411 0.523 . . . . 1.6599999999999999 112.411 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.519 ' OE2' ' HB3' ' A' ' 105' ' ' SER . 0.0 OUTLIER -69.34 -28.77 66.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.948 0.404 . . . . 2.8199999999999998 111.673 -177.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -77.46 -14.6 59.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.442 -0.344 . . . . 0.53000000000000003 111.425 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.49 HD21 ' CD1' ' A' ' 87' ' ' LEU . 96.0 mt -53.31 -58.33 7.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.818 0.342 . . . . 1.24 111.802 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -107.93 14.66 25.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.267 0.556 . . . . 3.7000000000000002 110.532 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.55 153.68 21.79 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.816 -0.629 . . . . 1.1200000000000001 111.882 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.76 30.49 0.41 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.429 2.753 . . . . 1.3100000000000001 113.102 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 9' ' ' ARG . 70.6 mt . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 115.309 -0.86 . . . . 1.1100000000000001 113.168 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.063 0.459 . . . . 0.80000000000000004 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 85.0 mtt-85 -115.72 149.86 43.83 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.07 -0.514 . . . . 3.0899999999999999 111.447 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HB2' HD11 ' A' ' 87' ' ' LEU . 2.9 Cg_exo -72.7 165.89 31.48 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.512 2.141 . . . . 0.46999999999999997 109.866 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.637 HH12 ' HB3' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -127.7 131.1 49.81 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.237 -0.438 . . . . 2.3700000000000001 110.043 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.0 tm? -98.64 112.79 24.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 1.3200000000000001 109.521 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.4 m -105.74 125.67 51.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.888 -0.596 . . . . 0.40000000000000002 110.711 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' LYS . 24.2 m -111.98 117.38 32.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 0.34999999999999998 109.174 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.712 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.6 ptp -126.53 133.6 51.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.178 0.513 . . . . 0.88 110.999 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -111.54 143.24 42.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.158 -0.928 . . . . 2.5800000000000001 110.146 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 52.6 mttt -62.36 104.59 0.51 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.349 -0.841 . . . . 0.92000000000000004 111.377 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.82 -80.2 0.93 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.044 -0.98 . . . . 1.28 111.623 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.98 47.5 2.23 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.723 2.282 . . . . 2.23 111.215 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m 61.58 27.6 17.03 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.12 -0.945 . . . . 2.8700000000000001 110.69 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.514 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -177.09 -178.07 46.52 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.024 -0.608 . . . . 1.9299999999999999 112.248 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 29.3 m-85 -106.55 -162.06 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.427 -0.583 . . . . 1.8200000000000001 109.427 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.67 73.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.115 -1.04 . . . . 0.42999999999999999 113.043 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -155.1 154.34 32.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.79 0.328 . . . . 0.40000000000000002 110.287 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -108.75 134.78 50.99 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.383 -0.599 . . . . 2.1800000000000002 109.383 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 35' ' ' GLN . 23.0 tp -105.24 152.66 22.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.351 -173.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.34 122.49 46.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.745 -0.835 . . . . 1.3400000000000001 108.745 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.468 0.651 . . . . 2.2999999999999998 111.198 -174.317 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' A' ' 26' ' ' LEU . 21.4 mm-40 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.874 0.368 . . . . 1.5 110.377 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.86 151.33 23.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 0.87 110.557 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.41 106.36 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.276 0.56 . . . . 0.39000000000000001 110.171 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.25 -54.35 38.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.006 -0.997 . . . . 2.8300000000000001 110.54 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 p -168.35 137.3 2.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.814 -0.63 . . . . 1.26 109.981 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.38 130.99 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.353 -0.61 . . . . 0.37 109.353 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.53 135.44 72.04 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.511 -0.313 . . . . 2.2799999999999998 110.246 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HA ' ' CD ' ' A' ' 47' ' ' GLU . 33.1 Cg_endo -63.94 139.23 66.81 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.776 2.318 . . . . 1.1699999999999999 112.406 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.18 48.27 6.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.304 -0.862 . . . . 2.3999999999999999 110.807 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 98.7 p -120.4 160.45 43.7 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.473 -0.785 . . . . 0.56999999999999995 109.539 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.6 Cg_endo -54.46 -29.41 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.167 1.911 . . . . 0.65000000000000002 111.575 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.712 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.23 -50.49 39.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.35999999999999999 110.54 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' CD ' ' HA ' ' A' ' 42' ' ' PRO . 44.0 tt0 -65.12 -35.85 82.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.297 -0.41 . . . . 2.0099999999999998 110.49 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.46999999999999997 111.641 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.7 p -72.99 -18.37 61.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.012 0.434 . . . . 0.40000000000000002 110.8 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.12 14.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.62 112.547 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.65 114.76 9.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.65000000000000002 110.355 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -97.53 149.65 21.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 4.3799999999999999 109.906 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.37 151.82 39.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.276 -0.42 . . . . 1.4399999999999999 110.585 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 70.35 10.7 7.32 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.774 0.671 . . . . 3.0600000000000001 111.78 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.7 m-20 -84.6 168.53 15.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.722 -0.473 . . . . 1.02 109.722 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -131.31 131.26 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.848 -0.427 . . . . 1.5700000000000001 109.848 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -72.57 130.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.228 0.537 . . . . 0.68000000000000005 111.203 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.69 HG11 ' HG2' ' A' ' 104' ' ' PRO . 23.6 t -107.22 -48.47 8.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.87 110.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 35.5 mt-10 -133.87 148.34 51.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.89000000000000001 110.756 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.23 117.78 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.958 -0.565 . . . . 0.66000000000000003 109.773 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 58.78 31.02 20.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.18 0.514 . . . . 1.1699999999999999 111.165 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.13 74.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.883 -0.675 . . . . 0.66000000000000003 112.805 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.04 120.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.279 -0.267 . . . . 1.1699999999999999 110.279 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 91.9 m -64.61 126.21 27.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.62 . . . . 1.6799999999999999 111.438 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.577 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.8 mmt -105.14 68.78 0.83 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.923 -0.769 . . . . 0.81000000000000005 108.923 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.7 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.56 -1.2 . . . . 3.75 110.811 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.99 25.93 5.7 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.611 -0.996 . . . . 1.47 110.611 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 71.9 mmtt -58.2 147.1 31.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.873 -0.663 . . . . 3.3599999999999999 111.642 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.545 ' HG3' ' H ' ' A' ' 72' ' ' ASP . 12.8 pt20 -77.11 161.36 28.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.092 -0.958 . . . . 2.8900000000000001 110.29 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.41 ' O ' HG23 ' A' ' 74' ' ' VAL . 85.0 t60 -55.4 -42.57 74.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 1.4199999999999999 110.446 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.04 92.87 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.71999999999999997 112.77 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 8.5 t0 -66.13 -47.09 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 2.0299999999999998 110.013 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.415 HG22 ' SD ' ' A' ' 65' ' ' MET . 47.7 t -62.62 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.477 -0.783 . . . . 1.0800000000000001 110.662 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 70' ' ' HIS . 95.8 t -63.5 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.71999999999999997 110.883 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -61.97 -39.22 91.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.66000000000000003 110.015 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.18 94.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.41999999999999998 111.012 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.057 0.456 . . . . 0.68999999999999995 110.629 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -68.93 -24.95 64.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 3.0899999999999999 111.219 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.63 -10.67 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.65000000000000002 111.093 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -33.31 70.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.702 -0.761 . . . . 0.59999999999999998 111.904 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.16 -109.38 3.36 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.019 -0.61 . . . . 1.1000000000000001 112.184 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 11.6 t70 -102.04 -23.97 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.616 -0.513 . . . . 2.1200000000000001 109.616 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.06 157.3 40.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.028 0.442 . . . . 2.1099999999999999 110.459 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -146.93 149.32 32.97 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.934 -0.575 . . . . 0.32000000000000001 109.856 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 14' ' ' THR . 57.0 mttp -114.36 116.82 29.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.037 0.446 . . . . 1.6299999999999999 109.896 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -109.54 136.35 49.07 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.838 -0.619 . . . . 0.28000000000000003 110.574 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.8 tp -104.83 125.12 50.55 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.183 -0.673 . . . . 0.51000000000000001 109.183 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 11.1 m -135.34 152.08 31.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.185 0.517 . . . . 0.33000000000000002 111.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 94' ' ' ASP . 16.1 m -130.57 150.97 35.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.354 -0.839 . . . . 0.41999999999999998 110.145 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.637 ' HB3' HH12 ' A' ' 11' ' ' ARG . 7.6 p-10 -89.97 176.16 6.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.449 -0.575 . . . . 1.9199999999999999 109.449 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -53.51 -48.93 68.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.211 0.448 . . . . 4.1600000000000001 112.211 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.2 -43.16 95.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 2.6800000000000002 111.138 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.0 m -71.25 -41.03 70.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.332 0.587 . . . . 0.46999999999999997 110.73 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 22.3 t0 -64.95 -39.31 93.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.528 -0.76 . . . . 1.1799999999999999 111.072 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.29 -35.73 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 1.9399999999999999 110.446 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -63.23 -48.03 79.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.72999999999999998 111.005 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HD1' HG13 ' A' ' 102' ' ' VAL . 20.3 m-85 -64.47 -36.04 82.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.29 -0.414 . . . . 0.44 111.701 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 36.2 mttp -58.72 -49.82 76.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.786 0.291 . . . . 1.9199999999999999 111.786 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 13.1 ptmt -70.85 -23.09 62.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 2.04 110.555 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.87 -7.16 59.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.861 -0.609 . . . . 1.3899999999999999 110.68 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 57.88 28.94 16.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.423 -0.808 . . . . 4.0899999999999999 111.299 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.431 HG13 ' HD1' ' A' ' 97' ' ' PHE . 10.8 p -132.28 147.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.043 -0.526 . . . . 1.4199999999999999 109.955 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -102.1 128.53 28.32 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 121.107 0.48 . . . . 1.3300000000000001 110.812 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.69 ' HG2' HG11 ' A' ' 58' ' ' VAL . 18.4 Cg_endo -63.71 155.98 60.16 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.655 2.236 . . . . 0.53000000000000003 112.845 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.641 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 2.1 m -150.12 175.68 11.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.326 -0.99 . . . . 1.4199999999999999 108.326 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.605 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 22.9 mp0 -59.39 -34.92 73.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.333 0.587 . . . . 1.6599999999999999 110.122 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.641 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.8 pt-20 -62.49 -30.21 71.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 2.8199999999999998 111.682 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.503 ' HB2' ' H ' ' A' ' 105' ' ' SER . 33.7 m80 -79.29 -24.48 42.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.53000000000000003 111.322 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.7 pp -91.96 -14.11 30.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.217 -0.447 . . . . 1.24 110.477 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -103.86 -50.91 3.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 3.7000000000000002 110.785 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.72 -142.6 8.67 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.89 -0.672 . . . . 1.1200000000000001 112.416 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -84.52 163.21 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.719 2.279 . . . . 1.3100000000000001 113.236 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.506 -0.77 . . . . 1.1100000000000001 109.249 175.751 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.477 0.656 . . . . 0.80000000000000004 109.876 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 113' ' ' LEU . 20.4 ptt85 -121.47 150.18 54.09 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.122 -0.945 . . . . 3.0899999999999999 109.9 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HB2' HD11 ' A' ' 87' ' ' LEU . 55.6 Cg_endo -69.16 158.36 58.04 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.46 2.107 . . . . 0.46999999999999997 111.938 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 11' ' ' ARG . 7.8 ptp180 -118.29 131.59 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.737 -0.665 . . . . 2.3700000000000001 110.016 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.5 tp -97.33 111.08 23.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 1.3200000000000001 109.803 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.412 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 32.2 m -94.77 117.22 29.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.833 -0.622 . . . . 0.40000000000000002 110.032 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 85' ' ' LYS . 35.9 m -110.46 117.87 34.74 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.305 -0.628 . . . . 0.34999999999999998 109.305 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 ptp -128.99 136.35 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.404 -0.362 . . . . 0.88 110.855 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -110.72 139.86 45.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.677 -0.692 . . . . 2.5800000000000001 109.249 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 11.7 ttmt -61.92 124.4 20.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.329 0.492 . . . . 0.92000000000000004 112.329 -173.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -149.85 17.91 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.629 -0.714 . . . . 1.28 111.323 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.73 -30.65 17.48 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.037 2.491 . . . . 2.23 112.508 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -109.1 19.93 18.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 2.8700000000000001 110.573 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.77 2.84 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.569 -0.824 . . . . 1.9299999999999999 111.959 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 26.6 m-85 -119.07 -48.46 2.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.753 0.311 . . . . 1.8200000000000001 110.527 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 70.02 1.23 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.0 -0.619 . . . . 0.42999999999999999 113.635 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -156.52 156.06 33.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.942 -0.392 . . . . 0.40000000000000002 109.942 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -101.81 126.48 48.69 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.82 -0.437 . . . . 2.1800000000000002 109.82 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 tp -100.34 152.74 19.97 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.966 -0.561 . . . . 1.52 110.432 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.61 122.7 46.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.305 -0.407 . . . . 1.3400000000000001 110.108 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.817 -0.628 . . . . 2.2999999999999998 109.999 -178.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.577 HE21 ' CA ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.823 0.345 . . . . 1.5 111.276 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -118.61 156.79 28.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.87 110.061 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG13 HD11 ' A' ' 51' ' ' LEU . 44.4 mm -96.37 110.06 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.151 0.5 . . . . 0.39000000000000001 109.719 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -66.21 -55.15 17.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 2.8300000000000001 110.371 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 p -169.67 139.24 1.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.812 -0.631 . . . . 1.26 109.599 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -96.41 138.05 22.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.341 -0.391 . . . . 0.37 109.984 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 t70 -71.59 124.0 90.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.178 -0.675 . . . . 2.2799999999999998 109.178 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 35.1 Cg_exo -56.48 132.85 54.31 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.11 2.54 . . . . 1.1699999999999999 113.751 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.0 t70 57.44 48.5 14.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.855 -1.066 . . . . 2.3999999999999999 110.917 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.496 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -110.72 169.58 6.17 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.56999999999999995 109.986 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.498 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.2 Cg_endo -55.16 -33.13 83.03 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.89 1.727 . . . . 0.65000000000000002 111.333 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.439 0.638 . . . . 0.35999999999999999 110.576 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.08 -50.61 73.04 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.276 -0.874 . . . . 2.0099999999999998 110.067 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -17.5 62.54 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.711 -1.586 . . . . 0.46999999999999997 111.353 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 51.6 p -84.72 -16.96 39.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.40000000000000002 110.071 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.22 0.35 35.43 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.754 -0.736 . . . . 0.62 112.697 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 37' ' ' ILE . 37.8 tp -61.62 128.13 34.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.314 . . . . 0.65000000000000002 110.31 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -117.86 154.21 32.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.251 -0.431 . . . . 4.3799999999999999 109.915 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -78.88 145.37 34.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.528 -0.305 . . . . 1.4399999999999999 110.305 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 85.3 mm-40 78.99 3.26 2.42 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.252 0.97 . . . . 3.0600000000000001 111.202 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 36.4 m-20 -74.13 156.81 36.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 1.02 109.724 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -123.93 129.21 50.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.721 -0.474 . . . . 1.5700000000000001 109.721 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.529 ' HA ' HG12 ' A' ' 88' ' ' VAL . 58.2 mt -76.22 130.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.225 0.536 . . . . 0.68000000000000005 111.416 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG22 ' NH1' ' A' ' 56' ' ' ARG . 21.8 t -107.5 -51.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.237 -0.892 . . . . 0.87 110.149 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 26.1 mt-10 -130.61 144.35 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.89000000000000001 111.031 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.31 118.2 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.333 -0.618 . . . . 0.66000000000000003 109.333 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 61.0 22.41 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.1699999999999999 110.937 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.98 6.28 63.49 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.66000000000000003 112.915 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.87 120.73 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 1.1699999999999999 110.37 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.537 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.2 m -63.51 130.02 42.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 1.6799999999999999 110.841 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.594 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 25.6 mmt -109.62 18.63 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.406 0.622 . . . . 0.81000000000000005 110.464 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -61.04 117.78 5.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.069 -0.969 . . . . 3.75 110.731 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.0 -16.76 50.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.833 -0.699 . . . . 1.47 112.951 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 65' ' ' MET . 68.8 mttm -75.6 173.16 11.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.149 0.5 . . . . 3.3599999999999999 111.808 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -103.36 -175.29 2.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.593 -0.73 . . . . 2.8900000000000001 111.463 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.414 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 86.3 t60 -63.08 -42.87 99.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.506 . . . . 1.4199999999999999 110.297 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.36 -39.68 96.49 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.737 -0.665 . . . . 0.71999999999999997 113.203 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -62.57 -47.47 83.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.046 0.451 . . . . 2.0299999999999998 110.765 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.33 -46.76 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 1.0800000000000001 110.968 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.93 -40.08 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.395 . . . . 0.71999999999999997 111.023 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.7 t -60.28 -42.01 94.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.66000000000000003 110.843 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.72 -43.38 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.41999999999999998 111.35 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.523 HG23 HG21 ' A' ' 84' ' ' THR . 80.6 mt -58.73 -42.38 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.427 0.632 . . . . 0.68999999999999995 110.407 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 78' ' ' ARG . 31.7 mtp180 -74.29 -31.98 62.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.462 -0.79 . . . . 3.0899999999999999 111.63 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.79 -7.63 59.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.438 -0.346 . . . . 0.65000000000000002 111.23 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.31 73.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.182 -0.532 . . . . 0.59999999999999998 112.186 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.57 -126.96 8.24 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.707 -0.759 . . . . 1.1000000000000001 111.652 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 8.5 t70 -84.02 -28.37 27.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 2.1200000000000001 110.017 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -128.85 160.2 33.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.105 0.479 . . . . 2.1099999999999999 110.618 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 77' ' ' ILE . 10.6 t -146.07 148.74 32.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.56 -0.745 . . . . 0.32000000000000001 109.647 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.8 mttp -116.42 117.36 29.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 1.6299999999999999 110.042 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.85 128.34 53.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.946 -0.57 . . . . 0.28000000000000003 109.75 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 10' ' ' PRO . 57.0 tp -103.92 114.76 29.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.679 -0.859 . . . . 0.51000000000000001 108.679 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.77 162.26 33.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 0.33000000000000002 110.885 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.22 146.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 0.41999999999999998 110.473 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.04 166.19 23.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.711 -0.677 . . . . 1.9199999999999999 109.85 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.5 ttm180 -53.39 -48.17 68.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.009 0.433 . . . . 4.1600000000000001 110.862 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -73.39 -28.13 61.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 2.6800000000000002 109.973 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 m -70.58 -47.82 58.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.371 -0.832 . . . . 0.46999999999999997 110.695 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -59.36 -45.04 92.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 1.1799999999999999 110.478 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 11.2 mm-40 -62.8 -36.14 82.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.9399999999999999 110.984 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.94 -46.09 89.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.72999999999999998 110.555 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.474 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 48.7 m-85 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.248 -0.433 . . . . 0.44 111.257 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -59.51 -49.72 76.7 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.537 0.199 . . . . 1.9199999999999999 111.537 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -70.92 -18.74 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 2.04 111.305 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 t -91.43 -19.51 22.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.306 0.574 . . . . 1.3899999999999999 109.829 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.601 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 67.02 31.75 6.73 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 114.692 -1.14 . . . . 4.0899999999999999 111.716 176.198 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.41 HG13 ' HD1' ' A' ' 97' ' ' PHE . 14.1 p -123.68 141.02 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 1.4199999999999999 109.852 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 66.7 mt -82.4 129.07 64.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 1.3300000000000001 110.367 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.474 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 14.5 Cg_exo -66.25 150.8 84.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.79 2.327 . . . . 0.53000000000000003 111.623 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 t -163.34 178.38 8.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.566 -0.531 . . . . 1.4199999999999999 109.566 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 71.1 mt-30 -55.13 -26.86 41.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.584 0.587 . . . . 1.6599999999999999 112.584 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -55.7 -30.66 61.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.212 0.529 . . . . 2.8199999999999998 111.389 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -89.77 -12.93 37.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.242 -0.435 . . . . 0.53000000000000003 111.114 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 87' ' ' LEU . 96.4 mt -64.68 111.33 2.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.024 -0.535 . . . . 1.24 110.43 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 56.34 36.04 26.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 3.7000000000000002 110.394 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.33 -167.86 11.45 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.605 -0.725 . . . . 1.1200000000000001 111.843 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.33 150.0 22.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.608 2.205 . . . . 1.3100000000000001 112.413 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 9' ' ' ARG . 65.3 mt . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 1.1100000000000001 109.361 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 81.5 mt . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.366 0.506 . . . . 0.80000000000000004 112.366 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -110.57 143.09 27.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 120.757 0.313 . . . . 3.0899999999999999 110.611 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HB3' HG12 ' A' ' 89' ' ' VAL . 64.6 Cg_endo -74.69 177.09 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.637 2.225 . . . . 0.46999999999999997 111.094 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -146.8 138.27 24.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.897 0.38 . . . . 2.3700000000000001 111.326 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.23 116.57 29.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.687 -0.688 . . . . 1.3200000000000001 110.139 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 4.3 m -97.38 115.91 28.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.12 -0.696 . . . . 0.40000000000000002 109.12 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 85' ' ' LYS . 27.7 m -110.23 117.42 33.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 0.34999999999999998 109.334 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.549 ' HE3' HD12 ' A' ' 86' ' ' LEU . 24.7 ptp -135.06 140.46 45.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.88 111.146 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -110.44 153.02 25.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.309 -0.626 . . . . 2.5800000000000001 109.309 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 5.4 ttmt -69.17 98.89 1.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.493 0.663 . . . . 0.92000000000000004 111.118 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -106.79 3.15 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.034 -0.985 . . . . 1.28 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HG3' ' A' ' 45' ' ' PRO . 41.4 Cg_endo -70.32 84.11 0.76 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.693 2.262 . . . . 2.23 113.013 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m 63.3 67.38 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.383 0.882 . . . . 2.8700000000000001 113.383 170.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.39 57.35 6.79 Favored Glycine 0 CA--C 1.517 0.162 0 C-N-CA 121.124 -0.56 . . . . 1.9299999999999999 114.308 168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 68.08 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.088 0.555 . . . . 1.8200000000000001 111.56 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.21 70.42 0.73 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.863 -0.684 . . . . 0.42999999999999999 112.771 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.48 152.4 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.751 -0.463 . . . . 0.40000000000000002 109.751 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -103.74 135.17 45.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.387 -0.37 . . . . 2.1800000000000002 110.144 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.515 HD13 ' H ' ' A' ' 27' ' ' HIS . 0.2 OUTLIER -101.32 151.86 21.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.891 -0.595 . . . . 1.52 109.536 -176.121 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.515 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -106.12 122.02 45.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 1.3400000000000001 110.065 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.988 -0.551 . . . . 2.2999999999999998 110.101 179.23 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.735 -0.468 . . . . 1.5 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 68.2 m-85 -103.98 147.56 27.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.135 0.493 . . . . 0.87 110.99 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.488 HG13 HD11 ' A' ' 51' ' ' LEU . 50.6 mm -78.87 106.98 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.469 -0.787 . . . . 0.39000000000000001 109.149 175.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 38' ' ' ARG . 39.5 ttt-85 -62.36 -53.25 57.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.37 -0.832 . . . . 2.8300000000000001 110.113 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 m -161.41 145.25 12.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 1.26 108.91 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.49 131.24 73.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.211 -0.663 . . . . 0.37 109.211 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 t70 -79.13 118.53 72.98 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.298 -0.41 . . . . 2.2799999999999998 109.895 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 50.2 Cg_exo -56.12 142.15 86.61 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.088 2.526 . . . . 1.1699999999999999 112.999 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 t70 67.93 47.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.347 -0.842 . . . . 2.3999999999999999 110.725 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 85.1 p -127.98 164.16 38.88 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.612 -0.722 . . . . 0.56999999999999995 109.178 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.562 ' HG3' ' HD2' ' A' ' 19' ' ' PRO . 12.1 Cg_endo -57.43 -33.62 96.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.599 1.532 . . . . 0.65000000000000002 111.326 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.0 -52.53 34.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.917 -0.583 . . . . 0.35999999999999999 110.7 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.09 -41.56 97.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 2.0099999999999998 110.273 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.77 -22.74 63.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.46999999999999997 111.867 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.45 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.1 p -72.83 -9.73 59.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.27 0.557 . . . . 0.40000000000000002 110.359 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.12 31.4 5.05 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.559 -0.746 . . . . 0.62 111.792 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.488 HD11 HG13 ' A' ' 37' ' ' ILE . 30.7 tp -97.13 139.53 32.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.019 -0.363 . . . . 0.65000000000000002 110.019 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -131.44 148.5 52.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 4.3799999999999999 109.506 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -73.23 149.87 42.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.093 -0.336 . . . . 1.4399999999999999 110.093 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 75.2 mt-30 78.89 5.91 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.191 0.932 . . . . 3.0600000000000001 111.477 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 47.9 m-20 -88.74 148.03 24.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 1.02 109.749 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 24.2 ttt180 -103.73 134.6 46.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 1.5700000000000001 111.24 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.94 130.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.642 . . . . 0.68000000000000005 110.031 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' A' ' 104' ' ' PRO . 41.3 t -111.24 -42.87 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.029 -0.532 . . . . 0.87 110.878 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.02 143.42 50.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.555 -0.293 . . . . 0.89000000000000001 110.506 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.7 120.03 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.804 -0.443 . . . . 0.66000000000000003 109.804 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 62.91 18.31 10.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.346 0.658 . . . . 1.1699999999999999 111.249 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 0.05 73.09 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.586 -0.816 . . . . 0.66000000000000003 111.858 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.11 128.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.855 -0.424 . . . . 1.1699999999999999 109.855 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.459 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 23.1 p -66.68 126.51 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.754 -0.657 . . . . 1.6799999999999999 111.773 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.3 mmt -133.68 38.81 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.81000000000000005 110.515 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' OE1' ' HB2' ' A' ' 64' ' ' CYS . 41.3 mp0 -61.22 -52.74 63.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 3.75 111.201 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.72 34.78 2.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.674 -0.774 . . . . 1.47 112.472 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.6 mmtp -79.58 -175.37 4.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.732 0.301 . . . . 3.3599999999999999 110.603 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -85.07 161.27 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.317 . . . . 2.8900000000000001 110.658 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -55.84 -42.81 76.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.859 -0.423 . . . . 1.4199999999999999 109.859 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.71 -39.11 94.82 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.5 -0.773 . . . . 0.71999999999999997 113.032 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.18 -47.59 79.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.969 0.384 . . . . 2.0299999999999998 111.354 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 65' ' ' MET . 48.7 t -64.55 -43.45 96.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.984 0.421 . . . . 1.0800000000000001 110.736 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 97.0 t -65.84 -41.89 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.71999999999999997 110.413 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -62.18 -44.95 95.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.66000000000000003 110.502 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.36 -39.56 76.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.41999999999999998 111.332 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.0 mt -57.46 -45.71 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.269 0.557 . . . . 0.68999999999999995 110.724 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 74' ' ' VAL . 10.2 mpt_? -75.25 -31.99 60.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.703 -0.681 . . . . 3.0899999999999999 110.983 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -14.75 63.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.65000000000000002 111.874 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.23 -13.83 67.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.824 -0.703 . . . . 0.59999999999999998 111.872 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.31 -99.82 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.869 -0.682 . . . . 1.1000000000000001 111.977 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 9.3 t70 -104.72 -21.58 13.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.856 0.36 . . . . 2.1200000000000001 110.528 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.29 162.29 31.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.844 0.354 . . . . 2.1099999999999999 110.497 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 t -148.75 148.46 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.978 -0.556 . . . . 0.32000000000000001 110.238 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HG2' HG23 ' A' ' 14' ' ' THR . 48.2 mttm -112.91 118.36 34.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.202 -0.453 . . . . 1.6299999999999999 109.954 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD12 ' HE3' ' A' ' 15' ' ' MET . 92.9 mt -105.82 127.66 53.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.976 0.417 . . . . 0.28000000000000003 109.983 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.9 tp -103.6 118.34 36.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.907 -0.775 . . . . 0.51000000000000001 108.907 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.2 m -125.52 162.0 29.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.109 -0.496 . . . . 0.33000000000000002 111.008 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 10' ' ' PRO . 8.3 m -126.95 142.95 41.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.41999999999999998 110.509 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -75.8 172.37 12.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.875 -0.602 . . . . 1.9199999999999999 109.785 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -59.65 -48.47 81.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.056 0.455 . . . . 4.1600000000000001 110.793 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.4 mp0 -65.48 -40.28 92.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.87 -0.604 . . . . 2.6800000000000002 110.273 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 8' ' ' LEU . 7.4 m -63.53 -50.9 67.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.31 -0.859 . . . . 0.46999999999999997 110.872 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 29.8 t70 -59.08 -41.69 88.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.874 -1.057 . . . . 1.1799999999999999 111.419 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.76 -36.93 62.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.414 -0.357 . . . . 1.9399999999999999 111.41 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.13 -47.54 84.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.72999999999999998 110.75 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -61.62 -38.26 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.44 111.524 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 24.2 mttp -66.32 -50.04 64.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.101 -0.24 . . . . 1.9199999999999999 111.567 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 16.5 ptmt -72.7 -18.47 61.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 2.04 111.42 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.6 t -89.84 -13.39 36.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.723 -0.843 . . . . 1.3899999999999999 108.723 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 68.12 33.46 4.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.633 -1.167 . . . . 4.0899999999999999 110.655 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.3 148.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.869 -1.06 . . . . 1.4199999999999999 109.987 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.7 mt -97.23 123.22 53.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 110.199 -0.297 . . . . 1.3300000000000001 110.199 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.607 ' HG2' HG11 ' A' ' 58' ' ' VAL . 36.9 Cg_endo -71.09 145.91 50.7 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.455 2.103 . . . . 0.53000000000000003 111.499 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.5 p -160.49 170.12 21.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.55 -0.295 . . . . 1.4199999999999999 110.97 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -55.89 -29.24 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.451 0.469 . . . . 1.6599999999999999 111.262 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -58.46 -30.83 67.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 2.8199999999999998 110.972 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -81.39 -15.35 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.53000000000000003 111.276 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.8 mt -67.42 -55.09 15.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.526 . . . . 1.24 110.349 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -97.58 16.61 19.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 3.7000000000000002 110.477 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.21 -163.54 11.35 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.907 -0.663 . . . . 1.1200000000000001 112.329 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -94.38 178.07 0.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.455 2.77 . . . . 1.3100000000000001 113.0 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 1.1100000000000001 109.137 175.762 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 92' ' ' GLU . 26.1 mt . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.237 0.541 . . . . 0.80000000000000004 111.222 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.968 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 18.3 ptp180 -137.96 141.79 33.73 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.046 -0.525 . . . . 3.0899999999999999 109.982 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HB2' HD21 ' A' ' 87' ' ' LEU . 30.2 Cg_endo -66.01 160.62 43.49 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.56 2.174 . . . . 0.46999999999999997 111.588 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.769 -0.65 . . . . 2.3700000000000001 110.431 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.61 HD13 HD12 ' A' ' 87' ' ' LEU . 63.0 tp -98.27 111.54 23.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 1.3200000000000001 109.765 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.534 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.8 m -98.8 117.1 32.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.40000000000000002 110.158 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.6 m -104.07 118.45 36.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.34999999999999998 108.539 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.524 ' HE3' HD12 ' A' ' 86' ' ' LEU . 21.4 ptp -131.04 133.6 45.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.101 0.476 . . . . 0.88 111.025 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 13.1 tmtt? -105.23 143.56 33.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 2.5800000000000001 109.258 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 ttmt -64.43 117.53 7.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.102 0.477 . . . . 0.92000000000000004 111.371 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.79 -124.03 4.08 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.618 -0.719 . . . . 1.28 111.869 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.15 -67.59 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.762 2.308 . . . . 2.23 113.223 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.2 m -121.18 34.87 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 2.8700000000000001 111.048 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.14 -141.45 12.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.546 -0.835 . . . . 1.9299999999999999 111.989 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 44' ' ' SER . 40.4 m-85 -107.22 -34.38 7.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.151 0.501 . . . . 1.8200000000000001 110.028 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.47 68.36 0.95 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.153 -0.93 . . . . 0.42999999999999999 112.91 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -156.88 156.7 33.58 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.802 -0.444 . . . . 0.40000000000000002 109.802 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -119.74 137.59 53.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.304 -0.407 . . . . 2.1800000000000002 110.143 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.62 153.88 19.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.456 0.646 . . . . 1.52 112.204 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 2.4 m-70 -105.8 121.57 44.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.005 -0.998 . . . . 1.3400000000000001 108.352 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.316 -0.88 0 N-CA-C 108.903 -0.777 . . . . 2.2999999999999998 108.903 178.928 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.282 0.563 . . . . 1.5 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.641 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 50.0 m-85 -124.5 158.04 33.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.233 -0.894 . . . . 0.87 109.096 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.3 mm -87.66 112.39 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.461 -0.57 . . . . 0.39000000000000001 109.461 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HA ' ' CD2' ' A' ' 27' ' ' HIS . 6.9 tmm_? -69.35 -55.68 9.72 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.097 -0.705 . . . . 2.8300000000000001 109.097 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -163.15 143.54 9.17 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.485 -0.931 . . . . 1.26 108.485 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.93 122.64 50.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.048 -0.723 . . . . 0.37 109.048 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 14.2 m-20 -62.29 115.29 15.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.499 -0.556 . . . . 2.2799999999999998 109.499 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 19.6 Cg_endo -58.0 150.88 61.58 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.857 2.372 . . . . 1.1699999999999999 113.003 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 66.66 47.65 1.55 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.039 -0.982 . . . . 2.3999999999999999 110.33 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 90.2 p -133.6 160.85 66.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.95 -0.568 . . . . 0.56999999999999995 110.629 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -28.53 83.81 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.443 2.095 . . . . 0.65000000000000002 111.451 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.42 76.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.35999999999999999 110.409 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -67.49 -41.54 84.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 2.0099999999999998 110.107 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.62 69.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.46999999999999997 111.975 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.534 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 62.0 p -70.72 -16.58 62.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.038 0.446 . . . . 0.40000000000000002 110.578 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.07 15.37 22.06 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.73 -0.748 . . . . 0.62 112.975 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -72.02 147.8 46.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.103 -0.332 . . . . 0.65000000000000002 110.103 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -140.84 157.62 45.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.957 -0.386 . . . . 4.3799999999999999 109.957 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -80.11 155.12 27.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.42 -0.355 . . . . 1.4399999999999999 110.831 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 83.8 mm-40 75.24 7.45 4.09 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.977 0.798 . . . . 3.0600000000000001 111.848 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 89.9 m-20 -93.12 154.91 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.946 -0.39 . . . . 1.02 109.946 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.604 ' HB3' HH11 ' A' ' 56' ' ' ARG . 0.0 OUTLIER -111.18 133.62 53.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.227 -0.442 . . . . 1.5700000000000001 109.888 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HA ' HG12 ' A' ' 88' ' ' VAL . 71.9 mt -78.25 124.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.68000000000000005 110.849 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.09 -25.78 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.899 -0.591 . . . . 0.87 112.08 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.2 mt-10 -140.24 145.2 37.05 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.32 . . . . 0.89000000000000001 110.625 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 65' ' ' MET . 96.6 t -131.44 124.83 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.66000000000000003 109.885 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.3 21.64 9.89 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.223 0.609 . . . . 1.1699999999999999 111.523 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.17 3.56 67.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.538 -0.839 . . . . 0.66000000000000003 112.665 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.95 128.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.105 -0.331 . . . . 1.1699999999999999 110.105 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.4 t -63.5 121.16 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 1.6799999999999999 110.467 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.806 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.9 mmt -108.72 -1.08 19.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 0.81000000000000005 111.238 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -71.86 84.28 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.47 0.652 . . . . 3.75 109.718 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.18 -8.29 5.09 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.627 -0.715 . . . . 1.47 111.749 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.806 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.8 mmtt -75.97 -172.36 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 3.3599999999999999 111.09 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -112.83 161.58 16.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 2.8900000000000001 110.216 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -56.28 -42.88 78.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 1.4199999999999999 110.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.59 -32.87 79.58 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.563 -0.827 . . . . 0.71999999999999997 112.503 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.5 -47.32 61.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 2.0299999999999998 110.432 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.477 HG12 ' SD ' ' A' ' 65' ' ' MET . 33.3 m -67.42 -41.92 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.944 -0.571 . . . . 1.0800000000000001 111.503 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.35 -40.05 81.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 0.71999999999999997 110.799 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -66.26 -38.23 87.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.66000000000000003 110.108 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.3 97.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.41999999999999998 111.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.554 HG23 HG21 ' A' ' 84' ' ' THR . 85.0 mt -58.38 -42.15 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.36 0.6 . . . . 0.68999999999999995 110.591 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -74.74 -35.83 62.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.66 -0.7 . . . . 3.0899999999999999 110.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.88 7.44 18.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.956 -0.566 . . . . 0.65000000000000002 111.869 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 -14.59 81.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.59999999999999998 112.013 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.01 -133.04 9.97 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.942 -0.863 . . . . 1.1000000000000001 110.942 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 2.9 t70 -103.85 11.17 36.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.524 0.678 . . . . 2.1200000000000001 109.69 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -149.2 159.58 44.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.298 -0.865 . . . . 2.1099999999999999 109.473 174.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.554 HG21 HG23 ' A' ' 77' ' ' ILE . 14.8 t -148.35 149.77 32.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.32000000000000001 110.52 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.536 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.1 mttt -110.89 117.07 32.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.059 -0.518 . . . . 1.6299999999999999 110.014 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.524 HD12 ' HE3' ' A' ' 15' ' ' MET . 85.0 mt -106.73 118.98 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.703 -0.48 . . . . 0.28000000000000003 109.703 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.61 HD12 HD13 ' A' ' 12' ' ' LEU . 4.8 tt -106.79 119.93 40.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.067 -0.716 . . . . 0.51000000000000001 109.067 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 57' ' ' ILE . 35.5 m -126.59 166.76 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.226 -0.443 . . . . 0.33000000000000002 110.958 -173.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 m -127.33 136.93 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.41999999999999998 110.72 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 166.37 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.368 -0.833 . . . . 1.9199999999999999 110.37 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -56.06 -47.5 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.302 . . . . 4.1600000000000001 110.843 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.647 ' HG3' HD23 ' A' ' 8' ' ' LEU . 11.2 pt-20 -60.57 -38.24 83.92 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.3 0.571 . . . . 2.6800000000000002 110.314 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.411 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 25.9 m -71.25 -48.35 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.24 -0.891 . . . . 0.46999999999999997 110.691 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.516 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 24.7 t70 -60.55 -49.04 79.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.959 -0.564 . . . . 1.1799999999999999 110.966 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.496 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 36.2 mt-10 -64.83 -27.55 68.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.9399999999999999 111.141 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.37 -48.52 55.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 0.72999999999999998 110.034 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 93' ' ' THR . 41.9 m-85 -66.71 -36.74 83.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.377 -0.374 . . . . 0.44 111.82 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.7 mtpp -57.79 -50.14 74.27 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.665 0.246 . . . . 1.9199999999999999 111.665 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.418 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 11.2 ptmm? -71.48 -33.96 69.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 2.04 110.757 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -75.55 -11.28 59.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.529 -0.759 . . . . 1.3899999999999999 111.969 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 55.71 33.49 21.46 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.406 0.682 . . . . 4.0899999999999999 111.174 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.31 143.74 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 1.4199999999999999 110.19 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.78 117.26 67.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.059 -0.349 . . . . 1.3300000000000001 110.059 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.77 140.86 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.349 2.033 . . . . 0.53000000000000003 111.51 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -157.73 175.07 14.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.427 -0.351 . . . . 1.4199999999999999 111.195 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.539 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 10.8 mt-30 -53.62 -34.77 59.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.266 0.555 . . . . 1.6599999999999999 111.127 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -59.3 -30.04 68.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.589 -0.732 . . . . 2.8199999999999998 111.026 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -87.81 -12.85 43.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.53000000000000003 112.103 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.55 HD21 HD11 ' A' ' 87' ' ' LEU . 77.0 mt -55.0 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.188 0.44 . . . . 1.24 112.188 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.968 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 9.9 t30 72.54 -14.7 0.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.684 -0.689 . . . . 3.7000000000000002 112.225 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 112' ' ' PRO . . . -83.68 -121.13 0.8 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.725 -0.75 . . . . 1.1200000000000001 112.669 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 111' ' ' GLY . 52.4 Cg_endo -87.33 110.85 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.868 2.379 . . . . 1.3100000000000001 112.768 -176.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 9' ' ' ARG . 58.2 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.622 . . . . 1.1100000000000001 109.447 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 93' ' ' THR . 86.6 mt . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 112.555 0.576 . . . . 0.80000000000000004 112.555 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.567 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 31.4 ptt180 -114.52 160.02 34.68 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.717 -0.846 . . . . 3.0899999999999999 108.717 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 30.7 Cg_endo -62.55 167.22 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.885 1.723 . . . . 0.46999999999999997 111.895 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.534 ' HG3' HG23 ' A' ' 88' ' ' VAL . 1.6 ptm180 -128.56 135.96 50.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.971 -0.559 . . . . 2.3700000000000001 110.347 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HG ' HD11 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -96.51 116.7 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 1.3200000000000001 110.248 -176.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 82.6 m -101.61 116.81 33.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.579 -0.526 . . . . 0.40000000000000002 109.579 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -108.79 120.27 41.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.399 -0.593 . . . . 0.34999999999999998 109.399 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.27 133.35 38.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.572 . . . . 0.88 111.548 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -101.87 144.23 30.78 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.375 -0.83 . . . . 2.5800000000000001 109.649 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.8 ttmt -65.66 113.01 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.036 0.446 . . . . 0.92000000000000004 110.562 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.01 -99.72 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.444 -0.798 . . . . 1.28 111.323 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.43 97.97 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.761 2.307 . . . . 2.23 112.327 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 t 71.39 -47.19 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.004 0.922 . . . . 2.8700000000000001 112.554 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 161.02 81.57 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.375 -0.917 . . . . 1.9299999999999999 112.83 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 44' ' ' SER . 23.3 m-85 68.13 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.267 0.627 . . . . 1.8200000000000001 111.601 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.81 69.76 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.896 -0.669 . . . . 0.42999999999999999 112.817 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.31 154.06 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.705 -0.48 . . . . 0.40000000000000002 109.705 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -119.27 131.46 55.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.806 0.336 . . . . 2.1800000000000002 110.99 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.42 133.61 45.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.016 -0.538 . . . . 1.52 110.222 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.1 p80 -120.44 139.38 52.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 1.3400000000000001 110.601 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 108.998 -0.741 . . . . 2.2999999999999998 108.998 177.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.5 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.447 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 68.8 m-85 -121.98 148.91 44.21 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.696 -0.853 . . . . 0.87 108.696 175.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 55' ' ' ASP . 38.2 mm -68.32 109.25 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 0.39000000000000001 109.775 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -65.81 -54.45 26.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.235 -1.024 . . . . 2.8300000000000001 108.235 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 m -166.34 135.46 3.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 1.26 109.348 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -94.65 121.81 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.386 -0.968 . . . . 0.37 108.386 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -78.22 121.52 84.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.255 -0.43 . . . . 2.2799999999999998 110.032 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.75 155.98 20.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.513 2.809 . . . . 1.1699999999999999 112.584 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.7 51.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.998 0.904 . . . . 2.3999999999999999 109.218 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.2 p -146.94 154.56 47.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.979 -1.009 . . . . 0.56999999999999995 109.508 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.89 -25.55 78.25 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 0.65000000000000002 111.705 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.2 70.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.35999999999999999 110.339 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -67.97 -35.0 77.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.218 0.533 . . . . 2.0099999999999998 109.808 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -18.97 60.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.566 -0.743 . . . . 0.46999999999999997 111.58 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 24.2 p -70.42 -18.1 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.138 0.494 . . . . 0.40000000000000002 109.78 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.31 -0.57 33.01 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.986 -0.626 . . . . 0.62 112.141 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD11 HG13 ' A' ' 37' ' ' ILE . 22.4 tp -61.76 139.39 58.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.541 0.21 . . . . 0.65000000000000002 110.735 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -124.56 -164.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.459 -0.571 . . . . 4.3799999999999999 109.459 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.0 140.72 29.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.971 0.415 . . . . 1.4399999999999999 111.081 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 68.91 26.82 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.952 -1.022 . . . . 3.0600000000000001 113.013 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.555 ' HB2' HG13 ' A' ' 37' ' ' ILE . 6.2 m-20 -69.7 142.93 53.25 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.377 -0.971 . . . . 1.02 108.377 167.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -108.69 128.44 54.86 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.517 -0.549 . . . . 1.5700000000000001 109.517 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 88' ' ' VAL . 24.4 mm -71.91 130.1 35.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 0.68000000000000005 111.257 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 104' ' ' PRO . 58.2 t -111.79 -51.52 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.87 109.959 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.6 mt-10 -136.89 152.49 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.746 -0.661 . . . . 0.89000000000000001 110.283 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 77' ' ' ILE . 87.7 t -129.45 115.7 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.527 . . . . 0.66000000000000003 109.579 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.21 26.49 15.89 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.478 0.486 . . . . 1.1699999999999999 111.157 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.54 13.31 67.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.852 -0.69 . . . . 0.66000000000000003 112.524 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.68 122.77 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.718 -0.475 . . . . 1.1699999999999999 109.718 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.577 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.1 t -65.53 129.77 40.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.037 -0.529 . . . . 1.6799999999999999 111.338 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.472 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.0 mmt -115.27 14.71 16.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.81000000000000005 111.159 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 103' ' ' ILE . 56.5 mm-40 -62.31 -31.06 71.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.622 . . . . 3.75 111.489 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.96 20.32 14.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 1.47 112.098 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 72' ' ' ASP . 71.9 mmtt -101.45 177.43 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.934 0.397 . . . . 3.3599999999999999 110.749 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -125.61 -178.39 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.9 -0.591 . . . . 2.8900000000000001 109.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -54.12 -41.15 68.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.781 0.289 . . . . 1.4199999999999999 111.781 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.62 93.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.643 -0.789 . . . . 0.71999999999999997 112.831 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 10.4 m-20 -65.58 -45.99 81.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 2.0299999999999998 110.972 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 77' ' ' ILE . 98.7 t -62.54 -46.96 95.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 1.0800000000000001 110.87 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.51 -37.87 78.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.834 0.349 . . . . 0.71999999999999997 111.444 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.6 t -61.55 -38.79 88.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.74 -0.467 . . . . 0.66000000000000003 109.74 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.58 78.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.41999999999999998 111.194 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 73' ' ' VAL . 28.7 mm -57.35 -42.46 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.678 0.751 . . . . 0.68999999999999995 109.378 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -74.81 -37.31 62.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.051 -0.977 . . . . 3.0899999999999999 111.079 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -6.36 40.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.543 . . . . 0.65000000000000002 111.988 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.16 -28.18 68.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.59999999999999998 112.578 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.74 -120.15 4.74 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.768 -0.73 . . . . 1.1000000000000001 111.442 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 51.4 m-20 -108.74 7.68 26.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 2.1200000000000001 110.482 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.39 156.73 41.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.75 . . . . 2.1099999999999999 108.974 171.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.32000000000000001 110.076 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -116.89 119.89 36.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 1.6299999999999999 109.596 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.2 128.26 53.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.979 -0.555 . . . . 0.28000000000000003 110.092 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 10' ' ' PRO . 23.2 tp -103.66 115.2 30.06 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.288 -1.004 . . . . 0.51000000000000001 108.288 174.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.534 HG23 ' HG3' ' A' ' 11' ' ' ARG . 16.1 m -127.58 163.89 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 111.044 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.38 139.15 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.591 -0.731 . . . . 0.41999999999999998 110.082 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.79 175.88 9.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.167 -0.469 . . . . 1.9199999999999999 109.817 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 91' ' ' ARG . 3.3 tpp180 -62.5 -42.04 99.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.708 0.262 . . . . 4.1600000000000001 111.708 -171.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.32 -42.91 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 2.6800000000000002 110.715 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' LEU . 85.7 m -66.48 -45.83 78.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.856 -0.611 . . . . 0.46999999999999997 111.451 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 40.7 t0 -58.97 -47.44 85.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 1.1799999999999999 109.318 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 68.2 mm-40 -59.95 -37.67 80.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 1.9399999999999999 110.821 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.65 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 84.5 t80 -62.96 -49.34 75.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.512 -0.313 . . . . 0.72999999999999998 110.973 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.415 ' HD1' HG13 ' A' ' 102' ' ' VAL . 32.1 m-85 -66.64 -38.15 86.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.601 -0.272 . . . . 0.44 111.45 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.1 mtpp -60.28 -48.79 80.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.721 0.296 . . . . 1.9199999999999999 111.326 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.2 pttt -71.47 -14.55 62.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.277 -0.419 . . . . 2.04 111.295 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.32 -10.62 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 1.3899999999999999 111.257 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.78 28.23 17.98 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.821 -0.627 . . . . 4.0899999999999999 111.502 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.415 HG13 ' HD1' ' A' ' 97' ' ' PHE . 10.1 p -123.82 142.12 41.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.998 0.428 . . . . 1.4199999999999999 110.848 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.74 HG23 ' HG3' ' A' ' 66' ' ' GLU . 70.5 mt -79.4 128.43 75.36 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.718 -0.674 . . . . 1.3300000000000001 110.971 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.681 ' HB2' HG11 ' A' ' 58' ' ' VAL . 6.1 Cg_exo -71.9 160.28 48.16 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.069 2.513 . . . . 0.53000000000000003 111.602 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -165.31 164.96 19.79 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.921 -0.312 . . . . 1.4199999999999999 110.735 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -59.22 -28.53 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 1.6599999999999999 110.931 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -58.91 -30.53 67.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.031 0.443 . . . . 2.8199999999999998 110.892 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -77.52 -15.16 59.44 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.53000000000000003 111.509 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.427 HD11 ' HG ' ' A' ' 12' ' ' LEU . 60.1 mt -65.01 -61.59 2.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.529 0.68 . . . . 1.24 110.455 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.37 19.72 9.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.127 -0.942 . . . . 3.7000000000000002 110.36 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.68 -175.81 14.17 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.855 -0.612 . . . . 1.1200000000000001 112.139 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -87.44 159.83 8.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.354 2.702 . . . . 1.3100000000000001 112.568 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' A' ' 9' ' ' ARG . 45.3 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.772 -0.649 . . . . 1.1100000000000001 109.321 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.443 0.639 . . . . 0.80000000000000004 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 32.2 ptt180 -119.98 161.4 38.55 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.434 -0.803 . . . . 3.0899999999999999 109.948 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.613 ' HB2' HD11 ' A' ' 87' ' ' LEU . 6.8 Cg_exo -70.28 169.73 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.463 2.109 . . . . 0.46999999999999997 111.703 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HG3' HG23 ' A' ' 88' ' ' VAL . 6.5 ptt180 -128.5 131.37 48.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 2.3700000000000001 110.505 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 85' ' ' LYS . 48.7 tp -95.43 110.57 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.009 -0.541 . . . . 1.3200000000000001 109.623 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 60.0 m -92.98 117.8 30.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 110.23 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 85' ' ' LYS . 23.8 m -106.56 118.76 37.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.487 -0.56 . . . . 0.34999999999999998 109.487 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.9 ptp -133.79 133.65 41.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.826 -0.624 . . . . 0.88 110.486 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.66 136.73 52.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.046 -0.525 . . . . 2.5800000000000001 110.016 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 9.5 ttmt -54.65 119.07 4.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.478 -0.783 . . . . 0.92000000000000004 111.337 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.43 -107.37 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.568 -0.825 . . . . 1.28 112.678 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.88 -66.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.163 2.575 . . . . 2.23 112.904 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 t -140.86 85.45 1.99 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.375 -0.602 . . . . 2.8700000000000001 109.375 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.32 -132.1 11.44 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.542 -0.837 . . . . 1.9299999999999999 111.724 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 44' ' ' SER . 48.7 m-85 -119.99 -31.5 4.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.173 0.511 . . . . 1.8200000000000001 110.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.42 68.05 1.2 Allowed Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.327 -0.851 . . . . 0.42999999999999999 113.245 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -156.92 151.89 26.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.753 -0.462 . . . . 0.40000000000000002 109.753 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.9 m120 -101.45 135.35 43.11 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.194 -0.669 . . . . 2.1800000000000002 109.194 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -101.29 151.18 22.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.045 0.45 . . . . 1.52 111.352 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -108.9 122.1 46.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.78 -0.646 . . . . 1.3400000000000001 110.1 -177.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 109.881 -0.414 . . . . 2.2999999999999998 109.881 176.735 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HG3' HG21 ' A' ' 73' ' ' VAL . 23.0 mm-40 . . . . . 0 CA--C 1.517 -0.29 0 N-CA-C 109.466 -0.568 . . . . 1.5 109.466 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.2 m-85 -119.96 157.79 28.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.737 -0.468 . . . . 0.87 109.737 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.556 HG13 HD11 ' A' ' 51' ' ' LEU . 47.5 mm -91.21 109.89 21.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.29 0.566 . . . . 0.39000000000000001 109.541 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 28.5 ttt180 -63.15 -48.19 79.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.93 -1.032 . . . . 2.8300000000000001 109.892 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -162.36 160.34 26.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.571 -0.9 . . . . 1.26 108.571 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.58 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.417 -0.586 . . . . 0.37 109.417 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.45 125.84 89.4 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.877 -0.416 . . . . 2.2799999999999998 109.877 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 141.85 97.92 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.747 2.298 . . . . 1.1699999999999999 112.069 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 64.59 49.86 2.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.609 -0.723 . . . . 2.3999999999999999 110.756 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 95.6 p -126.88 158.62 67.89 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.795 -0.639 . . . . 0.56999999999999995 110.234 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 11.3 Cg_endo -57.99 -27.86 80.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.257 1.971 . . . . 0.65000000000000002 111.147 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.97 59.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.35999999999999999 110.465 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.49 -38.23 90.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.286 -0.415 . . . . 2.0099999999999998 110.762 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.67 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.46999999999999997 111.415 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 59.5 p -70.68 -14.47 62.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.896 0.379 . . . . 0.40000000000000002 111.03 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.99 7.07 29.5 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.018 -0.61 . . . . 0.62 112.899 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 37' ' ' ILE . 19.7 tp -76.61 130.51 37.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.546 0.212 . . . . 0.65000000000000002 110.579 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.16 -163.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 4.3799999999999999 110.951 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.56 140.02 29.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.474 . . . . 1.4399999999999999 111.207 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 70.34 15.85 7.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.307 -0.86 . . . . 3.0600000000000001 112.162 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.1 m-20 -69.48 128.39 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.986 -0.376 . . . . 1.02 109.986 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.5 123.79 36.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 1.5700000000000001 110.583 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.16 124.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.68000000000000005 110.793 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.414 HG11 ' HD2' ' A' ' 104' ' ' PRO . 43.1 t -105.29 -45.15 8.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.87 110.949 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.5 mt-10 -132.82 153.52 51.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.89000000000000001 110.479 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -126.77 120.97 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.112 -0.495 . . . . 0.66000000000000003 109.842 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 63.57 17.77 10.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.192 0.597 . . . . 1.1699999999999999 111.205 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.512 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.8 4.62 65.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.66000000000000003 112.528 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.88 128.69 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.66 0.267 . . . . 1.1699999999999999 110.38 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.5 m -59.38 118.67 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.724 -0.671 . . . . 1.6799999999999999 111.558 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.8 mmt -126.88 70.79 1.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.81000000000000005 111.774 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -135.43 139.42 44.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.968 -0.382 . . . . 3.75 109.968 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.5 -0.46 89.25 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.938 -1.265 . . . . 1.47 109.938 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -74.2 163.56 27.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.15 -1.025 . . . . 3.3599999999999999 111.724 -178.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.4 177.81 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.594 -0.891 . . . . 2.8900000000000001 108.594 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -63.0 -37.85 88.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.841 0.353 . . . . 1.4199999999999999 110.684 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.79 92.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.256 -0.497 . . . . 0.71999999999999997 113.112 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.96 -47.55 80.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.958 0.409 . . . . 2.0299999999999998 110.966 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.511 HG21 ' HG3' ' A' ' 35' ' ' GLN . 3.4 m -71.81 -41.87 69.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.844 -0.616 . . . . 1.0800000000000001 111.496 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.6 t -61.99 -48.14 89.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.637 -0.256 . . . . 0.71999999999999997 110.75 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 t -62.47 -37.67 86.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.552 -0.295 . . . . 0.66000000000000003 110.303 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.89 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.797 0.332 . . . . 0.41999999999999998 111.468 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.95 -41.21 90.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 0.68999999999999995 110.805 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 69.0 mtp180 -74.03 -35.71 64.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 3.0899999999999999 111.091 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.17 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.65000000000000002 110.938 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.19 -21.06 67.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.021 -0.609 . . . . 0.59999999999999998 112.1 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -117.99 5.11 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.029 -0.605 . . . . 1.1000000000000001 111.963 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 39.6 m-20 -113.97 8.89 17.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 2.1200000000000001 110.876 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.06 160.22 42.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.11 -0.7 . . . . 2.1099999999999999 109.11 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.3 t -153.19 148.81 27.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.861 0.362 . . . . 0.32000000000000001 110.594 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HB3' HD11 ' A' ' 12' ' ' LEU . 6.9 mptt -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.389 -0.597 . . . . 1.6299999999999999 109.389 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.29 133.77 49.5 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.801 -0.444 . . . . 0.28000000000000003 109.801 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.613 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.3 tp -103.84 115.99 31.48 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.17 -0.678 . . . . 0.51000000000000001 109.17 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 14.3 m -131.62 155.41 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.019 -0.537 . . . . 0.33000000000000002 111.209 -173.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.72 146.95 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.411 -0.813 . . . . 0.41999999999999998 110.331 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.06 176.85 6.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.793 -0.64 . . . . 1.9199999999999999 109.396 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 ttm105 -56.4 -47.92 78.0 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.786 0.291 . . . . 4.1600000000000001 111.786 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.72 -40.82 89.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.116 0.484 . . . . 2.6800000000000002 110.819 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 -48.12 29.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.726 -0.67 . . . . 0.46999999999999997 111.154 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 5.5 t0 -60.78 -43.43 98.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 1.1799999999999999 110.307 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.33 -37.44 77.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.256 -0.429 . . . . 1.9399999999999999 110.669 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.431 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 91.3 t80 -63.16 -47.39 82.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.72999999999999998 110.296 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -67.4 -37.12 82.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.266 -0.425 . . . . 0.44 111.71 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 58.4 mttm -58.56 -50.15 74.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.913 0.387 . . . . 1.9199999999999999 110.821 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 96' ' ' PHE . 19.3 ptmt -69.7 -22.35 63.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.742 -0.663 . . . . 2.04 110.904 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.37 -16.41 37.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.563 . . . . 1.3899999999999999 111.072 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER 61.07 37.18 18.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.489 -0.778 . . . . 4.0899999999999999 111.393 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.54 138.18 50.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.891 0.376 . . . . 1.4199999999999999 110.688 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 70.0 mt -77.85 131.66 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 1.3300000000000001 110.748 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.476 ' HB3' ' HG3' ' A' ' 10' ' ' PRO . 5.9 Cg_exo -70.54 153.43 65.34 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.946 2.431 . . . . 0.53000000000000003 111.881 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 108' ' ' HIS . 21.9 p -158.19 178.39 10.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.592 -0.277 . . . . 1.4199999999999999 110.398 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.554 ' HA ' ' CD2' ' A' ' 109' ' ' LEU . 2.7 mp0 -55.61 -38.01 68.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 1.6599999999999999 110.722 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.91 -31.28 69.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.248 0.547 . . . . 2.8199999999999998 110.965 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.421 ' HB2' ' H ' ' A' ' 105' ' ' SER . 35.7 m80 -83.04 -25.48 32.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.53000000000000003 111.584 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 106' ' ' GLN . 4.4 pp -95.34 -28.87 14.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.769 -0.651 . . . . 1.24 110.959 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.424 ' N ' HD12 ' A' ' 109' ' ' LEU . 23.0 t-20 -93.42 -23.79 18.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 3.7000000000000002 110.034 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.51 -145.72 9.71 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.923 -0.656 . . . . 1.1200000000000001 112.299 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.78 169.01 2.51 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.151 2.568 . . . . 1.3100000000000001 112.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.709 -0.678 . . . . 1.1100000000000001 110.095 176.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.482 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 88.6 mt . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 121.635 0.731 . . . . 0.80000000000000004 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 109' ' ' LEU . 14.2 ptt180 -123.78 147.89 54.86 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.022 -0.99 . . . . 3.0899999999999999 109.025 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HB2' HD11 ' A' ' 87' ' ' LEU . 30.8 Cg_endo -68.52 149.62 74.52 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.586 1.524 . . . . 0.46999999999999997 110.798 172.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -120.6 135.49 55.08 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.283 -0.417 . . . . 2.3700000000000001 110.25 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -92.68 111.25 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.957 -0.565 . . . . 1.3200000000000001 110.159 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.29 117.61 30.37 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.517 -0.765 . . . . 0.40000000000000002 109.368 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' LYS . 27.0 m -109.57 119.05 38.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.685 -0.487 . . . . 0.34999999999999998 109.685 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.605 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 24.4 ptp -131.33 133.59 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.04 0.447 . . . . 0.88 111.003 -174.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -97.9 132.63 43.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.871 -0.604 . . . . 2.5800000000000001 109.421 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 20.6 ttmt -50.67 129.21 22.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.925 -0.58 . . . . 0.92000000000000004 111.517 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.97 -158.42 24.36 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.771 -0.728 . . . . 1.28 111.588 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.74 -27.46 44.57 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.06 2.507 . . . . 2.23 112.642 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 p -105.16 13.87 30.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.039 -0.528 . . . . 2.8700000000000001 110.563 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.06 2.73 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.615 -0.803 . . . . 1.9299999999999999 111.182 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.39 159.95 36.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.488 -0.93 . . . . 1.8200000000000001 108.488 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.78 75.17 0.4 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 119.883 -1.151 . . . . 0.42999999999999999 113.298 -173.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.03 168.77 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.849 0.357 . . . . 0.40000000000000002 110.54 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -131.53 143.27 50.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.914 -0.585 . . . . 2.1800000000000002 110.552 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.56 145.17 30.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.484 0.659 . . . . 1.52 111.835 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -110.65 129.38 55.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 1.3400000000000001 109.426 172.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.317 -0.831 0 N-CA-C 108.58 -0.896 . . . . 2.2999999999999998 108.58 175.018 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.568 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 2.7 mp0 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.961 -0.385 . . . . 1.5 109.961 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 61.6 m-85 -117.61 157.67 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.551 -0.907 . . . . 0.87 108.551 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG13 HD11 ' A' ' 51' ' ' LEU . 44.2 mm -90.91 109.43 20.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.598 -0.441 . . . . 0.39000000000000001 109.834 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -69.12 -54.63 13.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.889 -0.596 . . . . 2.8300000000000001 110.547 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -152.36 144.1 23.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.709 -0.678 . . . . 1.26 109.912 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.77 137.89 55.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.732 -0.47 . . . . 0.37 109.732 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -82.05 122.96 80.1 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.563 0.22 . . . . 2.2799999999999998 110.544 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -65.01 -19.68 63.78 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.867 2.378 . . . . 1.1699999999999999 112.538 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.78 4.51 52.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.913 -0.585 . . . . 2.3999999999999999 110.633 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 38.8 p -108.86 158.78 33.24 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 122.104 -0.372 . . . . 0.56999999999999995 110.783 -174.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 28.3 Cg_endo -63.06 -15.97 51.36 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.798 2.332 . . . . 0.65000000000000002 112.033 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -67.69 -51.51 48.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.096 -0.502 . . . . 0.35999999999999999 110.328 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' HG3' ' HA ' ' A' ' 42' ' ' PRO . 4.4 tm-20 -64.48 -40.65 96.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.918 -0.771 . . . . 2.0099999999999998 108.918 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.36 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.46999999999999997 111.966 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 15' ' ' MET . 60.3 p -77.32 -12.54 59.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.40000000000000002 110.898 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.25 9.44 27.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.783 -0.723 . . . . 0.62 112.734 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 37' ' ' ILE . 29.9 tp -78.17 141.58 38.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.727 0.298 . . . . 0.65000000000000002 110.497 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.8 tpp180 -143.63 164.82 29.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.383 -0.599 . . . . 4.3799999999999999 109.383 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.57 152.97 40.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.603 -0.271 . . . . 1.4399999999999999 111.231 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 74.64 11.32 3.92 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.061 0.851 . . . . 3.0600000000000001 112.135 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 17.9 m-20 -92.08 151.97 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.774 -0.454 . . . . 1.02 109.774 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -105.54 136.61 44.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.51 -0.313 . . . . 1.5700000000000001 110.666 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.65 130.15 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 0.68000000000000005 110.151 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.773 HG11 ' HG2' ' A' ' 104' ' ' PRO . 22.7 t -114.37 -47.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 0.87 111.057 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.5 mt-10 -126.29 148.82 49.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.887 0.375 . . . . 0.89000000000000001 110.928 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 63' ' ' VAL . 61.8 t -129.41 122.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.66000000000000003 109.206 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 62.87 21.09 12.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.785 0.434 . . . . 1.1699999999999999 111.056 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.3 74.73 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.733 -0.746 . . . . 0.66000000000000003 113.382 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 60' ' ' VAL . 14.6 p -107.61 138.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.38 0.59 . . . . 1.1699999999999999 110.111 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 50.9 t -74.5 136.81 42.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 1.6799999999999999 111.434 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.607 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 25.1 mmt -121.62 68.06 0.9 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.447 -0.797 . . . . 0.81000000000000005 111.128 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -103.69 -59.15 1.77 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.324 -0.398 . . . . 3.75 110.517 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.62 4.74 Favored Glycine 0 C--N 1.329 0.182 0 N-CA-C 111.548 -0.621 . . . . 1.47 111.548 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.607 ' HG2' ' HB3' ' A' ' 65' ' ' MET . 0.0 OUTLIER -110.94 -172.19 1.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.782 0.801 . . . . 3.3599999999999999 112.722 -171.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -121.46 150.0 42.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 2.8900000000000001 108.287 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -56.21 -43.7 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 118.267 0.485 . . . . 1.4199999999999999 110.162 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.66 88.15 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.696 -0.684 . . . . 0.71999999999999997 112.668 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.92 -40.03 83.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 2.0299999999999998 110.362 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 77' ' ' ILE . 63.9 t -65.29 -47.34 87.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.614 . . . . 1.0800000000000001 110.825 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' HA ' HD12 ' A' ' 77' ' ' ILE . 57.6 t -64.9 -36.78 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.21 0.529 . . . . 0.71999999999999997 110.071 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 t -61.58 -44.41 97.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.594 -0.73 . . . . 0.66000000000000003 110.163 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.82 -42.54 93.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.239 -0.437 . . . . 0.41999999999999998 111.227 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.522 HG23 HG21 ' A' ' 84' ' ' THR . 74.4 mt -58.9 -40.75 81.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.68999999999999995 110.773 177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 mtm-85 -74.18 -39.36 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 3.0899999999999999 110.976 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.68 10.47 9.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.65000000000000002 111.609 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.74 -33.77 74.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.207 -0.52 . . . . 0.59999999999999998 112.68 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.68 49.93 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 1.1000000000000001 111.63 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.634 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 32.2 m-20 67.54 1.57 2.6 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.574 0.749 . . . . 2.1200000000000001 112.485 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -151.6 154.28 36.13 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.825 -0.805 . . . . 2.1099999999999999 108.825 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.522 HG21 HG23 ' A' ' 77' ' ' ILE . 12.9 t -141.51 148.11 38.86 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.04 0.448 . . . . 0.32000000000000001 110.134 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 14' ' ' THR . 42.2 mttm -118.78 116.92 27.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.511 -0.551 . . . . 1.6299999999999999 109.511 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.6 mt -106.53 131.27 53.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.434 -0.348 . . . . 0.28000000000000003 110.128 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 10' ' ' PRO . 16.6 tp -103.79 117.12 33.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.934 -0.765 . . . . 0.51000000000000001 108.934 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 20.7 m -126.75 151.81 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.142 0.496 . . . . 0.33000000000000002 111.72 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.56 149.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.082 -0.963 . . . . 0.41999999999999998 109.717 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.243 -0.651 . . . . 1.9199999999999999 109.243 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -60.41 -43.89 96.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.89 0.33 . . . . 4.1600000000000001 111.89 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.08 -35.69 78.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.433 . . . . 2.6800000000000002 109.83 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 8' ' ' LEU . 89.6 m -69.3 -44.44 71.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.46999999999999997 110.832 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.631 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 33.7 t0 -58.77 -47.71 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.938 -0.393 . . . . 1.1799999999999999 109.938 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 50.1 mm-40 -61.1 -37.96 84.6 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.058 -0.519 . . . . 1.9399999999999999 110.823 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.723 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 66.6 t80 -62.11 -48.0 82.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.175 -0.466 . . . . 0.72999999999999998 110.672 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 102' ' ' VAL . 41.8 m-85 -67.34 -37.19 82.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.953 -0.567 . . . . 0.44 111.799 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.631 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 66.2 mttm -58.86 -50.82 72.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.051 0.453 . . . . 1.9199999999999999 111.385 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 18.9 pttp -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 2.04 111.367 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.494 ' HB3' HG12 ' A' ' 102' ' ' VAL . 35.4 t -82.4 -6.61 59.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.862 0.363 . . . . 1.3899999999999999 111.539 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER 56.68 40.65 29.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.638 -0.71 . . . . 4.0899999999999999 111.677 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.535 HG13 ' CD2' ' A' ' 97' ' ' PHE . 5.7 p -126.46 145.12 34.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.357 -0.383 . . . . 1.4199999999999999 110.492 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.38 121.66 67.21 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-O 120.979 0.419 . . . . 1.3300000000000001 111.113 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.773 ' HG2' HG11 ' A' ' 58' ' ' VAL . 24.4 Cg_endo -65.71 138.53 54.16 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.537 2.158 . . . . 0.53000000000000003 111.223 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.1 t -159.62 178.28 10.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.783 -0.451 . . . . 1.4199999999999999 109.783 -175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.534 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 99.3 mt-30 -54.75 -30.46 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.301 0.572 . . . . 1.6599999999999999 110.859 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.84 -30.39 67.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.616 -0.72 . . . . 2.8199999999999998 111.465 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -89.02 -14.0 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.482 0.549 . . . . 0.53000000000000003 112.482 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 95.8 mt -47.74 -54.54 11.9 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.348 0.405 . . . . 1.24 111.492 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -132.36 26.63 4.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.971 0.891 . . . . 3.7000000000000002 109.442 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.95 165.75 23.22 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.016 -0.993 . . . . 1.1200000000000001 110.776 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.74 124.9 12.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.221 1.947 . . . . 1.3100000000000001 112.172 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.197 -0.668 . . . . 1.1100000000000001 109.197 174.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.416 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 54.8 mt . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.29 0.567 . . . . 0.80000000000000004 110.606 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -119.82 156.26 54.24 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 3.0899999999999999 108.938 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' HD11 ' A' ' 87' ' ' LEU . 65.6 Cg_endo -71.58 -174.3 1.23 Allowed 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.356 2.038 . . . . 0.46999999999999997 112.146 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.441 ' HG3' HG23 ' A' ' 88' ' ' VAL . 15.6 ptt85 -146.65 135.36 22.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.3700000000000001 110.848 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.581 ' HG ' HD11 ' A' ' 109' ' ' LEU . 7.3 mt -92.85 121.7 34.49 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.542 . . . . 1.3200000000000001 110.849 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.0 m -109.1 129.1 55.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.002 -0.544 . . . . 0.40000000000000002 109.601 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -112.37 118.53 35.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.731 -0.47 . . . . 0.34999999999999998 109.731 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 25.1 ptp -130.44 142.48 50.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.013 -0.365 . . . . 0.88 110.013 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 14.5 ptpt -121.12 156.52 32.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.003 0.43 . . . . 2.5800000000000001 110.123 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.649 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 8.7 ttmt -61.37 117.17 5.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.797 -1.092 . . . . 0.92000000000000004 111.651 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.66 -149.29 9.17 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.53 -0.759 . . . . 1.28 112.181 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.83 -33.07 27.98 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.676 2.251 . . . . 2.23 113.258 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -110.27 -21.09 12.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.17 0.509 . . . . 2.8700000000000001 110.589 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.649 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 144.59 -116.3 0.93 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.131 -0.787 . . . . 1.9299999999999999 111.131 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.26 160.71 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.72 -0.844 . . . . 1.8200000000000001 108.72 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.14 71.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.599 -1.286 . . . . 0.42999999999999999 113.462 -171.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -155.63 150.88 26.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.986 -0.376 . . . . 0.40000000000000002 109.986 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.15 131.94 54.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 2.1800000000000002 109.61 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.416 HD13 HE21 ' A' ' 35' ' ' GLN . 93.2 mt -101.3 136.93 40.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.367 -0.379 . . . . 1.52 110.414 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.1 p80 -124.47 125.17 43.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.116 0.484 . . . . 1.3400000000000001 110.48 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.497 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 4.4 p . . . . . 0 C--N 1.32 -0.716 0 CA-C-N 115.338 -0.846 . . . . 2.2999999999999998 110.692 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.497 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 15.2 mm100 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 110.029 -0.36 . . . . 1.5 110.029 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 41.0 m-85 -122.04 147.58 45.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.979 -0.748 . . . . 0.87 108.979 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.569 HG13 HD11 ' A' ' 51' ' ' LEU . 39.1 mm -77.39 105.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.445 -0.576 . . . . 0.39000000000000001 109.445 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 49.1 ttt180 -75.12 -45.68 39.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.567 . . . . 2.8300000000000001 110.027 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -149.19 146.35 27.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 1.26 109.474 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.9 132.37 71.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.49 126.28 92.23 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.858 -0.61 . . . . 2.2799999999999998 110.693 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.45 124.03 15.27 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.657 2.238 . . . . 1.1699999999999999 112.595 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 64.42 36.08 9.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.177 -0.92 . . . . 2.3999999999999999 111.371 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 94.5 p -97.65 165.67 15.09 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.76 -0.654 . . . . 0.56999999999999995 109.402 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 12.8 Cg_endo -58.63 -25.6 75.69 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.829 1.686 . . . . 0.65000000000000002 111.276 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.42 -52.35 22.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.756 -0.656 . . . . 0.35999999999999999 110.409 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.85 -36.0 82.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.811 0.338 . . . . 2.0099999999999998 110.457 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.82 65.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.46999999999999997 112.016 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -80.98 -13.45 58.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.966 0.412 . . . . 0.40000000000000002 110.51 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 26.6 6.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.855 -0.612 . . . . 0.62 112.409 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.569 HD11 HG13 ' A' ' 37' ' ' ILE . 28.1 tp -94.9 133.25 38.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.65000000000000002 110.473 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -122.49 158.8 29.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.738 -0.467 . . . . 4.3799999999999999 109.738 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.16 29.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.043 0.386 . . . . 1.4399999999999999 112.043 -174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -132.99 1.17 3.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 3.0600000000000001 109.707 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 35.7 m-20 -88.29 154.35 20.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.556 -0.747 . . . . 1.02 111.235 -171.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 18.4 ttm180 -116.54 135.04 54.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.407 -0.59 . . . . 1.5700000000000001 109.407 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.99 123.13 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.65 -0.5 . . . . 0.68000000000000005 109.65 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.86 -44.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.251 -0.431 . . . . 0.87 110.42 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 34.9 mt-10 -134.48 143.53 47.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.89000000000000001 110.029 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.96 117.75 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.685 -0.487 . . . . 0.66000000000000003 109.685 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.59 30.29 19.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.48 0.487 . . . . 1.1699999999999999 110.945 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 -6.17 79.29 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.068 -0.587 . . . . 0.66000000000000003 112.974 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -95.88 124.15 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 0.231 . . . . 1.1699999999999999 110.557 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.543 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.2 t -66.22 136.93 56.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 1.6799999999999999 111.188 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.451 ' HA ' ' CG ' ' A' ' 68' ' ' LYS . 21.4 mmt -118.09 2.22 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.81000000000000005 111.82 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 97.88 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.357 -0.608 . . . . 3.75 109.357 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.88 12.94 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.47 111.659 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 65' ' ' MET . 34.7 mmtp -84.01 166.78 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 3.3599999999999999 110.877 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -94.29 174.21 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.645 . . . . 2.8900000000000001 110.83 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -57.53 -43.06 84.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 1.4199999999999999 110.359 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.04 96.77 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.71999999999999997 113.549 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.51 -40.61 76.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.605 0.241 . . . . 2.0299999999999998 110.897 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.65 -47.26 92.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 1.0800000000000001 110.552 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.48 -42.31 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.71999999999999997 110.881 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -61.53 -39.94 92.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 0.66000000000000003 110.941 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.83 94.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.41999999999999998 111.755 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG23 HG21 ' A' ' 84' ' ' THR . 72.4 mt -60.26 -45.18 96.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.231 0.539 . . . . 0.68999999999999995 110.075 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -66.0 -30.95 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.608 -0.723 . . . . 3.0899999999999999 110.895 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.23 -5.53 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.721 -0.672 . . . . 0.65000000000000002 111.318 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.28 79.17 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.554 -0.831 . . . . 0.59999999999999998 111.478 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.32 -100.4 2.08 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.106 -0.568 . . . . 1.1000000000000001 111.9 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.554 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 18.8 m-20 -119.23 -27.66 5.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.648 0.261 . . . . 2.1200000000000001 110.795 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.6 mt-10 -120.15 139.81 52.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.299 -1.0 . . . . 2.1099999999999999 108.299 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.437 HG21 HG23 ' A' ' 77' ' ' ILE . 13.8 t -138.02 149.65 46.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.818 0.342 . . . . 0.32000000000000001 110.954 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 121.08 42.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.149 -0.478 . . . . 1.6299999999999999 110.477 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.3 mt -107.14 135.65 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.156 -0.475 . . . . 0.28000000000000003 109.889 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.5 tp -104.24 119.34 38.74 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.202 -0.666 . . . . 0.51000000000000001 109.202 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.0 m -126.95 163.31 29.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.231 -0.44 . . . . 0.33000000000000002 111.08 -175.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.99 149.54 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.41999999999999998 111.229 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -90.41 175.57 7.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 1.9199999999999999 110.117 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 91' ' ' ARG . 25.2 ttm180 -58.48 -48.98 78.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 4.1600000000000001 111.045 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.1 mp0 -63.8 -41.01 97.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 2.6800000000000002 110.203 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 m -62.04 -51.42 68.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.46999999999999997 110.471 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.23 -43.86 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.137 -0.938 . . . . 1.1799999999999999 111.708 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 13.6 mm-40 -60.42 -45.68 92.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.207 -0.451 . . . . 1.9399999999999999 110.738 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -63.09 -47.63 82.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.495 0.497 . . . . 0.72999999999999998 111.336 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -65.89 -40.45 91.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.487 -0.324 . . . . 0.44 111.613 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -66.17 -44.59 83.62 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.988 -0.285 . . . . 1.9199999999999999 111.615 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.3 ptmt -70.27 -26.53 63.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.635 0.255 . . . . 2.04 111.087 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.5 t -93.75 -3.56 51.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.345 0.593 . . . . 1.3899999999999999 110.395 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.54 47.2 13.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.11 -0.95 . . . . 4.0899999999999999 110.918 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.82 137.9 53.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 1.4199999999999999 110.204 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 55.5 mt -88.99 125.49 62.24 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.985 -0.376 . . . . 1.3300000000000001 109.985 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 27.6 Cg_exo -61.9 154.23 62.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.97 2.447 . . . . 0.53000000000000003 112.07 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.7 p -163.46 167.21 21.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.612 -0.267 . . . . 1.4199999999999999 111.142 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -57.47 -29.3 64.13 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.732 0.645 . . . . 1.6599999999999999 111.405 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.44 -34.23 70.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 2.8199999999999998 110.49 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -75.8 -14.6 60.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.024 -0.989 . . . . 0.53000000000000003 111.101 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' A' ' 12' ' ' LEU . 89.5 mt -73.92 -32.51 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 1.24 110.776 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.14 -36.65 74.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 3.7000000000000002 111.866 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.44 -80.69 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.558 -1.306 . . . . 1.1200000000000001 113.863 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.0 132.83 29.21 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.223 2.615 . . . . 1.3100000000000001 114.386 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 114.846 -1.07 . . . . 1.1100000000000001 108.912 171.112 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' A' ' 96' ' ' PHE . 71.6 mt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.96 0.41 . . . . 0.80000000000000004 111.617 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.537 ' HB3' HD21 ' A' ' 113' ' ' LEU . 27.5 ptt180 -125.96 154.21 73.78 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.975 -0.38 . . . . 3.0899999999999999 109.975 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 48.4 Cg_endo -64.73 178.85 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.018 2.479 . . . . 0.46999999999999997 113.231 -172.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.66 HH12 ' HB3' ' A' ' 90' ' ' ASP . 7.8 ptp85 -137.76 131.98 32.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.988 -0.551 . . . . 2.3700000000000001 110.304 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.565 ' HG ' HD11 ' A' ' 109' ' ' LEU . 4.7 mt -93.59 111.01 22.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.3200000000000001 110.169 176.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 37.2 m -94.68 116.92 29.33 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.489 -0.56 . . . . 0.40000000000000002 109.489 177.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -105.96 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.675 -0.861 . . . . 0.34999999999999998 108.675 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.55 ' HE3' HD12 ' A' ' 86' ' ' LEU . 24.9 ptp -135.73 134.92 39.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.953 0.406 . . . . 0.88 110.806 -171.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 23.0 ttpp -92.49 147.09 23.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 2.5800000000000001 109.209 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 ttmt -59.62 123.46 16.98 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.129 -0.487 . . . . 0.92000000000000004 111.559 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.51 -157.36 21.51 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.389 -0.684 . . . . 1.28 111.389 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.26 -36.68 27.23 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.159 2.573 . . . . 2.23 113.233 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -93.8 21.29 6.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.8700000000000001 111.595 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.32 69.68 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.597 -0.811 . . . . 1.9299999999999999 111.273 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 74.89 -50.8 0.67 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.662 0.785 . . . . 1.8200000000000001 110.739 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 69.66 0.93 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.151 -0.547 . . . . 0.42999999999999999 113.347 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.33 168.88 25.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.013 -0.365 . . . . 0.40000000000000002 110.013 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 20.0 t-20 -133.76 127.19 32.24 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 2.1800000000000002 109.699 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.31 143.78 30.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.232 -0.44 . . . . 1.52 110.632 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.565 ' CD2' ' HB2' ' A' ' 36' ' ' PHE . 2.6 p80 -125.89 130.7 51.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.8 -0.445 . . . . 1.3400000000000001 109.8 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 115.618 -0.719 . . . . 2.2999999999999998 109.844 -177.808 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.778 0.323 . . . . 1.5 110.687 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.565 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 31.1 m-85 -114.27 142.99 45.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.384 -0.599 . . . . 0.87 109.384 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.528 HG13 HD11 ' A' ' 51' ' ' LEU . 32.9 mm -74.32 106.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.43 -0.582 . . . . 0.39000000000000001 109.43 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 52.0 ttt180 -69.65 -51.85 31.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.75 -0.659 . . . . 2.8300000000000001 110.382 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -163.32 135.38 5.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.985 -0.552 . . . . 1.26 110.309 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.5 134.29 37.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.43 -0.952 . . . . 0.37 108.43 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.2 m-20 -64.67 128.09 93.15 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.956 -0.387 . . . . 2.2799999999999998 109.956 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 52.4 Cg_exo -54.54 130.02 37.91 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.171 2.581 . . . . 1.1699999999999999 113.182 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.61 38.37 12.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.357 -0.838 . . . . 2.3999999999999999 110.81 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 79.0 p -97.76 164.7 16.94 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 109.693 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.4 Cg_endo -55.85 -34.17 90.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.751 1.634 . . . . 0.65000000000000002 111.125 172.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.84 -46.39 85.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.826 -0.624 . . . . 0.35999999999999999 110.244 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.27 -43.47 98.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.014 -0.539 . . . . 2.0099999999999998 110.337 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.85 63.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.46999999999999997 111.988 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.7 p -76.39 -14.83 60.05 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.40000000000000002 110.526 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.12 9.07 24.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.782 -0.723 . . . . 0.62 112.333 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD11 HG13 ' A' ' 37' ' ' ILE . 37.1 tp -79.79 128.06 32.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.85 0.357 . . . . 0.65000000000000002 110.115 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -123.42 -170.53 2.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.061 -0.518 . . . . 4.3799999999999999 110.222 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -95.65 151.65 19.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.673 -0.694 . . . . 1.4399999999999999 110.29 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 54.7 mt-30 73.02 25.05 2.41 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.825 0.703 . . . . 3.0600000000000001 110.96 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -95.81 155.25 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.243 -0.651 . . . . 1.02 109.243 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -124.69 129.55 50.72 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.603 -0.517 . . . . 1.5700000000000001 109.603 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.3 mt -73.41 132.06 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.68000000000000005 111.605 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.594 HG11 ' HB2' ' A' ' 104' ' ' PRO . 21.4 t -113.97 -47.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.415 -0.811 . . . . 0.87 110.443 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.1 mt-10 -132.8 149.51 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.89000000000000001 110.644 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.81 117.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.66000000000000003 109.637 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 57.24 34.21 24.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.986 -0.552 . . . . 1.1699999999999999 111.041 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.43 -4.63 84.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.925 -0.655 . . . . 0.66000000000000003 113.084 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.84 127.21 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.96 -0.385 . . . . 1.1699999999999999 109.96 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 41.8 t -74.25 135.39 42.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.992 0.425 . . . . 1.6799999999999999 110.369 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.806 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.5 mmt -116.79 30.15 7.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.81000000000000005 110.415 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HG2' HD12 ' A' ' 103' ' ' ILE . 21.5 tp10 -70.51 -34.42 72.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 3.75 110.943 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.11 -0.45 28.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.645 -0.788 . . . . 1.47 112.305 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.806 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.3 mmtp -71.95 168.73 17.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.762 0.792 . . . . 3.3599999999999999 112.791 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -106.12 169.81 8.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.518 -1.219 . . . . 2.8900000000000001 109.844 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -54.42 -43.93 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 1.4199999999999999 111.597 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.42 85.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.128 -0.558 . . . . 0.71999999999999997 113.387 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.97 -42.63 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.021 0.438 . . . . 2.0299999999999998 110.34 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 65' ' ' MET . 59.0 t -68.26 -47.18 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 1.0800000000000001 111.174 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.1 -38.55 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 0.71999999999999997 111.048 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -67.94 -36.69 80.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.66000000000000003 110.497 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.446 -0.343 . . . . 0.41999999999999998 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.552 HG23 HG21 ' A' ' 84' ' ' THR . 78.6 mt -58.38 -42.06 83.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.446 0.641 . . . . 0.68999999999999995 110.41 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -74.6 -31.69 62.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 3.0899999999999999 111.44 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 5.48 18.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.65000000000000002 111.325 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -13.37 83.23 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.682 -0.771 . . . . 0.59999999999999998 112.009 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -111.43 3.1 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.981 -0.628 . . . . 1.1000000000000001 111.699 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 14.0 m-20 -115.03 -6.64 12.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.908 0.385 . . . . 2.1200000000000001 110.503 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -143.8 157.01 44.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.594 . . . . 2.1099999999999999 109.622 173.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.552 HG21 HG23 ' A' ' 77' ' ' ILE . 11.9 t -137.57 149.73 46.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 0.32000000000000001 110.072 -175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -115.63 116.85 28.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.126 -0.488 . . . . 1.6299999999999999 109.796 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HE3' ' A' ' 15' ' ' MET . 78.0 mt -107.85 130.92 54.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.908 -0.587 . . . . 0.28000000000000003 109.836 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 10' ' ' PRO . 20.8 tp -104.59 115.21 29.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.814 -0.81 . . . . 0.51000000000000001 108.814 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.5 m -127.54 159.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.191 -0.459 . . . . 0.33000000000000002 111.377 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.39 150.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.734 . . . . 0.41999999999999998 110.031 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.66 ' HB3' HH12 ' A' ' 11' ' ' ARG . 4.3 p30 -88.85 176.51 7.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 1.9199999999999999 109.975 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.5 ttp180 -55.78 -49.99 71.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.755 0.65 . . . . 4.1600000000000001 112.755 -172.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.555 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 14.2 pt-20 -74.85 -34.35 62.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 2.6800000000000002 111.139 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.9 m -64.9 -41.92 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.02 -0.537 . . . . 0.46999999999999997 110.12 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 33.2 t70 -62.49 -38.05 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.608 . . . . 1.1799999999999999 109.963 177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 48.0 mt-10 -67.2 -35.52 79.79 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.144 -0.48 . . . . 1.9399999999999999 110.745 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.86 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 59.7 t80 -62.99 -49.62 73.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.896 0.379 . . . . 0.72999999999999998 110.318 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.458 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 27.8 m-85 -68.14 -38.86 82.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.911 -0.586 . . . . 0.44 112.06 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -64.61 -48.91 73.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.848 0.314 . . . . 1.9199999999999999 111.848 -176.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 22.4 pttp -67.63 -34.18 76.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.113 0.483 . . . . 2.04 110.427 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 67.8 m -75.22 -8.69 57.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.511 -0.768 . . . . 1.3899999999999999 112.048 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 55.86 32.82 20.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.312 0.645 . . . . 4.0899999999999999 111.734 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 97' ' ' PHE . 5.8 p -120.36 142.1 37.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.251 -0.431 . . . . 1.4199999999999999 110.228 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.565 HD12 ' HG2' ' A' ' 66' ' ' GLU . 45.9 mm -86.75 127.28 60.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 1.3300000000000001 110.625 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.594 ' HB2' HG11 ' A' ' 58' ' ' VAL . 16.9 Cg_exo -65.55 155.13 70.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.824 2.349 . . . . 0.53000000000000003 111.37 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.7 p -169.06 168.41 10.07 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.554 -0.459 . . . . 1.4199999999999999 111.807 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -57.0 -29.42 63.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 1.6599999999999999 111.273 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.93 -32.71 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.272 0.558 . . . . 2.8199999999999998 110.34 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -77.86 -13.7 59.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.53000000000000003 111.164 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.565 HD11 ' HG ' ' A' ' 12' ' ' LEU . 86.1 mt -75.19 -40.62 59.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 1.24 111.126 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -106.28 13.03 29.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.199 0.523 . . . . 3.7000000000000002 110.521 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.62 -172.1 12.42 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.827 -0.701 . . . . 1.1200000000000001 111.82 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -88.97 -179.59 2.16 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.213 2.609 . . . . 1.3100000000000001 112.258 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 9' ' ' ARG . 53.7 mt . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.09 -0.504 . . . . 1.1100000000000001 109.761 175.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.264 0.554 . . . . 0.80000000000000004 110.59 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -126.54 157.02 72.18 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 3.0899999999999999 109.433 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HB2' HD11 ' A' ' 87' ' ' LEU . 44.4 Cg_endo -70.15 174.73 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.328 2.019 . . . . 0.46999999999999997 111.782 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.452 ' HG3' HG23 ' A' ' 88' ' ' VAL . 7.0 ptp85 -132.02 130.6 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.261 -0.427 . . . . 2.3700000000000001 110.162 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.9 118.1 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 1.3200000000000001 110.182 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 12.8 m -108.88 117.49 34.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.215 -0.448 . . . . 0.40000000000000002 110.305 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -108.9 117.55 34.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.225 -1.028 . . . . 0.34999999999999998 108.225 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.582 ' HE3' HD12 ' A' ' 86' ' ' LEU . 23.0 ptp -131.15 144.63 51.52 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.744 -0.383 . . . . 0.88 111.164 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HG3' ' HG2' ' A' ' 83' ' ' GLU . 7.5 ttmm -118.89 146.0 45.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.614 -0.721 . . . . 2.5800000000000001 109.705 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 85.5 mttt -56.32 119.47 6.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.361 -0.836 . . . . 0.92000000000000004 112.188 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.37 -111.0 3.1 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.575 -1.193 . . . . 1.28 112.282 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.49 -74.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.243 2.629 . . . . 2.23 112.669 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -132.93 83.85 2.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.8700000000000001 110.495 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.97 71.29 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.004 -0.617 . . . . 1.9299999999999999 112.535 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.553 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 36.2 m-85 67.23 -87.3 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.047 0.539 . . . . 1.8200000000000001 110.774 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.45 70.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.625 -0.798 . . . . 0.42999999999999999 112.646 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.94 151.91 26.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.40000000000000002 109.271 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.24 123.65 45.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.207 -0.664 . . . . 2.1800000000000002 109.207 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 35' ' ' GLN . 30.3 tp -108.77 146.14 34.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.058 -0.519 . . . . 1.52 109.62 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.45 149.25 27.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.624 -0.43 . . . . 1.3400000000000001 111.435 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 109.166 -0.679 . . . . 2.2999999999999998 109.166 174.12 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.52 ' HB3' HD11 ' A' ' 26' ' ' LEU . 27.6 mm-40 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.13 -0.322 . . . . 1.5 110.13 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -109.92 140.59 43.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.87 110.554 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.543 HG13 HD11 ' A' ' 51' ' ' LEU . 36.9 mm -81.21 105.76 11.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.846 -0.798 . . . . 0.39000000000000001 108.846 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.02 -55.28 19.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.507 . . . . 2.8300000000000001 110.106 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 m -157.87 137.77 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.854 -0.612 . . . . 1.26 109.482 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.31 133.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.145 -0.687 . . . . 0.37 109.145 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.82 128.92 92.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.014 -0.539 . . . . 2.2799999999999998 109.774 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 125.41 19.02 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.753 2.302 . . . . 1.1699999999999999 113.063 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 63.14 43.46 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.934 -1.03 . . . . 2.3999999999999999 110.76 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.6 p -102.64 165.3 13.99 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.592 . . . . 0.56999999999999995 110.639 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 31.6 Cg_exo -56.11 -34.38 92.68 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.888 1.725 . . . . 0.65000000000000002 111.168 172.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.31 86.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.596 -0.729 . . . . 0.35999999999999999 110.186 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -61.06 -42.44 98.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 2.0099999999999998 110.132 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.37 -30.02 68.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.817 -0.629 . . . . 0.46999999999999997 112.069 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.2 p -70.96 -20.0 62.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.368 . . . . 0.40000000000000002 110.626 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.19 9.7 15.03 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.792 -0.718 . . . . 0.62 112.803 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.543 HD11 HG13 ' A' ' 37' ' ' ILE . 27.9 tp -69.33 125.17 25.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.65000000000000002 110.685 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 30.5 ttm180 -103.85 147.89 26.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.804 -0.634 . . . . 4.3799999999999999 109.918 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -74.77 144.21 43.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 1.4399999999999999 110.092 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 15.4 mm-40 78.87 5.88 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.099 0.875 . . . . 3.0600000000000001 111.31 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -85.12 149.93 25.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.693 -0.484 . . . . 1.02 109.693 176.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 56' ' ' ARG . 34.9 ttp180 -111.87 137.48 49.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.5700000000000001 110.258 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HA ' HG12 ' A' ' 88' ' ' VAL . 65.2 mt -74.56 128.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.985 -0.552 . . . . 0.68000000000000005 110.627 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.403 HG23 HD23 ' A' ' 87' ' ' LEU . 19.0 m -112.42 -32.89 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 0.87 111.21 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 27.4 mt-10 -134.38 142.85 47.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.89000000000000001 110.833 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.56 120.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.66000000000000003 109.797 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 85' ' ' LYS . 73.8 m-20 58.68 24.57 12.31 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.088 0.555 . . . . 1.1699999999999999 111.512 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.494 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.61 6.53 63.96 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.66000000000000003 112.915 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.47 124.18 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 1.1699999999999999 110.393 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.2 p -64.58 136.94 57.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.636 . . . . 1.6799999999999999 111.215 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.706 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.1 mmt -123.68 50.99 1.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.968 -0.56 . . . . 0.81000000000000005 111.074 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -36.11 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.922 -0.311 . . . . 3.75 111.514 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.38 -7.52 54.17 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.842 -0.694 . . . . 1.47 111.857 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.706 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.7 mmtp -70.71 149.16 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.223 0.535 . . . . 3.3599999999999999 111.436 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -86.45 170.62 11.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.367 -0.833 . . . . 2.8900000000000001 109.983 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -53.86 -43.52 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.657 0.265 . . . . 1.4199999999999999 111.241 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.03 99.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.045 -0.598 . . . . 0.71999999999999997 113.125 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 6.3 t70 -64.78 -43.97 91.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.913 0.387 . . . . 2.0299999999999998 110.216 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 65' ' ' MET . 46.5 t -63.55 -46.86 93.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 1.0800000000000001 111.015 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 97.7 t -66.68 -42.5 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.71999999999999997 111.114 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -64.51 -38.27 90.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.46 -0.336 . . . . 0.66000000000000003 110.387 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.09 93.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 0.41999999999999998 111.135 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 84' ' ' THR . 81.4 mt -61.15 -45.77 97.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.018 0.437 . . . . 0.68999999999999995 110.621 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 29.6 mtm180 -66.15 -33.2 75.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 3.0899999999999999 110.366 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.42 -0.36 36.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.952 -0.567 . . . . 0.65000000000000002 111.501 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.26 85.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.606 -0.807 . . . . 0.59999999999999998 111.695 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.29 -127.24 9.1 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.208 -0.757 . . . . 1.1000000000000001 111.208 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 42.1 m-20 -96.73 -12.97 23.04 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.032 -0.267 . . . . 2.1200000000000001 110.78 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -130.61 140.82 50.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.989 -0.375 . . . . 2.1099999999999999 109.989 177.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 77' ' ' ILE . 14.4 t -135.09 149.62 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.957 0.408 . . . . 0.32000000000000001 110.36 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 61' ' ' ASN . 95.0 mttt -106.31 117.81 35.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.248 -0.433 . . . . 1.6299999999999999 110.289 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD12 ' HE3' ' A' ' 15' ' ' MET . 85.0 mt -111.53 124.91 53.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.145 -0.479 . . . . 0.28000000000000003 109.815 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 34.8 tp -104.36 122.25 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.029 -0.73 . . . . 0.51000000000000001 109.029 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 10.5 m -130.15 164.58 32.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.208 -0.451 . . . . 0.33000000000000002 111.369 -174.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 m -136.72 145.79 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.658 -0.701 . . . . 0.41999999999999998 110.874 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.72 167.74 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.548 -0.751 . . . . 1.9199999999999999 109.473 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -56.59 -47.79 78.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.653 0.263 . . . . 4.1600000000000001 111.22 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -63.45 -31.42 72.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.347 0.594 . . . . 2.6800000000000002 110.086 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 m -76.54 -50.8 13.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.46999999999999997 111.021 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.7 -47.67 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.865 -0.607 . . . . 1.1799999999999999 111.656 -174.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 31.7 mt-10 -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.721 -0.391 . . . . 1.9399999999999999 110.767 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.38 -46.09 70.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.937 0.398 . . . . 0.72999999999999998 110.356 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 102' ' ' VAL . 22.9 m-85 -64.34 -44.24 92.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.008 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -61.42 -45.33 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.561 0.578 . . . . 1.9199999999999999 112.561 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 18.1 ptpt -65.47 -25.6 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 2.04 110.955 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.2 t -96.69 0.84 50.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 1.3899999999999999 110.645 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? 64.63 31.27 12.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.028 -0.533 . . . . 4.0899999999999999 111.716 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 35.0 t -109.82 139.6 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.491 -0.322 . . . . 1.4199999999999999 110.416 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.35 125.95 50.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.93 -0.396 . . . . 1.3300000000000001 109.93 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HB2' HG21 ' A' ' 58' ' ' VAL . 18.8 Cg_exo -65.62 139.53 58.68 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.464 2.11 . . . . 0.53000000000000003 111.42 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -154.01 166.93 31.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 1.4199999999999999 110.73 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.494 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 41.2 mt-30 -57.31 -31.98 66.21 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.441 0.463 . . . . 1.6599999999999999 111.049 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.38 -30.78 70.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.441 -0.345 . . . . 2.8199999999999998 111.3 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.37 -13.83 61.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.53000000000000003 111.403 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.31 -25.43 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.2 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -130.4 -14.89 3.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.496 -0.32 . . . . 3.7000000000000002 111.584 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.35 -177.11 34.44 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.866 -0.683 . . . . 1.1200000000000001 112.438 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.41 124.26 10.65 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.131 2.554 . . . . 1.3100000000000001 112.866 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' N ' HD22 ' A' ' 113' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.444 -0.762 0 CA-C-N 115.96 -0.564 . . . . 1.1100000000000001 109.825 169.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.948 0.404 . . . . 0.80000000000000004 110.901 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 15.9 ptp180 -119.7 147.02 42.94 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.322 -0.399 . . . . 3.0899999999999999 109.998 -177.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HD2' ' HA ' ' A' ' 109' ' ' LEU . 2.9 Cg_exo -72.26 165.14 33.53 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.899 2.399 . . . . 0.46999999999999997 111.358 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.79 ' HG3' HG23 ' A' ' 88' ' ' VAL . 5.5 ptt180 -122.9 131.0 53.54 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.663 -0.699 . . . . 2.3700000000000001 110.627 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.06 113.3 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 1.3200000000000001 110.03 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 30.5 m -96.87 128.74 44.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.832 -0.622 . . . . 0.40000000000000002 110.22 -176.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -117.79 117.49 29.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.34999999999999998 108.91 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.527 ' HE3' HD12 ' A' ' 86' ' ' LEU . 22.5 ptp -142.21 142.55 32.67 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.181 -0.463 . . . . 0.88 110.194 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 43.4 pttt -119.34 152.53 36.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.311 0.577 . . . . 2.5800000000000001 110.735 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.617 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.1 mtmt -55.55 110.45 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.347 -1.297 . . . . 0.92000000000000004 112.601 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.09 -129.82 6.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.272 -0.876 . . . . 1.28 112.145 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.29 -75.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.35 2.7 . . . . 2.23 113.616 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -96.91 34.05 1.78 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.891 0.377 . . . . 2.8700000000000001 111.329 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.617 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 71.77 83.86 0.23 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.585 -0.817 . . . . 1.9299999999999999 111.755 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.45 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 39.3 m-85 68.07 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.268 0.627 . . . . 1.8200000000000001 110.638 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.16 68.11 0.38 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.259 -0.496 . . . . 0.42999999999999999 112.572 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -157.34 153.23 27.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.928 -0.397 . . . . 0.40000000000000002 109.928 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.36 141.41 40.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 2.1800000000000002 110.626 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 26' ' ' LEU . 48.6 mt -101.52 154.91 18.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.624 -0.716 . . . . 1.52 111.715 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 1.5 t60 -105.67 141.81 36.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.188 -0.915 . . . . 1.3400000000000001 110.459 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.943 -0.571 . . . . 2.2999999999999998 110.454 -179.343 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.126 0.489 . . . . 1.5 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 38.9 m-85 -102.8 149.92 24.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.87 109.599 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 51' ' ' LEU . 48.5 mm -84.45 105.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.645 -0.502 . . . . 0.39000000000000001 109.645 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -70.13 -39.75 75.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.693 -0.685 . . . . 2.8300000000000001 110.033 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 p -165.73 152.2 9.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 1.26 109.825 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.08 128.63 74.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.37 109.348 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -70.86 135.88 85.41 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.327 -0.397 . . . . 2.2799999999999998 110.672 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.84 143.1 78.73 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.886 2.391 . . . . 1.1699999999999999 112.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 61.8 42.13 10.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.502 -0.772 . . . . 2.3999999999999999 111.202 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.1 p -118.18 159.34 43.62 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 0.56999999999999995 110.297 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 44.7 Cg_exo -51.15 -39.37 61.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.406 2.071 . . . . 0.65000000000000002 111.419 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.3 -52.31 64.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.461 -0.791 . . . . 0.35999999999999999 110.864 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -63.41 -39.63 95.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.171 -0.468 . . . . 2.0099999999999998 110.601 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.06 77.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 0.46999999999999997 111.866 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -70.84 -13.69 62.13 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.982 0.42 . . . . 0.40000000000000002 110.955 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.1 14.59 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.632 -0.794 . . . . 0.62 113.015 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 37' ' ' ILE . 29.2 tp -76.02 123.83 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.65000000000000002 110.297 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 52' ' ' ARG . 21.9 ttt180 -110.28 148.51 31.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.887 -0.597 . . . . 4.3799999999999999 110.117 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -68.79 148.23 50.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.203 -0.453 . . . . 1.4399999999999999 110.219 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 78.4 mt-30 78.62 0.7 2.54 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.194 0.934 . . . . 3.0600000000000001 111.27 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 15.3 m-20 -78.58 143.43 36.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.726 0.298 . . . . 1.02 110.603 177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 56' ' ' ARG . 36.8 ttp-105 -104.69 133.52 49.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.824 0.345 . . . . 1.5700000000000001 110.573 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.84 123.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.991 -0.549 . . . . 0.68000000000000005 109.735 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' HG2' ' A' ' 104' ' ' PRO . 42.2 t -101.86 -46.55 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.268 0.556 . . . . 0.87 110.584 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 32.7 mt-10 -129.92 145.51 51.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.698 . . . . 0.89000000000000001 110.083 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.405 HG11 HD13 ' A' ' 77' ' ' ILE . 24.8 t -125.59 130.59 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.606 -0.516 . . . . 0.66000000000000003 109.606 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 66.36 8.84 5.97 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.423 0.452 . . . . 1.1699999999999999 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 9.56 62.99 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.826 -0.702 . . . . 0.66000000000000003 111.593 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.78 131.03 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.585 0.354 . . . . 1.1699999999999999 110.171 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.545 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 44.1 t -70.1 136.29 50.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.999 -0.546 . . . . 1.6799999999999999 111.426 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.803 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.5 mmt -119.91 69.43 0.85 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.81000000000000005 110.583 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -98.07 -62.15 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 3.75 110.367 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.26 41.4 2.41 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.618 -0.593 . . . . 1.47 111.618 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.803 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.4 mmtp -107.42 -178.5 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.064 -0.347 . . . . 3.3599999999999999 110.064 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -125.61 172.28 9.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.605 -0.27 . . . . 2.8900000000000001 110.972 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -54.68 -44.21 73.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.518 0.511 . . . . 1.4199999999999999 111.366 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.43 84.45 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.993 -0.622 . . . . 0.71999999999999997 113.039 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.776 0.322 . . . . 2.0299999999999998 110.662 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.93 -45.5 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 1.0800000000000001 110.778 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.65 -36.64 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.294 -0.412 . . . . 0.71999999999999997 110.905 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -65.87 -36.15 82.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.855 -0.424 . . . . 0.66000000000000003 109.855 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.1 79.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.584 . . . . 0.41999999999999998 111.072 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 60' ' ' VAL . 18.8 mm -57.56 -44.49 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.546 0.688 . . . . 0.68999999999999995 109.464 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.52 -29.22 59.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.001 -1.0 . . . . 3.0899999999999999 110.936 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.86 44.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.65000000000000002 111.84 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.8 -12.35 83.0 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.448 -0.882 . . . . 0.59999999999999998 111.867 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 -125.92 8.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.974 -0.851 . . . . 1.1000000000000001 110.974 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 60.2 m-20 -94.6 -16.85 22.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.943 0.372 . . . . 2.1200000000000001 110.042 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.639 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 7.4 mt-10 -119.55 140.34 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.109 -0.7 . . . . 2.1099999999999999 109.109 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -129.77 145.52 51.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 110.511 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.5 mttm -113.62 117.77 32.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.913 -0.585 . . . . 1.6299999999999999 109.825 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.527 HD12 ' HE3' ' A' ' 15' ' ' MET . 81.1 mt -109.91 135.86 50.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.861 -0.608 . . . . 0.28000000000000003 110.159 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 10' ' ' PRO . 52.9 tp -104.55 117.09 33.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.09 -0.505 . . . . 0.51000000000000001 109.884 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.79 HG23 ' HG3' ' A' ' 11' ' ' ARG . 7.2 m -127.95 159.36 39.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.33000000000000002 110.72 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -128.83 148.1 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.0 -0.545 . . . . 0.41999999999999998 110.747 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.16 172.62 12.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.288 -0.634 . . . . 1.9199999999999999 109.288 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.0 ttp180 -61.0 -49.1 78.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.612 0.244 . . . . 4.1600000000000001 110.709 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -35.97 82.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.061 0.458 . . . . 2.6800000000000002 110.322 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -64.32 -51.44 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.46999999999999997 111.194 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.73 -33.99 76.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.1799999999999999 111.445 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 12.5 mm-40 -64.17 -41.56 97.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.895 0.379 . . . . 1.9399999999999999 110.056 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.715 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 70.2 t80 -63.28 -47.83 80.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.72999999999999998 111.367 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -66.76 -38.82 87.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.514 -0.312 . . . . 0.44 111.776 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.1 -41.82 85.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.376 0.51 . . . . 1.9199999999999999 112.376 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 58.6 pttt -68.24 -14.48 63.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 2.04 111.229 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.427 ' HB3' HG12 ' A' ' 102' ' ' VAL . 34.4 t -109.04 -11.4 14.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.274 0.559 . . . . 1.3899999999999999 109.574 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 65.38 35.29 7.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.761 -1.108 . . . . 4.0899999999999999 111.371 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' A' ' 100' ' ' CYS . 3.1 p -118.45 126.93 75.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 1.4199999999999999 110.124 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -72.15 128.29 89.26 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.3300000000000001 110.753 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' ' 58' ' ' VAL . 34.1 Cg_endo -67.65 143.9 63.98 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.734 2.289 . . . . 0.53000000000000003 111.355 176.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 m -151.23 174.72 12.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 110.024 -0.362 . . . . 1.4199999999999999 110.024 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.608 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 43.0 mt-30 -57.59 -40.3 78.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.926 0.393 . . . . 1.6599999999999999 111.166 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.5 mp0 -59.22 -35.27 73.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.293 0.568 . . . . 2.8199999999999998 110.259 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -73.9 -31.52 63.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.564 -0.743 . . . . 0.53000000000000003 111.525 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.4 pp -88.51 -16.53 32.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 1.24 110.864 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.77 -8.16 59.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.131 -0.486 . . . . 3.7000000000000002 111.24 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.89 -74.36 0.21 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.03 -1.081 . . . . 1.1200000000000001 113.723 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.17 116.08 4.54 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.344 2.696 . . . . 1.3100000000000001 114.12 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.326 -0.852 . . . . 1.1100000000000001 109.698 171.616 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 121.348 0.594 . . . . 0.80000000000000004 110.315 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -125.78 147.57 59.15 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.655 -0.702 . . . . 3.0899999999999999 109.731 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.8 Cg_endo -66.01 159.76 47.68 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.298 1.998 . . . . 0.46999999999999997 111.183 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.3 ptt85 -121.37 132.55 54.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.037 -0.529 . . . . 2.3700000000000001 110.396 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -92.72 111.86 23.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.729 -0.669 . . . . 1.3200000000000001 109.767 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 18.0 m -89.63 117.73 28.72 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.091 -0.707 . . . . 0.40000000000000002 109.091 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' LYS . 24.4 m -109.85 118.25 36.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.601 -0.518 . . . . 0.34999999999999998 109.601 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.672 ' HE3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -131.17 132.93 45.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.88 110.677 -175.206 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' NZ ' ' HB2' ' A' ' 16' ' ' LYS . 3.4 ttmp? -109.12 128.69 55.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 2.5800000000000001 109.529 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.4 ttmt -51.59 130.08 27.2 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.041 -0.981 . . . . 0.92000000000000004 112.768 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.09 -147.57 22.82 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.956 -0.858 . . . . 1.28 110.956 170.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.71 -28.8 6.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.879 2.386 . . . . 2.23 112.841 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -94.28 -27.2 16.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.364 0.505 . . . . 2.8700000000000001 112.364 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.57 64.79 0.59 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.8 -0.714 . . . . 1.9299999999999999 112.775 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.542 ' O ' ' HB2' ' A' ' 44' ' ' SER . 26.4 m-85 74.51 -74.58 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.629 0.772 . . . . 1.8200000000000001 111.013 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.96 69.07 0.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.64 . . . . 0.42999999999999999 113.007 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -155.71 154.76 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.8 -0.445 . . . . 0.40000000000000002 109.8 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.77 127.16 55.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.77 0.319 . . . . 2.1800000000000002 110.586 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.47 137.75 39.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 1.52 110.09 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 36' ' ' PHE . 41.8 p-80 -125.7 138.81 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.46 -0.496 . . . . 1.3400000000000001 110.705 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 115.265 -0.879 . . . . 2.2999999999999998 108.891 178.25 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.514 -0.441 0 CA-C-O 121.195 0.521 . . . . 1.5 111.036 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.702 ' HB2' ' CE1' ' A' ' 27' ' ' HIS . 52.9 m-85 -125.43 150.55 47.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.715 -0.846 . . . . 0.87 108.715 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.473 HG13 HD11 ' A' ' 51' ' ' LEU . 35.2 mm -75.85 111.17 11.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.839 -0.43 . . . . 0.39000000000000001 109.839 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 23.3 tpt180 -68.64 -57.05 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 2.8300000000000001 110.028 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 49.6 m -160.63 140.57 11.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.47 -0.786 . . . . 1.26 109.041 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.18 132.92 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.6 -0.889 . . . . 0.37 108.6 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.478 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 3.2 t70 -83.86 116.24 63.76 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.256 -0.429 . . . . 2.2799999999999998 109.998 -173.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 9.2 Cg_endo -53.64 150.84 26.89 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.721 2.28 . . . . 1.1699999999999999 111.904 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 64.36 56.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.051 0.929 . . . . 2.3999999999999999 109.96 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 87.9 p -145.65 156.27 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.187 -0.915 . . . . 0.56999999999999995 109.843 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.3 Cg_endo -61.2 -23.9 78.03 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.501 2.134 . . . . 0.65000000000000002 111.177 172.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.672 ' HA ' ' HE3' ' A' ' 15' ' ' MET . . . -69.09 -52.1 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.464 . . . . 0.35999999999999999 110.558 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.761 -0.459 . . . . 2.0099999999999998 109.761 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.69 -35.31 72.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.794 -0.639 . . . . 0.46999999999999997 112.064 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.0 p -70.02 -19.44 63.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.861 0.362 . . . . 0.40000000000000002 111.247 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.33 47.69 1.11 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.751 . . . . 0.62 112.468 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 HG13 ' A' ' 37' ' ' ILE . 34.6 tp -108.01 137.94 45.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.143 -0.317 . . . . 0.65000000000000002 110.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -118.95 153.09 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.754 -0.462 . . . . 4.3799999999999999 109.754 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -81.78 34.93 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.519 0.562 . . . . 1.4399999999999999 112.519 -173.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -152.73 17.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 3.0600000000000001 110.825 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.6 m-20 -94.48 159.68 14.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.92 -0.582 . . . . 1.02 110.45 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 56' ' ' ARG . 30.5 ttp180 -115.22 137.62 51.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.418 -0.586 . . . . 1.5700000000000001 109.418 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.56 126.73 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.98 -0.555 . . . . 0.68000000000000005 110.887 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.21 -42.01 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.87 110.736 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.9 mt-10 -131.82 143.05 49.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.39 -0.368 . . . . 0.89000000000000001 110.745 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.46 111.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.323 -0.621 . . . . 0.66000000000000003 109.323 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.67 29.68 19.18 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.374 0.421 . . . . 1.1699999999999999 111.36 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.2 -7.44 78.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.66000000000000003 112.577 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.65 121.4 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.809 -0.441 . . . . 1.1699999999999999 109.809 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.42 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 37.0 t -80.1 122.66 27.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.156 0.503 . . . . 1.6799999999999999 110.322 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.584 ' SD ' HG22 ' A' ' 73' ' ' VAL . 22.9 mmt -94.75 56.13 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.423 0.63 . . . . 0.81000000000000005 110.331 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.82 68.79 3.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.25 -0.886 . . . . 3.75 110.958 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.11 27.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 1.47 112.127 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 75.7 mmtt -69.3 152.92 44.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.312 0.577 . . . . 3.3599999999999999 111.142 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -83.52 153.55 24.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.19 -0.914 . . . . 2.8900000000000001 110.009 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.82 -40.34 66.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.014 -0.994 . . . . 1.4199999999999999 112.928 -165.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.4 -30.73 68.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.742 -0.742 . . . . 0.71999999999999997 112.365 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 42.8 t0 -68.75 -46.81 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.52 . . . . 2.0299999999999998 110.104 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.584 HG22 ' SD ' ' A' ' 65' ' ' MET . 58.9 t -62.36 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.459 -0.791 . . . . 1.0800000000000001 110.949 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 77' ' ' ILE . 97.5 t -64.09 -41.61 92.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.257 -0.428 . . . . 0.71999999999999997 110.988 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -61.38 -37.56 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.66000000000000003 110.592 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.12 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.41999999999999998 110.995 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 74' ' ' VAL . 72.6 mt -61.06 -42.1 91.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.151 0.501 . . . . 0.68999999999999995 110.281 176.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.72 -25.75 63.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.705 -0.68 . . . . 3.0899999999999999 110.8 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.49 61.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.65000000000000002 111.519 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.28 -20.51 76.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.587 -0.816 . . . . 0.59999999999999998 111.904 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.43 -84.59 1.33 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.953 -0.641 . . . . 1.1000000000000001 112.132 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 50.8 m-20 -120.42 1.1 10.67 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.856 -0.202 . . . . 2.1200000000000001 111.173 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -151.49 161.87 41.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.731 0.301 . . . . 2.1099999999999999 110.637 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.8 t -140.67 149.56 42.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.568 -0.53 . . . . 0.32000000000000001 109.568 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.7 mttp -119.18 117.22 28.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.802 -0.444 . . . . 1.6299999999999999 109.802 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -106.48 130.74 54.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.301 -0.409 . . . . 0.28000000000000003 110.242 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 57.8 tp -104.23 116.08 31.54 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.073 -0.714 . . . . 0.51000000000000001 109.073 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 18.3 m -127.86 158.27 39.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.227 0.536 . . . . 0.33000000000000002 111.884 -174.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 10' ' ' PRO . 25.9 m -128.03 147.88 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.41999999999999998 109.916 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.59 176.06 7.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.254 -0.647 . . . . 1.9199999999999999 109.254 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.6 ttp180 -54.04 -48.78 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.256 0.348 . . . . 4.1600000000000001 111.469 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.17 -38.05 63.8 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 121.108 -0.237 . . . . 2.6800000000000002 110.957 -173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.441 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 41.1 m -60.64 -47.62 85.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.886 0.374 . . . . 0.46999999999999997 110.186 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 28.9 t70 -58.66 -47.83 83.14 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.873 -0.603 . . . . 1.1799999999999999 110.772 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 48.7 mt-10 -64.77 -28.35 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 1.9399999999999999 110.823 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.11 -47.72 64.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.72999999999999998 110.323 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.489 ' CD2' HG13 ' A' ' 102' ' ' VAL . 46.9 m-85 -65.53 -36.8 84.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.446 -0.343 . . . . 0.44 111.278 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 29.1 mtpp -58.77 -49.36 77.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 1.9199999999999999 111.714 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -71.05 -29.63 65.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.494 . . . . 2.04 111.265 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.416 ' HB3' HG12 ' A' ' 102' ' ' VAL . 36.3 t -85.39 -11.38 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 1.3899999999999999 111.369 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? 63.16 43.97 6.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.73 -0.668 . . . . 4.0899999999999999 111.198 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -133.39 140.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.172 -0.467 . . . . 1.4199999999999999 110.29 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.7 mt -86.3 128.28 57.99 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.345 -0.388 . . . . 1.3300000000000001 110.868 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.98 136.23 55.68 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.497 2.131 . . . . 0.53000000000000003 111.193 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.9 t -155.8 172.67 17.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.892 -0.41 . . . . 1.4199999999999999 109.892 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.435 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 60.1 mt-30 -55.68 -31.26 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.581 0.551 . . . . 1.6599999999999999 111.472 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -59.75 -31.93 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.227 -0.442 . . . . 2.8199999999999998 111.639 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -80.38 -14.17 58.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.448 -0.342 . . . . 0.53000000000000003 111.531 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 87' ' ' LEU . 86.7 mt -59.91 -59.99 4.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.084 0.468 . . . . 1.24 110.848 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -101.98 -12.06 18.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 3.7000000000000002 111.179 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.42 175.93 38.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.794 -0.717 . . . . 1.1200000000000001 112.649 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.2 163.16 28.03 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.848 2.365 . . . . 1.3100000000000001 112.313 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.856 -0.611 . . . . 1.1100000000000001 109.588 175.727 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.181 0.515 . . . . 0.80000000000000004 110.105 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HG2' HD21 ' A' ' 113' ' ' LEU . 49.2 mtm180 -119.67 140.71 29.83 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.828 -0.624 . . . . 3.0899999999999999 110.127 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' VAL . 24.6 Cg_exo -65.53 178.54 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.231 2.621 . . . . 0.46999999999999997 112.141 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 87' ' ' LEU . 7.0 ptp85 -133.19 136.6 45.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.092 -0.504 . . . . 2.3700000000000001 111.85 -176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.596 ' HG ' ' CD1' ' A' ' 109' ' ' LEU . 4.1 mt -90.92 110.84 22.08 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.027 -0.731 . . . . 1.3200000000000001 109.027 173.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.8 115.63 27.71 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.117 -0.697 . . . . 0.40000000000000002 109.117 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.725 HG23 ' HG2' ' A' ' 85' ' ' LYS . 7.3 m -109.34 118.54 36.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.284 -0.636 . . . . 0.34999999999999998 109.284 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.493 ' HB2' ' HB2' ' A' ' 45' ' ' PRO . 23.1 ptp -128.31 133.13 48.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.294 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HE3' ' HB2' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -113.38 137.99 50.72 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.855 -0.795 . . . . 2.5800000000000001 108.855 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.558 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.9 ttmt -54.6 121.05 7.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.765 -0.652 . . . . 0.92000000000000004 111.179 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.98 -126.05 5.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.708 -0.758 . . . . 1.28 112.892 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.12 -43.05 45.1 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.221 2.614 . . . . 2.23 113.057 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 m -153.67 86.12 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.87 0.367 . . . . 2.8700000000000001 110.591 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.558 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 65.99 -136.12 35.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.893 -0.594 . . . . 1.9299999999999999 112.856 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 40.6 m-85 -124.66 -176.8 3.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.737 -0.838 . . . . 1.8200000000000001 108.737 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.61 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.963 -1.113 . . . . 0.42999999999999999 113.243 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.53 146.59 22.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.832 0.348 . . . . 0.40000000000000002 110.506 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.35 127.35 48.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.424 -0.584 . . . . 2.1800000000000002 109.424 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 35' ' ' GLN . 18.3 tp -101.71 147.84 25.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.258 0.551 . . . . 1.52 111.582 -169.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 1.3 m80 -109.56 121.98 46.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.71 . . . . 1.3400000000000001 110.268 177.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.316 -0.874 0 N-CA-C 107.269 -1.382 . . . . 2.2999999999999998 107.269 169.687 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.52 ' HB3' HD11 ' A' ' 26' ' ' LEU . 26.0 mm-40 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.783 0.325 . . . . 1.5 110.179 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 30.0 m-85 -109.32 157.73 18.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.413 -0.588 . . . . 0.87 109.413 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG13 HD11 ' A' ' 51' ' ' LEU . 38.3 mm -98.83 116.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.113 -0.328 . . . . 0.39000000000000001 110.113 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -76.87 -44.6 31.43 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.004 0.43 . . . . 2.8300000000000001 110.549 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.441 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 26.2 t -164.48 155.07 14.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.508 -0.769 . . . . 1.26 109.291 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.7 130.06 74.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.56 -0.533 . . . . 0.37 109.56 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.99 119.25 56.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.763 -0.458 . . . . 2.2799999999999998 109.763 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.3 140.25 81.87 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.648 2.232 . . . . 1.1699999999999999 112.698 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.585 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 12.3 m-20 65.36 39.31 5.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.31 -0.859 . . . . 2.3999999999999999 111.899 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.612 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 89.6 p -117.95 170.0 6.89 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.737 -0.665 . . . . 0.56999999999999995 109.365 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 6.3 Cg_endo -51.34 -35.0 52.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.107 1.872 . . . . 0.65000000000000002 112.015 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -47.42 62.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 0.35999999999999999 110.937 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 43' ' ' ASP . 5.0 tp10 -62.16 -40.49 96.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.997 0.427 . . . . 2.0099999999999998 110.232 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.68 -24.32 62.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.46999999999999997 111.763 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -75.93 -13.94 60.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.067 0.461 . . . . 0.40000000000000002 110.344 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.47 21.65 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.696 -0.764 . . . . 0.62 112.42 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.506 HD11 HG13 ' A' ' 37' ' ' ILE . 25.9 tp -79.16 132.63 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.65000000000000002 110.277 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 8.0 tpp180 -114.88 156.68 24.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.264 -0.273 . . . . 4.3799999999999999 110.264 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -87.07 30.24 0.78 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 1.4399999999999999 111.734 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.79 17.28 1.12 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.377 0.608 . . . . 3.0600000000000001 109.83 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.615 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.7 m-20 -104.6 159.28 15.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.065 -0.97 . . . . 1.02 110.355 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.549 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.8 tmm_? -128.12 130.9 48.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.2 -0.296 . . . . 1.5700000000000001 110.2 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.51 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.8 mt -75.58 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.68000000000000005 111.237 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.549 HG22 ' NH1' ' A' ' 56' ' ' ARG . 2.3 t -114.76 -46.32 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.758 -0.656 . . . . 0.87 110.299 177.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.6 mt-10 -123.69 148.13 46.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.89000000000000001 110.674 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 63' ' ' VAL . 99.6 t -125.53 119.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 0.66000000000000003 109.371 173.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.23 21.32 10.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 1.1699999999999999 111.45 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.88 9.38 61.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.669 -0.777 . . . . 0.66000000000000003 113.782 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 60' ' ' VAL . 11.2 p -115.31 136.25 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.412 0.606 . . . . 1.1699999999999999 109.816 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 7.2 p -74.69 136.97 41.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.488 -0.778 . . . . 1.6799999999999999 111.557 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.565 ' C ' ' HD2' ' A' ' 68' ' ' LYS . 22.4 mmt -108.36 67.45 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.057 -0.519 . . . . 0.81000000000000005 111.878 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -141.35 131.3 24.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.366 -0.834 . . . . 3.75 109.37 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.38 -0.37 74.65 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.291 -1.123 . . . . 1.47 110.291 -170.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HD3' ' H ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.0 164.4 13.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.356 -0.922 . . . . 3.3599999999999999 111.148 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -96.96 172.15 8.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.343 -0.844 . . . . 2.8900000000000001 109.041 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -62.2 -35.82 80.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.975 0.417 . . . . 1.4199999999999999 109.953 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.49 -33.73 88.04 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.71999999999999997 112.829 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.43 -46.76 81.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 2.0299999999999998 110.551 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 35' ' ' GLN . 46.4 t -62.4 -46.65 95.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.537 . . . . 1.0800000000000001 110.559 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.21 -42.85 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.71999999999999997 111.062 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -67.37 -36.55 81.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.445 -0.343 . . . . 0.66000000000000003 110.747 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.36 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.625 -0.261 . . . . 0.41999999999999998 111.549 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 84' ' ' THR . 77.9 mt -59.62 -45.34 94.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.283 0.563 . . . . 0.68999999999999995 110.345 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -72.66 -28.94 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.541 -0.754 . . . . 3.0899999999999999 110.918 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.53 -14.31 62.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.65000000000000002 111.406 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.61 -19.03 78.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.621 -0.8 . . . . 0.59999999999999998 112.047 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -104.28 3.14 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.714 -0.755 . . . . 1.1000000000000001 112.102 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.566 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 7.1 p-10 -98.0 -5.06 34.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.679 0.251 . . . . 2.1200000000000001 111.679 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -150.47 165.17 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.986 0.422 . . . . 2.1099999999999999 111.176 178.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.466 HG21 HG23 ' A' ' 77' ' ' ILE . 8.7 t -148.83 148.26 29.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.771 -0.65 . . . . 0.32000000000000001 109.688 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.725 ' HG2' HG23 ' A' ' 14' ' ' THR . 23.1 mttm -115.31 118.63 33.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.9 -0.407 . . . . 1.6299999999999999 109.9 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.35 125.87 51.47 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 0.28000000000000003 109.324 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD11 HD21 ' A' ' 109' ' ' LEU . 52.0 tp -102.1 115.17 29.98 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.611 -0.885 . . . . 0.51000000000000001 108.611 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 30.8 m -128.17 168.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.768 -0.651 . . . . 0.33000000000000002 110.207 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 10' ' ' PRO . 28.3 m -127.56 141.76 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.894 -0.594 . . . . 0.41999999999999998 110.352 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.93 172.08 14.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.145 -0.687 . . . . 1.9199999999999999 109.145 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.427 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 19.4 tpt85 -58.13 -46.6 85.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.926 0.394 . . . . 4.1600000000000001 111.152 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -64.88 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 2.6800000000000002 111.593 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 6.5 m -75.36 -43.8 48.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.185 0.517 . . . . 0.46999999999999997 110.536 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.442 ' HB2' HG23 ' A' ' 89' ' ' VAL . 24.4 t70 -59.38 -47.9 83.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 1.1799999999999999 111.618 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.6 -39.67 94.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.726 0.298 . . . . 1.9399999999999999 111.103 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -62.92 -49.32 75.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.72999999999999998 110.759 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.24 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -60.43 -49.22 78.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.489 0.551 . . . . 1.9199999999999999 112.489 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 7.2 ptmm? -68.7 -32.82 72.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.294 0.569 . . . . 2.04 110.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.494 ' HB3' HG23 ' A' ' 102' ' ' VAL . 62.0 m -76.47 -13.99 60.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.657 -0.701 . . . . 1.3899999999999999 111.295 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.5 27.71 15.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.45 -0.795 . . . . 4.0899999999999999 110.657 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 100' ' ' CYS . 59.5 t -102.71 139.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.805 -0.634 . . . . 1.4199999999999999 110.676 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.0 mp -84.82 122.66 74.52 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.005 -0.543 . . . . 1.3300000000000001 109.643 175.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HD2' HG11 ' A' ' 58' ' ' VAL . 3.0 Cg_exo -70.47 141.48 42.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.406 2.071 . . . . 0.53000000000000003 110.891 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -151.44 167.1 29.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.059 -0.256 . . . . 1.4199999999999999 110.787 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.601 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -52.5 -29.66 26.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.398 0.679 . . . . 1.6599999999999999 111.778 176.024 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.26 -30.67 64.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.441 0.639 . . . . 2.8199999999999998 110.902 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.73 -14.31 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.53000000000000003 110.704 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.601 ' CD1' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mt -70.03 114.24 8.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 1.24 110.33 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.479 ' HA ' ' NH1' ' A' ' 9' ' ' ARG . 66.2 t30 57.27 28.05 14.59 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.844 0.83 . . . . 3.7000000000000002 109.965 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.25 -169.05 12.42 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.228 -0.896 . . . . 1.1200000000000001 111.314 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 147.87 27.05 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.536 2.157 . . . . 1.3100000000000001 112.694 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 9' ' ' ARG . 47.6 mt . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.717 -0.674 . . . . 1.1100000000000001 110.161 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.5 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.129 0.49 . . . . 0.80000000000000004 110.772 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -130.54 148.86 71.67 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.758 -0.655 . . . . 3.0899999999999999 109.413 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.8 Cg_endo -70.38 162.98 40.43 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.566 2.177 . . . . 0.46999999999999997 111.419 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.448 ' NH1' HH12 ' A' ' 52' ' ' ARG . 6.4 ptp85 -127.65 136.12 51.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.167 -0.47 . . . . 2.3700000000000001 110.545 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HB2' HD11 ' A' ' 109' ' ' LEU . 46.5 tp -94.26 110.36 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.945 -0.57 . . . . 1.3200000000000001 109.707 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -98.91 116.9 32.2 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.323 -0.621 . . . . 0.40000000000000002 109.323 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 85' ' ' LYS . 45.7 m -111.36 119.3 38.4 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.464 -0.569 . . . . 0.34999999999999998 109.464 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.48 ' HE3' HD12 ' A' ' 86' ' ' LEU . 23.1 ptp -127.96 133.24 49.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.014 -0.539 . . . . 0.88 109.971 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -116.79 156.59 26.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.462 -0.79 . . . . 2.5800000000000001 110.138 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 86.0 mttt -68.55 125.72 27.4 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.264 -1.335 . . . . 0.92000000000000004 111.778 -172.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.86 -107.58 0.73 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.257 -1.338 . . . . 1.28 110.928 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HG2' ' HD3' ' A' ' 45' ' ' PRO . 33.5 Cg_endo -65.78 104.49 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.597 2.198 . . . . 2.23 111.361 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t 63.48 29.99 15.33 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.31 0.576 . . . . 2.8700000000000001 110.545 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.91 -97.09 1.11 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.269 -0.732 . . . . 1.9299999999999999 111.269 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 17.0 m-85 -119.53 -171.17 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.849 -0.797 . . . . 1.8200000000000001 108.849 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.57 78.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.1 -1.048 . . . . 0.42999999999999999 112.791 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -155.56 163.15 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.40000000000000002 110.605 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -128.88 129.22 45.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.939 -0.573 . . . . 2.1800000000000002 110.285 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.34 134.8 47.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.399 -0.364 . . . . 1.52 110.23 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.0 p80 -125.72 135.29 51.92 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.509 -0.476 . . . . 1.3400000000000001 110.734 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.408 -0.815 . . . . 2.2999999999999998 109.533 178.452 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.057 -0.349 . . . . 1.5 110.057 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 88.1 m-85 -109.11 154.94 21.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 0.87 109.18 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 53' ' ' ALA . 41.3 mm -77.84 107.87 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.002 0.429 . . . . 0.39000000000000001 110.153 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 30.7 ttt180 -67.92 -43.47 79.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 2.8300000000000001 109.823 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 p -175.66 140.15 0.44 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.534 -1.212 . . . . 1.26 109.668 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.28 121.37 60.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.0 -0.741 . . . . 0.37 109.0 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -66.05 122.47 81.32 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.669 -0.696 . . . . 2.2799999999999998 109.957 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.18 149.71 78.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.847 2.365 . . . . 1.1699999999999999 111.777 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.96 40.55 2.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 2.3999999999999999 110.905 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 p -130.72 164.44 41.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.61 -0.268 . . . . 0.56999999999999995 110.696 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD3' ' HG2' ' A' ' 19' ' ' PRO . 23.4 Cg_exo -64.23 -27.33 64.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.494 2.129 . . . . 0.65000000000000002 111.47 175.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -46.81 71.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.759 -0.655 . . . . 0.35999999999999999 110.241 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.87 -33.24 75.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.85 -0.614 . . . . 2.0099999999999998 109.971 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.25 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.46999999999999997 111.753 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.2 -13.51 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.40000000000000002 110.556 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.58 50.45 1.83 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.62 112.061 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.2 tp -99.66 149.6 23.13 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.798 -0.445 . . . . 0.65000000000000002 109.798 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 39.0 ttm180 -147.2 143.36 28.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.683 -0.235 . . . . 4.3799999999999999 110.575 -173.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -77.22 14.11 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.074 0.768 . . . . 1.4399999999999999 113.074 -173.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -115.44 -5.49 12.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.208 0.528 . . . . 3.0600000000000001 109.981 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.633 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -91.36 155.06 18.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.152 -0.931 . . . . 1.02 111.273 -172.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -124.85 134.29 52.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 1.5700000000000001 109.719 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 88' ' ' VAL . 41.7 mm -63.97 124.41 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.298 -0.41 . . . . 0.68000000000000005 111.06 -176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.11 -52.01 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.995 -0.548 . . . . 0.87 110.638 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 28.9 mt-10 -133.32 149.37 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.89000000000000001 110.213 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.33 123.4 66.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.78 -0.452 . . . . 0.66000000000000003 109.78 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 60.81 20.84 10.97 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.079 0.552 . . . . 1.1699999999999999 111.153 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.0 1.1 70.52 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.9 -0.667 . . . . 0.66000000000000003 112.217 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.43 120.66 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.16 -0.311 . . . . 1.1699999999999999 110.16 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.572 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -64.46 136.2 56.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 1.6799999999999999 111.492 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.516 ' HG3' HG12 ' A' ' 73' ' ' VAL . 26.6 mmt -121.47 73.64 1.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.777 -0.647 . . . . 0.81000000000000005 109.613 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.78 -57.37 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.22 -0.9 . . . . 3.75 110.667 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.9 13.77 45.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.026 -0.607 . . . . 1.47 111.927 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 30.8 mmtp -86.4 160.26 19.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.856 0.36 . . . . 3.3599999999999999 110.491 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -90.72 173.11 8.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.0 -0.545 . . . . 2.8900000000000001 111.429 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -58.48 -36.43 73.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.219 -0.446 . . . . 1.4199999999999999 110.086 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.1 -38.7 96.56 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.795 -0.717 . . . . 0.71999999999999997 112.415 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 68' ' ' LYS . 4.3 m-20 -62.57 -48.09 80.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.653 0.263 . . . . 2.0299999999999998 111.171 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.516 HG12 ' HG3' ' A' ' 65' ' ' MET . 33.4 m -67.42 -40.35 84.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 1.0800000000000001 111.367 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.44 -45.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.056 0.455 . . . . 0.71999999999999997 110.672 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -36.59 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 0.66000000000000003 110.414 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.47 96.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.655 0.264 . . . . 0.41999999999999998 111.187 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 84' ' ' THR . 85.9 mt -60.21 -45.2 96.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.205 0.526 . . . . 0.68999999999999995 110.274 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.63 -36.04 78.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 3.0899999999999999 110.913 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.65000000000000002 110.993 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.47 79.59 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 0.59999999999999998 111.273 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.28 -123.32 7.67 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.004 -0.617 . . . . 1.1000000000000001 111.659 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 1.3 m-20 -100.22 -4.16 30.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.829 0.347 . . . . 2.1200000000000001 110.46 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 26.0 mt-10 -135.05 140.05 45.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.357 -0.979 . . . . 2.1099999999999999 108.357 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 77' ' ' ILE . 12.6 t -139.66 148.03 41.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.897 0.38 . . . . 0.32000000000000001 110.464 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 14' ' ' THR . 60.2 mttm -116.73 123.97 48.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.265 -0.425 . . . . 1.6299999999999999 110.331 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.48 HD12 ' HE3' ' A' ' 15' ' ' MET . 95.0 mt -110.48 129.78 55.7 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.736 -0.468 . . . . 0.28000000000000003 109.736 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 59' ' ' GLU . 16.9 tp -104.75 119.18 38.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.048 -0.723 . . . . 0.51000000000000001 109.048 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 23.8 m -130.28 165.94 29.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.304 -0.407 . . . . 0.33000000000000002 111.623 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.43 160.09 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.532 -0.758 . . . . 0.41999999999999998 110.508 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' HH12 ' A' ' 11' ' ' ARG . 2.2 m-20 -77.29 175.59 9.58 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.492 0.495 . . . . 1.9199999999999999 110.418 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -61.89 -47.27 85.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 4.1600000000000001 110.767 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.41 -35.78 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 2.6800000000000002 110.093 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -65.89 -41.51 91.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 0.46999999999999997 110.797 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 20.4 t70 -58.66 -48.54 80.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 1.1799999999999999 110.194 176.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -62.17 -38.46 89.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 1.9399999999999999 111.108 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 77.7 t80 -63.74 -49.19 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.42 -0.354 . . . . 0.72999999999999998 111.283 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 19.6 m-85 -66.17 -38.27 87.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.476 -0.329 . . . . 0.44 111.212 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 31.3 mtpt -66.72 -43.53 84.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.455 -0.338 . . . . 1.9199999999999999 111.557 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 96' ' ' PHE . 52.0 pttt -71.75 -14.65 62.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 2.04 110.66 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 54.5 m -94.47 -6.22 44.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.227 0.537 . . . . 1.3899999999999999 110.566 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.576 ' HD2' ' N ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER 57.96 35.33 25.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.112 -0.949 . . . . 4.0899999999999999 111.454 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.24 147.33 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.796 -0.638 . . . . 1.4199999999999999 109.806 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.564 HG21 ' SG ' ' A' ' 64' ' ' CYS . 32.1 mm -87.99 132.19 40.73 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.324 -0.398 . . . . 1.3300000000000001 111.26 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.486 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 18.7 Cg_exo -65.35 137.4 51.11 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.557 2.171 . . . . 0.53000000000000003 110.462 173.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.4 p -153.04 174.25 14.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.774 -0.37 . . . . 1.4199999999999999 111.564 -172.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.444 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 98.3 mt-30 -59.49 -28.36 66.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 1.6599999999999999 110.298 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.89 -41.34 77.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.616 -0.72 . . . . 2.8199999999999998 110.429 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -78.95 -14.09 59.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.518 -0.764 . . . . 0.53000000000000003 111.398 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.6 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.825 0.345 . . . . 1.24 110.92 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -118.09 -37.64 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 3.7000000000000002 111.03 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.27 -166.44 36.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.164 -0.541 . . . . 1.1200000000000001 113.507 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.9 136.77 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.536 2.824 . . . . 1.3100000000000001 112.636 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.496 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 1.1100000000000001 109.909 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 121.305 0.574 . . . . 0.80000000000000004 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 14.1 ptt180 -126.74 160.2 60.0 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.616 -0.72 . . . . 3.0899999999999999 109.285 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.7 Cg_endo -65.79 178.6 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.446 2.097 . . . . 0.46999999999999997 111.984 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.539 ' HD3' HG23 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -137.31 132.5 33.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.108 -0.33 . . . . 2.3700000000000001 110.108 175.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HG ' HD11 ' A' ' 109' ' ' LEU . 3.7 mt -92.82 109.9 21.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.08 -0.509 . . . . 1.3200000000000001 109.843 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 17.9 m -91.19 116.64 28.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.966 -0.753 . . . . 0.40000000000000002 108.966 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 116.7 33.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.517 -0.92 . . . . 0.34999999999999998 108.517 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.9 ptp -140.21 134.13 30.7 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.148 -0.478 . . . . 0.88 110.195 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 17.9 pttp -110.9 156.28 21.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.266 0.555 . . . . 2.5800000000000001 110.583 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.574 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.8 ttmt -59.11 111.85 1.48 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.85 -1.068 . . . . 0.92000000000000004 112.163 -171.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 19' ' ' PRO . . . -110.53 -107.16 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.414 -0.812 . . . . 1.28 111.256 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 18' ' ' GLY . 27.7 Cg_exo -62.33 95.33 0.14 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.088 2.525 . . . . 2.23 112.126 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.0 t 72.53 -52.17 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.461 0.705 . . . . 2.8700000000000001 112.139 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.574 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -179.69 78.25 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 1.9299999999999999 111.885 -175.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 71.04 -63.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.342 0.657 . . . . 1.8200000000000001 110.913 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.12 69.31 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.158 -0.544 . . . . 0.42999999999999999 112.982 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.43 150.99 25.69 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.783 0.325 . . . . 0.40000000000000002 110.192 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 45.1 t-20 -102.26 129.33 48.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.894 0.378 . . . . 2.1800000000000002 109.982 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 35' ' ' GLN . 1.7 tm? -100.84 129.33 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.168 -0.679 . . . . 1.52 109.168 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.467 ' CD2' ' HG2' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -153.18 167.04 30.63 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.852 1.797 . . . . 1.3400000000000001 115.852 -167.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.643 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 70.5 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 113.209 -1.814 . . . . 2.2999999999999998 112.487 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.695 ' HB3' HD11 ' A' ' 26' ' ' LEU . 16.4 mm-40 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.523 -0.547 . . . . 1.5 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.643 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 50.3 m-85 -117.53 144.48 45.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.197 -1.001 . . . . 0.87 110.104 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.5 HG13 HD11 ' A' ' 51' ' ' LEU . 45.0 mm -81.56 115.3 23.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.541 -0.54 . . . . 0.39000000000000001 109.541 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 2.1 tmm_? -77.25 -49.31 15.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.234 -0.654 . . . . 2.8300000000000001 109.234 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.2 p -159.68 150.47 19.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.057 -0.974 . . . . 1.26 109.824 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.11 122.03 63.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.065 -0.717 . . . . 0.37 109.065 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.8 m-20 -67.42 133.02 93.02 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.589 . . . . 2.2799999999999998 110.436 -174.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 35.5 Cg_exo -59.71 145.2 98.78 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.672 2.248 . . . . 1.1699999999999999 112.033 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 34.4 m-20 74.54 15.59 3.34 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.997 0.81 . . . . 2.3999999999999999 111.657 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.5 p -95.09 155.22 39.23 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.752 0.31 . . . . 0.56999999999999995 110.238 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.68 -27.5 81.27 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.772 2.315 . . . . 0.65000000000000002 111.182 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -65.24 -48.81 71.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.732 -0.667 . . . . 0.35999999999999999 110.114 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 2.0099999999999998 110.272 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.42 69.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.46999999999999997 111.784 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 74.6 p -73.68 -12.15 60.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.40000000000000002 110.875 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.34 51.06 1.36 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.62 112.441 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.5 HD11 HG13 ' A' ' 37' ' ' ILE . 23.1 tp -100.83 142.62 32.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.0 0.429 . . . . 0.65000000000000002 110.759 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.515 ' HG2' ' H ' ' A' ' 54' ' ' GLN . 32.4 ttm180 -121.63 144.23 48.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 4.3799999999999999 109.805 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.71 26.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 1.4399999999999999 111.5 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -139.95 19.75 2.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.641 . . . . 3.0600000000000001 109.271 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -104.27 157.85 16.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.341 -0.845 . . . . 1.02 111.305 -176.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -115.89 133.08 56.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.604 -0.725 . . . . 1.5700000000000001 109.874 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' HA ' HG12 ' A' ' 88' ' ' VAL . 65.5 mt -76.63 124.43 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.296 -0.411 . . . . 0.68000000000000005 110.465 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -106.65 -46.0 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.87 110.523 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 43.1 mt-10 -127.07 146.23 50.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.89000000000000001 110.465 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 63' ' ' VAL . 85.9 t -131.48 118.93 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.22 -0.446 . . . . 0.66000000000000003 109.841 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 57.23 27.43 13.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.377 -0.374 . . . . 1.1699999999999999 111.582 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.5 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.6 6.75 63.81 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.66000000000000003 114.219 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 60' ' ' VAL . 12.1 p -115.41 135.07 56.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.784 0.792 . . . . 1.1699999999999999 110.092 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.426 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.1 t -80.74 136.63 36.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.508 -0.769 . . . . 1.6799999999999999 111.225 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.486 ' SD ' HG22 ' A' ' 73' ' ' VAL . 23.1 mmt -106.94 53.3 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.81000000000000005 110.479 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.09 -56.77 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 3.75 110.309 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.72 1.47 39.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 1.47 111.794 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.2 146.6 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.178 0.513 . . . . 3.3599999999999999 110.875 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -98.97 -179.46 4.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.661 -0.699 . . . . 2.8900000000000001 110.644 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -55.57 -43.87 76.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.401 . . . . 1.4199999999999999 110.773 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -37.85 95.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.734 -0.746 . . . . 0.71999999999999997 112.21 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.44 -47.51 75.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.987 0.422 . . . . 2.0299999999999998 110.876 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.486 HG22 ' SD ' ' A' ' 65' ' ' MET . 25.2 t -70.23 -47.14 68.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 1.0800000000000001 110.983 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.83 -36.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 0.71999999999999997 110.636 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -65.31 -47.0 78.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.187 -0.46 . . . . 0.66000000000000003 110.093 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.59 93.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.218 -0.446 . . . . 0.41999999999999998 111.651 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.423 HG23 HG21 ' A' ' 84' ' ' THR . 70.3 mt -58.94 -43.26 88.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.288 0.566 . . . . 0.68999999999999995 110.605 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -74.42 -30.08 61.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.516 -0.765 . . . . 3.0899999999999999 111.342 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.15 9.94 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.65000000000000002 111.727 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.1 -0.8 86.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.59999999999999998 111.798 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.37 -101.5 2.49 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.129 -0.788 . . . . 1.1000000000000001 111.129 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.497 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 6.0 t70 -128.86 -15.96 4.24 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.988 -0.285 . . . . 2.1200000000000001 110.664 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.2 mt-10 -119.3 144.34 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 2.1099999999999999 108.481 174.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 77' ' ' ILE . 13.3 t -135.34 148.82 49.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.094 0.473 . . . . 0.32000000000000001 110.395 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HB3' HD22 ' A' ' 12' ' ' LEU . 97.8 mttt -111.67 117.46 32.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 1.6299999999999999 109.856 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.8 mt -106.68 129.98 54.49 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.16 -0.473 . . . . 0.28000000000000003 109.797 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 10' ' ' PRO . 41.5 tp -104.8 115.31 30.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.284 -0.636 . . . . 0.51000000000000001 109.284 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.0 m -127.48 160.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.107 -0.497 . . . . 0.33000000000000002 110.861 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.88 138.77 53.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 0.41999999999999998 110.644 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.22 166.38 23.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.605 . . . . 1.9199999999999999 110.078 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 44.8 ttt180 -56.2 -48.01 77.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 4.1600000000000001 110.259 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.62 -33.69 76.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 2.6800000000000002 110.372 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.4 m -70.63 -51.8 25.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.302 -0.863 . . . . 0.46999999999999997 111.122 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.87 -30.72 68.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 1.1799999999999999 111.393 -172.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 26.4 mm-40 -62.02 -35.27 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.005 0.431 . . . . 1.9399999999999999 110.126 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -67.83 -45.7 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.72999999999999998 109.926 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -62.54 -36.91 84.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.44 111.498 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -59.66 -49.65 76.93 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.54 0.21 . . . . 1.9199999999999999 111.257 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ptmt -71.89 -26.48 62.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.419 -0.355 . . . . 2.04 111.048 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 m -81.19 -8.4 59.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.273 -0.421 . . . . 1.3899999999999999 111.242 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 58.53 39.63 24.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.338 -0.846 . . . . 4.0899999999999999 111.046 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.87 145.25 34.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 1.4199999999999999 110.924 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 63.9 mt -80.51 131.75 60.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 1.3300000000000001 110.572 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 22.4 Cg_exo -63.7 136.65 54.8 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.472 2.115 . . . . 0.53000000000000003 110.619 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 48.9 m -157.57 163.66 38.11 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.124 -0.23 . . . . 1.4199999999999999 110.677 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.5 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 50.8 mt-30 -56.89 -28.78 62.32 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.7 0.625 . . . . 1.6599999999999999 111.983 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.3 pt-20 -57.99 -29.97 65.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.114 0.483 . . . . 2.8199999999999998 111.061 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -82.97 -13.68 55.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.884 -0.598 . . . . 0.53000000000000003 110.98 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.501 HD11 HD13 ' A' ' 87' ' ' LEU . 66.8 mt -73.73 -53.77 9.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 1.24 110.087 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.51 48.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.454 -0.794 . . . . 3.7000000000000002 110.258 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.53 38.36 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.755 -0.736 . . . . 1.1200000000000001 111.959 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.94 174.54 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.048 2.499 . . . . 1.3100000000000001 112.783 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 9' ' ' ARG . 48.1 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.586 -0.734 . . . . 1.1100000000000001 109.737 175.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.997 0.904 . . . . 0.80000000000000004 109.038 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 110' ' ' ASN . 74.1 mtt180 -117.7 146.49 38.86 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.43 -1.259 . . . . 3.0899999999999999 109.481 -173.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 87' ' ' LEU . 48.0 Cg_endo -66.93 159.25 52.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.378 2.052 . . . . 0.46999999999999997 110.996 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HG3' HG23 ' A' ' 88' ' ' VAL . 6.3 ptp85 -114.92 129.55 56.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.209 -0.45 . . . . 2.3700000000000001 110.304 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.451 -0.574 . . . . 1.3200000000000001 109.451 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 21.4 m -93.85 116.18 28.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.535 -0.543 . . . . 0.40000000000000002 109.535 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 85' ' ' LYS . 25.5 m -108.57 116.95 32.94 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.661 -0.866 . . . . 0.34999999999999998 108.661 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.419 ' HE3' HD12 ' A' ' 86' ' ' LEU . 25.3 ptp -133.55 134.01 42.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.142 0.496 . . . . 0.88 111.201 -172.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -107.07 141.42 38.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.246 -0.888 . . . . 2.5800000000000001 109.997 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 39.0 mttm -59.79 107.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.695 -0.684 . . . . 0.92000000000000004 111.427 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 19' ' ' PRO . . . -104.41 -119.64 4.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.922 -1.036 . . . . 1.28 112.366 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 18' ' ' GLY . 43.1 Cg_exo -57.52 -58.01 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.079 2.519 . . . . 2.23 113.066 -176.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -121.37 36.4 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 2.8700000000000001 111.425 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 55.63 84.4 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.249 -0.501 . . . . 1.9299999999999999 112.736 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 8.7 m-85 67.32 -149.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.801 -0.444 . . . . 1.8200000000000001 109.801 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.91 73.34 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.391 -0.909 . . . . 0.42999999999999999 112.516 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -152.77 158.91 42.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.40000000000000002 110.539 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -113.91 133.4 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 2.1800000000000002 109.561 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 35' ' ' GLN . 3.1 tm? -109.23 129.38 55.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.024 -0.362 . . . . 1.52 110.024 -176.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.811 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.91 140.13 53.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.123 0.487 . . . . 1.3400000000000001 110.292 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.972 -0.558 . . . . 2.2999999999999998 110.066 -178.209 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.435 ' HB3' HD21 ' A' ' 26' ' ' LEU . 2.6 mp0 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.805 -0.443 . . . . 1.5 109.805 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.636 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 56.0 m-85 -122.08 142.31 50.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.926 -0.398 . . . . 0.87 109.926 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.534 HG13 HD11 ' A' ' 51' ' ' LEU . 43.7 mm -72.29 109.41 4.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.199 0.523 . . . . 0.39000000000000001 110.029 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.811 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.1 tpt180 -66.81 -42.88 85.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.256 -0.883 . . . . 2.8300000000000001 110.233 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -170.51 158.23 6.28 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.489 -0.778 . . . . 1.26 109.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.05 134.4 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.076 -0.713 . . . . 0.37 109.076 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.44 125.02 91.51 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.104 -0.498 . . . . 2.2799999999999998 109.932 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 Cg_endo -61.38 134.82 53.92 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.756 2.304 . . . . 1.1699999999999999 112.771 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.4 m-20 73.16 20.23 3.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.442 -0.799 . . . . 2.3999999999999999 112.194 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 97.2 p -97.48 160.4 28.86 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.873 -0.417 . . . . 0.56999999999999995 109.873 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 19.6 Cg_endo -60.06 -24.25 76.04 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.336 2.024 . . . . 0.65000000000000002 111.999 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.91 -40.97 75.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.35999999999999999 110.35 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -69.89 -39.38 76.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.201 -0.454 . . . . 2.0099999999999998 110.249 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.46999999999999997 111.79 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.5 p -75.45 -12.89 60.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.40000000000000002 110.529 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.83 -1.0 30.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.686 . . . . 0.62 112.29 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 37' ' ' ILE . 30.9 tp -74.82 131.15 40.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.891 0.377 . . . . 0.65000000000000002 110.466 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -132.77 -172.58 2.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.002 -0.544 . . . . 4.3799999999999999 110.271 177.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.36 154.46 19.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.515 -0.311 . . . . 1.4399999999999999 111.342 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 69.6 18.82 7.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.694 -0.685 . . . . 3.0600000000000001 111.235 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -90.57 150.21 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 1.02 109.784 175.135 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -120.53 129.1 53.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.534 -0.543 . . . . 1.5700000000000001 109.534 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' HG12 ' A' ' 88' ' ' VAL . 54.9 mt -76.26 136.67 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.68000000000000005 111.406 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.511 HG22 ' NH1' ' A' ' 56' ' ' ARG . 3.4 t -115.1 -50.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.481 -0.782 . . . . 0.87 110.098 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 31.2 mt-10 -128.88 149.07 50.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.939 -0.573 . . . . 0.89000000000000001 110.48 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -130.35 120.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.66000000000000003 110.004 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 60.35 27.61 17.19 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.949 0.5 . . . . 1.1699999999999999 111.447 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.01 82.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.66000000000000003 112.32 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.86 121.62 55.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.13 -0.322 . . . . 1.1699999999999999 110.13 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -70.23 135.27 48.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.421 . . . . 1.6799999999999999 110.813 -178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.754 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 23.8 mmt -112.67 64.39 0.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.596 0.712 . . . . 0.81000000000000005 110.333 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -93.44 99.19 11.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.01 -0.995 . . . . 3.75 110.875 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 4.33 81.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 1.47 112.474 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.754 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.5 mmtp -58.77 156.61 10.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.621 0.724 . . . . 3.3599999999999999 112.819 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -80.93 162.39 23.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.483 -1.235 . . . . 2.8900000000000001 109.969 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -59.16 -38.9 80.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.924 0.392 . . . . 1.4199999999999999 110.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.42 -41.2 91.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.751 -0.738 . . . . 0.71999999999999997 113.099 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.51 -41.08 89.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.718 0.259 . . . . 2.0299999999999998 111.215 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.1 m -69.41 -41.89 80.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 1.0800000000000001 111.383 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.53 -38.09 78.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.973 0.416 . . . . 0.71999999999999997 110.344 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -66.33 -35.85 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.66000000000000003 110.51 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.49 98.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.41999999999999998 111.567 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 HD21 ' A' ' 86' ' ' LEU . 62.9 mt -59.06 -42.26 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.295 0.569 . . . . 0.68999999999999995 110.628 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -74.14 -30.28 62.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.682 -0.69 . . . . 3.0899999999999999 110.706 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 -8.91 57.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.868 -0.605 . . . . 0.65000000000000002 111.446 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.09 -30.85 78.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.76 -0.734 . . . . 0.59999999999999998 111.683 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.65 -101.04 1.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.071 -0.585 . . . . 1.1000000000000001 112.132 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.64 -18.06 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.998 0.428 . . . . 2.1200000000000001 110.083 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.61 44.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.429 -0.582 . . . . 2.1099999999999999 109.429 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.438 HG21 HG23 ' A' ' 77' ' ' ILE . 15.1 t -140.32 149.37 42.67 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.262 -0.426 . . . . 0.32000000000000001 110.142 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.9 mttp -116.26 116.89 28.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.185 -0.461 . . . . 1.6299999999999999 109.989 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 77' ' ' ILE . 87.1 mt -108.3 126.87 53.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.105 -0.498 . . . . 0.28000000000000003 109.995 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 10' ' ' PRO . 31.0 tp -103.25 115.71 31.09 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.093 -0.706 . . . . 0.51000000000000001 109.093 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.4 m -127.39 164.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.767 -0.651 . . . . 0.33000000000000002 110.089 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -127.74 142.06 44.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.086 -0.507 . . . . 0.41999999999999998 111.14 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.21 168.74 17.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.23 -0.895 . . . . 1.9199999999999999 109.48 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 91' ' ' ARG . 6.5 ttp180 -56.58 -47.55 79.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.268 0.556 . . . . 4.1600000000000001 110.155 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.09 -35.92 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.438 -0.801 . . . . 2.6800000000000002 110.981 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 m -72.16 -49.95 31.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.46999999999999997 111.497 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.63 -46.75 88.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.109 0.48 . . . . 1.1799999999999999 110.301 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -63.01 -34.63 77.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.913 -0.585 . . . . 1.9399999999999999 111.269 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.81 -47.37 78.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.72999999999999998 110.438 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HD2' HG13 ' A' ' 102' ' ' VAL . 43.1 m-85 -65.1 -35.9 82.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.1 -0.5 . . . . 0.44 111.393 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -57.9 -49.1 77.88 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.505 0.187 . . . . 1.9199999999999999 111.505 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -71.01 -22.17 62.19 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.202 0.525 . . . . 2.04 110.812 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.9 m -84.81 -14.45 48.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.018 -0.537 . . . . 1.3899999999999999 110.817 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 57.63 33.97 23.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.418 -0.81 . . . . 4.0899999999999999 111.372 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.431 HG13 ' HD2' ' A' ' 97' ' ' PHE . 11.4 p -128.49 146.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.017 -0.538 . . . . 1.4199999999999999 109.953 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.2 mt -87.23 132.06 42.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 1.3300000000000001 111.322 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.04 143.37 84.56 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.783 2.322 . . . . 0.53000000000000003 110.942 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -156.01 163.04 40.2 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.82 -0.352 . . . . 1.4199999999999999 110.481 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.45 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 22.7 mt-30 -55.66 -29.01 58.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.679 0.612 . . . . 1.6599999999999999 110.904 174.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.54 -29.76 66.58 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.939 -0.573 . . . . 2.8199999999999998 111.839 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -87.24 -13.88 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.361 -0.381 . . . . 0.53000000000000003 111.798 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 73.2 mt -58.3 106.74 0.41 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.48 -0.327 . . . . 1.24 110.932 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.48 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 83.6 m-20 59.61 18.25 6.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.153 -0.476 . . . . 3.7000000000000002 111.638 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.2 179.3 23.01 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.445 -0.662 . . . . 1.1200000000000001 111.445 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.5 131.9 29.43 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.423 2.082 . . . . 1.3100000000000001 111.886 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 C--N 1.323 -0.551 0 N-CA-C 109.728 -0.471 . . . . 1.1100000000000001 109.728 175.754 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.348 0.594 . . . . 0.80000000000000004 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -112.45 145.98 34.02 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 3.0899999999999999 109.26 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HB2' HD11 ' A' ' 87' ' ' LEU . 32.8 Cg_endo -65.06 160.28 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.21 1.94 . . . . 0.46999999999999997 111.552 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -107.23 130.33 54.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.599 -0.728 . . . . 2.3700000000000001 109.904 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.6 tp -106.23 109.4 21.32 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.536 -0.542 . . . . 1.3200000000000001 109.536 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.2 m -96.26 117.5 30.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.743 -0.662 . . . . 0.40000000000000002 109.841 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -111.06 116.87 31.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.407 -0.961 . . . . 0.34999999999999998 108.407 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.652 ' HE3' HD12 ' A' ' 86' ' ' LEU . 22.8 ptp -132.88 133.54 43.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.942 0.401 . . . . 0.88 110.652 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.972 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 6.8 ttmt -108.78 137.38 46.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.233 0.54 . . . . 2.5800000000000001 110.459 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.645 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.5 ttmt -54.88 125.65 21.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.407 -1.27 . . . . 0.92000000000000004 112.045 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.91 -153.0 28.68 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.792 -0.64 . . . . 1.28 111.637 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.21 -33.99 58.26 Favored 'Trans proline' 0 CA--C 1.527 0.159 0 C-N-CA 122.912 2.408 . . . . 2.23 112.663 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.9 m -119.49 38.23 3.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.129 0.49 . . . . 2.8700000000000001 110.868 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.645 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.34 -108.91 2.85 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.325 -0.941 . . . . 1.9299999999999999 111.869 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 73.0 m-85 -130.82 -155.0 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.835 -0.802 . . . . 1.8200000000000001 108.835 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.86 73.35 0.22 Allowed Glycine 0 C--O 1.228 -0.265 0 C-N-CA 119.639 -1.267 . . . . 0.42999999999999999 113.467 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -157.28 152.01 25.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.849 0.325 . . . . 0.40000000000000002 110.701 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 3.0 t-20 -112.03 145.42 39.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.462 -0.569 . . . . 2.1800000000000002 109.462 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.36 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.375 0.607 . . . . 1.52 112.579 -172.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.429 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -107.82 121.5 44.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 1.3400000000000001 110.022 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.32 -0.702 0 N-CA-C 108.792 -0.818 . . . . 2.2999999999999998 108.792 172.782 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.026 0.441 . . . . 1.5 110.315 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 56' ' ' ARG . 51.6 m-85 -106.55 158.22 17.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 0.87 109.129 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.802 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.8 mm -80.35 110.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.973 -0.751 . . . . 0.39000000000000001 108.973 175.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 79.7 ttt180 -67.48 -46.72 72.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.431 0.634 . . . . 2.8300000000000001 109.905 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.9 p -167.59 131.64 1.79 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.932 -1.031 . . . . 1.26 108.881 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -95.01 127.99 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.314 -0.624 . . . . 0.37 109.314 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.2 115.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.275 -0.639 . . . . 2.2799999999999998 109.275 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.72 147.53 94.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.591 2.194 . . . . 1.1699999999999999 111.689 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 63.95 52.87 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.895 0.855 . . . . 2.3999999999999999 110.031 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.616 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -142.95 167.9 14.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.56999999999999995 110.113 176.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.3 Cg_endo -54.19 -36.04 84.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.65000000000000002 111.862 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.486 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -67.42 -48.52 67.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.35999999999999999 110.757 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.53 -38.54 90.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.254 -0.43 . . . . 2.0099999999999998 110.152 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.78 79.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.46999999999999997 111.589 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.8 p -72.8 -14.73 61.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.07 0.462 . . . . 0.40000000000000002 110.933 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.92 38.46 4.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.096 -0.573 . . . . 0.62 113.047 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.802 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -84.25 113.9 21.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 0.65000000000000002 109.839 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD2' ' OD1' ' A' ' 55' ' ' ASP . 40.7 ttm105 -94.0 137.95 32.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.74 0.305 . . . . 4.3799999999999999 110.579 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -82.34 35.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.509 0.559 . . . . 1.4399999999999999 112.509 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -143.65 -0.98 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 3.0600000000000001 110.341 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.589 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 29.4 m-20 -98.04 153.78 18.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.184 -0.462 . . . . 1.02 110.957 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 26.5 ttm105 -99.68 133.86 43.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 1.5700000000000001 110.704 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.5 mt -73.42 122.72 26.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.1 -0.704 . . . . 0.68000000000000005 109.1 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.4 t -105.69 -46.5 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.0 -0.545 . . . . 0.87 110.431 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.0 mt-10 -128.47 142.44 51.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.329 -0.396 . . . . 0.89000000000000001 110.627 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.95 118.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 0.66000000000000003 109.417 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 62.79 19.34 11.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.381 0.426 . . . . 1.1699999999999999 110.781 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.29 4.55 66.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.837 -0.697 . . . . 0.66000000000000003 112.425 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.26 115.52 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.037 -0.357 . . . . 1.1699999999999999 110.037 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 49.8 t -74.79 130.16 38.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.26 0.552 . . . . 1.6799999999999999 110.526 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.508 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.4 mmt -97.3 51.14 1.09 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.599 0.714 . . . . 0.81000000000000005 111.079 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.2 105.67 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.103 -0.953 . . . . 3.75 110.355 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.94 -2.49 87.72 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 1.47 112.712 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.1 mmtp -66.53 160.68 24.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.238 0.542 . . . . 3.3599999999999999 111.353 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.1 175.51 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.506 -0.77 . . . . 2.8900000000000001 110.281 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 8.1 t60 -53.77 -43.4 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.444 0.465 . . . . 1.4199999999999999 111.516 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.76 -41.84 88.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.71999999999999997 113.178 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.95 -40.26 97.12 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.964 0.411 . . . . 2.0299999999999998 110.655 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 77' ' ' ILE . 48.9 t -70.4 -47.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.898 -0.592 . . . . 1.0800000000000001 110.788 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' HA ' HD12 ' A' ' 77' ' ' ILE . 89.9 t -68.29 -40.69 82.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.71999999999999997 111.369 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -61.49 -38.93 89.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 0.66000000000000003 110.397 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.9 92.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.497 -0.32 . . . . 0.41999999999999998 111.138 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.527 HG23 HG21 ' A' ' 84' ' ' THR . 66.9 mt -58.76 -45.6 91.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.509 0.671 . . . . 0.68999999999999995 110.162 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.54 -25.42 59.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.257 -0.883 . . . . 3.0899999999999999 111.306 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.16 3.75 41.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.147 -0.479 . . . . 0.65000000000000002 111.187 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.87 9.06 54.61 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.985 -0.626 . . . . 0.59999999999999998 112.315 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.49 -120.13 5.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.772 -0.727 . . . . 1.1000000000000001 111.517 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.564 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 9.3 t70 -107.49 -31.58 8.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 2.1200000000000001 110.275 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.972 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -121.13 139.66 53.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.242 -0.435 . . . . 2.1099999999999999 110.273 175.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.527 HG21 HG23 ' A' ' 77' ' ' ILE . 9.1 t -130.66 150.06 52.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.805 -0.634 . . . . 0.32000000000000001 111.19 -170.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -108.57 118.53 37.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.586 -0.734 . . . . 1.6299999999999999 110.793 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.652 HD12 ' HE3' ' A' ' 15' ' ' MET . 80.2 mt -109.9 131.22 55.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.05 -0.523 . . . . 0.28000000000000003 109.845 176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.9 tp -104.19 119.6 39.31 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.604 -0.517 . . . . 0.51000000000000001 109.604 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.3 m -126.64 153.33 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.173 0.511 . . . . 0.33000000000000002 111.621 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.44 134.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.759 -0.655 . . . . 0.41999999999999998 110.288 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.16 171.45 14.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.713 -0.477 . . . . 1.9199999999999999 109.713 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 91' ' ' ARG . 34.2 ttm180 -52.44 -47.9 66.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.296 0.373 . . . . 4.1600000000000001 111.615 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.08 -42.32 76.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 2.6800000000000002 110.622 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.5 m -64.92 -46.59 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.762 -0.653 . . . . 0.46999999999999997 111.086 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.66 -47.27 84.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 1.1799999999999999 110.976 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 10.2 mm-40 -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.543 -0.299 . . . . 1.9399999999999999 110.478 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.805 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 87.8 t80 -63.28 -48.33 78.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.72999999999999998 110.497 176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 104' ' ' PRO . 34.2 m-85 -66.27 -38.14 87.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.831 0.348 . . . . 0.44 111.47 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -61.91 -48.53 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 1.9199999999999999 111.618 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.805 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.5 pttt -70.76 -15.56 62.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 2.04 111.445 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.49 ' HB3' HG12 ' A' ' 102' ' ' VAL . 42.4 t -93.19 -7.83 44.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 1.3899999999999999 110.196 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 59.35 29.45 19.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.281 -0.872 . . . . 4.0899999999999999 111.21 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 100' ' ' CYS . 12.2 p -115.58 152.41 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 1.4199999999999999 109.901 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.34 130.97 41.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.858 0.361 . . . . 1.3300000000000001 110.983 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 47.3 Cg_endo -71.99 135.42 25.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.423 2.082 . . . . 0.53000000000000003 111.244 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.0 t -158.43 173.92 15.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.295 -0.261 . . . . 1.4199999999999999 110.295 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.474 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 43.8 mt-30 -55.89 -30.57 61.78 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.322 0.389 . . . . 1.6599999999999999 111.636 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.79 -29.49 68.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 2.8199999999999998 110.929 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -86.04 -13.67 46.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.892 -0.594 . . . . 0.53000000000000003 111.561 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 86.7 mt -56.66 -73.59 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.885 0.374 . . . . 1.24 111.35 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -101.21 16.83 24.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.249 0.547 . . . . 3.7000000000000002 110.044 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.51 -175.36 23.25 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.454 -0.793 . . . . 1.1200000000000001 111.58 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.53 147.94 9.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 1.3100000000000001 112.466 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.009 -0.542 . . . . 1.1100000000000001 110.072 176.035 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 121.391 0.615 . . . . 0.80000000000000004 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -122.0 146.02 45.24 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.617 -0.72 . . . . 3.0899999999999999 109.801 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HB2' HD11 ' A' ' 87' ' ' LEU . 39.9 Cg_endo -68.32 173.57 9.44 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.488 2.125 . . . . 0.46999999999999997 111.696 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.426 HH22 ' HB3' ' A' ' 52' ' ' ARG . 24.3 ptt-85 -134.3 132.51 39.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.356 . . . . 2.3700000000000001 110.372 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -95.32 113.22 24.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.928 -0.578 . . . . 1.3200000000000001 109.879 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.6 m -96.79 118.86 34.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.981 -0.554 . . . . 0.40000000000000002 109.902 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.851 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.2 m -109.73 117.51 34.09 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.126 -0.694 . . . . 0.34999999999999998 109.126 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.0 ptp -128.89 133.7 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.88 111.259 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -107.67 143.6 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.238 -0.892 . . . . 2.5800000000000001 110.018 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.432 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 77.0 mttt -56.8 126.23 26.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.373 -0.831 . . . . 0.92000000000000004 111.25 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -124.3 1.62 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.451 -1.249 . . . . 1.28 111.011 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.18 -48.32 1.84 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.662 2.241 . . . . 2.23 112.365 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -118.86 -34.19 4.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 2.8700000000000001 111.491 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -174.61 -143.51 4.47 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.796 -0.716 . . . . 1.9299999999999999 112.227 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.672 ' O ' ' HB2' ' A' ' 44' ' ' SER . 32.7 m-85 -99.24 -44.35 6.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.649 0.261 . . . . 1.8200000000000001 110.894 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.68 69.25 0.9 Allowed Glycine 0 C--O 1.227 -0.292 0 C-N-CA 121.105 -0.569 . . . . 0.42999999999999999 113.213 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -156.89 153.75 28.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.432 -0.581 . . . . 0.40000000000000002 109.432 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -101.96 126.31 48.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.478 -0.564 . . . . 2.1800000000000002 109.478 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.511 HD11 ' HG3' ' A' ' 35' ' ' GLN . 2.0 tm? -99.22 123.28 43.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.441 -0.577 . . . . 1.52 109.441 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.684 ' CB ' ' HB2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -126.92 122.52 34.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.524 -0.762 . . . . 1.3400000000000001 111.256 -171.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.65 -0.704 . . . . 2.2999999999999998 110.266 179.491 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HG3' HD11 ' A' ' 26' ' ' LEU . 1.6 mp0 . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 1.5 109.555 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.31 147.66 37.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.87 110.204 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.95 106.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.091 -0.707 . . . . 0.39000000000000001 109.091 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.684 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 4.3 tmt_? -66.11 -42.39 89.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.941 -0.762 . . . . 2.8300000000000001 108.941 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 p -174.48 154.87 2.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.736 -1.12 . . . . 1.26 109.56 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -109.93 127.41 66.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.664 -0.495 . . . . 0.37 109.664 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -65.18 128.36 93.71 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.045 -0.525 . . . . 2.2799999999999998 109.973 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.51 144.9 98.22 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.477 2.118 . . . . 1.1699999999999999 112.251 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.15 54.49 1.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.466 -0.788 . . . . 2.3999999999999999 109.628 -177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.9 p -131.79 150.8 77.24 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.454 -0.794 . . . . 0.56999999999999995 111.086 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.5 Cg_endo -62.31 -24.14 75.7 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.65000000000000002 111.629 172.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.87 77.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.146 0.498 . . . . 0.35999999999999999 109.904 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.63 -32.0 73.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 2.0099999999999998 110.08 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.32 -32.01 68.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.009 -0.541 . . . . 0.46999999999999997 111.686 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.2 p -72.65 -13.23 61.32 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.037 0.446 . . . . 0.40000000000000002 110.697 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.07 26.44 6.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.741 -0.742 . . . . 0.62 112.709 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 tp -77.41 158.3 30.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.051 -0.351 . . . . 0.65000000000000002 110.051 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 39.5 ttm180 -158.04 160.92 37.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.811 -0.811 . . . . 4.3799999999999999 108.811 -173.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -83.45 152.41 24.99 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.129 -0.228 . . . . 1.4399999999999999 110.88 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 77.4 mt-30 80.92 1.2 1.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.114 0.884 . . . . 3.0600000000000001 112.175 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.63 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 33.2 m-20 -84.05 146.34 27.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.868 0.366 . . . . 1.02 110.49 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.4 ttp-105 -106.44 136.88 45.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.501 -0.555 . . . . 1.5700000000000001 109.501 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.11 123.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.804 -0.443 . . . . 0.68000000000000005 109.804 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.705 HG11 ' HG2' ' A' ' 104' ' ' PRO . 47.0 t -99.93 -49.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.674 -0.694 . . . . 0.87 110.117 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 23.2 mt-10 -126.45 142.87 51.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.89000000000000001 110.425 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 118.62 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.103 -0.498 . . . . 0.66000000000000003 109.711 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.2 30.12 19.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.956 0.408 . . . . 1.1699999999999999 110.966 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -3.68 73.89 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.891 -0.671 . . . . 0.66000000000000003 113.96 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.46 129.26 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.791 0.795 . . . . 1.1699999999999999 111.237 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.7 p -71.0 137.15 48.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.004 -0.998 . . . . 1.6799999999999999 112.028 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.762 ' HB3' HG22 ' A' ' 73' ' ' VAL . 24.1 mmt -115.0 11.46 16.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.81000000000000005 111.048 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 103' ' ' ILE . 72.8 mm-40 -59.42 -45.62 91.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 3.75 111.3 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.05 2.0 74.87 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.688 -0.768 . . . . 1.47 112.633 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.6 mmtt -90.72 179.53 5.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.208 -0.293 . . . . 3.3599999999999999 110.208 -177.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -111.98 174.47 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.666 -0.243 . . . . 2.8900000000000001 111.537 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -54.21 -43.93 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 1.4199999999999999 111.415 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.86 -30.78 76.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.92 -0.657 . . . . 0.71999999999999997 113.066 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.17 -46.1 62.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.936 0.398 . . . . 2.0299999999999998 110.808 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 65' ' ' MET . 25.1 t -62.57 -46.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.828 -0.624 . . . . 1.0800000000000001 111.049 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.05 -39.2 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.71999999999999997 111.183 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 t -68.44 -38.82 81.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.324 -0.398 . . . . 0.66000000000000003 110.646 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.68 85.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.41999999999999998 111.658 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.95 -43.17 91.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.191 0.519 . . . . 0.68999999999999995 110.432 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.4 -34.53 70.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 3.0899999999999999 110.592 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.74 -15.51 63.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 0.65000000000000002 111.415 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.4 80.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 0.59999999999999998 111.725 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.23 -111.7 4.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.978 -0.63 . . . . 1.1000000000000001 112.211 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 -8.34 35.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.664 0.269 . . . . 2.1200000000000001 110.706 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.44 162.4 40.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.428 -0.351 . . . . 2.1099999999999999 110.757 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 t -150.35 149.36 29.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.331 -0.395 . . . . 0.32000000000000001 110.3 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.851 ' HG2' HG23 ' A' ' 14' ' ' THR . 26.9 mttm -115.15 117.46 30.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.713 -0.477 . . . . 1.6299999999999999 109.713 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -107.89 129.73 55.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.857 0.36 . . . . 0.28000000000000003 110.302 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.502 HD23 ' HG3' ' A' ' 59' ' ' GLU . 37.5 tp -103.7 116.62 32.67 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.19 -0.67 . . . . 0.51000000000000001 109.19 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.52 161.83 34.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.005 -0.543 . . . . 0.33000000000000002 110.756 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 10' ' ' PRO . 8.5 m -133.87 133.35 56.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.746 -0.661 . . . . 0.41999999999999998 110.78 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.4 154.09 41.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 1.9199999999999999 109.183 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 70.5 ttt180 -52.72 -41.61 64.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.251 0.463 . . . . 4.1600000000000001 112.251 -170.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.34 -34.84 72.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.29 0.567 . . . . 2.6800000000000002 110.72 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -79.45 -41.83 26.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.332 -0.849 . . . . 0.46999999999999997 110.19 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 25.9 t0 -65.87 -39.01 90.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.206 -0.906 . . . . 1.1799999999999999 111.689 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 5.1 mm-40 -63.58 -36.34 83.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.992 0.425 . . . . 1.9399999999999999 110.061 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.16 -41.34 86.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 0.72999999999999998 110.45 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HD1' HG13 ' A' ' 102' ' ' VAL . 28.3 m-85 -65.76 -37.39 86.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.276 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 44.4 mttp -62.95 -49.89 72.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.323 . . . . 1.9199999999999999 111.266 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.86 -25.82 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 2.04 111.167 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.486 ' HB3' HG12 ' A' ' 102' ' ' VAL . 36.3 t -87.62 -11.87 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.045 0.45 . . . . 1.3899999999999999 110.676 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 61.96 35.54 16.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.366 -0.834 . . . . 4.0899999999999999 111.334 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 100' ' ' CYS . 10.0 p -128.56 142.47 43.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.241 -0.436 . . . . 1.4199999999999999 110.263 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 103' ' ' ILE . 3.0 mp -85.85 126.48 65.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.534 . . . . 1.3300000000000001 110.734 -176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.705 ' HG2' HG11 ' A' ' 58' ' ' VAL . 22.8 Cg_endo -63.42 146.4 93.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.75 2.3 . . . . 0.53000000000000003 111.617 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.5 p -157.67 173.04 17.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.639 -0.255 . . . . 1.4199999999999999 111.353 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.511 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 51.8 mt-30 -60.12 -28.83 68.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.442 0.464 . . . . 1.6599999999999999 110.703 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -58.47 -30.08 66.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.24 0.543 . . . . 2.8199999999999998 111.118 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -85.88 -14.56 44.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.53000000000000003 111.319 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.2 mt -63.09 107.64 1.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 1.24 110.443 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 60.41 24.79 14.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.96 -0.564 . . . . 3.7000000000000002 110.494 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.74 174.17 15.13 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.915 -0.66 . . . . 1.1200000000000001 111.973 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.87 136.39 38.31 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.902 2.401 . . . . 1.3100000000000001 111.906 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 109.269 -0.641 . . . . 1.1100000000000001 109.269 176.351 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.828 -0.805 . . . . 0.80000000000000004 108.828 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -126.61 156.74 72.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.953 -1.022 . . . . 3.0899999999999999 109.322 -174.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.5 Cg_endo -65.49 165.97 21.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.138 1.892 . . . . 0.46999999999999997 111.203 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.671 HH12 ' HB3' ' A' ' 90' ' ' ASP . 8.7 ptp85 -121.28 131.95 54.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.872 0.367 . . . . 2.3700000000000001 110.157 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.5 tp -98.24 111.03 23.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.218 0.533 . . . . 1.3200000000000001 109.83 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.3 m -98.92 117.59 33.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.544 -0.753 . . . . 0.40000000000000002 109.799 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -105.75 117.61 34.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.297 -0.631 . . . . 0.34999999999999998 109.297 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.62 142.49 51.48 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 0.88 111.072 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 37.1 ttpt -114.77 140.18 49.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.817 -0.629 . . . . 2.5800000000000001 109.622 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.691 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.6 ttmt -58.4 105.82 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.779 -0.452 . . . . 0.92000000000000004 109.779 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.35 -134.37 7.0 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 1.28 113.257 -172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.11 -53.74 2.82 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.291 2.66 . . . . 2.23 112.843 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -116.87 33.31 5.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.091 -0.504 . . . . 2.8700000000000001 110.663 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.691 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 90.58 -120.07 5.79 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.581 -0.819 . . . . 1.9299999999999999 111.389 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.526 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 52.7 m-85 -121.08 172.95 7.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.8200000000000001 109.283 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.28 73.75 0.41 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.159 -1.019 . . . . 0.42999999999999999 112.816 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -155.43 144.91 21.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.731 0.301 . . . . 0.40000000000000002 110.203 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 7.2 t-20 -103.57 141.04 36.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.207 -0.664 . . . . 2.1800000000000002 109.207 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.28 151.3 22.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.09 0.472 . . . . 1.52 111.535 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -108.82 122.27 46.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.645 . . . . 1.3400000000000001 110.287 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 121.196 0.522 . . . . 2.2999999999999998 109.862 175.629 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.595 ' HG3' HG21 ' A' ' 73' ' ' VAL . 26.7 mm-40 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.009 0.433 . . . . 1.5 110.448 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.8 m-85 -115.86 158.32 23.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.87 109.492 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG13 HD11 ' A' ' 51' ' ' LEU . 50.5 mm -87.28 106.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.553 -0.536 . . . . 0.39000000000000001 109.553 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 25.2 ttt180 -65.24 -50.09 67.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.874 -0.603 . . . . 2.8300000000000001 110.014 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 p -160.87 133.92 6.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 1.26 109.878 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 p -104.66 132.83 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.356 -0.609 . . . . 0.37 109.356 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.73 134.52 72.19 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.489 -0.56 . . . . 2.2799999999999998 109.489 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 52.6 Cg_exo -53.48 136.34 63.46 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.25 2.633 . . . . 1.1699999999999999 113.126 -177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p30 44.19 38.51 2.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.29 1.036 . . . . 2.3999999999999999 112.825 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.501 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 92.0 p -93.69 165.68 17.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.692 -0.855 . . . . 0.56999999999999995 108.692 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 10.4 Cg_endo -54.92 -30.31 68.2 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.789 1.659 . . . . 0.65000000000000002 111.488 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.01 67.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.814 -0.63 . . . . 0.35999999999999999 110.615 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 34.0 tt0 -70.03 -34.33 73.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.742 0.306 . . . . 2.0099999999999998 110.384 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -24.89 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.46999999999999997 111.959 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.9 p -75.83 -13.28 60.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.228 0.537 . . . . 0.40000000000000002 110.718 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.43 37.41 4.04 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.603 -0.726 . . . . 0.62 111.874 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 37' ' ' ILE . 17.4 tp -83.97 148.26 26.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.197 -0.298 . . . . 0.65000000000000002 110.197 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HD3' ' OD1' ' A' ' 55' ' ' ASP . 62.3 ttt-85 -128.95 151.42 49.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 4.3799999999999999 110.364 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.6 133.02 44.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.437 -0.347 . . . . 1.4399999999999999 111.37 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 12.9 mm-40 65.87 29.57 10.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.341 -0.845 . . . . 3.0600000000000001 111.599 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.561 ' OD1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -88.71 136.17 33.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.105 -0.702 . . . . 1.02 109.105 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.3 129.2 36.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.706 -0.225 . . . . 1.5700000000000001 110.626 -177.045 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.442 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 52.5 mt -82.87 123.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.68000000000000005 109.779 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.554 HG11 ' HG2' ' A' ' 104' ' ' PRO . 6.5 t -106.05 -35.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.245 -0.434 . . . . 0.87 110.614 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.0 mt-10 -136.48 143.02 43.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.291 -0.413 . . . . 0.89000000000000001 111.221 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG21 HG13 ' A' ' 73' ' ' VAL . 49.3 t -122.17 109.06 23.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.045 -0.724 . . . . 0.66000000000000003 109.045 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 46.47 43.18 11.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.958 0.885 . . . . 1.1699999999999999 111.579 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 94.26 -4.46 70.49 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.782 -1.099 . . . . 0.66000000000000003 114.19 174.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.4 t -98.33 119.54 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 117.522 0.661 . . . . 1.1699999999999999 110.471 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 p -67.92 130.55 43.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.384 -0.825 . . . . 1.6799999999999999 111.061 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.522 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mmt -117.2 45.28 1.92 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.989 -0.55 . . . . 0.81000000000000005 111.971 -174.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -90.95 -47.73 7.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.137 0.494 . . . . 3.75 110.62 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.2 18.37 57.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 1.47 112.187 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 72.2 mmtt -100.37 173.83 6.4 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.176 -0.305 . . . . 3.3599999999999999 110.176 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -112.85 178.49 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.591 -0.277 . . . . 2.8900000000000001 111.169 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.439 ' O ' HG23 ' A' ' 74' ' ' VAL . 81.8 t60 -54.88 -43.65 73.36 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.469 -0.332 . . . . 1.4199999999999999 111.141 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.45 -38.23 95.5 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.013 -0.613 . . . . 0.71999999999999997 112.831 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.68 -44.26 96.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.952 0.406 . . . . 2.0299999999999998 110.714 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.595 HG21 ' HG3' ' A' ' 35' ' ' GLN . 48.6 t -69.88 -46.81 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.763 -0.653 . . . . 1.0800000000000001 111.047 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.2 t -63.96 -38.12 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.429 -0.35 . . . . 0.71999999999999997 110.903 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.1 t -65.65 -36.04 82.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.051 -0.351 . . . . 0.66000000000000003 110.051 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.39 -34.52 78.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.41999999999999998 110.856 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.557 HG23 HG21 ' A' ' 84' ' ' THR . 29.0 mm -57.47 -45.42 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.7 0.762 . . . . 0.68999999999999995 109.548 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -75.26 -31.07 60.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.862 -1.063 . . . . 3.0899999999999999 111.119 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.28 -18.79 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.65000000000000002 111.637 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.03 -17.48 79.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.59999999999999998 112.252 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.47 -114.74 3.45 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.744 -0.741 . . . . 1.1000000000000001 111.628 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.644 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 34.3 m-20 -110.04 -9.28 14.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.164 0.507 . . . . 2.1200000000000001 110.25 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 1.8 pm0 -139.16 142.53 37.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.946 -0.57 . . . . 2.1099999999999999 110.153 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.557 HG21 HG23 ' A' ' 77' ' ' ILE . 10.2 t -133.01 151.17 52.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.435 -0.348 . . . . 0.32000000000000001 110.624 -174.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -111.07 118.0 34.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.257 -0.646 . . . . 1.6299999999999999 109.257 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.85 135.07 47.94 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.916 0.389 . . . . 0.28000000000000003 110.1 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 10' ' ' PRO . 26.4 tp -104.92 115.77 30.85 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.915 -0.772 . . . . 0.51000000000000001 108.915 176.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' A' ' 11' ' ' ARG . 13.2 m -127.46 158.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.33000000000000002 111.374 -176.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 147.66 30.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.41999999999999998 110.402 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.671 ' HB3' HH12 ' A' ' 11' ' ' ARG . 21.3 p30 -92.47 176.94 6.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.965 -0.561 . . . . 1.9199999999999999 110.298 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 54.4 ttp180 -54.72 -48.64 72.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.214 0.45 . . . . 4.1600000000000001 112.214 -174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 1.8 pm0 -65.65 -42.76 91.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.843 0.354 . . . . 2.6800000000000002 111.675 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -68.36 -44.67 74.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.07 -0.513 . . . . 0.46999999999999997 110.772 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -60.86 -47.25 87.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.928 -0.578 . . . . 1.1799999999999999 111.09 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 40.3 mt-10 -64.77 -32.85 74.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.605 -0.27 . . . . 1.9399999999999999 110.64 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -64.24 -48.43 75.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.72999999999999998 110.793 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CD2' HG13 ' A' ' 102' ' ' VAL . 30.4 m-85 -66.96 -38.74 86.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.642 -0.254 . . . . 0.44 111.495 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 95' ' ' GLU . 40.6 mtmt -63.85 -47.27 81.39 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.801 0.297 . . . . 1.9199999999999999 111.801 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.9 ptmt -65.79 -18.96 65.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.375 0.607 . . . . 2.04 110.537 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.477 ' HB2' HG12 ' A' ' 102' ' ' VAL . 92.4 m -94.04 -9.97 35.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.583 -0.735 . . . . 1.3899999999999999 111.079 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.16 26.92 12.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.346 -0.843 . . . . 4.0899999999999999 111.39 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -109.41 141.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.436 -0.579 . . . . 1.4199999999999999 109.436 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 37.3 mm -87.26 123.12 70.43 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.158 -0.474 . . . . 1.3300000000000001 110.434 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.554 ' HG2' HG11 ' A' ' 58' ' ' VAL . 18.6 Cg_endo -60.49 135.66 62.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.197 1.931 . . . . 0.53000000000000003 110.678 174.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 m -154.69 166.31 33.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.086 -0.339 . . . . 1.4199999999999999 110.086 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 48.3 mt-30 -62.06 -30.37 70.94 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.491 0.494 . . . . 1.6599999999999999 112.288 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.7 -29.35 70.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 2.8199999999999998 110.484 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.69 -14.93 60.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.994 -0.548 . . . . 0.53000000000000003 111.366 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 91.8 mt -62.25 -46.59 88.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.096 0.474 . . . . 1.24 110.362 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -128.61 75.99 1.67 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.619 -0.719 . . . . 3.7000000000000002 110.1 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.43 176.08 46.75 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.52 -0.764 . . . . 1.1200000000000001 111.312 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.98 111.08 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.556 2.171 . . . . 1.3100000000000001 112.642 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.448 -0.56 0 CA-C-N 116.192 -0.458 . . . . 1.1100000000000001 110.458 174.868 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.222 -0.351 . . . . 11.869999999999999 112.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.2 mm -93.97 52.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.91 0.862 . . . . 9.8599999999999994 109.534 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 14.1 t70 -92.98 130.78 35.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.262 -0.881 . . . . 6.96 109.759 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.0 -13.42 37.4 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.679 2.253 . . . . 6.6500000000000004 113.368 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.26 4.42 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.644 0.238 . . . . 7.9900000000000002 111.644 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' A' ' 3' ' ' ASP . 6.3 t -77.31 0.27 22.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 4.2599999999999998 110.952 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptp -89.37 -1.82 58.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 3.8399999999999999 110.604 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.1 mt -85.53 59.31 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 0.80000000000000004 110.08 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HB3' HD21 ' A' ' 113' ' ' LEU . 14.0 ptt180 -129.37 148.97 71.4 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 3.0899999999999999 110.424 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HB3' HG12 ' A' ' 89' ' ' VAL . 57.2 Cg_endo -70.43 174.5 9.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.787 2.324 . . . . 0.46999999999999997 112.642 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -134.22 140.47 46.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.793 -0.64 . . . . 2.3700000000000001 109.961 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.2 110.08 22.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.544 -0.539 . . . . 1.3200000000000001 109.544 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -89.78 116.2 27.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.759 -0.655 . . . . 0.40000000000000002 110.003 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -107.4 118.83 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.444 -0.576 . . . . 0.34999999999999998 109.444 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.788 ' HE1' ' HA ' ' A' ' 46' ' ' ALA . 22.7 ptp -137.39 133.26 34.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.89 0.376 . . . . 0.88 111.218 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 87.6 tttt -103.63 147.04 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.65 -0.704 . . . . 2.5800000000000001 109.298 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 14.4 mtmt -57.33 110.32 0.83 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.893 -0.594 . . . . 0.92000000000000004 110.747 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.96 -94.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.189 -0.914 . . . . 1.28 113.346 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.62 -72.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.803 2.336 . . . . 2.23 111.971 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -146.19 20.26 1.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.569 0.7 . . . . 2.8700000000000001 109.753 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 174.5 -156.76 23.73 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.22 -0.9 . . . . 1.9299999999999999 111.3 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 83.6 m-85 -112.02 168.17 9.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.337 -0.616 . . . . 1.8200000000000001 109.337 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.2 70.52 0.45 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.067 -1.063 . . . . 0.42999999999999999 113.089 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.81 163.1 40.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.01 -0.367 . . . . 0.40000000000000002 110.01 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 25.6 t-20 -129.06 129.77 45.7 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.041 -0.527 . . . . 2.1800000000000002 109.694 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.92 144.1 29.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.692 -0.484 . . . . 1.52 109.692 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.8 p80 -121.51 130.25 53.43 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.036 -0.666 . . . . 1.3400000000000001 110.158 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -93.69 124.92 38.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.439 -0.801 . . . . 2.2999999999999998 109.279 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.546 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.9 t70 -86.21 145.42 26.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.897 -0.408 . . . . 3.48 109.897 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 31.7 tptt -91.1 -4.51 56.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.249 -0.432 . . . . 4.54 111.097 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 m -116.32 -48.89 2.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.149 0.5 . . . . 3.4900000000000002 110.707 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 22.5 pttm -108.02 132.6 20.94 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.982 -0.554 . . . . 3.0 110.505 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 153.98 41.29 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.74 2.293 . . . . 2.2400000000000002 113.051 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.89 159.7 14.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.536 -0.756 . . . . 1.29 112.11 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.449 ' NE2' ' HA ' ' A' ' 70' ' ' HIS . 21.1 mm-40 -97.54 128.32 44.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.677 -0.49 . . . . 1.5 109.677 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 75.6 m-85 -112.11 143.71 42.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.301 -0.629 . . . . 0.87 109.301 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.56 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.1 mm -68.39 106.78 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.452 -0.573 . . . . 0.39000000000000001 109.452 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.4 ttt180 -75.47 -48.0 24.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 2.8300000000000001 109.809 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -159.63 143.78 14.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.33 -0.85 . . . . 1.26 109.957 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.79 145.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.724 -0.473 . . . . 0.37 109.724 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 11.0 t70 -87.68 121.92 70.69 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.34 -0.615 . . . . 2.2799999999999998 109.34 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 24.4 Cg_exo -62.26 -22.54 74.3 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 123.07 2.514 . . . . 1.1699999999999999 113.339 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -105.39 50.34 0.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.713 0.768 . . . . 2.3999999999999999 109.418 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 53.5 p -145.28 162.0 39.22 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.454 -0.793 . . . . 0.56999999999999995 110.035 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 18.9 Cg_endo -60.92 -18.44 57.09 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.045 2.496 . . . . 0.65000000000000002 112.435 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.788 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -67.83 -52.39 37.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 0.35999999999999999 110.798 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.78 -38.47 91.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.053 0.454 . . . . 2.0099999999999998 109.865 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.37 94.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.46999999999999997 111.223 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -70.93 -19.84 62.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.40000000000000002 111.016 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.23 39.12 2.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.962 -0.637 . . . . 0.62 112.813 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -90.15 95.29 10.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.65000000000000002 109.911 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -85.25 146.24 27.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 4.3799999999999999 110.26 -176.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -71.03 142.82 50.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 1.4399999999999999 110.845 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 2.0 mp0 78.96 -0.02 2.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.146 0.904 . . . . 3.0600000000000001 111.854 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.7 m-20 -81.71 150.5 27.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.606 -0.516 . . . . 1.02 109.606 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 31.4 ttp-105 -104.64 142.82 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.775 0.321 . . . . 1.5700000000000001 111.501 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 mm -72.82 123.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.592 -0.731 . . . . 0.68000000000000005 109.587 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 104' ' ' PRO . 43.5 t -111.92 -48.27 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.439 0.637 . . . . 0.87 109.943 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.5 mt-10 -125.68 146.37 49.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.391 -0.822 . . . . 0.89000000000000001 110.045 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.69 120.58 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.975 -0.557 . . . . 0.66000000000000003 109.88 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 62.21 23.06 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.555 -0.748 . . . . 1.1699999999999999 111.015 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 9.39 62.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.906 -0.664 . . . . 0.66000000000000003 112.609 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.5 t -114.02 128.04 71.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 1.1699999999999999 110.446 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.0 p -77.47 129.29 35.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.767 -0.651 . . . . 1.6799999999999999 110.914 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.716 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.6 mmt -117.15 26.89 9.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.167 0.432 . . . . 0.81000000000000005 112.167 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.69 114.97 7.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.393 . . . . 3.75 110.253 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.76 62.02 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.866 -0.683 . . . . 1.47 112.913 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.9 mmtp -92.37 166.98 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.214 -0.291 . . . . 3.3599999999999999 110.214 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.19 175.62 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.493 -0.321 . . . . 2.8900000000000001 111.057 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.449 ' HA ' ' NE2' ' A' ' 35' ' ' GLN . 20.8 t60 -58.94 -44.09 91.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.786 0.327 . . . . 1.4199999999999999 110.818 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -39.47 95.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.912 -0.661 . . . . 0.71999999999999997 112.122 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.75 -47.19 84.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 2.0299999999999998 111.174 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 77' ' ' ILE . 50.6 t -69.08 -47.52 74.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.0800000000000001 110.972 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.9 t -64.47 -41.99 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.465 -0.334 . . . . 0.71999999999999997 111.186 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -63.87 -35.79 81.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.981 -0.378 . . . . 0.66000000000000003 109.981 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.12 93.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.41999999999999998 110.942 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 73' ' ' VAL . 75.5 mt -60.87 -45.89 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.68999999999999995 110.384 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 52.0 mtp180 -68.18 -28.15 67.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.003 -0.544 . . . . 3.0899999999999999 110.816 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.24 8.98 16.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.116 -0.493 . . . . 0.65000000000000002 110.96 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.58 -21.12 58.73 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.85 -0.69 . . . . 0.59999999999999998 111.752 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -129.71 9.99 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.768 -0.729 . . . . 1.1000000000000001 111.995 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD2' ' HE3' ' A' ' 16' ' ' LYS . 11.6 p-10 -80.46 -23.94 39.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.748 0.309 . . . . 2.1200000000000001 111.083 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 2.2 pt-20 -138.26 162.67 33.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.89 0.376 . . . . 2.1099999999999999 110.815 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -143.79 149.17 36.65 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.815 -0.629 . . . . 0.32000000000000001 110.1 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -115.1 117.52 30.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.139 -0.482 . . . . 1.6299999999999999 109.878 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.463 HD12 ' HE3' ' A' ' 15' ' ' MET . 96.4 mt -109.05 135.64 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.065 -0.516 . . . . 0.28000000000000003 110.427 -177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 44.4 tp -105.72 121.33 43.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.351 -0.611 . . . . 0.51000000000000001 109.351 175.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.617 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.4 m -128.03 156.84 40.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.927 0.394 . . . . 0.33000000000000002 111.569 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 10' ' ' PRO . 13.6 m -130.63 139.77 50.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.749 . . . . 0.41999999999999998 110.382 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 173.65 6.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.778 -0.646 . . . . 1.9199999999999999 110.64 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.612 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.1 ttt-85 -62.41 -49.39 75.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.848 -0.427 . . . . 4.1600000000000001 109.848 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -39.56 94.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.204 0.526 . . . . 2.6800000000000002 110.429 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.5 m -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.274 -0.875 . . . . 0.46999999999999997 111.052 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.12 -37.29 78.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 1.1799999999999999 111.303 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 31.8 mm-40 -63.54 -36.23 83.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 1.9399999999999999 109.998 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 83.5 t80 -63.42 -46.82 84.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.743 -0.662 . . . . 0.72999999999999998 110.214 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 104' ' ' PRO . 34.6 m-85 -64.26 -38.45 91.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.401 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -58.85 -50.01 75.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.956 0.407 . . . . 1.9199999999999999 111.448 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -71.34 -19.04 62.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 2.04 111.663 -172.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -103.3 -2.5 27.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.926 0.393 . . . . 1.3899999999999999 110.8 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.57 45.3 19.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.595 -0.73 . . . . 4.0899999999999999 110.895 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.5 t -118.24 134.08 63.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 1.4199999999999999 110.69 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.6 mm -93.1 120.07 67.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.374 -0.375 . . . . 1.3300000000000001 110.018 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.485 ' HG2' HG11 ' A' ' 58' ' ' VAL . 32.8 Cg_endo -64.48 142.32 77.76 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.636 2.224 . . . . 0.53000000000000003 112.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.519 ' HB3' ' OE2' ' A' ' 107' ' ' GLU . 9.3 t -153.24 -179.27 7.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.4199999999999999 109.383 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -57.56 -30.99 65.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.411 0.523 . . . . 1.6599999999999999 112.411 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.519 ' OE2' ' HB3' ' A' ' 105' ' ' SER . 0.0 OUTLIER -69.34 -28.77 66.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.948 0.404 . . . . 2.8199999999999998 111.673 -177.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -77.46 -14.6 59.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.442 -0.344 . . . . 0.53000000000000003 111.425 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.49 HD21 ' CD1' ' A' ' 87' ' ' LEU . 96.0 mt -53.31 -58.33 7.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.818 0.342 . . . . 1.24 111.802 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -107.93 14.66 25.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.267 0.556 . . . . 3.7000000000000002 110.532 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.55 153.68 21.79 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.816 -0.629 . . . . 1.1200000000000001 111.882 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.76 30.49 0.41 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.429 2.753 . . . . 1.3100000000000001 113.102 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.544 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 70.6 mt 59.24 164.18 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.309 -0.86 . . . . 1.1100000000000001 113.168 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 18.1 Cg_endo -60.16 156.66 38.69 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.805 2.336 . . . . 1.1499999999999999 112.653 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.3 m -76.2 138.84 68.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.581 -0.736 . . . . 2.98 110.866 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.82 137.85 83.14 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.176 2.584 . . . . 4.2300000000000004 112.787 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 67.83 8.54 6.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.319 -0.855 . . . . 7.3300000000000001 112.245 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.9 m 73.58 -58.65 0.59 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.413 0.523 . . . . 8.7799999999999994 112.413 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -125.02 -81.64 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.068 -0.253 . . . . 9.3399999999999999 110.42 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -161.61 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.159 -0.543 . . . . 11.550000000000001 112.658 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 59.12 87.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.607 0.595 . . . . 13.92 112.607 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 pt -80.25 50.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.251 0.548 . . . . 16.210000000000001 110.917 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -69.94 121.75 17.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 18.82 111.243 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp 50.54 66.18 1.23 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.041 0.838 . . . . 20.829999999999998 111.575 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -82.39 81.07 8.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.808 -0.633 . . . . 22.5 109.686 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.45 -44.59 9.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.336 -0.393 . . . . 23.989999999999998 110.43 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.9 m 48.58 48.24 19.82 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.237 0.458 . . . . 25.0 112.237 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.378 -0.82 . . . . 27.52 109.363 175.46 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.969 -0.453 . . . . 11.869999999999999 111.969 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' H ' HG13 ' A' ' 2' ' ' ILE . 2.6 pp -92.85 169.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 9.8599999999999994 110.977 176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.469 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 13.4 m-20 -92.96 132.6 30.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 6.96 110.391 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 17.0 Cg_exo -67.87 -65.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.568 2.179 . . . . 6.6500000000000004 111.512 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -132.74 22.82 4.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 7.9900000000000002 110.029 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 3' ' ' ASP . 9.4 m -98.02 93.71 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 4.2599999999999998 111.381 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.9 ptp -108.56 18.16 21.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 3.8399999999999999 110.546 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt -86.72 57.28 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.80000000000000004 109.992 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 85.0 mtt-85 -115.72 149.86 43.83 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.07 -0.514 . . . . 3.0899999999999999 111.447 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HB2' HD11 ' A' ' 87' ' ' LEU . 2.9 Cg_exo -72.7 165.89 31.48 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.512 2.141 . . . . 0.46999999999999997 109.866 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.637 HH12 ' HB3' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -127.7 131.1 49.81 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.237 -0.438 . . . . 2.3700000000000001 110.043 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.0 tm? -98.64 112.79 24.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 1.3200000000000001 109.521 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.4 m -105.74 125.67 51.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.888 -0.596 . . . . 0.40000000000000002 110.711 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' LYS . 24.2 m -111.98 117.38 32.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 0.34999999999999998 109.174 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.712 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.6 ptp -126.53 133.6 51.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.178 0.513 . . . . 0.88 110.999 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -111.54 143.24 42.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.158 -0.928 . . . . 2.5800000000000001 110.146 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 52.6 mttt -62.36 104.59 0.51 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.349 -0.841 . . . . 0.92000000000000004 111.377 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.82 -80.2 0.93 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.044 -0.98 . . . . 1.28 111.623 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.98 47.5 2.23 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.723 2.282 . . . . 2.23 111.215 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m 61.58 27.6 17.03 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.12 -0.945 . . . . 2.8700000000000001 110.69 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.514 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -177.09 -178.07 46.52 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.024 -0.608 . . . . 1.9299999999999999 112.248 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 29.3 m-85 -106.55 -162.06 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.427 -0.583 . . . . 1.8200000000000001 109.427 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.67 73.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.115 -1.04 . . . . 0.42999999999999999 113.043 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -155.1 154.34 32.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.79 0.328 . . . . 0.40000000000000002 110.287 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -108.75 134.78 50.99 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.383 -0.599 . . . . 2.1800000000000002 109.383 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 35' ' ' GLN . 23.0 tp -105.24 152.66 22.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.351 -173.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.34 122.49 46.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.745 -0.835 . . . . 1.3400000000000001 108.745 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -132.11 50.9 2.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.468 0.651 . . . . 2.2999999999999998 111.198 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.32 142.2 28.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.359 -0.837 . . . . 3.48 110.118 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -78.87 -4.54 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.053 0.454 . . . . 4.54 110.566 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -77.42 -25.48 50.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 3.4900000000000002 110.913 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.27 129.53 21.64 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 3.0 110.893 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.29 151.62 38.47 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.227 1.952 . . . . 2.2400000000000002 111.399 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.93 155.61 21.55 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.596 -0.812 . . . . 1.29 111.212 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' A' ' 26' ' ' LEU . 21.4 mm-40 -102.23 128.81 48.59 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.49 -0.418 . . . . 1.5 110.377 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.86 151.33 23.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 0.87 110.557 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.41 106.36 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.276 0.56 . . . . 0.39000000000000001 110.171 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.25 -54.35 38.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.006 -0.997 . . . . 2.8300000000000001 110.54 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 p -168.35 137.3 2.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.814 -0.63 . . . . 1.26 109.981 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.38 130.99 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.353 -0.61 . . . . 0.37 109.353 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.53 135.44 72.04 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.511 -0.313 . . . . 2.2799999999999998 110.246 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HA ' ' CD ' ' A' ' 47' ' ' GLU . 33.1 Cg_endo -63.94 139.23 66.81 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.776 2.318 . . . . 1.1699999999999999 112.406 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.18 48.27 6.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.304 -0.862 . . . . 2.3999999999999999 110.807 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 98.7 p -120.4 160.45 43.7 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.473 -0.785 . . . . 0.56999999999999995 109.539 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.6 Cg_endo -54.46 -29.41 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.167 1.911 . . . . 0.65000000000000002 111.575 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.712 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.23 -50.49 39.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.35999999999999999 110.54 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' CD ' ' HA ' ' A' ' 42' ' ' PRO . 44.0 tt0 -65.12 -35.85 82.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.297 -0.41 . . . . 2.0099999999999998 110.49 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.46999999999999997 111.641 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.7 p -72.99 -18.37 61.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.012 0.434 . . . . 0.40000000000000002 110.8 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.12 14.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.62 112.547 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.65 114.76 9.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.65000000000000002 110.355 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -97.53 149.65 21.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 4.3799999999999999 109.906 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.37 151.82 39.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.276 -0.42 . . . . 1.4399999999999999 110.585 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 70.35 10.7 7.32 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.774 0.671 . . . . 3.0600000000000001 111.78 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.7 m-20 -84.6 168.53 15.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.722 -0.473 . . . . 1.02 109.722 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -131.31 131.26 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.848 -0.427 . . . . 1.5700000000000001 109.848 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -72.57 130.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.228 0.537 . . . . 0.68000000000000005 111.203 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.69 HG11 ' HG2' ' A' ' 104' ' ' PRO . 23.6 t -107.22 -48.47 8.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.87 110.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 35.5 mt-10 -133.87 148.34 51.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.89000000000000001 110.756 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.23 117.78 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.958 -0.565 . . . . 0.66000000000000003 109.773 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 58.78 31.02 20.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.18 0.514 . . . . 1.1699999999999999 111.165 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.13 74.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.883 -0.675 . . . . 0.66000000000000003 112.805 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.04 120.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.279 -0.267 . . . . 1.1699999999999999 110.279 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 91.9 m -64.61 126.21 27.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.62 . . . . 1.6799999999999999 111.438 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.577 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.8 mmt -105.14 68.78 0.83 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.923 -0.769 . . . . 0.81000000000000005 108.923 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.7 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.56 -1.2 . . . . 3.75 110.811 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.99 25.93 5.7 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.611 -0.996 . . . . 1.47 110.611 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 71.9 mmtt -58.2 147.1 31.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.873 -0.663 . . . . 3.3599999999999999 111.642 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.545 ' HG3' ' H ' ' A' ' 72' ' ' ASP . 12.8 pt20 -77.11 161.36 28.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.092 -0.958 . . . . 2.8900000000000001 110.29 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.41 ' O ' HG23 ' A' ' 74' ' ' VAL . 85.0 t60 -55.4 -42.57 74.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 1.4199999999999999 110.446 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.04 92.87 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.71999999999999997 112.77 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 8.5 t0 -66.13 -47.09 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 2.0299999999999998 110.013 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.415 HG22 ' SD ' ' A' ' 65' ' ' MET . 47.7 t -62.62 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.477 -0.783 . . . . 1.0800000000000001 110.662 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 70' ' ' HIS . 95.8 t -63.5 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.71999999999999997 110.883 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -61.97 -39.22 91.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.66000000000000003 110.015 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.18 94.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.41999999999999998 111.012 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.057 0.456 . . . . 0.68999999999999995 110.629 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -68.93 -24.95 64.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 3.0899999999999999 111.219 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.63 -10.67 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.65000000000000002 111.093 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -33.31 70.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.702 -0.761 . . . . 0.59999999999999998 111.904 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.16 -109.38 3.36 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.019 -0.61 . . . . 1.1000000000000001 112.184 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 11.6 t70 -102.04 -23.97 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.616 -0.513 . . . . 2.1200000000000001 109.616 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.06 157.3 40.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.028 0.442 . . . . 2.1099999999999999 110.459 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -146.93 149.32 32.97 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.934 -0.575 . . . . 0.32000000000000001 109.856 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 14' ' ' THR . 57.0 mttp -114.36 116.82 29.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.037 0.446 . . . . 1.6299999999999999 109.896 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -109.54 136.35 49.07 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.838 -0.619 . . . . 0.28000000000000003 110.574 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.8 tp -104.83 125.12 50.55 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.183 -0.673 . . . . 0.51000000000000001 109.183 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 11.1 m -135.34 152.08 31.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.185 0.517 . . . . 0.33000000000000002 111.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 94' ' ' ASP . 16.1 m -130.57 150.97 35.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.354 -0.839 . . . . 0.41999999999999998 110.145 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.637 ' HB3' HH12 ' A' ' 11' ' ' ARG . 7.6 p-10 -89.97 176.16 6.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.449 -0.575 . . . . 1.9199999999999999 109.449 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -53.51 -48.93 68.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.211 0.448 . . . . 4.1600000000000001 112.211 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.2 -43.16 95.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 2.6800000000000002 111.138 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.0 m -71.25 -41.03 70.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.332 0.587 . . . . 0.46999999999999997 110.73 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 22.3 t0 -64.95 -39.31 93.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.528 -0.76 . . . . 1.1799999999999999 111.072 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.29 -35.73 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 1.9399999999999999 110.446 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -63.23 -48.03 79.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.72999999999999998 111.005 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HD1' HG13 ' A' ' 102' ' ' VAL . 20.3 m-85 -64.47 -36.04 82.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.29 -0.414 . . . . 0.44 111.701 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 36.2 mttp -58.72 -49.82 76.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.786 0.291 . . . . 1.9199999999999999 111.786 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 13.1 ptmt -70.85 -23.09 62.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 2.04 110.555 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.87 -7.16 59.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.861 -0.609 . . . . 1.3899999999999999 110.68 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 57.88 28.94 16.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.423 -0.808 . . . . 4.0899999999999999 111.299 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 114' ' ' PRO . 10.8 p -132.28 147.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.043 -0.526 . . . . 1.4199999999999999 109.955 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -102.1 128.53 28.32 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 121.107 0.48 . . . . 1.3300000000000001 110.812 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.69 ' HG2' HG11 ' A' ' 58' ' ' VAL . 18.4 Cg_endo -63.71 155.98 60.16 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.655 2.236 . . . . 0.53000000000000003 112.845 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.641 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 2.1 m -150.12 175.68 11.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.326 -0.99 . . . . 1.4199999999999999 108.326 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.605 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 22.9 mp0 -59.39 -34.92 73.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.333 0.587 . . . . 1.6599999999999999 110.122 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.641 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.8 pt-20 -62.49 -30.21 71.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 2.8199999999999998 111.682 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.503 ' HB2' ' H ' ' A' ' 105' ' ' SER . 33.7 m80 -79.29 -24.48 42.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.53000000000000003 111.322 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.7 pp -91.96 -14.11 30.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.217 -0.447 . . . . 1.24 110.477 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -103.86 -50.91 3.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 3.7000000000000002 110.785 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.72 -142.6 8.67 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.89 -0.672 . . . . 1.1200000000000001 112.416 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -84.52 163.21 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.719 2.279 . . . . 1.3100000000000001 113.236 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 39.6 mt -91.85 165.89 19.23 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.506 -0.77 . . . . 1.1100000000000001 109.249 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 17.9 Cg_endo -60.14 134.29 55.16 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.119 1.88 . . . . 1.1499999999999999 111.494 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.52 118.94 75.12 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 2.98 110.295 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.15 109.27 0.47 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.965 2.444 . . . . 4.2300000000000004 112.045 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.46 -58.89 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.619 -0.718 . . . . 7.3300000000000001 110.008 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.0 m -88.83 107.61 19.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 8.7799999999999994 109.518 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -91.53 142.43 27.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.069 0.461 . . . . 9.3399999999999999 111.153 -174.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -130.1 141.25 12.46 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.191 -0.763 . . . . 11.550000000000001 111.191 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -86.65 118.73 26.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.914 0.388 . . . . 13.92 110.045 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 54.7 mt -85.87 93.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.945 -0.571 . . . . 16.210000000000001 110.889 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -82.85 150.06 26.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.701 -0.682 . . . . 18.82 109.401 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.69 48.96 1.72 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.69 0.626 . . . . 20.829999999999998 112.69 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -86.63 60.31 6.15 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.305 -0.628 . . . . 22.5 109.305 170.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -67.06 -71.4 0.2 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.691 -0.686 . . . . 23.989999999999998 110.52 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.0 t -169.88 90.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 25.0 110.003 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 128' ' ' ARG . 17.7 ptt85 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 119.187 -0.435 . . . . 27.52 110.065 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.901 -0.48 . . . . 11.869999999999999 111.901 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.694 ' H ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -107.21 137.22 39.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.127 0.489 . . . . 9.8599999999999994 110.918 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -94.54 107.92 33.32 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 6.96 110.083 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 15.19 1.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.741 2.294 . . . . 6.6500000000000004 112.858 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -99.85 -46.65 5.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.519 -0.309 . . . . 7.9900000000000002 110.902 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.879 HG22 ' HG ' ' A' ' 8' ' ' LEU . 7.3 m -57.11 111.22 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.534 -0.757 . . . . 4.2599999999999998 111.258 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -91.21 53.43 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.298 0.57 . . . . 3.8399999999999999 111.575 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.879 ' HG ' HG22 ' A' ' 6' ' ' THR . 69.5 mt -81.68 50.27 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.477 0.656 . . . . 0.80000000000000004 109.876 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 113' ' ' LEU . 20.4 ptt85 -121.47 150.18 54.09 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.122 -0.945 . . . . 3.0899999999999999 109.9 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HB2' HD11 ' A' ' 87' ' ' LEU . 55.6 Cg_endo -69.16 158.36 58.04 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.46 2.107 . . . . 0.46999999999999997 111.938 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 11' ' ' ARG . 7.8 ptp180 -118.29 131.59 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.737 -0.665 . . . . 2.3700000000000001 110.016 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.5 tp -97.33 111.08 23.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 1.3200000000000001 109.803 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.412 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 32.2 m -94.77 117.22 29.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.833 -0.622 . . . . 0.40000000000000002 110.032 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 85' ' ' LYS . 35.9 m -110.46 117.87 34.74 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.305 -0.628 . . . . 0.34999999999999998 109.305 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 ptp -128.99 136.35 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.404 -0.362 . . . . 0.88 110.855 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -110.72 139.86 45.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.677 -0.692 . . . . 2.5800000000000001 109.249 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 11.7 ttmt -61.92 124.4 20.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.329 0.492 . . . . 0.92000000000000004 112.329 -173.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -149.85 17.91 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.629 -0.714 . . . . 1.28 111.323 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.73 -30.65 17.48 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.037 2.491 . . . . 2.23 112.508 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -109.1 19.93 18.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 2.8700000000000001 110.573 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.77 2.84 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.569 -0.824 . . . . 1.9299999999999999 111.959 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 26.6 m-85 -119.07 -48.46 2.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.753 0.311 . . . . 1.8200000000000001 110.527 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 70.02 1.23 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.0 -0.619 . . . . 0.42999999999999999 113.635 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -156.52 156.06 33.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.942 -0.392 . . . . 0.40000000000000002 109.942 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -101.81 126.48 48.69 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.82 -0.437 . . . . 2.1800000000000002 109.82 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 tp -100.34 152.74 19.97 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.966 -0.561 . . . . 1.52 110.432 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -106.61 122.7 46.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.305 -0.407 . . . . 1.3400000000000001 110.108 -176.106 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 t -112.67 81.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.817 -0.628 . . . . 2.2999999999999998 109.999 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.13 120.87 27.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.623 -0.717 . . . . 3.48 109.484 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -90.34 -16.0 30.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 4.54 110.454 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.9 m -86.84 -16.16 36.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.74 -0.664 . . . . 3.4900000000000002 111.616 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -155.32 128.11 4.17 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 3.0 110.275 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.35 157.24 62.65 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.051 2.501 . . . . 2.2400000000000002 112.496 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.61 125.9 5.28 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.135 -0.786 . . . . 1.29 111.135 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.577 HE21 ' CA ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -94.42 139.77 30.69 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.436 -0.449 . . . . 1.5 111.276 -175.253 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -118.61 156.79 28.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.87 110.061 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG13 HD11 ' A' ' 51' ' ' LEU . 44.4 mm -96.37 110.06 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.151 0.5 . . . . 0.39000000000000001 109.719 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' HIS . 60.8 ttt180 -66.21 -55.15 17.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 2.8300000000000001 110.371 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 p -169.67 139.24 1.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.812 -0.631 . . . . 1.26 109.599 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -96.41 138.05 22.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.341 -0.391 . . . . 0.37 109.984 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 t70 -71.59 124.0 90.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.178 -0.675 . . . . 2.2799999999999998 109.178 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 35.1 Cg_exo -56.48 132.85 54.31 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.11 2.54 . . . . 1.1699999999999999 113.751 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.0 t70 57.44 48.5 14.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.855 -1.066 . . . . 2.3999999999999999 110.917 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.496 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -110.72 169.58 6.17 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.56999999999999995 109.986 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.498 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.2 Cg_endo -55.16 -33.13 83.03 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.89 1.727 . . . . 0.65000000000000002 111.333 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.439 0.638 . . . . 0.35999999999999999 110.576 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.08 -50.61 73.04 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.276 -0.874 . . . . 2.0099999999999998 110.067 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -17.5 62.54 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.711 -1.586 . . . . 0.46999999999999997 111.353 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 51.6 p -84.72 -16.96 39.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.40000000000000002 110.071 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.22 0.35 35.43 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.754 -0.736 . . . . 0.62 112.697 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 37' ' ' ILE . 37.8 tp -61.62 128.13 34.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.314 . . . . 0.65000000000000002 110.31 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -117.86 154.21 32.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.251 -0.431 . . . . 4.3799999999999999 109.915 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -78.88 145.37 34.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.528 -0.305 . . . . 1.4399999999999999 110.305 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 85.3 mm-40 78.99 3.26 2.42 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.252 0.97 . . . . 3.0600000000000001 111.202 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 36.4 m-20 -74.13 156.81 36.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 1.02 109.724 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -123.93 129.21 50.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.721 -0.474 . . . . 1.5700000000000001 109.721 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' HA ' HG12 ' A' ' 88' ' ' VAL . 58.2 mt -76.22 130.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.225 0.536 . . . . 0.68000000000000005 111.416 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG22 ' NH1' ' A' ' 56' ' ' ARG . 21.8 t -107.5 -51.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.237 -0.892 . . . . 0.87 110.149 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 26.1 mt-10 -130.61 144.35 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.89000000000000001 111.031 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.31 118.2 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.333 -0.618 . . . . 0.66000000000000003 109.333 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 61.0 22.41 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.1699999999999999 110.937 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.98 6.28 63.49 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.66000000000000003 112.915 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.87 120.73 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 1.1699999999999999 110.37 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.537 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.2 m -63.51 130.02 42.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 1.6799999999999999 110.841 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.594 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 25.6 mmt -109.62 18.63 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.406 0.622 . . . . 0.81000000000000005 110.464 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -61.04 117.78 5.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.069 -0.969 . . . . 3.75 110.731 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.0 -16.76 50.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.833 -0.699 . . . . 1.47 112.951 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 65' ' ' MET . 68.8 mttm -75.6 173.16 11.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.149 0.5 . . . . 3.3599999999999999 111.808 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -103.36 -175.29 2.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.593 -0.73 . . . . 2.8900000000000001 111.463 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.414 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 86.3 t60 -63.08 -42.87 99.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.506 . . . . 1.4199999999999999 110.297 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.36 -39.68 96.49 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.737 -0.665 . . . . 0.71999999999999997 113.203 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -62.57 -47.47 83.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.046 0.451 . . . . 2.0299999999999998 110.765 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.33 -46.76 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 1.0800000000000001 110.968 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.93 -40.08 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.395 . . . . 0.71999999999999997 111.023 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.7 t -60.28 -42.01 94.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.66000000000000003 110.843 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.72 -43.38 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.41999999999999998 111.35 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.523 HG23 HG21 ' A' ' 84' ' ' THR . 80.6 mt -58.73 -42.38 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.427 0.632 . . . . 0.68999999999999995 110.407 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 78' ' ' ARG . 31.7 mtp180 -74.29 -31.98 62.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.462 -0.79 . . . . 3.0899999999999999 111.63 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.79 -7.63 59.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.438 -0.346 . . . . 0.65000000000000002 111.23 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.31 73.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.182 -0.532 . . . . 0.59999999999999998 112.186 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.57 -126.96 8.24 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.707 -0.759 . . . . 1.1000000000000001 111.652 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 8.5 t70 -84.02 -28.37 27.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 2.1200000000000001 110.017 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -128.85 160.2 33.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.105 0.479 . . . . 2.1099999999999999 110.618 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 77' ' ' ILE . 10.6 t -146.07 148.74 32.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.56 -0.745 . . . . 0.32000000000000001 109.647 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.8 mttp -116.42 117.36 29.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 1.6299999999999999 110.042 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.85 128.34 53.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.946 -0.57 . . . . 0.28000000000000003 109.75 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 10' ' ' PRO . 57.0 tp -103.92 114.76 29.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.679 -0.859 . . . . 0.51000000000000001 108.679 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.77 162.26 33.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 0.33000000000000002 110.885 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.22 146.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 0.41999999999999998 110.473 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.04 166.19 23.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.711 -0.677 . . . . 1.9199999999999999 109.85 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.5 ttm180 -53.39 -48.17 68.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.009 0.433 . . . . 4.1600000000000001 110.862 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -73.39 -28.13 61.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 2.6800000000000002 109.973 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 m -70.58 -47.82 58.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.371 -0.832 . . . . 0.46999999999999997 110.695 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -59.36 -45.04 92.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 1.1799999999999999 110.478 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 11.2 mm-40 -62.8 -36.14 82.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.9399999999999999 110.984 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.94 -46.09 89.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.72999999999999998 110.555 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.474 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 48.7 m-85 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.248 -0.433 . . . . 0.44 111.257 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -59.51 -49.72 76.7 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.537 0.199 . . . . 1.9199999999999999 111.537 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -70.92 -18.74 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 2.04 111.305 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 t -91.43 -19.51 22.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.306 0.574 . . . . 1.3899999999999999 109.829 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.601 ' HA ' ' NE ' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 67.02 31.75 6.73 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 114.692 -1.14 . . . . 4.0899999999999999 111.716 176.198 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.41 HG13 ' HD1' ' A' ' 97' ' ' PHE . 14.1 p -123.68 141.02 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 1.4199999999999999 109.852 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 66.7 mt -82.4 129.07 64.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 1.3300000000000001 110.367 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.474 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 14.5 Cg_exo -66.25 150.8 84.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.79 2.327 . . . . 0.53000000000000003 111.623 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 t -163.34 178.38 8.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.566 -0.531 . . . . 1.4199999999999999 109.566 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 71.1 mt-30 -55.13 -26.86 41.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.584 0.587 . . . . 1.6599999999999999 112.584 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -55.7 -30.66 61.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.212 0.529 . . . . 2.8199999999999998 111.389 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -89.77 -12.93 37.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.242 -0.435 . . . . 0.53000000000000003 111.114 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 87' ' ' LEU . 96.4 mt -64.68 111.33 2.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.024 -0.535 . . . . 1.24 110.43 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 56.34 36.04 26.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 3.7000000000000002 110.394 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.33 -167.86 11.45 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.605 -0.725 . . . . 1.1200000000000001 111.843 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.33 150.0 22.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.608 2.205 . . . . 1.3100000000000001 112.413 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 9' ' ' ARG . 65.3 mt -93.8 131.37 32.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 1.1100000000000001 109.361 175.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.17 123.16 10.01 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.813 2.342 . . . . 1.1499999999999999 112.797 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.51 87.88 12.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.168 -0.924 . . . . 2.98 110.241 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.63 39.35 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.22 2.613 . . . . 4.2300000000000004 113.096 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 121' ' ' GLU . 14.7 t80 -157.53 93.08 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.5 . . . . 7.3300000000000001 109.985 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 119' ' ' ASN . 40.8 p -89.75 177.23 6.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 8.7799999999999994 110.684 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 118' ' ' THR . 36.6 m-80 68.13 33.46 4.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.18 0.514 . . . . 9.3399999999999999 110.582 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.19 104.63 1.67 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.591 -0.731 . . . . 11.550000000000001 112.846 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -82.38 70.05 9.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.332 -0.988 . . . . 13.92 108.332 174.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.6 pt -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.092 -0.958 . . . . 16.210000000000001 111.397 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -139.92 -41.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.927 -0.579 . . . . 18.82 111.493 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -176.08 -28.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.902 -0.136 . . . . 20.829999999999998 110.865 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.3 73.04 0.36 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.19 0.441 . . . . 22.5 112.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.65 98.58 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.645 -0.502 . . . . 23.989999999999998 109.645 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.3 t -113.43 165.59 12.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.248 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.789 -0.624 . . . . 27.52 109.921 177.754 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.718 -0.553 . . . . 11.869999999999999 111.718 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -129.49 113.97 29.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.984 -0.376 . . . . 9.8599999999999994 109.984 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p-10 -89.36 135.93 30.59 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.005 -0.368 . . . . 6.96 110.005 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 5.8 Cg_endo -87.46 8.47 4.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.903 2.402 . . . . 6.6500000000000004 112.14 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.416 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 95.9 m-85 -88.46 -19.49 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.03 -0.532 . . . . 7.9900000000000002 110.369 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 3' ' ' ASP . 14.0 t -79.91 -150.62 0.06 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.5 -0.773 . . . . 4.2599999999999998 110.755 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 7' ' ' MET . 20.6 ttt 76.32 13.92 2.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.625 0.77 . . . . 3.8399999999999999 110.63 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 81.5 mt 61.68 27.65 17.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.787 -0.642 . . . . 0.80000000000000004 112.366 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -110.57 143.09 27.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 120.757 0.313 . . . . 3.0899999999999999 110.611 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HB3' HG12 ' A' ' 89' ' ' VAL . 64.6 Cg_endo -74.69 177.09 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.637 2.225 . . . . 0.46999999999999997 111.094 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 5' ' ' PHE . 7.8 ptt-85 -146.8 138.27 24.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.897 0.38 . . . . 2.3700000000000001 111.326 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.23 116.57 29.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.687 -0.688 . . . . 1.3200000000000001 110.139 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 4.3 m -97.38 115.91 28.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.12 -0.696 . . . . 0.40000000000000002 109.12 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 85' ' ' LYS . 27.7 m -110.23 117.42 33.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 0.34999999999999998 109.334 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.549 ' HE3' HD12 ' A' ' 86' ' ' LEU . 24.7 ptp -135.06 140.46 45.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.88 111.146 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -110.44 153.02 25.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.309 -0.626 . . . . 2.5800000000000001 109.309 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 5.4 ttmt -69.17 98.89 1.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.493 0.663 . . . . 0.92000000000000004 111.118 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -106.79 3.15 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.034 -0.985 . . . . 1.28 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HG3' ' A' ' 45' ' ' PRO . 41.4 Cg_endo -70.32 84.11 0.76 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.693 2.262 . . . . 2.23 113.013 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m 63.3 67.38 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.383 0.882 . . . . 2.8700000000000001 113.383 170.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.39 57.35 6.79 Favored Glycine 0 CA--C 1.517 0.162 0 C-N-CA 121.124 -0.56 . . . . 1.9299999999999999 114.308 168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 68.08 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.088 0.555 . . . . 1.8200000000000001 111.56 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.21 70.42 0.73 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.863 -0.684 . . . . 0.42999999999999999 112.771 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.48 152.4 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.751 -0.463 . . . . 0.40000000000000002 109.751 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -103.74 135.17 45.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.387 -0.37 . . . . 2.1800000000000002 110.144 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.515 HD13 ' H ' ' A' ' 27' ' ' HIS . 0.2 OUTLIER -101.32 151.86 21.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.891 -0.595 . . . . 1.52 109.536 -176.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.515 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -106.12 122.02 45.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 1.3400000000000001 110.065 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -95.56 107.92 20.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.988 -0.551 . . . . 2.2999999999999998 110.101 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.31 156.66 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.451 -0.341 . . . . 3.48 110.392 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -136.53 10.94 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.687 0.756 . . . . 4.54 109.801 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.1 p -118.49 -39.3 3.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 3.4900000000000002 111.134 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -111.95 142.07 26.05 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.619 0.247 . . . . 3.0 110.466 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.38 153.53 40.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.823 2.349 . . . . 2.2400000000000002 112.505 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.496 ' HA3' ' HE ' ' A' ' 56' ' ' ARG . . . 89.89 166.63 41.69 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.864 -0.684 . . . . 1.29 111.59 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -116.21 130.76 56.95 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.735 -0.468 . . . . 1.5 109.735 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 68.2 m-85 -103.98 147.56 27.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.135 0.493 . . . . 0.87 110.99 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.488 HG13 HD11 ' A' ' 51' ' ' LEU . 50.6 mm -78.87 106.98 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.469 -0.787 . . . . 0.39000000000000001 109.149 175.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 38' ' ' ARG . 39.5 ttt-85 -62.36 -53.25 57.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.37 -0.832 . . . . 2.8300000000000001 110.113 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 m -161.41 145.25 12.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 1.26 108.91 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.49 131.24 73.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.211 -0.663 . . . . 0.37 109.211 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 t70 -79.13 118.53 72.98 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.298 -0.41 . . . . 2.2799999999999998 109.895 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 50.2 Cg_exo -56.12 142.15 86.61 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.088 2.526 . . . . 1.1699999999999999 112.999 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 t70 67.93 47.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.347 -0.842 . . . . 2.3999999999999999 110.725 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 85.1 p -127.98 164.16 38.88 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.612 -0.722 . . . . 0.56999999999999995 109.178 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.562 ' HG3' ' HD2' ' A' ' 19' ' ' PRO . 12.1 Cg_endo -57.43 -33.62 96.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.599 1.532 . . . . 0.65000000000000002 111.326 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.0 -52.53 34.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.917 -0.583 . . . . 0.35999999999999999 110.7 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.09 -41.56 97.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 2.0099999999999998 110.273 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.77 -22.74 63.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.46999999999999997 111.867 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.45 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.1 p -72.83 -9.73 59.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.27 0.557 . . . . 0.40000000000000002 110.359 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.12 31.4 5.05 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.559 -0.746 . . . . 0.62 111.792 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 HD11 HG13 ' A' ' 37' ' ' ILE . 30.7 tp -97.13 139.53 32.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.019 -0.363 . . . . 0.65000000000000002 110.019 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -131.44 148.5 52.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 4.3799999999999999 109.506 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -73.23 149.87 42.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.093 -0.336 . . . . 1.4399999999999999 110.093 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 75.2 mt-30 78.89 5.91 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.191 0.932 . . . . 3.0600000000000001 111.477 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 47.9 m-20 -88.74 148.03 24.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 1.02 109.749 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' HE ' ' HA3' ' A' ' 34' ' ' GLY . 24.2 ttt180 -103.73 134.6 46.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 1.5700000000000001 111.24 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.94 130.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.642 . . . . 0.68000000000000005 110.031 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' A' ' 104' ' ' PRO . 41.3 t -111.24 -42.87 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.029 -0.532 . . . . 0.87 110.878 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.02 143.42 50.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.555 -0.293 . . . . 0.89000000000000001 110.506 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.7 120.03 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.804 -0.443 . . . . 0.66000000000000003 109.804 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 62.91 18.31 10.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.346 0.658 . . . . 1.1699999999999999 111.249 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 0.05 73.09 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.586 -0.816 . . . . 0.66000000000000003 111.858 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.11 128.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.855 -0.424 . . . . 1.1699999999999999 109.855 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.459 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 23.1 p -66.68 126.51 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.754 -0.657 . . . . 1.6799999999999999 111.773 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.3 mmt -133.68 38.81 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.81000000000000005 110.515 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' OE1' ' HB2' ' A' ' 64' ' ' CYS . 41.3 mp0 -61.22 -52.74 63.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 3.75 111.201 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.72 34.78 2.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.674 -0.774 . . . . 1.47 112.472 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.6 mmtp -79.58 -175.37 4.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.732 0.301 . . . . 3.3599999999999999 110.603 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -85.07 161.27 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.317 . . . . 2.8900000000000001 110.658 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -55.84 -42.81 76.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.859 -0.423 . . . . 1.4199999999999999 109.859 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.71 -39.11 94.82 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.5 -0.773 . . . . 0.71999999999999997 113.032 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.18 -47.59 79.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.969 0.384 . . . . 2.0299999999999998 111.354 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 65' ' ' MET . 48.7 t -64.55 -43.45 96.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.984 0.421 . . . . 1.0800000000000001 110.736 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 97.0 t -65.84 -41.89 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.71999999999999997 110.413 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -62.18 -44.95 95.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.66000000000000003 110.502 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.36 -39.56 76.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.41999999999999998 111.332 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.0 mt -57.46 -45.71 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.269 0.557 . . . . 0.68999999999999995 110.724 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 74' ' ' VAL . 10.2 mpt_? -75.25 -31.99 60.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.703 -0.681 . . . . 3.0899999999999999 110.983 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -14.75 63.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.65000000000000002 111.874 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.23 -13.83 67.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.824 -0.703 . . . . 0.59999999999999998 111.872 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.31 -99.82 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.869 -0.682 . . . . 1.1000000000000001 111.977 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 9.3 t70 -104.72 -21.58 13.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.856 0.36 . . . . 2.1200000000000001 110.528 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.29 162.29 31.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.844 0.354 . . . . 2.1099999999999999 110.497 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 t -148.75 148.46 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.978 -0.556 . . . . 0.32000000000000001 110.238 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HG2' HG23 ' A' ' 14' ' ' THR . 48.2 mttm -112.91 118.36 34.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.202 -0.453 . . . . 1.6299999999999999 109.954 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD12 ' HE3' ' A' ' 15' ' ' MET . 92.9 mt -105.82 127.66 53.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.976 0.417 . . . . 0.28000000000000003 109.983 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.9 tp -103.6 118.34 36.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.907 -0.775 . . . . 0.51000000000000001 108.907 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.2 m -125.52 162.0 29.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.109 -0.496 . . . . 0.33000000000000002 111.008 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 10' ' ' PRO . 8.3 m -126.95 142.95 41.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.41999999999999998 110.509 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -75.8 172.37 12.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.875 -0.602 . . . . 1.9199999999999999 109.785 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -59.65 -48.47 81.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.056 0.455 . . . . 4.1600000000000001 110.793 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.4 mp0 -65.48 -40.28 92.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.87 -0.604 . . . . 2.6800000000000002 110.273 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 8' ' ' LEU . 7.4 m -63.53 -50.9 67.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.31 -0.859 . . . . 0.46999999999999997 110.872 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 29.8 t70 -59.08 -41.69 88.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.874 -1.057 . . . . 1.1799999999999999 111.419 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.76 -36.93 62.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.414 -0.357 . . . . 1.9399999999999999 111.41 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.13 -47.54 84.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.72999999999999998 110.75 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -61.62 -38.26 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.44 111.524 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 24.2 mttp -66.32 -50.04 64.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.101 -0.24 . . . . 1.9199999999999999 111.567 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 16.5 ptmt -72.7 -18.47 61.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 2.04 111.42 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.6 t -89.84 -13.39 36.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.723 -0.843 . . . . 1.3899999999999999 108.723 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 68.12 33.46 4.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.633 -1.167 . . . . 4.0899999999999999 110.655 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.485 HG11 ' HG3' ' A' ' 114' ' ' PRO . 46.2 t -113.3 148.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.869 -1.06 . . . . 1.4199999999999999 109.987 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.7 mt -97.23 123.22 53.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 110.199 -0.297 . . . . 1.3300000000000001 110.199 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.607 ' HG2' HG11 ' A' ' 58' ' ' VAL . 36.9 Cg_endo -71.09 145.91 50.7 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.455 2.103 . . . . 0.53000000000000003 111.499 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.5 p -160.49 170.12 21.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.55 -0.295 . . . . 1.4199999999999999 110.97 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -55.89 -29.24 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.451 0.469 . . . . 1.6599999999999999 111.262 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -58.46 -30.83 67.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 2.8199999999999998 110.972 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -81.39 -15.35 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.53000000000000003 111.276 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.8 mt -67.42 -55.09 15.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.526 . . . . 1.24 110.349 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -97.58 16.61 19.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 3.7000000000000002 110.477 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.21 -163.54 11.35 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.907 -0.663 . . . . 1.1200000000000001 112.329 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -94.38 178.07 0.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.455 2.77 . . . . 1.3100000000000001 113.0 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.21 129.83 25.06 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 1.1100000000000001 109.137 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.485 ' HG3' HG11 ' A' ' 102' ' ' VAL . 34.9 Cg_endo -66.22 129.98 22.96 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.705 2.27 . . . . 1.1499999999999999 112.636 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 5.1 p -105.79 122.95 40.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 2.98 110.96 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.9 Cg_exo -75.34 126.32 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.594 2.196 . . . . 4.2300000000000004 111.535 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.7 66.5 7.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.499 0.666 . . . . 7.3300000000000001 110.694 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.6 m -149.07 21.0 0.98 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.213 1.006 . . . . 8.7799999999999994 108.64 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.21 98.34 9.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.788 -1.096 . . . . 9.3399999999999999 109.484 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.72 179.33 39.84 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.824 -0.703 . . . . 11.550000000000001 111.657 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.8 33.74 21.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.319 0.58 . . . . 13.92 111.048 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 14.7 pt -93.67 81.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.703 0.763 . . . . 16.210000000000001 110.808 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -110.21 -63.23 1.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.406 -0.816 . . . . 18.82 109.581 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm 50.08 78.27 0.1 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.291 -0.868 . . . . 20.829999999999998 111.474 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.44 -70.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 22.5 109.98 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -169.25 97.59 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.351 -0.84 . . . . 23.989999999999998 108.849 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.5 t -139.72 142.06 36.86 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.337 -0.392 . . . . 25.0 110.305 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.277 -0.868 . . . . 27.52 109.308 177.175 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.341 -0.704 . . . . 11.869999999999999 111.341 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 pt -88.16 47.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.666 0.746 . . . . 9.8599999999999994 110.175 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.618 ' O ' HG22 ' A' ' 6' ' ' THR . 10.1 m-20 -68.05 123.51 87.41 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.211 -0.904 . . . . 6.96 111.246 -174.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 17.4 Cg_exo -67.48 -6.35 16.31 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.969 2.446 . . . . 6.6500000000000004 112.892 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -103.28 13.41 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 7.9900000000000002 111.746 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.625 HG23 ' HG ' ' A' ' 8' ' ' LEU . 10.5 t -114.36 -173.95 2.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.804 -0.443 . . . . 4.2599999999999998 109.804 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.445 ' HB3' ' HG2' ' A' ' 9' ' ' ARG . 51.6 mtt -77.57 -70.54 0.47 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.663 0.246 . . . . 3.8399999999999999 111.663 -172.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 92' ' ' GLU . 26.1 mt 52.8 36.55 21.67 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.264 0.977 . . . . 0.80000000000000004 111.222 -174.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.968 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 18.3 ptp180 -137.96 141.79 33.73 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.046 -0.525 . . . . 3.0899999999999999 109.982 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HB2' HD21 ' A' ' 87' ' ' LEU . 30.2 Cg_endo -66.01 160.62 43.49 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.56 2.174 . . . . 0.46999999999999997 111.588 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.769 -0.65 . . . . 2.3700000000000001 110.431 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.61 HD13 HD12 ' A' ' 87' ' ' LEU . 63.0 tp -98.27 111.54 23.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 1.3200000000000001 109.765 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.534 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.8 m -98.8 117.1 32.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.40000000000000002 110.158 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.6 m -104.07 118.45 36.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.34999999999999998 108.539 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.524 ' HE3' HD12 ' A' ' 86' ' ' LEU . 21.4 ptp -131.04 133.6 45.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.101 0.476 . . . . 0.88 111.025 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 13.1 tmtt? -105.23 143.56 33.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 2.5800000000000001 109.258 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 ttmt -64.43 117.53 7.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.102 0.477 . . . . 0.92000000000000004 111.371 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.79 -124.03 4.08 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.618 -0.719 . . . . 1.28 111.869 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.15 -67.59 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.762 2.308 . . . . 2.23 113.223 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.2 m -121.18 34.87 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 2.8700000000000001 111.048 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.14 -141.45 12.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.546 -0.835 . . . . 1.9299999999999999 111.989 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 44' ' ' SER . 40.4 m-85 -107.22 -34.38 7.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.151 0.501 . . . . 1.8200000000000001 110.028 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.47 68.36 0.95 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.153 -0.93 . . . . 0.42999999999999999 112.91 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -156.88 156.7 33.58 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.802 -0.444 . . . . 0.40000000000000002 109.802 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -119.74 137.59 53.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.304 -0.407 . . . . 2.1800000000000002 110.143 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.62 153.88 19.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.456 0.646 . . . . 1.52 112.204 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 2.4 m-70 -105.8 121.57 44.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.005 -0.998 . . . . 1.3400000000000001 108.352 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -134.84 87.74 2.37 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.903 -0.777 . . . . 2.2999999999999998 108.903 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.6 t70 -86.76 137.39 32.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.087 -0.96 . . . . 3.48 109.968 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 1.1 57.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 4.54 110.88 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.46 -52.32 3.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.813 -0.81 . . . . 3.4900000000000002 108.813 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 16.6 pttp -110.78 113.18 55.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.757 . . . . 3.0 110.443 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 163.02 39.88 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.902 2.401 . . . . 2.2400000000000002 113.192 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.64 145.82 8.94 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.899 -0.667 . . . . 1.29 111.555 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.76 126.95 41.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.282 0.563 . . . . 1.5 110.565 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.641 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 50.0 m-85 -124.5 158.04 33.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.233 -0.894 . . . . 0.87 109.096 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.3 mm -87.66 112.39 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.461 -0.57 . . . . 0.39000000000000001 109.461 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HA ' ' CD2' ' A' ' 27' ' ' HIS . 6.9 tmm_? -69.35 -55.68 9.72 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.097 -0.705 . . . . 2.8300000000000001 109.097 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -163.15 143.54 9.17 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.485 -0.931 . . . . 1.26 108.485 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.93 122.64 50.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.048 -0.723 . . . . 0.37 109.048 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 14.2 m-20 -62.29 115.29 15.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.499 -0.556 . . . . 2.2799999999999998 109.499 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 19.6 Cg_endo -58.0 150.88 61.58 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.857 2.372 . . . . 1.1699999999999999 113.003 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 66.66 47.65 1.55 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.039 -0.982 . . . . 2.3999999999999999 110.33 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 90.2 p -133.6 160.85 66.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.95 -0.568 . . . . 0.56999999999999995 110.629 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -28.53 83.81 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.443 2.095 . . . . 0.65000000000000002 111.451 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.42 76.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.35999999999999999 110.409 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -67.49 -41.54 84.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 2.0099999999999998 110.107 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.62 69.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.46999999999999997 111.975 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.534 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 62.0 p -70.72 -16.58 62.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.038 0.446 . . . . 0.40000000000000002 110.578 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.07 15.37 22.06 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.73 -0.748 . . . . 0.62 112.975 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -72.02 147.8 46.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.103 -0.332 . . . . 0.65000000000000002 110.103 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -140.84 157.62 45.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.957 -0.386 . . . . 4.3799999999999999 109.957 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -80.11 155.12 27.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.42 -0.355 . . . . 1.4399999999999999 110.831 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 83.8 mm-40 75.24 7.45 4.09 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.977 0.798 . . . . 3.0600000000000001 111.848 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 89.9 m-20 -93.12 154.91 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.946 -0.39 . . . . 1.02 109.946 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.604 ' HB3' HH11 ' A' ' 56' ' ' ARG . 0.0 OUTLIER -111.18 133.62 53.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.227 -0.442 . . . . 1.5700000000000001 109.888 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HA ' HG12 ' A' ' 88' ' ' VAL . 71.9 mt -78.25 124.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.68000000000000005 110.849 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.09 -25.78 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.899 -0.591 . . . . 0.87 112.08 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.2 mt-10 -140.24 145.2 37.05 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.32 . . . . 0.89000000000000001 110.625 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 65' ' ' MET . 96.6 t -131.44 124.83 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.66000000000000003 109.885 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.3 21.64 9.89 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.223 0.609 . . . . 1.1699999999999999 111.523 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.17 3.56 67.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.538 -0.839 . . . . 0.66000000000000003 112.665 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.95 128.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.105 -0.331 . . . . 1.1699999999999999 110.105 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.4 t -63.5 121.16 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 1.6799999999999999 110.467 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.806 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.9 mmt -108.72 -1.08 19.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 0.81000000000000005 111.238 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -71.86 84.28 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.47 0.652 . . . . 3.75 109.718 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.18 -8.29 5.09 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.627 -0.715 . . . . 1.47 111.749 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.806 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.8 mmtt -75.97 -172.36 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 3.3599999999999999 111.09 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -112.83 161.58 16.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 2.8900000000000001 110.216 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -56.28 -42.88 78.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 1.4199999999999999 110.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.59 -32.87 79.58 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.563 -0.827 . . . . 0.71999999999999997 112.503 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.5 -47.32 61.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 2.0299999999999998 110.432 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.477 HG12 ' SD ' ' A' ' 65' ' ' MET . 33.3 m -67.42 -41.92 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.944 -0.571 . . . . 1.0800000000000001 111.503 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.35 -40.05 81.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 0.71999999999999997 110.799 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -66.26 -38.23 87.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.66000000000000003 110.108 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.3 97.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.41999999999999998 111.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.554 HG23 HG21 ' A' ' 84' ' ' THR . 85.0 mt -58.38 -42.15 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.36 0.6 . . . . 0.68999999999999995 110.591 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -74.74 -35.83 62.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.66 -0.7 . . . . 3.0899999999999999 110.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.88 7.44 18.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.956 -0.566 . . . . 0.65000000000000002 111.869 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 -14.59 81.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.59999999999999998 112.013 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.01 -133.04 9.97 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.942 -0.863 . . . . 1.1000000000000001 110.942 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 2.9 t70 -103.85 11.17 36.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.524 0.678 . . . . 2.1200000000000001 109.69 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -149.2 159.58 44.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.298 -0.865 . . . . 2.1099999999999999 109.473 174.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.554 HG21 HG23 ' A' ' 77' ' ' ILE . 14.8 t -148.35 149.77 32.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.32000000000000001 110.52 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.536 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.1 mttt -110.89 117.07 32.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.059 -0.518 . . . . 1.6299999999999999 110.014 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.524 HD12 ' HE3' ' A' ' 15' ' ' MET . 85.0 mt -106.73 118.98 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.703 -0.48 . . . . 0.28000000000000003 109.703 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.61 HD12 HD13 ' A' ' 12' ' ' LEU . 4.8 tt -106.79 119.93 40.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.067 -0.716 . . . . 0.51000000000000001 109.067 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 57' ' ' ILE . 35.5 m -126.59 166.76 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.226 -0.443 . . . . 0.33000000000000002 110.958 -173.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 m -127.33 136.93 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.41999999999999998 110.72 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 166.37 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.368 -0.833 . . . . 1.9199999999999999 110.37 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -56.06 -47.5 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.302 . . . . 4.1600000000000001 110.843 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.647 ' HG3' HD23 ' A' ' 8' ' ' LEU . 11.2 pt-20 -60.57 -38.24 83.92 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.3 0.571 . . . . 2.6800000000000002 110.314 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.411 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 25.9 m -71.25 -48.35 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.24 -0.891 . . . . 0.46999999999999997 110.691 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.516 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 24.7 t70 -60.55 -49.04 79.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.959 -0.564 . . . . 1.1799999999999999 110.966 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.496 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 36.2 mt-10 -64.83 -27.55 68.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.9399999999999999 111.141 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.37 -48.52 55.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 0.72999999999999998 110.034 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 93' ' ' THR . 41.9 m-85 -66.71 -36.74 83.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.377 -0.374 . . . . 0.44 111.82 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.7 mtpp -57.79 -50.14 74.27 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.665 0.246 . . . . 1.9199999999999999 111.665 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 11.2 ptmm? -71.48 -33.96 69.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 2.04 110.757 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -75.55 -11.28 59.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.529 -0.759 . . . . 1.3899999999999999 111.969 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 55.71 33.49 21.46 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.406 0.682 . . . . 4.0899999999999999 111.174 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.31 143.74 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 1.4199999999999999 110.19 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.78 117.26 67.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.059 -0.349 . . . . 1.3300000000000001 110.059 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.77 140.86 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.349 2.033 . . . . 0.53000000000000003 111.51 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -157.73 175.07 14.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.427 -0.351 . . . . 1.4199999999999999 111.195 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.539 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 10.8 mt-30 -53.62 -34.77 59.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.266 0.555 . . . . 1.6599999999999999 111.127 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -59.3 -30.04 68.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.589 -0.732 . . . . 2.8199999999999998 111.026 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -87.81 -12.85 43.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.53000000000000003 112.103 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.55 HD21 HD11 ' A' ' 87' ' ' LEU . 77.0 mt -55.0 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.188 0.44 . . . . 1.24 112.188 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.968 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 9.9 t30 72.54 -14.7 0.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.684 -0.689 . . . . 3.7000000000000002 112.225 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 112' ' ' PRO . . . -83.68 -121.13 0.8 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.725 -0.75 . . . . 1.1200000000000001 112.669 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 111' ' ' GLY . 52.4 Cg_endo -87.33 110.85 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.868 2.379 . . . . 1.3100000000000001 112.768 -176.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 58.2 mt -79.01 167.25 36.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.622 . . . . 1.1100000000000001 109.447 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -44.75 -50.01 8.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.668 2.245 . . . . 1.1499999999999999 112.877 175.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 96.3 t 68.75 121.13 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.902 -1.045 . . . . 2.98 110.878 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 3.9 Cg_exo -74.23 52.5 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.333 2.689 . . . . 4.2300000000000004 113.086 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.7 t80 62.85 96.59 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.826 0.851 . . . . 7.3300000000000001 112.952 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -125.44 -45.83 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.271 -1.011 . . . . 8.7799999999999994 108.271 168.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -108.43 179.07 4.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.962 -1.017 . . . . 9.3399999999999999 109.277 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.38 -168.86 39.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.475 -0.869 . . . . 11.550000000000001 113.145 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.15 121.74 25.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.917 0.389 . . . . 13.92 110.588 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.0 pt -76.7 -26.51 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.907 -0.588 . . . . 16.210000000000001 110.586 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 50.82 74.36 0.24 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.782 0.676 . . . . 18.82 112.75 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -116.35 156.97 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 20.829999999999998 110.169 174.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -175.0 -66.4 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 22.5 109.934 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.85 -34.09 57.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 23.989999999999998 110.341 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.1 t -145.05 159.7 42.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.716 -0.674 . . . . 25.0 109.968 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 128' ' ' ARG . 37.4 ttm180 . . . . . 0 C--O 1.25 1.119 0 O-C-N 124.205 0.94 . . . . 27.52 110.636 174.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.776 -0.529 . . . . 11.869999999999999 111.776 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.4 pt -114.44 138.79 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 9.8599999999999994 110.764 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.54 141.57 24.82 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.369 -0.604 . . . . 6.96 109.369 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.86 -71.13 0.04 OUTLIER 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.403 2.069 . . . . 6.6500000000000004 113.175 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -143.72 58.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.31 . . . . 7.9900000000000002 111.504 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -91.26 99.97 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.501 -0.555 . . . . 4.2599999999999998 109.501 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.5 ' HG3' ' HG2' ' A' ' 9' ' ' ARG . 22.0 ptp -94.98 -15.0 23.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.641 -0.708 . . . . 3.8399999999999999 111.763 -168.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 93' ' ' THR . 86.6 mt 62.93 19.37 11.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.613 -0.721 . . . . 0.80000000000000004 112.555 174.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.567 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 31.4 ptt180 -114.52 160.02 34.68 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.717 -0.846 . . . . 3.0899999999999999 108.717 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 30.7 Cg_endo -62.55 167.22 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.885 1.723 . . . . 0.46999999999999997 111.895 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.534 ' HG3' HG23 ' A' ' 88' ' ' VAL . 1.6 ptm180 -128.56 135.96 50.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.971 -0.559 . . . . 2.3700000000000001 110.347 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HG ' HD11 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -96.51 116.7 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 1.3200000000000001 110.248 -176.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 82.6 m -101.61 116.81 33.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.579 -0.526 . . . . 0.40000000000000002 109.579 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -108.79 120.27 41.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.399 -0.593 . . . . 0.34999999999999998 109.399 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.27 133.35 38.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.572 . . . . 0.88 111.548 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -101.87 144.23 30.78 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.375 -0.83 . . . . 2.5800000000000001 109.649 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.8 ttmt -65.66 113.01 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.036 0.446 . . . . 0.92000000000000004 110.562 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.01 -99.72 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.444 -0.798 . . . . 1.28 111.323 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.43 97.97 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.761 2.307 . . . . 2.23 112.327 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 t 71.39 -47.19 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.004 0.922 . . . . 2.8700000000000001 112.554 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 161.02 81.57 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.375 -0.917 . . . . 1.9299999999999999 112.83 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 44' ' ' SER . 23.3 m-85 68.13 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.267 0.627 . . . . 1.8200000000000001 111.601 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.81 69.76 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.896 -0.669 . . . . 0.42999999999999999 112.817 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.31 154.06 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.705 -0.48 . . . . 0.40000000000000002 109.705 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -119.27 131.46 55.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.806 0.336 . . . . 2.1800000000000002 110.99 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.42 133.61 45.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.016 -0.538 . . . . 1.52 110.222 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.1 p80 -120.44 139.38 52.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 1.3400000000000001 110.601 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 133.22 52.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.998 -0.741 . . . . 2.2999999999999998 108.998 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.702 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.6 t70 -87.29 142.33 27.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.115 0.483 . . . . 3.48 110.478 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -77.72 -27.99 50.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.663 -0.699 . . . . 4.54 111.201 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 m -93.24 -43.39 8.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.253 -0.43 . . . . 3.4900000000000002 110.568 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 24.1 pttm -116.9 130.52 24.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 3.0 110.399 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.54 156.43 36.22 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.521 2.148 . . . . 2.2400000000000002 112.735 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.74 159.98 10.84 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.896 -0.669 . . . . 1.29 112.165 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -97.33 128.66 44.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.915 0.388 . . . . 1.5 110.163 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.447 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 68.8 m-85 -121.98 148.91 44.21 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.696 -0.853 . . . . 0.87 108.696 175.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 55' ' ' ASP . 38.2 mm -68.32 109.25 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 0.39000000000000001 109.775 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -65.81 -54.45 26.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.235 -1.024 . . . . 2.8300000000000001 108.235 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 m -166.34 135.46 3.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 1.26 109.348 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -94.65 121.81 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.386 -0.968 . . . . 0.37 108.386 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -78.22 121.52 84.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.255 -0.43 . . . . 2.2799999999999998 110.032 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.75 155.98 20.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.513 2.809 . . . . 1.1699999999999999 112.584 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.7 51.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.998 0.904 . . . . 2.3999999999999999 109.218 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.2 p -146.94 154.56 47.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.979 -1.009 . . . . 0.56999999999999995 109.508 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.89 -25.55 78.25 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 0.65000000000000002 111.705 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.2 70.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.35999999999999999 110.339 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -67.97 -35.0 77.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.218 0.533 . . . . 2.0099999999999998 109.808 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -18.97 60.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.566 -0.743 . . . . 0.46999999999999997 111.58 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 24.2 p -70.42 -18.1 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.138 0.494 . . . . 0.40000000000000002 109.78 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.31 -0.57 33.01 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.986 -0.626 . . . . 0.62 112.141 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD11 HG13 ' A' ' 37' ' ' ILE . 22.4 tp -61.76 139.39 58.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.541 0.21 . . . . 0.65000000000000002 110.735 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -124.56 -164.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.459 -0.571 . . . . 4.3799999999999999 109.459 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.0 140.72 29.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.971 0.415 . . . . 1.4399999999999999 111.081 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 68.91 26.82 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.952 -1.022 . . . . 3.0600000000000001 113.013 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.555 ' HB2' HG13 ' A' ' 37' ' ' ILE . 6.2 m-20 -69.7 142.93 53.25 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.377 -0.971 . . . . 1.02 108.377 167.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -108.69 128.44 54.86 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.517 -0.549 . . . . 1.5700000000000001 109.517 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 88' ' ' VAL . 24.4 mm -71.91 130.1 35.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 0.68000000000000005 111.257 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 104' ' ' PRO . 58.2 t -111.79 -51.52 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.87 109.959 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.6 mt-10 -136.89 152.49 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.746 -0.661 . . . . 0.89000000000000001 110.283 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 77' ' ' ILE . 87.7 t -129.45 115.7 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.527 . . . . 0.66000000000000003 109.579 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.21 26.49 15.89 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.478 0.486 . . . . 1.1699999999999999 111.157 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.54 13.31 67.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.852 -0.69 . . . . 0.66000000000000003 112.524 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.68 122.77 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.718 -0.475 . . . . 1.1699999999999999 109.718 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.577 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.1 t -65.53 129.77 40.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.037 -0.529 . . . . 1.6799999999999999 111.338 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.472 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.0 mmt -115.27 14.71 16.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.81000000000000005 111.159 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 103' ' ' ILE . 56.5 mm-40 -62.31 -31.06 71.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.622 . . . . 3.75 111.489 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.96 20.32 14.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 1.47 112.098 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 72' ' ' ASP . 71.9 mmtt -101.45 177.43 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.934 0.397 . . . . 3.3599999999999999 110.749 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -125.61 -178.39 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.9 -0.591 . . . . 2.8900000000000001 109.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -54.12 -41.15 68.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.781 0.289 . . . . 1.4199999999999999 111.781 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.62 93.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.643 -0.789 . . . . 0.71999999999999997 112.831 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 10.4 m-20 -65.58 -45.99 81.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 2.0299999999999998 110.972 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 77' ' ' ILE . 98.7 t -62.54 -46.96 95.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 1.0800000000000001 110.87 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.51 -37.87 78.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.834 0.349 . . . . 0.71999999999999997 111.444 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.6 t -61.55 -38.79 88.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.74 -0.467 . . . . 0.66000000000000003 109.74 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.58 78.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.41999999999999998 111.194 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 73' ' ' VAL . 28.7 mm -57.35 -42.46 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.678 0.751 . . . . 0.68999999999999995 109.378 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -74.81 -37.31 62.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.051 -0.977 . . . . 3.0899999999999999 111.079 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -6.36 40.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.543 . . . . 0.65000000000000002 111.988 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.16 -28.18 68.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.59999999999999998 112.578 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.74 -120.15 4.74 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.768 -0.73 . . . . 1.1000000000000001 111.442 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 51.4 m-20 -108.74 7.68 26.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 2.1200000000000001 110.482 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.39 156.73 41.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.75 . . . . 2.1099999999999999 108.974 171.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.32000000000000001 110.076 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -116.89 119.89 36.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 1.6299999999999999 109.596 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.2 128.26 53.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.979 -0.555 . . . . 0.28000000000000003 110.092 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 10' ' ' PRO . 23.2 tp -103.66 115.2 30.06 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.288 -1.004 . . . . 0.51000000000000001 108.288 174.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.534 HG23 ' HG3' ' A' ' 11' ' ' ARG . 16.1 m -127.58 163.89 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 111.044 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.38 139.15 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.591 -0.731 . . . . 0.41999999999999998 110.082 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.79 175.88 9.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.167 -0.469 . . . . 1.9199999999999999 109.817 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 91' ' ' ARG . 3.3 tpp180 -62.5 -42.04 99.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.708 0.262 . . . . 4.1600000000000001 111.708 -171.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.32 -42.91 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 2.6800000000000002 110.715 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' LEU . 85.7 m -66.48 -45.83 78.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.856 -0.611 . . . . 0.46999999999999997 111.451 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 40.7 t0 -58.97 -47.44 85.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 1.1799999999999999 109.318 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 68.2 mm-40 -59.95 -37.67 80.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 1.9399999999999999 110.821 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.65 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 84.5 t80 -62.96 -49.34 75.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.512 -0.313 . . . . 0.72999999999999998 110.973 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.415 ' HD1' HG13 ' A' ' 102' ' ' VAL . 32.1 m-85 -66.64 -38.15 86.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.601 -0.272 . . . . 0.44 111.45 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.1 mtpp -60.28 -48.79 80.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.721 0.296 . . . . 1.9199999999999999 111.326 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.2 pttt -71.47 -14.55 62.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.277 -0.419 . . . . 2.04 111.295 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.32 -10.62 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 1.3899999999999999 111.257 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.78 28.23 17.98 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.821 -0.627 . . . . 4.0899999999999999 111.502 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.658 HG11 ' HG3' ' A' ' 114' ' ' PRO . 10.1 p -123.82 142.12 41.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.998 0.428 . . . . 1.4199999999999999 110.848 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.74 HG23 ' HG3' ' A' ' 66' ' ' GLU . 70.5 mt -79.4 128.43 75.36 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.718 -0.674 . . . . 1.3300000000000001 110.971 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.681 ' HB2' HG11 ' A' ' 58' ' ' VAL . 6.1 Cg_exo -71.9 160.28 48.16 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.069 2.513 . . . . 0.53000000000000003 111.602 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -165.31 164.96 19.79 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.921 -0.312 . . . . 1.4199999999999999 110.735 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -59.22 -28.53 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 1.6599999999999999 110.931 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -58.91 -30.53 67.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.031 0.443 . . . . 2.8199999999999998 110.892 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -77.52 -15.16 59.44 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.53000000000000003 111.509 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.427 HD11 ' HG ' ' A' ' 12' ' ' LEU . 60.1 mt -65.01 -61.59 2.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.529 0.68 . . . . 1.24 110.455 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.37 19.72 9.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.127 -0.942 . . . . 3.7000000000000002 110.36 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.68 -175.81 14.17 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.855 -0.612 . . . . 1.1200000000000001 112.139 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -87.44 159.83 8.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.354 2.702 . . . . 1.3100000000000001 112.568 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' A' ' 9' ' ' ARG . 45.3 mt -84.74 154.34 61.52 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.772 -0.649 . . . . 1.1100000000000001 109.321 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.658 ' HG3' HG11 ' A' ' 102' ' ' VAL . 31.4 Cg_endo -64.57 112.52 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.506 2.138 . . . . 1.1499999999999999 112.717 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 15.5 m -150.22 145.93 19.37 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 114.778 -1.101 . . . . 2.98 109.57 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.9 Cg_exo -78.41 67.31 8.32 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.981 2.454 . . . . 4.2300000000000004 111.441 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -98.12 99.36 10.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 7.3300000000000001 110.895 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.2 m 59.09 -85.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.457 0.703 . . . . 8.7799999999999994 112.209 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -151.33 31.55 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 9.3399999999999999 109.646 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.15 66.91 2.5 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.553 -0.748 . . . . 11.550000000000001 113.214 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.6 105.38 17.33 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.283 -0.636 . . . . 13.92 109.283 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.3 pt -71.62 125.29 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 16.210000000000001 111.365 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -81.98 65.66 7.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.04 -0.527 . . . . 18.82 111.141 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -84.09 -6.26 59.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.628 -0.714 . . . . 20.829999999999998 109.62 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.01 -55.24 11.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.303 -0.862 . . . . 22.5 110.533 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -100.27 114.55 28.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.925 -0.58 . . . . 23.989999999999998 110.523 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m -111.34 44.21 1.36 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 25.0 111.657 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 128' ' ' ARG . 34.4 ttt180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.349 -0.834 . . . . 27.52 110.198 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.532 -0.627 . . . . 11.869999999999999 111.532 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.4 mt 53.0 86.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.375 0.607 . . . . 9.8599999999999994 111.216 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.12 139.0 95.01 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.71 -0.677 . . . . 6.96 110.75 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.35 46.66 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.115 2.543 . . . . 6.6500000000000004 111.888 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 62.3 74.33 0.44 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.413 -0.812 . . . . 7.9900000000000002 110.494 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -89.16 36.02 0.81 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.6 0.714 . . . . 4.2599999999999998 110.286 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 62.3 mtt -91.86 20.37 5.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.729 -0.669 . . . . 3.8399999999999999 110.271 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.67 54.84 2.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.542 -0.753 . . . . 0.80000000000000004 110.078 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 32.2 ptt180 -119.98 161.4 38.55 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.434 -0.803 . . . . 3.0899999999999999 109.948 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.613 ' HB2' HD11 ' A' ' 87' ' ' LEU . 6.8 Cg_exo -70.28 169.73 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.463 2.109 . . . . 0.46999999999999997 111.703 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HG3' HG23 ' A' ' 88' ' ' VAL . 6.5 ptt180 -128.5 131.37 48.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 2.3700000000000001 110.505 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 85' ' ' LYS . 48.7 tp -95.43 110.57 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.009 -0.541 . . . . 1.3200000000000001 109.623 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 60.0 m -92.98 117.8 30.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 110.23 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 85' ' ' LYS . 23.8 m -106.56 118.76 37.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.487 -0.56 . . . . 0.34999999999999998 109.487 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.9 ptp -133.79 133.65 41.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.826 -0.624 . . . . 0.88 110.486 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.66 136.73 52.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.046 -0.525 . . . . 2.5800000000000001 110.016 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 9.5 ttmt -54.65 119.07 4.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.478 -0.783 . . . . 0.92000000000000004 111.337 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.43 -107.37 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.568 -0.825 . . . . 1.28 112.678 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.88 -66.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.163 2.575 . . . . 2.23 112.904 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 t -140.86 85.45 1.99 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.375 -0.602 . . . . 2.8700000000000001 109.375 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.32 -132.1 11.44 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.542 -0.837 . . . . 1.9299999999999999 111.724 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 44' ' ' SER . 48.7 m-85 -119.99 -31.5 4.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.173 0.511 . . . . 1.8200000000000001 110.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.42 68.05 1.2 Allowed Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.327 -0.851 . . . . 0.42999999999999999 113.245 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -156.92 151.89 26.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.753 -0.462 . . . . 0.40000000000000002 109.753 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.9 m120 -101.45 135.35 43.11 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.194 -0.669 . . . . 2.1800000000000002 109.194 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -101.29 151.18 22.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.045 0.45 . . . . 1.52 111.352 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -108.9 122.1 46.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.78 -0.646 . . . . 1.3400000000000001 110.1 -177.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m -121.53 99.37 6.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.881 -0.414 . . . . 2.2999999999999998 109.881 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -98.03 122.54 41.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.949 0.405 . . . . 3.48 111.234 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -89.37 48.67 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.305 0.574 . . . . 4.54 109.872 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 t -158.21 -66.78 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.481 -0.781 . . . . 3.4900000000000002 109.349 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -95.67 119.67 64.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.847 -0.427 . . . . 3.0 109.847 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.64 150.85 69.45 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.871 2.381 . . . . 2.2400000000000002 112.691 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.8 172.11 13.46 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.267 -0.879 . . . . 1.29 110.981 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HG3' HG21 ' A' ' 73' ' ' VAL . 23.0 mm-40 -125.09 128.04 47.85 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.466 -0.568 . . . . 1.5 109.466 175.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.2 m-85 -119.96 157.79 28.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.737 -0.468 . . . . 0.87 109.737 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.556 HG13 HD11 ' A' ' 51' ' ' LEU . 47.5 mm -91.21 109.89 21.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.29 0.566 . . . . 0.39000000000000001 109.541 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 28.5 ttt180 -63.15 -48.19 79.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.93 -1.032 . . . . 2.8300000000000001 109.892 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -162.36 160.34 26.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.571 -0.9 . . . . 1.26 108.571 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.58 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.417 -0.586 . . . . 0.37 109.417 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.45 125.84 89.4 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.877 -0.416 . . . . 2.2799999999999998 109.877 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 141.85 97.92 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.747 2.298 . . . . 1.1699999999999999 112.069 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 64.59 49.86 2.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.609 -0.723 . . . . 2.3999999999999999 110.756 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 95.6 p -126.88 158.62 67.89 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.795 -0.639 . . . . 0.56999999999999995 110.234 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 11.3 Cg_endo -57.99 -27.86 80.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.257 1.971 . . . . 0.65000000000000002 111.147 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.97 59.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.35999999999999999 110.465 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.49 -38.23 90.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.286 -0.415 . . . . 2.0099999999999998 110.762 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.67 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.46999999999999997 111.415 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 59.5 p -70.68 -14.47 62.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.896 0.379 . . . . 0.40000000000000002 111.03 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.99 7.07 29.5 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.018 -0.61 . . . . 0.62 112.899 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 37' ' ' ILE . 19.7 tp -76.61 130.51 37.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.546 0.212 . . . . 0.65000000000000002 110.579 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.16 -163.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 4.3799999999999999 110.951 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.56 140.02 29.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.474 . . . . 1.4399999999999999 111.207 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 70.34 15.85 7.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.307 -0.86 . . . . 3.0600000000000001 112.162 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.1 m-20 -69.48 128.39 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.986 -0.376 . . . . 1.02 109.986 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.5 123.79 36.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 1.5700000000000001 110.583 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.16 124.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.68000000000000005 110.793 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.414 HG11 ' HD2' ' A' ' 104' ' ' PRO . 43.1 t -105.29 -45.15 8.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.87 110.949 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.5 mt-10 -132.82 153.52 51.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.89000000000000001 110.479 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -126.77 120.97 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.112 -0.495 . . . . 0.66000000000000003 109.842 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 63.57 17.77 10.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.192 0.597 . . . . 1.1699999999999999 111.205 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.512 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.8 4.62 65.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.66000000000000003 112.528 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.88 128.69 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.66 0.267 . . . . 1.1699999999999999 110.38 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.5 m -59.38 118.67 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.724 -0.671 . . . . 1.6799999999999999 111.558 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.8 mmt -126.88 70.79 1.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.81000000000000005 111.774 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -135.43 139.42 44.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.968 -0.382 . . . . 3.75 109.968 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.5 -0.46 89.25 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.938 -1.265 . . . . 1.47 109.938 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -74.2 163.56 27.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.15 -1.025 . . . . 3.3599999999999999 111.724 -178.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.4 177.81 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.594 -0.891 . . . . 2.8900000000000001 108.594 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -63.0 -37.85 88.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.841 0.353 . . . . 1.4199999999999999 110.684 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.79 92.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.256 -0.497 . . . . 0.71999999999999997 113.112 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.96 -47.55 80.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.958 0.409 . . . . 2.0299999999999998 110.966 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.511 HG21 ' HG3' ' A' ' 35' ' ' GLN . 3.4 m -71.81 -41.87 69.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.844 -0.616 . . . . 1.0800000000000001 111.496 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.6 t -61.99 -48.14 89.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.637 -0.256 . . . . 0.71999999999999997 110.75 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 t -62.47 -37.67 86.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.552 -0.295 . . . . 0.66000000000000003 110.303 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.89 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.797 0.332 . . . . 0.41999999999999998 111.468 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.95 -41.21 90.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 0.68999999999999995 110.805 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 69.0 mtp180 -74.03 -35.71 64.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 3.0899999999999999 111.091 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.17 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.65000000000000002 110.938 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.19 -21.06 67.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.021 -0.609 . . . . 0.59999999999999998 112.1 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -117.99 5.11 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.029 -0.605 . . . . 1.1000000000000001 111.963 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 39.6 m-20 -113.97 8.89 17.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 2.1200000000000001 110.876 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.06 160.22 42.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.11 -0.7 . . . . 2.1099999999999999 109.11 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.3 t -153.19 148.81 27.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.861 0.362 . . . . 0.32000000000000001 110.594 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HB3' HD11 ' A' ' 12' ' ' LEU . 6.9 mptt -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.389 -0.597 . . . . 1.6299999999999999 109.389 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.29 133.77 49.5 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.801 -0.444 . . . . 0.28000000000000003 109.801 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.613 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.3 tp -103.84 115.99 31.48 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.17 -0.678 . . . . 0.51000000000000001 109.17 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 14.3 m -131.62 155.41 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.019 -0.537 . . . . 0.33000000000000002 111.209 -173.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.72 146.95 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.411 -0.813 . . . . 0.41999999999999998 110.331 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.06 176.85 6.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.793 -0.64 . . . . 1.9199999999999999 109.396 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 ttm105 -56.4 -47.92 78.0 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.786 0.291 . . . . 4.1600000000000001 111.786 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.72 -40.82 89.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.116 0.484 . . . . 2.6800000000000002 110.819 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 -48.12 29.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.726 -0.67 . . . . 0.46999999999999997 111.154 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 5.5 t0 -60.78 -43.43 98.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 1.1799999999999999 110.307 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.33 -37.44 77.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.256 -0.429 . . . . 1.9399999999999999 110.669 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.431 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 91.3 t80 -63.16 -47.39 82.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.72999999999999998 110.296 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -67.4 -37.12 82.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.266 -0.425 . . . . 0.44 111.71 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 58.4 mttm -58.56 -50.15 74.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.913 0.387 . . . . 1.9199999999999999 110.821 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 96' ' ' PHE . 19.3 ptmt -69.7 -22.35 63.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.742 -0.663 . . . . 2.04 110.904 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.37 -16.41 37.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.563 . . . . 1.3899999999999999 111.072 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER 61.07 37.18 18.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.489 -0.778 . . . . 4.0899999999999999 111.393 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.488 HG11 ' HG3' ' A' ' 114' ' ' PRO . 12.7 p -134.54 138.18 50.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.891 0.376 . . . . 1.4199999999999999 110.688 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 70.0 mt -77.85 131.66 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 1.3300000000000001 110.748 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.476 ' HB3' ' HG3' ' A' ' 10' ' ' PRO . 5.9 Cg_exo -70.54 153.43 65.34 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.946 2.431 . . . . 0.53000000000000003 111.881 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 108' ' ' HIS . 21.9 p -158.19 178.39 10.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.592 -0.277 . . . . 1.4199999999999999 110.398 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.554 ' HA ' ' CD2' ' A' ' 109' ' ' LEU . 2.7 mp0 -55.61 -38.01 68.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 1.6599999999999999 110.722 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.91 -31.28 69.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.248 0.547 . . . . 2.8199999999999998 110.965 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.445 ' HD2' ' HD3' ' A' ' 114' ' ' PRO . 35.7 m80 -83.04 -25.48 32.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.53000000000000003 111.584 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 106' ' ' GLN . 4.4 pp -95.34 -28.87 14.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.769 -0.651 . . . . 1.24 110.959 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.424 ' N ' HD12 ' A' ' 109' ' ' LEU . 23.0 t-20 -93.42 -23.79 18.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 3.7000000000000002 110.034 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.51 -145.72 9.71 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.923 -0.656 . . . . 1.1200000000000001 112.299 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.78 169.01 2.51 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.151 2.568 . . . . 1.3100000000000001 112.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -90.53 151.16 43.83 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.709 -0.678 . . . . 1.1100000000000001 110.095 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.488 ' HG3' HG11 ' A' ' 102' ' ' VAL . 74.1 Cg_endo -73.17 165.21 33.3 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 123.13 2.553 . . . . 1.1499999999999999 112.351 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 7.3 p -88.56 124.09 66.67 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.923 -0.581 . . . . 2.98 109.92 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 19.3 Cg_exo -65.97 88.17 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.83 2.353 . . . . 4.2300000000000004 111.77 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -72.52 125.92 28.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.994 -0.548 . . . . 7.3300000000000001 110.234 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.6 m 62.55 68.83 0.63 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.646 -0.706 . . . . 8.7799999999999994 110.497 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -124.29 69.32 1.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.774 . . . . 9.3399999999999999 109.539 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.72 55.82 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.852 -0.69 . . . . 11.550000000000001 111.871 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -73.73 95.81 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 13.92 109.423 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.7 pt -84.7 107.46 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.597 0.713 . . . . 16.210000000000001 112.496 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -103.82 74.35 1.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.809 -0.812 . . . . 18.82 108.809 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -122.96 71.48 1.05 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.571 -0.529 . . . . 20.829999999999998 109.571 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.63 3.12 17.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 22.5 110.35 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.64 -37.54 0.33 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.679 0.791 . . . . 23.989999999999998 111.707 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.7 t 74.45 -42.81 0.51 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.945 0.898 . . . . 25.0 110.797 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.536 -0.745 . . . . 27.52 109.918 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 111.407 -0.677 . . . . 11.869999999999999 111.407 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.43 61.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.475 -0.935 . . . . 9.8599999999999994 108.475 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 6' ' ' THR . 6.1 m-20 -78.19 125.86 84.39 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.156 -0.929 . . . . 6.96 110.521 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.45 -9.99 27.65 Favored 'Trans proline' 0 C--O 1.229 0.074 0 C-N-CA 122.834 2.356 . . . . 6.6500000000000004 112.462 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -107.14 11.5 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.914 0.339 . . . . 7.9900000000000002 111.914 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' ' 9' ' ' ARG . 12.9 t -78.38 -35.95 46.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.166 -1.05 . . . . 4.2599999999999998 108.166 171.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.3 ttm 62.4 11.43 4.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.449 -1.25 . . . . 3.8399999999999999 112.419 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.482 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 88.6 mt 59.62 34.92 22.39 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.635 0.731 . . . . 0.80000000000000004 110.57 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 6' ' ' THR . 14.2 ptt180 -123.78 147.89 54.86 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.022 -0.99 . . . . 3.0899999999999999 109.025 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HB2' HD11 ' A' ' 87' ' ' LEU . 30.8 Cg_endo -68.52 149.62 74.52 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.586 1.524 . . . . 0.46999999999999997 110.798 172.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -120.6 135.49 55.08 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.283 -0.417 . . . . 2.3700000000000001 110.25 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -92.68 111.25 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.957 -0.565 . . . . 1.3200000000000001 110.159 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.29 117.61 30.37 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.517 -0.765 . . . . 0.40000000000000002 109.368 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' LYS . 27.0 m -109.57 119.05 38.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.685 -0.487 . . . . 0.34999999999999998 109.685 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.605 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 24.4 ptp -131.33 133.59 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.04 0.447 . . . . 0.88 111.003 -174.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -97.9 132.63 43.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.871 -0.604 . . . . 2.5800000000000001 109.421 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 20.6 ttmt -50.67 129.21 22.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.925 -0.58 . . . . 0.92000000000000004 111.517 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.97 -158.42 24.36 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.771 -0.728 . . . . 1.28 111.588 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.74 -27.46 44.57 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.06 2.507 . . . . 2.23 112.642 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 p -105.16 13.87 30.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.039 -0.528 . . . . 2.8700000000000001 110.563 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.06 2.73 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.615 -0.803 . . . . 1.9299999999999999 111.182 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.39 159.95 36.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.488 -0.93 . . . . 1.8200000000000001 108.488 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.78 75.17 0.4 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 119.883 -1.151 . . . . 0.42999999999999999 113.298 -173.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.03 168.77 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.849 0.357 . . . . 0.40000000000000002 110.54 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -131.53 143.27 50.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.914 -0.585 . . . . 2.1800000000000002 110.552 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.56 145.17 30.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.484 0.659 . . . . 1.52 111.835 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -110.65 129.38 55.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 1.3400000000000001 109.426 172.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.7 m -151.72 84.03 1.29 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.58 -0.896 . . . . 2.2999999999999998 108.58 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.0 153.23 21.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.326 -0.852 . . . . 3.48 111.074 -171.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -82.47 49.71 1.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.689 0.756 . . . . 4.54 109.72 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 t -151.33 -38.53 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.641 -1.163 . . . . 3.4900000000000002 109.261 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -141.45 128.18 11.49 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.795 -0.638 . . . . 3.0 109.979 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.77 158.28 35.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.551 2.167 . . . . 2.2400000000000002 112.41 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.46 166.26 13.07 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.224 -0.75 . . . . 1.29 111.224 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.568 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 2.7 mp0 -107.85 126.29 52.48 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.961 -0.385 . . . . 1.5 109.961 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 61.6 m-85 -117.61 157.67 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.551 -0.907 . . . . 0.87 108.551 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG13 HD11 ' A' ' 51' ' ' LEU . 44.2 mm -90.91 109.43 20.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.598 -0.441 . . . . 0.39000000000000001 109.834 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -69.12 -54.63 13.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.889 -0.596 . . . . 2.8300000000000001 110.547 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -152.36 144.1 23.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.709 -0.678 . . . . 1.26 109.912 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.77 137.89 55.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.732 -0.47 . . . . 0.37 109.732 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -82.05 122.96 80.1 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.563 0.22 . . . . 2.2799999999999998 110.544 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -65.01 -19.68 63.78 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.867 2.378 . . . . 1.1699999999999999 112.538 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.78 4.51 52.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.913 -0.585 . . . . 2.3999999999999999 110.633 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 38.8 p -108.86 158.78 33.24 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 122.104 -0.372 . . . . 0.56999999999999995 110.783 -174.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 28.3 Cg_endo -63.06 -15.97 51.36 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.798 2.332 . . . . 0.65000000000000002 112.033 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -67.69 -51.51 48.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.096 -0.502 . . . . 0.35999999999999999 110.328 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' HG3' ' HA ' ' A' ' 42' ' ' PRO . 4.4 tm-20 -64.48 -40.65 96.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.918 -0.771 . . . . 2.0099999999999998 108.918 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.36 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.46999999999999997 111.966 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 15' ' ' MET . 60.3 p -77.32 -12.54 59.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.40000000000000002 110.898 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.25 9.44 27.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.783 -0.723 . . . . 0.62 112.734 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 37' ' ' ILE . 29.9 tp -78.17 141.58 38.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.727 0.298 . . . . 0.65000000000000002 110.497 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.8 tpp180 -143.63 164.82 29.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.383 -0.599 . . . . 4.3799999999999999 109.383 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.57 152.97 40.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.603 -0.271 . . . . 1.4399999999999999 111.231 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 74.64 11.32 3.92 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.061 0.851 . . . . 3.0600000000000001 112.135 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 17.9 m-20 -92.08 151.97 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.774 -0.454 . . . . 1.02 109.774 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -105.54 136.61 44.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.51 -0.313 . . . . 1.5700000000000001 110.666 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.65 130.15 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 0.68000000000000005 110.151 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.773 HG11 ' HG2' ' A' ' 104' ' ' PRO . 22.7 t -114.37 -47.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 0.87 111.057 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.5 mt-10 -126.29 148.82 49.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.887 0.375 . . . . 0.89000000000000001 110.928 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 63' ' ' VAL . 61.8 t -129.41 122.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.66000000000000003 109.206 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 62.87 21.09 12.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.785 0.434 . . . . 1.1699999999999999 111.056 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.3 74.73 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.733 -0.746 . . . . 0.66000000000000003 113.382 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 60' ' ' VAL . 14.6 p -107.61 138.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.38 0.59 . . . . 1.1699999999999999 110.111 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 50.9 t -74.5 136.81 42.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 1.6799999999999999 111.434 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.607 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 25.1 mmt -121.62 68.06 0.9 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.447 -0.797 . . . . 0.81000000000000005 111.128 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -103.69 -59.15 1.77 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.324 -0.398 . . . . 3.75 110.517 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.62 4.74 Favored Glycine 0 C--N 1.329 0.182 0 N-CA-C 111.548 -0.621 . . . . 1.47 111.548 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.607 ' HG2' ' HB3' ' A' ' 65' ' ' MET . 0.0 OUTLIER -110.94 -172.19 1.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.782 0.801 . . . . 3.3599999999999999 112.722 -171.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -121.46 150.0 42.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 2.8900000000000001 108.287 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -56.21 -43.7 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 118.267 0.485 . . . . 1.4199999999999999 110.162 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.66 88.15 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.696 -0.684 . . . . 0.71999999999999997 112.668 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.92 -40.03 83.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 2.0299999999999998 110.362 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 77' ' ' ILE . 63.9 t -65.29 -47.34 87.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.614 . . . . 1.0800000000000001 110.825 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' HA ' HD12 ' A' ' 77' ' ' ILE . 57.6 t -64.9 -36.78 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.21 0.529 . . . . 0.71999999999999997 110.071 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 t -61.58 -44.41 97.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.594 -0.73 . . . . 0.66000000000000003 110.163 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.82 -42.54 93.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.239 -0.437 . . . . 0.41999999999999998 111.227 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.522 HG23 HG21 ' A' ' 84' ' ' THR . 74.4 mt -58.9 -40.75 81.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.68999999999999995 110.773 177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 mtm-85 -74.18 -39.36 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 3.0899999999999999 110.976 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.68 10.47 9.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.65000000000000002 111.609 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.74 -33.77 74.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.207 -0.52 . . . . 0.59999999999999998 112.68 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.68 49.93 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 1.1000000000000001 111.63 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.634 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 32.2 m-20 67.54 1.57 2.6 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.574 0.749 . . . . 2.1200000000000001 112.485 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -151.6 154.28 36.13 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.825 -0.805 . . . . 2.1099999999999999 108.825 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.522 HG21 HG23 ' A' ' 77' ' ' ILE . 12.9 t -141.51 148.11 38.86 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.04 0.448 . . . . 0.32000000000000001 110.134 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 14' ' ' THR . 42.2 mttm -118.78 116.92 27.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.511 -0.551 . . . . 1.6299999999999999 109.511 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.6 mt -106.53 131.27 53.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.434 -0.348 . . . . 0.28000000000000003 110.128 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 10' ' ' PRO . 16.6 tp -103.79 117.12 33.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.934 -0.765 . . . . 0.51000000000000001 108.934 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 20.7 m -126.75 151.81 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.142 0.496 . . . . 0.33000000000000002 111.72 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.56 149.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.082 -0.963 . . . . 0.41999999999999998 109.717 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.243 -0.651 . . . . 1.9199999999999999 109.243 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -60.41 -43.89 96.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.89 0.33 . . . . 4.1600000000000001 111.89 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.08 -35.69 78.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.433 . . . . 2.6800000000000002 109.83 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 8' ' ' LEU . 89.6 m -69.3 -44.44 71.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.46999999999999997 110.832 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.631 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 33.7 t0 -58.77 -47.71 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.938 -0.393 . . . . 1.1799999999999999 109.938 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 50.1 mm-40 -61.1 -37.96 84.6 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.058 -0.519 . . . . 1.9399999999999999 110.823 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.723 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 66.6 t80 -62.11 -48.0 82.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.175 -0.466 . . . . 0.72999999999999998 110.672 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 102' ' ' VAL . 41.8 m-85 -67.34 -37.19 82.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.953 -0.567 . . . . 0.44 111.799 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.631 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 66.2 mttm -58.86 -50.82 72.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.051 0.453 . . . . 1.9199999999999999 111.385 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 18.9 pttp -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 2.04 111.367 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.494 ' HB3' HG12 ' A' ' 102' ' ' VAL . 35.4 t -82.4 -6.61 59.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.862 0.363 . . . . 1.3899999999999999 111.539 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER 56.68 40.65 29.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.638 -0.71 . . . . 4.0899999999999999 111.677 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.535 HG13 ' CD2' ' A' ' 97' ' ' PHE . 5.7 p -126.46 145.12 34.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.357 -0.383 . . . . 1.4199999999999999 110.492 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.38 121.66 67.21 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-O 120.979 0.419 . . . . 1.3300000000000001 111.113 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.773 ' HG2' HG11 ' A' ' 58' ' ' VAL . 24.4 Cg_endo -65.71 138.53 54.16 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.537 2.158 . . . . 0.53000000000000003 111.223 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.1 t -159.62 178.28 10.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.783 -0.451 . . . . 1.4199999999999999 109.783 -175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.534 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 99.3 mt-30 -54.75 -30.46 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.301 0.572 . . . . 1.6599999999999999 110.859 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.84 -30.39 67.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.616 -0.72 . . . . 2.8199999999999998 111.465 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -89.02 -14.0 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.482 0.549 . . . . 0.53000000000000003 112.482 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 95.8 mt -47.74 -54.54 11.9 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.348 0.405 . . . . 1.24 111.492 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -132.36 26.63 4.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.971 0.891 . . . . 3.7000000000000002 109.442 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.95 165.75 23.22 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.016 -0.993 . . . . 1.1200000000000001 110.776 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.74 124.9 12.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.221 1.947 . . . . 1.3100000000000001 112.172 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.14 127.52 93.52 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.197 -0.668 . . . . 1.1100000000000001 109.197 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.85 146.07 76.83 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 123.079 2.519 . . . . 1.1499999999999999 112.857 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 4.4 p -98.07 118.38 63.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.489 -0.778 . . . . 2.98 110.757 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.4 Cg_exo -74.56 132.11 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.831 2.354 . . . . 4.2300000000000004 111.454 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.408 ' HB3' ' H ' ' A' ' 118' ' ' THR . 98.3 m-85 59.4 -151.35 0.42 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 123.365 0.416 . . . . 7.3300000000000001 110.167 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.408 ' H ' ' HB3' ' A' ' 117' ' ' PHE . 54.7 m -143.17 106.52 4.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.76 0.315 . . . . 8.7799999999999994 110.546 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.98 105.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 9.3399999999999999 110.609 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.1 -94.4 0.55 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.602 -0.809 . . . . 11.550000000000001 112.642 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -92.18 72.96 5.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.354 0.597 . . . . 13.92 111.114 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.1 pt -105.82 1.52 10.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.147 -0.686 . . . . 16.210000000000001 109.147 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -142.44 104.45 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 18.82 110.159 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.32 118.96 32.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 20.829999999999998 110.152 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.13 155.92 29.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.297 -0.26 . . . . 22.5 110.297 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -122.01 76.87 1.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.468 -0.568 . . . . 23.989999999999998 109.468 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -145.62 -57.82 0.32 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 25.0 109.964 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.873 -0.584 . . . . 27.52 109.704 177.134 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 111.262 -0.735 . . . . 11.869999999999999 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.412 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 39.5 mm 62.71 76.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.41 0.624 . . . . 9.8599999999999994 110.246 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.79 110.61 42.85 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.626 -0.715 . . . . 6.96 110.864 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 2' ' ' ILE . 14.0 Cg_exo -70.05 -33.86 14.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.827 2.351 . . . . 6.6500000000000004 111.369 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.12 69.54 0.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.56 -0.745 . . . . 7.9900000000000002 109.795 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -64.18 121.01 13.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.492 0.663 . . . . 4.2599999999999998 110.732 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 mtt -127.89 32.62 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.673 -0.694 . . . . 3.8399999999999999 109.819 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 54.8 mt -92.44 38.88 1.02 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.395 -0.82 . . . . 0.80000000000000004 110.606 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -119.82 156.26 54.24 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 3.0899999999999999 108.938 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' HD11 ' A' ' 87' ' ' LEU . 65.6 Cg_endo -71.58 -174.3 1.23 Allowed 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.356 2.038 . . . . 0.46999999999999997 112.146 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.441 ' HG3' HG23 ' A' ' 88' ' ' VAL . 15.6 ptt85 -146.65 135.36 22.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.3700000000000001 110.848 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.581 ' HG ' HD11 ' A' ' 109' ' ' LEU . 7.3 mt -92.85 121.7 34.49 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.542 . . . . 1.3200000000000001 110.849 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.0 m -109.1 129.1 55.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.002 -0.544 . . . . 0.40000000000000002 109.601 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -112.37 118.53 35.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.731 -0.47 . . . . 0.34999999999999998 109.731 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 25.1 ptp -130.44 142.48 50.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.013 -0.365 . . . . 0.88 110.013 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 14.5 ptpt -121.12 156.52 32.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.003 0.43 . . . . 2.5800000000000001 110.123 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.649 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 8.7 ttmt -61.37 117.17 5.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.797 -1.092 . . . . 0.92000000000000004 111.651 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.66 -149.29 9.17 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.53 -0.759 . . . . 1.28 112.181 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.83 -33.07 27.98 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.676 2.251 . . . . 2.23 113.258 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -110.27 -21.09 12.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.17 0.509 . . . . 2.8700000000000001 110.589 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.649 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 144.59 -116.3 0.93 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.131 -0.787 . . . . 1.9299999999999999 111.131 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.26 160.71 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.72 -0.844 . . . . 1.8200000000000001 108.72 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.14 71.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.599 -1.286 . . . . 0.42999999999999999 113.462 -171.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -155.63 150.88 26.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.986 -0.376 . . . . 0.40000000000000002 109.986 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.15 131.94 54.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 2.1800000000000002 109.61 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.416 HD13 HE21 ' A' ' 35' ' ' GLN . 93.2 mt -101.3 136.93 40.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.367 -0.379 . . . . 1.52 110.414 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.1 p80 -124.47 125.17 43.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.116 0.484 . . . . 1.3400000000000001 110.48 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.497 ' HB3' ' OE1' ' A' ' 35' ' ' GLN . 4.4 p -102.13 132.77 47.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.338 -0.846 . . . . 2.2999999999999998 110.692 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.08 134.1 33.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.024 -0.732 . . . . 3.48 109.024 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -81.79 -14.99 55.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.483 -0.326 . . . . 4.54 110.709 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -91.03 -53.23 4.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 3.4900000000000002 109.802 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -109.84 104.36 55.31 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.0 110.244 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.07 144.27 80.37 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.997 2.465 . . . . 2.2400000000000002 113.32 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.86 178.19 22.86 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.838 -1.074 . . . . 1.29 111.568 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.497 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 15.2 mm100 -122.93 127.42 48.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.029 -0.36 . . . . 1.5 110.029 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 41.0 m-85 -122.04 147.58 45.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.979 -0.748 . . . . 0.87 108.979 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.569 HG13 HD11 ' A' ' 51' ' ' LEU . 39.1 mm -77.39 105.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.445 -0.576 . . . . 0.39000000000000001 109.445 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 49.1 ttt180 -75.12 -45.68 39.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.567 . . . . 2.8300000000000001 110.027 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -149.19 146.35 27.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 1.26 109.474 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.9 132.37 71.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.49 126.28 92.23 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.858 -0.61 . . . . 2.2799999999999998 110.693 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.45 124.03 15.27 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.657 2.238 . . . . 1.1699999999999999 112.595 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 64.42 36.08 9.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.177 -0.92 . . . . 2.3999999999999999 111.371 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 94.5 p -97.65 165.67 15.09 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.76 -0.654 . . . . 0.56999999999999995 109.402 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 12.8 Cg_endo -58.63 -25.6 75.69 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.829 1.686 . . . . 0.65000000000000002 111.276 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.42 -52.35 22.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.756 -0.656 . . . . 0.35999999999999999 110.409 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.85 -36.0 82.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.811 0.338 . . . . 2.0099999999999998 110.457 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.82 65.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.46999999999999997 112.016 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -80.98 -13.45 58.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.966 0.412 . . . . 0.40000000000000002 110.51 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 26.6 6.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.855 -0.612 . . . . 0.62 112.409 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.569 HD11 HG13 ' A' ' 37' ' ' ILE . 28.1 tp -94.9 133.25 38.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.65000000000000002 110.473 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -122.49 158.8 29.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.738 -0.467 . . . . 4.3799999999999999 109.738 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.16 29.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.043 0.386 . . . . 1.4399999999999999 112.043 -174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -132.99 1.17 3.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 3.0600000000000001 109.707 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 35.7 m-20 -88.29 154.35 20.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.556 -0.747 . . . . 1.02 111.235 -171.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 18.4 ttm180 -116.54 135.04 54.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.407 -0.59 . . . . 1.5700000000000001 109.407 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.99 123.13 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.65 -0.5 . . . . 0.68000000000000005 109.65 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.86 -44.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.251 -0.431 . . . . 0.87 110.42 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 34.9 mt-10 -134.48 143.53 47.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.89000000000000001 110.029 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.96 117.75 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.685 -0.487 . . . . 0.66000000000000003 109.685 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.59 30.29 19.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.48 0.487 . . . . 1.1699999999999999 110.945 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 -6.17 79.29 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.068 -0.587 . . . . 0.66000000000000003 112.974 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -95.88 124.15 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 0.231 . . . . 1.1699999999999999 110.557 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.543 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.2 t -66.22 136.93 56.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 1.6799999999999999 111.188 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.451 ' HA ' ' CG ' ' A' ' 68' ' ' LYS . 21.4 mmt -118.09 2.22 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.81000000000000005 111.82 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 97.88 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.357 -0.608 . . . . 3.75 109.357 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.88 12.94 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.47 111.659 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 65' ' ' MET . 34.7 mmtp -84.01 166.78 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 3.3599999999999999 110.877 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -94.29 174.21 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.645 . . . . 2.8900000000000001 110.83 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -57.53 -43.06 84.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 1.4199999999999999 110.359 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.04 96.77 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.71999999999999997 113.549 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.51 -40.61 76.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.605 0.241 . . . . 2.0299999999999998 110.897 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.65 -47.26 92.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 1.0800000000000001 110.552 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.48 -42.31 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.71999999999999997 110.881 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -61.53 -39.94 92.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 0.66000000000000003 110.941 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.83 94.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.41999999999999998 111.755 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG23 HG21 ' A' ' 84' ' ' THR . 72.4 mt -60.26 -45.18 96.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.231 0.539 . . . . 0.68999999999999995 110.075 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -66.0 -30.95 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.608 -0.723 . . . . 3.0899999999999999 110.895 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.23 -5.53 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.721 -0.672 . . . . 0.65000000000000002 111.318 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.28 79.17 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.554 -0.831 . . . . 0.59999999999999998 111.478 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.32 -100.4 2.08 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.106 -0.568 . . . . 1.1000000000000001 111.9 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.554 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 18.8 m-20 -119.23 -27.66 5.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.648 0.261 . . . . 2.1200000000000001 110.795 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.6 mt-10 -120.15 139.81 52.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.299 -1.0 . . . . 2.1099999999999999 108.299 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.437 HG21 HG23 ' A' ' 77' ' ' ILE . 13.8 t -138.02 149.65 46.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.818 0.342 . . . . 0.32000000000000001 110.954 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 121.08 42.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.149 -0.478 . . . . 1.6299999999999999 110.477 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.3 mt -107.14 135.65 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.156 -0.475 . . . . 0.28000000000000003 109.889 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.5 tp -104.24 119.34 38.74 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.202 -0.666 . . . . 0.51000000000000001 109.202 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.0 m -126.95 163.31 29.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.231 -0.44 . . . . 0.33000000000000002 111.08 -175.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.99 149.54 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.41999999999999998 111.229 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -90.41 175.57 7.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 1.9199999999999999 110.117 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 91' ' ' ARG . 25.2 ttm180 -58.48 -48.98 78.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 4.1600000000000001 111.045 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.1 mp0 -63.8 -41.01 97.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 2.6800000000000002 110.203 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 m -62.04 -51.42 68.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.46999999999999997 110.471 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.23 -43.86 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.137 -0.938 . . . . 1.1799999999999999 111.708 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 13.6 mm-40 -60.42 -45.68 92.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.207 -0.451 . . . . 1.9399999999999999 110.738 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.409 ' CE2' ' HG2' ' A' ' 114' ' ' PRO . 65.2 t80 -63.09 -47.63 82.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.495 0.497 . . . . 0.72999999999999998 111.336 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -65.89 -40.45 91.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.487 -0.324 . . . . 0.44 111.613 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -66.17 -44.59 83.62 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.988 -0.285 . . . . 1.9199999999999999 111.615 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.3 ptmt -70.27 -26.53 63.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.635 0.255 . . . . 2.04 111.087 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.5 t -93.75 -3.56 51.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.345 0.593 . . . . 1.3899999999999999 110.395 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.54 47.2 13.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.11 -0.95 . . . . 4.0899999999999999 110.918 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.82 137.9 53.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 1.4199999999999999 110.204 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 55.5 mt -88.99 125.49 62.24 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.985 -0.376 . . . . 1.3300000000000001 109.985 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 27.6 Cg_exo -61.9 154.23 62.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.97 2.447 . . . . 0.53000000000000003 112.07 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.7 p -163.46 167.21 21.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.612 -0.267 . . . . 1.4199999999999999 111.142 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -57.47 -29.3 64.13 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.732 0.645 . . . . 1.6599999999999999 111.405 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.44 -34.23 70.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 2.8199999999999998 110.49 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -75.8 -14.6 60.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.024 -0.989 . . . . 0.53000000000000003 111.101 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' A' ' 12' ' ' LEU . 89.5 mt -73.92 -32.51 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 1.24 110.776 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.14 -36.65 74.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 3.7000000000000002 111.866 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.44 -80.69 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.558 -1.306 . . . . 1.1200000000000001 113.863 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.0 132.83 29.21 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.223 2.615 . . . . 1.3100000000000001 114.386 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 63.1 mt -95.97 167.79 11.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.846 -1.07 . . . . 1.1100000000000001 108.912 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 10.8 Cg_endo -56.95 145.98 82.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.074 1.849 . . . . 1.1499999999999999 112.107 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 95.3 t 73.35 117.74 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 115.58 -0.736 . . . . 2.98 111.384 -177.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 8.1 Cg_exo -71.91 86.11 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.047 2.498 . . . . 4.2300000000000004 112.027 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.54 -23.95 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.236 0.541 . . . . 7.3300000000000001 110.416 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -139.01 152.21 47.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.695 -0.684 . . . . 8.7799999999999994 109.602 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -115.43 86.07 2.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.351 0.596 . . . . 9.3399999999999999 109.898 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -139.73 164.3 26.07 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.333 -0.849 . . . . 11.550000000000001 111.215 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.48 109.65 20.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.369 . . . . 13.92 110.304 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 16.9 pt -72.72 102.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.535 0.684 . . . . 16.210000000000001 111.257 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.62 92.32 3.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.543 -0.753 . . . . 18.82 109.16 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -116.85 -71.33 0.74 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 20.829999999999998 109.536 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 45.27 50.47 9.74 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 124.013 0.821 . . . . 22.5 111.379 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.79 108.85 13.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.523 -0.917 . . . . 23.989999999999998 108.523 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.5 m -76.44 79.38 3.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.841 -0.618 . . . . 25.0 111.729 -173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.411 -0.804 . . . . 27.52 109.325 174.358 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.837 -0.505 . . . . 11.869999999999999 111.837 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.34 151.96 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.338 -0.616 . . . . 9.8599999999999994 109.338 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -91.04 109.73 37.23 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.503 -0.555 . . . . 6.96 109.503 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 -41.32 3.95 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.117 2.545 . . . . 6.6500000000000004 113.691 -173.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -127.07 22.58 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.763 -0.375 . . . . 7.9900000000000002 111.788 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.91 177.7 11.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.719 0.295 . . . . 4.2599999999999998 111.317 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -149.78 31.5 0.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.191 -0.67 . . . . 3.8399999999999999 109.191 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' A' ' 96' ' ' PHE . 71.6 mt -86.03 56.59 4.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.471 -0.786 . . . . 0.80000000000000004 111.617 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.537 ' HB3' HD21 ' A' ' 113' ' ' LEU . 27.5 ptt180 -125.96 154.21 73.78 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.975 -0.38 . . . . 3.0899999999999999 109.975 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 48.4 Cg_endo -64.73 178.85 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.018 2.479 . . . . 0.46999999999999997 113.231 -172.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.66 HH12 ' HB3' ' A' ' 90' ' ' ASP . 7.8 ptp85 -137.76 131.98 32.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.988 -0.551 . . . . 2.3700000000000001 110.304 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.565 ' HG ' HD11 ' A' ' 109' ' ' LEU . 4.7 mt -93.59 111.01 22.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.3200000000000001 110.169 176.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 37.2 m -94.68 116.92 29.33 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.489 -0.56 . . . . 0.40000000000000002 109.489 177.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -105.96 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.675 -0.861 . . . . 0.34999999999999998 108.675 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.55 ' HE3' HD12 ' A' ' 86' ' ' LEU . 24.9 ptp -135.73 134.92 39.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.953 0.406 . . . . 0.88 110.806 -171.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 23.0 ttpp -92.49 147.09 23.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 2.5800000000000001 109.209 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 ttmt -59.62 123.46 16.98 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.129 -0.487 . . . . 0.92000000000000004 111.559 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.51 -157.36 21.51 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.389 -0.684 . . . . 1.28 111.389 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.26 -36.68 27.23 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.159 2.573 . . . . 2.23 113.233 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -93.8 21.29 6.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.8700000000000001 111.595 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.32 69.68 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.597 -0.811 . . . . 1.9299999999999999 111.273 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 74.89 -50.8 0.67 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.662 0.785 . . . . 1.8200000000000001 110.739 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 69.66 0.93 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.151 -0.547 . . . . 0.42999999999999999 113.347 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.33 168.88 25.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.013 -0.365 . . . . 0.40000000000000002 110.013 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 20.0 t-20 -133.76 127.19 32.24 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 2.1800000000000002 109.699 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.31 143.78 30.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.232 -0.44 . . . . 1.52 110.632 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.565 ' CD2' ' HB2' ' A' ' 36' ' ' PHE . 2.6 p80 -125.89 130.7 51.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.8 -0.445 . . . . 1.3400000000000001 109.8 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.1 p -122.22 123.79 42.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.618 -0.719 . . . . 2.2999999999999998 109.844 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -85.71 137.63 32.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.11 0.481 . . . . 3.48 110.451 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -81.94 -6.77 59.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 4.54 109.816 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -87.82 -36.84 17.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.593 -0.731 . . . . 3.4900000000000002 110.507 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -138.9 128.63 14.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 3.0 110.36 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 159.25 49.67 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 2.2400000000000002 112.053 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.78 145.19 11.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.636 -0.793 . . . . 1.29 111.783 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.21 133.11 47.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.778 0.323 . . . . 1.5 110.687 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.565 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 31.1 m-85 -114.27 142.99 45.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.384 -0.599 . . . . 0.87 109.384 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.528 HG13 HD11 ' A' ' 51' ' ' LEU . 32.9 mm -74.32 106.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.43 -0.582 . . . . 0.39000000000000001 109.43 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 52.0 ttt180 -69.65 -51.85 31.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.75 -0.659 . . . . 2.8300000000000001 110.382 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -163.32 135.38 5.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.985 -0.552 . . . . 1.26 110.309 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.5 134.29 37.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.43 -0.952 . . . . 0.37 108.43 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.2 m-20 -64.67 128.09 93.15 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.956 -0.387 . . . . 2.2799999999999998 109.956 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 52.4 Cg_exo -54.54 130.02 37.91 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.171 2.581 . . . . 1.1699999999999999 113.182 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.61 38.37 12.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.357 -0.838 . . . . 2.3999999999999999 110.81 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 79.0 p -97.76 164.7 16.94 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 109.693 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.4 Cg_endo -55.85 -34.17 90.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.751 1.634 . . . . 0.65000000000000002 111.125 172.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.84 -46.39 85.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.826 -0.624 . . . . 0.35999999999999999 110.244 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.27 -43.47 98.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.014 -0.539 . . . . 2.0099999999999998 110.337 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.85 63.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.46999999999999997 111.988 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.7 p -76.39 -14.83 60.05 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.40000000000000002 110.526 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.12 9.07 24.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.782 -0.723 . . . . 0.62 112.333 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD11 HG13 ' A' ' 37' ' ' ILE . 37.1 tp -79.79 128.06 32.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.85 0.357 . . . . 0.65000000000000002 110.115 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -123.42 -170.53 2.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.061 -0.518 . . . . 4.3799999999999999 110.222 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -95.65 151.65 19.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.673 -0.694 . . . . 1.4399999999999999 110.29 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 54.7 mt-30 73.02 25.05 2.41 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.825 0.703 . . . . 3.0600000000000001 110.96 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -95.81 155.25 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.243 -0.651 . . . . 1.02 109.243 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.439 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -124.69 129.55 50.72 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.603 -0.517 . . . . 1.5700000000000001 109.603 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.3 mt -73.41 132.06 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.68000000000000005 111.605 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.594 HG11 ' HB2' ' A' ' 104' ' ' PRO . 21.4 t -113.97 -47.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.415 -0.811 . . . . 0.87 110.443 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.1 mt-10 -132.8 149.51 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.89000000000000001 110.644 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.81 117.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.66000000000000003 109.637 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 57.24 34.21 24.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.986 -0.552 . . . . 1.1699999999999999 111.041 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.43 -4.63 84.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.925 -0.655 . . . . 0.66000000000000003 113.084 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.84 127.21 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.96 -0.385 . . . . 1.1699999999999999 109.96 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 41.8 t -74.25 135.39 42.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.992 0.425 . . . . 1.6799999999999999 110.369 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.806 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.5 mmt -116.79 30.15 7.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.81000000000000005 110.415 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HG2' HD12 ' A' ' 103' ' ' ILE . 21.5 tp10 -70.51 -34.42 72.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 3.75 110.943 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.11 -0.45 28.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.645 -0.788 . . . . 1.47 112.305 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.806 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.3 mmtp -71.95 168.73 17.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.762 0.792 . . . . 3.3599999999999999 112.791 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -106.12 169.81 8.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.518 -1.219 . . . . 2.8900000000000001 109.844 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -54.42 -43.93 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 1.4199999999999999 111.597 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.42 85.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.128 -0.558 . . . . 0.71999999999999997 113.387 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.97 -42.63 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.021 0.438 . . . . 2.0299999999999998 110.34 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 65' ' ' MET . 59.0 t -68.26 -47.18 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 1.0800000000000001 111.174 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.1 -38.55 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 0.71999999999999997 111.048 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -67.94 -36.69 80.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.66000000000000003 110.497 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.446 -0.343 . . . . 0.41999999999999998 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.552 HG23 HG21 ' A' ' 84' ' ' THR . 78.6 mt -58.38 -42.06 83.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.446 0.641 . . . . 0.68999999999999995 110.41 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -74.6 -31.69 62.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 3.0899999999999999 111.44 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 5.48 18.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.65000000000000002 111.325 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -13.37 83.23 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.682 -0.771 . . . . 0.59999999999999998 112.009 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -111.43 3.1 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.981 -0.628 . . . . 1.1000000000000001 111.699 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 14.0 m-20 -115.03 -6.64 12.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.908 0.385 . . . . 2.1200000000000001 110.503 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -143.8 157.01 44.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.594 . . . . 2.1099999999999999 109.622 173.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.552 HG21 HG23 ' A' ' 77' ' ' ILE . 11.9 t -137.57 149.73 46.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 0.32000000000000001 110.072 -175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -115.63 116.85 28.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.126 -0.488 . . . . 1.6299999999999999 109.796 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HE3' ' A' ' 15' ' ' MET . 78.0 mt -107.85 130.92 54.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.908 -0.587 . . . . 0.28000000000000003 109.836 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 10' ' ' PRO . 20.8 tp -104.59 115.21 29.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.814 -0.81 . . . . 0.51000000000000001 108.814 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.5 m -127.54 159.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.191 -0.459 . . . . 0.33000000000000002 111.377 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.39 150.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.734 . . . . 0.41999999999999998 110.031 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.66 ' HB3' HH12 ' A' ' 11' ' ' ARG . 4.3 p30 -88.85 176.51 7.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 1.9199999999999999 109.975 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.5 ttp180 -55.78 -49.99 71.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.755 0.65 . . . . 4.1600000000000001 112.755 -172.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.555 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 14.2 pt-20 -74.85 -34.35 62.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 2.6800000000000002 111.139 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.9 m -64.9 -41.92 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.02 -0.537 . . . . 0.46999999999999997 110.12 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 33.2 t70 -62.49 -38.05 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.608 . . . . 1.1799999999999999 109.963 177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 48.0 mt-10 -67.2 -35.52 79.79 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.144 -0.48 . . . . 1.9399999999999999 110.745 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.86 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 59.7 t80 -62.99 -49.62 73.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.896 0.379 . . . . 0.72999999999999998 110.318 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.458 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 27.8 m-85 -68.14 -38.86 82.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.911 -0.586 . . . . 0.44 112.06 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -64.61 -48.91 73.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.848 0.314 . . . . 1.9199999999999999 111.848 -176.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 22.4 pttp -67.63 -34.18 76.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.113 0.483 . . . . 2.04 110.427 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 67.8 m -75.22 -8.69 57.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.511 -0.768 . . . . 1.3899999999999999 112.048 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 55.86 32.82 20.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.312 0.645 . . . . 4.0899999999999999 111.734 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 97' ' ' PHE . 5.8 p -120.36 142.1 37.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.251 -0.431 . . . . 1.4199999999999999 110.228 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.565 HD12 ' HG2' ' A' ' 66' ' ' GLU . 45.9 mm -86.75 127.28 60.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 1.3300000000000001 110.625 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.594 ' HB2' HG11 ' A' ' 58' ' ' VAL . 16.9 Cg_exo -65.55 155.13 70.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.824 2.349 . . . . 0.53000000000000003 111.37 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.7 p -169.06 168.41 10.07 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.554 -0.459 . . . . 1.4199999999999999 111.807 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -57.0 -29.42 63.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 1.6599999999999999 111.273 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.93 -32.71 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.272 0.558 . . . . 2.8199999999999998 110.34 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -77.86 -13.7 59.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.53000000000000003 111.164 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.565 HD11 ' HG ' ' A' ' 12' ' ' LEU . 86.1 mt -75.19 -40.62 59.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 1.24 111.126 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -106.28 13.03 29.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.199 0.523 . . . . 3.7000000000000002 110.521 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.62 -172.1 12.42 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.827 -0.701 . . . . 1.1200000000000001 111.82 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -88.97 -179.59 2.16 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.213 2.609 . . . . 1.3100000000000001 112.258 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 9' ' ' ARG . 53.7 mt -97.24 148.21 34.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.09 -0.504 . . . . 1.1100000000000001 109.761 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 113' ' ' LEU . 14.3 Cg_exo -68.35 144.0 60.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.111 2.54 . . . . 1.1499999999999999 112.045 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.3 m -74.41 155.44 87.68 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.423 -0.808 . . . . 2.98 110.795 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.84 66.54 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.687 2.258 . . . . 4.2300000000000004 112.066 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -68.14 121.36 16.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.706 -0.679 . . . . 7.3300000000000001 109.695 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 119' ' ' ASN . 3.2 m 70.4 173.63 0.3 Allowed 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.636 0.585 . . . . 8.7799999999999994 109.82 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.55 ' H ' HG22 ' A' ' 118' ' ' THR . 9.9 m120 74.21 146.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.869 0.842 . . . . 9.3399999999999999 112.46 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.12 36.17 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.868 -1.06 . . . . 11.550000000000001 110.457 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -118.61 97.18 5.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.162 0.481 . . . . 13.92 110.4 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.5 101.22 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.89 -0.782 . . . . 16.210000000000001 108.89 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.12 -8.73 59.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.902 -0.59 . . . . 18.82 110.988 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 58.19 46.36 15.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.955 -1.128 . . . . 20.829999999999998 107.955 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.632 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -73.35 71.12 1.24 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.922 -1.49 . . . . 22.5 111.128 -177.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -69.48 95.71 0.85 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.979 -1.01 . . . . 23.989999999999998 110.021 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.9 t -76.74 -42.08 42.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.673 -0.694 . . . . 27.52 109.676 -178.558 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 112.016 -0.434 . . . . 11.869999999999999 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -103.83 134.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.736 0.303 . . . . 9.8599999999999994 110.221 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.3 p-10 -73.72 135.21 78.09 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 6.96 110.787 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 62.5 Cg_endo -93.39 7.13 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.075 2.517 . . . . 6.6500000000000004 112.778 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -155.54 -58.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.958 0.408 . . . . 7.9900000000000002 110.305 -176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.4 m -151.44 145.62 25.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.496 -0.557 . . . . 4.2599999999999998 109.496 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.2 ptm -75.02 56.27 0.75 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.238 0.542 . . . . 3.8399999999999999 111.639 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.4 mt -108.96 59.87 0.6 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.264 0.554 . . . . 0.80000000000000004 110.59 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -126.54 157.02 72.18 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 3.0899999999999999 109.433 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HB2' HD11 ' A' ' 87' ' ' LEU . 44.4 Cg_endo -70.15 174.73 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.328 2.019 . . . . 0.46999999999999997 111.782 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.452 ' HG3' HG23 ' A' ' 88' ' ' VAL . 7.0 ptp85 -132.02 130.6 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.261 -0.427 . . . . 2.3700000000000001 110.162 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.9 118.1 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 1.3200000000000001 110.182 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 12.8 m -108.88 117.49 34.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.215 -0.448 . . . . 0.40000000000000002 110.305 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -108.9 117.55 34.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.225 -1.028 . . . . 0.34999999999999998 108.225 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.582 ' HE3' HD12 ' A' ' 86' ' ' LEU . 23.0 ptp -131.15 144.63 51.52 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.744 -0.383 . . . . 0.88 111.164 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HG3' ' HG2' ' A' ' 83' ' ' GLU . 7.5 ttmm -118.89 146.0 45.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.614 -0.721 . . . . 2.5800000000000001 109.705 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 85.5 mttt -56.32 119.47 6.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.361 -0.836 . . . . 0.92000000000000004 112.188 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.37 -111.0 3.1 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.575 -1.193 . . . . 1.28 112.282 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.49 -74.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.243 2.629 . . . . 2.23 112.669 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -132.93 83.85 2.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.8700000000000001 110.495 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.97 71.29 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.004 -0.617 . . . . 1.9299999999999999 112.535 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.553 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 36.2 m-85 67.23 -87.3 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.047 0.539 . . . . 1.8200000000000001 110.774 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.45 70.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.625 -0.798 . . . . 0.42999999999999999 112.646 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.94 151.91 26.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.40000000000000002 109.271 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.24 123.65 45.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.207 -0.664 . . . . 2.1800000000000002 109.207 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 35' ' ' GLN . 30.3 tp -108.77 146.14 34.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.058 -0.519 . . . . 1.52 109.62 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.45 149.25 27.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.624 -0.43 . . . . 1.3400000000000001 111.435 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -94.47 168.71 10.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.166 -0.679 . . . . 2.2999999999999998 109.166 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 23.9 t70 -125.93 146.39 49.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.563 -0.532 . . . . 3.48 109.563 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.13 2.61 53.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.349 -0.387 . . . . 4.54 111.371 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.6 t -123.86 -46.5 1.97 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.039 0.447 . . . . 3.4900000000000002 109.981 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 41.8 mmtm -99.4 126.8 36.36 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.192 -0.458 . . . . 3.0 110.078 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.19 156.65 46.66 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.581 2.187 . . . . 2.2400000000000002 112.147 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.72 167.38 22.55 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.819 -0.705 . . . . 1.29 111.611 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.52 ' HB3' HD11 ' A' ' 26' ' ' LEU . 27.6 mm-40 -98.9 128.09 44.99 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.13 -0.322 . . . . 1.5 110.13 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -109.92 140.59 43.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.87 110.554 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.543 HG13 HD11 ' A' ' 51' ' ' LEU . 36.9 mm -81.21 105.76 11.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.846 -0.798 . . . . 0.39000000000000001 108.846 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.02 -55.28 19.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.507 . . . . 2.8300000000000001 110.106 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 m -157.87 137.77 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.854 -0.612 . . . . 1.26 109.482 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.31 133.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.145 -0.687 . . . . 0.37 109.145 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.82 128.92 92.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.014 -0.539 . . . . 2.2799999999999998 109.774 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 125.41 19.02 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.753 2.302 . . . . 1.1699999999999999 113.063 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 63.14 43.46 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.934 -1.03 . . . . 2.3999999999999999 110.76 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.6 p -102.64 165.3 13.99 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.592 . . . . 0.56999999999999995 110.639 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 31.6 Cg_exo -56.11 -34.38 92.68 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.888 1.725 . . . . 0.65000000000000002 111.168 172.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.31 86.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.596 -0.729 . . . . 0.35999999999999999 110.186 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -61.06 -42.44 98.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 2.0099999999999998 110.132 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.37 -30.02 68.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.817 -0.629 . . . . 0.46999999999999997 112.069 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.2 p -70.96 -20.0 62.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.368 . . . . 0.40000000000000002 110.626 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.19 9.7 15.03 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.792 -0.718 . . . . 0.62 112.803 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.543 HD11 HG13 ' A' ' 37' ' ' ILE . 27.9 tp -69.33 125.17 25.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.65000000000000002 110.685 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 30.5 ttm180 -103.85 147.89 26.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.804 -0.634 . . . . 4.3799999999999999 109.918 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -74.77 144.21 43.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 1.4399999999999999 110.092 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 15.4 mm-40 78.87 5.88 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.099 0.875 . . . . 3.0600000000000001 111.31 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -85.12 149.93 25.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.693 -0.484 . . . . 1.02 109.693 176.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 56' ' ' ARG . 34.9 ttp180 -111.87 137.48 49.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.5700000000000001 110.258 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HA ' HG12 ' A' ' 88' ' ' VAL . 65.2 mt -74.56 128.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.985 -0.552 . . . . 0.68000000000000005 110.627 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.403 HG23 HD23 ' A' ' 87' ' ' LEU . 19.0 m -112.42 -32.89 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 0.87 111.21 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 27.4 mt-10 -134.38 142.85 47.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.89000000000000001 110.833 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.56 120.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.66000000000000003 109.797 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 85' ' ' LYS . 73.8 m-20 58.68 24.57 12.31 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.088 0.555 . . . . 1.1699999999999999 111.512 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.494 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.61 6.53 63.96 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.66000000000000003 112.915 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.47 124.18 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 1.1699999999999999 110.393 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.2 p -64.58 136.94 57.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.636 . . . . 1.6799999999999999 111.215 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.706 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.1 mmt -123.68 50.99 1.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.968 -0.56 . . . . 0.81000000000000005 111.074 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -36.11 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.922 -0.311 . . . . 3.75 111.514 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.38 -7.52 54.17 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.842 -0.694 . . . . 1.47 111.857 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.706 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.7 mmtp -70.71 149.16 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.223 0.535 . . . . 3.3599999999999999 111.436 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -86.45 170.62 11.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.367 -0.833 . . . . 2.8900000000000001 109.983 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -53.86 -43.52 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.657 0.265 . . . . 1.4199999999999999 111.241 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.03 99.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.045 -0.598 . . . . 0.71999999999999997 113.125 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 6.3 t70 -64.78 -43.97 91.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.913 0.387 . . . . 2.0299999999999998 110.216 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 65' ' ' MET . 46.5 t -63.55 -46.86 93.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 1.0800000000000001 111.015 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 97.7 t -66.68 -42.5 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.71999999999999997 111.114 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -64.51 -38.27 90.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.46 -0.336 . . . . 0.66000000000000003 110.387 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.09 93.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 0.41999999999999998 111.135 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 84' ' ' THR . 81.4 mt -61.15 -45.77 97.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.018 0.437 . . . . 0.68999999999999995 110.621 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 29.6 mtm180 -66.15 -33.2 75.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 3.0899999999999999 110.366 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.42 -0.36 36.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.952 -0.567 . . . . 0.65000000000000002 111.501 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.26 85.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.606 -0.807 . . . . 0.59999999999999998 111.695 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.29 -127.24 9.1 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.208 -0.757 . . . . 1.1000000000000001 111.208 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 42.1 m-20 -96.73 -12.97 23.04 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.032 -0.267 . . . . 2.1200000000000001 110.78 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -130.61 140.82 50.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.989 -0.375 . . . . 2.1099999999999999 109.989 177.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 77' ' ' ILE . 14.4 t -135.09 149.62 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.957 0.408 . . . . 0.32000000000000001 110.36 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 61' ' ' ASN . 95.0 mttt -106.31 117.81 35.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.248 -0.433 . . . . 1.6299999999999999 110.289 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD12 ' HE3' ' A' ' 15' ' ' MET . 85.0 mt -111.53 124.91 53.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.145 -0.479 . . . . 0.28000000000000003 109.815 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 34.8 tp -104.36 122.25 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.029 -0.73 . . . . 0.51000000000000001 109.029 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 10.5 m -130.15 164.58 32.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.208 -0.451 . . . . 0.33000000000000002 111.369 -174.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 m -136.72 145.79 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.658 -0.701 . . . . 0.41999999999999998 110.874 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.72 167.74 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.548 -0.751 . . . . 1.9199999999999999 109.473 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -56.59 -47.79 78.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.653 0.263 . . . . 4.1600000000000001 111.22 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -63.45 -31.42 72.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.347 0.594 . . . . 2.6800000000000002 110.086 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 m -76.54 -50.8 13.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.46999999999999997 111.021 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.7 -47.67 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.865 -0.607 . . . . 1.1799999999999999 111.656 -174.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 31.7 mt-10 -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.721 -0.391 . . . . 1.9399999999999999 110.767 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.38 -46.09 70.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.937 0.398 . . . . 0.72999999999999998 110.356 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 102' ' ' VAL . 22.9 m-85 -64.34 -44.24 92.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.008 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -61.42 -45.33 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.561 0.578 . . . . 1.9199999999999999 112.561 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 18.1 ptpt -65.47 -25.6 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 2.04 110.955 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.2 t -96.69 0.84 50.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 1.3899999999999999 110.645 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? 64.63 31.27 12.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.028 -0.533 . . . . 4.0899999999999999 111.716 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' A' ' 114' ' ' PRO . 35.0 t -109.82 139.6 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.491 -0.322 . . . . 1.4199999999999999 110.416 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.35 125.95 50.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.93 -0.396 . . . . 1.3300000000000001 109.93 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HB2' HG21 ' A' ' 58' ' ' VAL . 18.8 Cg_exo -65.62 139.53 58.68 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.464 2.11 . . . . 0.53000000000000003 111.42 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -154.01 166.93 31.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 1.4199999999999999 110.73 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.494 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 41.2 mt-30 -57.31 -31.98 66.21 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.441 0.463 . . . . 1.6599999999999999 111.049 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.38 -30.78 70.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.441 -0.345 . . . . 2.8199999999999998 111.3 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.37 -13.83 61.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.53000000000000003 111.403 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.31 -25.43 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.2 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -130.4 -14.89 3.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.496 -0.32 . . . . 3.7000000000000002 111.584 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.35 -177.11 34.44 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.866 -0.683 . . . . 1.1200000000000001 112.438 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.41 124.26 10.65 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.131 2.554 . . . . 1.3100000000000001 112.866 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' N ' HD22 ' A' ' 113' ' ' LEU . 3.0 mm? -65.67 146.64 98.97 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.96 -0.564 . . . . 1.1100000000000001 109.825 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.562 ' HB3' HG21 ' A' ' 102' ' ' VAL . 28.4 Cg_endo -62.8 144.6 93.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.785 2.323 . . . . 1.1499999999999999 112.449 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.472 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 4.2 p -159.99 130.18 3.5 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.077 -0.51 . . . . 2.98 110.333 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 19.7 Cg_exo -66.52 112.77 2.47 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.816 2.344 . . . . 4.2300000000000004 111.744 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -81.09 -30.88 34.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.24 -0.437 . . . . 7.3300000000000001 110.851 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 t -84.02 152.38 24.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.132 -0.486 . . . . 8.7799999999999994 110.394 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -122.31 111.59 17.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.88 -0.415 . . . . 9.3399999999999999 109.88 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.21 173.02 42.3 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.993 -0.622 . . . . 11.550000000000001 112.665 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.77 160.22 17.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.182 -0.303 . . . . 13.92 110.182 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -126.48 161.33 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.371 -0.377 . . . . 16.210000000000001 110.552 179.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -136.11 157.54 46.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.152 -0.476 . . . . 18.82 109.9 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 55.66 64.85 1.62 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.412 0.625 . . . . 20.829999999999998 110.224 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 4.1 mp0 -74.65 -30.09 61.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 22.5 110.046 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 66.97 -80.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.056 -0.975 . . . . 23.989999999999998 110.512 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -158.47 84.6 0.84 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.204 -0.903 . . . . 27.52 110.479 -176.111 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.394 -0.282 . . . . 11.869999999999999 112.394 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.3 pt -87.49 84.62 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 9.8599999999999994 111.481 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.75 114.06 61.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 6.96 110.012 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -87.27 9.86 3.76 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.911 2.407 . . . . 6.6500000000000004 113.009 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -106.22 -49.21 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.243 0.544 . . . . 7.9900000000000002 109.688 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 m -121.17 84.99 2.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.588 -0.733 . . . . 4.2599999999999998 110.011 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -95.39 19.29 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 3.8399999999999999 110.592 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.62 41.04 0.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 0.80000000000000004 110.901 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 15.9 ptp180 -119.7 147.02 42.94 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.322 -0.399 . . . . 3.0899999999999999 109.998 -177.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HD2' ' HA ' ' A' ' 109' ' ' LEU . 2.9 Cg_exo -72.26 165.14 33.53 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.899 2.399 . . . . 0.46999999999999997 111.358 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.79 ' HG3' HG23 ' A' ' 88' ' ' VAL . 5.5 ptt180 -122.9 131.0 53.54 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.663 -0.699 . . . . 2.3700000000000001 110.627 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.06 113.3 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 1.3200000000000001 110.03 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 30.5 m -96.87 128.74 44.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.832 -0.622 . . . . 0.40000000000000002 110.22 -176.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -117.79 117.49 29.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.34999999999999998 108.91 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.527 ' HE3' HD12 ' A' ' 86' ' ' LEU . 22.5 ptp -142.21 142.55 32.67 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.181 -0.463 . . . . 0.88 110.194 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 43.4 pttt -119.34 152.53 36.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.311 0.577 . . . . 2.5800000000000001 110.735 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.617 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.1 mtmt -55.55 110.45 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.347 -1.297 . . . . 0.92000000000000004 112.601 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.09 -129.82 6.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.272 -0.876 . . . . 1.28 112.145 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.29 -75.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.35 2.7 . . . . 2.23 113.616 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -96.91 34.05 1.78 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.891 0.377 . . . . 2.8700000000000001 111.329 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.617 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 71.77 83.86 0.23 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.585 -0.817 . . . . 1.9299999999999999 111.755 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.45 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 39.3 m-85 68.07 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.268 0.627 . . . . 1.8200000000000001 110.638 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.16 68.11 0.38 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.259 -0.496 . . . . 0.42999999999999999 112.572 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -157.34 153.23 27.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.928 -0.397 . . . . 0.40000000000000002 109.928 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.36 141.41 40.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 2.1800000000000002 110.626 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 26' ' ' LEU . 48.6 mt -101.52 154.91 18.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.624 -0.716 . . . . 1.52 111.715 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 1.5 t60 -105.67 141.81 36.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.188 -0.915 . . . . 1.3400000000000001 110.459 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -83.95 150.87 25.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.943 -0.571 . . . . 2.2999999999999998 110.454 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 5.1 p-10 -123.02 164.25 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.932 -0.576 . . . . 3.48 110.335 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -159.89 -49.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.82 -0.627 . . . . 4.54 109.769 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 p -84.41 -23.27 30.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 3.4900000000000002 111.206 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 23.8 pttm -157.82 140.04 10.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.03 -0.532 . . . . 3.0 110.074 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 14.3 Cg_exo -69.63 171.0 15.12 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.482 2.122 . . . . 2.2400000000000002 111.68 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 125.01 4.86 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.753 -0.736 . . . . 1.29 111.881 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -93.59 129.06 39.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 1.5 110.911 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 38.9 m-85 -102.8 149.92 24.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.87 109.599 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 51' ' ' LEU . 48.5 mm -84.45 105.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.645 -0.502 . . . . 0.39000000000000001 109.645 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -70.13 -39.75 75.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.693 -0.685 . . . . 2.8300000000000001 110.033 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 p -165.73 152.2 9.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 1.26 109.825 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.08 128.63 74.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.37 109.348 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -70.86 135.88 85.41 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.327 -0.397 . . . . 2.2799999999999998 110.672 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.84 143.1 78.73 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.886 2.391 . . . . 1.1699999999999999 112.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 61.8 42.13 10.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.502 -0.772 . . . . 2.3999999999999999 111.202 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.1 p -118.18 159.34 43.62 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 0.56999999999999995 110.297 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 44.7 Cg_exo -51.15 -39.37 61.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.406 2.071 . . . . 0.65000000000000002 111.419 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.3 -52.31 64.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.461 -0.791 . . . . 0.35999999999999999 110.864 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -63.41 -39.63 95.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.171 -0.468 . . . . 2.0099999999999998 110.601 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.06 77.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 0.46999999999999997 111.866 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -70.84 -13.69 62.13 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.982 0.42 . . . . 0.40000000000000002 110.955 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.1 14.59 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.632 -0.794 . . . . 0.62 113.015 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 37' ' ' ILE . 29.2 tp -76.02 123.83 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.65000000000000002 110.297 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 52' ' ' ARG . 21.9 ttt180 -110.28 148.51 31.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.887 -0.597 . . . . 4.3799999999999999 110.117 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -68.79 148.23 50.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.203 -0.453 . . . . 1.4399999999999999 110.219 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 78.4 mt-30 78.62 0.7 2.54 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.194 0.934 . . . . 3.0600000000000001 111.27 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 15.3 m-20 -78.58 143.43 36.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.726 0.298 . . . . 1.02 110.603 177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 56' ' ' ARG . 36.8 ttp-105 -104.69 133.52 49.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.824 0.345 . . . . 1.5700000000000001 110.573 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.84 123.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.991 -0.549 . . . . 0.68000000000000005 109.735 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' HG2' ' A' ' 104' ' ' PRO . 42.2 t -101.86 -46.55 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.268 0.556 . . . . 0.87 110.584 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 32.7 mt-10 -129.92 145.51 51.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.698 . . . . 0.89000000000000001 110.083 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.405 HG11 HD13 ' A' ' 77' ' ' ILE . 24.8 t -125.59 130.59 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.606 -0.516 . . . . 0.66000000000000003 109.606 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 66.36 8.84 5.97 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.423 0.452 . . . . 1.1699999999999999 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 9.56 62.99 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.826 -0.702 . . . . 0.66000000000000003 111.593 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.78 131.03 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.585 0.354 . . . . 1.1699999999999999 110.171 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.545 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 44.1 t -70.1 136.29 50.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.999 -0.546 . . . . 1.6799999999999999 111.426 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.803 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.5 mmt -119.91 69.43 0.85 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.81000000000000005 110.583 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -98.07 -62.15 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 3.75 110.367 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.26 41.4 2.41 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.618 -0.593 . . . . 1.47 111.618 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.803 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.4 mmtp -107.42 -178.5 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.064 -0.347 . . . . 3.3599999999999999 110.064 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -125.61 172.28 9.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.605 -0.27 . . . . 2.8900000000000001 110.972 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -54.68 -44.21 73.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.518 0.511 . . . . 1.4199999999999999 111.366 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.43 84.45 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.993 -0.622 . . . . 0.71999999999999997 113.039 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.776 0.322 . . . . 2.0299999999999998 110.662 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.93 -45.5 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 1.0800000000000001 110.778 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.65 -36.64 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.294 -0.412 . . . . 0.71999999999999997 110.905 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -65.87 -36.15 82.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.855 -0.424 . . . . 0.66000000000000003 109.855 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.1 79.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.584 . . . . 0.41999999999999998 111.072 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 60' ' ' VAL . 18.8 mm -57.56 -44.49 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.546 0.688 . . . . 0.68999999999999995 109.464 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.52 -29.22 59.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.001 -1.0 . . . . 3.0899999999999999 110.936 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.86 44.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.65000000000000002 111.84 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.8 -12.35 83.0 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.448 -0.882 . . . . 0.59999999999999998 111.867 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 -125.92 8.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.974 -0.851 . . . . 1.1000000000000001 110.974 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 60.2 m-20 -94.6 -16.85 22.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.943 0.372 . . . . 2.1200000000000001 110.042 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.639 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 7.4 mt-10 -119.55 140.34 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.109 -0.7 . . . . 2.1099999999999999 109.109 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -129.77 145.52 51.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 110.511 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.5 mttm -113.62 117.77 32.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.913 -0.585 . . . . 1.6299999999999999 109.825 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.527 HD12 ' HE3' ' A' ' 15' ' ' MET . 81.1 mt -109.91 135.86 50.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.861 -0.608 . . . . 0.28000000000000003 110.159 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 10' ' ' PRO . 52.9 tp -104.55 117.09 33.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.09 -0.505 . . . . 0.51000000000000001 109.884 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.79 HG23 ' HG3' ' A' ' 11' ' ' ARG . 7.2 m -127.95 159.36 39.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.33000000000000002 110.72 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -128.83 148.1 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.0 -0.545 . . . . 0.41999999999999998 110.747 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.16 172.62 12.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.288 -0.634 . . . . 1.9199999999999999 109.288 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.0 ttp180 -61.0 -49.1 78.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.612 0.244 . . . . 4.1600000000000001 110.709 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -35.97 82.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.061 0.458 . . . . 2.6800000000000002 110.322 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -64.32 -51.44 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.46999999999999997 111.194 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.73 -33.99 76.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.1799999999999999 111.445 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 12.5 mm-40 -64.17 -41.56 97.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.895 0.379 . . . . 1.9399999999999999 110.056 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.715 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 70.2 t80 -63.28 -47.83 80.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.72999999999999998 111.367 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -66.76 -38.82 87.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.514 -0.312 . . . . 0.44 111.776 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.1 -41.82 85.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.376 0.51 . . . . 1.9199999999999999 112.376 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 58.6 pttt -68.24 -14.48 63.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 2.04 111.229 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.427 ' HB3' HG12 ' A' ' 102' ' ' VAL . 34.4 t -109.04 -11.4 14.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.274 0.559 . . . . 1.3899999999999999 109.574 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 65.38 35.29 7.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.761 -1.108 . . . . 4.0899999999999999 111.371 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 114' ' ' PRO . 3.1 p -118.45 126.93 75.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 1.4199999999999999 110.124 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -72.15 128.29 89.26 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.3300000000000001 110.753 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' ' 58' ' ' VAL . 34.1 Cg_endo -67.65 143.9 63.98 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.734 2.289 . . . . 0.53000000000000003 111.355 176.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 m -151.23 174.72 12.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 110.024 -0.362 . . . . 1.4199999999999999 110.024 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.608 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 43.0 mt-30 -57.59 -40.3 78.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.926 0.393 . . . . 1.6599999999999999 111.166 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.5 mp0 -59.22 -35.27 73.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.293 0.568 . . . . 2.8199999999999998 110.259 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.557 ' CD2' ' HD3' ' A' ' 114' ' ' PRO . 28.2 m80 -73.9 -31.52 63.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.564 -0.743 . . . . 0.53000000000000003 111.525 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.4 pp -88.51 -16.53 32.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 1.24 110.864 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.77 -8.16 59.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.131 -0.486 . . . . 3.7000000000000002 111.24 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.89 -74.36 0.21 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.03 -1.081 . . . . 1.1200000000000001 113.723 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.17 116.08 4.54 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.344 2.696 . . . . 1.3100000000000001 114.12 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 mt -87.0 152.9 54.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.326 -0.852 . . . . 1.1100000000000001 109.698 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 108' ' ' HIS . 56.8 Cg_endo -69.48 138.14 38.01 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.993 2.462 . . . . 1.1499999999999999 112.547 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 27.2 m -84.94 144.76 42.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.835 -0.62 . . . . 2.98 110.546 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 6.3 Cg_exo -75.19 28.73 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.178 2.585 . . . . 4.2300000000000004 112.645 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.78 48.2 2.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 7.3300000000000001 109.97 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -135.59 9.1 3.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 8.7799999999999994 110.214 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -95.6 38.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 9.3399999999999999 110.999 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.81 3.75 19.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.604 -0.808 . . . . 11.550000000000001 112.431 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.25 140.07 32.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 13.92 111.175 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.69 98.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 16.210000000000001 109.994 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -114.55 95.33 5.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.362 -0.381 . . . . 18.82 110.212 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -81.45 64.07 6.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.443 . . . . 20.829999999999998 110.091 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -141.13 -56.88 0.5 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.877 -0.601 . . . . 22.5 109.535 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -84.45 43.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.541 0.686 . . . . 23.989999999999998 109.89 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 p -77.33 -24.92 50.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 25.0 110.773 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.436 ' HA ' ' HD2' ' A' ' 128' ' ' ARG . 18.0 tpt180 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.688 -0.672 . . . . 27.52 109.883 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.814 -0.514 . . . . 11.869999999999999 111.814 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 tt -99.93 141.66 16.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.756 -0.461 . . . . 9.8599999999999994 109.756 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.41 130.04 60.76 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.553 -0.536 . . . . 6.96 109.553 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.19 -18.21 63.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.09 2.527 . . . . 6.6500000000000004 112.259 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.74 -157.47 0.74 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.272 -1.01 . . . . 7.9900000000000002 108.272 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m 65.51 -0.59 1.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.406 0.521 . . . . 4.2599999999999998 112.406 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 70.3 mtm -83.28 -12.49 56.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.411 . . . . 3.8399999999999999 111.052 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -93.54 54.66 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 0.80000000000000004 110.315 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -125.78 147.57 59.15 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.655 -0.702 . . . . 3.0899999999999999 109.731 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.8 Cg_endo -66.01 159.76 47.68 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.298 1.998 . . . . 0.46999999999999997 111.183 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.3 ptt85 -121.37 132.55 54.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.037 -0.529 . . . . 2.3700000000000001 110.396 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -92.72 111.86 23.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.729 -0.669 . . . . 1.3200000000000001 109.767 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 18.0 m -89.63 117.73 28.72 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.091 -0.707 . . . . 0.40000000000000002 109.091 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' LYS . 24.4 m -109.85 118.25 36.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.601 -0.518 . . . . 0.34999999999999998 109.601 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.672 ' HE3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -131.17 132.93 45.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.88 110.677 -175.206 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' NZ ' ' HB2' ' A' ' 16' ' ' LYS . 3.4 ttmp? -109.12 128.69 55.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 2.5800000000000001 109.529 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.4 ttmt -51.59 130.08 27.2 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.041 -0.981 . . . . 0.92000000000000004 112.768 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.09 -147.57 22.82 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.956 -0.858 . . . . 1.28 110.956 170.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.71 -28.8 6.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.879 2.386 . . . . 2.23 112.841 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -94.28 -27.2 16.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.364 0.505 . . . . 2.8700000000000001 112.364 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.57 64.79 0.59 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.8 -0.714 . . . . 1.9299999999999999 112.775 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.542 ' O ' ' HB2' ' A' ' 44' ' ' SER . 26.4 m-85 74.51 -74.58 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.629 0.772 . . . . 1.8200000000000001 111.013 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.96 69.07 0.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.64 . . . . 0.42999999999999999 113.007 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -155.71 154.76 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.8 -0.445 . . . . 0.40000000000000002 109.8 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.77 127.16 55.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.77 0.319 . . . . 2.1800000000000002 110.586 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.47 137.75 39.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 1.52 110.09 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 36' ' ' PHE . 41.8 p-80 -125.7 138.81 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.46 -0.496 . . . . 1.3400000000000001 110.705 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -120.33 139.03 53.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.265 -0.879 . . . . 2.2999999999999998 108.891 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 10.9 t70 -86.31 134.48 33.74 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.975 -0.75 . . . . 3.48 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -82.71 -6.73 59.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.305 -0.407 . . . . 4.54 111.707 -173.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.4 m -107.78 -39.45 5.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.114 0.483 . . . . 3.4900000000000002 109.99 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 23.8 pttm -120.68 102.03 45.17 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.929 -0.578 . . . . 3.0 109.734 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 36.0 Cg_endo -63.2 155.99 58.13 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.583 2.189 . . . . 2.2400000000000002 113.042 -174.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.78 149.03 5.48 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.325 -0.852 . . . . 1.29 111.101 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.88 127.37 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.253 0.526 . . . . 1.5 111.036 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.702 ' HB2' ' CE1' ' A' ' 27' ' ' HIS . 52.9 m-85 -125.43 150.55 47.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.715 -0.846 . . . . 0.87 108.715 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.473 HG13 HD11 ' A' ' 51' ' ' LEU . 35.2 mm -75.85 111.17 11.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.839 -0.43 . . . . 0.39000000000000001 109.839 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 23.3 tpt180 -68.64 -57.05 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 2.8300000000000001 110.028 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 49.6 m -160.63 140.57 11.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.47 -0.786 . . . . 1.26 109.041 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.18 132.92 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.6 -0.889 . . . . 0.37 108.6 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.478 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 3.2 t70 -83.86 116.24 63.76 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.256 -0.429 . . . . 2.2799999999999998 109.998 -173.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 9.2 Cg_endo -53.64 150.84 26.89 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.721 2.28 . . . . 1.1699999999999999 111.904 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 64.36 56.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.051 0.929 . . . . 2.3999999999999999 109.96 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 87.9 p -145.65 156.27 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.187 -0.915 . . . . 0.56999999999999995 109.843 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.3 Cg_endo -61.2 -23.9 78.03 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.501 2.134 . . . . 0.65000000000000002 111.177 172.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.672 ' HA ' ' HE3' ' A' ' 15' ' ' MET . . . -69.09 -52.1 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.464 . . . . 0.35999999999999999 110.558 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.761 -0.459 . . . . 2.0099999999999998 109.761 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.69 -35.31 72.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.794 -0.639 . . . . 0.46999999999999997 112.064 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.0 p -70.02 -19.44 63.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.861 0.362 . . . . 0.40000000000000002 111.247 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.33 47.69 1.11 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.751 . . . . 0.62 112.468 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 HG13 ' A' ' 37' ' ' ILE . 34.6 tp -108.01 137.94 45.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.143 -0.317 . . . . 0.65000000000000002 110.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -118.95 153.09 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.754 -0.462 . . . . 4.3799999999999999 109.754 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -81.78 34.93 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.519 0.562 . . . . 1.4399999999999999 112.519 -173.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -152.73 17.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 3.0600000000000001 110.825 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.6 m-20 -94.48 159.68 14.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.92 -0.582 . . . . 1.02 110.45 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 56' ' ' ARG . 30.5 ttp180 -115.22 137.62 51.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.418 -0.586 . . . . 1.5700000000000001 109.418 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.56 126.73 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.98 -0.555 . . . . 0.68000000000000005 110.887 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.21 -42.01 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.87 110.736 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.9 mt-10 -131.82 143.05 49.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.39 -0.368 . . . . 0.89000000000000001 110.745 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.46 111.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.323 -0.621 . . . . 0.66000000000000003 109.323 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.67 29.68 19.18 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.374 0.421 . . . . 1.1699999999999999 111.36 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.2 -7.44 78.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.66000000000000003 112.577 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.65 121.4 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.809 -0.441 . . . . 1.1699999999999999 109.809 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.42 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 37.0 t -80.1 122.66 27.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.156 0.503 . . . . 1.6799999999999999 110.322 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.584 ' SD ' HG22 ' A' ' 73' ' ' VAL . 22.9 mmt -94.75 56.13 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.423 0.63 . . . . 0.81000000000000005 110.331 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.82 68.79 3.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.25 -0.886 . . . . 3.75 110.958 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.11 27.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 1.47 112.127 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 75.7 mmtt -69.3 152.92 44.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.312 0.577 . . . . 3.3599999999999999 111.142 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -83.52 153.55 24.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.19 -0.914 . . . . 2.8900000000000001 110.009 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.82 -40.34 66.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.014 -0.994 . . . . 1.4199999999999999 112.928 -165.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.4 -30.73 68.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.742 -0.742 . . . . 0.71999999999999997 112.365 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 42.8 t0 -68.75 -46.81 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.52 . . . . 2.0299999999999998 110.104 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.584 HG22 ' SD ' ' A' ' 65' ' ' MET . 58.9 t -62.36 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.459 -0.791 . . . . 1.0800000000000001 110.949 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 77' ' ' ILE . 97.5 t -64.09 -41.61 92.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.257 -0.428 . . . . 0.71999999999999997 110.988 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -61.38 -37.56 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.66000000000000003 110.592 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.12 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.41999999999999998 110.995 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 74' ' ' VAL . 72.6 mt -61.06 -42.1 91.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.151 0.501 . . . . 0.68999999999999995 110.281 176.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.72 -25.75 63.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.705 -0.68 . . . . 3.0899999999999999 110.8 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.49 61.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.65000000000000002 111.519 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.28 -20.51 76.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.587 -0.816 . . . . 0.59999999999999998 111.904 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.43 -84.59 1.33 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.953 -0.641 . . . . 1.1000000000000001 112.132 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 50.8 m-20 -120.42 1.1 10.67 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.856 -0.202 . . . . 2.1200000000000001 111.173 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -151.49 161.87 41.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.731 0.301 . . . . 2.1099999999999999 110.637 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.8 t -140.67 149.56 42.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.568 -0.53 . . . . 0.32000000000000001 109.568 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.7 mttp -119.18 117.22 28.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.802 -0.444 . . . . 1.6299999999999999 109.802 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -106.48 130.74 54.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.301 -0.409 . . . . 0.28000000000000003 110.242 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 57.8 tp -104.23 116.08 31.54 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.073 -0.714 . . . . 0.51000000000000001 109.073 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 18.3 m -127.86 158.27 39.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.227 0.536 . . . . 0.33000000000000002 111.884 -174.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 10' ' ' PRO . 25.9 m -128.03 147.88 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.41999999999999998 109.916 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.59 176.06 7.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.254 -0.647 . . . . 1.9199999999999999 109.254 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.6 ttp180 -54.04 -48.78 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.256 0.348 . . . . 4.1600000000000001 111.469 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.17 -38.05 63.8 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 121.108 -0.237 . . . . 2.6800000000000002 110.957 -173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.441 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 41.1 m -60.64 -47.62 85.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.886 0.374 . . . . 0.46999999999999997 110.186 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 28.9 t70 -58.66 -47.83 83.14 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.873 -0.603 . . . . 1.1799999999999999 110.772 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 48.7 mt-10 -64.77 -28.35 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 1.9399999999999999 110.823 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.11 -47.72 64.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.72999999999999998 110.323 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.489 ' CD2' HG13 ' A' ' 102' ' ' VAL . 46.9 m-85 -65.53 -36.8 84.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.446 -0.343 . . . . 0.44 111.278 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 29.1 mtpp -58.77 -49.36 77.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 1.9199999999999999 111.714 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -71.05 -29.63 65.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.494 . . . . 2.04 111.265 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.416 ' HB3' HG12 ' A' ' 102' ' ' VAL . 36.3 t -85.39 -11.38 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 1.3899999999999999 111.369 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? 63.16 43.97 6.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.73 -0.668 . . . . 4.0899999999999999 111.198 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.535 HG11 ' HG3' ' A' ' 114' ' ' PRO . 7.7 p -133.39 140.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.172 -0.467 . . . . 1.4199999999999999 110.29 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.7 mt -86.3 128.28 57.99 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.345 -0.388 . . . . 1.3300000000000001 110.868 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.98 136.23 55.68 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.497 2.131 . . . . 0.53000000000000003 111.193 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.9 t -155.8 172.67 17.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.892 -0.41 . . . . 1.4199999999999999 109.892 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.435 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 60.1 mt-30 -55.68 -31.26 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.581 0.551 . . . . 1.6599999999999999 111.472 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -59.75 -31.93 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.227 -0.442 . . . . 2.8199999999999998 111.639 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -80.38 -14.17 58.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.448 -0.342 . . . . 0.53000000000000003 111.531 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 87' ' ' LEU . 86.7 mt -59.91 -59.99 4.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.084 0.468 . . . . 1.24 110.848 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -101.98 -12.06 18.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 3.7000000000000002 111.179 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.42 175.93 38.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.794 -0.717 . . . . 1.1200000000000001 112.649 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.2 163.16 28.03 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.848 2.365 . . . . 1.3100000000000001 112.313 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.45 150.23 44.12 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.856 -0.611 . . . . 1.1100000000000001 109.588 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.535 ' HG3' HG11 ' A' ' 102' ' ' VAL . 38.9 Cg_endo -68.06 166.56 24.47 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.692 2.262 . . . . 1.1499999999999999 112.147 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 89.6 t 76.37 114.6 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 123.948 0.78 . . . . 2.98 110.614 -176.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 14.8 Cg_exo -68.37 100.29 0.65 Allowed 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.397 2.732 . . . . 4.2300000000000004 112.702 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -82.22 127.34 33.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.093 -0.503 . . . . 7.3300000000000001 110.203 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.6 m 62.16 57.0 2.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.554 0.692 . . . . 8.7799999999999994 110.834 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -96.06 -47.41 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.008 -0.542 . . . . 9.3399999999999999 110.253 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.81 -26.68 16.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.705 -0.76 . . . . 11.550000000000001 111.78 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.83 52.8 1.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.152 0.501 . . . . 13.92 110.994 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 -41.37 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.908 -0.587 . . . . 16.210000000000001 110.069 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -78.15 98.52 5.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.63 . . . . 18.82 109.507 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 124' ' ' LYS . 16.9 pttp -63.69 102.44 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.48 -0.782 . . . . 20.829999999999998 111.179 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.3 -37.32 77.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.963 -1.017 . . . . 22.5 111.082 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -128.56 110.69 12.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.851 -0.613 . . . . 23.989999999999998 110.354 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -82.81 54.96 2.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.171 0.51 . . . . 25.0 111.557 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 128' ' ' ARG . 26.0 tpt180 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 27.52 109.471 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.668 -0.573 . . . . 11.869999999999999 111.668 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.6 tt -86.42 93.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.572 0.701 . . . . 9.8599999999999994 111.179 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.87 133.53 69.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.112 -0.699 . . . . 6.96 109.112 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.23 36.09 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 123.098 2.532 . . . . 6.6500000000000004 113.857 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 50.58 45.39 26.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.034 0.445 . . . . 7.9900000000000002 110.687 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -58.2 150.95 20.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.374 -0.83 . . . . 4.2599999999999998 111.974 -172.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.2 ptp -102.63 52.7 0.79 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.962 -1.017 . . . . 3.8399999999999999 110.995 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.92 58.86 2.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 0.80000000000000004 110.105 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HG2' HD21 ' A' ' 113' ' ' LEU . 49.2 mtm180 -119.67 140.71 29.83 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.828 -0.624 . . . . 3.0899999999999999 110.127 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' VAL . 24.6 Cg_exo -65.53 178.54 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.231 2.621 . . . . 0.46999999999999997 112.141 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 87' ' ' LEU . 7.0 ptp85 -133.19 136.6 45.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.092 -0.504 . . . . 2.3700000000000001 111.85 -176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.596 ' HG ' ' CD1' ' A' ' 109' ' ' LEU . 4.1 mt -90.92 110.84 22.08 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.027 -0.731 . . . . 1.3200000000000001 109.027 173.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.8 115.63 27.71 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.117 -0.697 . . . . 0.40000000000000002 109.117 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.725 HG23 ' HG2' ' A' ' 85' ' ' LYS . 7.3 m -109.34 118.54 36.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.284 -0.636 . . . . 0.34999999999999998 109.284 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.493 ' HB2' ' HB2' ' A' ' 45' ' ' PRO . 23.1 ptp -128.31 133.13 48.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.294 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HE3' ' HB2' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -113.38 137.99 50.72 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.855 -0.795 . . . . 2.5800000000000001 108.855 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.558 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.9 ttmt -54.6 121.05 7.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.765 -0.652 . . . . 0.92000000000000004 111.179 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.98 -126.05 5.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.708 -0.758 . . . . 1.28 112.892 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.12 -43.05 45.1 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.221 2.614 . . . . 2.23 113.057 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 m -153.67 86.12 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.87 0.367 . . . . 2.8700000000000001 110.591 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.558 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 65.99 -136.12 35.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.893 -0.594 . . . . 1.9299999999999999 112.856 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 40.6 m-85 -124.66 -176.8 3.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.737 -0.838 . . . . 1.8200000000000001 108.737 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.61 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.963 -1.113 . . . . 0.42999999999999999 113.243 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.53 146.59 22.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.832 0.348 . . . . 0.40000000000000002 110.506 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.35 127.35 48.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.424 -0.584 . . . . 2.1800000000000002 109.424 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 35' ' ' GLN . 18.3 tp -101.71 147.84 25.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.258 0.551 . . . . 1.52 111.582 -169.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 1.3 m80 -109.56 121.98 46.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.71 . . . . 1.3400000000000001 110.268 177.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -117.32 101.73 8.66 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.269 -1.382 . . . . 2.2999999999999998 107.269 169.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 2.6 t70 -85.65 158.06 20.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.204 0.526 . . . . 3.48 111.739 -165.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -85.6 115.95 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.249 -0.887 . . . . 4.54 109.619 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.4 m 79.96 -18.47 0.5 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.013 0.82 . . . . 3.4900000000000002 112.158 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 62.8 mttp -98.4 112.97 63.57 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.82 -0.437 . . . . 3.0 109.82 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.1 150.18 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.394 2.062 . . . . 2.2400000000000002 112.238 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.88 173.57 19.98 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.932 -0.867 . . . . 1.29 110.932 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.52 ' HB3' HD11 ' A' ' 26' ' ' LEU . 26.0 mm-40 -121.53 128.73 52.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.783 0.325 . . . . 1.5 110.179 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 30.0 m-85 -109.32 157.73 18.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.413 -0.588 . . . . 0.87 109.413 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG13 HD11 ' A' ' 51' ' ' LEU . 38.3 mm -98.83 116.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.113 -0.328 . . . . 0.39000000000000001 110.113 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -76.87 -44.6 31.43 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.004 0.43 . . . . 2.8300000000000001 110.549 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.441 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 26.2 t -164.48 155.07 14.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.508 -0.769 . . . . 1.26 109.291 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.7 130.06 74.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.56 -0.533 . . . . 0.37 109.56 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.99 119.25 56.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.763 -0.458 . . . . 2.2799999999999998 109.763 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.3 140.25 81.87 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.648 2.232 . . . . 1.1699999999999999 112.698 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.585 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 12.3 m-20 65.36 39.31 5.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.31 -0.859 . . . . 2.3999999999999999 111.899 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.612 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 89.6 p -117.95 170.0 6.89 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.737 -0.665 . . . . 0.56999999999999995 109.365 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 6.3 Cg_endo -51.34 -35.0 52.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.107 1.872 . . . . 0.65000000000000002 112.015 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -47.42 62.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 0.35999999999999999 110.937 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 43' ' ' ASP . 5.0 tp10 -62.16 -40.49 96.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.997 0.427 . . . . 2.0099999999999998 110.232 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.68 -24.32 62.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.46999999999999997 111.763 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -75.93 -13.94 60.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.067 0.461 . . . . 0.40000000000000002 110.344 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.47 21.65 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.696 -0.764 . . . . 0.62 112.42 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.506 HD11 HG13 ' A' ' 37' ' ' ILE . 25.9 tp -79.16 132.63 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.65000000000000002 110.277 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 8.0 tpp180 -114.88 156.68 24.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.264 -0.273 . . . . 4.3799999999999999 110.264 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -87.07 30.24 0.78 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 1.4399999999999999 111.734 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.79 17.28 1.12 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.377 0.608 . . . . 3.0600000000000001 109.83 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.615 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.7 m-20 -104.6 159.28 15.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.065 -0.97 . . . . 1.02 110.355 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.549 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.8 tmm_? -128.12 130.9 48.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.2 -0.296 . . . . 1.5700000000000001 110.2 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.51 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.8 mt -75.58 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.68000000000000005 111.237 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.549 HG22 ' NH1' ' A' ' 56' ' ' ARG . 2.3 t -114.76 -46.32 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.758 -0.656 . . . . 0.87 110.299 177.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.6 mt-10 -123.69 148.13 46.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.89000000000000001 110.674 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 63' ' ' VAL . 99.6 t -125.53 119.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 0.66000000000000003 109.371 173.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.23 21.32 10.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 1.1699999999999999 111.45 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.88 9.38 61.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.669 -0.777 . . . . 0.66000000000000003 113.782 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 60' ' ' VAL . 11.2 p -115.31 136.25 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.412 0.606 . . . . 1.1699999999999999 109.816 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 7.2 p -74.69 136.97 41.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.488 -0.778 . . . . 1.6799999999999999 111.557 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.565 ' C ' ' HD2' ' A' ' 68' ' ' LYS . 22.4 mmt -108.36 67.45 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.057 -0.519 . . . . 0.81000000000000005 111.878 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -141.35 131.3 24.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.366 -0.834 . . . . 3.75 109.37 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.38 -0.37 74.65 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.291 -1.123 . . . . 1.47 110.291 -170.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HD3' ' H ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.0 164.4 13.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.356 -0.922 . . . . 3.3599999999999999 111.148 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -96.96 172.15 8.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.343 -0.844 . . . . 2.8900000000000001 109.041 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -62.2 -35.82 80.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.975 0.417 . . . . 1.4199999999999999 109.953 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.49 -33.73 88.04 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.71999999999999997 112.829 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.43 -46.76 81.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 2.0299999999999998 110.551 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 35' ' ' GLN . 46.4 t -62.4 -46.65 95.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.537 . . . . 1.0800000000000001 110.559 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.21 -42.85 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.71999999999999997 111.062 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -67.37 -36.55 81.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.445 -0.343 . . . . 0.66000000000000003 110.747 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.36 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.625 -0.261 . . . . 0.41999999999999998 111.549 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 84' ' ' THR . 77.9 mt -59.62 -45.34 94.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.283 0.563 . . . . 0.68999999999999995 110.345 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -72.66 -28.94 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.541 -0.754 . . . . 3.0899999999999999 110.918 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.53 -14.31 62.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.65000000000000002 111.406 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.61 -19.03 78.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.621 -0.8 . . . . 0.59999999999999998 112.047 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -104.28 3.14 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.714 -0.755 . . . . 1.1000000000000001 112.102 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.566 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 7.1 p-10 -98.0 -5.06 34.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.679 0.251 . . . . 2.1200000000000001 111.679 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -150.47 165.17 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.986 0.422 . . . . 2.1099999999999999 111.176 178.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.466 HG21 HG23 ' A' ' 77' ' ' ILE . 8.7 t -148.83 148.26 29.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.771 -0.65 . . . . 0.32000000000000001 109.688 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.725 ' HG2' HG23 ' A' ' 14' ' ' THR . 23.1 mttm -115.31 118.63 33.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.9 -0.407 . . . . 1.6299999999999999 109.9 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.35 125.87 51.47 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 0.28000000000000003 109.324 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD11 HD21 ' A' ' 109' ' ' LEU . 52.0 tp -102.1 115.17 29.98 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.611 -0.885 . . . . 0.51000000000000001 108.611 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 30.8 m -128.17 168.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.768 -0.651 . . . . 0.33000000000000002 110.207 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 10' ' ' PRO . 28.3 m -127.56 141.76 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.894 -0.594 . . . . 0.41999999999999998 110.352 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.93 172.08 14.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.145 -0.687 . . . . 1.9199999999999999 109.145 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 19.4 tpt85 -58.13 -46.6 85.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.926 0.394 . . . . 4.1600000000000001 111.152 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -64.88 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 2.6800000000000002 111.593 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 6.5 m -75.36 -43.8 48.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.185 0.517 . . . . 0.46999999999999997 110.536 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.442 ' HB2' HG23 ' A' ' 89' ' ' VAL . 24.4 t70 -59.38 -47.9 83.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 1.1799999999999999 111.618 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.6 -39.67 94.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.726 0.298 . . . . 1.9399999999999999 111.103 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -62.92 -49.32 75.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.72999999999999998 110.759 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.24 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -60.43 -49.22 78.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.489 0.551 . . . . 1.9199999999999999 112.489 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 7.2 ptmm? -68.7 -32.82 72.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.294 0.569 . . . . 2.04 110.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.494 ' HB3' HG23 ' A' ' 102' ' ' VAL . 62.0 m -76.47 -13.99 60.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.657 -0.701 . . . . 1.3899999999999999 111.295 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.5 27.71 15.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.45 -0.795 . . . . 4.0899999999999999 110.657 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 100' ' ' CYS . 59.5 t -102.71 139.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.805 -0.634 . . . . 1.4199999999999999 110.676 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.0 mp -84.82 122.66 74.52 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.005 -0.543 . . . . 1.3300000000000001 109.643 175.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HD2' HG11 ' A' ' 58' ' ' VAL . 3.0 Cg_exo -70.47 141.48 42.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.406 2.071 . . . . 0.53000000000000003 110.891 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -151.44 167.1 29.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.059 -0.256 . . . . 1.4199999999999999 110.787 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.601 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -52.5 -29.66 26.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.398 0.679 . . . . 1.6599999999999999 111.778 176.024 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.26 -30.67 64.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.441 0.639 . . . . 2.8199999999999998 110.902 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.73 -14.31 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.53000000000000003 110.704 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.601 ' CD1' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mt -70.03 114.24 8.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 1.24 110.33 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.479 ' HA ' ' NH1' ' A' ' 9' ' ' ARG . 66.2 t30 57.27 28.05 14.59 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.844 0.83 . . . . 3.7000000000000002 109.965 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.25 -169.05 12.42 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.228 -0.896 . . . . 1.1200000000000001 111.314 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 147.87 27.05 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.536 2.157 . . . . 1.3100000000000001 112.694 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 9' ' ' ARG . 47.6 mt -89.7 145.63 33.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.717 -0.674 . . . . 1.1100000000000001 110.161 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.434 ' HG3' HG11 ' A' ' 102' ' ' VAL . 36.5 Cg_endo -65.0 147.47 89.06 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.842 2.361 . . . . 1.1499999999999999 111.826 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 7.6 p -55.96 129.2 72.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 2.98 110.903 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 33.6 Cg_exo -58.8 89.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.071 2.514 . . . . 4.2300000000000004 112.045 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.618 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 3.8 t80 -70.36 124.6 24.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 7.3300000000000001 110.268 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -101.06 39.96 1.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.816 -0.629 . . . . 8.7799999999999994 111.415 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.618 ' HB3' ' CE2' ' A' ' 117' ' ' PHE . 51.3 t30 -133.78 108.49 8.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.946 -0.57 . . . . 9.3399999999999999 110.064 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.42 53.86 0.48 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.175 -0.77 . . . . 11.550000000000001 111.175 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.16 99.46 7.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 13.92 110.538 -174.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.6 mt -77.25 -46.33 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.906 -0.588 . . . . 16.210000000000001 110.932 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 60.3 91.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.577 0.704 . . . . 18.82 110.942 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -79.3 -6.01 55.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.109 -0.95 . . . . 20.829999999999998 109.944 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.94 -44.94 71.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.167 -0.924 . . . . 22.5 111.449 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -102.86 28.91 5.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.157 -0.474 . . . . 23.989999999999998 111.694 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.9 p -71.01 -66.49 0.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.19 -0.3 . . . . 25.0 110.19 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 109.177 -0.675 . . . . 27.52 109.177 174.068 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.737 -0.545 . . . . 11.869999999999999 111.737 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.0 mp -107.07 122.89 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.758 -0.46 . . . . 9.8599999999999994 109.758 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -91.34 109.53 36.48 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.244 -0.434 . . . . 6.96 109.847 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.02 -10.85 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.369 2.046 . . . . 6.6500000000000004 112.921 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.31 -79.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.648 0.261 . . . . 7.9900000000000002 110.633 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m 60.5 82.64 0.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.534 0.683 . . . . 4.2599999999999998 110.948 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptm -84.87 23.32 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 3.8399999999999999 110.561 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.5 mt -84.12 61.47 6.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 0.80000000000000004 110.772 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -130.54 148.86 71.67 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.758 -0.655 . . . . 3.0899999999999999 109.413 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.8 Cg_endo -70.38 162.98 40.43 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.566 2.177 . . . . 0.46999999999999997 111.419 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.448 ' NH1' HH12 ' A' ' 52' ' ' ARG . 6.4 ptp85 -127.65 136.12 51.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.167 -0.47 . . . . 2.3700000000000001 110.545 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HB2' HD11 ' A' ' 109' ' ' LEU . 46.5 tp -94.26 110.36 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.945 -0.57 . . . . 1.3200000000000001 109.707 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -98.91 116.9 32.2 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.323 -0.621 . . . . 0.40000000000000002 109.323 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 85' ' ' LYS . 45.7 m -111.36 119.3 38.4 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.464 -0.569 . . . . 0.34999999999999998 109.464 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.48 ' HE3' HD12 ' A' ' 86' ' ' LEU . 23.1 ptp -127.96 133.24 49.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.014 -0.539 . . . . 0.88 109.971 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -116.79 156.59 26.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.462 -0.79 . . . . 2.5800000000000001 110.138 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 86.0 mttt -68.55 125.72 27.4 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.264 -1.335 . . . . 0.92000000000000004 111.778 -172.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.86 -107.58 0.73 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.257 -1.338 . . . . 1.28 110.928 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HG2' ' HD3' ' A' ' 45' ' ' PRO . 33.5 Cg_endo -65.78 104.49 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.597 2.198 . . . . 2.23 111.361 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t 63.48 29.99 15.33 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.31 0.576 . . . . 2.8700000000000001 110.545 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.91 -97.09 1.11 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.269 -0.732 . . . . 1.9299999999999999 111.269 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 17.0 m-85 -119.53 -171.17 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.849 -0.797 . . . . 1.8200000000000001 108.849 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.57 78.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.1 -1.048 . . . . 0.42999999999999999 112.791 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -155.56 163.15 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.40000000000000002 110.605 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -128.88 129.22 45.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.939 -0.573 . . . . 2.1800000000000002 110.285 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.34 134.8 47.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.399 -0.364 . . . . 1.52 110.23 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.0 p80 -125.72 135.29 51.92 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.509 -0.476 . . . . 1.3400000000000001 110.734 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -102.31 122.39 44.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.408 -0.815 . . . . 2.2999999999999998 109.533 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.9 152.71 22.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.556 -0.535 . . . . 3.48 109.556 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -85.86 -24.62 26.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.829 -0.623 . . . . 4.54 110.56 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -101.49 -42.16 6.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.841 -0.618 . . . . 3.4900000000000002 109.99 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -94.34 117.74 67.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 3.0 110.407 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 154.22 58.66 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.502 2.134 . . . . 2.2400000000000002 112.231 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.0 161.52 30.76 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.9 -0.667 . . . . 1.29 111.961 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.87 128.76 40.32 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.057 -0.349 . . . . 1.5 110.057 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 88.1 m-85 -109.11 154.94 21.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 0.87 109.18 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 53' ' ' ALA . 41.3 mm -77.84 107.87 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.002 0.429 . . . . 0.39000000000000001 110.153 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 30.7 ttt180 -67.92 -43.47 79.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 2.8300000000000001 109.823 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 p -175.66 140.15 0.44 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.534 -1.212 . . . . 1.26 109.668 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.28 121.37 60.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.0 -0.741 . . . . 0.37 109.0 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -66.05 122.47 81.32 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.669 -0.696 . . . . 2.2799999999999998 109.957 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.18 149.71 78.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.847 2.365 . . . . 1.1699999999999999 111.777 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.96 40.55 2.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 2.3999999999999999 110.905 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 p -130.72 164.44 41.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.61 -0.268 . . . . 0.56999999999999995 110.696 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD3' ' HG2' ' A' ' 19' ' ' PRO . 23.4 Cg_exo -64.23 -27.33 64.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.494 2.129 . . . . 0.65000000000000002 111.47 175.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -46.81 71.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.759 -0.655 . . . . 0.35999999999999999 110.241 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.87 -33.24 75.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.85 -0.614 . . . . 2.0099999999999998 109.971 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.25 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.46999999999999997 111.753 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.2 -13.51 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.40000000000000002 110.556 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.58 50.45 1.83 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.62 112.061 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.2 tp -99.66 149.6 23.13 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.798 -0.445 . . . . 0.65000000000000002 109.798 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 39.0 ttm180 -147.2 143.36 28.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.683 -0.235 . . . . 4.3799999999999999 110.575 -173.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -77.22 14.11 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.074 0.768 . . . . 1.4399999999999999 113.074 -173.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -115.44 -5.49 12.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.208 0.528 . . . . 3.0600000000000001 109.981 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.633 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -91.36 155.06 18.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.152 -0.931 . . . . 1.02 111.273 -172.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -124.85 134.29 52.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 1.5700000000000001 109.719 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 88' ' ' VAL . 41.7 mm -63.97 124.41 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.298 -0.41 . . . . 0.68000000000000005 111.06 -176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.11 -52.01 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.995 -0.548 . . . . 0.87 110.638 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 28.9 mt-10 -133.32 149.37 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.89000000000000001 110.213 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.33 123.4 66.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.78 -0.452 . . . . 0.66000000000000003 109.78 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 60.81 20.84 10.97 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.079 0.552 . . . . 1.1699999999999999 111.153 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.0 1.1 70.52 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.9 -0.667 . . . . 0.66000000000000003 112.217 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.43 120.66 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.16 -0.311 . . . . 1.1699999999999999 110.16 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.572 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -64.46 136.2 56.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 1.6799999999999999 111.492 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.516 ' HG3' HG12 ' A' ' 73' ' ' VAL . 26.6 mmt -121.47 73.64 1.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.777 -0.647 . . . . 0.81000000000000005 109.613 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.78 -57.37 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.22 -0.9 . . . . 3.75 110.667 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.9 13.77 45.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.026 -0.607 . . . . 1.47 111.927 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 30.8 mmtp -86.4 160.26 19.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.856 0.36 . . . . 3.3599999999999999 110.491 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -90.72 173.11 8.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.0 -0.545 . . . . 2.8900000000000001 111.429 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -58.48 -36.43 73.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.219 -0.446 . . . . 1.4199999999999999 110.086 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.1 -38.7 96.56 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.795 -0.717 . . . . 0.71999999999999997 112.415 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 68' ' ' LYS . 4.3 m-20 -62.57 -48.09 80.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.653 0.263 . . . . 2.0299999999999998 111.171 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.516 HG12 ' HG3' ' A' ' 65' ' ' MET . 33.4 m -67.42 -40.35 84.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 1.0800000000000001 111.367 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.44 -45.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.056 0.455 . . . . 0.71999999999999997 110.672 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -36.59 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 0.66000000000000003 110.414 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.47 96.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.655 0.264 . . . . 0.41999999999999998 111.187 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 84' ' ' THR . 85.9 mt -60.21 -45.2 96.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.205 0.526 . . . . 0.68999999999999995 110.274 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.63 -36.04 78.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 3.0899999999999999 110.913 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.65000000000000002 110.993 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.47 79.59 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 0.59999999999999998 111.273 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.28 -123.32 7.67 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.004 -0.617 . . . . 1.1000000000000001 111.659 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 1.3 m-20 -100.22 -4.16 30.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.829 0.347 . . . . 2.1200000000000001 110.46 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 26.0 mt-10 -135.05 140.05 45.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.357 -0.979 . . . . 2.1099999999999999 108.357 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 77' ' ' ILE . 12.6 t -139.66 148.03 41.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.897 0.38 . . . . 0.32000000000000001 110.464 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 14' ' ' THR . 60.2 mttm -116.73 123.97 48.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.265 -0.425 . . . . 1.6299999999999999 110.331 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.48 HD12 ' HE3' ' A' ' 15' ' ' MET . 95.0 mt -110.48 129.78 55.7 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.736 -0.468 . . . . 0.28000000000000003 109.736 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 59' ' ' GLU . 16.9 tp -104.75 119.18 38.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.048 -0.723 . . . . 0.51000000000000001 109.048 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 23.8 m -130.28 165.94 29.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.304 -0.407 . . . . 0.33000000000000002 111.623 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.43 160.09 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.532 -0.758 . . . . 0.41999999999999998 110.508 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' HH12 ' A' ' 11' ' ' ARG . 2.2 m-20 -77.29 175.59 9.58 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.492 0.495 . . . . 1.9199999999999999 110.418 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -61.89 -47.27 85.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 4.1600000000000001 110.767 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.41 -35.78 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 2.6800000000000002 110.093 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -65.89 -41.51 91.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 0.46999999999999997 110.797 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 20.4 t70 -58.66 -48.54 80.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 1.1799999999999999 110.194 176.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -62.17 -38.46 89.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 1.9399999999999999 111.108 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 77.7 t80 -63.74 -49.19 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.42 -0.354 . . . . 0.72999999999999998 111.283 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 19.6 m-85 -66.17 -38.27 87.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.476 -0.329 . . . . 0.44 111.212 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 31.3 mtpt -66.72 -43.53 84.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.455 -0.338 . . . . 1.9199999999999999 111.557 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 96' ' ' PHE . 52.0 pttt -71.75 -14.65 62.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 2.04 110.66 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 54.5 m -94.47 -6.22 44.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.227 0.537 . . . . 1.3899999999999999 110.566 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.576 ' HD2' ' N ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER 57.96 35.33 25.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.112 -0.949 . . . . 4.0899999999999999 111.454 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 114' ' ' PRO . 10.9 p -132.24 147.33 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.796 -0.638 . . . . 1.4199999999999999 109.806 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.564 HG21 ' SG ' ' A' ' 64' ' ' CYS . 32.1 mm -87.99 132.19 40.73 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.324 -0.398 . . . . 1.3300000000000001 111.26 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.486 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 18.7 Cg_exo -65.35 137.4 51.11 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.557 2.171 . . . . 0.53000000000000003 110.462 173.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.4 p -153.04 174.25 14.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.774 -0.37 . . . . 1.4199999999999999 111.564 -172.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.444 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 98.3 mt-30 -59.49 -28.36 66.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 1.6599999999999999 110.298 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.89 -41.34 77.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.616 -0.72 . . . . 2.8199999999999998 110.429 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -78.95 -14.09 59.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.518 -0.764 . . . . 0.53000000000000003 111.398 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.6 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.825 0.345 . . . . 1.24 110.92 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -118.09 -37.64 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 3.7000000000000002 111.03 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.27 -166.44 36.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.164 -0.541 . . . . 1.1200000000000001 113.507 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.9 136.77 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.536 2.824 . . . . 1.3100000000000001 112.636 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.496 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.8 mm? -63.11 154.86 76.0 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 1.1100000000000001 109.909 171.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.61 ' HB3' HG11 ' A' ' 102' ' ' VAL . 7.1 Cg_endo -48.4 -31.27 17.31 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.312 3.341 . . . . 1.1499999999999999 115.015 -168.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.8 m -66.33 119.45 62.35 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.678 -0.692 . . . . 2.98 111.012 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.665 ' HB2' ' HB3' ' A' ' 119' ' ' ASN . 34.6 Cg_endo -66.24 92.32 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.582 2.188 . . . . 4.2300000000000004 111.542 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -52.9 109.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.576 -0.738 . . . . 7.3300000000000001 111.603 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.3 p 59.64 23.05 11.8 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.085 0.954 . . . . 8.7799999999999994 112.047 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 116' ' ' PRO . 9.8 t30 -116.62 121.74 42.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.172 -0.467 . . . . 9.3399999999999999 110.209 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.32 -96.37 0.7 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.656 -0.783 . . . . 11.550000000000001 112.213 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 57.02 40.2 28.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.553 0.692 . . . . 13.92 110.731 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 pt -98.95 122.14 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.236 -0.893 . . . . 16.210000000000001 110.575 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -145.54 -85.14 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.332 -0.394 . . . . 18.82 110.126 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -112.59 0.91 15.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.996 0.427 . . . . 20.829999999999998 110.158 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.78 141.16 4.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 22.5 110.064 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -174.85 132.17 0.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 23.989999999999998 109.379 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.1 m 52.99 41.46 32.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.173 0.511 . . . . 25.0 110.795 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.656 -0.688 . . . . 27.52 109.988 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.834 -0.506 . . . . 11.869999999999999 111.834 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.534 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 23.6 pt -76.65 140.21 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.773 0.32 . . . . 9.8599999999999994 110.47 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.92 114.98 60.91 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.341 0.591 . . . . 6.96 112.212 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 2' ' ' ILE . 18.8 Cg_endo -90.83 -51.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.943 2.429 . . . . 6.6500000000000004 111.564 169.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -154.59 57.96 0.69 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.644 -0.707 . . . . 7.9900000000000002 110.079 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.513 HG22 ' HG ' ' A' ' 8' ' ' LEU . 3.3 m -81.23 73.5 8.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.496 0.665 . . . . 4.2599999999999998 110.585 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptm -84.33 51.94 2.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.314 -0.857 . . . . 3.8399999999999999 111.168 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 6' ' ' THR . 81.1 mt -80.97 60.38 4.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.305 0.574 . . . . 0.80000000000000004 110.436 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 14.1 ptt180 -126.74 160.2 60.0 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.616 -0.72 . . . . 3.0899999999999999 109.285 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.7 Cg_endo -65.79 178.6 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.446 2.097 . . . . 0.46999999999999997 111.984 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.539 ' HD3' HG23 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -137.31 132.5 33.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.108 -0.33 . . . . 2.3700000000000001 110.108 175.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HG ' HD11 ' A' ' 109' ' ' LEU . 3.7 mt -92.82 109.9 21.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.08 -0.509 . . . . 1.3200000000000001 109.843 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 17.9 m -91.19 116.64 28.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.966 -0.753 . . . . 0.40000000000000002 108.966 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 116.7 33.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.517 -0.92 . . . . 0.34999999999999998 108.517 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.9 ptp -140.21 134.13 30.7 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.148 -0.478 . . . . 0.88 110.195 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 17.9 pttp -110.9 156.28 21.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.266 0.555 . . . . 2.5800000000000001 110.583 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.574 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.8 ttmt -59.11 111.85 1.48 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.85 -1.068 . . . . 0.92000000000000004 112.163 -171.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 19' ' ' PRO . . . -110.53 -107.16 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.414 -0.812 . . . . 1.28 111.256 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 18' ' ' GLY . 27.7 Cg_exo -62.33 95.33 0.14 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.088 2.525 . . . . 2.23 112.126 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.0 t 72.53 -52.17 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.461 0.705 . . . . 2.8700000000000001 112.139 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.574 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -179.69 78.25 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 1.9299999999999999 111.885 -175.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 71.04 -63.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.342 0.657 . . . . 1.8200000000000001 110.913 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.12 69.31 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.158 -0.544 . . . . 0.42999999999999999 112.982 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.43 150.99 25.69 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.783 0.325 . . . . 0.40000000000000002 110.192 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 45.1 t-20 -102.26 129.33 48.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.894 0.378 . . . . 2.1800000000000002 109.982 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 35' ' ' GLN . 1.7 tm? -100.84 129.33 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.168 -0.679 . . . . 1.52 109.168 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.467 ' CD2' ' HG2' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -153.18 167.04 30.63 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.852 1.797 . . . . 1.3400000000000001 115.852 -167.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.643 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 70.5 m 87.39 12.61 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 113.209 -1.814 . . . . 2.2999999999999998 112.487 169.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 70' ' ' HIS . 1.7 p-10 -129.67 163.26 26.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.173 0.511 . . . . 3.48 110.928 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -166.26 -25.75 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.945 -1.025 . . . . 4.54 109.054 170.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -150.04 19.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.645 -0.707 . . . . 3.4900000000000002 110.281 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -126.18 135.4 27.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.932 -0.396 . . . . 3.0 109.932 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 154.08 68.44 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.408 2.072 . . . . 2.2400000000000002 111.003 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 105.88 2.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.429 -0.891 . . . . 1.29 110.984 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.695 ' HB3' HD11 ' A' ' 26' ' ' LEU . 10.4 mm100 -100.4 140.51 34.55 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 1.5 109.523 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.643 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 50.3 m-85 -117.53 144.48 45.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.197 -1.001 . . . . 0.87 110.104 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.5 HG13 HD11 ' A' ' 51' ' ' LEU . 45.0 mm -81.56 115.3 23.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.541 -0.54 . . . . 0.39000000000000001 109.541 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 2.1 tmm_? -77.25 -49.31 15.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.234 -0.654 . . . . 2.8300000000000001 109.234 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.2 p -159.68 150.47 19.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.057 -0.974 . . . . 1.26 109.824 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.11 122.03 63.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.065 -0.717 . . . . 0.37 109.065 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.8 m-20 -67.42 133.02 93.02 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.589 . . . . 2.2799999999999998 110.436 -174.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 35.5 Cg_exo -59.71 145.2 98.78 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.672 2.248 . . . . 1.1699999999999999 112.033 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 34.4 m-20 74.54 15.59 3.34 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.997 0.81 . . . . 2.3999999999999999 111.657 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.5 p -95.09 155.22 39.23 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.752 0.31 . . . . 0.56999999999999995 110.238 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.68 -27.5 81.27 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.772 2.315 . . . . 0.65000000000000002 111.182 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -65.24 -48.81 71.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.732 -0.667 . . . . 0.35999999999999999 110.114 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 2.0099999999999998 110.272 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.42 69.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.46999999999999997 111.784 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 74.6 p -73.68 -12.15 60.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.40000000000000002 110.875 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.34 51.06 1.36 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.62 112.441 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.5 HD11 HG13 ' A' ' 37' ' ' ILE . 23.1 tp -100.83 142.62 32.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.0 0.429 . . . . 0.65000000000000002 110.759 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.515 ' HG2' ' H ' ' A' ' 54' ' ' GLN . 32.4 ttm180 -121.63 144.23 48.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 4.3799999999999999 109.805 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.71 26.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 1.4399999999999999 111.5 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -139.95 19.75 2.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.641 . . . . 3.0600000000000001 109.271 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -104.27 157.85 16.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.341 -0.845 . . . . 1.02 111.305 -176.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -115.89 133.08 56.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.604 -0.725 . . . . 1.5700000000000001 109.874 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' HA ' HG12 ' A' ' 88' ' ' VAL . 65.5 mt -76.63 124.43 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.296 -0.411 . . . . 0.68000000000000005 110.465 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -106.65 -46.0 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.87 110.523 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 43.1 mt-10 -127.07 146.23 50.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.89000000000000001 110.465 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 63' ' ' VAL . 85.9 t -131.48 118.93 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.22 -0.446 . . . . 0.66000000000000003 109.841 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 57.23 27.43 13.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.377 -0.374 . . . . 1.1699999999999999 111.582 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.5 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.6 6.75 63.81 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.66000000000000003 114.219 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 60' ' ' VAL . 12.1 p -115.41 135.07 56.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.784 0.792 . . . . 1.1699999999999999 110.092 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.426 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.1 t -80.74 136.63 36.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.508 -0.769 . . . . 1.6799999999999999 111.225 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.486 ' SD ' HG22 ' A' ' 73' ' ' VAL . 23.1 mmt -106.94 53.3 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.81000000000000005 110.479 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.09 -56.77 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 3.75 110.309 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.72 1.47 39.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 1.47 111.794 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.2 146.6 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.178 0.513 . . . . 3.3599999999999999 110.875 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -98.97 -179.46 4.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.661 -0.699 . . . . 2.8900000000000001 110.644 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.549 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 40.7 t60 -55.57 -43.87 76.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.401 . . . . 1.4199999999999999 110.773 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -37.85 95.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.734 -0.746 . . . . 0.71999999999999997 112.21 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.44 -47.51 75.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.987 0.422 . . . . 2.0299999999999998 110.876 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.486 HG22 ' SD ' ' A' ' 65' ' ' MET . 25.2 t -70.23 -47.14 68.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 1.0800000000000001 110.983 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.83 -36.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 0.71999999999999997 110.636 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -65.31 -47.0 78.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.187 -0.46 . . . . 0.66000000000000003 110.093 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.59 93.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.218 -0.446 . . . . 0.41999999999999998 111.651 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.423 HG23 HG21 ' A' ' 84' ' ' THR . 70.3 mt -58.94 -43.26 88.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.288 0.566 . . . . 0.68999999999999995 110.605 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -74.42 -30.08 61.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.516 -0.765 . . . . 3.0899999999999999 111.342 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.15 9.94 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.65000000000000002 111.727 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.1 -0.8 86.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.59999999999999998 111.798 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.37 -101.5 2.49 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.129 -0.788 . . . . 1.1000000000000001 111.129 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.497 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 6.0 t70 -128.86 -15.96 4.24 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.988 -0.285 . . . . 2.1200000000000001 110.664 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.2 mt-10 -119.3 144.34 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 2.1099999999999999 108.481 174.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 77' ' ' ILE . 13.3 t -135.34 148.82 49.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.094 0.473 . . . . 0.32000000000000001 110.395 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HB3' HD22 ' A' ' 12' ' ' LEU . 97.8 mttt -111.67 117.46 32.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 1.6299999999999999 109.856 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.8 mt -106.68 129.98 54.49 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.16 -0.473 . . . . 0.28000000000000003 109.797 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 10' ' ' PRO . 41.5 tp -104.8 115.31 30.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.284 -0.636 . . . . 0.51000000000000001 109.284 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.0 m -127.48 160.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.107 -0.497 . . . . 0.33000000000000002 110.861 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.88 138.77 53.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 0.41999999999999998 110.644 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.22 166.38 23.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.605 . . . . 1.9199999999999999 110.078 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 44.8 ttt180 -56.2 -48.01 77.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 4.1600000000000001 110.259 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.62 -33.69 76.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 2.6800000000000002 110.372 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.4 m -70.63 -51.8 25.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.302 -0.863 . . . . 0.46999999999999997 111.122 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.87 -30.72 68.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 1.1799999999999999 111.393 -172.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 26.4 mm-40 -62.02 -35.27 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.005 0.431 . . . . 1.9399999999999999 110.126 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -67.83 -45.7 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.72999999999999998 109.926 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -62.54 -36.91 84.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.44 111.498 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -59.66 -49.65 76.93 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.54 0.21 . . . . 1.9199999999999999 111.257 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ptmt -71.89 -26.48 62.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.419 -0.355 . . . . 2.04 111.048 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 m -81.19 -8.4 59.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.273 -0.421 . . . . 1.3899999999999999 111.242 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 58.53 39.63 24.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.338 -0.846 . . . . 4.0899999999999999 111.046 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.448 HG11 ' CG ' ' A' ' 114' ' ' PRO . 7.3 p -132.87 145.25 34.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 1.4199999999999999 110.924 -176.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 63.9 mt -80.51 131.75 60.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 1.3300000000000001 110.572 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 22.4 Cg_exo -63.7 136.65 54.8 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.472 2.115 . . . . 0.53000000000000003 110.619 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 48.9 m -157.57 163.66 38.11 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.124 -0.23 . . . . 1.4199999999999999 110.677 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.5 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 50.8 mt-30 -56.89 -28.78 62.32 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.7 0.625 . . . . 1.6599999999999999 111.983 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.3 pt-20 -57.99 -29.97 65.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.114 0.483 . . . . 2.8199999999999998 111.061 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.427 ' CD2' ' HD3' ' A' ' 114' ' ' PRO . 35.9 m80 -82.97 -13.68 55.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.884 -0.598 . . . . 0.53000000000000003 110.98 -177.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.501 HD11 HD13 ' A' ' 87' ' ' LEU . 66.8 mt -73.73 -53.77 9.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 1.24 110.087 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.51 48.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.454 -0.794 . . . . 3.7000000000000002 110.258 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.53 38.36 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.755 -0.736 . . . . 1.1200000000000001 111.959 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.94 174.54 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.048 2.499 . . . . 1.3100000000000001 112.783 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 9' ' ' ARG . 48.1 mt -88.43 138.23 30.3 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.586 -0.734 . . . . 1.1100000000000001 109.737 175.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.448 ' CG ' HG11 ' A' ' 102' ' ' VAL . 48.0 Cg_endo -68.23 127.41 15.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.808 2.338 . . . . 1.1499999999999999 112.578 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 27.3 m -125.96 144.97 50.39 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 2.98 109.662 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 13.3 Cg_exo -70.4 72.64 1.74 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.922 2.415 . . . . 4.2300000000000004 112.038 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.92 142.17 28.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.785 -0.45 . . . . 7.3300000000000001 109.785 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.0 p -72.88 89.22 1.38 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 8.7799999999999994 111.652 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.97 156.21 22.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.769 -0.65 . . . . 9.3399999999999999 110.385 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.57 157.16 49.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.078 -0.582 . . . . 11.550000000000001 112.392 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.72 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.106 0.479 . . . . 13.92 111.46 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 57.8 mt -84.55 86.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.686 -0.857 . . . . 16.210000000000001 108.686 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -73.54 122.66 22.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 18.82 110.978 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -118.58 57.12 0.87 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.172 -0.922 . . . . 20.829999999999998 109.655 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -61.93 -59.31 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.773 -1.103 . . . . 22.5 110.669 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -102.53 106.17 16.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 23.989999999999998 110.113 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.2 t -130.78 120.71 24.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.829 -0.623 . . . . 25.0 109.919 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.708 -0.663 . . . . 27.52 109.465 179.471 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 112.035 -0.426 . . . . 11.869999999999999 112.035 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.9 mt 71.17 110.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.329 0.585 . . . . 9.8599999999999994 110.75 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 16.2 t70 -85.51 135.63 38.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.828 -0.624 . . . . 6.96 109.567 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 32.5 Cg_exo -59.62 -16.87 38.93 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.391 2.727 . . . . 6.6500000000000004 112.784 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 8' ' ' LEU . 18.6 p90 -136.38 -152.76 0.46 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.917 -1.142 . . . . 7.9900000000000002 107.917 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.541 HG22 ' HG3' ' A' ' 7' ' ' MET . 23.1 m 71.73 129.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 4.2599999999999998 111.661 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 6' ' ' THR . 85.1 mtp 66.58 11.82 8.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.8 . . . . 3.8399999999999999 111.415 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 5' ' ' PHE . 65.9 mt -93.63 64.38 3.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.997 0.904 . . . . 0.80000000000000004 109.038 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 110' ' ' ASN . 74.1 mtt180 -117.7 146.49 38.86 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.43 -1.259 . . . . 3.0899999999999999 109.481 -173.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 87' ' ' LEU . 48.0 Cg_endo -66.93 159.25 52.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.378 2.052 . . . . 0.46999999999999997 110.996 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HG3' HG23 ' A' ' 88' ' ' VAL . 6.3 ptp85 -114.92 129.55 56.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.209 -0.45 . . . . 2.3700000000000001 110.304 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.451 -0.574 . . . . 1.3200000000000001 109.451 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 21.4 m -93.85 116.18 28.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.535 -0.543 . . . . 0.40000000000000002 109.535 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 85' ' ' LYS . 25.5 m -108.57 116.95 32.94 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.661 -0.866 . . . . 0.34999999999999998 108.661 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.419 ' HE3' HD12 ' A' ' 86' ' ' LEU . 25.3 ptp -133.55 134.01 42.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.142 0.496 . . . . 0.88 111.201 -172.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -107.07 141.42 38.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.246 -0.888 . . . . 2.5800000000000001 109.997 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 39.0 mttm -59.79 107.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.695 -0.684 . . . . 0.92000000000000004 111.427 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 19' ' ' PRO . . . -104.41 -119.64 4.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.922 -1.036 . . . . 1.28 112.366 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 18' ' ' GLY . 43.1 Cg_exo -57.52 -58.01 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.079 2.519 . . . . 2.23 113.066 -176.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -121.37 36.4 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 2.8700000000000001 111.425 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 55.63 84.4 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.249 -0.501 . . . . 1.9299999999999999 112.736 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 8.7 m-85 67.32 -149.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.801 -0.444 . . . . 1.8200000000000001 109.801 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.91 73.34 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.391 -0.909 . . . . 0.42999999999999999 112.516 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -152.77 158.91 42.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.40000000000000002 110.539 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -113.91 133.4 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 2.1800000000000002 109.561 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 35' ' ' GLN . 3.1 tm? -109.23 129.38 55.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.024 -0.362 . . . . 1.52 110.024 -176.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.811 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.91 140.13 53.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.123 0.487 . . . . 1.3400000000000001 110.292 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -126.36 142.57 51.48 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.972 -0.558 . . . . 2.2999999999999998 110.066 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 8.6 t70 -92.26 141.27 28.74 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.67 -0.863 . . . . 3.48 108.67 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.36 -9.79 23.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 4.54 110.965 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 t -97.53 -44.02 6.99 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.186 -0.672 . . . . 3.4900000000000002 109.186 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 22.2 pttm -117.43 114.22 38.37 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.636 . . . . 3.0 109.889 176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.7 140.23 84.11 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.012 2.475 . . . . 2.2400000000000002 113.193 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.82 135.47 2.9 Favored Glycine 0 C--N 1.312 -0.752 0 CA-C-N 114.618 -1.174 . . . . 1.29 112.115 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.435 ' HB3' HD21 ' A' ' 26' ' ' LEU . 2.6 mp0 -101.28 128.3 47.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.805 -0.443 . . . . 1.5 109.805 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.636 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 56.0 m-85 -122.08 142.31 50.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.926 -0.398 . . . . 0.87 109.926 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.534 HG13 HD11 ' A' ' 51' ' ' LEU . 43.7 mm -72.29 109.41 4.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.199 0.523 . . . . 0.39000000000000001 110.029 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.811 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.1 tpt180 -66.81 -42.88 85.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.256 -0.883 . . . . 2.8300000000000001 110.233 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -170.51 158.23 6.28 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.489 -0.778 . . . . 1.26 109.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.05 134.4 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.076 -0.713 . . . . 0.37 109.076 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.44 125.02 91.51 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.104 -0.498 . . . . 2.2799999999999998 109.932 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 Cg_endo -61.38 134.82 53.92 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.756 2.304 . . . . 1.1699999999999999 112.771 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.4 m-20 73.16 20.23 3.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.442 -0.799 . . . . 2.3999999999999999 112.194 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 97.2 p -97.48 160.4 28.86 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.873 -0.417 . . . . 0.56999999999999995 109.873 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 19.6 Cg_endo -60.06 -24.25 76.04 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.336 2.024 . . . . 0.65000000000000002 111.999 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.91 -40.97 75.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.35999999999999999 110.35 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -69.89 -39.38 76.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.201 -0.454 . . . . 2.0099999999999998 110.249 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.46999999999999997 111.79 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.5 p -75.45 -12.89 60.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.40000000000000002 110.529 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.83 -1.0 30.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.686 . . . . 0.62 112.29 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 37' ' ' ILE . 30.9 tp -74.82 131.15 40.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.891 0.377 . . . . 0.65000000000000002 110.466 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -132.77 -172.58 2.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.002 -0.544 . . . . 4.3799999999999999 110.271 177.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.36 154.46 19.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.515 -0.311 . . . . 1.4399999999999999 111.342 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 69.6 18.82 7.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.694 -0.685 . . . . 3.0600000000000001 111.235 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -90.57 150.21 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 1.02 109.784 175.135 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -120.53 129.1 53.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.534 -0.543 . . . . 1.5700000000000001 109.534 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' HG12 ' A' ' 88' ' ' VAL . 54.9 mt -76.26 136.67 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.68000000000000005 111.406 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.511 HG22 ' NH1' ' A' ' 56' ' ' ARG . 3.4 t -115.1 -50.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.481 -0.782 . . . . 0.87 110.098 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 31.2 mt-10 -128.88 149.07 50.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.939 -0.573 . . . . 0.89000000000000001 110.48 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -130.35 120.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.66000000000000003 110.004 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 60.35 27.61 17.19 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.949 0.5 . . . . 1.1699999999999999 111.447 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.01 82.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.66000000000000003 112.32 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.86 121.62 55.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.13 -0.322 . . . . 1.1699999999999999 110.13 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -70.23 135.27 48.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.421 . . . . 1.6799999999999999 110.813 -178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.754 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 23.8 mmt -112.67 64.39 0.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.596 0.712 . . . . 0.81000000000000005 110.333 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -93.44 99.19 11.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.01 -0.995 . . . . 3.75 110.875 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 4.33 81.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 1.47 112.474 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.754 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.5 mmtp -58.77 156.61 10.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.621 0.724 . . . . 3.3599999999999999 112.819 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -80.93 162.39 23.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.483 -1.235 . . . . 2.8900000000000001 109.969 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -59.16 -38.9 80.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.924 0.392 . . . . 1.4199999999999999 110.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.42 -41.2 91.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.751 -0.738 . . . . 0.71999999999999997 113.099 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.51 -41.08 89.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.718 0.259 . . . . 2.0299999999999998 111.215 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.1 m -69.41 -41.89 80.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 1.0800000000000001 111.383 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.53 -38.09 78.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.973 0.416 . . . . 0.71999999999999997 110.344 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -66.33 -35.85 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.66000000000000003 110.51 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.49 98.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.41999999999999998 111.567 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 HD21 ' A' ' 86' ' ' LEU . 62.9 mt -59.06 -42.26 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.295 0.569 . . . . 0.68999999999999995 110.628 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -74.14 -30.28 62.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.682 -0.69 . . . . 3.0899999999999999 110.706 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 -8.91 57.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.868 -0.605 . . . . 0.65000000000000002 111.446 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.09 -30.85 78.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.76 -0.734 . . . . 0.59999999999999998 111.683 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.65 -101.04 1.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.071 -0.585 . . . . 1.1000000000000001 112.132 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.64 -18.06 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.998 0.428 . . . . 2.1200000000000001 110.083 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.61 44.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.429 -0.582 . . . . 2.1099999999999999 109.429 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.438 HG21 HG23 ' A' ' 77' ' ' ILE . 15.1 t -140.32 149.37 42.67 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.262 -0.426 . . . . 0.32000000000000001 110.142 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.9 mttp -116.26 116.89 28.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.185 -0.461 . . . . 1.6299999999999999 109.989 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 77' ' ' ILE . 87.1 mt -108.3 126.87 53.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.105 -0.498 . . . . 0.28000000000000003 109.995 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 10' ' ' PRO . 31.0 tp -103.25 115.71 31.09 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.093 -0.706 . . . . 0.51000000000000001 109.093 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.4 m -127.39 164.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.767 -0.651 . . . . 0.33000000000000002 110.089 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -127.74 142.06 44.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.086 -0.507 . . . . 0.41999999999999998 111.14 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.21 168.74 17.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.23 -0.895 . . . . 1.9199999999999999 109.48 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 91' ' ' ARG . 6.5 ttp180 -56.58 -47.55 79.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.268 0.556 . . . . 4.1600000000000001 110.155 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.09 -35.92 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.438 -0.801 . . . . 2.6800000000000002 110.981 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 m -72.16 -49.95 31.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.46999999999999997 111.497 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.63 -46.75 88.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.109 0.48 . . . . 1.1799999999999999 110.301 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -63.01 -34.63 77.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.913 -0.585 . . . . 1.9399999999999999 111.269 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.81 -47.37 78.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.72999999999999998 110.438 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HD2' HG13 ' A' ' 102' ' ' VAL . 43.1 m-85 -65.1 -35.9 82.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.1 -0.5 . . . . 0.44 111.393 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -57.9 -49.1 77.88 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.505 0.187 . . . . 1.9199999999999999 111.505 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -71.01 -22.17 62.19 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.202 0.525 . . . . 2.04 110.812 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 116' ' ' PRO . 85.9 m -84.81 -14.45 48.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.018 -0.537 . . . . 1.3899999999999999 110.817 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 57.63 33.97 23.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.418 -0.81 . . . . 4.0899999999999999 111.372 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.458 HG11 ' HG2' ' A' ' 114' ' ' PRO . 11.4 p -128.49 146.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.017 -0.538 . . . . 1.4199999999999999 109.953 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.2 mt -87.23 132.06 42.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 1.3300000000000001 111.322 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.04 143.37 84.56 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.783 2.322 . . . . 0.53000000000000003 110.942 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -156.01 163.04 40.2 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.82 -0.352 . . . . 1.4199999999999999 110.481 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.45 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 22.7 mt-30 -55.66 -29.01 58.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.679 0.612 . . . . 1.6599999999999999 110.904 174.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.54 -29.76 66.58 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.939 -0.573 . . . . 2.8199999999999998 111.839 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -87.24 -13.88 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.361 -0.381 . . . . 0.53000000000000003 111.798 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 73.2 mt -58.3 106.74 0.41 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.48 -0.327 . . . . 1.24 110.932 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.48 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 83.6 m-20 59.61 18.25 6.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.153 -0.476 . . . . 3.7000000000000002 111.638 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.2 179.3 23.01 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.445 -0.662 . . . . 1.1200000000000001 111.445 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.5 131.9 29.43 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.423 2.082 . . . . 1.3100000000000001 111.886 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.3 mt -78.88 132.34 64.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.728 -0.471 . . . . 1.1100000000000001 109.728 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HG2' HG11 ' A' ' 102' ' ' VAL . 30.4 Cg_endo -64.47 149.45 89.97 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.416 2.744 . . . . 1.1499999999999999 113.02 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 p -128.77 83.29 66.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 122.002 0.906 . . . . 2.98 109.969 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 100' ' ' CYS . 3.0 Cg_endo -87.58 5.65 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.445 2.763 . . . . 4.2300000000000004 112.068 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 63.88 -69.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.596 -1.184 . . . . 7.3300000000000001 112.01 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 m 58.95 59.61 2.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.876 0.846 . . . . 8.7799999999999994 110.213 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -94.78 -21.15 18.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.428 -0.806 . . . . 9.3399999999999999 109.593 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.74 149.55 28.6 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.87 -0.681 . . . . 11.550000000000001 111.969 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -73.52 106.69 5.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.804 0.335 . . . . 13.92 110.339 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.73 109.12 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 16.210000000000001 110.446 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -126.89 87.71 2.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.445 . . . . 18.82 110.343 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.217 0.532 . . . . 20.829999999999998 110.737 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.11 155.55 18.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.696 -0.684 . . . . 22.5 110.756 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -115.22 66.61 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.941 -0.572 . . . . 23.989999999999998 110.417 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 p -81.34 90.77 6.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.381 0.61 . . . . 25.0 109.86 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.537 -0.756 . . . . 27.52 110.808 -175.16 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.952 0 N-CA-C 111.816 -0.513 . . . . 11.869999999999999 111.816 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.6 pt -114.61 36.36 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 9.8599999999999994 109.637 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.56 116.53 65.03 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.193 -0.912 . . . . 6.96 110.636 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.06 -26.46 30.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.838 2.359 . . . . 6.6500000000000004 111.622 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -95.64 71.49 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 7.9900000000000002 110.271 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -124.95 160.29 29.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 4.2599999999999998 111.117 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 ptm -92.14 21.39 5.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 3.8399999999999999 111.596 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.8 mt -109.25 41.05 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.348 0.594 . . . . 0.80000000000000004 110.62 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -112.45 145.98 34.02 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 3.0899999999999999 109.26 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HB2' HD11 ' A' ' 87' ' ' LEU . 32.8 Cg_endo -65.06 160.28 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.21 1.94 . . . . 0.46999999999999997 111.552 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -107.23 130.33 54.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.599 -0.728 . . . . 2.3700000000000001 109.904 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.6 tp -106.23 109.4 21.32 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.536 -0.542 . . . . 1.3200000000000001 109.536 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.2 m -96.26 117.5 30.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.743 -0.662 . . . . 0.40000000000000002 109.841 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -111.06 116.87 31.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.407 -0.961 . . . . 0.34999999999999998 108.407 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.652 ' HE3' HD12 ' A' ' 86' ' ' LEU . 22.8 ptp -132.88 133.54 43.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.942 0.401 . . . . 0.88 110.652 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.972 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 6.8 ttmt -108.78 137.38 46.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.233 0.54 . . . . 2.5800000000000001 110.459 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.645 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.5 ttmt -54.88 125.65 21.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.407 -1.27 . . . . 0.92000000000000004 112.045 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.91 -153.0 28.68 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.792 -0.64 . . . . 1.28 111.637 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.21 -33.99 58.26 Favored 'Trans proline' 0 CA--C 1.527 0.159 0 C-N-CA 122.912 2.408 . . . . 2.23 112.663 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.9 m -119.49 38.23 3.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.129 0.49 . . . . 2.8700000000000001 110.868 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.645 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.34 -108.91 2.85 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.325 -0.941 . . . . 1.9299999999999999 111.869 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 73.0 m-85 -130.82 -155.0 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.835 -0.802 . . . . 1.8200000000000001 108.835 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.86 73.35 0.22 Allowed Glycine 0 C--O 1.228 -0.265 0 C-N-CA 119.639 -1.267 . . . . 0.42999999999999999 113.467 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -157.28 152.01 25.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.849 0.325 . . . . 0.40000000000000002 110.701 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 3.0 t-20 -112.03 145.42 39.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.462 -0.569 . . . . 2.1800000000000002 109.462 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.36 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.375 0.607 . . . . 1.52 112.579 -172.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -107.82 121.5 44.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 1.3400000000000001 110.022 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -105.76 92.45 4.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.792 -0.818 . . . . 2.2999999999999998 108.792 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.69 131.97 34.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.562 0.696 . . . . 3.48 111.982 -170.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 26.4 pttt -96.46 44.81 1.06 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.941 -1.027 . . . . 4.54 111.032 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.7 p -162.59 -57.54 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.321 -0.854 . . . . 3.4900000000000002 109.804 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -101.57 131.11 23.36 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 3.0 110.162 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.95 155.04 30.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.668 2.245 . . . . 2.2400000000000002 113.233 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.24 158.25 24.06 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.235 -0.893 . . . . 1.29 111.848 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -93.21 127.37 38.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.026 0.441 . . . . 1.5 110.315 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 56' ' ' ARG . 51.6 m-85 -106.55 158.22 17.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 0.87 109.129 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.802 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.8 mm -80.35 110.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.973 -0.751 . . . . 0.39000000000000001 108.973 175.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 79.7 ttt180 -67.48 -46.72 72.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.431 0.634 . . . . 2.8300000000000001 109.905 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.9 p -167.59 131.64 1.79 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.932 -1.031 . . . . 1.26 108.881 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -95.01 127.99 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.314 -0.624 . . . . 0.37 109.314 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.2 115.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.275 -0.639 . . . . 2.2799999999999998 109.275 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.72 147.53 94.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.591 2.194 . . . . 1.1699999999999999 111.689 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 63.95 52.87 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.895 0.855 . . . . 2.3999999999999999 110.031 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.616 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -142.95 167.9 14.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.56999999999999995 110.113 176.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.3 Cg_endo -54.19 -36.04 84.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.65000000000000002 111.862 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.486 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -67.42 -48.52 67.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.35999999999999999 110.757 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.53 -38.54 90.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.254 -0.43 . . . . 2.0099999999999998 110.152 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.78 79.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.46999999999999997 111.589 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.8 p -72.8 -14.73 61.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.07 0.462 . . . . 0.40000000000000002 110.933 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.92 38.46 4.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.096 -0.573 . . . . 0.62 113.047 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.802 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -84.25 113.9 21.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 0.65000000000000002 109.839 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD2' ' OD1' ' A' ' 55' ' ' ASP . 40.7 ttm105 -94.0 137.95 32.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.74 0.305 . . . . 4.3799999999999999 110.579 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -82.34 35.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.509 0.559 . . . . 1.4399999999999999 112.509 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -143.65 -0.98 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 3.0600000000000001 110.341 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.589 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 29.4 m-20 -98.04 153.78 18.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.184 -0.462 . . . . 1.02 110.957 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 26.5 ttm105 -99.68 133.86 43.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 1.5700000000000001 110.704 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.5 mt -73.42 122.72 26.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.1 -0.704 . . . . 0.68000000000000005 109.1 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.4 t -105.69 -46.5 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.0 -0.545 . . . . 0.87 110.431 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.0 mt-10 -128.47 142.44 51.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.329 -0.396 . . . . 0.89000000000000001 110.627 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.95 118.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 0.66000000000000003 109.417 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 62.79 19.34 11.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.381 0.426 . . . . 1.1699999999999999 110.781 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.29 4.55 66.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.837 -0.697 . . . . 0.66000000000000003 112.425 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.26 115.52 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.037 -0.357 . . . . 1.1699999999999999 110.037 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 49.8 t -74.79 130.16 38.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.26 0.552 . . . . 1.6799999999999999 110.526 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.508 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.4 mmt -97.3 51.14 1.09 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.599 0.714 . . . . 0.81000000000000005 111.079 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.2 105.67 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.103 -0.953 . . . . 3.75 110.355 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.94 -2.49 87.72 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 1.47 112.712 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.1 mmtp -66.53 160.68 24.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.238 0.542 . . . . 3.3599999999999999 111.353 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.1 175.51 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.506 -0.77 . . . . 2.8900000000000001 110.281 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 8.1 t60 -53.77 -43.4 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.444 0.465 . . . . 1.4199999999999999 111.516 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.76 -41.84 88.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.71999999999999997 113.178 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.95 -40.26 97.12 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.964 0.411 . . . . 2.0299999999999998 110.655 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 77' ' ' ILE . 48.9 t -70.4 -47.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.898 -0.592 . . . . 1.0800000000000001 110.788 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' HA ' HD12 ' A' ' 77' ' ' ILE . 89.9 t -68.29 -40.69 82.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.71999999999999997 111.369 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -61.49 -38.93 89.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 0.66000000000000003 110.397 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.9 92.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.497 -0.32 . . . . 0.41999999999999998 111.138 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.527 HG23 HG21 ' A' ' 84' ' ' THR . 66.9 mt -58.76 -45.6 91.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.509 0.671 . . . . 0.68999999999999995 110.162 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.54 -25.42 59.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.257 -0.883 . . . . 3.0899999999999999 111.306 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.16 3.75 41.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.147 -0.479 . . . . 0.65000000000000002 111.187 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.87 9.06 54.61 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.985 -0.626 . . . . 0.59999999999999998 112.315 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.49 -120.13 5.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.772 -0.727 . . . . 1.1000000000000001 111.517 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.564 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 9.3 t70 -107.49 -31.58 8.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 2.1200000000000001 110.275 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.972 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -121.13 139.66 53.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.242 -0.435 . . . . 2.1099999999999999 110.273 175.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.527 HG21 HG23 ' A' ' 77' ' ' ILE . 9.1 t -130.66 150.06 52.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.805 -0.634 . . . . 0.32000000000000001 111.19 -170.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -108.57 118.53 37.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.586 -0.734 . . . . 1.6299999999999999 110.793 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.652 HD12 ' HE3' ' A' ' 15' ' ' MET . 80.2 mt -109.9 131.22 55.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.05 -0.523 . . . . 0.28000000000000003 109.845 176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.9 tp -104.19 119.6 39.31 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.604 -0.517 . . . . 0.51000000000000001 109.604 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.3 m -126.64 153.33 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.173 0.511 . . . . 0.33000000000000002 111.621 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.44 134.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.759 -0.655 . . . . 0.41999999999999998 110.288 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.16 171.45 14.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.713 -0.477 . . . . 1.9199999999999999 109.713 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 91' ' ' ARG . 34.2 ttm180 -52.44 -47.9 66.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.296 0.373 . . . . 4.1600000000000001 111.615 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.08 -42.32 76.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 2.6800000000000002 110.622 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.5 m -64.92 -46.59 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.762 -0.653 . . . . 0.46999999999999997 111.086 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.66 -47.27 84.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 1.1799999999999999 110.976 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 10.2 mm-40 -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.543 -0.299 . . . . 1.9399999999999999 110.478 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.805 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 87.8 t80 -63.28 -48.33 78.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.72999999999999998 110.497 176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 104' ' ' PRO . 34.2 m-85 -66.27 -38.14 87.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.831 0.348 . . . . 0.44 111.47 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -61.91 -48.53 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 1.9199999999999999 111.618 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.805 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.5 pttt -70.76 -15.56 62.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 2.04 111.445 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.49 ' HB3' HG12 ' A' ' 102' ' ' VAL . 42.4 t -93.19 -7.83 44.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 1.3899999999999999 110.196 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 59.35 29.45 19.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.281 -0.872 . . . . 4.0899999999999999 111.21 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 100' ' ' CYS . 12.2 p -115.58 152.41 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 1.4199999999999999 109.901 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.34 130.97 41.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.858 0.361 . . . . 1.3300000000000001 110.983 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 47.3 Cg_endo -71.99 135.42 25.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.423 2.082 . . . . 0.53000000000000003 111.244 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.0 t -158.43 173.92 15.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.295 -0.261 . . . . 1.4199999999999999 110.295 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.474 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 43.8 mt-30 -55.89 -30.57 61.78 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.322 0.389 . . . . 1.6599999999999999 111.636 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.79 -29.49 68.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 2.8199999999999998 110.929 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -86.04 -13.67 46.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.892 -0.594 . . . . 0.53000000000000003 111.561 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 86.7 mt -56.66 -73.59 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.885 0.374 . . . . 1.24 111.35 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -101.21 16.83 24.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.249 0.547 . . . . 3.7000000000000002 110.044 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.51 -175.36 23.25 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.454 -0.793 . . . . 1.1200000000000001 111.58 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.53 147.94 9.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 1.3100000000000001 112.466 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 mt -79.37 135.15 57.63 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.009 -0.542 . . . . 1.1100000000000001 110.072 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.405 ' HG3' HG11 ' A' ' 102' ' ' VAL . 59.5 Cg_endo -71.07 160.81 48.08 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.239 2.626 . . . . 1.1499999999999999 113.238 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 15.4 m -91.39 140.45 25.52 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.209 -0.905 . . . . 2.98 108.802 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 25.3 Cg_exo -64.66 65.48 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.477 2.785 . . . . 4.2300000000000004 114.326 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -96.76 93.89 6.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.584 -0.895 . . . . 7.3300000000000001 108.584 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 t -59.18 112.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.351 0.596 . . . . 8.7799999999999994 111.426 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -143.94 134.3 24.58 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.162 -0.681 . . . . 9.3399999999999999 109.162 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.88 117.4 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.643 -0.789 . . . . 11.550000000000001 112.259 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.83 34.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.363 0.601 . . . . 13.92 110.618 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 43.0 mm -98.41 -15.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 16.210000000000001 110.628 -175.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -67.19 -24.47 65.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.056 0.455 . . . . 18.82 110.549 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.49 -0.11 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 20.829999999999998 110.712 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.71 -0.48 57.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.647 0.737 . . . . 22.5 109.226 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -116.41 -173.17 2.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.198 -0.91 . . . . 23.989999999999998 109.548 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.5 m -63.66 -53.32 53.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.819 0.342 . . . . 25.0 110.131 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.778 -0.63 . . . . 27.52 109.445 176.822 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.29 -0.324 . . . . 11.869999999999999 112.29 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 tp -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.058 0.456 . . . . 9.8599999999999994 110.386 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' OD2' ' HB ' ' A' ' 6' ' ' THR . 3.6 p-10 -91.91 111.82 51.71 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.923 -0.58 . . . . 6.96 109.451 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 3' ' ' ASP . 15.3 Cg_endo -56.13 -41.5 76.08 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.114 3.209 . . . . 6.6500000000000004 113.703 -170.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.08 102.6 8.43 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.686 -0.487 . . . . 7.9900000000000002 109.686 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.47 ' HB ' ' OD2' ' A' ' 3' ' ' ASP . 14.8 t -127.07 163.45 23.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.617 -0.72 . . . . 4.2599999999999998 110.877 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -108.96 29.1 7.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.062 -0.517 . . . . 3.8399999999999999 110.766 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' HG ' ' OG1' ' A' ' 6' ' ' THR . 90.0 mt -76.48 71.97 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.391 0.615 . . . . 0.80000000000000004 111.091 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -122.0 146.02 45.24 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.617 -0.72 . . . . 3.0899999999999999 109.801 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HB2' HD11 ' A' ' 87' ' ' LEU . 39.9 Cg_endo -68.32 173.57 9.44 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.488 2.125 . . . . 0.46999999999999997 111.696 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.426 HH22 ' HB3' ' A' ' 52' ' ' ARG . 24.3 ptt-85 -134.3 132.51 39.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.356 . . . . 2.3700000000000001 110.372 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -95.32 113.22 24.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.928 -0.578 . . . . 1.3200000000000001 109.879 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.6 m -96.79 118.86 34.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.981 -0.554 . . . . 0.40000000000000002 109.902 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.851 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.2 m -109.73 117.51 34.09 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.126 -0.694 . . . . 0.34999999999999998 109.126 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.0 ptp -128.89 133.7 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.88 111.259 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -107.67 143.6 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.238 -0.892 . . . . 2.5800000000000001 110.018 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.432 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 77.0 mttt -56.8 126.23 26.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.373 -0.831 . . . . 0.92000000000000004 111.25 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -124.3 1.62 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.451 -1.249 . . . . 1.28 111.011 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.18 -48.32 1.84 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.662 2.241 . . . . 2.23 112.365 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -118.86 -34.19 4.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 2.8700000000000001 111.491 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -174.61 -143.51 4.47 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.796 -0.716 . . . . 1.9299999999999999 112.227 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.672 ' O ' ' HB2' ' A' ' 44' ' ' SER . 32.7 m-85 -99.24 -44.35 6.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.649 0.261 . . . . 1.8200000000000001 110.894 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.68 69.25 0.9 Allowed Glycine 0 C--O 1.227 -0.292 0 C-N-CA 121.105 -0.569 . . . . 0.42999999999999999 113.213 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -156.89 153.75 28.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.432 -0.581 . . . . 0.40000000000000002 109.432 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -101.96 126.31 48.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.478 -0.564 . . . . 2.1800000000000002 109.478 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.511 HD11 ' HG3' ' A' ' 35' ' ' GLN . 2.0 tm? -99.22 123.28 43.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.441 -0.577 . . . . 1.52 109.441 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.684 ' CB ' ' HB2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -126.92 122.52 34.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.524 -0.762 . . . . 1.3400000000000001 111.256 -171.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -112.05 170.91 7.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.65 -0.704 . . . . 2.2999999999999998 110.266 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.1 t70 -121.21 152.88 38.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.214 -0.662 . . . . 3.48 109.214 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.14 -7.09 40.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.258 -0.428 . . . . 4.54 111.121 -174.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 m -116.39 -45.89 2.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 3.4900000000000002 110.645 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 24.8 pttm -105.32 127.8 27.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.431 . . . . 3.0 110.354 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 16.9 Cg_exo -68.62 169.24 17.81 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.931 2.421 . . . . 2.2400000000000002 112.602 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.23 136.94 9.25 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.374 -0.83 . . . . 1.29 112.18 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HG3' HD11 ' A' ' 26' ' ' LEU . 1.6 mp0 -93.72 128.43 39.92 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.555 -0.535 . . . . 1.5 109.555 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.31 147.66 37.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.87 110.204 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.95 106.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.091 -0.707 . . . . 0.39000000000000001 109.091 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.684 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 4.3 tmt_? -66.11 -42.39 89.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.941 -0.762 . . . . 2.8300000000000001 108.941 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 p -174.48 154.87 2.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.736 -1.12 . . . . 1.26 109.56 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -109.93 127.41 66.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.664 -0.495 . . . . 0.37 109.664 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -65.18 128.36 93.71 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.045 -0.525 . . . . 2.2799999999999998 109.973 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.51 144.9 98.22 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.477 2.118 . . . . 1.1699999999999999 112.251 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.15 54.49 1.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.466 -0.788 . . . . 2.3999999999999999 109.628 -177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.9 p -131.79 150.8 77.24 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.454 -0.794 . . . . 0.56999999999999995 111.086 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.5 Cg_endo -62.31 -24.14 75.7 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.65000000000000002 111.629 172.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.87 77.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.146 0.498 . . . . 0.35999999999999999 109.904 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.63 -32.0 73.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 2.0099999999999998 110.08 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.32 -32.01 68.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.009 -0.541 . . . . 0.46999999999999997 111.686 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.2 p -72.65 -13.23 61.32 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.037 0.446 . . . . 0.40000000000000002 110.697 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.07 26.44 6.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.741 -0.742 . . . . 0.62 112.709 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 tp -77.41 158.3 30.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.051 -0.351 . . . . 0.65000000000000002 110.051 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 39.5 ttm180 -158.04 160.92 37.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.811 -0.811 . . . . 4.3799999999999999 108.811 -173.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -83.45 152.41 24.99 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.129 -0.228 . . . . 1.4399999999999999 110.88 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 77.4 mt-30 80.92 1.2 1.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.114 0.884 . . . . 3.0600000000000001 112.175 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.63 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 33.2 m-20 -84.05 146.34 27.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.868 0.366 . . . . 1.02 110.49 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.4 ttp-105 -106.44 136.88 45.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.501 -0.555 . . . . 1.5700000000000001 109.501 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.11 123.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.804 -0.443 . . . . 0.68000000000000005 109.804 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.705 HG11 ' HG2' ' A' ' 104' ' ' PRO . 47.0 t -99.93 -49.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.674 -0.694 . . . . 0.87 110.117 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 23.2 mt-10 -126.45 142.87 51.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.89000000000000001 110.425 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 118.62 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.103 -0.498 . . . . 0.66000000000000003 109.711 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.2 30.12 19.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.956 0.408 . . . . 1.1699999999999999 110.966 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -3.68 73.89 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.891 -0.671 . . . . 0.66000000000000003 113.96 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.46 129.26 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.791 0.795 . . . . 1.1699999999999999 111.237 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.7 p -71.0 137.15 48.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.004 -0.998 . . . . 1.6799999999999999 112.028 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.762 ' HB3' HG22 ' A' ' 73' ' ' VAL . 24.1 mmt -115.0 11.46 16.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.81000000000000005 111.048 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 103' ' ' ILE . 72.8 mm-40 -59.42 -45.62 91.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 3.75 111.3 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.05 2.0 74.87 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.688 -0.768 . . . . 1.47 112.633 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.6 mmtt -90.72 179.53 5.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.208 -0.293 . . . . 3.3599999999999999 110.208 -177.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -111.98 174.47 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.666 -0.243 . . . . 2.8900000000000001 111.537 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -54.21 -43.93 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 1.4199999999999999 111.415 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.86 -30.78 76.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.92 -0.657 . . . . 0.71999999999999997 113.066 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.17 -46.1 62.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.936 0.398 . . . . 2.0299999999999998 110.808 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 65' ' ' MET . 25.1 t -62.57 -46.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.828 -0.624 . . . . 1.0800000000000001 111.049 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.05 -39.2 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.71999999999999997 111.183 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 t -68.44 -38.82 81.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.324 -0.398 . . . . 0.66000000000000003 110.646 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.68 85.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.41999999999999998 111.658 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.95 -43.17 91.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.191 0.519 . . . . 0.68999999999999995 110.432 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.4 -34.53 70.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 3.0899999999999999 110.592 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.74 -15.51 63.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 0.65000000000000002 111.415 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.4 80.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 0.59999999999999998 111.725 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.23 -111.7 4.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.978 -0.63 . . . . 1.1000000000000001 112.211 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 -8.34 35.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.664 0.269 . . . . 2.1200000000000001 110.706 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.44 162.4 40.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.428 -0.351 . . . . 2.1099999999999999 110.757 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 t -150.35 149.36 29.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.331 -0.395 . . . . 0.32000000000000001 110.3 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.851 ' HG2' HG23 ' A' ' 14' ' ' THR . 26.9 mttm -115.15 117.46 30.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.713 -0.477 . . . . 1.6299999999999999 109.713 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -107.89 129.73 55.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.857 0.36 . . . . 0.28000000000000003 110.302 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.502 HD23 ' HG3' ' A' ' 59' ' ' GLU . 37.5 tp -103.7 116.62 32.67 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.19 -0.67 . . . . 0.51000000000000001 109.19 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.52 161.83 34.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.005 -0.543 . . . . 0.33000000000000002 110.756 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 10' ' ' PRO . 8.5 m -133.87 133.35 56.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.746 -0.661 . . . . 0.41999999999999998 110.78 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.4 154.09 41.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 1.9199999999999999 109.183 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 70.5 ttt180 -52.72 -41.61 64.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.251 0.463 . . . . 4.1600000000000001 112.251 -170.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.34 -34.84 72.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.29 0.567 . . . . 2.6800000000000002 110.72 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -79.45 -41.83 26.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.332 -0.849 . . . . 0.46999999999999997 110.19 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 25.9 t0 -65.87 -39.01 90.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.206 -0.906 . . . . 1.1799999999999999 111.689 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 5.1 mm-40 -63.58 -36.34 83.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.992 0.425 . . . . 1.9399999999999999 110.061 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.16 -41.34 86.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 0.72999999999999998 110.45 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HD1' HG13 ' A' ' 102' ' ' VAL . 28.3 m-85 -65.76 -37.39 86.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.276 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 44.4 mttp -62.95 -49.89 72.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.323 . . . . 1.9199999999999999 111.266 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.86 -25.82 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 2.04 111.167 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.486 ' HB3' HG12 ' A' ' 102' ' ' VAL . 36.3 t -87.62 -11.87 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.045 0.45 . . . . 1.3899999999999999 110.676 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 61.96 35.54 16.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.366 -0.834 . . . . 4.0899999999999999 111.334 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 100' ' ' CYS . 10.0 p -128.56 142.47 43.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.241 -0.436 . . . . 1.4199999999999999 110.263 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 103' ' ' ILE . 3.0 mp -85.85 126.48 65.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.534 . . . . 1.3300000000000001 110.734 -176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.705 ' HG2' HG11 ' A' ' 58' ' ' VAL . 22.8 Cg_endo -63.42 146.4 93.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.75 2.3 . . . . 0.53000000000000003 111.617 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.5 p -157.67 173.04 17.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.639 -0.255 . . . . 1.4199999999999999 111.353 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.511 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 51.8 mt-30 -60.12 -28.83 68.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.442 0.464 . . . . 1.6599999999999999 110.703 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -58.47 -30.08 66.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.24 0.543 . . . . 2.8199999999999998 111.118 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -85.88 -14.56 44.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.53000000000000003 111.319 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.2 mt -63.09 107.64 1.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 1.24 110.443 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 60.41 24.79 14.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.96 -0.564 . . . . 3.7000000000000002 110.494 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.74 174.17 15.13 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.915 -0.66 . . . . 1.1200000000000001 111.973 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.87 136.39 38.31 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.902 2.401 . . . . 1.3100000000000001 111.906 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 37.5 mt -80.96 161.3 63.76 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 109.269 -0.641 . . . . 1.1100000000000001 109.269 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 77.7 Cg_exo -45.59 154.64 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.75 2.967 . . . . 1.1499999999999999 114.446 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 114' ' ' PRO . 90.1 t 79.28 123.06 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 114.645 -1.161 . . . . 2.98 111.386 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 6.8 Cg_exo -73.62 89.44 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.127 2.551 . . . . 4.2300000000000004 111.235 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -73.63 -18.39 61.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 7.3300000000000001 110.871 -175.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.4 t -140.79 31.78 1.82 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.135 0.493 . . . . 8.7799999999999994 110.154 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 65.87 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.359 -0.837 . . . . 9.3399999999999999 110.782 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.87 -63.67 4.21 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.08 -0.581 . . . . 11.550000000000001 112.832 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -81.57 74.19 8.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 13.92 110.865 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 11.1 pt -141.24 101.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.255 -0.884 . . . . 16.210000000000001 109.515 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -128.1 -73.01 0.6 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.228 -0.442 . . . . 18.82 110.649 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -105.49 68.38 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.083 0.468 . . . . 20.829999999999998 110.793 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.19 137.41 32.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.634 -0.712 . . . . 22.5 109.845 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -83.22 -32.56 26.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.641 . . . . 23.989999999999998 110.37 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.1 t -170.2 -67.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 25.0 109.36 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.827 -0.606 . . . . 27.52 109.638 177.546 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.084 -0.806 . . . . 11.869999999999999 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.5 tt -84.05 78.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.564 1.173 . . . . 9.8599999999999994 108.752 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.97 139.39 90.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.107 -1.406 . . . . 6.96 111.373 -170.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.74 -31.64 92.14 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.279 2.653 . . . . 6.6500000000000004 112.096 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' MET . 25.9 p90 -117.82 -152.09 0.5 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.558 -1.275 . . . . 7.9900000000000002 107.558 171.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 HH21 ' A' ' 9' ' ' ARG . 27.1 m 71.61 -12.65 0.62 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.577 0.703 . . . . 4.2599999999999998 111.192 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 5' ' ' PHE . 91.8 mmm -92.96 -3.22 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 3.8399999999999999 110.277 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -80.04 68.52 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.828 -0.805 . . . . 0.80000000000000004 108.828 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.484 HH21 HG22 ' A' ' 6' ' ' THR . 10.5 ptp180 -126.61 156.74 72.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.953 -1.022 . . . . 3.0899999999999999 109.322 -174.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.5 Cg_endo -65.49 165.97 21.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.138 1.892 . . . . 0.46999999999999997 111.203 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.671 HH12 ' HB3' ' A' ' 90' ' ' ASP . 8.7 ptp85 -121.28 131.95 54.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.872 0.367 . . . . 2.3700000000000001 110.157 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.5 tp -98.24 111.03 23.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.218 0.533 . . . . 1.3200000000000001 109.83 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.3 m -98.92 117.59 33.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.544 -0.753 . . . . 0.40000000000000002 109.799 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -105.75 117.61 34.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.297 -0.631 . . . . 0.34999999999999998 109.297 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.62 142.49 51.48 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 0.88 111.072 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 37.1 ttpt -114.77 140.18 49.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.817 -0.629 . . . . 2.5800000000000001 109.622 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.691 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.6 ttmt -58.4 105.82 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.779 -0.452 . . . . 0.92000000000000004 109.779 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.35 -134.37 7.0 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 1.28 113.257 -172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.11 -53.74 2.82 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.291 2.66 . . . . 2.23 112.843 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -116.87 33.31 5.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.091 -0.504 . . . . 2.8700000000000001 110.663 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.691 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 90.58 -120.07 5.79 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.581 -0.819 . . . . 1.9299999999999999 111.389 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.526 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 52.7 m-85 -121.08 172.95 7.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.8200000000000001 109.283 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.28 73.75 0.41 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.159 -1.019 . . . . 0.42999999999999999 112.816 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -155.43 144.91 21.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.731 0.301 . . . . 0.40000000000000002 110.203 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 7.2 t-20 -103.57 141.04 36.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.207 -0.664 . . . . 2.1800000000000002 109.207 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.28 151.3 22.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.09 0.472 . . . . 1.52 111.535 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -108.82 122.27 46.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.645 . . . . 1.3400000000000001 110.287 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 p -135.31 92.92 2.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.196 0.522 . . . . 2.2999999999999998 109.862 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.66 150.41 24.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 3.48 110.902 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.07 8.73 38.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 4.54 109.46 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 m -107.93 -47.89 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.269 -0.878 . . . . 3.4900000000000002 110.507 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -126.78 134.77 26.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 3.0 110.675 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 159.87 46.07 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.79 2.327 . . . . 2.2400000000000002 112.304 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 157.88 17.83 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.116 -0.794 . . . . 1.29 111.116 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.595 ' HG3' HG21 ' A' ' 73' ' ' VAL . 26.7 mm-40 -111.32 128.85 56.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.009 0.433 . . . . 1.5 110.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.8 m-85 -115.86 158.32 23.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.87 109.492 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG13 HD11 ' A' ' 51' ' ' LEU . 50.5 mm -87.28 106.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.553 -0.536 . . . . 0.39000000000000001 109.553 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 25.2 ttt180 -65.24 -50.09 67.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.874 -0.603 . . . . 2.8300000000000001 110.014 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 p -160.87 133.92 6.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 1.26 109.878 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 p -104.66 132.83 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.356 -0.609 . . . . 0.37 109.356 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.73 134.52 72.19 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.489 -0.56 . . . . 2.2799999999999998 109.489 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 52.6 Cg_exo -53.48 136.34 63.46 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.25 2.633 . . . . 1.1699999999999999 113.126 -177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p30 44.19 38.51 2.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.29 1.036 . . . . 2.3999999999999999 112.825 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.501 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 92.0 p -93.69 165.68 17.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.692 -0.855 . . . . 0.56999999999999995 108.692 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 10.4 Cg_endo -54.92 -30.31 68.2 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.789 1.659 . . . . 0.65000000000000002 111.488 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.01 67.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.814 -0.63 . . . . 0.35999999999999999 110.615 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 34.0 tt0 -70.03 -34.33 73.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.742 0.306 . . . . 2.0099999999999998 110.384 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -24.89 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.46999999999999997 111.959 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.9 p -75.83 -13.28 60.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.228 0.537 . . . . 0.40000000000000002 110.718 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.43 37.41 4.04 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.603 -0.726 . . . . 0.62 111.874 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 37' ' ' ILE . 17.4 tp -83.97 148.26 26.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.197 -0.298 . . . . 0.65000000000000002 110.197 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HD3' ' OD1' ' A' ' 55' ' ' ASP . 62.3 ttt-85 -128.95 151.42 49.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 4.3799999999999999 110.364 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.6 133.02 44.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.437 -0.347 . . . . 1.4399999999999999 111.37 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 12.9 mm-40 65.87 29.57 10.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.341 -0.845 . . . . 3.0600000000000001 111.599 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.561 ' OD1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -88.71 136.17 33.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.105 -0.702 . . . . 1.02 109.105 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.3 129.2 36.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.706 -0.225 . . . . 1.5700000000000001 110.626 -177.045 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.442 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 52.5 mt -82.87 123.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.68000000000000005 109.779 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.554 HG11 ' HG2' ' A' ' 104' ' ' PRO . 6.5 t -106.05 -35.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.245 -0.434 . . . . 0.87 110.614 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.0 mt-10 -136.48 143.02 43.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.291 -0.413 . . . . 0.89000000000000001 111.221 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG21 HG13 ' A' ' 73' ' ' VAL . 49.3 t -122.17 109.06 23.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.045 -0.724 . . . . 0.66000000000000003 109.045 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 46.47 43.18 11.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.958 0.885 . . . . 1.1699999999999999 111.579 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 94.26 -4.46 70.49 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.782 -1.099 . . . . 0.66000000000000003 114.19 174.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.4 t -98.33 119.54 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 117.522 0.661 . . . . 1.1699999999999999 110.471 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 p -67.92 130.55 43.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.384 -0.825 . . . . 1.6799999999999999 111.061 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.522 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mmt -117.2 45.28 1.92 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.989 -0.55 . . . . 0.81000000000000005 111.971 -174.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -90.95 -47.73 7.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.137 0.494 . . . . 3.75 110.62 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.2 18.37 57.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 1.47 112.187 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 72.2 mmtt -100.37 173.83 6.4 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.176 -0.305 . . . . 3.3599999999999999 110.176 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -112.85 178.49 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.591 -0.277 . . . . 2.8900000000000001 111.169 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.439 ' O ' HG23 ' A' ' 74' ' ' VAL . 81.8 t60 -54.88 -43.65 73.36 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.469 -0.332 . . . . 1.4199999999999999 111.141 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.45 -38.23 95.5 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.013 -0.613 . . . . 0.71999999999999997 112.831 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.68 -44.26 96.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.952 0.406 . . . . 2.0299999999999998 110.714 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.595 HG21 ' HG3' ' A' ' 35' ' ' GLN . 48.6 t -69.88 -46.81 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.763 -0.653 . . . . 1.0800000000000001 111.047 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.2 t -63.96 -38.12 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.429 -0.35 . . . . 0.71999999999999997 110.903 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.1 t -65.65 -36.04 82.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.051 -0.351 . . . . 0.66000000000000003 110.051 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.39 -34.52 78.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.41999999999999998 110.856 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.557 HG23 HG21 ' A' ' 84' ' ' THR . 29.0 mm -57.47 -45.42 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.7 0.762 . . . . 0.68999999999999995 109.548 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -75.26 -31.07 60.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.862 -1.063 . . . . 3.0899999999999999 111.119 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.28 -18.79 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.65000000000000002 111.637 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.03 -17.48 79.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.59999999999999998 112.252 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.47 -114.74 3.45 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.744 -0.741 . . . . 1.1000000000000001 111.628 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.644 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 34.3 m-20 -110.04 -9.28 14.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.164 0.507 . . . . 2.1200000000000001 110.25 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 1.8 pm0 -139.16 142.53 37.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.946 -0.57 . . . . 2.1099999999999999 110.153 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.557 HG21 HG23 ' A' ' 77' ' ' ILE . 10.2 t -133.01 151.17 52.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.435 -0.348 . . . . 0.32000000000000001 110.624 -174.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -111.07 118.0 34.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.257 -0.646 . . . . 1.6299999999999999 109.257 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.85 135.07 47.94 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.916 0.389 . . . . 0.28000000000000003 110.1 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 10' ' ' PRO . 26.4 tp -104.92 115.77 30.85 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.915 -0.772 . . . . 0.51000000000000001 108.915 176.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' A' ' 11' ' ' ARG . 13.2 m -127.46 158.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.33000000000000002 111.374 -176.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 147.66 30.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.41999999999999998 110.402 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.671 ' HB3' HH12 ' A' ' 11' ' ' ARG . 21.3 p30 -92.47 176.94 6.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.965 -0.561 . . . . 1.9199999999999999 110.298 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 54.4 ttp180 -54.72 -48.64 72.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.214 0.45 . . . . 4.1600000000000001 112.214 -174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 1.8 pm0 -65.65 -42.76 91.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.843 0.354 . . . . 2.6800000000000002 111.675 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -68.36 -44.67 74.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.07 -0.513 . . . . 0.46999999999999997 110.772 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -60.86 -47.25 87.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.928 -0.578 . . . . 1.1799999999999999 111.09 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 40.3 mt-10 -64.77 -32.85 74.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.605 -0.27 . . . . 1.9399999999999999 110.64 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -64.24 -48.43 75.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.72999999999999998 110.793 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CD2' HG13 ' A' ' 102' ' ' VAL . 30.4 m-85 -66.96 -38.74 86.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.642 -0.254 . . . . 0.44 111.495 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 95' ' ' GLU . 40.6 mtmt -63.85 -47.27 81.39 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.801 0.297 . . . . 1.9199999999999999 111.801 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.9 ptmt -65.79 -18.96 65.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.375 0.607 . . . . 2.04 110.537 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.477 ' HB2' HG12 ' A' ' 102' ' ' VAL . 92.4 m -94.04 -9.97 35.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.583 -0.735 . . . . 1.3899999999999999 111.079 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.16 26.92 12.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.346 -0.843 . . . . 4.0899999999999999 111.39 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -109.41 141.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.436 -0.579 . . . . 1.4199999999999999 109.436 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 37.3 mm -87.26 123.12 70.43 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.158 -0.474 . . . . 1.3300000000000001 110.434 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.554 ' HG2' HG11 ' A' ' 58' ' ' VAL . 18.6 Cg_endo -60.49 135.66 62.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.197 1.931 . . . . 0.53000000000000003 110.678 174.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 m -154.69 166.31 33.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.086 -0.339 . . . . 1.4199999999999999 110.086 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 48.3 mt-30 -62.06 -30.37 70.94 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.491 0.494 . . . . 1.6599999999999999 112.288 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.7 -29.35 70.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 2.8199999999999998 110.484 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.69 -14.93 60.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.994 -0.548 . . . . 0.53000000000000003 111.366 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 91.8 mt -62.25 -46.59 88.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.096 0.474 . . . . 1.24 110.362 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -128.61 75.99 1.67 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.619 -0.719 . . . . 3.7000000000000002 110.1 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.43 176.08 46.75 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.52 -0.764 . . . . 1.1200000000000001 111.312 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.98 111.08 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.556 2.171 . . . . 1.3100000000000001 112.642 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.53 135.89 85.88 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 116.192 -0.458 . . . . 1.1100000000000001 110.458 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.93 136.58 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.611 2.208 . . . . 1.1499999999999999 112.444 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.04 125.21 2.02 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.649 -0.705 . . . . 2.98 110.526 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -84.04 118.52 2.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.585 2.19 . . . . 4.2300000000000004 111.969 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -103.35 -46.59 4.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.061 0.458 . . . . 7.3300000000000001 109.79 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.9 m -80.12 115.0 19.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.692 -0.686 . . . . 8.7799999999999994 110.515 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.35 48.72 1.44 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 9.3399999999999999 110.998 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.5 -41.08 5.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.909 -0.662 . . . . 11.550000000000001 113.018 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.36 8.02 35.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.285 0.564 . . . . 13.92 111.104 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 47.1 mt -108.55 82.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.502 -0.925 . . . . 16.210000000000001 108.502 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -97.78 61.93 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.95 -0.568 . . . . 18.82 112.237 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.03 -3.02 20.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.471 -0.937 . . . . 20.829999999999998 108.471 167.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -71.89 148.5 46.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.547 -1.206 . . . . 22.5 110.638 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -128.7 -59.51 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 23.989999999999998 110.202 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.2 t -178.29 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 . . . . . 0 C--O 1.245 0.851 0 CA-C-N 114.846 -1.07 . . . . 27.52 109.16 175.796 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.159 0.504 . . . . 0.8 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HB3' HD21 ' A' ' 113' ' ' LEU . 14.0 ptt180 -129.37 148.97 71.4 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 3.09 110.424 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HB3' HG12 ' A' ' 89' ' ' VAL . 57.2 Cg_endo -70.43 174.5 9.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.787 2.324 . . . . 0.47 112.642 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -134.22 140.47 46.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.793 -0.64 . . . . 2.37 109.961 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.2 110.08 22.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.544 -0.539 . . . . 1.32 109.544 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -89.78 116.2 27.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.759 -0.655 . . . . 0.4 110.003 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -107.4 118.83 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.444 -0.576 . . . . 0.35 109.444 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.788 ' HE1' ' HA ' ' A' ' 46' ' ' ALA . 22.7 ptp -137.39 133.26 34.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.89 0.376 . . . . 0.88 111.218 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 87.6 tttt -103.63 147.04 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.65 -0.704 . . . . 2.58 109.298 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 14.4 mtmt -57.33 110.32 0.83 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.893 -0.594 . . . . 0.92 110.747 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.96 -94.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.189 -0.914 . . . . 1.28 113.346 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.62 -72.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.803 2.336 . . . . 2.23 111.971 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -146.19 20.26 1.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.569 0.7 . . . . 2.87 109.753 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 174.5 -156.76 23.73 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.22 -0.9 . . . . 1.93 111.3 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 83.6 m-85 -112.02 168.17 9.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.337 -0.616 . . . . 1.82 109.337 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.2 70.52 0.45 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.067 -1.063 . . . . 0.43 113.089 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.81 163.1 40.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.01 -0.367 . . . . 0.4 110.01 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 25.6 t-20 -129.06 129.77 45.7 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.041 -0.527 . . . . 2.18 109.694 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.92 144.1 29.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.692 -0.484 . . . . 1.52 109.692 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.8 p80 -121.51 130.25 53.43 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.036 -0.666 . . . . 1.34 110.158 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.439 -0.801 . . . . 2.3 109.279 179.262 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 35' ' ' GLN . 4.2 mm100 . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.677 -0.49 . . . . 1.5 109.677 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 75.6 m-85 -112.11 143.71 42.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.301 -0.629 . . . . 0.87 109.301 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.56 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.1 mm -68.39 106.78 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.452 -0.573 . . . . 0.39 109.452 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.4 ttt180 -75.47 -48.0 24.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 2.83 109.809 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -159.63 143.78 14.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.33 -0.85 . . . . 1.26 109.957 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.79 145.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.724 -0.473 . . . . 0.37 109.724 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 11.0 t70 -87.68 121.92 70.69 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.34 -0.615 . . . . 2.28 109.34 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 24.4 Cg_exo -62.26 -22.54 74.3 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 123.07 2.514 . . . . 1.17 113.339 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -105.39 50.34 0.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.713 0.768 . . . . 2.4 109.418 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 53.5 p -145.28 162.0 39.22 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.454 -0.793 . . . . 0.57 110.035 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 18.9 Cg_endo -60.92 -18.44 57.09 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.045 2.496 . . . . 0.65 112.435 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.788 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -67.83 -52.39 37.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 0.36 110.798 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.78 -38.47 91.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.053 0.454 . . . . 2.01 109.865 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.37 94.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.47 111.223 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -70.93 -19.84 62.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.4 111.016 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.23 39.12 2.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.962 -0.637 . . . . 0.62 112.813 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -90.15 95.29 10.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.65 109.911 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -85.25 146.24 27.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 4.38 110.26 -176.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -71.03 142.82 50.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 1.44 110.845 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 2.0 mp0 78.96 -0.02 2.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.146 0.904 . . . . 3.06 111.854 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.7 m-20 -81.71 150.5 27.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.606 -0.516 . . . . 1.02 109.606 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 31.4 ttp-105 -104.64 142.82 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.775 0.321 . . . . 1.57 111.501 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 mm -72.82 123.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.592 -0.731 . . . . 0.68 109.587 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 104' ' ' PRO . 43.5 t -111.92 -48.27 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.439 0.637 . . . . 0.87 109.943 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.5 mt-10 -125.68 146.37 49.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.391 -0.822 . . . . 0.89 110.045 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.69 120.58 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.975 -0.557 . . . . 0.66 109.88 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 62.21 23.06 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.555 -0.748 . . . . 1.17 111.015 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 9.39 62.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.906 -0.664 . . . . 0.66 112.609 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.5 t -114.02 128.04 71.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 1.17 110.446 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.0 p -77.47 129.29 35.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.767 -0.651 . . . . 1.68 110.914 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.716 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.6 mmt -117.15 26.89 9.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.167 0.432 . . . . 0.81 112.167 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.69 114.97 7.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.393 . . . . 3.75 110.253 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.76 62.02 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.866 -0.683 . . . . 1.47 112.913 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.9 mmtp -92.37 166.98 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.214 -0.291 . . . . 3.36 110.214 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.19 175.62 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.493 -0.321 . . . . 2.89 111.057 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -58.94 -44.09 91.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.786 0.327 . . . . 1.42 110.818 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -39.47 95.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.912 -0.661 . . . . 0.72 112.122 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.75 -47.19 84.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 2.03 111.174 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 77' ' ' ILE . 50.6 t -69.08 -47.52 74.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.08 110.972 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.9 t -64.47 -41.99 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.465 -0.334 . . . . 0.72 111.186 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -63.87 -35.79 81.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.981 -0.378 . . . . 0.66 109.981 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.12 93.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.942 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 73' ' ' VAL . 75.5 mt -60.87 -45.89 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.69 110.384 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 52.0 mtp180 -68.18 -28.15 67.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.003 -0.544 . . . . 3.09 110.816 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.24 8.98 16.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.116 -0.493 . . . . 0.65 110.96 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.58 -21.12 58.73 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.85 -0.69 . . . . 0.6 111.752 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -129.71 9.99 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.768 -0.729 . . . . 1.1 111.995 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD2' ' HE3' ' A' ' 16' ' ' LYS . 11.6 p-10 -80.46 -23.94 39.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.748 0.309 . . . . 2.12 111.083 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 2.2 pt-20 -138.26 162.67 33.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.89 0.376 . . . . 2.11 110.815 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -143.79 149.17 36.65 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.815 -0.629 . . . . 0.32 110.1 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -115.1 117.52 30.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.139 -0.482 . . . . 1.63 109.878 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.463 HD12 ' HE3' ' A' ' 15' ' ' MET . 96.4 mt -109.05 135.64 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.065 -0.516 . . . . 0.28 110.427 -177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 44.4 tp -105.72 121.33 43.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.351 -0.611 . . . . 0.51 109.351 175.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.617 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.4 m -128.03 156.84 40.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.927 0.394 . . . . 0.33 111.569 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 10' ' ' PRO . 13.6 m -130.63 139.77 50.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.749 . . . . 0.42 110.382 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 173.65 6.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.778 -0.646 . . . . 1.92 110.64 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.612 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.1 ttt-85 -62.41 -49.39 75.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.848 -0.427 . . . . 4.16 109.848 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -39.56 94.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.204 0.526 . . . . 2.68 110.429 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.5 m -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.274 -0.875 . . . . 0.47 111.052 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.12 -37.29 78.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 1.18 111.303 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 31.8 mm-40 -63.54 -36.23 83.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 1.94 109.998 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 83.5 t80 -63.42 -46.82 84.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.743 -0.662 . . . . 0.73 110.214 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 104' ' ' PRO . 34.6 m-85 -64.26 -38.45 91.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.401 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -58.85 -50.01 75.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.956 0.407 . . . . 1.92 111.448 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -71.34 -19.04 62.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 2.04 111.663 -172.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -103.3 -2.5 27.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.926 0.393 . . . . 1.39 110.8 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.57 45.3 19.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.595 -0.73 . . . . 4.09 110.895 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.5 t -118.24 134.08 63.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 1.42 110.69 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.6 mm -93.1 120.07 67.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.374 -0.375 . . . . 1.33 110.018 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.485 ' HG2' HG11 ' A' ' 58' ' ' VAL . 32.8 Cg_endo -64.48 142.32 77.76 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.636 2.224 . . . . 0.53 112.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.519 ' HB3' ' OE2' ' A' ' 107' ' ' GLU . 9.3 t -153.24 -179.27 7.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.42 109.383 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -57.56 -30.99 65.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.411 0.523 . . . . 1.66 112.411 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.519 ' OE2' ' HB3' ' A' ' 105' ' ' SER . 0.0 OUTLIER -69.34 -28.77 66.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.948 0.404 . . . . 2.82 111.673 -177.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -77.46 -14.6 59.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.442 -0.344 . . . . 0.53 111.425 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.49 HD21 ' CD1' ' A' ' 87' ' ' LEU . 96.0 mt -53.31 -58.33 7.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.818 0.342 . . . . 1.24 111.802 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -107.93 14.66 25.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.267 0.556 . . . . 3.7 110.532 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.55 153.68 21.79 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.816 -0.629 . . . . 1.12 111.882 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.76 30.49 0.41 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.429 2.753 . . . . 1.31 113.102 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 9' ' ' ARG . 70.6 mt . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 115.309 -0.86 . . . . 1.11 113.168 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.063 0.459 . . . . 0.8 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 85.0 mtt-85 -115.72 149.86 43.83 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.07 -0.514 . . . . 3.09 111.447 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HB2' HD11 ' A' ' 87' ' ' LEU . 2.9 Cg_exo -72.7 165.89 31.48 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.512 2.141 . . . . 0.47 109.866 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.637 HH12 ' HB3' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -127.7 131.1 49.81 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.237 -0.438 . . . . 2.37 110.043 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.0 tm? -98.64 112.79 24.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 1.32 109.521 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.4 m -105.74 125.67 51.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.888 -0.596 . . . . 0.4 110.711 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' LYS . 24.2 m -111.98 117.38 32.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 0.35 109.174 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.712 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.6 ptp -126.53 133.6 51.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.178 0.513 . . . . 0.88 110.999 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -111.54 143.24 42.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.158 -0.928 . . . . 2.58 110.146 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 52.6 mttt -62.36 104.59 0.51 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.349 -0.841 . . . . 0.92 111.377 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.82 -80.2 0.93 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.044 -0.98 . . . . 1.28 111.623 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.98 47.5 2.23 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.723 2.282 . . . . 2.23 111.215 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m 61.58 27.6 17.03 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.12 -0.945 . . . . 2.87 110.69 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.514 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -177.09 -178.07 46.52 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.024 -0.608 . . . . 1.93 112.248 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 29.3 m-85 -106.55 -162.06 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.427 -0.583 . . . . 1.82 109.427 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.67 73.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.115 -1.04 . . . . 0.43 113.043 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -155.1 154.34 32.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.79 0.328 . . . . 0.4 110.287 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -108.75 134.78 50.99 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.383 -0.599 . . . . 2.18 109.383 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 35' ' ' GLN . 23.0 tp -105.24 152.66 22.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.351 -173.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.34 122.49 46.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.745 -0.835 . . . . 1.34 108.745 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.468 0.651 . . . . 2.3 111.198 -174.317 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' A' ' 26' ' ' LEU . 21.4 mm-40 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.874 0.368 . . . . 1.5 110.377 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.86 151.33 23.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 0.87 110.557 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.41 106.36 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.276 0.56 . . . . 0.39 110.171 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.25 -54.35 38.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.006 -0.997 . . . . 2.83 110.54 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 p -168.35 137.3 2.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.814 -0.63 . . . . 1.26 109.981 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.38 130.99 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.353 -0.61 . . . . 0.37 109.353 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.53 135.44 72.04 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.511 -0.313 . . . . 2.28 110.246 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HA ' ' CD ' ' A' ' 47' ' ' GLU . 33.1 Cg_endo -63.94 139.23 66.81 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.776 2.318 . . . . 1.17 112.406 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.18 48.27 6.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.304 -0.862 . . . . 2.4 110.807 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 98.7 p -120.4 160.45 43.7 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.473 -0.785 . . . . 0.57 109.539 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.6 Cg_endo -54.46 -29.41 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.167 1.911 . . . . 0.65 111.575 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.712 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.23 -50.49 39.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.36 110.54 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' CD ' ' HA ' ' A' ' 42' ' ' PRO . 44.0 tt0 -65.12 -35.85 82.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.297 -0.41 . . . . 2.01 110.49 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.47 111.641 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.7 p -72.99 -18.37 61.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.012 0.434 . . . . 0.4 110.8 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.12 14.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.62 112.547 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.65 114.76 9.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.65 110.355 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -97.53 149.65 21.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 4.38 109.906 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.37 151.82 39.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.276 -0.42 . . . . 1.44 110.585 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 70.35 10.7 7.32 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.774 0.671 . . . . 3.06 111.78 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.7 m-20 -84.6 168.53 15.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.722 -0.473 . . . . 1.02 109.722 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -131.31 131.26 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.848 -0.427 . . . . 1.57 109.848 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -72.57 130.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.228 0.537 . . . . 0.68 111.203 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.69 HG11 ' HG2' ' A' ' 104' ' ' PRO . 23.6 t -107.22 -48.47 8.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.87 110.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 35.5 mt-10 -133.87 148.34 51.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.89 110.756 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.23 117.78 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.958 -0.565 . . . . 0.66 109.773 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 58.78 31.02 20.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.18 0.514 . . . . 1.17 111.165 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.13 74.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.883 -0.675 . . . . 0.66 112.805 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.04 120.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.279 -0.267 . . . . 1.17 110.279 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 91.9 m -64.61 126.21 27.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.62 . . . . 1.68 111.438 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.577 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.8 mmt -105.14 68.78 0.83 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.923 -0.769 . . . . 0.81 108.923 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.7 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.56 -1.2 . . . . 3.75 110.811 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.99 25.93 5.7 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.611 -0.996 . . . . 1.47 110.611 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 71.9 mmtt -58.2 147.1 31.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.873 -0.663 . . . . 3.36 111.642 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.545 ' HG3' ' H ' ' A' ' 72' ' ' ASP . 12.8 pt20 -77.11 161.36 28.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.092 -0.958 . . . . 2.89 110.29 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.41 ' O ' HG23 ' A' ' 74' ' ' VAL . 85.0 t60 -55.4 -42.57 74.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 1.42 110.446 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.04 92.87 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.72 112.77 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 8.5 t0 -66.13 -47.09 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 2.03 110.013 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.415 HG22 ' SD ' ' A' ' 65' ' ' MET . 47.7 t -62.62 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.477 -0.783 . . . . 1.08 110.662 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 70' ' ' HIS . 95.8 t -63.5 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.72 110.883 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -61.97 -39.22 91.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.66 110.015 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.18 94.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.42 111.012 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.057 0.456 . . . . 0.69 110.629 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -68.93 -24.95 64.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 3.09 111.219 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.63 -10.67 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.65 111.093 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -33.31 70.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.702 -0.761 . . . . 0.6 111.904 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.16 -109.38 3.36 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.019 -0.61 . . . . 1.1 112.184 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 11.6 t70 -102.04 -23.97 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.616 -0.513 . . . . 2.12 109.616 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.06 157.3 40.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.028 0.442 . . . . 2.11 110.459 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -146.93 149.32 32.97 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.934 -0.575 . . . . 0.32 109.856 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 14' ' ' THR . 57.0 mttp -114.36 116.82 29.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.037 0.446 . . . . 1.63 109.896 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -109.54 136.35 49.07 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.838 -0.619 . . . . 0.28 110.574 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.8 tp -104.83 125.12 50.55 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.183 -0.673 . . . . 0.51 109.183 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 11.1 m -135.34 152.08 31.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.185 0.517 . . . . 0.33 111.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 94' ' ' ASP . 16.1 m -130.57 150.97 35.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.354 -0.839 . . . . 0.42 110.145 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.637 ' HB3' HH12 ' A' ' 11' ' ' ARG . 7.6 p-10 -89.97 176.16 6.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.449 -0.575 . . . . 1.92 109.449 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -53.51 -48.93 68.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.211 0.448 . . . . 4.16 112.211 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.2 -43.16 95.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 2.68 111.138 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.0 m -71.25 -41.03 70.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.332 0.587 . . . . 0.47 110.73 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 22.3 t0 -64.95 -39.31 93.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.528 -0.76 . . . . 1.18 111.072 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.29 -35.73 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 1.94 110.446 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -63.23 -48.03 79.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.73 111.005 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HD1' HG13 ' A' ' 102' ' ' VAL . 20.3 m-85 -64.47 -36.04 82.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.29 -0.414 . . . . 0.44 111.701 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 36.2 mttp -58.72 -49.82 76.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.786 0.291 . . . . 1.92 111.786 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 13.1 ptmt -70.85 -23.09 62.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 2.04 110.555 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.87 -7.16 59.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.861 -0.609 . . . . 1.39 110.68 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 57.88 28.94 16.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.423 -0.808 . . . . 4.09 111.299 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.431 HG13 ' HD1' ' A' ' 97' ' ' PHE . 10.8 p -132.28 147.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.043 -0.526 . . . . 1.42 109.955 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -102.1 128.53 28.32 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 121.107 0.48 . . . . 1.33 110.812 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.69 ' HG2' HG11 ' A' ' 58' ' ' VAL . 18.4 Cg_endo -63.71 155.98 60.16 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.655 2.236 . . . . 0.53 112.845 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.641 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 2.1 m -150.12 175.68 11.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.326 -0.99 . . . . 1.42 108.326 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.605 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 22.9 mp0 -59.39 -34.92 73.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.333 0.587 . . . . 1.66 110.122 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.641 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.8 pt-20 -62.49 -30.21 71.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 2.82 111.682 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.503 ' HB2' ' H ' ' A' ' 105' ' ' SER . 33.7 m80 -79.29 -24.48 42.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.53 111.322 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.7 pp -91.96 -14.11 30.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.217 -0.447 . . . . 1.24 110.477 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -103.86 -50.91 3.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 3.7 110.785 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.72 -142.6 8.67 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.89 -0.672 . . . . 1.12 112.416 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -84.52 163.21 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.719 2.279 . . . . 1.31 113.236 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.506 -0.77 . . . . 1.11 109.249 175.751 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.477 0.656 . . . . 0.8 109.876 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 113' ' ' LEU . 20.4 ptt85 -121.47 150.18 54.09 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.122 -0.945 . . . . 3.09 109.9 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HB2' HD11 ' A' ' 87' ' ' LEU . 55.6 Cg_endo -69.16 158.36 58.04 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.46 2.107 . . . . 0.47 111.938 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 11' ' ' ARG . 7.8 ptp180 -118.29 131.59 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.737 -0.665 . . . . 2.37 110.016 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.5 tp -97.33 111.08 23.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 1.32 109.803 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.412 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 32.2 m -94.77 117.22 29.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.833 -0.622 . . . . 0.4 110.032 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 85' ' ' LYS . 35.9 m -110.46 117.87 34.74 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.305 -0.628 . . . . 0.35 109.305 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 ptp -128.99 136.35 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.404 -0.362 . . . . 0.88 110.855 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -110.72 139.86 45.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.677 -0.692 . . . . 2.58 109.249 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 11.7 ttmt -61.92 124.4 20.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.329 0.492 . . . . 0.92 112.329 -173.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -149.85 17.91 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.629 -0.714 . . . . 1.28 111.323 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.73 -30.65 17.48 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.037 2.491 . . . . 2.23 112.508 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -109.1 19.93 18.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 2.87 110.573 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.77 2.84 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.569 -0.824 . . . . 1.93 111.959 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 26.6 m-85 -119.07 -48.46 2.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.753 0.311 . . . . 1.82 110.527 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 70.02 1.23 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.0 -0.619 . . . . 0.43 113.635 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -156.52 156.06 33.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.942 -0.392 . . . . 0.4 109.942 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -101.81 126.48 48.69 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.82 -0.437 . . . . 2.18 109.82 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 tp -100.34 152.74 19.97 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.966 -0.561 . . . . 1.52 110.432 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -106.61 122.7 46.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.305 -0.407 . . . . 1.34 110.108 -176.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.817 -0.628 . . . . 2.3 109.999 -178.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.577 HE21 ' CA ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.823 0.345 . . . . 1.5 111.276 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -118.61 156.79 28.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.87 110.061 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG13 HD11 ' A' ' 51' ' ' LEU . 44.4 mm -96.37 110.06 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.151 0.5 . . . . 0.39 109.719 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' HIS . 60.8 ttt180 -66.21 -55.15 17.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 2.83 110.371 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 p -169.67 139.24 1.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.812 -0.631 . . . . 1.26 109.599 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -96.41 138.05 22.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.341 -0.391 . . . . 0.37 109.984 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 t70 -71.59 124.0 90.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.178 -0.675 . . . . 2.28 109.178 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 35.1 Cg_exo -56.48 132.85 54.31 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.11 2.54 . . . . 1.17 113.751 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.0 t70 57.44 48.5 14.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.855 -1.066 . . . . 2.4 110.917 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.496 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -110.72 169.58 6.17 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.57 109.986 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.498 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.2 Cg_endo -55.16 -33.13 83.03 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.89 1.727 . . . . 0.65 111.333 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.439 0.638 . . . . 0.36 110.576 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.08 -50.61 73.04 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.276 -0.874 . . . . 2.01 110.067 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -17.5 62.54 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.711 -1.586 . . . . 0.47 111.353 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 51.6 p -84.72 -16.96 39.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.4 110.071 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.22 0.35 35.43 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.754 -0.736 . . . . 0.62 112.697 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 37' ' ' ILE . 37.8 tp -61.62 128.13 34.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.314 . . . . 0.65 110.31 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -117.86 154.21 32.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.251 -0.431 . . . . 4.38 109.915 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -78.88 145.37 34.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.528 -0.305 . . . . 1.44 110.305 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 85.3 mm-40 78.99 3.26 2.42 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.252 0.97 . . . . 3.06 111.202 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 36.4 m-20 -74.13 156.81 36.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 1.02 109.724 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -123.93 129.21 50.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.721 -0.474 . . . . 1.57 109.721 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.529 ' HA ' HG12 ' A' ' 88' ' ' VAL . 58.2 mt -76.22 130.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.225 0.536 . . . . 0.68 111.416 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.481 HG22 ' NH1' ' A' ' 56' ' ' ARG . 21.8 t -107.5 -51.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.237 -0.892 . . . . 0.87 110.149 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 26.1 mt-10 -130.61 144.35 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.89 111.031 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.31 118.2 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.333 -0.618 . . . . 0.66 109.333 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 61.0 22.41 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.17 110.937 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.98 6.28 63.49 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.66 112.915 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.87 120.73 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 1.17 110.37 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.537 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.2 m -63.51 130.02 42.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 1.68 110.841 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.594 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 25.6 mmt -109.62 18.63 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.406 0.622 . . . . 0.81 110.464 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -61.04 117.78 5.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.069 -0.969 . . . . 3.75 110.731 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.0 -16.76 50.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.833 -0.699 . . . . 1.47 112.951 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 65' ' ' MET . 68.8 mttm -75.6 173.16 11.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.149 0.5 . . . . 3.36 111.808 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -103.36 -175.29 2.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.593 -0.73 . . . . 2.89 111.463 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.414 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 86.3 t60 -63.08 -42.87 99.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.506 . . . . 1.42 110.297 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.36 -39.68 96.49 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.737 -0.665 . . . . 0.72 113.203 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -62.57 -47.47 83.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.046 0.451 . . . . 2.03 110.765 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.33 -46.76 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 1.08 110.968 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.93 -40.08 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.395 . . . . 0.72 111.023 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.7 t -60.28 -42.01 94.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.66 110.843 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.72 -43.38 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.42 111.35 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.523 HG23 HG21 ' A' ' 84' ' ' THR . 80.6 mt -58.73 -42.38 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.427 0.632 . . . . 0.69 110.407 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 78' ' ' ARG . 31.7 mtp180 -74.29 -31.98 62.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.462 -0.79 . . . . 3.09 111.63 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.79 -7.63 59.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.438 -0.346 . . . . 0.65 111.23 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.31 73.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.182 -0.532 . . . . 0.6 112.186 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.57 -126.96 8.24 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.707 -0.759 . . . . 1.1 111.652 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 8.5 t70 -84.02 -28.37 27.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 2.12 110.017 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -128.85 160.2 33.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.105 0.479 . . . . 2.11 110.618 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 77' ' ' ILE . 10.6 t -146.07 148.74 32.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.56 -0.745 . . . . 0.32 109.647 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.8 mttp -116.42 117.36 29.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 1.63 110.042 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.85 128.34 53.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.946 -0.57 . . . . 0.28 109.75 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 10' ' ' PRO . 57.0 tp -103.92 114.76 29.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.679 -0.859 . . . . 0.51 108.679 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.77 162.26 33.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 0.33 110.885 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.22 146.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 0.42 110.473 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.04 166.19 23.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.711 -0.677 . . . . 1.92 109.85 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.5 ttm180 -53.39 -48.17 68.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.009 0.433 . . . . 4.16 110.862 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -73.39 -28.13 61.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 2.68 109.973 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 m -70.58 -47.82 58.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.371 -0.832 . . . . 0.47 110.695 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -59.36 -45.04 92.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 1.18 110.478 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 11.2 mm-40 -62.8 -36.14 82.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.94 110.984 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.94 -46.09 89.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.73 110.555 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.474 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 48.7 m-85 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.248 -0.433 . . . . 0.44 111.257 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -59.51 -49.72 76.7 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.537 0.199 . . . . 1.92 111.537 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -70.92 -18.74 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 2.04 111.305 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 t -91.43 -19.51 22.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.306 0.574 . . . . 1.39 109.829 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 67.02 31.75 6.73 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 114.692 -1.14 . . . . 4.09 111.716 176.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.41 HG13 ' HD1' ' A' ' 97' ' ' PHE . 14.1 p -123.68 141.02 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 1.42 109.852 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 66.7 mt -82.4 129.07 64.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 1.33 110.367 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.474 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 14.5 Cg_exo -66.25 150.8 84.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.79 2.327 . . . . 0.53 111.623 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 t -163.34 178.38 8.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.566 -0.531 . . . . 1.42 109.566 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 71.1 mt-30 -55.13 -26.86 41.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.584 0.587 . . . . 1.66 112.584 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -55.7 -30.66 61.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.212 0.529 . . . . 2.82 111.389 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -89.77 -12.93 37.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.242 -0.435 . . . . 0.53 111.114 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 106' ' ' GLN . 96.4 mt -64.68 111.33 2.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.024 -0.535 . . . . 1.24 110.43 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 56.34 36.04 26.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 3.7 110.394 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.33 -167.86 11.45 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.605 -0.725 . . . . 1.12 111.843 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.33 150.0 22.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.608 2.205 . . . . 1.31 112.413 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 9' ' ' ARG . 65.3 mt . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 1.11 109.361 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 81.5 mt . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 112.366 0.506 . . . . 0.8 112.366 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -110.57 143.09 27.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 120.757 0.313 . . . . 3.09 110.611 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HB3' HG12 ' A' ' 89' ' ' VAL . 64.6 Cg_endo -74.69 177.09 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.637 2.225 . . . . 0.47 111.094 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -146.8 138.27 24.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.897 0.38 . . . . 2.37 111.326 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.23 116.57 29.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.687 -0.688 . . . . 1.32 110.139 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 4.3 m -97.38 115.91 28.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.12 -0.696 . . . . 0.4 109.12 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 85' ' ' LYS . 27.7 m -110.23 117.42 33.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 0.35 109.334 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.549 ' HE3' HD12 ' A' ' 86' ' ' LEU . 24.7 ptp -135.06 140.46 45.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.88 111.146 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -110.44 153.02 25.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.309 -0.626 . . . . 2.58 109.309 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 5.4 ttmt -69.17 98.89 1.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.493 0.663 . . . . 0.92 111.118 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -106.79 3.15 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.034 -0.985 . . . . 1.28 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HG3' ' A' ' 45' ' ' PRO . 41.4 Cg_endo -70.32 84.11 0.76 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.693 2.262 . . . . 2.23 113.013 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m 63.3 67.38 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.383 0.882 . . . . 2.87 113.383 170.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.39 57.35 6.79 Favored Glycine 0 CA--C 1.517 0.162 0 C-N-CA 121.124 -0.56 . . . . 1.93 114.308 168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 68.08 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.088 0.555 . . . . 1.82 111.56 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.21 70.42 0.73 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.863 -0.684 . . . . 0.43 112.771 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.48 152.4 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.751 -0.463 . . . . 0.4 109.751 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -103.74 135.17 45.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.387 -0.37 . . . . 2.18 110.144 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.515 HD13 ' H ' ' A' ' 27' ' ' HIS . 0.2 OUTLIER -101.32 151.86 21.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.891 -0.595 . . . . 1.52 109.536 -176.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.515 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -106.12 122.02 45.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 1.34 110.065 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.988 -0.551 . . . . 2.3 110.101 179.23 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.735 -0.468 . . . . 1.5 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 68.2 m-85 -103.98 147.56 27.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.135 0.493 . . . . 0.87 110.99 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.488 HG13 HD11 ' A' ' 51' ' ' LEU . 50.6 mm -78.87 106.98 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.469 -0.787 . . . . 0.39 109.149 175.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 39.5 ttt-85 -62.36 -53.25 57.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.37 -0.832 . . . . 2.83 110.113 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 m -161.41 145.25 12.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 1.26 108.91 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.49 131.24 73.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.211 -0.663 . . . . 0.37 109.211 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 t70 -79.13 118.53 72.98 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.298 -0.41 . . . . 2.28 109.895 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 50.2 Cg_exo -56.12 142.15 86.61 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.088 2.526 . . . . 1.17 112.999 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 t70 67.93 47.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.347 -0.842 . . . . 2.4 110.725 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 85.1 p -127.98 164.16 38.88 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.612 -0.722 . . . . 0.57 109.178 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.562 ' HG3' ' HD2' ' A' ' 19' ' ' PRO . 12.1 Cg_endo -57.43 -33.62 96.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.599 1.532 . . . . 0.65 111.326 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.0 -52.53 34.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.917 -0.583 . . . . 0.36 110.7 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.09 -41.56 97.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 2.01 110.273 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.77 -22.74 63.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.47 111.867 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.45 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.1 p -72.83 -9.73 59.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.27 0.557 . . . . 0.4 110.359 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.12 31.4 5.05 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.559 -0.746 . . . . 0.62 111.792 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.488 HD11 HG13 ' A' ' 37' ' ' ILE . 30.7 tp -97.13 139.53 32.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.019 -0.363 . . . . 0.65 110.019 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -131.44 148.5 52.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 4.38 109.506 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -73.23 149.87 42.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.093 -0.336 . . . . 1.44 110.093 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 75.2 mt-30 78.89 5.91 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.191 0.932 . . . . 3.06 111.477 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 47.9 m-20 -88.74 148.03 24.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 1.02 109.749 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 24.2 ttt180 -103.73 134.6 46.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 1.57 111.24 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.94 130.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.642 . . . . 0.68 110.031 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' A' ' 104' ' ' PRO . 41.3 t -111.24 -42.87 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.029 -0.532 . . . . 0.87 110.878 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.02 143.42 50.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.555 -0.293 . . . . 0.89 110.506 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.7 120.03 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.804 -0.443 . . . . 0.66 109.804 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 62.91 18.31 10.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.346 0.658 . . . . 1.17 111.249 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 0.05 73.09 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.586 -0.816 . . . . 0.66 111.858 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.11 128.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.855 -0.424 . . . . 1.17 109.855 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.459 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 23.1 p -66.68 126.51 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.754 -0.657 . . . . 1.68 111.773 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.3 mmt -133.68 38.81 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.81 110.515 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' OE1' ' HB2' ' A' ' 64' ' ' CYS . 41.3 mp0 -61.22 -52.74 63.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 3.75 111.201 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.72 34.78 2.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.674 -0.774 . . . . 1.47 112.472 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.6 mmtp -79.58 -175.37 4.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.732 0.301 . . . . 3.36 110.603 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -85.07 161.27 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.317 . . . . 2.89 110.658 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -55.84 -42.81 76.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.859 -0.423 . . . . 1.42 109.859 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.71 -39.11 94.82 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.5 -0.773 . . . . 0.72 113.032 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.18 -47.59 79.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.969 0.384 . . . . 2.03 111.354 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 65' ' ' MET . 48.7 t -64.55 -43.45 96.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.984 0.421 . . . . 1.08 110.736 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 97.0 t -65.84 -41.89 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.72 110.413 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -62.18 -44.95 95.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.66 110.502 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.36 -39.56 76.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.42 111.332 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.0 mt -57.46 -45.71 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.269 0.557 . . . . 0.69 110.724 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 74' ' ' VAL . 10.2 mpt_? -75.25 -31.99 60.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.703 -0.681 . . . . 3.09 110.983 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -14.75 63.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.65 111.874 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.23 -13.83 67.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.824 -0.703 . . . . 0.6 111.872 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.31 -99.82 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.869 -0.682 . . . . 1.1 111.977 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 9.3 t70 -104.72 -21.58 13.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.856 0.36 . . . . 2.12 110.528 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.29 162.29 31.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.844 0.354 . . . . 2.11 110.497 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 t -148.75 148.46 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.978 -0.556 . . . . 0.32 110.238 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HG2' HG23 ' A' ' 14' ' ' THR . 48.2 mttm -112.91 118.36 34.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.202 -0.453 . . . . 1.63 109.954 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD12 ' HE3' ' A' ' 15' ' ' MET . 92.9 mt -105.82 127.66 53.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.976 0.417 . . . . 0.28 109.983 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.9 tp -103.6 118.34 36.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.907 -0.775 . . . . 0.51 108.907 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.2 m -125.52 162.0 29.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.109 -0.496 . . . . 0.33 111.008 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 10' ' ' PRO . 8.3 m -126.95 142.95 41.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.42 110.509 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -75.8 172.37 12.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.875 -0.602 . . . . 1.92 109.785 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -59.65 -48.47 81.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.056 0.455 . . . . 4.16 110.793 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.4 mp0 -65.48 -40.28 92.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.87 -0.604 . . . . 2.68 110.273 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 8' ' ' LEU . 7.4 m -63.53 -50.9 67.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.31 -0.859 . . . . 0.47 110.872 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 29.8 t70 -59.08 -41.69 88.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.874 -1.057 . . . . 1.18 111.419 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.76 -36.93 62.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.414 -0.357 . . . . 1.94 111.41 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.13 -47.54 84.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.73 110.75 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -61.62 -38.26 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.44 111.524 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 24.2 mttp -66.32 -50.04 64.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.101 -0.24 . . . . 1.92 111.567 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 16.5 ptmt -72.7 -18.47 61.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 2.04 111.42 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.6 t -89.84 -13.39 36.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.723 -0.843 . . . . 1.39 108.723 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 68.12 33.46 4.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.633 -1.167 . . . . 4.09 110.655 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.3 148.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.869 -1.06 . . . . 1.42 109.987 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.7 mt -97.23 123.22 53.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 110.199 -0.297 . . . . 1.33 110.199 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.607 ' HG2' HG11 ' A' ' 58' ' ' VAL . 36.9 Cg_endo -71.09 145.91 50.7 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.455 2.103 . . . . 0.53 111.499 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.5 p -160.49 170.12 21.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.55 -0.295 . . . . 1.42 110.97 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -55.89 -29.24 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.451 0.469 . . . . 1.66 111.262 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -58.46 -30.83 67.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 2.82 110.972 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -81.39 -15.35 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.53 111.276 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.8 mt -67.42 -55.09 15.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.526 . . . . 1.24 110.349 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -97.58 16.61 19.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 3.7 110.477 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.21 -163.54 11.35 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.907 -0.663 . . . . 1.12 112.329 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -94.38 178.07 0.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.455 2.77 . . . . 1.31 113.0 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 1.11 109.137 175.762 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 92' ' ' GLU . 26.1 mt . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.237 0.541 . . . . 0.8 111.222 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.968 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 18.3 ptp180 -137.96 141.79 33.73 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.046 -0.525 . . . . 3.09 109.982 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HB2' HD21 ' A' ' 87' ' ' LEU . 30.2 Cg_endo -66.01 160.62 43.49 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.56 2.174 . . . . 0.47 111.588 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.769 -0.65 . . . . 2.37 110.431 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.61 HD13 HD12 ' A' ' 87' ' ' LEU . 63.0 tp -98.27 111.54 23.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 1.32 109.765 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.534 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.8 m -98.8 117.1 32.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.4 110.158 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.6 m -104.07 118.45 36.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.35 108.539 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.524 ' HE3' HD12 ' A' ' 86' ' ' LEU . 21.4 ptp -131.04 133.6 45.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.101 0.476 . . . . 0.88 111.025 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 13.1 tmtt? -105.23 143.56 33.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 2.58 109.258 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 ttmt -64.43 117.53 7.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.102 0.477 . . . . 0.92 111.371 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.79 -124.03 4.08 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.618 -0.719 . . . . 1.28 111.869 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.15 -67.59 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.762 2.308 . . . . 2.23 113.223 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.2 m -121.18 34.87 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 2.87 111.048 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.14 -141.45 12.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.546 -0.835 . . . . 1.93 111.989 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 44' ' ' SER . 40.4 m-85 -107.22 -34.38 7.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.151 0.501 . . . . 1.82 110.028 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.47 68.36 0.95 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.153 -0.93 . . . . 0.43 112.91 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -156.88 156.7 33.58 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.802 -0.444 . . . . 0.4 109.802 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -119.74 137.59 53.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.304 -0.407 . . . . 2.18 110.143 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.62 153.88 19.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.456 0.646 . . . . 1.52 112.204 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 2.4 m-70 -105.8 121.57 44.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.005 -0.998 . . . . 1.34 108.352 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.316 -0.88 0 N-CA-C 108.903 -0.777 . . . . 2.3 108.903 178.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.282 0.563 . . . . 1.5 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.641 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 50.0 m-85 -124.5 158.04 33.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.233 -0.894 . . . . 0.87 109.096 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.3 mm -87.66 112.39 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.461 -0.57 . . . . 0.39 109.461 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HA ' ' CD2' ' A' ' 27' ' ' HIS . 6.9 tmm_? -69.35 -55.68 9.72 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.097 -0.705 . . . . 2.83 109.097 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -163.15 143.54 9.17 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.485 -0.931 . . . . 1.26 108.485 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.93 122.64 50.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.048 -0.723 . . . . 0.37 109.048 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 14.2 m-20 -62.29 115.29 15.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.499 -0.556 . . . . 2.28 109.499 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 19.6 Cg_endo -58.0 150.88 61.58 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.857 2.372 . . . . 1.17 113.003 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 66.66 47.65 1.55 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.039 -0.982 . . . . 2.4 110.33 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 90.2 p -133.6 160.85 66.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.95 -0.568 . . . . 0.57 110.629 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -28.53 83.81 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.443 2.095 . . . . 0.65 111.451 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.42 76.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.409 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -67.49 -41.54 84.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 2.01 110.107 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.62 69.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.47 111.975 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.534 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 62.0 p -70.72 -16.58 62.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.038 0.446 . . . . 0.4 110.578 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.07 15.37 22.06 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.73 -0.748 . . . . 0.62 112.975 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -72.02 147.8 46.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.103 -0.332 . . . . 0.65 110.103 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -140.84 157.62 45.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.957 -0.386 . . . . 4.38 109.957 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -80.11 155.12 27.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.42 -0.355 . . . . 1.44 110.831 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 14.1 mm100 75.24 7.45 4.09 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.977 0.798 . . . . 3.06 111.848 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 89.9 m-20 -93.12 154.91 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.946 -0.39 . . . . 1.02 109.946 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.604 HH11 ' HB3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -111.18 133.62 53.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.227 -0.442 . . . . 1.57 109.888 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HA ' HG12 ' A' ' 88' ' ' VAL . 71.9 mt -78.25 124.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.68 110.849 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.09 -25.78 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.899 -0.591 . . . . 0.87 112.08 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.2 mt-10 -140.24 145.2 37.05 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.32 . . . . 0.89 110.625 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 65' ' ' MET . 96.6 t -131.44 124.83 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.66 109.885 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.3 21.64 9.89 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.223 0.609 . . . . 1.17 111.523 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.17 3.56 67.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.538 -0.839 . . . . 0.66 112.665 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.95 128.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.105 -0.331 . . . . 1.17 110.105 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.4 t -63.5 121.16 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 1.68 110.467 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.806 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.9 mmt -108.72 -1.08 19.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 0.81 111.238 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -71.86 84.28 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.47 0.652 . . . . 3.75 109.718 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.18 -8.29 5.09 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.627 -0.715 . . . . 1.47 111.749 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.806 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.8 mmtt -75.97 -172.36 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 3.36 111.09 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -112.83 161.58 16.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 2.89 110.216 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -56.28 -42.88 78.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 1.42 110.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.59 -32.87 79.58 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.563 -0.827 . . . . 0.72 112.503 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.5 -47.32 61.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 2.03 110.432 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.477 HG12 ' SD ' ' A' ' 65' ' ' MET . 33.3 m -67.42 -41.92 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.944 -0.571 . . . . 1.08 111.503 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.35 -40.05 81.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 0.72 110.799 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -66.26 -38.23 87.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.66 110.108 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.3 97.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.42 111.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.554 HG23 HG21 ' A' ' 84' ' ' THR . 85.0 mt -58.38 -42.15 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.36 0.6 . . . . 0.69 110.591 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -74.74 -35.83 62.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.66 -0.7 . . . . 3.09 110.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.88 7.44 18.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.956 -0.566 . . . . 0.65 111.869 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 -14.59 81.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.6 112.013 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.01 -133.04 9.97 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.942 -0.863 . . . . 1.1 110.942 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 2.9 t70 -103.85 11.17 36.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.524 0.678 . . . . 2.12 109.69 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -149.2 159.58 44.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.298 -0.865 . . . . 2.11 109.473 174.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.554 HG21 HG23 ' A' ' 77' ' ' ILE . 14.8 t -148.35 149.77 32.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.32 110.52 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.536 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.1 mttt -110.89 117.07 32.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.059 -0.518 . . . . 1.63 110.014 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.524 HD12 ' HE3' ' A' ' 15' ' ' MET . 85.0 mt -106.73 118.98 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.703 -0.48 . . . . 0.28 109.703 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.61 HD12 HD13 ' A' ' 12' ' ' LEU . 4.8 tt -106.79 119.93 40.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.067 -0.716 . . . . 0.51 109.067 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 57' ' ' ILE . 35.5 m -126.59 166.76 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.226 -0.443 . . . . 0.33 110.958 -173.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 m -127.33 136.93 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.42 110.72 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 166.37 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.368 -0.833 . . . . 1.92 110.37 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -56.06 -47.5 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.302 . . . . 4.16 110.843 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.647 ' HG3' HD23 ' A' ' 8' ' ' LEU . 11.2 pt-20 -60.57 -38.24 83.92 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.3 0.571 . . . . 2.68 110.314 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.411 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 25.9 m -71.25 -48.35 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.24 -0.891 . . . . 0.47 110.691 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.516 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 24.7 t70 -60.55 -49.04 79.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.959 -0.564 . . . . 1.18 110.966 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.496 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 36.2 mt-10 -64.83 -27.55 68.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.94 111.141 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.37 -48.52 55.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 0.73 110.034 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 93' ' ' THR . 41.9 m-85 -66.71 -36.74 83.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.377 -0.374 . . . . 0.44 111.82 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.7 mtpp -57.79 -50.14 74.27 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.665 0.246 . . . . 1.92 111.665 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 99' ' ' LYS . 11.2 ptmm? -71.48 -33.96 69.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 2.04 110.757 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -75.55 -11.28 59.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.529 -0.759 . . . . 1.39 111.969 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 55.71 33.49 21.46 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.406 0.682 . . . . 4.09 111.174 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.31 143.74 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 1.42 110.19 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.78 117.26 67.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.059 -0.349 . . . . 1.33 110.059 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.77 140.86 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.349 2.033 . . . . 0.53 111.51 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -157.73 175.07 14.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.427 -0.351 . . . . 1.42 111.195 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.539 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 10.8 mt-30 -53.62 -34.77 59.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.266 0.555 . . . . 1.66 111.127 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -59.3 -30.04 68.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.589 -0.732 . . . . 2.82 111.026 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -87.81 -12.85 43.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.53 112.103 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.55 HD21 HD11 ' A' ' 87' ' ' LEU . 77.0 mt -55.0 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.188 0.44 . . . . 1.24 112.188 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.968 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 9.9 t30 72.54 -14.7 0.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.684 -0.689 . . . . 3.7 112.225 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 112' ' ' PRO . . . -83.68 -121.13 0.8 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.725 -0.75 . . . . 1.12 112.669 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 111' ' ' GLY . 52.4 Cg_endo -87.33 110.85 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.868 2.379 . . . . 1.31 112.768 -176.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 9' ' ' ARG . 58.2 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.622 . . . . 1.11 109.447 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 93' ' ' THR . 86.6 mt . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 112.555 0.576 . . . . 0.8 112.555 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.567 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 31.4 ptt180 -114.52 160.02 34.68 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.717 -0.846 . . . . 3.09 108.717 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 30.7 Cg_endo -62.55 167.22 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.885 1.723 . . . . 0.47 111.895 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.534 ' HG3' HG23 ' A' ' 88' ' ' VAL . 1.6 ptm180 -128.56 135.96 50.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.971 -0.559 . . . . 2.37 110.347 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HG ' HD11 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -96.51 116.7 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 1.32 110.248 -176.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 82.6 m -101.61 116.81 33.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.579 -0.526 . . . . 0.4 109.579 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -108.79 120.27 41.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.399 -0.593 . . . . 0.35 109.399 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.27 133.35 38.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.572 . . . . 0.88 111.548 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -101.87 144.23 30.78 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.375 -0.83 . . . . 2.58 109.649 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.8 ttmt -65.66 113.01 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.036 0.446 . . . . 0.92 110.562 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.01 -99.72 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.444 -0.798 . . . . 1.28 111.323 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.43 97.97 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.761 2.307 . . . . 2.23 112.327 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 t 71.39 -47.19 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.004 0.922 . . . . 2.87 112.554 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 161.02 81.57 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.375 -0.917 . . . . 1.93 112.83 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 44' ' ' SER . 23.3 m-85 68.13 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.267 0.627 . . . . 1.82 111.601 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.81 69.76 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.896 -0.669 . . . . 0.43 112.817 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.31 154.06 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.705 -0.48 . . . . 0.4 109.705 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -119.27 131.46 55.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.806 0.336 . . . . 2.18 110.99 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.42 133.61 45.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.016 -0.538 . . . . 1.52 110.222 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.1 p80 -120.44 139.38 52.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 1.34 110.601 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 108.998 -0.741 . . . . 2.3 108.998 177.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.915 0.388 . . . . 1.5 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.447 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 68.8 m-85 -121.98 148.91 44.21 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.696 -0.853 . . . . 0.87 108.696 175.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 55' ' ' ASP . 38.2 mm -68.32 109.25 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 0.39 109.775 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -65.81 -54.45 26.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.235 -1.024 . . . . 2.83 108.235 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 m -166.34 135.46 3.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 1.26 109.348 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -94.65 121.81 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.386 -0.968 . . . . 0.37 108.386 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -78.22 121.52 84.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.255 -0.43 . . . . 2.28 110.032 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.75 155.98 20.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.513 2.809 . . . . 1.17 112.584 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.7 51.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.998 0.904 . . . . 2.4 109.218 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.2 p -146.94 154.56 47.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.979 -1.009 . . . . 0.57 109.508 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.89 -25.55 78.25 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 0.65 111.705 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.2 70.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.36 110.339 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -67.97 -35.0 77.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.218 0.533 . . . . 2.01 109.808 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -18.97 60.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.566 -0.743 . . . . 0.47 111.58 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 24.2 p -70.42 -18.1 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.138 0.494 . . . . 0.4 109.78 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.31 -0.57 33.01 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.986 -0.626 . . . . 0.62 112.141 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD11 HG13 ' A' ' 37' ' ' ILE . 22.4 tp -61.76 139.39 58.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.541 0.21 . . . . 0.65 110.735 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -124.56 -164.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.459 -0.571 . . . . 4.38 109.459 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.0 140.72 29.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.971 0.415 . . . . 1.44 111.081 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 68.91 26.82 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.952 -1.022 . . . . 3.06 113.013 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.555 ' HB2' HG13 ' A' ' 37' ' ' ILE . 6.2 m-20 -69.7 142.93 53.25 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.377 -0.971 . . . . 1.02 108.377 167.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -108.69 128.44 54.86 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.517 -0.549 . . . . 1.57 109.517 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 88' ' ' VAL . 24.4 mm -71.91 130.1 35.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 0.68 111.257 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 104' ' ' PRO . 58.2 t -111.79 -51.52 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.87 109.959 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.6 mt-10 -136.89 152.49 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.746 -0.661 . . . . 0.89 110.283 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 77' ' ' ILE . 87.7 t -129.45 115.7 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.527 . . . . 0.66 109.579 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.21 26.49 15.89 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.478 0.486 . . . . 1.17 111.157 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.54 13.31 67.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.852 -0.69 . . . . 0.66 112.524 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.68 122.77 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.718 -0.475 . . . . 1.17 109.718 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.577 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.1 t -65.53 129.77 40.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.037 -0.529 . . . . 1.68 111.338 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.472 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.0 mmt -115.27 14.71 16.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.81 111.159 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 103' ' ' ILE . 56.5 mm-40 -62.31 -31.06 71.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.622 . . . . 3.75 111.489 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.96 20.32 14.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 1.47 112.098 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 72' ' ' ASP . 71.9 mmtt -101.45 177.43 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.934 0.397 . . . . 3.36 110.749 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -125.61 -178.39 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.9 -0.591 . . . . 2.89 109.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -54.12 -41.15 68.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.781 0.289 . . . . 1.42 111.781 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.62 93.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.643 -0.789 . . . . 0.72 112.831 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 10.4 m-20 -65.58 -45.99 81.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 2.03 110.972 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 77' ' ' ILE . 98.7 t -62.54 -46.96 95.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 1.08 110.87 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.51 -37.87 78.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.834 0.349 . . . . 0.72 111.444 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.6 t -61.55 -38.79 88.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.74 -0.467 . . . . 0.66 109.74 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.58 78.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.42 111.194 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 73' ' ' VAL . 28.7 mm -57.35 -42.46 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.678 0.751 . . . . 0.69 109.378 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -74.81 -37.31 62.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.051 -0.977 . . . . 3.09 111.079 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -6.36 40.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.543 . . . . 0.65 111.988 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.16 -28.18 68.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.6 112.578 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.74 -120.15 4.74 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.768 -0.73 . . . . 1.1 111.442 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 51.4 m-20 -108.74 7.68 26.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 2.12 110.482 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.39 156.73 41.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.75 . . . . 2.11 108.974 171.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.32 110.076 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -116.89 119.89 36.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 1.63 109.596 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.2 128.26 53.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.979 -0.555 . . . . 0.28 110.092 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 10' ' ' PRO . 23.2 tp -103.66 115.2 30.06 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.288 -1.004 . . . . 0.51 108.288 174.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.534 HG23 ' HG3' ' A' ' 11' ' ' ARG . 16.1 m -127.58 163.89 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.004 -0.544 . . . . 0.33 111.044 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.38 139.15 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.591 -0.731 . . . . 0.42 110.082 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.79 175.88 9.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.167 -0.469 . . . . 1.92 109.817 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 91' ' ' ARG . 3.3 tpp180 -62.5 -42.04 99.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.708 0.262 . . . . 4.16 111.708 -171.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.32 -42.91 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 2.68 110.715 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' LEU . 85.7 m -66.48 -45.83 78.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.856 -0.611 . . . . 0.47 111.451 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 40.7 t0 -58.97 -47.44 85.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 1.18 109.318 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 68.2 mm-40 -59.95 -37.67 80.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 1.94 110.821 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.65 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 84.5 t80 -62.96 -49.34 75.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.512 -0.313 . . . . 0.73 110.973 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.415 ' HD1' HG13 ' A' ' 102' ' ' VAL . 32.1 m-85 -66.64 -38.15 86.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.601 -0.272 . . . . 0.44 111.45 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.1 mtpp -60.28 -48.79 80.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.721 0.296 . . . . 1.92 111.326 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.2 pttt -71.47 -14.55 62.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.277 -0.419 . . . . 2.04 111.295 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.32 -10.62 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 1.39 111.257 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.78 28.23 17.98 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.821 -0.627 . . . . 4.09 111.502 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.415 HG13 ' HD1' ' A' ' 97' ' ' PHE . 10.1 p -123.82 142.12 41.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.998 0.428 . . . . 1.42 110.848 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.74 HG23 ' HG3' ' A' ' 66' ' ' GLU . 70.5 mt -79.4 128.43 75.36 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.718 -0.674 . . . . 1.33 110.971 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.681 ' HB2' HG11 ' A' ' 58' ' ' VAL . 6.1 Cg_exo -71.9 160.28 48.16 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.069 2.513 . . . . 0.53 111.602 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -165.31 164.96 19.79 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.921 -0.312 . . . . 1.42 110.735 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -59.22 -28.53 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 1.66 110.931 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -58.91 -30.53 67.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.031 0.443 . . . . 2.82 110.892 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -77.52 -15.16 59.44 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.53 111.509 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.427 HD11 ' HG ' ' A' ' 12' ' ' LEU . 60.1 mt -65.01 -61.59 2.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.529 0.68 . . . . 1.24 110.455 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.37 19.72 9.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.127 -0.942 . . . . 3.7 110.36 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.68 -175.81 14.17 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.855 -0.612 . . . . 1.12 112.139 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -87.44 159.83 8.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.354 2.702 . . . . 1.31 112.568 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' A' ' 9' ' ' ARG . 45.3 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.772 -0.649 . . . . 1.11 109.321 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.443 0.639 . . . . 0.8 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 32.2 ptt180 -119.98 161.4 38.55 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.434 -0.803 . . . . 3.09 109.948 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.613 ' HB2' HD11 ' A' ' 87' ' ' LEU . 6.8 Cg_exo -70.28 169.73 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.463 2.109 . . . . 0.47 111.703 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HG3' HG23 ' A' ' 88' ' ' VAL . 6.5 ptt180 -128.5 131.37 48.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 2.37 110.505 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 85' ' ' LYS . 48.7 tp -95.43 110.57 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.009 -0.541 . . . . 1.32 109.623 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 60.0 m -92.98 117.8 30.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.23 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 85' ' ' LYS . 23.8 m -106.56 118.76 37.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.487 -0.56 . . . . 0.35 109.487 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.9 ptp -133.79 133.65 41.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.826 -0.624 . . . . 0.88 110.486 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.66 136.73 52.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.046 -0.525 . . . . 2.58 110.016 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 9.5 ttmt -54.65 119.07 4.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.478 -0.783 . . . . 0.92 111.337 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.43 -107.37 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.568 -0.825 . . . . 1.28 112.678 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.88 -66.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.163 2.575 . . . . 2.23 112.904 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 t -140.86 85.45 1.99 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.375 -0.602 . . . . 2.87 109.375 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.32 -132.1 11.44 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.542 -0.837 . . . . 1.93 111.724 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 44' ' ' SER . 48.7 m-85 -119.99 -31.5 4.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.173 0.511 . . . . 1.82 110.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.42 68.05 1.2 Allowed Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.327 -0.851 . . . . 0.43 113.245 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -156.92 151.89 26.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.753 -0.462 . . . . 0.4 109.753 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.9 m120 -101.45 135.35 43.11 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.194 -0.669 . . . . 2.18 109.194 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -101.29 151.18 22.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.045 0.45 . . . . 1.52 111.352 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -108.9 122.1 46.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.78 -0.646 . . . . 1.34 110.1 -177.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 109.881 -0.414 . . . . 2.3 109.881 176.735 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HG3' HG21 ' A' ' 73' ' ' VAL . 23.0 mm-40 . . . . . 0 CA--C 1.517 -0.29 0 N-CA-C 109.466 -0.568 . . . . 1.5 109.466 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.2 m-85 -119.96 157.79 28.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.737 -0.468 . . . . 0.87 109.737 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.556 HG13 HD11 ' A' ' 51' ' ' LEU . 47.5 mm -91.21 109.89 21.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.29 0.566 . . . . 0.39 109.541 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 28.5 ttt180 -63.15 -48.19 79.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.93 -1.032 . . . . 2.83 109.892 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -162.36 160.34 26.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.571 -0.9 . . . . 1.26 108.571 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.58 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.417 -0.586 . . . . 0.37 109.417 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.45 125.84 89.4 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.877 -0.416 . . . . 2.28 109.877 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 141.85 97.92 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.747 2.298 . . . . 1.17 112.069 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 64.59 49.86 2.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.756 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 95.6 p -126.88 158.62 67.89 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.795 -0.639 . . . . 0.57 110.234 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 11.3 Cg_endo -57.99 -27.86 80.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.257 1.971 . . . . 0.65 111.147 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.97 59.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.36 110.465 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.49 -38.23 90.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.286 -0.415 . . . . 2.01 110.762 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.67 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.47 111.415 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 59.5 p -70.68 -14.47 62.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.896 0.379 . . . . 0.4 111.03 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.99 7.07 29.5 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.018 -0.61 . . . . 0.62 112.899 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 37' ' ' ILE . 19.7 tp -76.61 130.51 37.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.546 0.212 . . . . 0.65 110.579 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.16 -163.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 4.38 110.951 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.56 140.02 29.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.474 . . . . 1.44 111.207 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 70.34 15.85 7.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.307 -0.86 . . . . 3.06 112.162 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.1 m-20 -69.48 128.39 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.986 -0.376 . . . . 1.02 109.986 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.5 123.79 36.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 1.57 110.583 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.16 124.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.68 110.793 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.414 HG11 ' HD2' ' A' ' 104' ' ' PRO . 43.1 t -105.29 -45.15 8.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.87 110.949 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.5 mt-10 -132.82 153.52 51.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.89 110.479 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -126.77 120.97 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.112 -0.495 . . . . 0.66 109.842 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 63.57 17.77 10.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.192 0.597 . . . . 1.17 111.205 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.512 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.8 4.62 65.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.66 112.528 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.88 128.69 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.66 0.267 . . . . 1.17 110.38 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.5 m -59.38 118.67 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.724 -0.671 . . . . 1.68 111.558 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.8 mmt -126.88 70.79 1.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.81 111.774 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -135.43 139.42 44.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.968 -0.382 . . . . 3.75 109.968 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.5 -0.46 89.25 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.938 -1.265 . . . . 1.47 109.938 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -74.2 163.56 27.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.15 -1.025 . . . . 3.36 111.724 -178.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.4 177.81 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.594 -0.891 . . . . 2.89 108.594 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -63.0 -37.85 88.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.841 0.353 . . . . 1.42 110.684 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.79 92.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.256 -0.497 . . . . 0.72 113.112 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.96 -47.55 80.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.958 0.409 . . . . 2.03 110.966 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.511 HG21 ' HG3' ' A' ' 35' ' ' GLN . 3.4 m -71.81 -41.87 69.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.844 -0.616 . . . . 1.08 111.496 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.6 t -61.99 -48.14 89.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.637 -0.256 . . . . 0.72 110.75 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 t -62.47 -37.67 86.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.552 -0.295 . . . . 0.66 110.303 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.89 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.797 0.332 . . . . 0.42 111.468 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.95 -41.21 90.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 0.69 110.805 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 69.0 mtp180 -74.03 -35.71 64.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 3.09 111.091 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.17 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.65 110.938 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.19 -21.06 67.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.021 -0.609 . . . . 0.6 112.1 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -117.99 5.11 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.029 -0.605 . . . . 1.1 111.963 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 39.6 m-20 -113.97 8.89 17.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 2.12 110.876 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.06 160.22 42.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.11 -0.7 . . . . 2.11 109.11 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.3 t -153.19 148.81 27.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.861 0.362 . . . . 0.32 110.594 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HB3' HD11 ' A' ' 12' ' ' LEU . 6.9 mptt -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.389 -0.597 . . . . 1.63 109.389 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.29 133.77 49.5 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.801 -0.444 . . . . 0.28 109.801 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.613 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.3 tp -103.84 115.99 31.48 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.17 -0.678 . . . . 0.51 109.17 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 14.3 m -131.62 155.41 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.019 -0.537 . . . . 0.33 111.209 -173.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.72 146.95 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.411 -0.813 . . . . 0.42 110.331 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.06 176.85 6.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.793 -0.64 . . . . 1.92 109.396 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 ttm105 -56.4 -47.92 78.0 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.786 0.291 . . . . 4.16 111.786 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.72 -40.82 89.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.116 0.484 . . . . 2.68 110.819 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 -48.12 29.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.726 -0.67 . . . . 0.47 111.154 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 5.5 t0 -60.78 -43.43 98.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 1.18 110.307 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.33 -37.44 77.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.256 -0.429 . . . . 1.94 110.669 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.431 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 91.3 t80 -63.16 -47.39 82.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.73 110.296 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -67.4 -37.12 82.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.266 -0.425 . . . . 0.44 111.71 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 58.4 mttm -58.56 -50.15 74.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.913 0.387 . . . . 1.92 110.821 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 96' ' ' PHE . 19.3 ptmt -69.7 -22.35 63.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.742 -0.663 . . . . 2.04 110.904 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.37 -16.41 37.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.563 . . . . 1.39 111.072 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER 61.07 37.18 18.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.489 -0.778 . . . . 4.09 111.393 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.54 138.18 50.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.891 0.376 . . . . 1.42 110.688 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 70.0 mt -77.85 131.66 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 1.33 110.748 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.476 ' HB3' ' HG3' ' A' ' 10' ' ' PRO . 5.9 Cg_exo -70.54 153.43 65.34 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.946 2.431 . . . . 0.53 111.881 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 108' ' ' HIS . 21.9 p -158.19 178.39 10.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.592 -0.277 . . . . 1.42 110.398 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.554 ' HA ' ' CD2' ' A' ' 109' ' ' LEU . 2.7 mp0 -55.61 -38.01 68.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 1.66 110.722 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.91 -31.28 69.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.248 0.547 . . . . 2.82 110.965 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.421 ' HB2' ' H ' ' A' ' 105' ' ' SER . 35.7 m80 -83.04 -25.48 32.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.53 111.584 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 106' ' ' GLN . 4.4 pp -95.34 -28.87 14.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.769 -0.651 . . . . 1.24 110.959 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.424 ' N ' HD12 ' A' ' 109' ' ' LEU . 23.0 t-20 -93.42 -23.79 18.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 3.7 110.034 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.51 -145.72 9.71 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.923 -0.656 . . . . 1.12 112.299 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.78 169.01 2.51 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.151 2.568 . . . . 1.31 112.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.709 -0.678 . . . . 1.11 110.095 176.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.482 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 88.6 mt . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 121.635 0.731 . . . . 0.8 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 109' ' ' LEU . 14.2 ptt180 -123.78 147.89 54.86 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.022 -0.99 . . . . 3.09 109.025 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HB2' HD11 ' A' ' 87' ' ' LEU . 30.8 Cg_endo -68.52 149.62 74.52 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.586 1.524 . . . . 0.47 110.798 172.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -120.6 135.49 55.08 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.283 -0.417 . . . . 2.37 110.25 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -92.68 111.25 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.957 -0.565 . . . . 1.32 110.159 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.29 117.61 30.37 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.517 -0.765 . . . . 0.4 109.368 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' LYS . 27.0 m -109.57 119.05 38.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.685 -0.487 . . . . 0.35 109.685 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.605 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 24.4 ptp -131.33 133.59 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.04 0.447 . . . . 0.88 111.003 -174.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -97.9 132.63 43.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.871 -0.604 . . . . 2.58 109.421 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 20.6 ttmt -50.67 129.21 22.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.925 -0.58 . . . . 0.92 111.517 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.97 -158.42 24.36 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.771 -0.728 . . . . 1.28 111.588 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.74 -27.46 44.57 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.06 2.507 . . . . 2.23 112.642 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 p -105.16 13.87 30.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.039 -0.528 . . . . 2.87 110.563 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.06 2.73 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.615 -0.803 . . . . 1.93 111.182 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.39 159.95 36.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.488 -0.93 . . . . 1.82 108.488 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.78 75.17 0.4 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 119.883 -1.151 . . . . 0.43 113.298 -173.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.03 168.77 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.849 0.357 . . . . 0.4 110.54 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -131.53 143.27 50.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.914 -0.585 . . . . 2.18 110.552 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.56 145.17 30.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.484 0.659 . . . . 1.52 111.835 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -110.65 129.38 55.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 1.34 109.426 172.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.317 -0.831 0 N-CA-C 108.58 -0.896 . . . . 2.3 108.58 175.018 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.568 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 2.7 mp0 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.961 -0.385 . . . . 1.5 109.961 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 61.6 m-85 -117.61 157.67 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.551 -0.907 . . . . 0.87 108.551 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG13 HD11 ' A' ' 51' ' ' LEU . 44.2 mm -90.91 109.43 20.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.598 -0.441 . . . . 0.39 109.834 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -69.12 -54.63 13.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.889 -0.596 . . . . 2.83 110.547 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -152.36 144.1 23.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.709 -0.678 . . . . 1.26 109.912 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.77 137.89 55.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.732 -0.47 . . . . 0.37 109.732 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -82.05 122.96 80.1 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.563 0.22 . . . . 2.28 110.544 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -65.01 -19.68 63.78 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.867 2.378 . . . . 1.17 112.538 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.78 4.51 52.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.913 -0.585 . . . . 2.4 110.633 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 38.8 p -108.86 158.78 33.24 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 122.104 -0.372 . . . . 0.57 110.783 -174.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 28.3 Cg_endo -63.06 -15.97 51.36 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.798 2.332 . . . . 0.65 112.033 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -67.69 -51.51 48.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.096 -0.502 . . . . 0.36 110.328 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' HG3' ' HA ' ' A' ' 42' ' ' PRO . 4.4 tm-20 -64.48 -40.65 96.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.918 -0.771 . . . . 2.01 108.918 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.36 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.47 111.966 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 15' ' ' MET . 60.3 p -77.32 -12.54 59.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.4 110.898 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.25 9.44 27.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.783 -0.723 . . . . 0.62 112.734 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 37' ' ' ILE . 29.9 tp -78.17 141.58 38.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.727 0.298 . . . . 0.65 110.497 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.8 tpp180 -143.63 164.82 29.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.383 -0.599 . . . . 4.38 109.383 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.57 152.97 40.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.603 -0.271 . . . . 1.44 111.231 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 74.64 11.32 3.92 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.061 0.851 . . . . 3.06 112.135 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 17.9 m-20 -92.08 151.97 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.774 -0.454 . . . . 1.02 109.774 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -105.54 136.61 44.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.51 -0.313 . . . . 1.57 110.666 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.65 130.15 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 0.68 110.151 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.773 HG11 ' HG2' ' A' ' 104' ' ' PRO . 22.7 t -114.37 -47.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 0.87 111.057 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.5 mt-10 -126.29 148.82 49.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.887 0.375 . . . . 0.89 110.928 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 63' ' ' VAL . 61.8 t -129.41 122.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.66 109.206 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 62.87 21.09 12.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.785 0.434 . . . . 1.17 111.056 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.3 74.73 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.733 -0.746 . . . . 0.66 113.382 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 60' ' ' VAL . 14.6 p -107.61 138.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.38 0.59 . . . . 1.17 110.111 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 50.9 t -74.5 136.81 42.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 1.68 111.434 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.607 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 25.1 mmt -121.62 68.06 0.9 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.447 -0.797 . . . . 0.81 111.128 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -103.69 -59.15 1.77 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.324 -0.398 . . . . 3.75 110.517 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.62 4.74 Favored Glycine 0 C--N 1.329 0.182 0 N-CA-C 111.548 -0.621 . . . . 1.47 111.548 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.607 ' HG2' ' HB3' ' A' ' 65' ' ' MET . 0.0 OUTLIER -110.94 -172.19 1.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.782 0.801 . . . . 3.36 112.722 -171.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -121.46 150.0 42.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 2.89 108.287 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -56.21 -43.7 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 118.267 0.485 . . . . 1.42 110.162 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.66 88.15 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.696 -0.684 . . . . 0.72 112.668 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.92 -40.03 83.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 2.03 110.362 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 77' ' ' ILE . 63.9 t -65.29 -47.34 87.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.614 . . . . 1.08 110.825 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' HA ' HD12 ' A' ' 77' ' ' ILE . 57.6 t -64.9 -36.78 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.21 0.529 . . . . 0.72 110.071 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 t -61.58 -44.41 97.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.594 -0.73 . . . . 0.66 110.163 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.82 -42.54 93.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.227 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.522 HG23 HG21 ' A' ' 84' ' ' THR . 74.4 mt -58.9 -40.75 81.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.69 110.773 177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 mtm-85 -74.18 -39.36 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 3.09 110.976 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.68 10.47 9.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.65 111.609 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.74 -33.77 74.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.207 -0.52 . . . . 0.6 112.68 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.68 49.93 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 1.1 111.63 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.634 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 32.2 m-20 67.54 1.57 2.6 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.574 0.749 . . . . 2.12 112.485 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -151.6 154.28 36.13 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.825 -0.805 . . . . 2.11 108.825 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.522 HG21 HG23 ' A' ' 77' ' ' ILE . 12.9 t -141.51 148.11 38.86 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.04 0.448 . . . . 0.32 110.134 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 14' ' ' THR . 42.2 mttm -118.78 116.92 27.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.511 -0.551 . . . . 1.63 109.511 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.6 mt -106.53 131.27 53.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.434 -0.348 . . . . 0.28 110.128 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 10' ' ' PRO . 16.6 tp -103.79 117.12 33.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.934 -0.765 . . . . 0.51 108.934 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 20.7 m -126.75 151.81 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.142 0.496 . . . . 0.33 111.72 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.56 149.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.082 -0.963 . . . . 0.42 109.717 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.243 -0.651 . . . . 1.92 109.243 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -60.41 -43.89 96.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.89 0.33 . . . . 4.16 111.89 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.08 -35.69 78.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.433 . . . . 2.68 109.83 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 8' ' ' LEU . 89.6 m -69.3 -44.44 71.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.47 110.832 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.631 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 33.7 t0 -58.77 -47.71 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.938 -0.393 . . . . 1.18 109.938 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 50.1 mm-40 -61.1 -37.96 84.6 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.058 -0.519 . . . . 1.94 110.823 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.723 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 66.6 t80 -62.11 -48.0 82.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.175 -0.466 . . . . 0.73 110.672 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 102' ' ' VAL . 41.8 m-85 -67.34 -37.19 82.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.953 -0.567 . . . . 0.44 111.799 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.631 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 66.2 mttm -58.86 -50.82 72.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.051 0.453 . . . . 1.92 111.385 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 18.9 pttp -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 2.04 111.367 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.494 ' HB3' HG12 ' A' ' 102' ' ' VAL . 35.4 t -82.4 -6.61 59.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.862 0.363 . . . . 1.39 111.539 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER 56.68 40.65 29.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.638 -0.71 . . . . 4.09 111.677 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.535 HG13 ' CD2' ' A' ' 97' ' ' PHE . 5.7 p -126.46 145.12 34.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.357 -0.383 . . . . 1.42 110.492 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.38 121.66 67.21 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-O 120.979 0.419 . . . . 1.33 111.113 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.773 ' HG2' HG11 ' A' ' 58' ' ' VAL . 24.4 Cg_endo -65.71 138.53 54.16 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.537 2.158 . . . . 0.53 111.223 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.1 t -159.62 178.28 10.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.783 -0.451 . . . . 1.42 109.783 -175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.534 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 99.3 mt-30 -54.75 -30.46 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.301 0.572 . . . . 1.66 110.859 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.84 -30.39 67.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.616 -0.72 . . . . 2.82 111.465 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -89.02 -14.0 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.482 0.549 . . . . 0.53 112.482 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 95.8 mt -47.74 -54.54 11.9 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.348 0.405 . . . . 1.24 111.492 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -132.36 26.63 4.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.971 0.891 . . . . 3.7 109.442 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.95 165.75 23.22 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.016 -0.993 . . . . 1.12 110.776 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.74 124.9 12.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.221 1.947 . . . . 1.31 112.172 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.197 -0.668 . . . . 1.11 109.197 174.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.416 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 54.8 mt . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.29 0.567 . . . . 0.8 110.606 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -119.82 156.26 54.24 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 3.09 108.938 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' HD11 ' A' ' 87' ' ' LEU . 65.6 Cg_endo -71.58 -174.3 1.23 Allowed 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.356 2.038 . . . . 0.47 112.146 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.441 ' HG3' HG23 ' A' ' 88' ' ' VAL . 15.6 ptt85 -146.65 135.36 22.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.37 110.848 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.581 ' HG ' HD11 ' A' ' 109' ' ' LEU . 7.3 mt -92.85 121.7 34.49 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.542 . . . . 1.32 110.849 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.0 m -109.1 129.1 55.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.002 -0.544 . . . . 0.4 109.601 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -112.37 118.53 35.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.731 -0.47 . . . . 0.35 109.731 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 25.1 ptp -130.44 142.48 50.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.013 -0.365 . . . . 0.88 110.013 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 14.5 ptpt -121.12 156.52 32.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.003 0.43 . . . . 2.58 110.123 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.649 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 8.7 ttmt -61.37 117.17 5.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.797 -1.092 . . . . 0.92 111.651 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.66 -149.29 9.17 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.53 -0.759 . . . . 1.28 112.181 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.83 -33.07 27.98 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.676 2.251 . . . . 2.23 113.258 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -110.27 -21.09 12.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.17 0.509 . . . . 2.87 110.589 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.649 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 144.59 -116.3 0.93 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.131 -0.787 . . . . 1.93 111.131 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.26 160.71 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.72 -0.844 . . . . 1.82 108.72 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.14 71.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.599 -1.286 . . . . 0.43 113.462 -171.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -155.63 150.88 26.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.986 -0.376 . . . . 0.4 109.986 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.15 131.94 54.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 2.18 109.61 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.2 mt -101.3 136.93 40.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.367 -0.379 . . . . 1.52 110.414 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.1 p80 -124.47 125.17 43.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.116 0.484 . . . . 1.34 110.48 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.761 ' HB3' HE22 ' A' ' 35' ' ' GLN . 4.4 p . . . . . 0 C--N 1.32 -0.716 0 CA-C-N 115.338 -0.846 . . . . 2.3 110.692 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.761 HE22 ' HB3' ' A' ' 28' ' ' SER . 26.3 mm-40 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 110.029 -0.36 . . . . 1.5 110.029 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 41.0 m-85 -122.04 147.58 45.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.979 -0.748 . . . . 0.87 108.979 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.569 HG13 HD11 ' A' ' 51' ' ' LEU . 39.1 mm -77.39 105.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.445 -0.576 . . . . 0.39 109.445 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 49.1 ttt180 -75.12 -45.68 39.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.567 . . . . 2.83 110.027 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -149.19 146.35 27.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 1.26 109.474 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.9 132.37 71.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.49 126.28 92.23 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.858 -0.61 . . . . 2.28 110.693 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.45 124.03 15.27 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.657 2.238 . . . . 1.17 112.595 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 64.42 36.08 9.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.177 -0.92 . . . . 2.4 111.371 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 94.5 p -97.65 165.67 15.09 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.76 -0.654 . . . . 0.57 109.402 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 12.8 Cg_endo -58.63 -25.6 75.69 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.829 1.686 . . . . 0.65 111.276 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.42 -52.35 22.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.756 -0.656 . . . . 0.36 110.409 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.85 -36.0 82.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.811 0.338 . . . . 2.01 110.457 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.82 65.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.47 112.016 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -80.98 -13.45 58.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.966 0.412 . . . . 0.4 110.51 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 26.6 6.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.855 -0.612 . . . . 0.62 112.409 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.569 HD11 HG13 ' A' ' 37' ' ' ILE . 28.1 tp -94.9 133.25 38.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.65 110.473 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -122.49 158.8 29.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.738 -0.467 . . . . 4.38 109.738 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.16 29.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.043 0.386 . . . . 1.44 112.043 -174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -132.99 1.17 3.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 3.06 109.707 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 35.7 m-20 -88.29 154.35 20.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.556 -0.747 . . . . 1.02 111.235 -171.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 18.4 ttm180 -116.54 135.04 54.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.407 -0.59 . . . . 1.57 109.407 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.99 123.13 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.65 -0.5 . . . . 0.68 109.65 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.86 -44.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.251 -0.431 . . . . 0.87 110.42 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 34.9 mt-10 -134.48 143.53 47.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.89 110.029 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.96 117.75 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.685 -0.487 . . . . 0.66 109.685 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.59 30.29 19.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.48 0.487 . . . . 1.17 110.945 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 -6.17 79.29 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.068 -0.587 . . . . 0.66 112.974 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -95.88 124.15 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 0.231 . . . . 1.17 110.557 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.543 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.2 t -66.22 136.93 56.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 1.68 111.188 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.451 ' HA ' ' CG ' ' A' ' 68' ' ' LYS . 21.4 mmt -118.09 2.22 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.81 111.82 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 97.88 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.357 -0.608 . . . . 3.75 109.357 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.88 12.94 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.47 111.659 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 65' ' ' MET . 34.7 mmtp -84.01 166.78 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 3.36 110.877 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -94.29 174.21 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.645 . . . . 2.89 110.83 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -57.53 -43.06 84.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 1.42 110.359 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.04 96.77 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.72 113.549 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.51 -40.61 76.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.605 0.241 . . . . 2.03 110.897 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.65 -47.26 92.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 1.08 110.552 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.48 -42.31 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.72 110.881 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -61.53 -39.94 92.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 0.66 110.941 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.83 94.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.42 111.755 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG23 HG21 ' A' ' 84' ' ' THR . 72.4 mt -60.26 -45.18 96.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.231 0.539 . . . . 0.69 110.075 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -66.0 -30.95 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.608 -0.723 . . . . 3.09 110.895 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.23 -5.53 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.721 -0.672 . . . . 0.65 111.318 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.28 79.17 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.554 -0.831 . . . . 0.6 111.478 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.32 -100.4 2.08 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.106 -0.568 . . . . 1.1 111.9 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.554 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 18.8 m-20 -119.23 -27.66 5.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.648 0.261 . . . . 2.12 110.795 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.6 mt-10 -120.15 139.81 52.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.299 -1.0 . . . . 2.11 108.299 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.437 HG21 HG23 ' A' ' 77' ' ' ILE . 13.8 t -138.02 149.65 46.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.818 0.342 . . . . 0.32 110.954 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 121.08 42.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.149 -0.478 . . . . 1.63 110.477 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.3 mt -107.14 135.65 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.156 -0.475 . . . . 0.28 109.889 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.5 tp -104.24 119.34 38.74 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.202 -0.666 . . . . 0.51 109.202 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.0 m -126.95 163.31 29.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.231 -0.44 . . . . 0.33 111.08 -175.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.99 149.54 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.42 111.229 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -90.41 175.57 7.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 1.92 110.117 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 91' ' ' ARG . 25.2 ttm180 -58.48 -48.98 78.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 4.16 111.045 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.1 mp0 -63.8 -41.01 97.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 2.68 110.203 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 m -62.04 -51.42 68.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.47 110.471 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.23 -43.86 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.137 -0.938 . . . . 1.18 111.708 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 13.6 mm-40 -60.42 -45.68 92.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.207 -0.451 . . . . 1.94 110.738 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -63.09 -47.63 82.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.495 0.497 . . . . 0.73 111.336 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -65.89 -40.45 91.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.487 -0.324 . . . . 0.44 111.613 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -66.17 -44.59 83.62 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.988 -0.285 . . . . 1.92 111.615 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.3 ptmt -70.27 -26.53 63.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.635 0.255 . . . . 2.04 111.087 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.5 t -93.75 -3.56 51.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.345 0.593 . . . . 1.39 110.395 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.54 47.2 13.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.11 -0.95 . . . . 4.09 110.918 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.82 137.9 53.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 1.42 110.204 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 55.5 mt -88.99 125.49 62.24 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.985 -0.376 . . . . 1.33 109.985 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 27.6 Cg_exo -61.9 154.23 62.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.97 2.447 . . . . 0.53 112.07 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.7 p -163.46 167.21 21.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.612 -0.267 . . . . 1.42 111.142 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -57.47 -29.3 64.13 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.732 0.645 . . . . 1.66 111.405 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.44 -34.23 70.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 2.82 110.49 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -75.8 -14.6 60.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.024 -0.989 . . . . 0.53 111.101 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' A' ' 12' ' ' LEU . 89.5 mt -73.92 -32.51 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 1.24 110.776 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.14 -36.65 74.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 3.7 111.866 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.44 -80.69 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.558 -1.306 . . . . 1.12 113.863 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.0 132.83 29.21 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.223 2.615 . . . . 1.31 114.386 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 114.846 -1.07 . . . . 1.11 108.912 171.112 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' A' ' 96' ' ' PHE . 71.6 mt . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.96 0.41 . . . . 0.8 111.617 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.537 ' HB3' HD21 ' A' ' 113' ' ' LEU . 27.5 ptt180 -125.96 154.21 73.78 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.975 -0.38 . . . . 3.09 109.975 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 48.4 Cg_endo -64.73 178.85 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.018 2.479 . . . . 0.47 113.231 -172.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.66 HH12 ' HB3' ' A' ' 90' ' ' ASP . 7.8 ptp85 -137.76 131.98 32.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.988 -0.551 . . . . 2.37 110.304 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.565 ' HG ' HD11 ' A' ' 109' ' ' LEU . 4.7 mt -93.59 111.01 22.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.32 110.169 176.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 37.2 m -94.68 116.92 29.33 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.489 -0.56 . . . . 0.4 109.489 177.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -105.96 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.675 -0.861 . . . . 0.35 108.675 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.55 ' HE3' HD12 ' A' ' 86' ' ' LEU . 24.9 ptp -135.73 134.92 39.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.953 0.406 . . . . 0.88 110.806 -171.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 23.0 ttpp -92.49 147.09 23.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 2.58 109.209 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 ttmt -59.62 123.46 16.98 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.129 -0.487 . . . . 0.92 111.559 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.51 -157.36 21.51 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.389 -0.684 . . . . 1.28 111.389 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.26 -36.68 27.23 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.159 2.573 . . . . 2.23 113.233 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -93.8 21.29 6.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.87 111.595 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.32 69.68 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.597 -0.811 . . . . 1.93 111.273 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 74.89 -50.8 0.67 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.662 0.785 . . . . 1.82 110.739 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 69.66 0.93 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.151 -0.547 . . . . 0.43 113.347 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.33 168.88 25.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.013 -0.365 . . . . 0.4 110.013 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 20.0 t-20 -133.76 127.19 32.24 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 2.18 109.699 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.31 143.78 30.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.232 -0.44 . . . . 1.52 110.632 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.565 ' CD2' ' HB2' ' A' ' 36' ' ' PHE . 2.6 p80 -125.89 130.7 51.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.8 -0.445 . . . . 1.34 109.8 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 115.618 -0.719 . . . . 2.3 109.844 -177.808 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.778 0.323 . . . . 1.5 110.687 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.565 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 31.1 m-85 -114.27 142.99 45.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.384 -0.599 . . . . 0.87 109.384 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.528 HG13 HD11 ' A' ' 51' ' ' LEU . 32.9 mm -74.32 106.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.43 -0.582 . . . . 0.39 109.43 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 52.0 ttt180 -69.65 -51.85 31.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.75 -0.659 . . . . 2.83 110.382 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -163.32 135.38 5.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.985 -0.552 . . . . 1.26 110.309 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.5 134.29 37.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.43 -0.952 . . . . 0.37 108.43 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.2 m-20 -64.67 128.09 93.15 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.956 -0.387 . . . . 2.28 109.956 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 52.4 Cg_exo -54.54 130.02 37.91 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.171 2.581 . . . . 1.17 113.182 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.61 38.37 12.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.357 -0.838 . . . . 2.4 110.81 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 79.0 p -97.76 164.7 16.94 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.13 -0.486 . . . . 0.57 109.693 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.4 Cg_endo -55.85 -34.17 90.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.751 1.634 . . . . 0.65 111.125 172.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.84 -46.39 85.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.826 -0.624 . . . . 0.36 110.244 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.27 -43.47 98.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.014 -0.539 . . . . 2.01 110.337 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.85 63.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.47 111.988 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.7 p -76.39 -14.83 60.05 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.4 110.526 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.12 9.07 24.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.782 -0.723 . . . . 0.62 112.333 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD11 HG13 ' A' ' 37' ' ' ILE . 37.1 tp -79.79 128.06 32.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.85 0.357 . . . . 0.65 110.115 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -123.42 -170.53 2.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.061 -0.518 . . . . 4.38 110.222 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -95.65 151.65 19.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.673 -0.694 . . . . 1.44 110.29 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 54.7 mt-30 73.02 25.05 2.41 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.825 0.703 . . . . 3.06 110.96 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -95.81 155.25 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.243 -0.651 . . . . 1.02 109.243 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -124.69 129.55 50.72 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.603 -0.517 . . . . 1.57 109.603 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.3 mt -73.41 132.06 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.68 111.605 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.594 HG11 ' HB2' ' A' ' 104' ' ' PRO . 21.4 t -113.97 -47.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.415 -0.811 . . . . 0.87 110.443 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.1 mt-10 -132.8 149.51 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.89 110.644 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.81 117.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.66 109.637 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 57.24 34.21 24.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.986 -0.552 . . . . 1.17 111.041 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 89.43 -4.63 84.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.925 -0.655 . . . . 0.66 113.084 176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.84 127.21 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.96 -0.385 . . . . 1.17 109.96 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 41.8 t -74.25 135.39 42.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.992 0.425 . . . . 1.68 110.369 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.806 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.5 mmt -116.79 30.15 7.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.81 110.415 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HG2' HD12 ' A' ' 103' ' ' ILE . 21.5 tp10 -70.51 -34.42 72.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 3.75 110.943 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.11 -0.45 28.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.645 -0.788 . . . . 1.47 112.305 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.806 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.3 mmtp -71.95 168.73 17.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.762 0.792 . . . . 3.36 112.791 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -106.12 169.81 8.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.518 -1.219 . . . . 2.89 109.844 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -54.42 -43.93 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 1.42 111.597 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.42 85.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.128 -0.558 . . . . 0.72 113.387 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.97 -42.63 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.021 0.438 . . . . 2.03 110.34 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 65' ' ' MET . 59.0 t -68.26 -47.18 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 1.08 111.174 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.1 -38.55 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 0.72 111.048 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -67.94 -36.69 80.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.66 110.497 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.446 -0.343 . . . . 0.42 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.552 HG23 HG21 ' A' ' 84' ' ' THR . 78.6 mt -58.38 -42.06 83.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.446 0.641 . . . . 0.69 110.41 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -74.6 -31.69 62.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 3.09 111.44 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 5.48 18.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.65 111.325 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -13.37 83.23 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.682 -0.771 . . . . 0.6 112.009 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -111.43 3.1 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.981 -0.628 . . . . 1.1 111.699 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 14.0 m-20 -115.03 -6.64 12.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.908 0.385 . . . . 2.12 110.503 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -143.8 157.01 44.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.594 . . . . 2.11 109.622 173.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.552 HG21 HG23 ' A' ' 77' ' ' ILE . 11.9 t -137.57 149.73 46.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 0.32 110.072 -175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -115.63 116.85 28.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.126 -0.488 . . . . 1.63 109.796 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HE3' ' A' ' 15' ' ' MET . 78.0 mt -107.85 130.92 54.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.908 -0.587 . . . . 0.28 109.836 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 10' ' ' PRO . 20.8 tp -104.59 115.21 29.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.814 -0.81 . . . . 0.51 108.814 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.5 m -127.54 159.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.191 -0.459 . . . . 0.33 111.377 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.39 150.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.734 . . . . 0.42 110.031 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.66 ' HB3' HH12 ' A' ' 11' ' ' ARG . 4.3 p30 -88.85 176.51 7.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 1.92 109.975 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.5 ttp180 -55.78 -49.99 71.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.755 0.65 . . . . 4.16 112.755 -172.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.555 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 14.2 pt-20 -74.85 -34.35 62.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 2.68 111.139 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.9 m -64.9 -41.92 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.02 -0.537 . . . . 0.47 110.12 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 33.2 t70 -62.49 -38.05 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.608 . . . . 1.18 109.963 177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 48.0 mt-10 -67.2 -35.52 79.79 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.144 -0.48 . . . . 1.94 110.745 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.86 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 59.7 t80 -62.99 -49.62 73.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.896 0.379 . . . . 0.73 110.318 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.458 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 27.8 m-85 -68.14 -38.86 82.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.911 -0.586 . . . . 0.44 112.06 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -64.61 -48.91 73.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.848 0.314 . . . . 1.92 111.848 -176.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 22.4 pttp -67.63 -34.18 76.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.113 0.483 . . . . 2.04 110.427 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 67.8 m -75.22 -8.69 57.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.511 -0.768 . . . . 1.39 112.048 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 55.86 32.82 20.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.312 0.645 . . . . 4.09 111.734 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 97' ' ' PHE . 5.8 p -120.36 142.1 37.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.251 -0.431 . . . . 1.42 110.228 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.565 HD12 ' HG2' ' A' ' 66' ' ' GLU . 45.9 mm -86.75 127.28 60.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 1.33 110.625 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.594 ' HB2' HG11 ' A' ' 58' ' ' VAL . 16.9 Cg_exo -65.55 155.13 70.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.824 2.349 . . . . 0.53 111.37 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.7 p -169.06 168.41 10.07 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.554 -0.459 . . . . 1.42 111.807 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.552 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 40.0 mt-30 -57.0 -29.42 63.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 1.66 111.273 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.93 -32.71 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.272 0.558 . . . . 2.82 110.34 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -77.86 -13.7 59.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.53 111.164 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.565 HD11 ' HG ' ' A' ' 12' ' ' LEU . 86.1 mt -75.19 -40.62 59.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 1.24 111.126 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -106.28 13.03 29.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.199 0.523 . . . . 3.7 110.521 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.62 -172.1 12.42 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.827 -0.701 . . . . 1.12 111.82 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -88.97 -179.59 2.16 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.213 2.609 . . . . 1.31 112.258 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 9' ' ' ARG . 53.7 mt . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.09 -0.504 . . . . 1.11 109.761 175.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.264 0.554 . . . . 0.8 110.59 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -126.54 157.02 72.18 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 3.09 109.433 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HB2' HD11 ' A' ' 87' ' ' LEU . 44.4 Cg_endo -70.15 174.73 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.328 2.019 . . . . 0.47 111.782 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.452 ' HG3' HG23 ' A' ' 88' ' ' VAL . 7.0 ptp85 -132.02 130.6 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.261 -0.427 . . . . 2.37 110.162 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.9 118.1 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 1.32 110.182 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 12.8 m -108.88 117.49 34.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.215 -0.448 . . . . 0.4 110.305 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -108.9 117.55 34.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.225 -1.028 . . . . 0.35 108.225 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.582 ' HE3' HD12 ' A' ' 86' ' ' LEU . 23.0 ptp -131.15 144.63 51.52 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.744 -0.383 . . . . 0.88 111.164 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HG3' ' HG2' ' A' ' 83' ' ' GLU . 7.5 ttmm -118.89 146.0 45.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.614 -0.721 . . . . 2.58 109.705 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 85.5 mttt -56.32 119.47 6.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.361 -0.836 . . . . 0.92 112.188 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.37 -111.0 3.1 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.575 -1.193 . . . . 1.28 112.282 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.49 -74.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.243 2.629 . . . . 2.23 112.669 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -132.93 83.85 2.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.87 110.495 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.97 71.29 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.004 -0.617 . . . . 1.93 112.535 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.553 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 36.2 m-85 67.23 -87.3 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.047 0.539 . . . . 1.82 110.774 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.45 70.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.625 -0.798 . . . . 0.43 112.646 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.94 151.91 26.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.4 109.271 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.24 123.65 45.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.207 -0.664 . . . . 2.18 109.207 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 35' ' ' GLN . 30.3 tp -108.77 146.14 34.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.058 -0.519 . . . . 1.52 109.62 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.45 149.25 27.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.624 -0.43 . . . . 1.34 111.435 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 109.166 -0.679 . . . . 2.3 109.166 174.12 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.52 ' HB3' HD11 ' A' ' 26' ' ' LEU . 27.6 mm-40 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.13 -0.322 . . . . 1.5 110.13 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -109.92 140.59 43.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.87 110.554 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.543 HG13 HD11 ' A' ' 51' ' ' LEU . 36.9 mm -81.21 105.76 11.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.846 -0.798 . . . . 0.39 108.846 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.02 -55.28 19.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.507 . . . . 2.83 110.106 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 m -157.87 137.77 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.854 -0.612 . . . . 1.26 109.482 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.31 133.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.145 -0.687 . . . . 0.37 109.145 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.82 128.92 92.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.014 -0.539 . . . . 2.28 109.774 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 125.41 19.02 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.753 2.302 . . . . 1.17 113.063 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 63.14 43.46 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.934 -1.03 . . . . 2.4 110.76 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.6 p -102.64 165.3 13.99 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.592 . . . . 0.57 110.639 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 31.6 Cg_exo -56.11 -34.38 92.68 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.888 1.725 . . . . 0.65 111.168 172.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.31 86.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.596 -0.729 . . . . 0.36 110.186 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -61.06 -42.44 98.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 2.01 110.132 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.37 -30.02 68.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.817 -0.629 . . . . 0.47 112.069 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.2 p -70.96 -20.0 62.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.368 . . . . 0.4 110.626 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.19 9.7 15.03 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.792 -0.718 . . . . 0.62 112.803 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.543 HD11 HG13 ' A' ' 37' ' ' ILE . 27.9 tp -69.33 125.17 25.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.65 110.685 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 30.5 ttm180 -103.85 147.89 26.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.804 -0.634 . . . . 4.38 109.918 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -74.77 144.21 43.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 1.44 110.092 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 15.4 mm-40 78.87 5.88 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.099 0.875 . . . . 3.06 111.31 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -85.12 149.93 25.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.693 -0.484 . . . . 1.02 109.693 176.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' HD3' HH11 ' A' ' 56' ' ' ARG . 34.9 ttp180 -111.87 137.48 49.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.57 110.258 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HA ' HG12 ' A' ' 88' ' ' VAL . 65.2 mt -74.56 128.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.985 -0.552 . . . . 0.68 110.627 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.403 HG23 HD23 ' A' ' 87' ' ' LEU . 19.0 m -112.42 -32.89 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 0.87 111.21 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 27.4 mt-10 -134.38 142.85 47.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.89 110.833 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.56 120.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.66 109.797 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 85' ' ' LYS . 73.8 m-20 58.68 24.57 12.31 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.088 0.555 . . . . 1.17 111.512 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.494 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.61 6.53 63.96 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.66 112.915 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.47 124.18 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 1.17 110.393 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.2 p -64.58 136.94 57.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.636 . . . . 1.68 111.215 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.706 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.1 mmt -123.68 50.99 1.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.968 -0.56 . . . . 0.81 111.074 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -36.11 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.922 -0.311 . . . . 3.75 111.514 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.38 -7.52 54.17 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.842 -0.694 . . . . 1.47 111.857 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.706 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.7 mmtp -70.71 149.16 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.223 0.535 . . . . 3.36 111.436 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -86.45 170.62 11.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.367 -0.833 . . . . 2.89 109.983 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -53.86 -43.52 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.657 0.265 . . . . 1.42 111.241 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.03 99.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.045 -0.598 . . . . 0.72 113.125 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 6.3 t70 -64.78 -43.97 91.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.913 0.387 . . . . 2.03 110.216 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 65' ' ' MET . 46.5 t -63.55 -46.86 93.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 1.08 111.015 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 97.7 t -66.68 -42.5 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.72 111.114 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -64.51 -38.27 90.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.46 -0.336 . . . . 0.66 110.387 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.09 93.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 0.42 111.135 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 84' ' ' THR . 81.4 mt -61.15 -45.77 97.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.018 0.437 . . . . 0.69 110.621 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 29.6 mtm180 -66.15 -33.2 75.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 3.09 110.366 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.42 -0.36 36.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.952 -0.567 . . . . 0.65 111.501 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.26 85.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.606 -0.807 . . . . 0.6 111.695 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.29 -127.24 9.1 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.208 -0.757 . . . . 1.1 111.208 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 42.1 m-20 -96.73 -12.97 23.04 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.032 -0.267 . . . . 2.12 110.78 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -130.61 140.82 50.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.989 -0.375 . . . . 2.11 109.989 177.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 77' ' ' ILE . 14.4 t -135.09 149.62 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.957 0.408 . . . . 0.32 110.36 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 61' ' ' ASN . 95.0 mttt -106.31 117.81 35.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.248 -0.433 . . . . 1.63 110.289 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD12 ' HE3' ' A' ' 15' ' ' MET . 85.0 mt -111.53 124.91 53.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.145 -0.479 . . . . 0.28 109.815 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 34.8 tp -104.36 122.25 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.029 -0.73 . . . . 0.51 109.029 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 10.5 m -130.15 164.58 32.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.208 -0.451 . . . . 0.33 111.369 -174.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 m -136.72 145.79 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.658 -0.701 . . . . 0.42 110.874 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.72 167.74 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.548 -0.751 . . . . 1.92 109.473 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -56.59 -47.79 78.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.653 0.263 . . . . 4.16 111.22 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -63.45 -31.42 72.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.347 0.594 . . . . 2.68 110.086 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 m -76.54 -50.8 13.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.47 111.021 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.7 -47.67 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.865 -0.607 . . . . 1.18 111.656 -174.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 31.7 mt-10 -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.721 -0.391 . . . . 1.94 110.767 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.38 -46.09 70.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.937 0.398 . . . . 0.73 110.356 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 102' ' ' VAL . 22.9 m-85 -64.34 -44.24 92.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.008 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -61.42 -45.33 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.561 0.578 . . . . 1.92 112.561 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 18.1 ptpt -65.47 -25.6 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 2.04 110.955 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.2 t -96.69 0.84 50.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 1.39 110.645 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? 64.63 31.27 12.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.028 -0.533 . . . . 4.09 111.716 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 35.0 t -109.82 139.6 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.491 -0.322 . . . . 1.42 110.416 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.35 125.95 50.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.93 -0.396 . . . . 1.33 109.93 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HB2' HG21 ' A' ' 58' ' ' VAL . 18.8 Cg_exo -65.62 139.53 58.68 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.464 2.11 . . . . 0.53 111.42 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -154.01 166.93 31.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 1.42 110.73 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.494 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 41.2 mt-30 -57.31 -31.98 66.21 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.441 0.463 . . . . 1.66 111.049 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.38 -30.78 70.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.441 -0.345 . . . . 2.82 111.3 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.37 -13.83 61.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.53 111.403 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.31 -25.43 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.2 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -130.4 -14.89 3.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.496 -0.32 . . . . 3.7 111.584 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.35 -177.11 34.44 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.866 -0.683 . . . . 1.12 112.438 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.41 124.26 10.65 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.131 2.554 . . . . 1.31 112.866 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 113' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.444 -0.762 0 CA-C-N 115.96 -0.564 . . . . 1.11 109.825 169.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.948 0.404 . . . . 0.8 110.901 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 15.9 ptp180 -119.7 147.02 42.94 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.322 -0.399 . . . . 3.09 109.998 -177.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HD2' ' HA ' ' A' ' 109' ' ' LEU . 2.9 Cg_exo -72.26 165.14 33.53 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.899 2.399 . . . . 0.47 111.358 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.79 ' HG3' HG23 ' A' ' 88' ' ' VAL . 5.5 ptt180 -122.9 131.0 53.54 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.663 -0.699 . . . . 2.37 110.627 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.06 113.3 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 1.32 110.03 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 30.5 m -96.87 128.74 44.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.832 -0.622 . . . . 0.4 110.22 -176.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -117.79 117.49 29.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.35 108.91 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.527 ' HE3' HD12 ' A' ' 86' ' ' LEU . 22.5 ptp -142.21 142.55 32.67 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.181 -0.463 . . . . 0.88 110.194 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 43.4 pttt -119.34 152.53 36.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.311 0.577 . . . . 2.58 110.735 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.617 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.1 mtmt -55.55 110.45 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.347 -1.297 . . . . 0.92 112.601 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.09 -129.82 6.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.272 -0.876 . . . . 1.28 112.145 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.29 -75.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.35 2.7 . . . . 2.23 113.616 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -96.91 34.05 1.78 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.891 0.377 . . . . 2.87 111.329 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.617 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 71.77 83.86 0.23 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.585 -0.817 . . . . 1.93 111.755 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.45 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 39.3 m-85 68.07 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.268 0.627 . . . . 1.82 110.638 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.16 68.11 0.38 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.259 -0.496 . . . . 0.43 112.572 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -157.34 153.23 27.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.928 -0.397 . . . . 0.4 109.928 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.36 141.41 40.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 2.18 110.626 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 26' ' ' LEU . 48.6 mt -101.52 154.91 18.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.624 -0.716 . . . . 1.52 111.715 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 2.2 t-80 -105.67 141.81 36.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.188 -0.915 . . . . 1.34 110.459 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.943 -0.571 . . . . 2.3 110.454 -179.343 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.126 0.489 . . . . 1.5 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 38.9 m-85 -102.8 149.92 24.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.87 109.599 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 51' ' ' LEU . 48.5 mm -84.45 105.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.645 -0.502 . . . . 0.39 109.645 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -70.13 -39.75 75.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.693 -0.685 . . . . 2.83 110.033 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 p -165.73 152.2 9.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 1.26 109.825 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.08 128.63 74.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.37 109.348 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -70.86 135.88 85.41 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.327 -0.397 . . . . 2.28 110.672 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.84 143.1 78.73 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.886 2.391 . . . . 1.17 112.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 61.8 42.13 10.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.502 -0.772 . . . . 2.4 111.202 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.1 p -118.18 159.34 43.62 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 0.57 110.297 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 44.7 Cg_exo -51.15 -39.37 61.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.406 2.071 . . . . 0.65 111.419 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.3 -52.31 64.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.461 -0.791 . . . . 0.36 110.864 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -63.41 -39.63 95.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.171 -0.468 . . . . 2.01 110.601 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.06 77.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 0.47 111.866 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -70.84 -13.69 62.13 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.982 0.42 . . . . 0.4 110.955 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.1 14.59 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.632 -0.794 . . . . 0.62 113.015 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 37' ' ' ILE . 29.2 tp -76.02 123.83 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.65 110.297 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 52' ' ' ARG . 21.9 ttt180 -110.28 148.51 31.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.887 -0.597 . . . . 4.38 110.117 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -68.79 148.23 50.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.203 -0.453 . . . . 1.44 110.219 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 78.4 mt-30 78.62 0.7 2.54 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.194 0.934 . . . . 3.06 111.27 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 15.3 m-20 -78.58 143.43 36.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.726 0.298 . . . . 1.02 110.603 177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 56' ' ' ARG . 36.8 ttp-105 -104.69 133.52 49.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.824 0.345 . . . . 1.57 110.573 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.84 123.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.991 -0.549 . . . . 0.68 109.735 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' HG2' ' A' ' 104' ' ' PRO . 42.2 t -101.86 -46.55 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.268 0.556 . . . . 0.87 110.584 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 32.7 mt-10 -129.92 145.51 51.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.698 . . . . 0.89 110.083 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.405 HG11 HD13 ' A' ' 77' ' ' ILE . 24.8 t -125.59 130.59 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.606 -0.516 . . . . 0.66 109.606 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.36 8.84 5.97 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.423 0.452 . . . . 1.17 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 9.56 62.99 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.826 -0.702 . . . . 0.66 111.593 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.78 131.03 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.585 0.354 . . . . 1.17 110.171 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.545 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 44.1 t -70.1 136.29 50.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.999 -0.546 . . . . 1.68 111.426 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.803 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.5 mmt -119.91 69.43 0.85 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.81 110.583 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -98.07 -62.15 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 3.75 110.367 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.26 41.4 2.41 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.618 -0.593 . . . . 1.47 111.618 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.803 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.4 mmtp -107.42 -178.5 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.064 -0.347 . . . . 3.36 110.064 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -125.61 172.28 9.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.605 -0.27 . . . . 2.89 110.972 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -54.68 -44.21 73.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.518 0.511 . . . . 1.42 111.366 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.43 84.45 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.993 -0.622 . . . . 0.72 113.039 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.776 0.322 . . . . 2.03 110.662 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.93 -45.5 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 1.08 110.778 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.65 -36.64 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.294 -0.412 . . . . 0.72 110.905 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -65.87 -36.15 82.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.855 -0.424 . . . . 0.66 109.855 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.1 79.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.584 . . . . 0.42 111.072 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 60' ' ' VAL . 18.8 mm -57.56 -44.49 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.546 0.688 . . . . 0.69 109.464 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.52 -29.22 59.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.001 -1.0 . . . . 3.09 110.936 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.86 44.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.65 111.84 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.8 -12.35 83.0 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.448 -0.882 . . . . 0.6 111.867 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 -125.92 8.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.974 -0.851 . . . . 1.1 110.974 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 60.2 m-20 -94.6 -16.85 22.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.943 0.372 . . . . 2.12 110.042 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.639 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 7.4 mt-10 -119.55 140.34 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.109 -0.7 . . . . 2.11 109.109 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -129.77 145.52 51.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.026 0.441 . . . . 0.32 110.511 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.5 mttm -113.62 117.77 32.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.913 -0.585 . . . . 1.63 109.825 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.527 HD12 ' HE3' ' A' ' 15' ' ' MET . 81.1 mt -109.91 135.86 50.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.861 -0.608 . . . . 0.28 110.159 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 10' ' ' PRO . 52.9 tp -104.55 117.09 33.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.09 -0.505 . . . . 0.51 109.884 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.79 HG23 ' HG3' ' A' ' 11' ' ' ARG . 7.2 m -127.95 159.36 39.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.33 110.72 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -128.83 148.1 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.0 -0.545 . . . . 0.42 110.747 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.16 172.62 12.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.288 -0.634 . . . . 1.92 109.288 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.0 ttp180 -61.0 -49.1 78.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.612 0.244 . . . . 4.16 110.709 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -35.97 82.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.061 0.458 . . . . 2.68 110.322 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -64.32 -51.44 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.47 111.194 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.73 -33.99 76.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.18 111.445 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 12.5 mm-40 -64.17 -41.56 97.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.895 0.379 . . . . 1.94 110.056 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.715 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 70.2 t80 -63.28 -47.83 80.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.73 111.367 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -66.76 -38.82 87.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.514 -0.312 . . . . 0.44 111.776 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.1 -41.82 85.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.376 0.51 . . . . 1.92 112.376 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 58.6 pttt -68.24 -14.48 63.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 2.04 111.229 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.427 ' HB3' HG12 ' A' ' 102' ' ' VAL . 34.4 t -109.04 -11.4 14.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.274 0.559 . . . . 1.39 109.574 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 65.38 35.29 7.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.761 -1.108 . . . . 4.09 111.371 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' A' ' 100' ' ' CYS . 3.1 p -118.45 126.93 75.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 1.42 110.124 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -72.15 128.29 89.26 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.33 110.753 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' ' 58' ' ' VAL . 34.1 Cg_endo -67.65 143.9 63.98 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.734 2.289 . . . . 0.53 111.355 176.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 m -151.23 174.72 12.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 110.024 -0.362 . . . . 1.42 110.024 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.608 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 43.0 mt-30 -57.59 -40.3 78.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.926 0.393 . . . . 1.66 111.166 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.5 mp0 -59.22 -35.27 73.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.293 0.568 . . . . 2.82 110.259 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -73.9 -31.52 63.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.564 -0.743 . . . . 0.53 111.525 -177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.4 pp -88.51 -16.53 32.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 1.24 110.864 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.77 -8.16 59.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.131 -0.486 . . . . 3.7 111.24 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.89 -74.36 0.21 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.03 -1.081 . . . . 1.12 113.723 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.17 116.08 4.54 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.344 2.696 . . . . 1.31 114.12 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.326 -0.852 . . . . 1.11 109.698 171.616 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 121.348 0.594 . . . . 0.8 110.315 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -125.78 147.57 59.15 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.655 -0.702 . . . . 3.09 109.731 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.8 Cg_endo -66.01 159.76 47.68 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.298 1.998 . . . . 0.47 111.183 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.3 ptt85 -121.37 132.55 54.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.037 -0.529 . . . . 2.37 110.396 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -92.72 111.86 23.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.729 -0.669 . . . . 1.32 109.767 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 18.0 m -89.63 117.73 28.72 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.091 -0.707 . . . . 0.4 109.091 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' LYS . 24.4 m -109.85 118.25 36.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.601 -0.518 . . . . 0.35 109.601 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.672 ' HE3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -131.17 132.93 45.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.88 110.677 -175.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 3.4 ttmp? -109.12 128.69 55.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 2.58 109.529 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.4 ttmt -51.59 130.08 27.2 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.041 -0.981 . . . . 0.92 112.768 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.09 -147.57 22.82 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.956 -0.858 . . . . 1.28 110.956 170.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.71 -28.8 6.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.879 2.386 . . . . 2.23 112.841 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -94.28 -27.2 16.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.364 0.505 . . . . 2.87 112.364 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.57 64.79 0.59 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.8 -0.714 . . . . 1.93 112.775 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.542 ' O ' ' HB2' ' A' ' 44' ' ' SER . 26.4 m-85 74.51 -74.58 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.629 0.772 . . . . 1.82 111.013 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.96 69.07 0.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.64 . . . . 0.43 113.007 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -155.71 154.76 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.8 -0.445 . . . . 0.4 109.8 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.77 127.16 55.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.77 0.319 . . . . 2.18 110.586 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.47 137.75 39.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 1.52 110.09 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.497 ' NE2' ' HB2' ' A' ' 36' ' ' PHE . 11.6 p80 -125.7 138.81 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.46 -0.496 . . . . 1.34 110.705 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 115.265 -0.879 . . . . 2.3 108.891 178.25 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.514 -0.441 0 CA-C-O 121.195 0.521 . . . . 1.5 111.036 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 52.9 m-85 -125.43 150.55 47.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.715 -0.846 . . . . 0.87 108.715 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.473 HG13 HD11 ' A' ' 51' ' ' LEU . 35.2 mm -75.85 111.17 11.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.839 -0.43 . . . . 0.39 109.839 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 23.3 tpt180 -68.64 -57.05 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 2.83 110.028 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 49.6 m -160.63 140.57 11.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.47 -0.786 . . . . 1.26 109.041 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.18 132.92 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.6 -0.889 . . . . 0.37 108.6 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.478 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 3.2 t70 -83.86 116.24 63.76 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.256 -0.429 . . . . 2.28 109.998 -173.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 9.2 Cg_endo -53.64 150.84 26.89 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.721 2.28 . . . . 1.17 111.904 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 64.36 56.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.051 0.929 . . . . 2.4 109.96 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 87.9 p -145.65 156.27 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.187 -0.915 . . . . 0.57 109.843 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.3 Cg_endo -61.2 -23.9 78.03 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.501 2.134 . . . . 0.65 111.177 172.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.672 ' HA ' ' HE3' ' A' ' 15' ' ' MET . . . -69.09 -52.1 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.464 . . . . 0.36 110.558 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.761 -0.459 . . . . 2.01 109.761 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.69 -35.31 72.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.794 -0.639 . . . . 0.47 112.064 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.0 p -70.02 -19.44 63.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.861 0.362 . . . . 0.4 111.247 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.33 47.69 1.11 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.751 . . . . 0.62 112.468 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 HG13 ' A' ' 37' ' ' ILE . 34.6 tp -108.01 137.94 45.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.143 -0.317 . . . . 0.65 110.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -118.95 153.09 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.754 -0.462 . . . . 4.38 109.754 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -81.78 34.93 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.519 0.562 . . . . 1.44 112.519 -173.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -152.73 17.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 3.06 110.825 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.6 m-20 -94.48 159.68 14.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.92 -0.582 . . . . 1.02 110.45 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 56' ' ' ARG . 30.5 ttp180 -115.22 137.62 51.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.418 -0.586 . . . . 1.57 109.418 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.56 126.73 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.98 -0.555 . . . . 0.68 110.887 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.21 -42.01 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.87 110.736 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.9 mt-10 -131.82 143.05 49.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.39 -0.368 . . . . 0.89 110.745 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.46 111.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.323 -0.621 . . . . 0.66 109.323 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.67 29.68 19.18 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.374 0.421 . . . . 1.17 111.36 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.2 -7.44 78.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.66 112.577 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.65 121.4 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.809 -0.441 . . . . 1.17 109.809 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.42 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 37.0 t -80.1 122.66 27.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.156 0.503 . . . . 1.68 110.322 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.584 ' SD ' HG22 ' A' ' 73' ' ' VAL . 22.9 mmt -94.75 56.13 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.423 0.63 . . . . 0.81 110.331 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.82 68.79 3.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.25 -0.886 . . . . 3.75 110.958 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.11 27.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 1.47 112.127 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 75.7 mmtt -69.3 152.92 44.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.312 0.577 . . . . 3.36 111.142 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.52 153.55 24.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.19 -0.914 . . . . 2.89 110.009 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.82 -40.34 66.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.014 -0.994 . . . . 1.42 112.928 -165.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.4 -30.73 68.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.742 -0.742 . . . . 0.72 112.365 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 42.8 t0 -68.75 -46.81 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.52 . . . . 2.03 110.104 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.584 HG22 ' SD ' ' A' ' 65' ' ' MET . 58.9 t -62.36 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.459 -0.791 . . . . 1.08 110.949 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 77' ' ' ILE . 97.5 t -64.09 -41.61 92.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.257 -0.428 . . . . 0.72 110.988 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -61.38 -37.56 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.66 110.592 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.12 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.42 110.995 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 74' ' ' VAL . 72.6 mt -61.06 -42.1 91.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.151 0.501 . . . . 0.69 110.281 176.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.72 -25.75 63.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.705 -0.68 . . . . 3.09 110.8 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.49 61.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.65 111.519 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.28 -20.51 76.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.587 -0.816 . . . . 0.6 111.904 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.43 -84.59 1.33 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.953 -0.641 . . . . 1.1 112.132 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 50.8 m-20 -120.42 1.1 10.67 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.856 -0.202 . . . . 2.12 111.173 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -151.49 161.87 41.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.731 0.301 . . . . 2.11 110.637 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.8 t -140.67 149.56 42.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.568 -0.53 . . . . 0.32 109.568 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.7 mttp -119.18 117.22 28.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.802 -0.444 . . . . 1.63 109.802 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -106.48 130.74 54.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.301 -0.409 . . . . 0.28 110.242 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 57.8 tp -104.23 116.08 31.54 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.073 -0.714 . . . . 0.51 109.073 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 18.3 m -127.86 158.27 39.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.227 0.536 . . . . 0.33 111.884 -174.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 10' ' ' PRO . 25.9 m -128.03 147.88 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.42 109.916 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.59 176.06 7.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.254 -0.647 . . . . 1.92 109.254 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.6 ttp180 -54.04 -48.78 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.256 0.348 . . . . 4.16 111.469 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.17 -38.05 63.8 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 121.108 -0.237 . . . . 2.68 110.957 -173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.441 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 41.1 m -60.64 -47.62 85.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.886 0.374 . . . . 0.47 110.186 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 28.9 t70 -58.66 -47.83 83.14 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.873 -0.603 . . . . 1.18 110.772 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 48.7 mt-10 -64.77 -28.35 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 1.94 110.823 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.11 -47.72 64.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.73 110.323 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.489 ' CD2' HG13 ' A' ' 102' ' ' VAL . 46.9 m-85 -65.53 -36.8 84.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.446 -0.343 . . . . 0.44 111.278 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 29.1 mtpp -58.77 -49.36 77.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 1.92 111.714 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -71.05 -29.63 65.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.494 . . . . 2.04 111.265 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.416 ' HB3' HG12 ' A' ' 102' ' ' VAL . 36.3 t -85.39 -11.38 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 1.39 111.369 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? 63.16 43.97 6.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.73 -0.668 . . . . 4.09 111.198 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -133.39 140.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.172 -0.467 . . . . 1.42 110.29 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.7 mt -86.3 128.28 57.99 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.345 -0.388 . . . . 1.33 110.868 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.98 136.23 55.68 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.497 2.131 . . . . 0.53 111.193 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.9 t -155.8 172.67 17.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.892 -0.41 . . . . 1.42 109.892 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.435 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 60.1 mt-30 -55.68 -31.26 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.581 0.551 . . . . 1.66 111.472 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -59.75 -31.93 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.227 -0.442 . . . . 2.82 111.639 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -80.38 -14.17 58.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.448 -0.342 . . . . 0.53 111.531 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 87' ' ' LEU . 86.7 mt -59.91 -59.99 4.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.084 0.468 . . . . 1.24 110.848 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -101.98 -12.06 18.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 3.7 111.179 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.42 175.93 38.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.794 -0.717 . . . . 1.12 112.649 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.2 163.16 28.03 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.848 2.365 . . . . 1.31 112.313 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.856 -0.611 . . . . 1.11 109.588 175.727 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.181 0.515 . . . . 0.8 110.105 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HG2' HD21 ' A' ' 113' ' ' LEU . 49.2 mtm180 -119.67 140.71 29.83 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.828 -0.624 . . . . 3.09 110.127 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' VAL . 24.6 Cg_exo -65.53 178.54 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.231 2.621 . . . . 0.47 112.141 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 87' ' ' LEU . 7.0 ptp85 -133.19 136.6 45.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.092 -0.504 . . . . 2.37 111.85 -176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.596 ' HG ' ' CD1' ' A' ' 109' ' ' LEU . 4.1 mt -90.92 110.84 22.08 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.027 -0.731 . . . . 1.32 109.027 173.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.8 115.63 27.71 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.117 -0.697 . . . . 0.4 109.117 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.725 HG23 ' HG2' ' A' ' 85' ' ' LYS . 7.3 m -109.34 118.54 36.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.284 -0.636 . . . . 0.35 109.284 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.493 ' HB2' ' HB2' ' A' ' 45' ' ' PRO . 23.1 ptp -128.31 133.13 48.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.294 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HE3' ' HB2' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -113.38 137.99 50.72 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.855 -0.795 . . . . 2.58 108.855 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.558 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.9 ttmt -54.6 121.05 7.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.765 -0.652 . . . . 0.92 111.179 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.98 -126.05 5.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.708 -0.758 . . . . 1.28 112.892 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.12 -43.05 45.1 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.221 2.614 . . . . 2.23 113.057 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 m -153.67 86.12 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.87 0.367 . . . . 2.87 110.591 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.558 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 65.99 -136.12 35.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.893 -0.594 . . . . 1.93 112.856 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 40.6 m-85 -124.66 -176.8 3.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.737 -0.838 . . . . 1.82 108.737 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.61 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.963 -1.113 . . . . 0.43 113.243 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.53 146.59 22.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.832 0.348 . . . . 0.4 110.506 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.35 127.35 48.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.424 -0.584 . . . . 2.18 109.424 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 35' ' ' GLN . 18.3 tp -101.71 147.84 25.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.258 0.551 . . . . 1.52 111.582 -169.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 4.8 m-70 -109.56 121.98 46.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.71 . . . . 1.34 110.268 177.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.316 -0.874 0 N-CA-C 107.269 -1.382 . . . . 2.3 107.269 169.687 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.52 ' HB3' HD11 ' A' ' 26' ' ' LEU . 26.0 mm-40 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.783 0.325 . . . . 1.5 110.179 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 30.0 m-85 -109.32 157.73 18.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.413 -0.588 . . . . 0.87 109.413 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG13 HD11 ' A' ' 51' ' ' LEU . 38.3 mm -98.83 116.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.113 -0.328 . . . . 0.39 110.113 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 59.8 ttt180 -76.87 -44.6 31.43 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.004 0.43 . . . . 2.83 110.549 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.441 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 26.2 t -164.48 155.07 14.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.508 -0.769 . . . . 1.26 109.291 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.7 130.06 74.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.56 -0.533 . . . . 0.37 109.56 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.99 119.25 56.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.763 -0.458 . . . . 2.28 109.763 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.3 140.25 81.87 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.648 2.232 . . . . 1.17 112.698 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.585 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 12.3 m-20 65.36 39.31 5.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.31 -0.859 . . . . 2.4 111.899 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.612 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 89.6 p -117.95 170.0 6.89 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.737 -0.665 . . . . 0.57 109.365 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 6.3 Cg_endo -51.34 -35.0 52.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.107 1.872 . . . . 0.65 112.015 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -47.42 62.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 0.36 110.937 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 43' ' ' ASP . 5.0 tp10 -62.16 -40.49 96.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.997 0.427 . . . . 2.01 110.232 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.68 -24.32 62.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.47 111.763 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -75.93 -13.94 60.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.067 0.461 . . . . 0.4 110.344 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.47 21.65 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.696 -0.764 . . . . 0.62 112.42 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.506 HD11 HG13 ' A' ' 37' ' ' ILE . 25.9 tp -79.16 132.63 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.65 110.277 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 8.0 tpp180 -114.88 156.68 24.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.264 -0.273 . . . . 4.38 110.264 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -87.07 30.24 0.78 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 1.44 111.734 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.79 17.28 1.12 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.377 0.608 . . . . 3.06 109.83 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.615 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.7 m-20 -104.6 159.28 15.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.065 -0.97 . . . . 1.02 110.355 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.549 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.8 tmm_? -128.12 130.9 48.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.2 -0.296 . . . . 1.57 110.2 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.51 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.8 mt -75.58 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.68 111.237 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.549 HG22 ' NH1' ' A' ' 56' ' ' ARG . 2.3 t -114.76 -46.32 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.758 -0.656 . . . . 0.87 110.299 177.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.6 mt-10 -123.69 148.13 46.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.89 110.674 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 63' ' ' VAL . 99.6 t -125.53 119.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 0.66 109.371 173.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.23 21.32 10.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 1.17 111.45 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.88 9.38 61.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.669 -0.777 . . . . 0.66 113.782 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 60' ' ' VAL . 11.2 p -115.31 136.25 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.412 0.606 . . . . 1.17 109.816 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 7.2 p -74.69 136.97 41.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.488 -0.778 . . . . 1.68 111.557 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.565 ' C ' ' HD2' ' A' ' 68' ' ' LYS . 22.4 mmt -108.36 67.45 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.057 -0.519 . . . . 0.81 111.878 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -141.35 131.3 24.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.366 -0.834 . . . . 3.75 109.37 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.38 -0.37 74.65 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.291 -1.123 . . . . 1.47 110.291 -170.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HD3' ' H ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.0 164.4 13.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.356 -0.922 . . . . 3.36 111.148 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -96.96 172.15 8.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.343 -0.844 . . . . 2.89 109.041 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -62.2 -35.82 80.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.975 0.417 . . . . 1.42 109.953 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.49 -33.73 88.04 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.72 112.829 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.43 -46.76 81.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 2.03 110.551 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 35' ' ' GLN . 46.4 t -62.4 -46.65 95.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.537 . . . . 1.08 110.559 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.21 -42.85 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.72 111.062 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -67.37 -36.55 81.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.445 -0.343 . . . . 0.66 110.747 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.36 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.625 -0.261 . . . . 0.42 111.549 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 84' ' ' THR . 77.9 mt -59.62 -45.34 94.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.283 0.563 . . . . 0.69 110.345 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -72.66 -28.94 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.541 -0.754 . . . . 3.09 110.918 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.53 -14.31 62.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.65 111.406 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.61 -19.03 78.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.621 -0.8 . . . . 0.6 112.047 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -104.28 3.14 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.714 -0.755 . . . . 1.1 112.102 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.566 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 7.1 p-10 -98.0 -5.06 34.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.679 0.251 . . . . 2.12 111.679 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -150.47 165.17 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.986 0.422 . . . . 2.11 111.176 178.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.466 HG21 HG23 ' A' ' 77' ' ' ILE . 8.7 t -148.83 148.26 29.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.771 -0.65 . . . . 0.32 109.688 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.725 ' HG2' HG23 ' A' ' 14' ' ' THR . 23.1 mttm -115.31 118.63 33.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.9 -0.407 . . . . 1.63 109.9 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.35 125.87 51.47 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 0.28 109.324 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD11 HD21 ' A' ' 109' ' ' LEU . 52.0 tp -102.1 115.17 29.98 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.611 -0.885 . . . . 0.51 108.611 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 30.8 m -128.17 168.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.768 -0.651 . . . . 0.33 110.207 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 10' ' ' PRO . 28.3 m -127.56 141.76 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.894 -0.594 . . . . 0.42 110.352 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.93 172.08 14.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.145 -0.687 . . . . 1.92 109.145 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.427 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 19.4 tpt85 -58.13 -46.6 85.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.926 0.394 . . . . 4.16 111.152 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -64.88 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 2.68 111.593 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 6.5 m -75.36 -43.8 48.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.185 0.517 . . . . 0.47 110.536 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.442 ' HB2' HG23 ' A' ' 89' ' ' VAL . 24.4 t70 -59.38 -47.9 83.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 1.18 111.618 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.6 -39.67 94.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.726 0.298 . . . . 1.94 111.103 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -62.92 -49.32 75.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.73 110.759 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.24 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -60.43 -49.22 78.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.489 0.551 . . . . 1.92 112.489 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 7.2 ptmm? -68.7 -32.82 72.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.294 0.569 . . . . 2.04 110.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.494 ' HB3' HG23 ' A' ' 102' ' ' VAL . 62.0 m -76.47 -13.99 60.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.657 -0.701 . . . . 1.39 111.295 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.5 27.71 15.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.45 -0.795 . . . . 4.09 110.657 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 100' ' ' CYS . 59.5 t -102.71 139.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.805 -0.634 . . . . 1.42 110.676 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.0 mp -84.82 122.66 74.52 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.005 -0.543 . . . . 1.33 109.643 175.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HD2' HG11 ' A' ' 58' ' ' VAL . 3.0 Cg_exo -70.47 141.48 42.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.406 2.071 . . . . 0.53 110.891 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -151.44 167.1 29.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.059 -0.256 . . . . 1.42 110.787 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.601 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -52.5 -29.66 26.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.398 0.679 . . . . 1.66 111.778 176.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.26 -30.67 64.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.441 0.639 . . . . 2.82 110.902 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.73 -14.31 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.53 110.704 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.601 ' CD1' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mt -70.03 114.24 8.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 1.24 110.33 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.479 ' HA ' ' NH1' ' A' ' 9' ' ' ARG . 66.2 t30 57.27 28.05 14.59 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.844 0.83 . . . . 3.7 109.965 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.25 -169.05 12.42 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.228 -0.896 . . . . 1.12 111.314 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 147.87 27.05 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.536 2.157 . . . . 1.31 112.694 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 9' ' ' ARG . 47.6 mt . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.717 -0.674 . . . . 1.11 110.161 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.5 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.129 0.49 . . . . 0.8 110.772 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -130.54 148.86 71.67 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.758 -0.655 . . . . 3.09 109.413 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.8 Cg_endo -70.38 162.98 40.43 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.566 2.177 . . . . 0.47 111.419 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.448 ' NH1' HH12 ' A' ' 52' ' ' ARG . 6.4 ptp85 -127.65 136.12 51.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.167 -0.47 . . . . 2.37 110.545 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HB2' HD11 ' A' ' 109' ' ' LEU . 46.5 tp -94.26 110.36 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.945 -0.57 . . . . 1.32 109.707 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -98.91 116.9 32.2 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.323 -0.621 . . . . 0.4 109.323 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 85' ' ' LYS . 45.7 m -111.36 119.3 38.4 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.464 -0.569 . . . . 0.35 109.464 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.48 ' HE3' HD12 ' A' ' 86' ' ' LEU . 23.1 ptp -127.96 133.24 49.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.014 -0.539 . . . . 0.88 109.971 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -116.79 156.59 26.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.462 -0.79 . . . . 2.58 110.138 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 86.0 mttt -68.55 125.72 27.4 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.264 -1.335 . . . . 0.92 111.778 -172.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.86 -107.58 0.73 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.257 -1.338 . . . . 1.28 110.928 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HG2' ' HD3' ' A' ' 45' ' ' PRO . 33.5 Cg_endo -65.78 104.49 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.597 2.198 . . . . 2.23 111.361 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t 63.48 29.99 15.33 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.31 0.576 . . . . 2.87 110.545 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.91 -97.09 1.11 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.269 -0.732 . . . . 1.93 111.269 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 17.0 m-85 -119.53 -171.17 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.849 -0.797 . . . . 1.82 108.849 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.57 78.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.1 -1.048 . . . . 0.43 112.791 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -155.56 163.15 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.4 110.605 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -128.88 129.22 45.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.939 -0.573 . . . . 2.18 110.285 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.34 134.8 47.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.399 -0.364 . . . . 1.52 110.23 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.0 p80 -125.72 135.29 51.92 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.509 -0.476 . . . . 1.34 110.734 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.408 -0.815 . . . . 2.3 109.533 178.452 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.057 -0.349 . . . . 1.5 110.057 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 88.1 m-85 -109.11 154.94 21.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 0.87 109.18 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 53' ' ' ALA . 41.3 mm -77.84 107.87 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.002 0.429 . . . . 0.39 110.153 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 30.7 ttt180 -67.92 -43.47 79.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 2.83 109.823 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 p -175.66 140.15 0.44 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.534 -1.212 . . . . 1.26 109.668 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.28 121.37 60.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.0 -0.741 . . . . 0.37 109.0 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -66.05 122.47 81.32 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.669 -0.696 . . . . 2.28 109.957 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.18 149.71 78.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.847 2.365 . . . . 1.17 111.777 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.96 40.55 2.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 2.4 110.905 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 p -130.72 164.44 41.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.61 -0.268 . . . . 0.57 110.696 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD3' ' HG2' ' A' ' 19' ' ' PRO . 23.4 Cg_exo -64.23 -27.33 64.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.494 2.129 . . . . 0.65 111.47 175.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -46.81 71.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.759 -0.655 . . . . 0.36 110.241 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.87 -33.24 75.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.85 -0.614 . . . . 2.01 109.971 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.25 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.47 111.753 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.2 -13.51 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.4 110.556 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.58 50.45 1.83 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.62 112.061 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.2 tp -99.66 149.6 23.13 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.798 -0.445 . . . . 0.65 109.798 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 39.0 ttm180 -147.2 143.36 28.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.683 -0.235 . . . . 4.38 110.575 -173.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -77.22 14.11 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.074 0.768 . . . . 1.44 113.074 -173.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -115.44 -5.49 12.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.208 0.528 . . . . 3.06 109.981 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.633 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -91.36 155.06 18.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.152 -0.931 . . . . 1.02 111.273 -172.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -124.85 134.29 52.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 1.57 109.719 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 88' ' ' VAL . 41.7 mm -63.97 124.41 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.298 -0.41 . . . . 0.68 111.06 -176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.11 -52.01 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.995 -0.548 . . . . 0.87 110.638 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 28.9 mt-10 -133.32 149.37 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.89 110.213 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.33 123.4 66.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.78 -0.452 . . . . 0.66 109.78 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 60.81 20.84 10.97 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.079 0.552 . . . . 1.17 111.153 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.0 1.1 70.52 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.9 -0.667 . . . . 0.66 112.217 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.43 120.66 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.16 -0.311 . . . . 1.17 110.16 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.572 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -64.46 136.2 56.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 1.68 111.492 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.516 ' HG3' HG12 ' A' ' 73' ' ' VAL . 26.6 mmt -121.47 73.64 1.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.777 -0.647 . . . . 0.81 109.613 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.78 -57.37 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.22 -0.9 . . . . 3.75 110.667 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.9 13.77 45.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.026 -0.607 . . . . 1.47 111.927 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 30.8 mmtp -86.4 160.26 19.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.856 0.36 . . . . 3.36 110.491 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -90.72 173.11 8.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.0 -0.545 . . . . 2.89 111.429 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -58.48 -36.43 73.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.219 -0.446 . . . . 1.42 110.086 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.1 -38.7 96.56 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.795 -0.717 . . . . 0.72 112.415 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 68' ' ' LYS . 4.3 m-20 -62.57 -48.09 80.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.653 0.263 . . . . 2.03 111.171 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.516 HG12 ' HG3' ' A' ' 65' ' ' MET . 33.4 m -67.42 -40.35 84.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 1.08 111.367 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.44 -45.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.056 0.455 . . . . 0.72 110.672 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -36.59 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 0.66 110.414 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.47 96.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.655 0.264 . . . . 0.42 111.187 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 84' ' ' THR . 85.9 mt -60.21 -45.2 96.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.205 0.526 . . . . 0.69 110.274 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.63 -36.04 78.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 3.09 110.913 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.65 110.993 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.47 79.59 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 0.6 111.273 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.28 -123.32 7.67 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.004 -0.617 . . . . 1.1 111.659 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 1.3 m-20 -100.22 -4.16 30.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.829 0.347 . . . . 2.12 110.46 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 26.0 mt-10 -135.05 140.05 45.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.357 -0.979 . . . . 2.11 108.357 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 77' ' ' ILE . 12.6 t -139.66 148.03 41.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.897 0.38 . . . . 0.32 110.464 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 14' ' ' THR . 60.2 mttm -116.73 123.97 48.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.265 -0.425 . . . . 1.63 110.331 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.48 HD12 ' HE3' ' A' ' 15' ' ' MET . 95.0 mt -110.48 129.78 55.7 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.736 -0.468 . . . . 0.28 109.736 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 59' ' ' GLU . 16.9 tp -104.75 119.18 38.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.048 -0.723 . . . . 0.51 109.048 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 23.8 m -130.28 165.94 29.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.304 -0.407 . . . . 0.33 111.623 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.43 160.09 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.532 -0.758 . . . . 0.42 110.508 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' HH12 ' A' ' 11' ' ' ARG . 2.2 m-20 -77.29 175.59 9.58 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.492 0.495 . . . . 1.92 110.418 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -61.89 -47.27 85.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 4.16 110.767 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.41 -35.78 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 2.68 110.093 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -65.89 -41.51 91.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 0.47 110.797 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 20.4 t70 -58.66 -48.54 80.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 1.18 110.194 176.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -62.17 -38.46 89.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 1.94 111.108 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 77.7 t80 -63.74 -49.19 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.42 -0.354 . . . . 0.73 111.283 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 19.6 m-85 -66.17 -38.27 87.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.476 -0.329 . . . . 0.44 111.212 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 31.3 mtpt -66.72 -43.53 84.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.455 -0.338 . . . . 1.92 111.557 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 96' ' ' PHE . 52.0 pttt -71.75 -14.65 62.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 2.04 110.66 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 54.5 m -94.47 -6.22 44.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.227 0.537 . . . . 1.39 110.566 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.576 ' HD2' ' N ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER 57.96 35.33 25.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.112 -0.949 . . . . 4.09 111.454 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.24 147.33 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.796 -0.638 . . . . 1.42 109.806 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.564 HG21 ' SG ' ' A' ' 64' ' ' CYS . 32.1 mm -87.99 132.19 40.73 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.324 -0.398 . . . . 1.33 111.26 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.486 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 18.7 Cg_exo -65.35 137.4 51.11 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.557 2.171 . . . . 0.53 110.462 173.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.4 p -153.04 174.25 14.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.774 -0.37 . . . . 1.42 111.564 -172.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.444 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 98.3 mt-30 -59.49 -28.36 66.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 1.66 110.298 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.89 -41.34 77.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.616 -0.72 . . . . 2.82 110.429 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -78.95 -14.09 59.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.518 -0.764 . . . . 0.53 111.398 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.6 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.825 0.345 . . . . 1.24 110.92 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -118.09 -37.64 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 3.7 111.03 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.27 -166.44 36.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.164 -0.541 . . . . 1.12 113.507 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.9 136.77 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.536 2.824 . . . . 1.31 112.636 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 113' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 1.11 109.909 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 121.305 0.574 . . . . 0.8 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 14.1 ptt180 -126.74 160.2 60.0 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.616 -0.72 . . . . 3.09 109.285 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.7 Cg_endo -65.79 178.6 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.446 2.097 . . . . 0.47 111.984 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.539 ' HD3' HG23 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -137.31 132.5 33.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.108 -0.33 . . . . 2.37 110.108 175.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HG ' HD11 ' A' ' 109' ' ' LEU . 3.7 mt -92.82 109.9 21.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.08 -0.509 . . . . 1.32 109.843 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 17.9 m -91.19 116.64 28.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.966 -0.753 . . . . 0.4 108.966 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 116.7 33.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.517 -0.92 . . . . 0.35 108.517 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.9 ptp -140.21 134.13 30.7 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.148 -0.478 . . . . 0.88 110.195 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 17.9 pttp -110.9 156.28 21.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.266 0.555 . . . . 2.58 110.583 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.574 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.8 ttmt -59.11 111.85 1.48 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.85 -1.068 . . . . 0.92 112.163 -171.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 19' ' ' PRO . . . -110.53 -107.16 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.414 -0.812 . . . . 1.28 111.256 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 18' ' ' GLY . 27.7 Cg_exo -62.33 95.33 0.14 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.088 2.525 . . . . 2.23 112.126 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.0 t 72.53 -52.17 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.461 0.705 . . . . 2.87 112.139 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.574 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -179.69 78.25 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 1.93 111.885 -175.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 71.04 -63.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.342 0.657 . . . . 1.82 110.913 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.12 69.31 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.158 -0.544 . . . . 0.43 112.982 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.43 150.99 25.69 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.783 0.325 . . . . 0.4 110.192 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 45.1 t-20 -102.26 129.33 48.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.894 0.378 . . . . 2.18 109.982 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 35' ' ' GLN . 1.7 tm? -100.84 129.33 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.168 -0.679 . . . . 1.52 109.168 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -153.18 167.04 30.63 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.852 1.797 . . . . 1.34 115.852 -167.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.643 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 70.5 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 113.209 -1.814 . . . . 2.3 112.487 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.695 ' HB3' HD11 ' A' ' 26' ' ' LEU . 16.4 mm-40 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.523 -0.547 . . . . 1.5 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.643 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 50.3 m-85 -117.53 144.48 45.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.197 -1.001 . . . . 0.87 110.104 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.5 HG13 HD11 ' A' ' 51' ' ' LEU . 45.0 mm -81.56 115.3 23.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.541 -0.54 . . . . 0.39 109.541 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 2.1 tmm_? -77.25 -49.31 15.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.234 -0.654 . . . . 2.83 109.234 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.2 p -159.68 150.47 19.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.057 -0.974 . . . . 1.26 109.824 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.11 122.03 63.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.065 -0.717 . . . . 0.37 109.065 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.8 m-20 -67.42 133.02 93.02 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.589 . . . . 2.28 110.436 -174.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 35.5 Cg_exo -59.71 145.2 98.78 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.672 2.248 . . . . 1.17 112.033 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 34.4 m-20 74.54 15.59 3.34 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.997 0.81 . . . . 2.4 111.657 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.5 p -95.09 155.22 39.23 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.752 0.31 . . . . 0.57 110.238 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.68 -27.5 81.27 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.772 2.315 . . . . 0.65 111.182 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -65.24 -48.81 71.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.732 -0.667 . . . . 0.36 110.114 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 2.01 110.272 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.42 69.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.47 111.784 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 74.6 p -73.68 -12.15 60.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.4 110.875 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.34 51.06 1.36 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.62 112.441 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.5 HD11 HG13 ' A' ' 37' ' ' ILE . 23.1 tp -100.83 142.62 32.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.0 0.429 . . . . 0.65 110.759 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.515 ' HG2' ' H ' ' A' ' 54' ' ' GLN . 32.4 ttm180 -121.63 144.23 48.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 4.38 109.805 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.71 26.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 1.44 111.5 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -139.95 19.75 2.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.641 . . . . 3.06 109.271 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -104.27 157.85 16.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.341 -0.845 . . . . 1.02 111.305 -176.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -115.89 133.08 56.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.604 -0.725 . . . . 1.57 109.874 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' HA ' HG12 ' A' ' 88' ' ' VAL . 65.5 mt -76.63 124.43 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.296 -0.411 . . . . 0.68 110.465 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -106.65 -46.0 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.87 110.523 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 43.1 mt-10 -127.07 146.23 50.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.89 110.465 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 63' ' ' VAL . 85.9 t -131.48 118.93 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.22 -0.446 . . . . 0.66 109.841 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 57.23 27.43 13.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.377 -0.374 . . . . 1.17 111.582 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.5 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.6 6.75 63.81 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.66 114.219 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 60' ' ' VAL . 12.1 p -115.41 135.07 56.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.784 0.792 . . . . 1.17 110.092 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.426 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.1 t -80.74 136.63 36.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.508 -0.769 . . . . 1.68 111.225 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.486 ' SD ' HG22 ' A' ' 73' ' ' VAL . 23.1 mmt -106.94 53.3 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.81 110.479 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.09 -56.77 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 3.75 110.309 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.72 1.47 39.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 1.47 111.794 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.2 146.6 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.178 0.513 . . . . 3.36 110.875 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -98.97 -179.46 4.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.661 -0.699 . . . . 2.89 110.644 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -55.57 -43.87 76.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.401 . . . . 1.42 110.773 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -37.85 95.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.734 -0.746 . . . . 0.72 112.21 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.44 -47.51 75.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.987 0.422 . . . . 2.03 110.876 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.486 HG22 ' SD ' ' A' ' 65' ' ' MET . 25.2 t -70.23 -47.14 68.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 1.08 110.983 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.83 -36.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 0.72 110.636 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -65.31 -47.0 78.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.187 -0.46 . . . . 0.66 110.093 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.59 93.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.218 -0.446 . . . . 0.42 111.651 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.423 HG23 HG21 ' A' ' 84' ' ' THR . 70.3 mt -58.94 -43.26 88.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.288 0.566 . . . . 0.69 110.605 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -74.42 -30.08 61.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.516 -0.765 . . . . 3.09 111.342 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.15 9.94 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.65 111.727 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.1 -0.8 86.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.6 111.798 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.37 -101.5 2.49 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.129 -0.788 . . . . 1.1 111.129 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.497 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 6.0 t70 -128.86 -15.96 4.24 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.988 -0.285 . . . . 2.12 110.664 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.2 mt-10 -119.3 144.34 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 2.11 108.481 174.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 77' ' ' ILE . 13.3 t -135.34 148.82 49.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.094 0.473 . . . . 0.32 110.395 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HB3' HD22 ' A' ' 12' ' ' LEU . 97.8 mttt -111.67 117.46 32.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 1.63 109.856 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.8 mt -106.68 129.98 54.49 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.16 -0.473 . . . . 0.28 109.797 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 10' ' ' PRO . 41.5 tp -104.8 115.31 30.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.284 -0.636 . . . . 0.51 109.284 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.0 m -127.48 160.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.107 -0.497 . . . . 0.33 110.861 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.88 138.77 53.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 0.42 110.644 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.22 166.38 23.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.605 . . . . 1.92 110.078 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 44.8 ttt180 -56.2 -48.01 77.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 4.16 110.259 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.62 -33.69 76.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 2.68 110.372 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.4 m -70.63 -51.8 25.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.302 -0.863 . . . . 0.47 111.122 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.87 -30.72 68.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 1.18 111.393 -172.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 26.4 mm-40 -62.02 -35.27 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.005 0.431 . . . . 1.94 110.126 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -67.83 -45.7 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.73 109.926 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -62.54 -36.91 84.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.44 111.498 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -59.66 -49.65 76.93 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.54 0.21 . . . . 1.92 111.257 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ptmt -71.89 -26.48 62.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.419 -0.355 . . . . 2.04 111.048 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 m -81.19 -8.4 59.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.273 -0.421 . . . . 1.39 111.242 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 58.53 39.63 24.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.338 -0.846 . . . . 4.09 111.046 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.87 145.25 34.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 1.42 110.924 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 63.9 mt -80.51 131.75 60.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 1.33 110.572 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 22.4 Cg_exo -63.7 136.65 54.8 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.472 2.115 . . . . 0.53 110.619 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 48.9 m -157.57 163.66 38.11 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.124 -0.23 . . . . 1.42 110.677 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.5 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 50.8 mt-30 -56.89 -28.78 62.32 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.7 0.625 . . . . 1.66 111.983 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.3 pt-20 -57.99 -29.97 65.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.114 0.483 . . . . 2.82 111.061 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -82.97 -13.68 55.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.884 -0.598 . . . . 0.53 110.98 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.501 HD11 HD13 ' A' ' 87' ' ' LEU . 66.8 mt -73.73 -53.77 9.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 1.24 110.087 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.51 48.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.454 -0.794 . . . . 3.7 110.258 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.53 38.36 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.755 -0.736 . . . . 1.12 111.959 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.94 174.54 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.048 2.499 . . . . 1.31 112.783 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 9' ' ' ARG . 48.1 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.586 -0.734 . . . . 1.11 109.737 175.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.997 0.904 . . . . 0.8 109.038 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 110' ' ' ASN . 74.1 mtt180 -117.7 146.49 38.86 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.43 -1.259 . . . . 3.09 109.481 -173.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 87' ' ' LEU . 48.0 Cg_endo -66.93 159.25 52.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.378 2.052 . . . . 0.47 110.996 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HG3' HG23 ' A' ' 88' ' ' VAL . 6.3 ptp85 -114.92 129.55 56.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.209 -0.45 . . . . 2.37 110.304 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.451 -0.574 . . . . 1.32 109.451 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 21.4 m -93.85 116.18 28.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.535 -0.543 . . . . 0.4 109.535 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 85' ' ' LYS . 25.5 m -108.57 116.95 32.94 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.661 -0.866 . . . . 0.35 108.661 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.419 ' HE3' HD12 ' A' ' 86' ' ' LEU . 25.3 ptp -133.55 134.01 42.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.142 0.496 . . . . 0.88 111.201 -172.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -107.07 141.42 38.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.246 -0.888 . . . . 2.58 109.997 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 39.0 mttm -59.79 107.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.695 -0.684 . . . . 0.92 111.427 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 19' ' ' PRO . . . -104.41 -119.64 4.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.922 -1.036 . . . . 1.28 112.366 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 18' ' ' GLY . 43.1 Cg_exo -57.52 -58.01 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.079 2.519 . . . . 2.23 113.066 -176.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -121.37 36.4 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 2.87 111.425 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 55.63 84.4 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.249 -0.501 . . . . 1.93 112.736 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 8.7 m-85 67.32 -149.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.801 -0.444 . . . . 1.82 109.801 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.91 73.34 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.391 -0.909 . . . . 0.43 112.516 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -152.77 158.91 42.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.4 110.539 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -113.91 133.4 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 2.18 109.561 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 35' ' ' GLN . 3.1 tm? -109.23 129.38 55.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.024 -0.362 . . . . 1.52 110.024 -176.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.811 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.91 140.13 53.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.123 0.487 . . . . 1.34 110.292 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.972 -0.558 . . . . 2.3 110.066 -178.209 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.435 ' HB3' HD21 ' A' ' 26' ' ' LEU . 2.6 mp0 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.805 -0.443 . . . . 1.5 109.805 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.636 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 56.0 m-85 -122.08 142.31 50.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.926 -0.398 . . . . 0.87 109.926 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.534 HG13 HD11 ' A' ' 51' ' ' LEU . 43.7 mm -72.29 109.41 4.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.199 0.523 . . . . 0.39 110.029 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.811 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.1 tpt180 -66.81 -42.88 85.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.256 -0.883 . . . . 2.83 110.233 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -170.51 158.23 6.28 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.489 -0.778 . . . . 1.26 109.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.05 134.4 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.076 -0.713 . . . . 0.37 109.076 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.44 125.02 91.51 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.104 -0.498 . . . . 2.28 109.932 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 Cg_endo -61.38 134.82 53.92 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.756 2.304 . . . . 1.17 112.771 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.4 m-20 73.16 20.23 3.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.442 -0.799 . . . . 2.4 112.194 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 97.2 p -97.48 160.4 28.86 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.873 -0.417 . . . . 0.57 109.873 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 19.6 Cg_endo -60.06 -24.25 76.04 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.336 2.024 . . . . 0.65 111.999 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.91 -40.97 75.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.36 110.35 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -69.89 -39.38 76.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.201 -0.454 . . . . 2.01 110.249 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.47 111.79 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.5 p -75.45 -12.89 60.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.4 110.529 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.83 -1.0 30.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.686 . . . . 0.62 112.29 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 37' ' ' ILE . 30.9 tp -74.82 131.15 40.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.891 0.377 . . . . 0.65 110.466 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -132.77 -172.58 2.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.002 -0.544 . . . . 4.38 110.271 177.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.36 154.46 19.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.515 -0.311 . . . . 1.44 111.342 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 69.6 18.82 7.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.694 -0.685 . . . . 3.06 111.235 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -90.57 150.21 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 1.02 109.784 175.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -120.53 129.1 53.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.534 -0.543 . . . . 1.57 109.534 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' HG12 ' A' ' 88' ' ' VAL . 54.9 mt -76.26 136.67 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.68 111.406 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.511 HG22 ' NH1' ' A' ' 56' ' ' ARG . 3.4 t -115.1 -50.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.481 -0.782 . . . . 0.87 110.098 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 31.2 mt-10 -128.88 149.07 50.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.939 -0.573 . . . . 0.89 110.48 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -130.35 120.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.66 110.004 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 60.35 27.61 17.19 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.949 0.5 . . . . 1.17 111.447 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.01 82.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.66 112.32 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.86 121.62 55.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.13 -0.322 . . . . 1.17 110.13 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -70.23 135.27 48.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.421 . . . . 1.68 110.813 -178.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.754 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 23.8 mmt -112.67 64.39 0.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.596 0.712 . . . . 0.81 110.333 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -93.44 99.19 11.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.01 -0.995 . . . . 3.75 110.875 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 4.33 81.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 1.47 112.474 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.754 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.5 mmtp -58.77 156.61 10.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.621 0.724 . . . . 3.36 112.819 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -80.93 162.39 23.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.483 -1.235 . . . . 2.89 109.969 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -59.16 -38.9 80.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.924 0.392 . . . . 1.42 110.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.42 -41.2 91.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.751 -0.738 . . . . 0.72 113.099 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.51 -41.08 89.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.718 0.259 . . . . 2.03 111.215 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.1 m -69.41 -41.89 80.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 1.08 111.383 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.53 -38.09 78.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.973 0.416 . . . . 0.72 110.344 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -66.33 -35.85 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.66 110.51 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.49 98.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.42 111.567 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 HD21 ' A' ' 86' ' ' LEU . 62.9 mt -59.06 -42.26 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.295 0.569 . . . . 0.69 110.628 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -74.14 -30.28 62.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.682 -0.69 . . . . 3.09 110.706 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 -8.91 57.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.868 -0.605 . . . . 0.65 111.446 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.09 -30.85 78.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.76 -0.734 . . . . 0.6 111.683 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.65 -101.04 1.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.071 -0.585 . . . . 1.1 112.132 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.64 -18.06 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.998 0.428 . . . . 2.12 110.083 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.61 44.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.429 -0.582 . . . . 2.11 109.429 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.438 HG21 HG23 ' A' ' 77' ' ' ILE . 15.1 t -140.32 149.37 42.67 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.262 -0.426 . . . . 0.32 110.142 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.9 mttp -116.26 116.89 28.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.185 -0.461 . . . . 1.63 109.989 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 77' ' ' ILE . 87.1 mt -108.3 126.87 53.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.105 -0.498 . . . . 0.28 109.995 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 10' ' ' PRO . 31.0 tp -103.25 115.71 31.09 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.093 -0.706 . . . . 0.51 109.093 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.4 m -127.39 164.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.767 -0.651 . . . . 0.33 110.089 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -127.74 142.06 44.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.086 -0.507 . . . . 0.42 111.14 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.21 168.74 17.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.23 -0.895 . . . . 1.92 109.48 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 91' ' ' ARG . 6.5 ttp180 -56.58 -47.55 79.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.268 0.556 . . . . 4.16 110.155 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.09 -35.92 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.438 -0.801 . . . . 2.68 110.981 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 m -72.16 -49.95 31.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.47 111.497 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.63 -46.75 88.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.109 0.48 . . . . 1.18 110.301 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -63.01 -34.63 77.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.913 -0.585 . . . . 1.94 111.269 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.81 -47.37 78.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.73 110.438 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HD2' HG13 ' A' ' 102' ' ' VAL . 43.1 m-85 -65.1 -35.9 82.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.1 -0.5 . . . . 0.44 111.393 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -57.9 -49.1 77.88 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.505 0.187 . . . . 1.92 111.505 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -71.01 -22.17 62.19 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.202 0.525 . . . . 2.04 110.812 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.9 m -84.81 -14.45 48.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.018 -0.537 . . . . 1.39 110.817 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 57.63 33.97 23.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.418 -0.81 . . . . 4.09 111.372 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.431 HG13 ' HD2' ' A' ' 97' ' ' PHE . 11.4 p -128.49 146.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.017 -0.538 . . . . 1.42 109.953 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.2 mt -87.23 132.06 42.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 1.33 111.322 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.04 143.37 84.56 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.783 2.322 . . . . 0.53 110.942 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -156.01 163.04 40.2 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.82 -0.352 . . . . 1.42 110.481 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.45 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 22.7 mt-30 -55.66 -29.01 58.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.679 0.612 . . . . 1.66 110.904 174.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.54 -29.76 66.58 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.939 -0.573 . . . . 2.82 111.839 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -87.24 -13.88 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.361 -0.381 . . . . 0.53 111.798 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 73.2 mt -58.3 106.74 0.41 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.48 -0.327 . . . . 1.24 110.932 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.48 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 83.6 m-20 59.61 18.25 6.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.153 -0.476 . . . . 3.7 111.638 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.2 179.3 23.01 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.445 -0.662 . . . . 1.12 111.445 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.5 131.9 29.43 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.423 2.082 . . . . 1.31 111.886 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 C--N 1.323 -0.551 0 N-CA-C 109.728 -0.471 . . . . 1.11 109.728 175.754 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.348 0.594 . . . . 0.8 110.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -112.45 145.98 34.02 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 3.09 109.26 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HB2' HD11 ' A' ' 87' ' ' LEU . 32.8 Cg_endo -65.06 160.28 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.21 1.94 . . . . 0.47 111.552 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -107.23 130.33 54.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.599 -0.728 . . . . 2.37 109.904 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.6 tp -106.23 109.4 21.32 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.536 -0.542 . . . . 1.32 109.536 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.2 m -96.26 117.5 30.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.743 -0.662 . . . . 0.4 109.841 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -111.06 116.87 31.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.407 -0.961 . . . . 0.35 108.407 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.652 ' HE3' HD12 ' A' ' 86' ' ' LEU . 22.8 ptp -132.88 133.54 43.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.942 0.401 . . . . 0.88 110.652 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.972 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 6.8 ttmt -108.78 137.38 46.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.233 0.54 . . . . 2.58 110.459 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.645 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.5 ttmt -54.88 125.65 21.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.407 -1.27 . . . . 0.92 112.045 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.91 -153.0 28.68 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.792 -0.64 . . . . 1.28 111.637 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.21 -33.99 58.26 Favored 'Trans proline' 0 CA--C 1.527 0.159 0 C-N-CA 122.912 2.408 . . . . 2.23 112.663 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.9 m -119.49 38.23 3.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.129 0.49 . . . . 2.87 110.868 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.645 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.34 -108.91 2.85 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.325 -0.941 . . . . 1.93 111.869 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 73.0 m-85 -130.82 -155.0 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.835 -0.802 . . . . 1.82 108.835 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.86 73.35 0.22 Allowed Glycine 0 C--O 1.228 -0.265 0 C-N-CA 119.639 -1.267 . . . . 0.43 113.467 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -157.28 152.01 25.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.849 0.325 . . . . 0.4 110.701 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 3.0 t-20 -112.03 145.42 39.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.462 -0.569 . . . . 2.18 109.462 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.36 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.375 0.607 . . . . 1.52 112.579 -172.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -107.82 121.5 44.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 1.34 110.022 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.32 -0.702 0 N-CA-C 108.792 -0.818 . . . . 2.3 108.792 172.782 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.026 0.441 . . . . 1.5 110.315 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 56' ' ' ARG . 51.6 m-85 -106.55 158.22 17.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 0.87 109.129 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.802 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.8 mm -80.35 110.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.973 -0.751 . . . . 0.39 108.973 175.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 79.7 ttt180 -67.48 -46.72 72.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.431 0.634 . . . . 2.83 109.905 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.9 p -167.59 131.64 1.79 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.932 -1.031 . . . . 1.26 108.881 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -95.01 127.99 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.314 -0.624 . . . . 0.37 109.314 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.2 115.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.275 -0.639 . . . . 2.28 109.275 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.72 147.53 94.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.591 2.194 . . . . 1.17 111.689 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 63.95 52.87 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.895 0.855 . . . . 2.4 110.031 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.616 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -142.95 167.9 14.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.57 110.113 176.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.3 Cg_endo -54.19 -36.04 84.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.65 111.862 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.486 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -67.42 -48.52 67.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.36 110.757 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.53 -38.54 90.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.254 -0.43 . . . . 2.01 110.152 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.78 79.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.47 111.589 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.8 p -72.8 -14.73 61.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.07 0.462 . . . . 0.4 110.933 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.92 38.46 4.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.096 -0.573 . . . . 0.62 113.047 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.802 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -84.25 113.9 21.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 0.65 109.839 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD2' ' OD1' ' A' ' 55' ' ' ASP . 40.7 ttm105 -94.0 137.95 32.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.74 0.305 . . . . 4.38 110.579 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -82.34 35.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.509 0.559 . . . . 1.44 112.509 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -143.65 -0.98 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 3.06 110.341 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.589 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 29.4 m-20 -98.04 153.78 18.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.184 -0.462 . . . . 1.02 110.957 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 26.5 ttm105 -99.68 133.86 43.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 1.57 110.704 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.5 mt -73.42 122.72 26.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.1 -0.704 . . . . 0.68 109.1 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.4 t -105.69 -46.5 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.0 -0.545 . . . . 0.87 110.431 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.0 mt-10 -128.47 142.44 51.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.329 -0.396 . . . . 0.89 110.627 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.95 118.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 0.66 109.417 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 62.79 19.34 11.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.381 0.426 . . . . 1.17 110.781 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.29 4.55 66.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.837 -0.697 . . . . 0.66 112.425 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.26 115.52 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.037 -0.357 . . . . 1.17 110.037 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 49.8 t -74.79 130.16 38.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.26 0.552 . . . . 1.68 110.526 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.508 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.4 mmt -97.3 51.14 1.09 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.599 0.714 . . . . 0.81 111.079 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.2 105.67 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.103 -0.953 . . . . 3.75 110.355 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.94 -2.49 87.72 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 1.47 112.712 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.1 mmtp -66.53 160.68 24.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.238 0.542 . . . . 3.36 111.353 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.1 175.51 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.506 -0.77 . . . . 2.89 110.281 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 8.1 t60 -53.77 -43.4 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.444 0.465 . . . . 1.42 111.516 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.76 -41.84 88.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.72 113.178 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.95 -40.26 97.12 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.964 0.411 . . . . 2.03 110.655 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 77' ' ' ILE . 48.9 t -70.4 -47.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.898 -0.592 . . . . 1.08 110.788 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' HA ' HD12 ' A' ' 77' ' ' ILE . 89.9 t -68.29 -40.69 82.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.72 111.369 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -61.49 -38.93 89.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 0.66 110.397 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.9 92.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.497 -0.32 . . . . 0.42 111.138 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.527 HG23 HG21 ' A' ' 84' ' ' THR . 66.9 mt -58.76 -45.6 91.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.509 0.671 . . . . 0.69 110.162 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.54 -25.42 59.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.257 -0.883 . . . . 3.09 111.306 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.16 3.75 41.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.147 -0.479 . . . . 0.65 111.187 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.87 9.06 54.61 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.985 -0.626 . . . . 0.6 112.315 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.49 -120.13 5.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.772 -0.727 . . . . 1.1 111.517 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.564 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 9.3 t70 -107.49 -31.58 8.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 2.12 110.275 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.972 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -121.13 139.66 53.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.242 -0.435 . . . . 2.11 110.273 175.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.527 HG21 HG23 ' A' ' 77' ' ' ILE . 9.1 t -130.66 150.06 52.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.805 -0.634 . . . . 0.32 111.19 -170.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -108.57 118.53 37.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.586 -0.734 . . . . 1.63 110.793 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.652 HD12 ' HE3' ' A' ' 15' ' ' MET . 80.2 mt -109.9 131.22 55.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.05 -0.523 . . . . 0.28 109.845 176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.9 tp -104.19 119.6 39.31 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.604 -0.517 . . . . 0.51 109.604 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.3 m -126.64 153.33 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.173 0.511 . . . . 0.33 111.621 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.44 134.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.759 -0.655 . . . . 0.42 110.288 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.16 171.45 14.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.713 -0.477 . . . . 1.92 109.713 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 91' ' ' ARG . 34.2 ttm180 -52.44 -47.9 66.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.296 0.373 . . . . 4.16 111.615 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.08 -42.32 76.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 2.68 110.622 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.5 m -64.92 -46.59 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.762 -0.653 . . . . 0.47 111.086 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.66 -47.27 84.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 1.18 110.976 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 10.2 mm-40 -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.543 -0.299 . . . . 1.94 110.478 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.805 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 87.8 t80 -63.28 -48.33 78.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.73 110.497 176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 104' ' ' PRO . 34.2 m-85 -66.27 -38.14 87.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.831 0.348 . . . . 0.44 111.47 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -61.91 -48.53 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 1.92 111.618 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.805 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.5 pttt -70.76 -15.56 62.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 2.04 111.445 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.49 ' HB3' HG12 ' A' ' 102' ' ' VAL . 42.4 t -93.19 -7.83 44.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 1.39 110.196 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 59.35 29.45 19.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.281 -0.872 . . . . 4.09 111.21 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 100' ' ' CYS . 12.2 p -115.58 152.41 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 1.42 109.901 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.34 130.97 41.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.858 0.361 . . . . 1.33 110.983 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 47.3 Cg_endo -71.99 135.42 25.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.423 2.082 . . . . 0.53 111.244 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.0 t -158.43 173.92 15.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.295 -0.261 . . . . 1.42 110.295 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.474 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 43.8 mt-30 -55.89 -30.57 61.78 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.322 0.389 . . . . 1.66 111.636 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.79 -29.49 68.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 2.82 110.929 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -86.04 -13.67 46.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.892 -0.594 . . . . 0.53 111.561 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 86.7 mt -56.66 -73.59 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.885 0.374 . . . . 1.24 111.35 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -101.21 16.83 24.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.249 0.547 . . . . 3.7 110.044 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.51 -175.36 23.25 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.454 -0.793 . . . . 1.12 111.58 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.53 147.94 9.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 1.31 112.466 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.009 -0.542 . . . . 1.11 110.072 176.035 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 121.391 0.615 . . . . 0.8 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -122.0 146.02 45.24 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.617 -0.72 . . . . 3.09 109.801 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HB2' HD11 ' A' ' 87' ' ' LEU . 39.9 Cg_endo -68.32 173.57 9.44 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.488 2.125 . . . . 0.47 111.696 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.426 HH22 ' HB3' ' A' ' 52' ' ' ARG . 24.3 ptt-85 -134.3 132.51 39.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.356 . . . . 2.37 110.372 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -95.32 113.22 24.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.928 -0.578 . . . . 1.32 109.879 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.6 m -96.79 118.86 34.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.981 -0.554 . . . . 0.4 109.902 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.851 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.2 m -109.73 117.51 34.09 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.126 -0.694 . . . . 0.35 109.126 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.0 ptp -128.89 133.7 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.88 111.259 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -107.67 143.6 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.238 -0.892 . . . . 2.58 110.018 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.432 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 77.0 mttt -56.8 126.23 26.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.373 -0.831 . . . . 0.92 111.25 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -124.3 1.62 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.451 -1.249 . . . . 1.28 111.011 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.18 -48.32 1.84 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.662 2.241 . . . . 2.23 112.365 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -118.86 -34.19 4.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 2.87 111.491 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -174.61 -143.51 4.47 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.796 -0.716 . . . . 1.93 112.227 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.672 ' O ' ' HB2' ' A' ' 44' ' ' SER . 32.7 m-85 -99.24 -44.35 6.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.649 0.261 . . . . 1.82 110.894 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.68 69.25 0.9 Allowed Glycine 0 C--O 1.227 -0.292 0 C-N-CA 121.105 -0.569 . . . . 0.43 113.213 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -156.89 153.75 28.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.432 -0.581 . . . . 0.4 109.432 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.437 HD22 ' HD2' ' A' ' 38' ' ' ARG . 60.9 t30 -101.96 126.31 48.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.478 -0.564 . . . . 2.18 109.478 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.511 HD11 ' HG3' ' A' ' 35' ' ' GLN . 2.0 tm? -99.22 123.28 43.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.441 -0.577 . . . . 1.52 109.441 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.684 ' CB ' ' HB2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -126.92 122.52 34.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.524 -0.762 . . . . 1.34 111.256 -171.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.65 -0.704 . . . . 2.3 110.266 179.491 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HG3' HD11 ' A' ' 26' ' ' LEU . 1.6 mp0 . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 1.5 109.555 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.31 147.66 37.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.87 110.204 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.95 106.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.091 -0.707 . . . . 0.39 109.091 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.684 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 4.3 tmt_? -66.11 -42.39 89.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.941 -0.762 . . . . 2.83 108.941 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 p -174.48 154.87 2.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.736 -1.12 . . . . 1.26 109.56 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -109.93 127.41 66.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.664 -0.495 . . . . 0.37 109.664 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -65.18 128.36 93.71 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.045 -0.525 . . . . 2.28 109.973 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.51 144.9 98.22 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.477 2.118 . . . . 1.17 112.251 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.15 54.49 1.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.466 -0.788 . . . . 2.4 109.628 -177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.9 p -131.79 150.8 77.24 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.454 -0.794 . . . . 0.57 111.086 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.5 Cg_endo -62.31 -24.14 75.7 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.65 111.629 172.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.87 77.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.146 0.498 . . . . 0.36 109.904 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.63 -32.0 73.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 2.01 110.08 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.32 -32.01 68.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.009 -0.541 . . . . 0.47 111.686 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.2 p -72.65 -13.23 61.32 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.037 0.446 . . . . 0.4 110.697 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.07 26.44 6.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.741 -0.742 . . . . 0.62 112.709 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 tp -77.41 158.3 30.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.051 -0.351 . . . . 0.65 110.051 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 39.5 ttm180 -158.04 160.92 37.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.811 -0.811 . . . . 4.38 108.811 -173.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -83.45 152.41 24.99 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.129 -0.228 . . . . 1.44 110.88 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 25.1 mt-30 80.92 1.2 1.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.114 0.884 . . . . 3.06 112.175 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.63 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 33.2 m-20 -84.05 146.34 27.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.868 0.366 . . . . 1.02 110.49 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.4 ttp-105 -106.44 136.88 45.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.501 -0.555 . . . . 1.57 109.501 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.11 123.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.804 -0.443 . . . . 0.68 109.804 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.705 HG11 ' HG2' ' A' ' 104' ' ' PRO . 47.0 t -99.93 -49.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.674 -0.694 . . . . 0.87 110.117 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 23.2 mt-10 -126.45 142.87 51.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.89 110.425 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 118.62 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.103 -0.498 . . . . 0.66 109.711 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.2 30.12 19.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.956 0.408 . . . . 1.17 110.966 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -3.68 73.89 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.891 -0.671 . . . . 0.66 113.96 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.46 129.26 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.791 0.795 . . . . 1.17 111.237 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.7 p -71.0 137.15 48.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.004 -0.998 . . . . 1.68 112.028 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.762 ' HB3' HG22 ' A' ' 73' ' ' VAL . 24.1 mmt -115.0 11.46 16.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.81 111.048 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 103' ' ' ILE . 72.8 mm-40 -59.42 -45.62 91.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 3.75 111.3 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.05 2.0 74.87 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.688 -0.768 . . . . 1.47 112.633 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.6 mmtt -90.72 179.53 5.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.208 -0.293 . . . . 3.36 110.208 -177.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -111.98 174.47 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.666 -0.243 . . . . 2.89 111.537 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.21 -43.93 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 1.42 111.415 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.86 -30.78 76.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.92 -0.657 . . . . 0.72 113.066 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.17 -46.1 62.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.936 0.398 . . . . 2.03 110.808 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 65' ' ' MET . 25.1 t -62.57 -46.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.828 -0.624 . . . . 1.08 111.049 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.05 -39.2 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.72 111.183 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 t -68.44 -38.82 81.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.324 -0.398 . . . . 0.66 110.646 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.68 85.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.42 111.658 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.95 -43.17 91.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.191 0.519 . . . . 0.69 110.432 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.4 -34.53 70.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 3.09 110.592 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.74 -15.51 63.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 0.65 111.415 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.4 80.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 0.6 111.725 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.23 -111.7 4.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.978 -0.63 . . . . 1.1 112.211 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 -8.34 35.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.664 0.269 . . . . 2.12 110.706 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.44 162.4 40.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.428 -0.351 . . . . 2.11 110.757 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 t -150.35 149.36 29.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.331 -0.395 . . . . 0.32 110.3 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.851 ' HG2' HG23 ' A' ' 14' ' ' THR . 26.9 mttm -115.15 117.46 30.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.713 -0.477 . . . . 1.63 109.713 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -107.89 129.73 55.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.857 0.36 . . . . 0.28 110.302 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.502 HD23 ' HG3' ' A' ' 59' ' ' GLU . 37.5 tp -103.7 116.62 32.67 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.19 -0.67 . . . . 0.51 109.19 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.52 161.83 34.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.005 -0.543 . . . . 0.33 110.756 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 10' ' ' PRO . 8.5 m -133.87 133.35 56.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.746 -0.661 . . . . 0.42 110.78 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.4 154.09 41.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 1.92 109.183 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 70.5 ttt180 -52.72 -41.61 64.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.251 0.463 . . . . 4.16 112.251 -170.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.34 -34.84 72.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.29 0.567 . . . . 2.68 110.72 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -79.45 -41.83 26.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.332 -0.849 . . . . 0.47 110.19 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 25.9 t0 -65.87 -39.01 90.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.206 -0.906 . . . . 1.18 111.689 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 5.1 mm-40 -63.58 -36.34 83.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.992 0.425 . . . . 1.94 110.061 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.16 -41.34 86.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 0.73 110.45 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HD1' HG13 ' A' ' 102' ' ' VAL . 28.3 m-85 -65.76 -37.39 86.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.276 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 44.4 mttp -62.95 -49.89 72.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.323 . . . . 1.92 111.266 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.86 -25.82 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 2.04 111.167 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.486 ' HB3' HG12 ' A' ' 102' ' ' VAL . 36.3 t -87.62 -11.87 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.045 0.45 . . . . 1.39 110.676 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 61.96 35.54 16.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.366 -0.834 . . . . 4.09 111.334 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 100' ' ' CYS . 10.0 p -128.56 142.47 43.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.241 -0.436 . . . . 1.42 110.263 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 103' ' ' ILE . 3.0 mp -85.85 126.48 65.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.534 . . . . 1.33 110.734 -176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.705 ' HG2' HG11 ' A' ' 58' ' ' VAL . 22.8 Cg_endo -63.42 146.4 93.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.75 2.3 . . . . 0.53 111.617 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.5 p -157.67 173.04 17.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.639 -0.255 . . . . 1.42 111.353 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.511 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 51.8 mt-30 -60.12 -28.83 68.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.442 0.464 . . . . 1.66 110.703 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -58.47 -30.08 66.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.24 0.543 . . . . 2.82 111.118 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -85.88 -14.56 44.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.53 111.319 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.2 mt -63.09 107.64 1.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 1.24 110.443 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 60.41 24.79 14.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.96 -0.564 . . . . 3.7 110.494 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.74 174.17 15.13 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.915 -0.66 . . . . 1.12 111.973 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.87 136.39 38.31 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.902 2.401 . . . . 1.31 111.906 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 109.269 -0.641 . . . . 1.11 109.269 176.351 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.828 -0.805 . . . . 0.8 108.828 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -126.61 156.74 72.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.953 -1.022 . . . . 3.09 109.322 -174.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.5 Cg_endo -65.49 165.97 21.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.138 1.892 . . . . 0.47 111.203 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.671 HH12 ' HB3' ' A' ' 90' ' ' ASP . 8.7 ptp85 -121.28 131.95 54.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.872 0.367 . . . . 2.37 110.157 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.5 tp -98.24 111.03 23.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.218 0.533 . . . . 1.32 109.83 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.3 m -98.92 117.59 33.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.544 -0.753 . . . . 0.4 109.799 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -105.75 117.61 34.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.297 -0.631 . . . . 0.35 109.297 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.62 142.49 51.48 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 0.88 111.072 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 37.1 ttpt -114.77 140.18 49.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.817 -0.629 . . . . 2.58 109.622 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.691 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.6 ttmt -58.4 105.82 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.779 -0.452 . . . . 0.92 109.779 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.35 -134.37 7.0 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 1.28 113.257 -172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.11 -53.74 2.82 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.291 2.66 . . . . 2.23 112.843 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -116.87 33.31 5.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.091 -0.504 . . . . 2.87 110.663 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.691 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 90.58 -120.07 5.79 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.581 -0.819 . . . . 1.93 111.389 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.526 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 52.7 m-85 -121.08 172.95 7.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.82 109.283 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.28 73.75 0.41 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.159 -1.019 . . . . 0.43 112.816 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -155.43 144.91 21.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.731 0.301 . . . . 0.4 110.203 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 7.2 t-20 -103.57 141.04 36.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.207 -0.664 . . . . 2.18 109.207 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.28 151.3 22.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.09 0.472 . . . . 1.52 111.535 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -108.82 122.27 46.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.645 . . . . 1.34 110.287 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 121.196 0.522 . . . . 2.3 109.862 175.629 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.595 ' HG3' HG21 ' A' ' 73' ' ' VAL . 26.7 mm-40 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.009 0.433 . . . . 1.5 110.448 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.8 m-85 -115.86 158.32 23.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.87 109.492 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG13 HD11 ' A' ' 51' ' ' LEU . 50.5 mm -87.28 106.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.553 -0.536 . . . . 0.39 109.553 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 25.2 ttt180 -65.24 -50.09 67.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.874 -0.603 . . . . 2.83 110.014 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 p -160.87 133.92 6.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 1.26 109.878 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 p -104.66 132.83 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.356 -0.609 . . . . 0.37 109.356 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.73 134.52 72.19 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.489 -0.56 . . . . 2.28 109.489 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 52.6 Cg_exo -53.48 136.34 63.46 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.25 2.633 . . . . 1.17 113.126 -177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p30 44.19 38.51 2.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.29 1.036 . . . . 2.4 112.825 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.501 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 92.0 p -93.69 165.68 17.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.692 -0.855 . . . . 0.57 108.692 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 10.4 Cg_endo -54.92 -30.31 68.2 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.789 1.659 . . . . 0.65 111.488 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.01 67.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.814 -0.63 . . . . 0.36 110.615 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 34.0 tt0 -70.03 -34.33 73.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.742 0.306 . . . . 2.01 110.384 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -24.89 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.47 111.959 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.9 p -75.83 -13.28 60.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.228 0.537 . . . . 0.4 110.718 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.43 37.41 4.04 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.603 -0.726 . . . . 0.62 111.874 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 37' ' ' ILE . 17.4 tp -83.97 148.26 26.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.197 -0.298 . . . . 0.65 110.197 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HD3' ' OD1' ' A' ' 55' ' ' ASP . 62.3 ttt-85 -128.95 151.42 49.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 4.38 110.364 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.6 133.02 44.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.437 -0.347 . . . . 1.44 111.37 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 12.9 mm-40 65.87 29.57 10.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.341 -0.845 . . . . 3.06 111.599 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.561 ' OD1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -88.71 136.17 33.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.105 -0.702 . . . . 1.02 109.105 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.3 129.2 36.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.706 -0.225 . . . . 1.57 110.626 -177.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.442 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 52.5 mt -82.87 123.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.68 109.779 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.554 HG11 ' HG2' ' A' ' 104' ' ' PRO . 6.5 t -106.05 -35.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.245 -0.434 . . . . 0.87 110.614 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.0 mt-10 -136.48 143.02 43.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.291 -0.413 . . . . 0.89 111.221 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG12 ' ND2' ' A' ' 61' ' ' ASN . 49.3 t -122.17 109.06 23.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.045 -0.724 . . . . 0.66 109.045 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.53 ' ND2' HG12 ' A' ' 60' ' ' VAL . 10.4 p30 46.47 43.18 11.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.958 0.885 . . . . 1.17 111.579 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 94.26 -4.46 70.49 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.782 -1.099 . . . . 0.66 114.19 174.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.4 t -98.33 119.54 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 117.522 0.661 . . . . 1.17 110.471 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 p -67.92 130.55 43.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.384 -0.825 . . . . 1.68 111.061 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.522 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mmt -117.2 45.28 1.92 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.989 -0.55 . . . . 0.81 111.971 -174.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -90.95 -47.73 7.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.137 0.494 . . . . 3.75 110.62 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.2 18.37 57.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 1.47 112.187 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 72.2 mmtt -100.37 173.83 6.4 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.176 -0.305 . . . . 3.36 110.176 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -112.85 178.49 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.591 -0.277 . . . . 2.89 111.169 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.439 ' O ' HG23 ' A' ' 74' ' ' VAL . 55.2 t-80 -54.88 -43.65 73.36 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.469 -0.332 . . . . 1.42 111.141 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.45 -38.23 95.5 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.013 -0.613 . . . . 0.72 112.831 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.68 -44.26 96.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.952 0.406 . . . . 2.03 110.714 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.595 HG21 ' HG3' ' A' ' 35' ' ' GLN . 48.6 t -69.88 -46.81 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.763 -0.653 . . . . 1.08 111.047 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.2 t -63.96 -38.12 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.429 -0.35 . . . . 0.72 110.903 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.1 t -65.65 -36.04 82.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.051 -0.351 . . . . 0.66 110.051 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.39 -34.52 78.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.42 110.856 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.557 HG23 HG21 ' A' ' 84' ' ' THR . 29.0 mm -57.47 -45.42 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.7 0.762 . . . . 0.69 109.548 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -75.26 -31.07 60.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.862 -1.063 . . . . 3.09 111.119 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.28 -18.79 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.65 111.637 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.03 -17.48 79.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.6 112.252 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.47 -114.74 3.45 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.744 -0.741 . . . . 1.1 111.628 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.644 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 34.3 m-20 -110.04 -9.28 14.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.164 0.507 . . . . 2.12 110.25 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 1.8 pm0 -139.16 142.53 37.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.946 -0.57 . . . . 2.11 110.153 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.557 HG21 HG23 ' A' ' 77' ' ' ILE . 10.2 t -133.01 151.17 52.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.435 -0.348 . . . . 0.32 110.624 -174.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -111.07 118.0 34.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.257 -0.646 . . . . 1.63 109.257 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.85 135.07 47.94 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.916 0.389 . . . . 0.28 110.1 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 10' ' ' PRO . 26.4 tp -104.92 115.77 30.85 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.915 -0.772 . . . . 0.51 108.915 176.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' A' ' 11' ' ' ARG . 13.2 m -127.46 158.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.33 111.374 -176.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 147.66 30.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.42 110.402 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.671 ' HB3' HH12 ' A' ' 11' ' ' ARG . 21.3 p30 -92.47 176.94 6.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.965 -0.561 . . . . 1.92 110.298 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 54.4 ttp180 -54.72 -48.64 72.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.214 0.45 . . . . 4.16 112.214 -174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 1.8 pm0 -65.65 -42.76 91.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.843 0.354 . . . . 2.68 111.675 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -68.36 -44.67 74.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.07 -0.513 . . . . 0.47 110.772 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -60.86 -47.25 87.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.928 -0.578 . . . . 1.18 111.09 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 40.3 mt-10 -64.77 -32.85 74.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.605 -0.27 . . . . 1.94 110.64 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -64.24 -48.43 75.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.73 110.793 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CD2' HG13 ' A' ' 102' ' ' VAL . 30.4 m-85 -66.96 -38.74 86.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.642 -0.254 . . . . 0.44 111.495 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 95' ' ' GLU . 40.6 mtmt -63.85 -47.27 81.39 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.801 0.297 . . . . 1.92 111.801 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.9 ptmt -65.79 -18.96 65.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.375 0.607 . . . . 2.04 110.537 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.477 ' HB2' HG12 ' A' ' 102' ' ' VAL . 92.4 m -94.04 -9.97 35.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.583 -0.735 . . . . 1.39 111.079 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.16 26.92 12.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.346 -0.843 . . . . 4.09 111.39 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -109.41 141.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.436 -0.579 . . . . 1.42 109.436 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 37.3 mm -87.26 123.12 70.43 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.158 -0.474 . . . . 1.33 110.434 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.554 ' HG2' HG11 ' A' ' 58' ' ' VAL . 18.6 Cg_endo -60.49 135.66 62.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.197 1.931 . . . . 0.53 110.678 174.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 m -154.69 166.31 33.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.086 -0.339 . . . . 1.42 110.086 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 48.3 mt-30 -62.06 -30.37 70.94 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.491 0.494 . . . . 1.66 112.288 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.7 -29.35 70.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 2.82 110.484 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.69 -14.93 60.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.994 -0.548 . . . . 0.53 111.366 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 91.8 mt -62.25 -46.59 88.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.096 0.474 . . . . 1.24 110.362 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -128.61 75.99 1.67 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.619 -0.719 . . . . 3.7 110.1 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.43 176.08 46.75 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.52 -0.764 . . . . 1.12 111.312 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.98 111.08 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.556 2.171 . . . . 1.31 112.642 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.448 -0.56 0 CA-C-N 116.192 -0.458 . . . . 1.11 110.458 174.868 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.222 -0.351 . . . . 11.87 112.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.2 mm -93.97 52.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.91 0.862 . . . . 9.86 109.534 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 14.1 t70 -92.98 130.78 35.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.262 -0.881 . . . . 6.96 109.759 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.0 -13.42 37.4 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.679 2.253 . . . . 6.65 113.368 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -113.26 4.42 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.644 0.238 . . . . 7.99 111.644 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' A' ' 3' ' ' ASP . 6.3 t -77.31 0.27 22.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 4.26 110.952 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptp -89.37 -1.82 58.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 3.84 110.604 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.1 mt -85.53 59.31 5.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 0.8 110.08 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HB3' HD21 ' A' ' 113' ' ' LEU . 14.0 ptt180 -129.37 148.97 71.4 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 3.09 110.424 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HB3' HG12 ' A' ' 89' ' ' VAL . 57.2 Cg_endo -70.43 174.5 9.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.787 2.324 . . . . 0.47 112.642 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -134.22 140.47 46.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.793 -0.64 . . . . 2.37 109.961 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.7 tp -95.2 110.08 22.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.544 -0.539 . . . . 1.32 109.544 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -89.78 116.2 27.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.759 -0.655 . . . . 0.4 110.003 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -107.4 118.83 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.444 -0.576 . . . . 0.35 109.444 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.788 ' HE1' ' HA ' ' A' ' 46' ' ' ALA . 22.7 ptp -137.39 133.26 34.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.89 0.376 . . . . 0.88 111.218 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 87.6 tttt -103.63 147.04 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.65 -0.704 . . . . 2.58 109.298 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 14.4 mtmt -57.33 110.32 0.83 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.893 -0.594 . . . . 0.92 110.747 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.96 -94.19 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.189 -0.914 . . . . 1.28 113.346 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.62 -72.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.803 2.336 . . . . 2.23 111.971 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -146.19 20.26 1.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.569 0.7 . . . . 2.87 109.753 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 174.5 -156.76 23.73 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.22 -0.9 . . . . 1.93 111.3 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 83.6 m-85 -112.02 168.17 9.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.337 -0.616 . . . . 1.82 109.337 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.2 70.52 0.45 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.067 -1.063 . . . . 0.43 113.089 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.81 163.1 40.25 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.01 -0.367 . . . . 0.4 110.01 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.544 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 25.6 t-20 -129.06 129.77 45.7 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.041 -0.527 . . . . 2.18 109.694 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.0 mt -99.92 144.1 29.37 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.692 -0.484 . . . . 1.52 109.692 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.8 p80 -121.51 130.25 53.43 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.036 -0.666 . . . . 1.34 110.158 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 m -93.69 124.92 38.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.439 -0.801 . . . . 2.3 109.279 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.546 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.9 t70 -86.21 145.42 26.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.897 -0.408 . . . . 3.48 109.897 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 30' ' ' LYS . 31.7 tptt -91.1 -4.51 56.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.249 -0.432 . . . . 4.54 111.097 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 m -116.32 -48.89 2.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.149 0.5 . . . . 3.49 110.707 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 22.5 pttm -108.02 132.6 20.94 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.982 -0.554 . . . . 3.0 110.505 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.19 153.98 41.29 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.74 2.293 . . . . 2.24 113.051 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.89 159.7 14.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.536 -0.756 . . . . 1.29 112.11 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 35' ' ' GLN . 4.2 mm100 -97.54 128.32 44.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.677 -0.49 . . . . 1.5 109.677 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 75.6 m-85 -112.11 143.71 42.69 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.301 -0.629 . . . . 0.87 109.301 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.56 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.1 mm -68.39 106.78 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.452 -0.573 . . . . 0.39 109.452 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.4 ttt180 -75.47 -48.0 24.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.814 -0.63 . . . . 2.83 109.809 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -159.63 143.78 14.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.33 -0.85 . . . . 1.26 109.957 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.79 145.24 31.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.724 -0.473 . . . . 0.37 109.724 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 11.0 t70 -87.68 121.92 70.69 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.34 -0.615 . . . . 2.28 109.34 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 24.4 Cg_exo -62.26 -22.54 74.3 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 123.07 2.514 . . . . 1.17 113.339 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -105.39 50.34 0.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.713 0.768 . . . . 2.4 109.418 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 53.5 p -145.28 162.0 39.22 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.454 -0.793 . . . . 0.57 110.035 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 18.9 Cg_endo -60.92 -18.44 57.09 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.045 2.496 . . . . 0.65 112.435 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.788 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -67.83 -52.39 37.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.859 0.362 . . . . 0.36 110.798 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.78 -38.47 91.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.053 0.454 . . . . 2.01 109.865 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.37 94.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.47 111.223 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -70.93 -19.84 62.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.4 111.016 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.23 39.12 2.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.962 -0.637 . . . . 0.62 112.813 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -90.15 95.29 10.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.091 0.472 . . . . 0.65 109.911 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -85.25 146.24 27.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 4.38 110.26 -176.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -71.03 142.82 50.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 1.44 110.845 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 2.0 mp0 78.96 -0.02 2.4 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.146 0.904 . . . . 3.06 111.854 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.7 m-20 -81.71 150.5 27.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.606 -0.516 . . . . 1.02 109.606 175.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 31.4 ttp-105 -104.64 142.82 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.775 0.321 . . . . 1.57 111.501 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 mm -72.82 123.98 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.592 -0.731 . . . . 0.68 109.587 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 104' ' ' PRO . 43.5 t -111.92 -48.27 6.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.439 0.637 . . . . 0.87 109.943 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.5 mt-10 -125.68 146.37 49.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.391 -0.822 . . . . 0.89 110.045 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.69 120.58 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.975 -0.557 . . . . 0.66 109.88 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 62.21 23.06 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.555 -0.748 . . . . 1.17 111.015 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 9.39 62.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.906 -0.664 . . . . 0.66 112.609 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.5 t -114.02 128.04 71.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 1.17 110.446 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.0 p -77.47 129.29 35.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.767 -0.651 . . . . 1.68 110.914 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.716 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.6 mmt -117.15 26.89 9.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.167 0.432 . . . . 0.81 112.167 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.69 114.97 7.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.334 -0.393 . . . . 3.75 110.253 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.18 7.76 62.02 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.866 -0.683 . . . . 1.47 112.913 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.9 mmtp -92.37 166.98 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.214 -0.291 . . . . 3.36 110.214 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.19 175.62 6.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.493 -0.321 . . . . 2.89 111.057 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -58.94 -44.09 91.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.786 0.327 . . . . 1.42 110.818 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.7 -39.47 95.32 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.912 -0.661 . . . . 0.72 112.122 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.75 -47.19 84.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.844 0.354 . . . . 2.03 111.174 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 77' ' ' ILE . 50.6 t -69.08 -47.52 74.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.08 110.972 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.9 t -64.47 -41.99 93.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.465 -0.334 . . . . 0.72 111.186 -177.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.2 t -63.87 -35.79 81.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.981 -0.378 . . . . 0.66 109.981 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.52 -41.12 93.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.942 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 73' ' ' VAL . 75.5 mt -60.87 -45.89 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.175 -0.466 . . . . 0.69 110.384 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 52.0 mtp180 -68.18 -28.15 67.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.003 -0.544 . . . . 3.09 110.816 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.24 8.98 16.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.116 -0.493 . . . . 0.65 110.96 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.58 -21.12 58.73 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.85 -0.69 . . . . 0.6 111.752 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -129.71 9.99 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.768 -0.729 . . . . 1.1 111.995 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' OD2' ' HE3' ' A' ' 16' ' ' LYS . 11.6 p-10 -80.46 -23.94 39.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.748 0.309 . . . . 2.12 111.083 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 2.2 pt-20 -138.26 162.67 33.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.89 0.376 . . . . 2.11 110.815 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -143.79 149.17 36.65 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.815 -0.629 . . . . 0.32 110.1 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -115.1 117.52 30.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.139 -0.482 . . . . 1.63 109.878 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.463 HD12 ' HE3' ' A' ' 15' ' ' MET . 96.4 mt -109.05 135.64 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.065 -0.516 . . . . 0.28 110.427 -177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 44.4 tp -105.72 121.33 43.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.351 -0.611 . . . . 0.51 109.351 175.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.617 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.4 m -128.03 156.84 40.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.927 0.394 . . . . 0.33 111.569 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 10' ' ' PRO . 13.6 m -130.63 139.77 50.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.749 . . . . 0.42 110.382 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 173.65 6.41 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.778 -0.646 . . . . 1.92 110.64 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.612 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 40.1 ttt-85 -62.41 -49.39 75.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.848 -0.427 . . . . 4.16 109.848 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -39.56 94.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.204 0.526 . . . . 2.68 110.429 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.5 m -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.274 -0.875 . . . . 0.47 111.052 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.12 -37.29 78.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.023 -0.535 . . . . 1.18 111.303 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 31.8 mm-40 -63.54 -36.23 83.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 1.94 109.998 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 83.5 t80 -63.42 -46.82 84.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.743 -0.662 . . . . 0.73 110.214 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 104' ' ' PRO . 34.6 m-85 -64.26 -38.45 91.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.401 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -58.85 -50.01 75.6 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.956 0.407 . . . . 1.92 111.448 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -71.34 -19.04 62.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 2.04 111.663 -172.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -103.3 -2.5 27.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.926 0.393 . . . . 1.39 110.8 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.57 45.3 19.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.595 -0.73 . . . . 4.09 110.895 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.5 t -118.24 134.08 63.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.655 -0.702 . . . . 1.42 110.69 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.6 mm -93.1 120.07 67.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.374 -0.375 . . . . 1.33 110.018 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.485 ' HG2' HG11 ' A' ' 58' ' ' VAL . 32.8 Cg_endo -64.48 142.32 77.76 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.636 2.224 . . . . 0.53 112.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.519 ' HB3' ' OE2' ' A' ' 107' ' ' GLU . 9.3 t -153.24 -179.27 7.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.383 -0.599 . . . . 1.42 109.383 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -57.56 -30.99 65.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.411 0.523 . . . . 1.66 112.411 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.519 ' OE2' ' HB3' ' A' ' 105' ' ' SER . 0.0 OUTLIER -69.34 -28.77 66.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.948 0.404 . . . . 2.82 111.673 -177.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -77.46 -14.6 59.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.442 -0.344 . . . . 0.53 111.425 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.49 HD21 ' CD1' ' A' ' 87' ' ' LEU . 96.0 mt -53.31 -58.33 7.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.818 0.342 . . . . 1.24 111.802 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -107.93 14.66 25.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.267 0.556 . . . . 3.7 110.532 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.55 153.68 21.79 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.816 -0.629 . . . . 1.12 111.882 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.76 30.49 0.41 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.429 2.753 . . . . 1.31 113.102 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.544 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 70.6 mt 59.24 164.18 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.309 -0.86 . . . . 1.11 113.168 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 18.1 Cg_endo -60.16 156.66 38.69 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.805 2.336 . . . . 1.15 112.653 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.3 m -76.2 138.84 68.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.581 -0.736 . . . . 2.98 110.866 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.82 137.85 83.14 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.176 2.584 . . . . 4.23 112.787 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 67.83 8.54 6.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.319 -0.855 . . . . 7.33 112.245 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.9 m 73.58 -58.65 0.59 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.413 0.523 . . . . 8.78 112.413 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -125.02 -81.64 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.068 -0.253 . . . . 9.34 110.42 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.78 -161.61 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.159 -0.543 . . . . 11.55 112.658 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 59.12 87.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.607 0.595 . . . . 13.92 112.607 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 pt -80.25 50.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.251 0.548 . . . . 16.21 110.917 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -69.94 121.75 17.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 18.82 111.243 -177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp 50.54 66.18 1.23 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.041 0.838 . . . . 20.83 111.575 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -82.39 81.07 8.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.808 -0.633 . . . . 22.5 109.686 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -90.45 -44.59 9.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.336 -0.393 . . . . 23.99 110.43 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.9 m 48.58 48.24 19.82 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.237 0.458 . . . . 25.0 112.237 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.378 -0.82 . . . . 27.52 109.363 175.46 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.969 -0.453 . . . . 11.87 111.969 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' H ' HG13 ' A' ' 2' ' ' ILE . 2.6 pp -92.85 169.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 9.86 110.977 176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.469 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 13.4 m-20 -92.96 132.6 30.57 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 6.96 110.391 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 17.0 Cg_exo -67.87 -65.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.568 2.179 . . . . 6.65 111.512 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -132.74 22.82 4.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.546 . . . . 7.99 110.029 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 3' ' ' ASP . 9.4 m -98.02 93.71 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.459 . . . . 4.26 111.381 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.9 ptp -108.56 18.16 21.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 3.84 110.546 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt -86.72 57.28 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.8 109.992 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 85.0 mtt-85 -115.72 149.86 43.83 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.07 -0.514 . . . . 3.09 111.447 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HB2' HD11 ' A' ' 87' ' ' LEU . 2.9 Cg_exo -72.7 165.89 31.48 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 122.512 2.141 . . . . 0.47 109.866 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.637 HH12 ' HB3' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -127.7 131.1 49.81 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.237 -0.438 . . . . 2.37 110.043 178.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HB2' HD21 ' A' ' 109' ' ' LEU . 2.0 tm? -98.64 112.79 24.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 1.32 109.521 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.4 m -105.74 125.67 51.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.888 -0.596 . . . . 0.4 110.711 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' LYS . 24.2 m -111.98 117.38 32.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 0.35 109.174 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.712 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.6 ptp -126.53 133.6 51.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.178 0.513 . . . . 0.88 110.999 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -111.54 143.24 42.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.158 -0.928 . . . . 2.58 110.146 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' A' ' 82' ' ' ASP . 52.6 mttt -62.36 104.59 0.51 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.349 -0.841 . . . . 0.92 111.377 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.82 -80.2 0.93 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.044 -0.98 . . . . 1.28 111.623 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.98 47.5 2.23 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.723 2.282 . . . . 2.23 111.215 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m 61.58 27.6 17.03 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.12 -0.945 . . . . 2.87 110.69 -175.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.514 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -177.09 -178.07 46.52 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.024 -0.608 . . . . 1.93 112.248 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 29.3 m-85 -106.55 -162.06 0.83 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.427 -0.583 . . . . 1.82 109.427 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.67 73.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.115 -1.04 . . . . 0.43 113.043 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -155.1 154.34 32.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.79 0.328 . . . . 0.4 110.287 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -108.75 134.78 50.99 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.383 -0.599 . . . . 2.18 109.383 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 35' ' ' GLN . 23.0 tp -105.24 152.66 22.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.351 -173.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.34 122.49 46.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.745 -0.835 . . . . 1.34 108.745 175.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -132.11 50.9 2.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.468 0.651 . . . . 2.3 111.198 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.32 142.2 28.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.359 -0.837 . . . . 3.48 110.118 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -78.87 -4.54 50.15 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.053 0.454 . . . . 4.54 110.566 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -77.42 -25.48 50.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 3.49 110.913 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.27 129.53 21.64 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 3.0 110.893 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.29 151.62 38.47 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.227 1.952 . . . . 2.24 111.399 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.93 155.61 21.55 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.596 -0.812 . . . . 1.29 111.212 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' A' ' 26' ' ' LEU . 21.4 mm-40 -102.23 128.81 48.59 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 122.49 -0.418 . . . . 1.5 110.377 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.86 151.33 23.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.146 -0.479 . . . . 0.87 110.557 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.41 106.36 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.276 0.56 . . . . 0.39 110.171 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.25 -54.35 38.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.006 -0.997 . . . . 2.83 110.54 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 p -168.35 137.3 2.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.814 -0.63 . . . . 1.26 109.981 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.38 130.99 52.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.353 -0.61 . . . . 0.37 109.353 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.53 135.44 72.04 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.511 -0.313 . . . . 2.28 110.246 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HA ' ' CD ' ' A' ' 47' ' ' GLU . 33.1 Cg_endo -63.94 139.23 66.81 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.776 2.318 . . . . 1.17 112.406 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.18 48.27 6.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.304 -0.862 . . . . 2.4 110.807 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 98.7 p -120.4 160.45 43.7 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.473 -0.785 . . . . 0.57 109.539 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.6 Cg_endo -54.46 -29.41 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.167 1.911 . . . . 0.65 111.575 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.712 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.23 -50.49 39.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.36 110.54 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' CD ' ' HA ' ' A' ' 42' ' ' PRO . 44.0 tt0 -65.12 -35.85 82.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.297 -0.41 . . . . 2.01 110.49 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.51 -31.1 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.47 111.641 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.7 p -72.99 -18.37 61.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.012 0.434 . . . . 0.4 110.8 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.88 14.12 14.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.62 112.547 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.65 114.76 9.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.65 110.355 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -97.53 149.65 21.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.797 -0.638 . . . . 4.38 109.906 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.37 151.82 39.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.276 -0.42 . . . . 1.44 110.585 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 70.35 10.7 7.32 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.774 0.671 . . . . 3.06 111.78 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.7 m-20 -84.6 168.53 15.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.722 -0.473 . . . . 1.02 109.722 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -131.31 131.26 43.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.848 -0.427 . . . . 1.57 109.848 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -72.57 130.65 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.228 0.537 . . . . 0.68 111.203 -175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.69 HG11 ' HG2' ' A' ' 104' ' ' PRO . 23.6 t -107.22 -48.47 8.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.87 110.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 35.5 mt-10 -133.87 148.34 51.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.89 110.756 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.23 117.78 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.958 -0.565 . . . . 0.66 109.773 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 58.78 31.02 20.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.18 0.514 . . . . 1.17 111.165 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.13 74.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.883 -0.675 . . . . 0.66 112.805 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.04 120.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.279 -0.267 . . . . 1.17 110.279 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 91.9 m -64.61 126.21 27.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.62 . . . . 1.68 111.438 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.577 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.8 mmt -105.14 68.78 0.83 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.923 -0.769 . . . . 0.81 108.923 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.7 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.56 -1.2 . . . . 3.75 110.811 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -124.99 25.93 5.7 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.611 -0.996 . . . . 1.47 110.611 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 71.9 mmtt -58.2 147.1 31.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.873 -0.663 . . . . 3.36 111.642 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.545 ' HG3' ' H ' ' A' ' 72' ' ' ASP . 12.8 pt20 -77.11 161.36 28.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.092 -0.958 . . . . 2.89 110.29 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.41 ' O ' HG23 ' A' ' 74' ' ' VAL . 85.0 t60 -55.4 -42.57 74.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 1.42 110.446 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.04 92.87 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.72 112.77 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 8.5 t0 -66.13 -47.09 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 2.03 110.013 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.415 HG22 ' SD ' ' A' ' 65' ' ' MET . 47.7 t -62.62 -46.01 97.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.477 -0.783 . . . . 1.08 110.662 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 70' ' ' HIS . 95.8 t -63.5 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.72 110.883 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -61.97 -39.22 91.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.66 110.015 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.18 94.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.42 111.012 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.057 0.456 . . . . 0.69 110.629 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -68.93 -24.95 64.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 3.09 111.219 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.63 -10.67 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.65 111.093 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.76 -33.31 70.97 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.702 -0.761 . . . . 0.6 111.904 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.16 -109.38 3.36 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.019 -0.61 . . . . 1.1 112.184 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 11.6 t70 -102.04 -23.97 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.616 -0.513 . . . . 2.12 109.616 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.06 157.3 40.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.028 0.442 . . . . 2.11 110.459 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -146.93 149.32 32.97 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.934 -0.575 . . . . 0.32 109.856 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 14' ' ' THR . 57.0 mttp -114.36 116.82 29.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.037 0.446 . . . . 1.63 109.896 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -109.54 136.35 49.07 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.838 -0.619 . . . . 0.28 110.574 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.8 tp -104.83 125.12 50.55 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.183 -0.673 . . . . 0.51 109.183 175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 11.1 m -135.34 152.08 31.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.185 0.517 . . . . 0.33 111.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 94' ' ' ASP . 16.1 m -130.57 150.97 35.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.354 -0.839 . . . . 0.42 110.145 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.637 ' HB3' HH12 ' A' ' 11' ' ' ARG . 7.6 p-10 -89.97 176.16 6.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.449 -0.575 . . . . 1.92 109.449 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -53.51 -48.93 68.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.211 0.448 . . . . 4.16 112.211 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.2 -43.16 95.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 2.68 111.138 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.0 m -71.25 -41.03 70.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.332 0.587 . . . . 0.47 110.73 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 22.3 t0 -64.95 -39.31 93.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.528 -0.76 . . . . 1.18 111.072 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.29 -35.73 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 1.94 110.446 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -63.23 -48.03 79.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.948 -0.569 . . . . 0.73 111.005 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HD1' HG13 ' A' ' 102' ' ' VAL . 20.3 m-85 -64.47 -36.04 82.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.29 -0.414 . . . . 0.44 111.701 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 36.2 mttp -58.72 -49.82 76.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.786 0.291 . . . . 1.92 111.786 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 13.1 ptmt -70.85 -23.09 62.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 2.04 110.555 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 98.4 m -80.87 -7.16 59.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.861 -0.609 . . . . 1.39 110.68 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 57.88 28.94 16.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.423 -0.808 . . . . 4.09 111.299 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 114' ' ' PRO . 10.8 p -132.28 147.22 32.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.043 -0.526 . . . . 1.42 109.955 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -102.1 128.53 28.32 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-O 121.107 0.48 . . . . 1.33 110.812 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.69 ' HG2' HG11 ' A' ' 58' ' ' VAL . 18.4 Cg_endo -63.71 155.98 60.16 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.655 2.236 . . . . 0.53 112.845 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.641 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 2.1 m -150.12 175.68 11.51 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.326 -0.99 . . . . 1.42 108.326 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.605 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 22.9 mp0 -59.39 -34.92 73.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.333 0.587 . . . . 1.66 110.122 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.641 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.8 pt-20 -62.49 -30.21 71.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 2.82 111.682 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.503 ' HB2' ' H ' ' A' ' 105' ' ' SER . 33.7 m80 -79.29 -24.48 42.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.868 0.366 . . . . 0.53 111.322 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.7 pp -91.96 -14.11 30.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.217 -0.447 . . . . 1.24 110.477 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -103.86 -50.91 3.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 3.7 110.785 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.72 -142.6 8.67 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.89 -0.672 . . . . 1.12 112.416 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -84.52 163.21 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.719 2.279 . . . . 1.31 113.236 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 39.6 mt -91.85 165.89 19.23 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.506 -0.77 . . . . 1.11 109.249 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 17.9 Cg_endo -60.14 134.29 55.16 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.119 1.88 . . . . 1.15 111.494 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.52 118.94 75.12 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.01 -0.541 . . . . 2.98 110.295 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.15 109.27 0.47 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.965 2.444 . . . . 4.23 112.045 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.46 -58.89 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.619 -0.718 . . . . 7.33 110.008 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.0 m -88.83 107.61 19.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 8.78 109.518 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -91.53 142.43 27.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.069 0.461 . . . . 9.34 111.153 -174.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -130.1 141.25 12.46 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.191 -0.763 . . . . 11.55 111.191 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -86.65 118.73 26.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.914 0.388 . . . . 13.92 110.045 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 54.7 mt -85.87 93.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.945 -0.571 . . . . 16.21 110.889 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -82.85 150.06 26.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.701 -0.682 . . . . 18.82 109.401 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.69 48.96 1.72 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.69 0.626 . . . . 20.83 112.69 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -86.63 60.31 6.15 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.305 -0.628 . . . . 22.5 109.305 170.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -67.06 -71.4 0.2 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.691 -0.686 . . . . 23.99 110.52 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.0 t -169.88 90.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 25.0 110.003 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 128' ' ' ARG . 17.7 ptt85 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 119.187 -0.435 . . . . 27.52 110.065 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.901 -0.48 . . . . 11.87 111.901 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -107.21 137.22 39.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.127 0.489 . . . . 9.86 110.918 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -94.54 107.92 33.32 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 6.96 110.083 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 15.19 1.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.741 2.294 . . . . 6.65 112.858 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -99.85 -46.65 5.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.519 -0.309 . . . . 7.99 110.902 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.879 HG22 ' HG ' ' A' ' 8' ' ' LEU . 7.3 m -57.11 111.22 0.99 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.534 -0.757 . . . . 4.26 111.258 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -91.21 53.43 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.298 0.57 . . . . 3.84 111.575 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.879 ' HG ' HG22 ' A' ' 6' ' ' THR . 69.5 mt -81.68 50.27 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.477 0.656 . . . . 0.8 109.876 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 113' ' ' LEU . 20.4 ptt85 -121.47 150.18 54.09 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.122 -0.945 . . . . 3.09 109.9 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HB2' HD11 ' A' ' 87' ' ' LEU . 55.6 Cg_endo -69.16 158.36 58.04 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.46 2.107 . . . . 0.47 111.938 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 11' ' ' ARG . 7.8 ptp180 -118.29 131.59 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.737 -0.665 . . . . 2.37 110.016 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.5 tp -97.33 111.08 23.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 1.32 109.803 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.412 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 32.2 m -94.77 117.22 29.78 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.833 -0.622 . . . . 0.4 110.032 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 85' ' ' LYS . 35.9 m -110.46 117.87 34.74 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.305 -0.628 . . . . 0.35 109.305 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 ptp -128.99 136.35 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.404 -0.362 . . . . 0.88 110.855 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -110.72 139.86 45.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.677 -0.692 . . . . 2.58 109.249 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 11.7 ttmt -61.92 124.4 20.68 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.329 0.492 . . . . 0.92 112.329 -173.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -149.85 17.91 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.629 -0.714 . . . . 1.28 111.323 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.73 -30.65 17.48 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.037 2.491 . . . . 2.23 112.508 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.4 m -109.1 19.93 18.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.238 -0.437 . . . . 2.87 110.573 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.77 2.84 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.569 -0.824 . . . . 1.93 111.959 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 26.6 m-85 -119.07 -48.46 2.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.753 0.311 . . . . 1.82 110.527 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 70.02 1.23 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.0 -0.619 . . . . 0.43 113.635 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -156.52 156.06 33.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.942 -0.392 . . . . 0.4 109.942 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -101.81 126.48 48.69 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.82 -0.437 . . . . 2.18 109.82 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 tp -100.34 152.74 19.97 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.966 -0.561 . . . . 1.52 110.432 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -106.61 122.7 46.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.305 -0.407 . . . . 1.34 110.108 -176.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 t -112.67 81.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.817 -0.628 . . . . 2.3 109.999 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.13 120.87 27.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.623 -0.717 . . . . 3.48 109.484 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -90.34 -16.0 30.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.84 -0.618 . . . . 4.54 110.454 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.9 m -86.84 -16.16 36.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.74 -0.664 . . . . 3.49 111.616 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -155.32 128.11 4.17 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 3.0 110.275 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.35 157.24 62.65 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.051 2.501 . . . . 2.24 112.496 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.61 125.9 5.28 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.135 -0.786 . . . . 1.29 111.135 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.577 HE21 ' CA ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -94.42 139.77 30.69 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 122.436 -0.449 . . . . 1.5 111.276 -175.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -118.61 156.79 28.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.87 110.061 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG13 HD11 ' A' ' 51' ' ' LEU . 44.4 mm -96.37 110.06 23.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.151 0.5 . . . . 0.39 109.719 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' HIS . 60.8 ttt180 -66.21 -55.15 17.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 2.83 110.371 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 p -169.67 139.24 1.98 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.812 -0.631 . . . . 1.26 109.599 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -96.41 138.05 22.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.341 -0.391 . . . . 0.37 109.984 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 t70 -71.59 124.0 90.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.178 -0.675 . . . . 2.28 109.178 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 35.1 Cg_exo -56.48 132.85 54.31 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.11 2.54 . . . . 1.17 113.751 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.0 t70 57.44 48.5 14.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.855 -1.066 . . . . 2.4 110.917 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.496 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -110.72 169.58 6.17 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.57 109.986 173.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.498 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 9.2 Cg_endo -55.16 -33.13 83.03 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.89 1.727 . . . . 0.65 111.333 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.439 0.638 . . . . 0.36 110.576 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -60.08 -50.61 73.04 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.276 -0.874 . . . . 2.01 110.067 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.24 -17.5 62.54 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.711 -1.586 . . . . 0.47 111.353 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 51.6 p -84.72 -16.96 39.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.4 110.071 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.22 0.35 35.43 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.754 -0.736 . . . . 0.62 112.697 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 37' ' ' ILE . 37.8 tp -61.62 128.13 34.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.314 . . . . 0.65 110.31 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -117.86 154.21 32.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.251 -0.431 . . . . 4.38 109.915 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -78.88 145.37 34.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.528 -0.305 . . . . 1.44 110.305 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 85.3 mm-40 78.99 3.26 2.42 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.252 0.97 . . . . 3.06 111.202 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 36.4 m-20 -74.13 156.81 36.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 1.02 109.724 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' ' 58' ' ' VAL . 7.9 tmm_? -123.93 129.21 50.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.721 -0.474 . . . . 1.57 109.721 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' HA ' HG12 ' A' ' 88' ' ' VAL . 58.2 mt -76.22 130.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.225 0.536 . . . . 0.68 111.416 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.481 HG22 ' NH1' ' A' ' 56' ' ' ARG . 21.8 t -107.5 -51.73 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.237 -0.892 . . . . 0.87 110.149 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 26.1 mt-10 -130.61 144.35 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.89 111.031 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.31 118.2 55.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.333 -0.618 . . . . 0.66 109.333 172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 61.0 22.41 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.17 110.937 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.98 6.28 63.49 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.723 -0.671 . . . . 0.66 112.915 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.87 120.73 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 1.17 110.37 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.537 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.2 m -63.51 130.02 42.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.482 . . . . 1.68 110.841 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.594 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 25.6 mmt -109.62 18.63 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.406 0.622 . . . . 0.81 110.464 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -61.04 117.78 5.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.069 -0.969 . . . . 3.75 110.731 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.0 -16.76 50.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.833 -0.699 . . . . 1.47 112.951 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 65' ' ' MET . 68.8 mttm -75.6 173.16 11.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.149 0.5 . . . . 3.36 111.808 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -103.36 -175.29 2.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.593 -0.73 . . . . 2.89 111.463 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.414 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 86.3 t60 -63.08 -42.87 99.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.506 . . . . 1.42 110.297 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.36 -39.68 96.49 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.737 -0.665 . . . . 0.72 113.203 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -62.57 -47.47 83.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.046 0.451 . . . . 2.03 110.765 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.33 -46.76 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 1.08 110.968 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.93 -40.08 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.395 . . . . 0.72 111.023 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.7 t -60.28 -42.01 94.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.66 110.843 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.72 -43.38 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.42 111.35 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.523 HG23 HG21 ' A' ' 84' ' ' THR . 80.6 mt -58.73 -42.38 85.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.427 0.632 . . . . 0.69 110.407 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 78' ' ' ARG . 31.7 mtp180 -74.29 -31.98 62.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.462 -0.79 . . . . 3.09 111.63 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.79 -7.63 59.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.438 -0.346 . . . . 0.65 111.23 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.31 73.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.182 -0.532 . . . . 0.6 112.186 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.57 -126.96 8.24 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.707 -0.759 . . . . 1.1 111.652 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 8.5 t70 -84.02 -28.37 27.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 2.12 110.017 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -128.85 160.2 33.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.105 0.479 . . . . 2.11 110.618 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 77' ' ' ILE . 10.6 t -146.07 148.74 32.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.56 -0.745 . . . . 0.32 109.647 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.8 mttp -116.42 117.36 29.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 1.63 110.042 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -105.85 128.34 53.69 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.946 -0.57 . . . . 0.28 109.75 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 10' ' ' PRO . 57.0 tp -103.92 114.76 29.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.679 -0.859 . . . . 0.51 108.679 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.77 162.26 33.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.958 -0.564 . . . . 0.33 110.885 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.22 146.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 0.42 110.473 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.04 166.19 23.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.711 -0.677 . . . . 1.92 109.85 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.5 ttm180 -53.39 -48.17 68.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.009 0.433 . . . . 4.16 110.862 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -73.39 -28.13 61.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 2.68 109.973 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 m -70.58 -47.82 58.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.371 -0.832 . . . . 0.47 110.695 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -59.36 -45.04 92.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 1.18 110.478 -176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 11.2 mm-40 -62.8 -36.14 82.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 1.94 110.984 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.94 -46.09 89.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.73 110.555 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.474 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 48.7 m-85 -65.69 -36.95 85.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.248 -0.433 . . . . 0.44 111.257 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -59.51 -49.72 76.7 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 111.537 0.199 . . . . 1.92 111.537 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -70.92 -18.74 62.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 2.04 111.305 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 t -91.43 -19.51 22.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.306 0.574 . . . . 1.39 109.829 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 101' ' ' ARG . 0.3 OUTLIER 67.02 31.75 6.73 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 114.692 -1.14 . . . . 4.09 111.716 176.198 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.41 HG13 ' HD1' ' A' ' 97' ' ' PHE . 14.1 p -123.68 141.02 45.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 1.42 109.852 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.447 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 66.7 mt -82.4 129.07 64.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.34 -0.391 . . . . 1.33 110.367 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.474 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 14.5 Cg_exo -66.25 150.8 84.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.79 2.327 . . . . 0.53 111.623 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.5 t -163.34 178.38 8.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.566 -0.531 . . . . 1.42 109.566 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 71.1 mt-30 -55.13 -26.86 41.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.584 0.587 . . . . 1.66 112.584 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -55.7 -30.66 61.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.212 0.529 . . . . 2.82 111.389 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -89.77 -12.93 37.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.242 -0.435 . . . . 0.53 111.114 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 106' ' ' GLN . 96.4 mt -64.68 111.33 2.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.024 -0.535 . . . . 1.24 110.43 175.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 56.34 36.04 26.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 3.7 110.394 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.33 -167.86 11.45 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.605 -0.725 . . . . 1.12 111.843 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.33 150.0 22.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.608 2.205 . . . . 1.31 112.413 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 9' ' ' ARG . 65.3 mt -93.8 131.37 32.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 1.11 109.361 175.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.17 123.16 10.01 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.813 2.342 . . . . 1.15 112.797 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.51 87.88 12.99 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.168 -0.924 . . . . 2.98 110.241 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.63 39.35 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.22 2.613 . . . . 4.23 113.096 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 121' ' ' GLU . 14.7 t80 -157.53 93.08 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.5 . . . . 7.33 109.985 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 119' ' ' ASN . 40.8 p -89.75 177.23 6.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 8.78 110.684 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 118' ' ' THR . 36.6 m-80 68.13 33.46 4.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.18 0.514 . . . . 9.34 110.582 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.19 104.63 1.67 Allowed Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.591 -0.731 . . . . 11.55 112.846 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -82.38 70.05 9.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.332 -0.988 . . . . 13.92 108.332 174.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.6 pt -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.092 -0.958 . . . . 16.21 111.397 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -139.92 -41.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.927 -0.579 . . . . 18.82 111.493 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -176.08 -28.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.902 -0.136 . . . . 20.83 110.865 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 52.3 73.04 0.36 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 112.19 0.441 . . . . 22.5 112.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.65 98.58 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.645 -0.502 . . . . 23.99 109.645 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.3 t -113.43 165.59 12.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.248 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.789 -0.624 . . . . 27.52 109.921 177.754 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.718 -0.553 . . . . 11.87 111.718 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -129.49 113.97 29.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.984 -0.376 . . . . 9.86 109.984 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p-10 -89.36 135.93 30.59 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.005 -0.368 . . . . 6.96 110.005 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 5.8 Cg_endo -87.46 8.47 4.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.903 2.402 . . . . 6.65 112.14 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.416 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 95.9 m-85 -88.46 -19.49 26.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.03 -0.532 . . . . 7.99 110.369 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 3' ' ' ASP . 14.0 t -79.91 -150.62 0.06 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.5 -0.773 . . . . 4.26 110.755 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 7' ' ' MET . 20.6 ttt 76.32 13.92 2.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.625 0.77 . . . . 3.84 110.63 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 81.5 mt 61.68 27.65 17.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.787 -0.642 . . . . 0.8 112.366 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -110.57 143.09 27.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 120.757 0.313 . . . . 3.09 110.611 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HB3' HG12 ' A' ' 89' ' ' VAL . 64.6 Cg_endo -74.69 177.09 8.93 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.637 2.225 . . . . 0.47 111.094 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 5' ' ' PHE . 7.8 ptt-85 -146.8 138.27 24.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.897 0.38 . . . . 2.37 111.326 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.23 116.57 29.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.687 -0.688 . . . . 1.32 110.139 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 4.3 m -97.38 115.91 28.61 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.12 -0.696 . . . . 0.4 109.12 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.436 HG23 ' HG2' ' A' ' 85' ' ' LYS . 27.7 m -110.23 117.42 33.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 0.35 109.334 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.549 ' HE3' HD12 ' A' ' 86' ' ' LEU . 24.7 ptp -135.06 140.46 45.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.88 111.146 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -110.44 153.02 25.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.309 -0.626 . . . . 2.58 109.309 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 5.4 ttmt -69.17 98.89 1.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.493 0.663 . . . . 0.92 111.118 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.02 -106.79 3.15 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.034 -0.985 . . . . 1.28 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD2' ' HG3' ' A' ' 45' ' ' PRO . 41.4 Cg_endo -70.32 84.11 0.76 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.693 2.262 . . . . 2.23 113.013 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m 63.3 67.38 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.383 0.882 . . . . 2.87 113.383 170.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.39 57.35 6.79 Favored Glycine 0 CA--C 1.517 0.162 0 C-N-CA 121.124 -0.56 . . . . 1.93 114.308 168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 68.08 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.088 0.555 . . . . 1.82 111.56 174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.21 70.42 0.73 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.863 -0.684 . . . . 0.43 112.771 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.48 152.4 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.751 -0.463 . . . . 0.4 109.751 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -103.74 135.17 45.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.387 -0.37 . . . . 2.18 110.144 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.515 HD13 ' H ' ' A' ' 27' ' ' HIS . 0.2 OUTLIER -101.32 151.86 21.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.891 -0.595 . . . . 1.52 109.536 -176.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.515 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -106.12 122.02 45.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.867 0.365 . . . . 1.34 110.065 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -95.56 107.92 20.13 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.988 -0.551 . . . . 2.3 110.101 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.31 156.66 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.451 -0.341 . . . . 3.48 110.392 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -136.53 10.94 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.687 0.756 . . . . 4.54 109.801 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.1 p -118.49 -39.3 3.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 3.49 111.134 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -111.95 142.07 26.05 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.619 0.247 . . . . 3.0 110.466 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.38 153.53 40.06 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.823 2.349 . . . . 2.24 112.505 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.496 ' HA3' ' HE ' ' A' ' 56' ' ' ARG . . . 89.89 166.63 41.69 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.864 -0.684 . . . . 1.29 111.59 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -116.21 130.76 56.95 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.735 -0.468 . . . . 1.5 109.735 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 68.2 m-85 -103.98 147.56 27.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.135 0.493 . . . . 0.87 110.99 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.488 HG13 HD11 ' A' ' 51' ' ' LEU . 50.6 mm -78.87 106.98 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.469 -0.787 . . . . 0.39 109.149 175.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 39.5 ttt-85 -62.36 -53.25 57.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.37 -0.832 . . . . 2.83 110.113 -177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 m -161.41 145.25 12.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 1.26 108.91 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.49 131.24 73.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.211 -0.663 . . . . 0.37 109.211 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 t70 -79.13 118.53 72.98 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.298 -0.41 . . . . 2.28 109.895 -175.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 50.2 Cg_exo -56.12 142.15 86.61 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.088 2.526 . . . . 1.17 112.999 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 t70 67.93 47.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.347 -0.842 . . . . 2.4 110.725 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 85.1 p -127.98 164.16 38.88 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.612 -0.722 . . . . 0.57 109.178 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.562 ' HG3' ' HD2' ' A' ' 19' ' ' PRO . 12.1 Cg_endo -57.43 -33.62 96.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.599 1.532 . . . . 0.65 111.326 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.0 -52.53 34.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.917 -0.583 . . . . 0.36 110.7 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.09 -41.56 97.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.941 0.4 . . . . 2.01 110.273 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.77 -22.74 63.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.47 111.867 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.45 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.1 p -72.83 -9.73 59.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.27 0.557 . . . . 0.4 110.359 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.12 31.4 5.05 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.559 -0.746 . . . . 0.62 111.792 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 HD11 HG13 ' A' ' 37' ' ' ILE . 30.7 tp -97.13 139.53 32.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.019 -0.363 . . . . 0.65 110.019 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -131.44 148.5 52.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 4.38 109.506 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -73.23 149.87 42.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.093 -0.336 . . . . 1.44 110.093 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 75.2 mt-30 78.89 5.91 2.3 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.191 0.932 . . . . 3.06 111.477 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 47.9 m-20 -88.74 148.03 24.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 1.02 109.749 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' HE ' ' HA3' ' A' ' 34' ' ' GLY . 24.2 ttt180 -103.73 134.6 46.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.781 0.324 . . . . 1.57 111.24 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.94 130.94 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.642 . . . . 0.68 110.031 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' A' ' 104' ' ' PRO . 41.3 t -111.24 -42.87 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.029 -0.532 . . . . 0.87 110.878 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -131.02 143.42 50.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.555 -0.293 . . . . 0.89 110.506 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.7 120.03 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.804 -0.443 . . . . 0.66 109.804 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 62.91 18.31 10.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.346 0.658 . . . . 1.17 111.249 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.65 0.05 73.09 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.586 -0.816 . . . . 0.66 111.858 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.11 128.9 44.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.855 -0.424 . . . . 1.17 109.855 176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.459 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 23.1 p -66.68 126.51 29.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.754 -0.657 . . . . 1.68 111.773 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.3 mmt -133.68 38.81 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.81 110.515 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' OE1' ' HB2' ' A' ' 64' ' ' CYS . 41.3 mp0 -61.22 -52.74 63.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 3.75 111.201 -176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -130.72 34.78 2.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.674 -0.774 . . . . 1.47 112.472 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.6 mmtp -79.58 -175.37 4.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.732 0.301 . . . . 3.36 110.603 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -85.07 161.27 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.317 . . . . 2.89 110.658 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -55.84 -42.81 76.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.859 -0.423 . . . . 1.42 109.859 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.71 -39.11 94.82 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.5 -0.773 . . . . 0.72 113.032 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.18 -47.59 79.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.969 0.384 . . . . 2.03 111.354 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 65' ' ' MET . 48.7 t -64.55 -43.45 96.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.984 0.421 . . . . 1.08 110.736 -177.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 97.0 t -65.84 -41.89 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.72 110.413 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -62.18 -44.95 95.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.66 110.502 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.36 -39.56 76.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.348 . . . . 0.42 111.332 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.0 mt -57.46 -45.71 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.269 0.557 . . . . 0.69 110.724 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 74' ' ' VAL . 10.2 mpt_? -75.25 -31.99 60.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.703 -0.681 . . . . 3.09 110.983 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.43 -14.75 63.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.65 111.874 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.23 -13.83 67.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.824 -0.703 . . . . 0.6 111.872 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.31 -99.82 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.869 -0.682 . . . . 1.1 111.977 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 9.3 t70 -104.72 -21.58 13.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.856 0.36 . . . . 2.12 110.528 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.29 162.29 31.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.844 0.354 . . . . 2.11 110.497 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 t -148.75 148.46 30.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.978 -0.556 . . . . 0.32 110.238 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HG2' HG23 ' A' ' 14' ' ' THR . 48.2 mttm -112.91 118.36 34.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.202 -0.453 . . . . 1.63 109.954 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD12 ' HE3' ' A' ' 15' ' ' MET . 92.9 mt -105.82 127.66 53.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.976 0.417 . . . . 0.28 109.983 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.9 tp -103.6 118.34 36.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.907 -0.775 . . . . 0.51 108.907 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.2 m -125.52 162.0 29.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.109 -0.496 . . . . 0.33 111.008 -175.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 10' ' ' PRO . 8.3 m -126.95 142.95 41.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.42 110.509 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -75.8 172.37 12.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.875 -0.602 . . . . 1.92 109.785 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -59.65 -48.47 81.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.056 0.455 . . . . 4.16 110.793 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.4 mp0 -65.48 -40.28 92.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.87 -0.604 . . . . 2.68 110.273 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 8' ' ' LEU . 7.4 m -63.53 -50.9 67.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.31 -0.859 . . . . 0.47 110.872 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 29.8 t70 -59.08 -41.69 88.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.874 -1.057 . . . . 1.18 111.419 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.76 -36.93 62.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.414 -0.357 . . . . 1.94 111.41 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.13 -47.54 84.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.389 -0.368 . . . . 0.73 110.75 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -61.62 -38.26 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.44 111.524 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 24.2 mttp -66.32 -50.04 64.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.101 -0.24 . . . . 1.92 111.567 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' A' ' 99' ' ' LYS . 16.5 ptmt -72.7 -18.47 61.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 2.04 111.42 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.6 t -89.84 -13.39 36.63 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.723 -0.843 . . . . 1.39 108.723 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 68.12 33.46 4.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.633 -1.167 . . . . 4.09 110.655 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.485 HG11 ' HG3' ' A' ' 114' ' ' PRO . 46.2 t -113.3 148.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.869 -1.06 . . . . 1.42 109.987 -177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.7 mt -97.23 123.22 53.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 110.199 -0.297 . . . . 1.33 110.199 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.607 ' HG2' HG11 ' A' ' 58' ' ' VAL . 36.9 Cg_endo -71.09 145.91 50.7 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.455 2.103 . . . . 0.53 111.499 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.5 p -160.49 170.12 21.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.55 -0.295 . . . . 1.42 110.97 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -55.89 -29.24 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.451 0.469 . . . . 1.66 111.262 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -58.46 -30.83 67.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 2.82 110.972 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -81.39 -15.35 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.53 111.276 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.8 mt -67.42 -55.09 15.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.526 . . . . 1.24 110.349 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -97.58 16.61 19.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 3.7 110.477 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.21 -163.54 11.35 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.907 -0.663 . . . . 1.12 112.329 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -94.38 178.07 0.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.455 2.77 . . . . 1.31 113.0 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.21 129.83 25.06 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 1.11 109.137 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.485 ' HG3' HG11 ' A' ' 102' ' ' VAL . 34.9 Cg_endo -66.22 129.98 22.96 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.705 2.27 . . . . 1.15 112.636 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 5.1 p -105.79 122.95 40.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 2.98 110.96 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.9 Cg_exo -75.34 126.32 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.594 2.196 . . . . 4.23 111.535 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.7 66.5 7.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.499 0.666 . . . . 7.33 110.694 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.6 m -149.07 21.0 0.98 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.213 1.006 . . . . 8.78 108.64 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.21 98.34 9.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.788 -1.096 . . . . 9.34 109.484 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.72 179.33 39.84 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.824 -0.703 . . . . 11.55 111.657 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.8 33.74 21.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.319 0.58 . . . . 13.92 111.048 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 14.7 pt -93.67 81.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.703 0.763 . . . . 16.21 110.808 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -110.21 -63.23 1.41 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.406 -0.816 . . . . 18.82 109.581 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm 50.08 78.27 0.1 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.291 -0.868 . . . . 20.83 111.474 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.44 -70.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.99 -0.55 . . . . 22.5 109.98 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -169.25 97.59 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.351 -0.84 . . . . 23.99 108.849 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.5 t -139.72 142.06 36.86 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.337 -0.392 . . . . 25.0 110.305 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.277 -0.868 . . . . 27.52 109.308 177.175 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.341 -0.704 . . . . 11.87 111.341 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 pt -88.16 47.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.666 0.746 . . . . 9.86 110.175 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.618 ' O ' HG22 ' A' ' 6' ' ' THR . 10.1 m-20 -68.05 123.51 87.41 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.211 -0.904 . . . . 6.96 111.246 -174.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 17.4 Cg_exo -67.48 -6.35 16.31 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.969 2.446 . . . . 6.65 112.892 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -103.28 13.41 33.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 7.99 111.746 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.625 HG23 ' HG ' ' A' ' 8' ' ' LEU . 10.5 t -114.36 -173.95 2.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.804 -0.443 . . . . 4.26 109.804 173.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.445 ' HB3' ' HG2' ' A' ' 9' ' ' ARG . 51.6 mtt -77.57 -70.54 0.47 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.663 0.246 . . . . 3.84 111.663 -172.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 92' ' ' GLU . 26.1 mt 52.8 36.55 21.67 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.264 0.977 . . . . 0.8 111.222 -174.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.968 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 18.3 ptp180 -137.96 141.79 33.73 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.046 -0.525 . . . . 3.09 109.982 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HB2' HD21 ' A' ' 87' ' ' LEU . 30.2 Cg_endo -66.01 160.62 43.49 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.56 2.174 . . . . 0.47 111.588 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.769 -0.65 . . . . 2.37 110.431 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.61 HD13 HD12 ' A' ' 87' ' ' LEU . 63.0 tp -98.27 111.54 23.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 1.32 109.765 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.534 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.8 m -98.8 117.1 32.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.4 110.158 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.6 m -104.07 118.45 36.7 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.539 -0.911 . . . . 0.35 108.539 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.524 ' HE3' HD12 ' A' ' 86' ' ' LEU . 21.4 ptp -131.04 133.6 45.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.101 0.476 . . . . 0.88 111.025 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HG2' ' HB3' ' A' ' 83' ' ' GLU . 13.1 tmtt? -105.23 143.56 33.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.592 -0.731 . . . . 2.58 109.258 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 3.4 ttmt -64.43 117.53 7.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.102 0.477 . . . . 0.92 111.371 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.79 -124.03 4.08 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.618 -0.719 . . . . 1.28 111.869 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.15 -67.59 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.762 2.308 . . . . 2.23 113.223 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.2 m -121.18 34.87 5.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 2.87 111.048 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.14 -141.45 12.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.546 -0.835 . . . . 1.93 111.989 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 44' ' ' SER . 40.4 m-85 -107.22 -34.38 7.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.151 0.501 . . . . 1.82 110.028 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.47 68.36 0.95 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.153 -0.93 . . . . 0.43 112.91 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -156.88 156.7 33.58 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.802 -0.444 . . . . 0.4 109.802 176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -119.74 137.59 53.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.304 -0.407 . . . . 2.18 110.143 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.62 153.88 19.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.456 0.646 . . . . 1.52 112.204 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 2.4 m-70 -105.8 121.57 44.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.005 -0.998 . . . . 1.34 108.352 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -134.84 87.74 2.37 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.903 -0.777 . . . . 2.3 108.903 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 7.6 t70 -86.76 137.39 32.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.087 -0.96 . . . . 3.48 109.968 -173.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 1.1 57.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 4.54 110.88 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.46 -52.32 3.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.813 -0.81 . . . . 3.49 108.813 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 16.6 pttp -110.78 113.18 55.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.536 -0.757 . . . . 3.0 110.443 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.36 163.02 39.88 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.902 2.401 . . . . 2.24 113.192 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.64 145.82 8.94 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.899 -0.667 . . . . 1.29 111.555 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.76 126.95 41.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.282 0.563 . . . . 1.5 110.565 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.641 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 50.0 m-85 -124.5 158.04 33.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.233 -0.894 . . . . 0.87 109.096 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.3 mm -87.66 112.39 23.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.461 -0.57 . . . . 0.39 109.461 175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HA ' ' CD2' ' A' ' 27' ' ' HIS . 6.9 tmm_? -69.35 -55.68 9.72 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.097 -0.705 . . . . 2.83 109.097 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -163.15 143.54 9.17 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.485 -0.931 . . . . 1.26 108.485 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.9 p -98.93 122.64 50.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.048 -0.723 . . . . 0.37 109.048 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 14.2 m-20 -62.29 115.29 15.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.499 -0.556 . . . . 2.28 109.499 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 19.6 Cg_endo -58.0 150.88 61.58 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.857 2.372 . . . . 1.17 113.003 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 66.66 47.65 1.55 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.039 -0.982 . . . . 2.4 110.33 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 90.2 p -133.6 160.85 66.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.95 -0.568 . . . . 0.57 110.629 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -28.53 83.81 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.443 2.095 . . . . 0.65 111.451 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.42 76.46 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.409 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -67.49 -41.54 84.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 2.01 110.107 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.62 69.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.47 111.975 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.534 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 62.0 p -70.72 -16.58 62.79 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.038 0.446 . . . . 0.4 110.578 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.07 15.37 22.06 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.73 -0.748 . . . . 0.62 112.975 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -72.02 147.8 46.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.103 -0.332 . . . . 0.65 110.103 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -140.84 157.62 45.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.957 -0.386 . . . . 4.38 109.957 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -80.11 155.12 27.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.42 -0.355 . . . . 1.44 110.831 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 14.1 mm100 75.24 7.45 4.09 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.977 0.798 . . . . 3.06 111.848 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 89.9 m-20 -93.12 154.91 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.946 -0.39 . . . . 1.02 109.946 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.604 HH11 ' HB3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -111.18 133.62 53.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.227 -0.442 . . . . 1.57 109.888 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HA ' HG12 ' A' ' 88' ' ' VAL . 71.9 mt -78.25 124.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.68 110.849 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.09 -25.78 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.899 -0.591 . . . . 0.87 112.08 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.2 mt-10 -140.24 145.2 37.05 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.32 . . . . 0.89 110.625 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 65' ' ' MET . 96.6 t -131.44 124.83 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.66 109.885 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.3 21.64 9.89 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.223 0.609 . . . . 1.17 111.523 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.17 3.56 67.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.538 -0.839 . . . . 0.66 112.665 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.95 128.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.105 -0.331 . . . . 1.17 110.105 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.4 t -63.5 121.16 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.949 0.404 . . . . 1.68 110.467 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.806 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 25.9 mmt -108.72 -1.08 19.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.866 -0.606 . . . . 0.81 111.238 -176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -71.86 84.28 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.47 0.652 . . . . 3.75 109.718 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.18 -8.29 5.09 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.627 -0.715 . . . . 1.47 111.749 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.806 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.8 mmtt -75.97 -172.36 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 3.36 111.09 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -112.83 161.58 16.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 2.89 110.216 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -56.28 -42.88 78.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.726 0.298 . . . . 1.42 110.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.59 -32.87 79.58 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.563 -0.827 . . . . 0.72 112.503 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.5 -47.32 61.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 2.03 110.432 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.477 HG12 ' SD ' ' A' ' 65' ' ' MET . 33.3 m -67.42 -41.92 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.944 -0.571 . . . . 1.08 111.503 -176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.35 -40.05 81.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 0.72 110.799 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -66.26 -38.23 87.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.66 110.108 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.3 97.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.42 111.264 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.554 HG23 HG21 ' A' ' 84' ' ' THR . 85.0 mt -58.38 -42.15 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.36 0.6 . . . . 0.69 110.591 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -74.74 -35.83 62.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.66 -0.7 . . . . 3.09 110.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.88 7.44 18.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.956 -0.566 . . . . 0.65 111.869 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 -14.59 81.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.6 112.013 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.01 -133.04 9.97 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.942 -0.863 . . . . 1.1 110.942 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 2.9 t70 -103.85 11.17 36.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.524 0.678 . . . . 2.12 109.69 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -149.2 159.58 44.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.298 -0.865 . . . . 2.11 109.473 174.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.554 HG21 HG23 ' A' ' 77' ' ' ILE . 14.8 t -148.35 149.77 32.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.32 110.52 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.536 ' HB3' HD11 ' A' ' 12' ' ' LEU . 76.1 mttt -110.89 117.07 32.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.059 -0.518 . . . . 1.63 110.014 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.524 HD12 ' HE3' ' A' ' 15' ' ' MET . 85.0 mt -106.73 118.98 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.703 -0.48 . . . . 0.28 109.703 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.61 HD12 HD13 ' A' ' 12' ' ' LEU . 4.8 tt -106.79 119.93 40.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.067 -0.716 . . . . 0.51 109.067 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 57' ' ' ILE . 35.5 m -126.59 166.76 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.226 -0.443 . . . . 0.33 110.958 -173.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 m -127.33 136.93 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.42 110.72 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 166.37 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.368 -0.833 . . . . 1.92 110.37 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -56.06 -47.5 77.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.302 . . . . 4.16 110.843 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.647 ' HG3' HD23 ' A' ' 8' ' ' LEU . 11.2 pt-20 -60.57 -38.24 83.92 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.3 0.571 . . . . 2.68 110.314 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.411 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 25.9 m -71.25 -48.35 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.24 -0.891 . . . . 0.47 110.691 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.516 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 24.7 t70 -60.55 -49.04 79.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.959 -0.564 . . . . 1.18 110.966 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.496 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 36.2 mt-10 -64.83 -27.55 68.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.94 111.141 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.37 -48.52 55.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 0.73 110.034 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 93' ' ' THR . 41.9 m-85 -66.71 -36.74 83.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.377 -0.374 . . . . 0.44 111.82 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.7 mtpp -57.79 -50.14 74.27 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.665 0.246 . . . . 1.92 111.665 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 99' ' ' LYS . 11.2 ptmm? -71.48 -33.96 69.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 2.04 110.757 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -75.55 -11.28 59.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.529 -0.759 . . . . 1.39 111.969 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 55.71 33.49 21.46 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.406 0.682 . . . . 4.09 111.174 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.31 143.74 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 1.42 110.19 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.2 mm -89.78 117.26 67.97 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.059 -0.349 . . . . 1.33 110.059 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.77 140.86 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.349 2.033 . . . . 0.53 111.51 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.4 p -157.73 175.07 14.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.427 -0.351 . . . . 1.42 111.195 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.539 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 10.8 mt-30 -53.62 -34.77 59.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.266 0.555 . . . . 1.66 111.127 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -59.3 -30.04 68.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.589 -0.732 . . . . 2.82 111.026 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -87.81 -12.85 43.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.53 112.103 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.55 HD21 HD11 ' A' ' 87' ' ' LEU . 77.0 mt -55.0 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.188 0.44 . . . . 1.24 112.188 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.968 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 9.9 t30 72.54 -14.7 0.54 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.684 -0.689 . . . . 3.7 112.225 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 112' ' ' PRO . . . -83.68 -121.13 0.8 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.725 -0.75 . . . . 1.12 112.669 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 111' ' ' GLY . 52.4 Cg_endo -87.33 110.85 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.868 2.379 . . . . 1.31 112.768 -176.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 58.2 mt -79.01 167.25 36.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.622 . . . . 1.11 109.447 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -44.75 -50.01 8.86 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.668 2.245 . . . . 1.15 112.877 175.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 96.3 t 68.75 121.13 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.902 -1.045 . . . . 2.98 110.878 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 3.9 Cg_exo -74.23 52.5 2.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.333 2.689 . . . . 4.23 113.086 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.7 t80 62.85 96.59 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.826 0.851 . . . . 7.33 112.952 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 m -125.44 -45.83 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.271 -1.011 . . . . 8.78 108.271 168.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -108.43 179.07 4.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.962 -1.017 . . . . 9.34 109.277 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.38 -168.86 39.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.475 -0.869 . . . . 11.55 113.145 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -80.15 121.74 25.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.917 0.389 . . . . 13.92 110.588 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.0 pt -76.7 -26.51 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.907 -0.588 . . . . 16.21 110.586 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 50.82 74.36 0.24 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.782 0.676 . . . . 18.82 112.75 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -116.35 156.97 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 20.83 110.169 174.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -175.0 -66.4 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 22.5 109.934 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.85 -34.09 57.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.753 -0.658 . . . . 23.99 110.341 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.1 t -145.05 159.7 42.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.716 -0.674 . . . . 25.0 109.968 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 128' ' ' ARG . 37.4 ttm180 . . . . . 0 C--O 1.25 1.119 0 O-C-N 124.205 0.94 . . . . 27.52 110.636 174.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.776 -0.529 . . . . 11.87 111.776 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.4 pt -114.44 138.79 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 9.86 110.764 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.54 141.57 24.82 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.369 -0.604 . . . . 6.96 109.369 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.86 -71.13 0.04 OUTLIER 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.403 2.069 . . . . 6.65 113.175 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -143.72 58.96 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.31 . . . . 7.99 111.504 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -91.26 99.97 12.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.501 -0.555 . . . . 4.26 109.501 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.5 ' HG3' ' HG2' ' A' ' 9' ' ' ARG . 22.0 ptp -94.98 -15.0 23.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.641 -0.708 . . . . 3.84 111.763 -168.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 93' ' ' THR . 86.6 mt 62.93 19.37 11.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.613 -0.721 . . . . 0.8 112.555 174.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.567 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 31.4 ptt180 -114.52 160.02 34.68 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.717 -0.846 . . . . 3.09 108.717 173.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 30.7 Cg_endo -62.55 167.22 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.885 1.723 . . . . 0.47 111.895 -177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.534 ' HG3' HG23 ' A' ' 88' ' ' VAL . 1.6 ptm180 -128.56 135.96 50.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.971 -0.559 . . . . 2.37 110.347 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HG ' HD11 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -96.51 116.7 29.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 1.32 110.248 -176.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 82.6 m -101.61 116.81 33.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.579 -0.526 . . . . 0.4 109.579 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -108.79 120.27 41.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.399 -0.593 . . . . 0.35 109.399 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.27 133.35 38.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.572 . . . . 0.88 111.548 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -101.87 144.23 30.78 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.375 -0.83 . . . . 2.58 109.649 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.8 ttmt -65.66 113.01 3.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.036 0.446 . . . . 0.92 110.562 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.01 -99.72 1.57 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.444 -0.798 . . . . 1.28 111.323 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.43 97.97 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.761 2.307 . . . . 2.23 112.327 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 t 71.39 -47.19 0.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.004 0.922 . . . . 2.87 112.554 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 161.02 81.57 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.375 -0.917 . . . . 1.93 112.83 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 44' ' ' SER . 23.3 m-85 68.13 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.267 0.627 . . . . 1.82 111.601 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.81 69.76 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.896 -0.669 . . . . 0.43 112.817 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.31 154.06 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.705 -0.48 . . . . 0.4 109.705 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -119.27 131.46 55.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.806 0.336 . . . . 2.18 110.99 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.42 133.61 45.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.016 -0.538 . . . . 1.52 110.222 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.1 p80 -120.44 139.38 52.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 1.34 110.601 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.17 133.22 52.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.998 -0.741 . . . . 2.3 108.998 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.702 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.6 t70 -87.29 142.33 27.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.115 0.483 . . . . 3.48 110.478 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -77.72 -27.99 50.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.663 -0.699 . . . . 4.54 111.201 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 m -93.24 -43.39 8.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.253 -0.43 . . . . 3.49 110.568 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 24.1 pttm -116.9 130.52 24.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.357 -0.383 . . . . 3.0 110.399 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.54 156.43 36.22 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.521 2.148 . . . . 2.24 112.735 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.74 159.98 10.84 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.896 -0.669 . . . . 1.29 112.165 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -97.33 128.66 44.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.915 0.388 . . . . 1.5 110.163 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.447 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 68.8 m-85 -121.98 148.91 44.21 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.696 -0.853 . . . . 0.87 108.696 175.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.555 HG13 ' HB2' ' A' ' 55' ' ' ASP . 38.2 mm -68.32 109.25 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 0.39 109.775 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -65.81 -54.45 26.73 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.235 -1.024 . . . . 2.83 108.235 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 m -166.34 135.46 3.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 1.26 109.348 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -94.65 121.81 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.386 -0.968 . . . . 0.37 108.386 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -78.22 121.52 84.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.255 -0.43 . . . . 2.28 110.032 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.75 155.98 20.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.513 2.809 . . . . 1.17 112.584 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.7 51.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.998 0.904 . . . . 2.4 109.218 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.2 p -146.94 154.56 47.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.979 -1.009 . . . . 0.57 109.508 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.89 -25.55 78.25 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 0.65 111.705 174.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.52 -43.2 70.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.36 110.339 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -67.97 -35.0 77.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.218 0.533 . . . . 2.01 109.808 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -18.97 60.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.566 -0.743 . . . . 0.47 111.58 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 24.2 p -70.42 -18.1 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.138 0.494 . . . . 0.4 109.78 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.31 -0.57 33.01 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.986 -0.626 . . . . 0.62 112.141 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD11 HG13 ' A' ' 37' ' ' ILE . 22.4 tp -61.76 139.39 58.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.541 0.21 . . . . 0.65 110.735 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -124.56 -164.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.459 -0.571 . . . . 4.38 109.459 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.0 140.72 29.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.971 0.415 . . . . 1.44 111.081 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 68.91 26.82 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.952 -1.022 . . . . 3.06 113.013 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.555 ' HB2' HG13 ' A' ' 37' ' ' ILE . 6.2 m-20 -69.7 142.93 53.25 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.377 -0.971 . . . . 1.02 108.377 167.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -108.69 128.44 54.86 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.517 -0.549 . . . . 1.57 109.517 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 88' ' ' VAL . 24.4 mm -71.91 130.1 35.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 0.68 111.257 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 104' ' ' PRO . 58.2 t -111.79 -51.52 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.87 109.959 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.6 mt-10 -136.89 152.49 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.746 -0.661 . . . . 0.89 110.283 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 77' ' ' ILE . 87.7 t -129.45 115.7 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.527 . . . . 0.66 109.579 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.21 26.49 15.89 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.478 0.486 . . . . 1.17 111.157 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.54 13.31 67.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.852 -0.69 . . . . 0.66 112.524 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.68 122.77 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.718 -0.475 . . . . 1.17 109.718 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.577 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.1 t -65.53 129.77 40.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.037 -0.529 . . . . 1.68 111.338 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.472 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.0 mmt -115.27 14.71 16.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.81 111.159 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 103' ' ' ILE . 56.5 mm-40 -62.31 -31.06 71.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.622 . . . . 3.75 111.489 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.96 20.32 14.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 1.47 112.098 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 72' ' ' ASP . 71.9 mmtt -101.45 177.43 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.934 0.397 . . . . 3.36 110.749 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -125.61 -178.39 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.9 -0.591 . . . . 2.89 109.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -54.12 -41.15 68.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.781 0.289 . . . . 1.42 111.781 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.62 93.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.643 -0.789 . . . . 0.72 112.831 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 68' ' ' LYS . 10.4 m-20 -65.58 -45.99 81.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 2.03 110.972 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 77' ' ' ILE . 98.7 t -62.54 -46.96 95.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 1.08 110.87 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.51 -37.87 78.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.834 0.349 . . . . 0.72 111.444 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.6 t -61.55 -38.79 88.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.74 -0.467 . . . . 0.66 109.74 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.58 78.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.42 111.194 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 73' ' ' VAL . 28.7 mm -57.35 -42.46 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.678 0.751 . . . . 0.69 109.378 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -74.81 -37.31 62.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.051 -0.977 . . . . 3.09 111.079 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -6.36 40.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.543 . . . . 0.65 111.988 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.16 -28.18 68.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.6 112.578 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.74 -120.15 4.74 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.768 -0.73 . . . . 1.1 111.442 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 51.4 m-20 -108.74 7.68 26.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 2.12 110.482 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.39 156.73 41.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.974 -0.75 . . . . 2.11 108.974 171.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.927 0.394 . . . . 0.32 110.076 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -116.89 119.89 36.76 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 1.63 109.596 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.2 128.26 53.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.979 -0.555 . . . . 0.28 110.092 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 10' ' ' PRO . 23.2 tp -103.66 115.2 30.06 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.288 -1.004 . . . . 0.51 108.288 174.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.534 HG23 ' HG3' ' A' ' 11' ' ' ARG . 16.1 m -127.58 163.89 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 116.004 -0.544 . . . . 0.33 111.044 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.38 139.15 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.591 -0.731 . . . . 0.42 110.082 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.79 175.88 9.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.167 -0.469 . . . . 1.92 109.817 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 91' ' ' ARG . 3.3 tpp180 -62.5 -42.04 99.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 111.708 0.262 . . . . 4.16 111.708 -171.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.32 -42.91 87.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 2.68 110.715 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' LEU . 85.7 m -66.48 -45.83 78.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.856 -0.611 . . . . 0.47 111.451 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 40.7 t0 -58.97 -47.44 85.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 1.18 109.318 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 68.2 mm-40 -59.95 -37.67 80.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 1.94 110.821 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.65 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 84.5 t80 -62.96 -49.34 75.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.512 -0.313 . . . . 0.73 110.973 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.415 ' HD1' HG13 ' A' ' 102' ' ' VAL . 32.1 m-85 -66.64 -38.15 86.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.601 -0.272 . . . . 0.44 111.45 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 28.1 mtpp -60.28 -48.79 80.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.721 0.296 . . . . 1.92 111.326 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.2 pttt -71.47 -14.55 62.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.277 -0.419 . . . . 2.04 111.295 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 99.5 m -93.32 -10.62 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 1.39 111.257 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.78 28.23 17.98 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.821 -0.627 . . . . 4.09 111.502 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.658 HG11 ' HG3' ' A' ' 114' ' ' PRO . 10.1 p -123.82 142.12 41.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.998 0.428 . . . . 1.42 110.848 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.74 HG23 ' HG3' ' A' ' 66' ' ' GLU . 70.5 mt -79.4 128.43 75.36 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.718 -0.674 . . . . 1.33 110.971 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.681 ' HB2' HG11 ' A' ' 58' ' ' VAL . 6.1 Cg_exo -71.9 160.28 48.16 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.069 2.513 . . . . 0.53 111.602 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.2 p -165.31 164.96 19.79 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.921 -0.312 . . . . 1.42 110.735 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -59.22 -28.53 66.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 1.66 110.931 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -58.91 -30.53 67.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.031 0.443 . . . . 2.82 110.892 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -77.52 -15.16 59.44 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.324 -0.398 . . . . 0.53 111.509 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.427 HD11 ' HG ' ' A' ' 12' ' ' LEU . 60.1 mt -65.01 -61.59 2.07 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.529 0.68 . . . . 1.24 110.455 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.37 19.72 9.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.127 -0.942 . . . . 3.7 110.36 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.68 -175.81 14.17 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.855 -0.612 . . . . 1.12 112.139 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -87.44 159.83 8.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.354 2.702 . . . . 1.31 112.568 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' A' ' 9' ' ' ARG . 45.3 mt -84.74 154.34 61.52 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.772 -0.649 . . . . 1.11 109.321 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.658 ' HG3' HG11 ' A' ' 102' ' ' VAL . 31.4 Cg_endo -64.57 112.52 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.506 2.138 . . . . 1.15 112.717 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 15.5 m -150.22 145.93 19.37 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 114.778 -1.101 . . . . 2.98 109.57 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.9 Cg_exo -78.41 67.31 8.32 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.981 2.454 . . . . 4.23 111.441 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -98.12 99.36 10.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.183 -0.462 . . . . 7.33 110.895 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.2 m 59.09 -85.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.457 0.703 . . . . 8.78 112.209 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -151.33 31.55 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 9.34 109.646 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.15 66.91 2.5 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.553 -0.748 . . . . 11.55 113.214 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.6 105.38 17.33 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.283 -0.636 . . . . 13.92 109.283 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.3 pt -71.62 125.29 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 16.21 111.365 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -81.98 65.66 7.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.04 -0.527 . . . . 18.82 111.141 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -84.09 -6.26 59.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.628 -0.714 . . . . 20.83 109.62 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -69.01 -55.24 11.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.303 -0.862 . . . . 22.5 110.533 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -100.27 114.55 28.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.925 -0.58 . . . . 23.99 110.523 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m -111.34 44.21 1.36 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 25.0 111.657 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 128' ' ' ARG . 34.4 ttt180 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.349 -0.834 . . . . 27.52 110.198 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.532 -0.627 . . . . 11.87 111.532 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.4 mt 53.0 86.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.375 0.607 . . . . 9.86 111.216 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.12 139.0 95.01 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.71 -0.677 . . . . 6.96 110.75 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.35 46.66 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.115 2.543 . . . . 6.65 111.888 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 62.3 74.33 0.44 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.413 -0.812 . . . . 7.99 110.494 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -89.16 36.02 0.81 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.6 0.714 . . . . 4.26 110.286 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 62.3 mtt -91.86 20.37 5.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.729 -0.669 . . . . 3.84 110.271 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.67 54.84 2.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.542 -0.753 . . . . 0.8 110.078 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 109' ' ' LEU . 32.2 ptt180 -119.98 161.4 38.55 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.434 -0.803 . . . . 3.09 109.948 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.613 ' HB2' HD11 ' A' ' 87' ' ' LEU . 6.8 Cg_exo -70.28 169.73 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.463 2.109 . . . . 0.47 111.703 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HG3' HG23 ' A' ' 88' ' ' VAL . 6.5 ptt180 -128.5 131.37 48.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.834 -0.621 . . . . 2.37 110.505 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 85' ' ' LYS . 48.7 tp -95.43 110.57 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.009 -0.541 . . . . 1.32 109.623 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 60.0 m -92.98 117.8 30.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.23 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 85' ' ' LYS . 23.8 m -106.56 118.76 37.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.487 -0.56 . . . . 0.35 109.487 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.9 ptp -133.79 133.65 41.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.826 -0.624 . . . . 0.88 110.486 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.66 136.73 52.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.046 -0.525 . . . . 2.58 110.016 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 9.5 ttmt -54.65 119.07 4.77 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.478 -0.783 . . . . 0.92 111.337 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.43 -107.37 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.568 -0.825 . . . . 1.28 112.678 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.88 -66.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.163 2.575 . . . . 2.23 112.904 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 t -140.86 85.45 1.99 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.375 -0.602 . . . . 2.87 109.375 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.32 -132.1 11.44 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.542 -0.837 . . . . 1.93 111.724 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 44' ' ' SER . 48.7 m-85 -119.99 -31.5 4.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.173 0.511 . . . . 1.82 110.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.42 68.05 1.2 Allowed Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.327 -0.851 . . . . 0.43 113.245 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -156.92 151.89 26.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.753 -0.462 . . . . 0.4 109.753 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.9 m120 -101.45 135.35 43.11 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.194 -0.669 . . . . 2.18 109.194 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -101.29 151.18 22.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.045 0.45 . . . . 1.52 111.352 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -108.9 122.1 46.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.78 -0.646 . . . . 1.34 110.1 -177.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.3 m -121.53 99.37 6.43 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.881 -0.414 . . . . 2.3 109.881 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -98.03 122.54 41.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.949 0.405 . . . . 3.48 111.234 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -89.37 48.67 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.305 0.574 . . . . 4.54 109.872 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 t -158.21 -66.78 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.481 -0.781 . . . . 3.49 109.349 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -95.67 119.67 64.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.847 -0.427 . . . . 3.0 109.847 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.64 150.85 69.45 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.871 2.381 . . . . 2.24 112.691 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.8 172.11 13.46 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.267 -0.879 . . . . 1.29 110.981 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HG3' HG21 ' A' ' 73' ' ' VAL . 23.0 mm-40 -125.09 128.04 47.85 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.466 -0.568 . . . . 1.5 109.466 175.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.2 m-85 -119.96 157.79 28.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.737 -0.468 . . . . 0.87 109.737 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.556 HG13 HD11 ' A' ' 51' ' ' LEU . 47.5 mm -91.21 109.89 21.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.29 0.566 . . . . 0.39 109.541 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 28.5 ttt180 -63.15 -48.19 79.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.93 -1.032 . . . . 2.83 109.892 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -162.36 160.34 26.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.571 -0.9 . . . . 1.26 108.571 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.58 132.44 71.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.417 -0.586 . . . . 0.37 109.417 174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -74.45 125.84 89.4 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.877 -0.416 . . . . 2.28 109.877 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 141.85 97.92 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.747 2.298 . . . . 1.17 112.069 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 64.59 49.86 2.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.756 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 95.6 p -126.88 158.62 67.89 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.795 -0.639 . . . . 0.57 110.234 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 11.3 Cg_endo -57.99 -27.86 80.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.257 1.971 . . . . 0.65 111.147 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.79 -51.97 59.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.36 110.465 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.49 -38.23 90.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.286 -0.415 . . . . 2.01 110.762 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.67 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.47 111.415 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 59.5 p -70.68 -14.47 62.47 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.896 0.379 . . . . 0.4 111.03 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.99 7.07 29.5 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.018 -0.61 . . . . 0.62 112.899 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.556 HD11 HG13 ' A' ' 37' ' ' ILE . 19.7 tp -76.61 130.51 37.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.546 0.212 . . . . 0.65 110.579 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.16 -163.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 4.38 110.951 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.56 140.02 29.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.156 -0.474 . . . . 1.44 111.207 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 70.34 15.85 7.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.307 -0.86 . . . . 3.06 112.162 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.1 m-20 -69.48 128.39 36.36 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.986 -0.376 . . . . 1.02 109.986 173.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.5 123.79 36.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 1.57 110.583 -179.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.16 124.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.68 110.793 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.414 HG11 ' HD2' ' A' ' 104' ' ' PRO . 43.1 t -105.29 -45.15 8.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.87 110.949 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 30.5 mt-10 -132.82 153.52 51.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.89 110.479 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -126.77 120.97 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.112 -0.495 . . . . 0.66 109.842 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 63.57 17.77 10.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.192 0.597 . . . . 1.17 111.205 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.512 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.8 4.62 65.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.66 112.528 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.88 128.69 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.66 0.267 . . . . 1.17 110.38 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 92.5 m -59.38 118.67 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.724 -0.671 . . . . 1.68 111.558 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.8 mmt -126.88 70.79 1.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.916 -0.584 . . . . 0.81 111.774 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -135.43 139.42 44.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.968 -0.382 . . . . 3.75 109.968 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.5 -0.46 89.25 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.938 -1.265 . . . . 1.47 109.938 -168.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -74.2 163.56 27.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.15 -1.025 . . . . 3.36 111.724 -178.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -99.4 177.81 5.07 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.594 -0.891 . . . . 2.89 108.594 173.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -63.0 -37.85 88.83 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.841 0.353 . . . . 1.42 110.684 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.79 92.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.256 -0.497 . . . . 0.72 113.112 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.96 -47.55 80.0 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.958 0.409 . . . . 2.03 110.966 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.511 HG21 ' HG3' ' A' ' 35' ' ' GLN . 3.4 m -71.81 -41.87 69.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.844 -0.616 . . . . 1.08 111.496 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 69.6 t -61.99 -48.14 89.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.637 -0.256 . . . . 0.72 110.75 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 t -62.47 -37.67 86.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.552 -0.295 . . . . 0.66 110.303 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.89 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.797 0.332 . . . . 0.42 111.468 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.95 -41.21 90.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 0.69 110.805 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 69.0 mtp180 -74.03 -35.71 64.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 3.09 111.091 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.41 -17.17 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.65 110.938 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.19 -21.06 67.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.021 -0.609 . . . . 0.6 112.1 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -117.99 5.11 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.029 -0.605 . . . . 1.1 111.963 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 39.6 m-20 -113.97 8.89 17.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 2.12 110.876 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.06 160.22 42.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.11 -0.7 . . . . 2.11 109.11 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.3 t -153.19 148.81 27.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.861 0.362 . . . . 0.32 110.594 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HB3' HD11 ' A' ' 12' ' ' LEU . 6.9 mptt -112.93 121.95 46.18 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.389 -0.597 . . . . 1.63 109.389 175.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.29 133.77 49.5 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.801 -0.444 . . . . 0.28 109.801 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.613 HD11 ' HB2' ' A' ' 10' ' ' PRO . 64.3 tp -103.84 115.99 31.48 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.17 -0.678 . . . . 0.51 109.17 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 14.3 m -131.62 155.41 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.019 -0.537 . . . . 0.33 111.209 -173.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.72 146.95 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.411 -0.813 . . . . 0.42 110.331 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.06 176.85 6.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.793 -0.64 . . . . 1.92 109.396 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 ttm105 -56.4 -47.92 78.0 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.786 0.291 . . . . 4.16 111.786 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.72 -40.82 89.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.116 0.484 . . . . 2.68 110.819 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.2 m -74.37 -48.12 29.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.726 -0.67 . . . . 0.47 111.154 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 5.5 t0 -60.78 -43.43 98.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 1.18 110.307 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -59.33 -37.44 77.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.256 -0.429 . . . . 1.94 110.669 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.431 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 91.3 t80 -63.16 -47.39 82.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.049 0.452 . . . . 0.73 110.296 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -67.4 -37.12 82.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.266 -0.425 . . . . 0.44 111.71 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 58.4 mttm -58.56 -50.15 74.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.913 0.387 . . . . 1.92 110.821 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 96' ' ' PHE . 19.3 ptmt -69.7 -22.35 63.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.742 -0.663 . . . . 2.04 110.904 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.37 -16.41 37.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.563 . . . . 1.39 111.072 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER 61.07 37.18 18.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.489 -0.778 . . . . 4.09 111.393 -178.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.488 HG11 ' HG3' ' A' ' 114' ' ' PRO . 12.7 p -134.54 138.18 50.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.891 0.376 . . . . 1.42 110.688 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 70.0 mt -77.85 131.66 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 1.33 110.748 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.476 ' HB3' ' HG3' ' A' ' 10' ' ' PRO . 5.9 Cg_exo -70.54 153.43 65.34 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.946 2.431 . . . . 0.53 111.881 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 108' ' ' HIS . 21.9 p -158.19 178.39 10.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.592 -0.277 . . . . 1.42 110.398 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.554 ' HA ' ' CD2' ' A' ' 109' ' ' LEU . 2.7 mp0 -55.61 -38.01 68.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 1.66 110.722 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -59.91 -31.28 69.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.248 0.547 . . . . 2.82 110.965 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.445 ' HD2' ' HD3' ' A' ' 114' ' ' PRO . 35.7 m80 -83.04 -25.48 32.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.53 111.584 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 106' ' ' GLN . 4.4 pp -95.34 -28.87 14.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.769 -0.651 . . . . 1.24 110.959 -175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.424 ' N ' HD12 ' A' ' 109' ' ' LEU . 23.0 t-20 -93.42 -23.79 18.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 3.7 110.034 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.51 -145.72 9.71 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.923 -0.656 . . . . 1.12 112.299 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.78 169.01 2.51 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.151 2.568 . . . . 1.31 112.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -90.53 151.16 43.83 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.709 -0.678 . . . . 1.11 110.095 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.488 ' HG3' HG11 ' A' ' 102' ' ' VAL . 74.1 Cg_endo -73.17 165.21 33.3 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 123.13 2.553 . . . . 1.15 112.351 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 7.3 p -88.56 124.09 66.67 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.923 -0.581 . . . . 2.98 109.92 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 19.3 Cg_exo -65.97 88.17 0.24 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.83 2.353 . . . . 4.23 111.77 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -72.52 125.92 28.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.994 -0.548 . . . . 7.33 110.234 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.6 m 62.55 68.83 0.63 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.646 -0.706 . . . . 8.78 110.497 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -124.29 69.32 1.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.496 -0.774 . . . . 9.34 109.539 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.72 55.82 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.852 -0.69 . . . . 11.55 111.871 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -73.73 95.81 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.423 -0.584 . . . . 13.92 109.423 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.7 pt -84.7 107.46 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.597 0.713 . . . . 16.21 112.496 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -103.82 74.35 1.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.809 -0.812 . . . . 18.82 108.809 170.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -122.96 71.48 1.05 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.571 -0.529 . . . . 20.83 109.571 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.63 3.12 17.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.962 -0.563 . . . . 22.5 110.35 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.64 -37.54 0.33 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.679 0.791 . . . . 23.99 111.707 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.7 t 74.45 -42.81 0.51 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.945 0.898 . . . . 25.0 110.797 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.536 -0.745 . . . . 27.52 109.918 177.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 111.407 -0.677 . . . . 11.87 111.407 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.1 mm -90.43 61.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.475 -0.935 . . . . 9.86 108.475 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 6' ' ' THR . 6.1 m-20 -78.19 125.86 84.39 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.156 -0.929 . . . . 6.96 110.521 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.45 -9.99 27.65 Favored 'Trans proline' 0 C--O 1.229 0.074 0 C-N-CA 122.834 2.356 . . . . 6.65 112.462 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -107.14 11.5 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.914 0.339 . . . . 7.99 111.914 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' ' 9' ' ' ARG . 12.9 t -78.38 -35.95 46.55 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.166 -1.05 . . . . 4.26 108.166 171.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.3 ttm 62.4 11.43 4.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.449 -1.25 . . . . 3.84 112.419 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.482 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 88.6 mt 59.62 34.92 22.39 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.635 0.731 . . . . 0.8 110.57 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 6' ' ' THR . 14.2 ptt180 -123.78 147.89 54.86 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.022 -0.99 . . . . 3.09 109.025 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HB2' HD11 ' A' ' 87' ' ' LEU . 30.8 Cg_endo -68.52 149.62 74.52 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.586 1.524 . . . . 0.47 110.798 172.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -120.6 135.49 55.08 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.283 -0.417 . . . . 2.37 110.25 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -92.68 111.25 22.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.957 -0.565 . . . . 1.32 110.159 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.29 117.61 30.37 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.517 -0.765 . . . . 0.4 109.368 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' LYS . 27.0 m -109.57 119.05 38.22 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.685 -0.487 . . . . 0.35 109.685 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.605 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 24.4 ptp -131.33 133.59 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.04 0.447 . . . . 0.88 111.003 -174.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -97.9 132.63 43.32 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.871 -0.604 . . . . 2.58 109.421 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 20.6 ttmt -50.67 129.21 22.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.925 -0.58 . . . . 0.92 111.517 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.97 -158.42 24.36 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.771 -0.728 . . . . 1.28 111.588 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.74 -27.46 44.57 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.06 2.507 . . . . 2.23 112.642 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.0 p -105.16 13.87 30.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.039 -0.528 . . . . 2.87 110.563 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.49 -108.06 2.73 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.615 -0.803 . . . . 1.93 111.182 -173.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.39 159.95 36.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.488 -0.93 . . . . 1.82 108.488 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.78 75.17 0.4 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 119.883 -1.151 . . . . 0.43 113.298 -173.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.03 168.77 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.849 0.357 . . . . 0.4 110.54 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -131.53 143.27 50.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.914 -0.585 . . . . 2.18 110.552 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.56 145.17 30.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.484 0.659 . . . . 1.52 111.835 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -110.65 129.38 55.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 1.34 109.426 172.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.7 m -151.72 84.03 1.29 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.58 -0.896 . . . . 2.3 108.58 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.0 153.23 21.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.326 -0.852 . . . . 3.48 111.074 -171.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -82.47 49.71 1.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.689 0.756 . . . . 4.54 109.72 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 t -151.33 -38.53 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.641 -1.163 . . . . 3.49 109.261 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -141.45 128.18 11.49 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.795 -0.638 . . . . 3.0 109.979 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.77 158.28 35.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.551 2.167 . . . . 2.24 112.41 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.46 166.26 13.07 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.224 -0.75 . . . . 1.29 111.224 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.568 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 2.7 mp0 -107.85 126.29 52.48 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.961 -0.385 . . . . 1.5 109.961 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 61.6 m-85 -117.61 157.67 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.551 -0.907 . . . . 0.87 108.551 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG13 HD11 ' A' ' 51' ' ' LEU . 44.2 mm -90.91 109.43 20.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 C-N-CA 120.598 -0.441 . . . . 0.39 109.834 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -69.12 -54.63 13.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.889 -0.596 . . . . 2.83 110.547 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -152.36 144.1 23.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.709 -0.678 . . . . 1.26 109.912 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.77 137.89 55.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.732 -0.47 . . . . 0.37 109.732 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -82.05 122.96 80.1 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.563 0.22 . . . . 2.28 110.544 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -65.01 -19.68 63.78 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.867 2.378 . . . . 1.17 112.538 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.78 4.51 52.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.913 -0.585 . . . . 2.4 110.633 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 38.8 p -108.86 158.78 33.24 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 122.104 -0.372 . . . . 0.57 110.783 -174.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 28.3 Cg_endo -63.06 -15.97 51.36 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.798 2.332 . . . . 0.65 112.033 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -67.69 -51.51 48.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.096 -0.502 . . . . 0.36 110.328 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' HG3' ' HA ' ' A' ' 42' ' ' PRO . 4.4 tm-20 -64.48 -40.65 96.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.918 -0.771 . . . . 2.01 108.918 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.36 69.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.961 -0.563 . . . . 0.47 111.966 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 15' ' ' MET . 60.3 p -77.32 -12.54 59.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.928 0.394 . . . . 0.4 110.898 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.25 9.44 27.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.783 -0.723 . . . . 0.62 112.734 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 37' ' ' ILE . 29.9 tp -78.17 141.58 38.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.727 0.298 . . . . 0.65 110.497 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.8 tpp180 -143.63 164.82 29.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.383 -0.599 . . . . 4.38 109.383 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.57 152.97 40.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.603 -0.271 . . . . 1.44 111.231 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 74.64 11.32 3.92 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.061 0.851 . . . . 3.06 112.135 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 17.9 m-20 -92.08 151.97 20.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.774 -0.454 . . . . 1.02 109.774 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -105.54 136.61 44.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.51 -0.313 . . . . 1.57 110.666 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.65 130.15 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.294 -0.412 . . . . 0.68 110.151 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.773 HG11 ' HG2' ' A' ' 104' ' ' PRO . 22.7 t -114.37 -47.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 0.87 111.057 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.5 mt-10 -126.29 148.82 49.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.887 0.375 . . . . 0.89 110.928 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 63' ' ' VAL . 61.8 t -129.41 122.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.66 109.206 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 62.87 21.09 12.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.785 0.434 . . . . 1.17 111.056 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.3 74.73 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.733 -0.746 . . . . 0.66 113.382 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 60' ' ' VAL . 14.6 p -107.61 138.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.38 0.59 . . . . 1.17 110.111 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 50.9 t -74.5 136.81 42.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 1.68 111.434 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.607 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 25.1 mmt -121.62 68.06 0.9 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.447 -0.797 . . . . 0.81 111.128 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -103.69 -59.15 1.77 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.324 -0.398 . . . . 3.75 110.517 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.62 4.74 Favored Glycine 0 C--N 1.329 0.182 0 N-CA-C 111.548 -0.621 . . . . 1.47 111.548 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.607 ' HG2' ' HB3' ' A' ' 65' ' ' MET . 0.0 OUTLIER -110.94 -172.19 1.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.782 0.801 . . . . 3.36 112.722 -171.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -121.46 150.0 42.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.377 -1.283 . . . . 2.89 108.287 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -56.21 -43.7 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 118.267 0.485 . . . . 1.42 110.162 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.66 88.15 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.696 -0.684 . . . . 0.72 112.668 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.92 -40.03 83.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 2.03 110.362 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 77' ' ' ILE . 63.9 t -65.29 -47.34 87.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.85 -0.614 . . . . 1.08 110.825 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' HA ' HD12 ' A' ' 77' ' ' ILE . 57.6 t -64.9 -36.78 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.21 0.529 . . . . 0.72 110.071 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 t -61.58 -44.41 97.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.594 -0.73 . . . . 0.66 110.163 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.82 -42.54 93.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.227 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.522 HG23 HG21 ' A' ' 84' ' ' THR . 74.4 mt -58.9 -40.75 81.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.69 110.773 177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.5 mtm-85 -74.18 -39.36 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 3.09 110.976 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.68 10.47 9.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 0.65 111.609 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.74 -33.77 74.3 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.207 -0.52 . . . . 0.6 112.68 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.68 49.93 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 1.1 111.63 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.634 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 32.2 m-20 67.54 1.57 2.6 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.574 0.749 . . . . 2.12 112.485 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -151.6 154.28 36.13 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.825 -0.805 . . . . 2.11 108.825 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.522 HG21 HG23 ' A' ' 77' ' ' ILE . 12.9 t -141.51 148.11 38.86 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.04 0.448 . . . . 0.32 110.134 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 14' ' ' THR . 42.2 mttm -118.78 116.92 27.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.511 -0.551 . . . . 1.63 109.511 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.6 mt -106.53 131.27 53.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.434 -0.348 . . . . 0.28 110.128 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 10' ' ' PRO . 16.6 tp -103.79 117.12 33.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.934 -0.765 . . . . 0.51 108.934 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 20.7 m -126.75 151.81 33.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.142 0.496 . . . . 0.33 111.72 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.7 m -127.56 149.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.082 -0.963 . . . . 0.42 109.717 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.243 -0.651 . . . . 1.92 109.243 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -60.41 -43.89 96.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.89 0.33 . . . . 4.16 111.89 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.08 -35.69 78.59 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.433 . . . . 2.68 109.83 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 8' ' ' LEU . 89.6 m -69.3 -44.44 71.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.47 110.832 176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.631 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 33.7 t0 -58.77 -47.71 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.938 -0.393 . . . . 1.18 109.938 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 50.1 mm-40 -61.1 -37.96 84.6 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.058 -0.519 . . . . 1.94 110.823 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.723 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 66.6 t80 -62.11 -48.0 82.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.175 -0.466 . . . . 0.73 110.672 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CD2' HG13 ' A' ' 102' ' ' VAL . 41.8 m-85 -67.34 -37.19 82.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.953 -0.567 . . . . 0.44 111.799 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.631 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 66.2 mttm -58.86 -50.82 72.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.051 0.453 . . . . 1.92 111.385 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.723 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 18.9 pttp -71.12 -31.97 68.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.744 -0.662 . . . . 2.04 111.367 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.494 ' HB3' HG12 ' A' ' 102' ' ' VAL . 35.4 t -82.4 -6.61 59.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.862 0.363 . . . . 1.39 111.539 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER 56.68 40.65 29.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.638 -0.71 . . . . 4.09 111.677 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.535 HG13 ' CD2' ' A' ' 97' ' ' PHE . 5.7 p -126.46 145.12 34.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.357 -0.383 . . . . 1.42 110.492 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.38 121.66 67.21 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-O 120.979 0.419 . . . . 1.33 111.113 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.773 ' HG2' HG11 ' A' ' 58' ' ' VAL . 24.4 Cg_endo -65.71 138.53 54.16 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.537 2.158 . . . . 0.53 111.223 175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.1 t -159.62 178.28 10.01 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.783 -0.451 . . . . 1.42 109.783 -175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.534 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 99.3 mt-30 -54.75 -30.46 56.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.301 0.572 . . . . 1.66 110.859 176.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.84 -30.39 67.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.616 -0.72 . . . . 2.82 111.465 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -89.02 -14.0 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.482 0.549 . . . . 0.53 112.482 -176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 95.8 mt -47.74 -54.54 11.9 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.348 0.405 . . . . 1.24 111.492 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -132.36 26.63 4.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.971 0.891 . . . . 3.7 109.442 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.95 165.75 23.22 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.016 -0.993 . . . . 1.12 110.776 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.74 124.9 12.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.221 1.947 . . . . 1.31 112.172 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.14 127.52 93.52 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.197 -0.668 . . . . 1.11 109.197 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.85 146.07 76.83 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 123.079 2.519 . . . . 1.15 112.857 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 4.4 p -98.07 118.38 63.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.489 -0.778 . . . . 2.98 110.757 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.4 Cg_exo -74.56 132.11 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.831 2.354 . . . . 4.23 111.454 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.408 ' HB3' ' H ' ' A' ' 118' ' ' THR . 98.3 m-85 59.4 -151.35 0.42 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 123.365 0.416 . . . . 7.33 110.167 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.408 ' H ' ' HB3' ' A' ' 117' ' ' PHE . 54.7 m -143.17 106.52 4.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.76 0.315 . . . . 8.78 110.546 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.98 105.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 9.34 110.609 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.1 -94.4 0.55 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.602 -0.809 . . . . 11.55 112.642 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -92.18 72.96 5.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.354 0.597 . . . . 13.92 111.114 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.1 pt -105.82 1.52 10.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.147 -0.686 . . . . 16.21 109.147 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -142.44 104.45 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.204 -0.907 . . . . 18.82 110.159 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.32 118.96 32.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.048 -0.524 . . . . 20.83 110.152 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.13 155.92 29.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.297 -0.26 . . . . 22.5 110.297 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -122.01 76.87 1.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.468 -0.568 . . . . 23.99 109.468 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -145.62 -57.82 0.32 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 25.0 109.964 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.873 -0.584 . . . . 27.52 109.704 177.134 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 111.262 -0.735 . . . . 11.87 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.412 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 39.5 mm 62.71 76.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.41 0.624 . . . . 9.86 110.246 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.79 110.61 42.85 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.626 -0.715 . . . . 6.96 110.864 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 2' ' ' ILE . 14.0 Cg_exo -70.05 -33.86 14.71 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.827 2.351 . . . . 6.65 111.369 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.12 69.54 0.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.56 -0.745 . . . . 7.99 109.795 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -64.18 121.01 13.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.492 0.663 . . . . 4.26 110.732 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 mtt -127.89 32.62 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.673 -0.694 . . . . 3.84 109.819 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' CD2' ' HB3' ' A' ' 92' ' ' GLU . 54.8 mt -92.44 38.88 1.02 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.395 -0.82 . . . . 0.8 110.606 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -119.82 156.26 54.24 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.938 -0.764 . . . . 3.09 108.938 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' HD11 ' A' ' 87' ' ' LEU . 65.6 Cg_endo -71.58 -174.3 1.23 Allowed 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.356 2.038 . . . . 0.47 112.146 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.441 ' HG3' HG23 ' A' ' 88' ' ' VAL . 15.6 ptt85 -146.65 135.36 22.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.37 110.848 176.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.581 ' HG ' HD11 ' A' ' 109' ' ' LEU . 7.3 mt -92.85 121.7 34.49 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.009 -0.542 . . . . 1.32 110.849 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.0 m -109.1 129.1 55.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.002 -0.544 . . . . 0.4 109.601 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.5 m -112.37 118.53 35.48 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.731 -0.47 . . . . 0.35 109.731 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 25.1 ptp -130.44 142.48 50.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.013 -0.365 . . . . 0.88 110.013 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 14.5 ptpt -121.12 156.52 32.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.003 0.43 . . . . 2.58 110.123 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.649 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 8.7 ttmt -61.37 117.17 5.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.797 -1.092 . . . . 0.92 111.651 -174.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.66 -149.29 9.17 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.53 -0.759 . . . . 1.28 112.181 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.83 -33.07 27.98 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.676 2.251 . . . . 2.23 113.258 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -110.27 -21.09 12.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.17 0.509 . . . . 2.87 110.589 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.649 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 144.59 -116.3 0.93 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.131 -0.787 . . . . 1.93 111.131 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.26 160.71 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.72 -0.844 . . . . 1.82 108.72 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.14 71.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.599 -1.286 . . . . 0.43 113.462 -171.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -155.63 150.88 26.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.986 -0.376 . . . . 0.4 109.986 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -110.15 131.94 54.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 2.18 109.61 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.2 mt -101.3 136.93 40.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.367 -0.379 . . . . 1.52 110.414 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.1 p80 -124.47 125.17 43.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.116 0.484 . . . . 1.34 110.48 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.761 ' HB3' HE22 ' A' ' 35' ' ' GLN . 4.4 p -102.13 132.77 47.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.338 -0.846 . . . . 2.3 110.692 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -87.08 134.1 33.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.024 -0.732 . . . . 3.48 109.024 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -81.79 -14.99 55.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.483 -0.326 . . . . 4.54 110.709 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -91.03 -53.23 4.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 3.49 109.802 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -109.84 104.36 55.31 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.0 110.244 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -56.07 144.27 80.37 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.997 2.465 . . . . 2.24 113.32 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.86 178.19 22.86 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.838 -1.074 . . . . 1.29 111.568 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.761 HE22 ' HB3' ' A' ' 28' ' ' SER . 26.3 mm-40 -122.93 127.42 48.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.029 -0.36 . . . . 1.5 110.029 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 41.0 m-85 -122.04 147.58 45.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.979 -0.748 . . . . 0.87 108.979 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.569 HG13 HD11 ' A' ' 51' ' ' LEU . 39.1 mm -77.39 105.94 6.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.445 -0.576 . . . . 0.39 109.445 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 49.1 ttt180 -75.12 -45.68 39.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.567 . . . . 2.83 110.027 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -149.19 146.35 27.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 1.26 109.474 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.9 132.37 71.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.49 126.28 92.23 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.858 -0.61 . . . . 2.28 110.693 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.45 124.03 15.27 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.657 2.238 . . . . 1.17 112.595 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 64.42 36.08 9.15 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.177 -0.92 . . . . 2.4 111.371 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 94.5 p -97.65 165.67 15.09 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.76 -0.654 . . . . 0.57 109.402 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 12.8 Cg_endo -58.63 -25.6 75.69 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.829 1.686 . . . . 0.65 111.276 173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -70.42 -52.35 22.95 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.756 -0.656 . . . . 0.36 110.409 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -63.85 -36.0 82.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.811 0.338 . . . . 2.01 110.457 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -22.82 65.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.47 112.016 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -80.98 -13.45 58.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.966 0.412 . . . . 0.4 110.51 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 26.6 6.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.855 -0.612 . . . . 0.62 112.409 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.569 HD11 HG13 ' A' ' 37' ' ' ILE . 28.1 tp -94.9 133.25 38.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.65 110.473 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -122.49 158.8 29.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.738 -0.467 . . . . 4.38 109.738 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.16 29.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.043 0.386 . . . . 1.44 112.043 -174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -132.99 1.17 3.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.707 -0.479 . . . . 3.06 109.707 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 35.7 m-20 -88.29 154.35 20.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.556 -0.747 . . . . 1.02 111.235 -171.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 18.4 ttm180 -116.54 135.04 54.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.407 -0.59 . . . . 1.57 109.407 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.99 123.13 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.65 -0.5 . . . . 0.68 109.65 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -105.86 -44.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.251 -0.431 . . . . 0.87 110.42 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 34.9 mt-10 -134.48 143.53 47.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.314 -0.403 . . . . 0.89 110.029 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.96 117.75 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.685 -0.487 . . . . 0.66 109.685 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.59 30.29 19.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.48 0.487 . . . . 1.17 110.945 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 -6.17 79.29 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.068 -0.587 . . . . 0.66 112.974 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -95.88 124.15 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 0.231 . . . . 1.17 110.557 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.543 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 47.2 t -66.22 136.93 56.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.141 -0.481 . . . . 1.68 111.188 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.451 ' HA ' ' CG ' ' A' ' 68' ' ' LYS . 21.4 mmt -118.09 2.22 12.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.81 111.82 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 97.88 4.78 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.357 -0.608 . . . . 3.75 109.357 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.88 12.94 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.656 -0.702 . . . . 1.47 111.659 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 65' ' ' MET . 34.7 mmtp -84.01 166.78 17.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 3.36 110.877 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -94.29 174.21 7.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.645 . . . . 2.89 110.83 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -57.53 -43.06 84.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 1.42 110.359 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.04 96.77 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.72 113.549 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.51 -40.61 76.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.605 0.241 . . . . 2.03 110.897 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.65 -47.26 92.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 1.08 110.552 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.48 -42.31 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.72 110.881 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -61.53 -39.94 92.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 0.66 110.941 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.83 94.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.42 111.755 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG23 HG21 ' A' ' 84' ' ' THR . 72.4 mt -60.26 -45.18 96.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.231 0.539 . . . . 0.69 110.075 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -66.0 -30.95 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.608 -0.723 . . . . 3.09 110.895 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.23 -5.53 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.721 -0.672 . . . . 0.65 111.318 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.28 79.17 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.554 -0.831 . . . . 0.6 111.478 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.32 -100.4 2.08 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.106 -0.568 . . . . 1.1 111.9 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.554 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 18.8 m-20 -119.23 -27.66 5.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.648 0.261 . . . . 2.12 110.795 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.6 mt-10 -120.15 139.81 52.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.299 -1.0 . . . . 2.11 108.299 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.437 HG21 HG23 ' A' ' 77' ' ' ILE . 13.8 t -138.02 149.65 46.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.818 0.342 . . . . 0.32 110.954 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 121.08 42.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.149 -0.478 . . . . 1.63 110.477 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.3 mt -107.14 135.65 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.156 -0.475 . . . . 0.28 109.889 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.5 tp -104.24 119.34 38.74 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.202 -0.666 . . . . 0.51 109.202 176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.0 m -126.95 163.31 29.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.231 -0.44 . . . . 0.33 111.08 -175.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.99 149.54 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.42 111.229 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -90.41 175.57 7.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.834 -0.621 . . . . 1.92 110.117 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 91' ' ' ARG . 25.2 ttm180 -58.48 -48.98 78.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 4.16 111.045 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 5.1 mp0 -63.8 -41.01 97.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 2.68 110.203 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 m -62.04 -51.42 68.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.47 110.471 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.23 -43.86 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.137 -0.938 . . . . 1.18 111.708 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 13.6 mm-40 -60.42 -45.68 92.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.207 -0.451 . . . . 1.94 110.738 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.409 ' CE2' ' HG2' ' A' ' 114' ' ' PRO . 65.2 t80 -63.09 -47.63 82.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.495 0.497 . . . . 0.73 111.336 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -65.89 -40.45 91.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.487 -0.324 . . . . 0.44 111.613 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -66.17 -44.59 83.62 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.988 -0.285 . . . . 1.92 111.615 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.3 ptmt -70.27 -26.53 63.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.635 0.255 . . . . 2.04 111.087 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.5 t -93.75 -3.56 51.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.345 0.593 . . . . 1.39 110.395 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 58.54 47.2 13.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.11 -0.95 . . . . 4.09 110.918 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.82 137.9 53.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 1.42 110.204 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 55.5 mt -88.99 125.49 62.24 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.985 -0.376 . . . . 1.33 109.985 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 27.6 Cg_exo -61.9 154.23 62.88 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.97 2.447 . . . . 0.53 112.07 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.7 p -163.46 167.21 21.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.612 -0.267 . . . . 1.42 111.142 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -57.47 -29.3 64.13 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.732 0.645 . . . . 1.66 111.405 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.44 -34.23 70.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.553 0.692 . . . . 2.82 110.49 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -75.8 -14.6 60.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.024 -0.989 . . . . 0.53 111.101 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' A' ' 12' ' ' LEU . 89.5 mt -73.92 -32.51 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 1.24 110.776 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.14 -36.65 74.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 3.7 111.866 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.44 -80.69 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.558 -1.306 . . . . 1.12 113.863 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.0 132.83 29.21 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 123.223 2.615 . . . . 1.31 114.386 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 63.1 mt -95.97 167.79 11.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 114.846 -1.07 . . . . 1.11 108.912 171.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 10.8 Cg_endo -56.95 145.98 82.17 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.074 1.849 . . . . 1.15 112.107 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 95.3 t 73.35 117.74 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 115.58 -0.736 . . . . 2.98 111.384 -177.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 8.1 Cg_exo -71.91 86.11 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.047 2.498 . . . . 4.23 112.027 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.54 -23.95 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.236 0.541 . . . . 7.33 110.416 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -139.01 152.21 47.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.695 -0.684 . . . . 8.78 109.602 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -115.43 86.07 2.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.351 0.596 . . . . 9.34 109.898 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -139.73 164.3 26.07 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.333 -0.849 . . . . 11.55 111.215 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.48 109.65 20.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.876 0.369 . . . . 13.92 110.304 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 16.9 pt -72.72 102.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.535 0.684 . . . . 16.21 111.257 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.62 92.32 3.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.543 -0.753 . . . . 18.82 109.16 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -116.85 -71.33 0.74 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 20.83 109.536 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 45.27 50.47 9.74 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 124.013 0.821 . . . . 22.5 111.379 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -79.79 108.85 13.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.523 -0.917 . . . . 23.99 108.523 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.5 m -76.44 79.38 3.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.841 -0.618 . . . . 25.0 111.729 -173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.411 -0.804 . . . . 27.52 109.325 174.358 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.837 -0.505 . . . . 11.87 111.837 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.6 tt -149.34 151.96 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.338 -0.616 . . . . 9.86 109.338 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -91.04 109.73 37.23 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.503 -0.555 . . . . 6.96 109.503 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 -41.32 3.95 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.117 2.545 . . . . 6.65 113.691 -173.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -127.07 22.58 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.763 -0.375 . . . . 7.99 111.788 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.91 177.7 11.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.719 0.295 . . . . 4.26 111.317 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -149.78 31.5 0.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.191 -0.67 . . . . 3.84 109.191 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' A' ' 96' ' ' PHE . 71.6 mt -86.03 56.59 4.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.471 -0.786 . . . . 0.8 111.617 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.537 ' HB3' HD21 ' A' ' 113' ' ' LEU . 27.5 ptt180 -125.96 154.21 73.78 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.975 -0.38 . . . . 3.09 109.975 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 9' ' ' ARG . 48.4 Cg_endo -64.73 178.85 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.018 2.479 . . . . 0.47 113.231 -172.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.66 HH12 ' HB3' ' A' ' 90' ' ' ASP . 7.8 ptp85 -137.76 131.98 32.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.988 -0.551 . . . . 2.37 110.304 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.565 ' HG ' HD11 ' A' ' 109' ' ' LEU . 4.7 mt -93.59 111.01 22.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.029 0.442 . . . . 1.32 110.169 176.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 37.2 m -94.68 116.92 29.33 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.489 -0.56 . . . . 0.4 109.489 177.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -105.96 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.675 -0.861 . . . . 0.35 108.675 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.55 ' HE3' HD12 ' A' ' 86' ' ' LEU . 24.9 ptp -135.73 134.92 39.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.953 0.406 . . . . 0.88 110.806 -171.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 23.0 ttpp -92.49 147.09 23.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.716 -0.674 . . . . 2.58 109.209 176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.7 ttmt -59.62 123.46 16.98 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.129 -0.487 . . . . 0.92 111.559 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.51 -157.36 21.51 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.389 -0.684 . . . . 1.28 111.389 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.26 -36.68 27.23 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.159 2.573 . . . . 2.23 113.233 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 m -93.8 21.29 6.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.87 111.595 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.32 69.68 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.597 -0.811 . . . . 1.93 111.273 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 74.89 -50.8 0.67 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.662 0.785 . . . . 1.82 110.739 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 69.66 0.93 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.151 -0.547 . . . . 0.43 113.347 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.33 168.88 25.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.013 -0.365 . . . . 0.4 110.013 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 20.0 t-20 -133.76 127.19 32.24 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 2.18 109.699 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.7 mt -101.31 143.78 30.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.232 -0.44 . . . . 1.52 110.632 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.565 ' CD2' ' HB2' ' A' ' 36' ' ' PHE . 2.6 p80 -125.89 130.7 51.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.8 -0.445 . . . . 1.34 109.8 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.1 p -122.22 123.79 42.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.618 -0.719 . . . . 2.3 109.844 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -85.71 137.63 32.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.11 0.481 . . . . 3.48 110.451 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -81.94 -6.77 59.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.809 -0.632 . . . . 4.54 109.816 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 p -87.82 -36.84 17.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.593 -0.731 . . . . 3.49 110.507 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -138.9 128.63 14.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.85 -0.614 . . . . 3.0 110.36 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 159.25 49.67 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 2.24 112.053 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.78 145.19 11.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.636 -0.793 . . . . 1.29 111.783 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.21 133.11 47.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.778 0.323 . . . . 1.5 110.687 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.565 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 31.1 m-85 -114.27 142.99 45.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.384 -0.599 . . . . 0.87 109.384 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.528 HG13 HD11 ' A' ' 51' ' ' LEU . 32.9 mm -74.32 106.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.43 -0.582 . . . . 0.39 109.43 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HD3' ' OD1' ' A' ' 25' ' ' ASN . 52.0 ttt180 -69.65 -51.85 31.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.75 -0.659 . . . . 2.83 110.382 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -163.32 135.38 5.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.985 -0.552 . . . . 1.26 110.309 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.5 134.29 37.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.43 -0.952 . . . . 0.37 108.43 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.2 m-20 -64.67 128.09 93.15 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.956 -0.387 . . . . 2.28 109.956 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 41' ' ' ASP . 52.4 Cg_exo -54.54 130.02 37.91 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.171 2.581 . . . . 1.17 113.182 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.61 38.37 12.29 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.357 -0.838 . . . . 2.4 110.81 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 79.0 p -97.76 164.7 16.94 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 116.13 -0.486 . . . . 0.57 109.693 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.4 Cg_endo -55.85 -34.17 90.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.751 1.634 . . . . 0.65 111.125 172.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.84 -46.39 85.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.826 -0.624 . . . . 0.36 110.244 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.27 -43.47 98.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.014 -0.539 . . . . 2.01 110.337 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.85 63.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.47 111.988 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.7 p -76.39 -14.83 60.05 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.4 110.526 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.12 9.07 24.73 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.782 -0.723 . . . . 0.62 112.333 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD11 HG13 ' A' ' 37' ' ' ILE . 37.1 tp -79.79 128.06 32.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.85 0.357 . . . . 0.65 110.115 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -123.42 -170.53 2.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.061 -0.518 . . . . 4.38 110.222 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -95.65 151.65 19.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.673 -0.694 . . . . 1.44 110.29 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 54.7 mt-30 73.02 25.05 2.41 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.825 0.703 . . . . 3.06 110.96 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -95.81 155.25 16.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.243 -0.651 . . . . 1.02 109.243 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.439 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -124.69 129.55 50.72 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.603 -0.517 . . . . 1.57 109.603 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.3 mt -73.41 132.06 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.535 . . . . 0.68 111.605 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.594 HG11 ' HB2' ' A' ' 104' ' ' PRO . 21.4 t -113.97 -47.11 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.415 -0.811 . . . . 0.87 110.443 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.1 mt-10 -132.8 149.51 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 0.89 110.644 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.81 117.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.66 109.637 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 57.24 34.21 24.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.986 -0.552 . . . . 1.17 111.041 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 89.43 -4.63 84.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.925 -0.655 . . . . 0.66 113.084 176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.84 127.21 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.96 -0.385 . . . . 1.17 109.96 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 41.8 t -74.25 135.39 42.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.992 0.425 . . . . 1.68 110.369 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.806 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 22.5 mmt -116.79 30.15 7.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.81 110.415 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HG2' HD12 ' A' ' 103' ' ' ILE . 21.5 tp10 -70.51 -34.42 72.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 3.75 110.943 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -111.11 -0.45 28.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.645 -0.788 . . . . 1.47 112.305 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.806 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.3 mmtp -71.95 168.73 17.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.762 0.792 . . . . 3.36 112.791 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -106.12 169.81 8.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.518 -1.219 . . . . 2.89 109.844 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -54.42 -43.93 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 1.42 111.597 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.42 85.99 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.128 -0.558 . . . . 0.72 113.387 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -67.97 -42.63 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.021 0.438 . . . . 2.03 110.34 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 65' ' ' MET . 59.0 t -68.26 -47.18 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 1.08 111.174 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.1 -38.55 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 0.72 111.048 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 t -67.94 -36.69 80.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.408 -0.36 . . . . 0.66 110.497 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.446 -0.343 . . . . 0.42 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.552 HG23 HG21 ' A' ' 84' ' ' THR . 78.6 mt -58.38 -42.06 83.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.446 0.641 . . . . 0.69 110.41 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -74.6 -31.69 62.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 3.09 111.44 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.86 5.48 18.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.65 111.325 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.98 -13.37 83.23 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.682 -0.771 . . . . 0.6 112.009 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.04 -111.43 3.1 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.981 -0.628 . . . . 1.1 111.699 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 14.0 m-20 -115.03 -6.64 12.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.908 0.385 . . . . 2.12 110.503 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -143.8 157.01 44.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.594 . . . . 2.11 109.622 173.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.552 HG21 HG23 ' A' ' 77' ' ' ILE . 11.9 t -137.57 149.73 46.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.849 0.357 . . . . 0.32 110.072 -175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -115.63 116.85 28.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.126 -0.488 . . . . 1.63 109.796 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HE3' ' A' ' 15' ' ' MET . 78.0 mt -107.85 130.92 54.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.908 -0.587 . . . . 0.28 109.836 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 10' ' ' PRO . 20.8 tp -104.59 115.21 29.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.814 -0.81 . . . . 0.51 108.814 175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.5 m -127.54 159.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.191 -0.459 . . . . 0.33 111.377 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.39 150.59 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.734 . . . . 0.42 110.031 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.66 ' HB3' HH12 ' A' ' 11' ' ' ARG . 4.3 p30 -88.85 176.51 7.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 1.92 109.975 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.5 ttp180 -55.78 -49.99 71.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.755 0.65 . . . . 4.16 112.755 -172.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.555 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 14.2 pt-20 -74.85 -34.35 62.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.83 0.348 . . . . 2.68 111.139 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.9 m -64.9 -41.92 95.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.02 -0.537 . . . . 0.47 110.12 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 33.2 t70 -62.49 -38.05 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.608 . . . . 1.18 109.963 177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 48.0 mt-10 -67.2 -35.52 79.79 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.144 -0.48 . . . . 1.94 110.745 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.86 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 59.7 t80 -62.99 -49.62 73.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.896 0.379 . . . . 0.73 110.318 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.458 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 27.8 m-85 -68.14 -38.86 82.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.911 -0.586 . . . . 0.44 112.06 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -64.61 -48.91 73.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.848 0.314 . . . . 1.92 111.848 -176.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 96' ' ' PHE . 22.4 pttp -67.63 -34.18 76.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.113 0.483 . . . . 2.04 110.427 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 67.8 m -75.22 -8.69 57.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.511 -0.768 . . . . 1.39 112.048 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 55.86 32.82 20.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.312 0.645 . . . . 4.09 111.734 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 97' ' ' PHE . 5.8 p -120.36 142.1 37.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.251 -0.431 . . . . 1.42 110.228 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.565 HD12 ' HG2' ' A' ' 66' ' ' GLU . 45.9 mm -86.75 127.28 60.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 1.33 110.625 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.594 ' HB2' HG11 ' A' ' 58' ' ' VAL . 16.9 Cg_exo -65.55 155.13 70.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.824 2.349 . . . . 0.53 111.37 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.7 p -169.06 168.41 10.07 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.554 -0.459 . . . . 1.42 111.807 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.552 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 40.0 mt-30 -57.0 -29.42 63.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.381 -0.827 . . . . 1.66 111.273 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.93 -32.71 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.272 0.558 . . . . 2.82 110.34 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -77.86 -13.7 59.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.53 111.164 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.565 HD11 ' HG ' ' A' ' 12' ' ' LEU . 86.1 mt -75.19 -40.62 59.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 1.24 111.126 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -106.28 13.03 29.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.199 0.523 . . . . 3.7 110.521 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.62 -172.1 12.42 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.827 -0.701 . . . . 1.12 111.82 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -88.97 -179.59 2.16 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.213 2.609 . . . . 1.31 112.258 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 9' ' ' ARG . 53.7 mt -97.24 148.21 34.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.09 -0.504 . . . . 1.11 109.761 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 113' ' ' LEU . 14.3 Cg_exo -68.35 144.0 60.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.111 2.54 . . . . 1.15 112.045 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.3 m -74.41 155.44 87.68 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.423 -0.808 . . . . 2.98 110.795 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.84 66.54 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.687 2.258 . . . . 4.23 112.066 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -68.14 121.36 16.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.706 -0.679 . . . . 7.33 109.695 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 119' ' ' ASN . 3.2 m 70.4 173.63 0.3 Allowed 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.636 0.585 . . . . 8.78 109.82 -175.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.55 ' H ' HG22 ' A' ' 118' ' ' THR . 9.9 m120 74.21 146.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.869 0.842 . . . . 9.34 112.46 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.12 36.17 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.868 -1.06 . . . . 11.55 110.457 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -118.61 97.18 5.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.162 0.481 . . . . 13.92 110.4 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.5 101.22 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.89 -0.782 . . . . 16.21 108.89 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.12 -8.73 59.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.902 -0.59 . . . . 18.82 110.988 -172.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 58.19 46.36 15.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.955 -1.128 . . . . 20.83 107.955 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -73.35 71.12 1.24 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.922 -1.49 . . . . 22.5 111.128 -177.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -69.48 95.71 0.85 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.979 -1.01 . . . . 23.99 110.021 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.9 t -76.74 -42.08 42.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.673 -0.694 . . . . 27.52 109.676 -178.558 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 112.016 -0.434 . . . . 11.87 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -103.83 134.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.736 0.303 . . . . 9.86 110.221 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.3 p-10 -73.72 135.21 78.09 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.098 -0.501 . . . . 6.96 110.787 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 62.5 Cg_endo -93.39 7.13 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.075 2.517 . . . . 6.65 112.778 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -155.54 -58.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.958 0.408 . . . . 7.99 110.305 -176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.4 m -151.44 145.62 25.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.496 -0.557 . . . . 4.26 109.496 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.2 ptm -75.02 56.27 0.75 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.238 0.542 . . . . 3.84 111.639 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.4 mt -108.96 59.87 0.6 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.264 0.554 . . . . 0.8 110.59 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -126.54 157.02 72.18 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.812 -0.631 . . . . 3.09 109.433 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HB2' HD11 ' A' ' 87' ' ' LEU . 44.4 Cg_endo -70.15 174.73 9.42 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.328 2.019 . . . . 0.47 111.782 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.452 ' HG3' HG23 ' A' ' 88' ' ' VAL . 7.0 ptp85 -132.02 130.6 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.261 -0.427 . . . . 2.37 110.162 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.9 118.1 31.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.814 0.34 . . . . 1.32 110.182 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 12.8 m -108.88 117.49 34.34 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.215 -0.448 . . . . 0.4 110.305 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.2 m -108.9 117.55 34.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.225 -1.028 . . . . 0.35 108.225 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.582 ' HE3' HD12 ' A' ' 86' ' ' LEU . 23.0 ptp -131.15 144.63 51.52 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.744 -0.383 . . . . 0.88 111.164 -171.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HG3' ' HG2' ' A' ' 83' ' ' GLU . 7.5 ttmm -118.89 146.0 45.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.614 -0.721 . . . . 2.58 109.705 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 85.5 mttt -56.32 119.47 6.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.361 -0.836 . . . . 0.92 112.188 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.37 -111.0 3.1 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.575 -1.193 . . . . 1.28 112.282 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -57.49 -74.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.243 2.629 . . . . 2.23 112.669 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -132.93 83.85 2.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.496 -0.32 . . . . 2.87 110.495 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.97 71.29 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.004 -0.617 . . . . 1.93 112.535 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.553 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 36.2 m-85 67.23 -87.3 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.047 0.539 . . . . 1.82 110.774 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.45 70.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.625 -0.798 . . . . 0.43 112.646 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.94 151.91 26.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.4 109.271 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -101.24 123.65 45.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.207 -0.664 . . . . 2.18 109.207 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 35' ' ' GLN . 30.3 tp -108.77 146.14 34.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.058 -0.519 . . . . 1.52 109.62 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -153.45 149.25 27.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.624 -0.43 . . . . 1.34 111.435 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -94.47 168.71 10.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.166 -0.679 . . . . 2.3 109.166 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 23.9 t70 -125.93 146.39 49.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.563 -0.532 . . . . 3.48 109.563 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.13 2.61 53.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.349 -0.387 . . . . 4.54 111.371 -174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.6 t -123.86 -46.5 1.97 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.039 0.447 . . . . 3.49 109.981 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 41.8 mmtm -99.4 126.8 36.36 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.192 -0.458 . . . . 3.0 110.078 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.19 156.65 46.66 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.581 2.187 . . . . 2.24 112.147 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.72 167.38 22.55 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.819 -0.705 . . . . 1.29 111.611 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.52 ' HB3' HD11 ' A' ' 26' ' ' LEU . 27.6 mm-40 -98.9 128.09 44.99 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.13 -0.322 . . . . 1.5 110.13 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -109.92 140.59 43.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.87 110.554 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.543 HG13 HD11 ' A' ' 51' ' ' LEU . 36.9 mm -81.21 105.76 11.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.846 -0.798 . . . . 0.39 108.846 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.02 -55.28 19.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.507 . . . . 2.83 110.106 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 m -157.87 137.77 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.854 -0.612 . . . . 1.26 109.482 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.31 133.83 33.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.145 -0.687 . . . . 0.37 109.145 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.82 128.92 92.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.014 -0.539 . . . . 2.28 109.774 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.64 125.41 19.02 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.753 2.302 . . . . 1.17 113.063 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.8 t70 63.14 43.46 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.934 -1.03 . . . . 2.4 110.76 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.6 p -102.64 165.3 13.99 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.592 . . . . 0.57 110.639 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 31.6 Cg_exo -56.11 -34.38 92.68 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.888 1.725 . . . . 0.65 111.168 172.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.31 86.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.596 -0.729 . . . . 0.36 110.186 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -61.06 -42.44 98.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 2.01 110.132 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.37 -30.02 68.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.817 -0.629 . . . . 0.47 112.069 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.2 p -70.96 -20.0 62.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.368 . . . . 0.4 110.626 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.19 9.7 15.03 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.792 -0.718 . . . . 0.62 112.803 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.543 HD11 HG13 ' A' ' 37' ' ' ILE . 27.9 tp -69.33 125.17 25.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.397 . . . . 0.65 110.685 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 30.5 ttm180 -103.85 147.89 26.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.804 -0.634 . . . . 4.38 109.918 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -74.77 144.21 43.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 1.44 110.092 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 15.4 mm-40 78.87 5.88 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.099 0.875 . . . . 3.06 111.31 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -85.12 149.93 25.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.693 -0.484 . . . . 1.02 109.693 176.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' HD3' HH11 ' A' ' 56' ' ' ARG . 34.9 ttp180 -111.87 137.48 49.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.57 110.258 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HA ' HG12 ' A' ' 88' ' ' VAL . 65.2 mt -74.56 128.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.985 -0.552 . . . . 0.68 110.627 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.403 HG23 HD23 ' A' ' 87' ' ' LEU . 19.0 m -112.42 -32.89 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 0.87 111.21 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 27.4 mt-10 -134.38 142.85 47.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.358 . . . . 0.89 110.833 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.56 120.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.66 109.797 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 85' ' ' LYS . 73.8 m-20 58.68 24.57 12.31 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.088 0.555 . . . . 1.17 111.512 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.494 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.61 6.53 63.96 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.66 112.915 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.47 124.18 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.757 0.313 . . . . 1.17 110.393 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.2 p -64.58 136.94 57.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.636 . . . . 1.68 111.215 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.706 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.1 mmt -123.68 50.99 1.55 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.968 -0.56 . . . . 0.81 111.074 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -36.11 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.922 -0.311 . . . . 3.75 111.514 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.38 -7.52 54.17 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.842 -0.694 . . . . 1.47 111.857 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.706 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.7 mmtp -70.71 149.16 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.223 0.535 . . . . 3.36 111.436 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -86.45 170.62 11.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.367 -0.833 . . . . 2.89 109.983 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -53.86 -43.52 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.657 0.265 . . . . 1.42 111.241 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.03 99.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.045 -0.598 . . . . 0.72 113.125 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 6.3 t70 -64.78 -43.97 91.51 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.913 0.387 . . . . 2.03 110.216 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 65' ' ' MET . 46.5 t -63.55 -46.86 93.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 1.08 111.015 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 97.7 t -66.68 -42.5 89.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.241 -0.436 . . . . 0.72 111.114 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -64.51 -38.27 90.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.46 -0.336 . . . . 0.66 110.387 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.09 93.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 0.42 111.135 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 84' ' ' THR . 81.4 mt -61.15 -45.77 97.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.018 0.437 . . . . 0.69 110.621 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 29.6 mtm180 -66.15 -33.2 75.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 3.09 110.366 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.42 -0.36 36.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.952 -0.567 . . . . 0.65 111.501 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.95 -11.26 85.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.606 -0.807 . . . . 0.6 111.695 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.29 -127.24 9.1 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.208 -0.757 . . . . 1.1 111.208 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 42.1 m-20 -96.73 -12.97 23.04 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.032 -0.267 . . . . 2.12 110.78 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -130.61 140.82 50.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.989 -0.375 . . . . 2.11 109.989 177.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 77' ' ' ILE . 14.4 t -135.09 149.62 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.957 0.408 . . . . 0.32 110.36 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 61' ' ' ASN . 95.0 mttt -106.31 117.81 35.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.248 -0.433 . . . . 1.63 110.289 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD12 ' HE3' ' A' ' 15' ' ' MET . 85.0 mt -111.53 124.91 53.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.145 -0.479 . . . . 0.28 109.815 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 34.8 tp -104.36 122.25 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.029 -0.73 . . . . 0.51 109.029 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 10.5 m -130.15 164.58 32.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.208 -0.451 . . . . 0.33 111.369 -174.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 m -136.72 145.79 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.658 -0.701 . . . . 0.42 110.874 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.72 167.74 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.548 -0.751 . . . . 1.92 109.473 177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -56.59 -47.79 78.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.653 0.263 . . . . 4.16 111.22 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -63.45 -31.42 72.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.347 0.594 . . . . 2.68 110.086 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 m -76.54 -50.8 13.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.47 111.021 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.7 -47.67 82.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.865 -0.607 . . . . 1.18 111.656 -174.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 31.7 mt-10 -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.721 -0.391 . . . . 1.94 110.767 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -68.38 -46.09 70.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.937 0.398 . . . . 0.73 110.356 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 102' ' ' VAL . 22.9 m-85 -64.34 -44.24 92.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.008 176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -61.42 -45.33 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.561 0.578 . . . . 1.92 112.561 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 18.1 ptpt -65.47 -25.6 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 2.04 110.955 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.2 t -96.69 0.84 50.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 1.39 110.645 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? 64.63 31.27 12.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.028 -0.533 . . . . 4.09 111.716 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' A' ' 114' ' ' PRO . 35.0 t -109.82 139.6 32.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.491 -0.322 . . . . 1.42 110.416 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.35 125.95 50.12 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.93 -0.396 . . . . 1.33 109.93 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HB2' HG21 ' A' ' 58' ' ' VAL . 18.8 Cg_exo -65.62 139.53 58.68 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.464 2.11 . . . . 0.53 111.42 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.6 p -154.01 166.93 31.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 1.42 110.73 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.494 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 41.2 mt-30 -57.31 -31.98 66.21 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.441 0.463 . . . . 1.66 111.049 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.38 -30.78 70.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.441 -0.345 . . . . 2.82 111.3 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -73.37 -13.83 61.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.53 111.403 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.31 -25.43 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.2 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -130.4 -14.89 3.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.496 -0.32 . . . . 3.7 111.584 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.35 -177.11 34.44 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.866 -0.683 . . . . 1.12 112.438 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.41 124.26 10.65 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.131 2.554 . . . . 1.31 112.866 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 113' ' ' LEU . 3.0 mm? -65.67 146.64 98.97 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.96 -0.564 . . . . 1.11 109.825 169.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.562 ' HB3' HG21 ' A' ' 102' ' ' VAL . 28.4 Cg_endo -62.8 144.6 93.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.785 2.323 . . . . 1.15 112.449 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.472 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 4.2 p -159.99 130.18 3.5 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.077 -0.51 . . . . 2.98 110.333 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 19.7 Cg_exo -66.52 112.77 2.47 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.816 2.344 . . . . 4.23 111.744 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -81.09 -30.88 34.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.24 -0.437 . . . . 7.33 110.851 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 t -84.02 152.38 24.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.132 -0.486 . . . . 8.78 110.394 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -122.31 111.59 17.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.88 -0.415 . . . . 9.34 109.88 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.21 173.02 42.3 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.993 -0.622 . . . . 11.55 112.665 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -88.77 160.22 17.39 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.182 -0.303 . . . . 13.92 110.182 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -126.48 161.33 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.371 -0.377 . . . . 16.21 110.552 179.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -136.11 157.54 46.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.152 -0.476 . . . . 18.82 109.9 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 55.66 64.85 1.62 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.412 0.625 . . . . 20.83 110.224 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 4.1 mp0 -74.65 -30.09 61.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.736 -0.666 . . . . 22.5 110.046 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 66.97 -80.86 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.056 -0.975 . . . . 23.99 110.512 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 67.7 m -158.47 84.6 0.84 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.204 -0.903 . . . . 27.52 110.479 -176.111 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.394 -0.282 . . . . 11.87 112.394 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.3 pt -87.49 84.62 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 9.86 111.481 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.75 114.06 61.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 6.96 110.012 176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -87.27 9.86 3.76 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.911 2.407 . . . . 6.65 113.009 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -106.22 -49.21 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.243 0.544 . . . . 7.99 109.688 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 m -121.17 84.99 2.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.588 -0.733 . . . . 4.26 110.011 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -95.39 19.29 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.719 -0.673 . . . . 3.84 110.592 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.62 41.04 0.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.615 . . . . 0.8 110.901 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 15.9 ptp180 -119.7 147.02 42.94 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.322 -0.399 . . . . 3.09 109.998 -177.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HD2' ' HA ' ' A' ' 109' ' ' LEU . 2.9 Cg_exo -72.26 165.14 33.53 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.899 2.399 . . . . 0.47 111.358 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.79 ' HG3' HG23 ' A' ' 88' ' ' VAL . 5.5 ptt180 -122.9 131.0 53.54 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.663 -0.699 . . . . 2.37 110.627 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.6 tp -102.06 113.3 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 1.32 110.03 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 30.5 m -96.87 128.74 44.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.832 -0.622 . . . . 0.4 110.22 -176.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -117.79 117.49 29.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.35 108.91 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.527 ' HE3' HD12 ' A' ' 86' ' ' LEU . 22.5 ptp -142.21 142.55 32.67 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.181 -0.463 . . . . 0.88 110.194 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 43.4 pttt -119.34 152.53 36.6 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.311 0.577 . . . . 2.58 110.735 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.617 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.1 mtmt -55.55 110.45 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.347 -1.297 . . . . 0.92 112.601 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.09 -129.82 6.69 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.272 -0.876 . . . . 1.28 112.145 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.29 -75.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.35 2.7 . . . . 2.23 113.616 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -96.91 34.05 1.78 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.891 0.377 . . . . 2.87 111.329 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.617 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 71.77 83.86 0.23 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.585 -0.817 . . . . 1.93 111.755 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.45 ' O ' ' HD2' ' A' ' 45' ' ' PRO . 39.3 m-85 68.07 -78.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.268 0.627 . . . . 1.82 110.638 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.16 68.11 0.38 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.259 -0.496 . . . . 0.43 112.572 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -157.34 153.23 27.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.928 -0.397 . . . . 0.4 109.928 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.36 141.41 40.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 2.18 110.626 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 26' ' ' LEU . 48.6 mt -101.52 154.91 18.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.624 -0.716 . . . . 1.52 111.715 -174.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 36' ' ' PHE . 2.2 t-80 -105.67 141.81 36.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.188 -0.915 . . . . 1.34 110.459 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -83.95 150.87 25.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.943 -0.571 . . . . 2.3 110.454 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 5.1 p-10 -123.02 164.25 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.932 -0.576 . . . . 3.48 110.335 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -159.89 -49.04 0.05 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.82 -0.627 . . . . 4.54 109.769 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 p -84.41 -23.27 30.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 3.49 111.206 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 23.8 pttm -157.82 140.04 10.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.03 -0.532 . . . . 3.0 110.074 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 14.3 Cg_exo -69.63 171.0 15.12 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.482 2.122 . . . . 2.24 111.68 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.04 125.01 4.86 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.753 -0.736 . . . . 1.29 111.881 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -93.59 129.06 39.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 1.5 110.911 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 38.9 m-85 -102.8 149.92 24.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.671 -0.695 . . . . 0.87 109.599 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 51' ' ' LEU . 48.5 mm -84.45 105.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.645 -0.502 . . . . 0.39 109.645 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -70.13 -39.75 75.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.693 -0.685 . . . . 2.83 110.033 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 p -165.73 152.2 9.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 1.26 109.825 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.08 128.63 74.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.348 -0.612 . . . . 0.37 109.348 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -70.86 135.88 85.41 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.327 -0.397 . . . . 2.28 110.672 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.84 143.1 78.73 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.886 2.391 . . . . 1.17 112.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 61.8 42.13 10.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.502 -0.772 . . . . 2.4 111.202 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.1 p -118.18 159.34 43.62 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 0.57 110.297 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 22' ' ' TYR . 44.7 Cg_exo -51.15 -39.37 61.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.406 2.071 . . . . 0.65 111.419 173.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.3 -52.31 64.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.461 -0.791 . . . . 0.36 110.864 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -63.41 -39.63 95.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.171 -0.468 . . . . 2.01 110.601 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.06 77.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 0.47 111.866 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 p -70.84 -13.69 62.13 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.982 0.42 . . . . 0.4 110.955 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.1 14.59 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.632 -0.794 . . . . 0.62 113.015 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 37' ' ' ILE . 29.2 tp -76.02 123.83 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.99 0.424 . . . . 0.65 110.297 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 52' ' ' ARG . 21.9 ttt180 -110.28 148.51 31.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.887 -0.597 . . . . 4.38 110.117 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -68.79 148.23 50.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.203 -0.453 . . . . 1.44 110.219 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 78.4 mt-30 78.62 0.7 2.54 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.194 0.934 . . . . 3.06 111.27 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 15.3 m-20 -78.58 143.43 36.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.726 0.298 . . . . 1.02 110.603 177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 56' ' ' ARG . 36.8 ttp-105 -104.69 133.52 49.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.824 0.345 . . . . 1.57 110.573 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.84 123.72 32.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.991 -0.549 . . . . 0.68 109.735 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' HG2' ' A' ' 104' ' ' PRO . 42.2 t -101.86 -46.55 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.268 0.556 . . . . 0.87 110.584 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 32.7 mt-10 -129.92 145.51 51.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.698 . . . . 0.89 110.083 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.405 HG11 HD13 ' A' ' 77' ' ' ILE . 24.8 t -125.59 130.59 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.606 -0.516 . . . . 0.66 109.606 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.36 8.84 5.97 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.423 0.452 . . . . 1.17 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.45 9.56 62.99 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.826 -0.702 . . . . 0.66 111.593 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -104.78 131.03 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.585 0.354 . . . . 1.17 110.171 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.545 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 44.1 t -70.1 136.29 50.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.999 -0.546 . . . . 1.68 111.426 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.803 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.5 mmt -119.91 69.43 0.85 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.81 110.583 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -98.07 -62.15 1.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.742 -0.663 . . . . 3.75 110.367 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.26 41.4 2.41 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.618 -0.593 . . . . 1.47 111.618 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.803 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 33.4 mmtp -107.42 -178.5 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.064 -0.347 . . . . 3.36 110.064 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -125.61 172.28 9.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.605 -0.27 . . . . 2.89 110.972 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -54.68 -44.21 73.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.518 0.511 . . . . 1.42 111.366 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.49 -34.43 84.45 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.993 -0.622 . . . . 0.72 113.039 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.776 0.322 . . . . 2.03 110.662 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.93 -45.5 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 1.08 110.778 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.65 -36.64 78.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.294 -0.412 . . . . 0.72 110.905 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -65.87 -36.15 82.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.855 -0.424 . . . . 0.66 109.855 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.1 79.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.916 -0.584 . . . . 0.42 111.072 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 60' ' ' VAL . 18.8 mm -57.56 -44.49 85.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.546 0.688 . . . . 0.69 109.464 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.52 -29.22 59.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.001 -1.0 . . . . 3.09 110.936 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.86 44.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.65 111.84 -176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.8 -12.35 83.0 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.448 -0.882 . . . . 0.6 111.867 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.2 -125.92 8.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.974 -0.851 . . . . 1.1 110.974 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 60.2 m-20 -94.6 -16.85 22.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.943 0.372 . . . . 2.12 110.042 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.639 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 7.4 mt-10 -119.55 140.34 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.109 -0.7 . . . . 2.11 109.109 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 t -129.77 145.52 51.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.026 0.441 . . . . 0.32 110.511 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 59.5 mttm -113.62 117.77 32.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.913 -0.585 . . . . 1.63 109.825 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.527 HD12 ' HE3' ' A' ' 15' ' ' MET . 81.1 mt -109.91 135.86 50.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.861 -0.608 . . . . 0.28 110.159 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 10' ' ' PRO . 52.9 tp -104.55 117.09 33.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.09 -0.505 . . . . 0.51 109.884 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.79 HG23 ' HG3' ' A' ' 11' ' ' ARG . 7.2 m -127.95 159.36 39.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.006 -0.543 . . . . 0.33 110.72 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -128.83 148.1 33.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.0 -0.545 . . . . 0.42 110.747 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.16 172.62 12.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.288 -0.634 . . . . 1.92 109.288 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 36.0 ttp180 -61.0 -49.1 78.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.612 0.244 . . . . 4.16 110.709 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -35.97 82.32 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.061 0.458 . . . . 2.68 110.322 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -64.32 -51.44 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.47 111.194 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.73 -33.99 76.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.18 111.445 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 12.5 mm-40 -64.17 -41.56 97.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.895 0.379 . . . . 1.94 110.056 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.715 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 70.2 t80 -63.28 -47.83 80.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.812 -0.631 . . . . 0.73 111.367 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -66.76 -38.82 87.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.514 -0.312 . . . . 0.44 111.776 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.1 -41.82 85.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.376 0.51 . . . . 1.92 112.376 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 58.6 pttt -68.24 -14.48 63.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 2.04 111.229 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.427 ' HB3' HG12 ' A' ' 102' ' ' VAL . 34.4 t -109.04 -11.4 14.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.274 0.559 . . . . 1.39 109.574 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 65.38 35.29 7.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.761 -1.108 . . . . 4.09 111.371 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 114' ' ' PRO . 3.1 p -118.45 126.93 75.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 1.42 110.124 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -72.15 128.29 89.26 Favored Pre-proline 0 C--N 1.321 -0.63 0 CA-C-N 115.93 -0.577 . . . . 1.33 110.753 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' ' 58' ' ' VAL . 34.1 Cg_endo -67.65 143.9 63.98 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.734 2.289 . . . . 0.53 111.355 176.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.4 m -151.23 174.72 12.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 110.024 -0.362 . . . . 1.42 110.024 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.608 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 43.0 mt-30 -57.59 -40.3 78.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.926 0.393 . . . . 1.66 111.166 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 1.5 mp0 -59.22 -35.27 73.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.293 0.568 . . . . 2.82 110.259 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.557 ' CD2' ' HD3' ' A' ' 114' ' ' PRO . 28.2 m80 -73.9 -31.52 63.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.564 -0.743 . . . . 0.53 111.525 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 106' ' ' GLN . 4.4 pp -88.51 -16.53 32.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.938 -0.574 . . . . 1.24 110.864 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.77 -8.16 59.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.131 -0.486 . . . . 3.7 111.24 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.89 -74.36 0.21 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.03 -1.081 . . . . 1.12 113.723 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.17 116.08 4.54 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.344 2.696 . . . . 1.31 114.12 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.4 mt -87.0 152.9 54.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.326 -0.852 . . . . 1.11 109.698 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.557 ' HD3' ' CD2' ' A' ' 108' ' ' HIS . 56.8 Cg_endo -69.48 138.14 38.01 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.993 2.462 . . . . 1.15 112.547 -176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 27.2 m -84.94 144.76 42.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.835 -0.62 . . . . 2.98 110.546 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 6.3 Cg_exo -75.19 28.73 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.178 2.585 . . . . 4.23 112.645 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.78 48.2 2.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.515 0.674 . . . . 7.33 109.97 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -135.59 9.1 3.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.489 -0.778 . . . . 8.78 110.214 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -95.6 38.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.112 -0.495 . . . . 9.34 110.999 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.81 3.75 19.33 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.604 -0.808 . . . . 11.55 112.431 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -83.25 140.07 32.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.2 0.524 . . . . 13.92 111.175 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.69 98.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 16.21 109.994 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -114.55 95.33 5.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.362 -0.381 . . . . 18.82 110.212 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -81.45 64.07 6.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.443 . . . . 20.83 110.091 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -141.13 -56.88 0.5 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.877 -0.601 . . . . 22.5 109.535 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -84.45 43.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.541 0.686 . . . . 23.99 109.89 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 p -77.33 -24.92 50.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 25.0 110.773 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.436 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 18.0 tpt180 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.688 -0.672 . . . . 27.52 109.883 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.814 -0.514 . . . . 11.87 111.814 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 tt -99.93 141.66 16.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.756 -0.461 . . . . 9.86 109.756 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.41 130.04 60.76 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.553 -0.536 . . . . 6.96 109.553 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.19 -18.21 63.87 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.09 2.527 . . . . 6.65 112.259 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.74 -157.47 0.74 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.272 -1.01 . . . . 7.99 108.272 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.1 m 65.51 -0.59 1.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.406 0.521 . . . . 4.26 112.406 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 70.3 mtm -83.28 -12.49 56.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.411 . . . . 3.84 111.052 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -93.54 54.66 2.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.348 0.594 . . . . 0.8 110.315 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -125.78 147.57 59.15 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.655 -0.702 . . . . 3.09 109.731 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.8 Cg_endo -66.01 159.76 47.68 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.298 1.998 . . . . 0.47 111.183 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.3 ptt85 -121.37 132.55 54.83 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.037 -0.529 . . . . 2.37 110.396 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp -92.72 111.86 23.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.729 -0.669 . . . . 1.32 109.767 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 18.0 m -89.63 117.73 28.72 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.091 -0.707 . . . . 0.4 109.091 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' LYS . 24.4 m -109.85 118.25 36.0 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.601 -0.518 . . . . 0.35 109.601 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.672 ' HE3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -131.17 132.93 45.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.88 110.677 -175.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 3.4 ttmp? -109.12 128.69 55.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 2.58 109.529 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 82' ' ' ASP . 12.4 ttmt -51.59 130.08 27.2 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.041 -0.981 . . . . 0.92 112.768 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.09 -147.57 22.82 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.956 -0.858 . . . . 1.28 110.956 170.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.71 -28.8 6.15 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.879 2.386 . . . . 2.23 112.841 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -94.28 -27.2 16.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.364 0.505 . . . . 2.87 112.364 -173.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.57 64.79 0.59 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.8 -0.714 . . . . 1.93 112.775 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.542 ' O ' ' HB2' ' A' ' 44' ' ' SER . 26.4 m-85 74.51 -74.58 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.629 0.772 . . . . 1.82 111.013 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.96 69.07 0.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.957 -0.64 . . . . 0.43 113.007 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -155.71 154.76 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.8 -0.445 . . . . 0.4 109.8 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.77 127.16 55.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.77 0.319 . . . . 2.18 110.586 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.47 137.75 39.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 1.52 110.09 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.497 ' NE2' ' HB2' ' A' ' 36' ' ' PHE . 11.6 p80 -125.7 138.81 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.46 -0.496 . . . . 1.34 110.705 176.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 t -120.33 139.03 53.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.265 -0.879 . . . . 2.3 108.891 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 10.9 t70 -86.31 134.48 33.74 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.975 -0.75 . . . . 3.48 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -82.71 -6.73 59.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.305 -0.407 . . . . 4.54 111.707 -173.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.4 m -107.78 -39.45 5.57 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.114 0.483 . . . . 3.49 109.99 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 23.8 pttm -120.68 102.03 45.17 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.929 -0.578 . . . . 3.0 109.734 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 36.0 Cg_endo -63.2 155.99 58.13 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.583 2.189 . . . . 2.24 113.042 -174.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.78 149.03 5.48 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.325 -0.852 . . . . 1.29 111.101 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.88 127.37 47.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.253 0.526 . . . . 1.5 111.036 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 52.9 m-85 -125.43 150.55 47.2 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.715 -0.846 . . . . 0.87 108.715 177.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.473 HG13 HD11 ' A' ' 51' ' ' LEU . 35.2 mm -75.85 111.17 11.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.839 -0.43 . . . . 0.39 109.839 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 23.3 tpt180 -68.64 -57.05 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 2.83 110.028 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 49.6 m -160.63 140.57 11.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.47 -0.786 . . . . 1.26 109.041 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.18 132.92 52.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.6 -0.889 . . . . 0.37 108.6 174.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.478 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 3.2 t70 -83.86 116.24 63.76 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.256 -0.429 . . . . 2.28 109.998 -173.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 9.2 Cg_endo -53.64 150.84 26.89 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.721 2.28 . . . . 1.17 111.904 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 64.36 56.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.051 0.929 . . . . 2.4 109.96 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 87.9 p -145.65 156.27 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.187 -0.915 . . . . 0.57 109.843 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.3 Cg_endo -61.2 -23.9 78.03 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.501 2.134 . . . . 0.65 111.177 172.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.672 ' HA ' ' HE3' ' A' ' 15' ' ' MET . . . -69.09 -52.1 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.464 . . . . 0.36 110.558 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.29 -45.99 92.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.761 -0.459 . . . . 2.01 109.761 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.69 -35.31 72.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.794 -0.639 . . . . 0.47 112.064 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.0 p -70.02 -19.44 63.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.861 0.362 . . . . 0.4 111.247 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.33 47.69 1.11 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.751 . . . . 0.62 112.468 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 HG13 ' A' ' 37' ' ' ILE . 34.6 tp -108.01 137.94 45.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.143 -0.317 . . . . 0.65 110.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -118.95 153.09 35.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.754 -0.462 . . . . 4.38 109.754 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -81.78 34.93 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.519 0.562 . . . . 1.44 112.519 -173.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -152.73 17.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 3.06 110.825 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.6 m-20 -94.48 159.68 14.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.92 -0.582 . . . . 1.02 110.45 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 56' ' ' ARG . 30.5 ttp180 -115.22 137.62 51.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.418 -0.586 . . . . 1.57 109.418 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.56 126.73 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.98 -0.555 . . . . 0.68 110.887 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.21 -42.01 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.87 110.736 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.9 mt-10 -131.82 143.05 49.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.39 -0.368 . . . . 0.89 110.745 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.46 111.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.323 -0.621 . . . . 0.66 109.323 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.67 29.68 19.18 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.374 0.421 . . . . 1.17 111.36 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.2 -7.44 78.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.66 112.577 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.65 121.4 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.809 -0.441 . . . . 1.17 109.809 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.42 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 37.0 t -80.1 122.66 27.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.156 0.503 . . . . 1.68 110.322 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.584 ' SD ' HG22 ' A' ' 73' ' ' VAL . 22.9 mmt -94.75 56.13 1.99 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.423 0.63 . . . . 0.81 110.331 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -77.82 68.79 3.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.25 -0.886 . . . . 3.75 110.958 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.03 26.11 27.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.761 . . . . 1.47 112.127 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 75.7 mmtt -69.3 152.92 44.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.312 0.577 . . . . 3.36 111.142 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -83.52 153.55 24.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.19 -0.914 . . . . 2.89 110.009 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.82 -40.34 66.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.014 -0.994 . . . . 1.42 112.928 -165.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.4 -30.73 68.87 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.742 -0.742 . . . . 0.72 112.365 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' OD2' ' HD2' ' A' ' 68' ' ' LYS . 42.8 t0 -68.75 -46.81 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.191 0.52 . . . . 2.03 110.104 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.584 HG22 ' SD ' ' A' ' 65' ' ' MET . 58.9 t -62.36 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.459 -0.791 . . . . 1.08 110.949 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 77' ' ' ILE . 97.5 t -64.09 -41.61 92.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.257 -0.428 . . . . 0.72 110.988 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -61.38 -37.56 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.66 110.592 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.12 87.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.42 110.995 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 74' ' ' VAL . 72.6 mt -61.06 -42.1 91.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.151 0.501 . . . . 0.69 110.281 176.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.72 -25.75 63.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.705 -0.68 . . . . 3.09 110.8 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.49 61.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.65 111.519 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.28 -20.51 76.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.587 -0.816 . . . . 0.6 111.904 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.43 -84.59 1.33 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.953 -0.641 . . . . 1.1 112.132 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 50.8 m-20 -120.42 1.1 10.67 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.856 -0.202 . . . . 2.12 111.173 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -151.49 161.87 41.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.731 0.301 . . . . 2.11 110.637 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.8 t -140.67 149.56 42.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.568 -0.53 . . . . 0.32 109.568 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.7 mttp -119.18 117.22 28.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.802 -0.444 . . . . 1.63 109.802 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -106.48 130.74 54.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.301 -0.409 . . . . 0.28 110.242 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 59' ' ' GLU . 57.8 tp -104.23 116.08 31.54 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.073 -0.714 . . . . 0.51 109.073 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 18.3 m -127.86 158.27 39.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.227 0.536 . . . . 0.33 111.884 -174.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 10' ' ' PRO . 25.9 m -128.03 147.88 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.42 109.916 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.59 176.06 7.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.254 -0.647 . . . . 1.92 109.254 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.625 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 7.6 ttp180 -54.04 -48.78 70.18 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.256 0.348 . . . . 4.16 111.469 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.17 -38.05 63.8 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 121.108 -0.237 . . . . 2.68 110.957 -173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.441 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 41.1 m -60.64 -47.62 85.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.886 0.374 . . . . 0.47 110.186 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 28.9 t70 -58.66 -47.83 83.14 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.873 -0.603 . . . . 1.18 110.772 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 48.7 mt-10 -64.77 -28.35 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.399 -0.364 . . . . 1.94 110.823 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.11 -47.72 64.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.73 110.323 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.489 ' CD2' HG13 ' A' ' 102' ' ' VAL . 46.9 m-85 -65.53 -36.8 84.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.446 -0.343 . . . . 0.44 111.278 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 29.1 mtpp -58.77 -49.36 77.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 1.92 111.714 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -71.05 -29.63 65.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.494 . . . . 2.04 111.265 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.416 ' HB3' HG12 ' A' ' 102' ' ' VAL . 36.3 t -85.39 -11.38 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 1.39 111.369 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? 63.16 43.97 6.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.73 -0.668 . . . . 4.09 111.198 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.535 HG11 ' HG3' ' A' ' 114' ' ' PRO . 7.7 p -133.39 140.28 47.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.172 -0.467 . . . . 1.42 110.29 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.7 mt -86.3 128.28 57.99 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.345 -0.388 . . . . 1.33 110.868 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.98 136.23 55.68 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.497 2.131 . . . . 0.53 111.193 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.9 t -155.8 172.67 17.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.892 -0.41 . . . . 1.42 109.892 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.435 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 60.1 mt-30 -55.68 -31.26 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.581 0.551 . . . . 1.66 111.472 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -59.75 -31.93 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.227 -0.442 . . . . 2.82 111.639 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -80.38 -14.17 58.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.448 -0.342 . . . . 0.53 111.531 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 87' ' ' LEU . 86.7 mt -59.91 -59.99 4.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.084 0.468 . . . . 1.24 110.848 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -101.98 -12.06 18.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 3.7 111.179 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.42 175.93 38.02 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.794 -0.717 . . . . 1.12 112.649 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.2 163.16 28.03 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.848 2.365 . . . . 1.31 112.313 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.45 150.23 44.12 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.856 -0.611 . . . . 1.11 109.588 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.535 ' HG3' HG11 ' A' ' 102' ' ' VAL . 38.9 Cg_endo -68.06 166.56 24.47 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.692 2.262 . . . . 1.15 112.147 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 89.6 t 76.37 114.6 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 123.948 0.78 . . . . 2.98 110.614 -176.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 14.8 Cg_exo -68.37 100.29 0.65 Allowed 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.397 2.732 . . . . 4.23 112.702 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -82.22 127.34 33.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.093 -0.503 . . . . 7.33 110.203 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.6 m 62.16 57.0 2.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.554 0.692 . . . . 8.78 110.834 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -96.06 -47.41 6.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.008 -0.542 . . . . 9.34 110.253 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.81 -26.68 16.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.705 -0.76 . . . . 11.55 111.78 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.83 52.8 1.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.152 0.501 . . . . 13.92 110.994 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 -41.37 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.908 -0.587 . . . . 16.21 110.069 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -78.15 98.52 5.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.63 . . . . 18.82 109.507 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 124' ' ' LYS . 16.9 pttp -63.69 102.44 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.48 -0.782 . . . . 20.83 111.179 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.3 -37.32 77.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.963 -1.017 . . . . 22.5 111.082 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 128' ' ' ARG . 9.7 t30 -128.56 110.69 12.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.851 -0.613 . . . . 23.99 110.354 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -82.81 54.96 2.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.171 0.51 . . . . 25.0 111.557 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.555 ' HB3' HD21 ' A' ' 126' ' ' ASN . 26.0 tpt180 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.214 -0.898 . . . . 27.52 109.471 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.668 -0.573 . . . . 11.87 111.668 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.6 tt -86.42 93.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.572 0.701 . . . . 9.86 111.179 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.87 133.53 69.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.112 -0.699 . . . . 6.96 109.112 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.23 36.09 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 123.098 2.532 . . . . 6.65 113.857 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 50.58 45.39 26.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.034 0.445 . . . . 7.99 110.687 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -58.2 150.95 20.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.374 -0.83 . . . . 4.26 111.974 -172.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.2 ptp -102.63 52.7 0.79 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.962 -1.017 . . . . 3.84 110.995 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.92 58.86 2.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.969 -0.559 . . . . 0.8 110.105 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HG2' HD21 ' A' ' 113' ' ' LEU . 49.2 mtm180 -119.67 140.71 29.83 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.828 -0.624 . . . . 3.09 110.127 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' VAL . 24.6 Cg_exo -65.53 178.54 2.09 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.231 2.621 . . . . 0.47 112.141 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 87' ' ' LEU . 7.0 ptp85 -133.19 136.6 45.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.092 -0.504 . . . . 2.37 111.85 -176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.596 ' HG ' ' CD1' ' A' ' 109' ' ' LEU . 4.1 mt -90.92 110.84 22.08 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.027 -0.731 . . . . 1.32 109.027 173.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.8 m -95.8 115.63 27.71 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.117 -0.697 . . . . 0.4 109.117 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.725 HG23 ' HG2' ' A' ' 85' ' ' LYS . 7.3 m -109.34 118.54 36.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.284 -0.636 . . . . 0.35 109.284 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.493 ' HB2' ' HB2' ' A' ' 45' ' ' PRO . 23.1 ptp -128.31 133.13 48.67 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.294 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HE3' ' HB2' ' A' ' 82' ' ' ASP . 0.7 OUTLIER -113.38 137.99 50.72 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.855 -0.795 . . . . 2.58 108.855 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.558 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 4.9 ttmt -54.6 121.05 7.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.765 -0.652 . . . . 0.92 111.179 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.98 -126.05 5.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.708 -0.758 . . . . 1.28 112.892 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.12 -43.05 45.1 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.221 2.614 . . . . 2.23 113.057 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 m -153.67 86.12 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.87 0.367 . . . . 2.87 110.591 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.558 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 65.99 -136.12 35.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.893 -0.594 . . . . 1.93 112.856 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 40.6 m-85 -124.66 -176.8 3.63 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.737 -0.838 . . . . 1.82 108.737 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -146.61 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.963 -1.113 . . . . 0.43 113.243 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.53 146.59 22.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.832 0.348 . . . . 0.4 110.506 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.35 127.35 48.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.424 -0.584 . . . . 2.18 109.424 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 35' ' ' GLN . 18.3 tp -101.71 147.84 25.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.258 0.551 . . . . 1.52 111.582 -169.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 36' ' ' PHE . 4.8 m-70 -109.56 121.98 46.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.71 . . . . 1.34 110.268 177.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -117.32 101.73 8.66 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.269 -1.382 . . . . 2.3 107.269 169.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 2.6 t70 -85.65 158.06 20.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.204 0.526 . . . . 3.48 111.739 -165.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -85.6 115.95 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.249 -0.887 . . . . 4.54 109.619 176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.4 m 79.96 -18.47 0.5 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.013 0.82 . . . . 3.49 112.158 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 29' ' ' ASP . 62.8 mttp -98.4 112.97 63.57 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.82 -0.437 . . . . 3.0 109.82 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.1 150.18 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.394 2.062 . . . . 2.24 112.238 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.88 173.57 19.98 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.932 -0.867 . . . . 1.29 110.932 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.52 ' HB3' HD11 ' A' ' 26' ' ' LEU . 26.0 mm-40 -121.53 128.73 52.34 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.783 0.325 . . . . 1.5 110.179 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . 30.0 m-85 -109.32 157.73 18.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.413 -0.588 . . . . 0.87 109.413 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG13 HD11 ' A' ' 51' ' ' LEU . 38.3 mm -98.83 116.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.113 -0.328 . . . . 0.39 110.113 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 59.8 ttt180 -76.87 -44.6 31.43 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.004 0.43 . . . . 2.83 110.549 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.441 ' HA ' ' CB ' ' A' ' 53' ' ' ALA . 26.2 t -164.48 155.07 14.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.508 -0.769 . . . . 1.26 109.291 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.7 130.06 74.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 109.56 -0.533 . . . . 0.37 109.56 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.99 119.25 56.85 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.763 -0.458 . . . . 2.28 109.763 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.3 140.25 81.87 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.648 2.232 . . . . 1.17 112.698 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.585 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 12.3 m-20 65.36 39.31 5.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.31 -0.859 . . . . 2.4 111.899 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.612 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 89.6 p -117.95 170.0 6.89 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.737 -0.665 . . . . 0.57 109.365 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 6.3 Cg_endo -51.34 -35.0 52.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.107 1.872 . . . . 0.65 112.015 174.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.92 -47.42 62.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 0.36 110.937 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 43' ' ' ASP . 5.0 tp10 -62.16 -40.49 96.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.997 0.427 . . . . 2.01 110.232 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.68 -24.32 62.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.47 111.763 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -75.93 -13.94 60.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.067 0.461 . . . . 0.4 110.344 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.47 21.65 18.93 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.696 -0.764 . . . . 0.62 112.42 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.506 HD11 HG13 ' A' ' 37' ' ' ILE . 25.9 tp -79.16 132.63 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.678 0.275 . . . . 0.65 110.277 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 8.0 tpp180 -114.88 156.68 24.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.264 -0.273 . . . . 4.38 110.264 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 39' ' ' SER . . . -87.07 30.24 0.78 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 1.44 111.734 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.79 17.28 1.12 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.377 0.608 . . . . 3.06 109.83 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.615 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.7 m-20 -104.6 159.28 15.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.065 -0.97 . . . . 1.02 110.355 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.549 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.8 tmm_? -128.12 130.9 48.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.2 -0.296 . . . . 1.57 110.2 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.51 ' HA ' HG12 ' A' ' 88' ' ' VAL . 56.8 mt -75.58 133.62 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.68 111.237 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.549 HG22 ' NH1' ' A' ' 56' ' ' ARG . 2.3 t -114.76 -46.32 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.758 -0.656 . . . . 0.87 110.299 177.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 38.6 mt-10 -123.69 148.13 46.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.89 110.674 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 63' ' ' VAL . 99.6 t -125.53 119.54 55.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.371 -0.603 . . . . 0.66 109.371 173.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.23 21.32 10.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 1.17 111.45 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.88 9.38 61.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.669 -0.777 . . . . 0.66 113.782 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 60' ' ' VAL . 11.2 p -115.31 136.25 52.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.412 0.606 . . . . 1.17 109.816 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 7.2 p -74.69 136.97 41.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.488 -0.778 . . . . 1.68 111.557 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.565 ' C ' ' HD2' ' A' ' 68' ' ' LYS . 22.4 mmt -108.36 67.45 0.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.057 -0.519 . . . . 0.81 111.878 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -141.35 131.3 24.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.366 -0.834 . . . . 3.75 109.37 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.38 -0.37 74.65 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.291 -1.123 . . . . 1.47 110.291 -170.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.579 ' HD3' ' H ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.0 164.4 13.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.356 -0.922 . . . . 3.36 111.148 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -96.96 172.15 8.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.343 -0.844 . . . . 2.89 109.041 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -62.2 -35.82 80.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.975 0.417 . . . . 1.42 109.953 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.49 -33.73 88.04 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.72 112.829 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -64.43 -46.76 81.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 2.03 110.551 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 35' ' ' GLN . 46.4 t -62.4 -46.65 95.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.02 -0.537 . . . . 1.08 110.559 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.21 -42.85 97.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.72 111.062 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -67.37 -36.55 81.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.445 -0.343 . . . . 0.66 110.747 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.36 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.625 -0.261 . . . . 0.42 111.549 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 84' ' ' THR . 77.9 mt -59.62 -45.34 94.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.283 0.563 . . . . 0.69 110.345 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -72.66 -28.94 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.541 -0.754 . . . . 3.09 110.918 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.53 -14.31 62.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.65 111.406 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.61 -19.03 78.92 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.621 -0.8 . . . . 0.6 112.047 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -104.28 3.14 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.714 -0.755 . . . . 1.1 112.102 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.566 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 7.1 p-10 -98.0 -5.06 34.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.679 0.251 . . . . 2.12 111.679 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -150.47 165.17 34.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.986 0.422 . . . . 2.11 111.176 178.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.466 HG21 HG23 ' A' ' 77' ' ' ILE . 8.7 t -148.83 148.26 29.71 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.771 -0.65 . . . . 0.32 109.688 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.725 ' HG2' HG23 ' A' ' 14' ' ' THR . 23.1 mttm -115.31 118.63 33.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.9 -0.407 . . . . 1.63 109.9 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.35 125.87 51.47 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 0.28 109.324 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD11 HD21 ' A' ' 109' ' ' LEU . 52.0 tp -102.1 115.17 29.98 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.611 -0.885 . . . . 0.51 108.611 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 30.8 m -128.17 168.13 21.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.768 -0.651 . . . . 0.33 110.207 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 10' ' ' PRO . 28.3 m -127.56 141.76 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.894 -0.594 . . . . 0.42 110.352 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.93 172.08 14.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.145 -0.687 . . . . 1.92 109.145 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 19.4 tpt85 -58.13 -46.6 85.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.926 0.394 . . . . 4.16 111.152 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -64.88 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 2.68 111.593 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 6.5 m -75.36 -43.8 48.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.185 0.517 . . . . 0.47 110.536 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.442 ' HB2' HG23 ' A' ' 89' ' ' VAL . 24.4 t70 -59.38 -47.9 83.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 1.18 111.618 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -63.6 -39.67 94.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.726 0.298 . . . . 1.94 111.103 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -62.92 -49.32 75.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.73 110.759 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -66.37 -37.08 84.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.24 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -60.43 -49.22 78.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.489 0.551 . . . . 1.92 112.489 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 7.2 ptmm? -68.7 -32.82 72.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.294 0.569 . . . . 2.04 110.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.494 ' HB3' HG23 ' A' ' 102' ' ' VAL . 62.0 m -76.47 -13.99 60.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.657 -0.701 . . . . 1.39 111.295 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.5 27.71 15.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.45 -0.795 . . . . 4.09 110.657 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 100' ' ' CYS . 59.5 t -102.71 139.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.805 -0.634 . . . . 1.42 110.676 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 2.0 mp -84.82 122.66 74.52 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.005 -0.543 . . . . 1.33 109.643 175.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HD2' HG11 ' A' ' 58' ' ' VAL . 3.0 Cg_exo -70.47 141.48 42.46 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.406 2.071 . . . . 0.53 110.891 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -151.44 167.1 29.04 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.059 -0.256 . . . . 1.42 110.787 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.601 ' HA ' ' CD1' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -52.5 -29.66 26.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.398 0.679 . . . . 1.66 111.778 176.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.26 -30.67 64.85 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.441 0.639 . . . . 2.82 110.902 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -88.73 -14.31 37.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.919 -0.582 . . . . 0.53 110.704 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.601 ' CD1' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mt -70.03 114.24 8.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 1.24 110.33 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.479 ' HA ' ' NH1' ' A' ' 9' ' ' ARG . 66.2 t30 57.27 28.05 14.59 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.844 0.83 . . . . 3.7 109.965 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -130.25 -169.05 12.42 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.228 -0.896 . . . . 1.12 111.314 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 147.87 27.05 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.536 2.157 . . . . 1.31 112.694 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 9' ' ' ARG . 47.6 mt -89.7 145.63 33.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.717 -0.674 . . . . 1.11 110.161 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.434 ' HG3' HG11 ' A' ' 102' ' ' VAL . 36.5 Cg_endo -65.0 147.47 89.06 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.842 2.361 . . . . 1.15 111.826 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 7.6 p -55.96 129.2 72.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 2.98 110.903 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 33.6 Cg_exo -58.8 89.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.071 2.514 . . . . 4.23 112.045 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.618 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 3.8 t80 -70.36 124.6 24.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 7.33 110.268 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -101.06 39.96 1.34 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.816 -0.629 . . . . 8.78 111.415 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.618 ' HB3' ' CE2' ' A' ' 117' ' ' PHE . 4.1 t-20 -133.78 108.49 8.52 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.946 -0.57 . . . . 9.34 110.064 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.42 53.86 0.48 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.175 -0.77 . . . . 11.55 111.175 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.16 99.46 7.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 13.92 110.538 -174.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.6 mt -77.25 -46.33 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.906 -0.588 . . . . 16.21 110.932 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 60.3 91.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.577 0.704 . . . . 18.82 110.942 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -79.3 -6.01 55.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.109 -0.95 . . . . 20.83 109.944 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.94 -44.94 71.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.167 -0.924 . . . . 22.5 111.449 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -102.86 28.91 5.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.157 -0.474 . . . . 23.99 111.694 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.9 p -71.01 -66.49 0.61 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.19 -0.3 . . . . 25.0 110.19 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 109.177 -0.675 . . . . 27.52 109.177 174.068 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.737 -0.545 . . . . 11.87 111.737 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.0 mp -107.07 122.89 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.758 -0.46 . . . . 9.86 109.758 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -91.34 109.53 36.48 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.244 -0.434 . . . . 6.96 109.847 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.02 -10.85 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.369 2.046 . . . . 6.65 112.921 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.31 -79.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.648 0.261 . . . . 7.99 110.633 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m 60.5 82.64 0.16 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.534 0.683 . . . . 4.26 110.948 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptm -84.87 23.32 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.762 -0.654 . . . . 3.84 110.561 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.5 mt -84.12 61.47 6.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.704 -0.68 . . . . 0.8 110.772 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -130.54 148.86 71.67 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.758 -0.655 . . . . 3.09 109.413 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.8 Cg_endo -70.38 162.98 40.43 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.566 2.177 . . . . 0.47 111.419 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.448 ' NH1' HH12 ' A' ' 52' ' ' ARG . 6.4 ptp85 -127.65 136.12 51.18 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.167 -0.47 . . . . 2.37 110.545 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HB2' HD11 ' A' ' 109' ' ' LEU . 46.5 tp -94.26 110.36 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.945 -0.57 . . . . 1.32 109.707 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 m -98.91 116.9 32.2 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.323 -0.621 . . . . 0.4 109.323 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 85' ' ' LYS . 45.7 m -111.36 119.3 38.4 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.464 -0.569 . . . . 0.35 109.464 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.48 ' HE3' HD12 ' A' ' 86' ' ' LEU . 23.1 ptp -127.96 133.24 49.2 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.014 -0.539 . . . . 0.88 109.971 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -116.79 156.59 26.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.462 -0.79 . . . . 2.58 110.138 176.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 22' ' ' TYR . 86.0 mttt -68.55 125.72 27.4 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.264 -1.335 . . . . 0.92 111.778 -172.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.86 -107.58 0.73 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.257 -1.338 . . . . 1.28 110.928 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HG2' ' HD3' ' A' ' 45' ' ' PRO . 33.5 Cg_endo -65.78 104.49 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.597 2.198 . . . . 2.23 111.361 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.0 t 63.48 29.99 15.33 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.31 0.576 . . . . 2.87 110.545 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.91 -97.09 1.11 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.269 -0.732 . . . . 1.93 111.269 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' CZ ' ' HG3' ' A' ' 17' ' ' LYS . 17.0 m-85 -119.53 -171.17 2.07 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.849 -0.797 . . . . 1.82 108.849 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.57 78.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.1 -1.048 . . . . 0.43 112.791 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -155.56 163.15 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.4 110.605 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -128.88 129.22 45.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.939 -0.573 . . . . 2.18 110.285 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.34 134.8 47.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.399 -0.364 . . . . 1.52 110.23 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.0 p80 -125.72 135.29 51.92 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.509 -0.476 . . . . 1.34 110.734 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -102.31 122.39 44.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.408 -0.815 . . . . 2.3 109.533 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.9 152.71 22.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.556 -0.535 . . . . 3.48 109.556 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -85.86 -24.62 26.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.829 -0.623 . . . . 4.54 110.56 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -101.49 -42.16 6.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.841 -0.618 . . . . 3.49 109.99 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -94.34 117.74 67.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 3.0 110.407 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 154.22 58.66 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.502 2.134 . . . . 2.24 112.231 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.0 161.52 30.76 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.9 -0.667 . . . . 1.29 111.961 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.87 128.76 40.32 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.057 -0.349 . . . . 1.5 110.057 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 88.1 m-85 -109.11 154.94 21.58 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 0.87 109.18 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 53' ' ' ALA . 41.3 mm -77.84 107.87 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.002 0.429 . . . . 0.39 110.153 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 30.7 ttt180 -67.92 -43.47 79.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 2.83 109.823 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 p -175.66 140.15 0.44 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.534 -1.212 . . . . 1.26 109.668 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.28 121.37 60.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.0 -0.741 . . . . 0.37 109.0 170.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -66.05 122.47 81.32 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.669 -0.696 . . . . 2.28 109.957 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.18 149.71 78.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.847 2.365 . . . . 1.17 111.777 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.96 40.55 2.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 2.4 110.905 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.4 p -130.72 164.44 41.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.61 -0.268 . . . . 0.57 110.696 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD3' ' HG2' ' A' ' 19' ' ' PRO . 23.4 Cg_exo -64.23 -27.33 64.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.494 2.129 . . . . 0.65 111.47 175.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -46.81 71.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.759 -0.655 . . . . 0.36 110.241 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.87 -33.24 75.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.85 -0.614 . . . . 2.01 109.971 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.25 67.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.47 111.753 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -70.2 -13.51 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.4 110.556 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.58 50.45 1.83 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.62 112.061 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 51' ' ' LEU . 15.2 tp -99.66 149.6 23.13 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.798 -0.445 . . . . 0.65 109.798 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB3' ' OD1' ' A' ' 55' ' ' ASP . 39.0 ttm180 -147.2 143.36 28.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.683 -0.235 . . . . 4.38 110.575 -173.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -77.22 14.11 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.074 0.768 . . . . 1.44 113.074 -173.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -115.44 -5.49 12.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.208 0.528 . . . . 3.06 109.981 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.633 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -91.36 155.06 18.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.152 -0.931 . . . . 1.02 111.273 -172.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -124.85 134.29 52.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 1.57 109.719 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 88' ' ' VAL . 41.7 mm -63.97 124.41 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.298 -0.41 . . . . 0.68 111.06 -176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 t -109.11 -52.01 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.995 -0.548 . . . . 0.87 110.638 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 28.9 mt-10 -133.32 149.37 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.89 110.213 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.33 123.4 66.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.78 -0.452 . . . . 0.66 109.78 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 60.81 20.84 10.97 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.079 0.552 . . . . 1.17 111.153 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.0 1.1 70.52 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.9 -0.667 . . . . 0.66 112.217 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.43 120.66 49.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.16 -0.311 . . . . 1.17 110.16 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.572 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -64.46 136.2 56.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 1.68 111.492 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.516 ' HG3' HG12 ' A' ' 73' ' ' VAL . 26.6 mmt -121.47 73.64 1.07 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.777 -0.647 . . . . 0.81 109.613 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -97.78 -57.37 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.22 -0.9 . . . . 3.75 110.667 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.9 13.77 45.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.026 -0.607 . . . . 1.47 111.927 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 30.8 mmtp -86.4 160.26 19.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.856 0.36 . . . . 3.36 110.491 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -90.72 173.11 8.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.0 -0.545 . . . . 2.89 111.429 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -58.48 -36.43 73.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.219 -0.446 . . . . 1.42 110.086 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.1 -38.7 96.56 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.795 -0.717 . . . . 0.72 112.415 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 68' ' ' LYS . 4.3 m-20 -62.57 -48.09 80.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.653 0.263 . . . . 2.03 111.171 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.516 HG12 ' HG3' ' A' ' 65' ' ' MET . 33.4 m -67.42 -40.35 84.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 1.08 111.367 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.44 -45.28 82.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.056 0.455 . . . . 0.72 110.672 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -36.59 84.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 0.66 110.414 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.47 96.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.655 0.264 . . . . 0.42 111.187 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 84' ' ' THR . 85.9 mt -60.21 -45.2 96.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.205 0.526 . . . . 0.69 110.274 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.63 -36.04 78.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 3.09 110.913 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.65 110.993 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.47 79.59 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.614 -0.803 . . . . 0.6 111.273 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.28 -123.32 7.67 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.004 -0.617 . . . . 1.1 111.659 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 17' ' ' LYS . 1.3 m-20 -100.22 -4.16 30.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.829 0.347 . . . . 2.12 110.46 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 16' ' ' LYS . 26.0 mt-10 -135.05 140.05 45.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.357 -0.979 . . . . 2.11 108.357 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 77' ' ' ILE . 12.6 t -139.66 148.03 41.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.897 0.38 . . . . 0.32 110.464 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 14' ' ' THR . 60.2 mttm -116.73 123.97 48.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.265 -0.425 . . . . 1.63 110.331 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.48 HD12 ' HE3' ' A' ' 15' ' ' MET . 95.0 mt -110.48 129.78 55.7 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.736 -0.468 . . . . 0.28 109.736 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 59' ' ' GLU . 16.9 tp -104.75 119.18 38.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.048 -0.723 . . . . 0.51 109.048 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 23.8 m -130.28 165.94 29.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.304 -0.407 . . . . 0.33 111.623 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.43 160.09 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.532 -0.758 . . . . 0.42 110.508 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' HH12 ' A' ' 11' ' ' ARG . 2.2 m-20 -77.29 175.59 9.58 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.492 0.495 . . . . 1.92 110.418 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -61.89 -47.27 85.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 4.16 110.767 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.41 -35.78 68.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 2.68 110.093 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -65.89 -41.51 91.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.773 -0.649 . . . . 0.47 110.797 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 20.4 t70 -58.66 -48.54 80.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.067 -0.515 . . . . 1.18 110.194 176.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -62.17 -38.46 89.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 1.94 111.108 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 99' ' ' LYS . 77.7 t80 -63.74 -49.19 74.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.42 -0.354 . . . . 0.73 111.283 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CG ' ' HG3' ' A' ' 104' ' ' PRO . 19.6 m-85 -66.17 -38.27 87.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.476 -0.329 . . . . 0.44 111.212 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 31.3 mtpt -66.72 -43.53 84.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.455 -0.338 . . . . 1.92 111.557 177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 96' ' ' PHE . 52.0 pttt -71.75 -14.65 62.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 2.04 110.66 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 54.5 m -94.47 -6.22 44.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.227 0.537 . . . . 1.39 110.566 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.576 ' HD2' ' N ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER 57.96 35.33 25.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.112 -0.949 . . . . 4.09 111.454 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 114' ' ' PRO . 10.9 p -132.24 147.33 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.796 -0.638 . . . . 1.42 109.806 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.564 HG21 ' SG ' ' A' ' 64' ' ' CYS . 32.1 mm -87.99 132.19 40.73 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.324 -0.398 . . . . 1.33 111.26 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.486 ' HG3' ' CG ' ' A' ' 97' ' ' PHE . 18.7 Cg_exo -65.35 137.4 51.11 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.557 2.171 . . . . 0.53 110.462 173.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.4 p -153.04 174.25 14.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.774 -0.37 . . . . 1.42 111.564 -172.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.444 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 98.3 mt-30 -59.49 -28.36 66.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 1.66 110.298 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.89 -41.34 77.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.616 -0.72 . . . . 2.82 110.429 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -78.95 -14.09 59.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.518 -0.764 . . . . 0.53 111.398 -175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.6 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.825 0.345 . . . . 1.24 110.92 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -118.09 -37.64 3.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 3.7 111.03 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.27 -166.44 36.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.164 -0.541 . . . . 1.12 113.507 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.9 136.77 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.536 2.824 . . . . 1.31 112.636 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 113' ' ' LEU . 2.8 mm? -63.11 154.86 76.0 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 1.11 109.909 171.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.61 ' HB3' HG11 ' A' ' 102' ' ' VAL . 7.1 Cg_endo -48.4 -31.27 17.31 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.312 3.341 . . . . 1.15 115.015 -168.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.8 m -66.33 119.45 62.35 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.678 -0.692 . . . . 2.98 111.012 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.665 ' HB2' ' HB3' ' A' ' 119' ' ' ASN . 34.6 Cg_endo -66.24 92.32 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.582 2.188 . . . . 4.23 111.542 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -52.9 109.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.576 -0.738 . . . . 7.33 111.603 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.3 p 59.64 23.05 11.8 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.085 0.954 . . . . 8.78 112.047 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 116' ' ' PRO . 9.8 t30 -116.62 121.74 42.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.172 -0.467 . . . . 9.34 110.209 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.32 -96.37 0.7 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.656 -0.783 . . . . 11.55 112.213 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 57.02 40.2 28.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.553 0.692 . . . . 13.92 110.731 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 pt -98.95 122.14 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.236 -0.893 . . . . 16.21 110.575 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -145.54 -85.14 0.12 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.332 -0.394 . . . . 18.82 110.126 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -112.59 0.91 15.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.996 0.427 . . . . 20.83 110.158 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -165.78 141.16 4.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.589 -0.732 . . . . 22.5 110.064 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -174.85 132.17 0.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 23.99 109.379 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.1 m 52.99 41.46 32.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.173 0.511 . . . . 25.0 110.795 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.656 -0.688 . . . . 27.52 109.988 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.834 -0.506 . . . . 11.87 111.834 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.534 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 23.6 pt -76.65 140.21 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.773 0.32 . . . . 9.86 110.47 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.92 114.98 60.91 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.341 0.591 . . . . 6.96 112.212 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 2' ' ' ILE . 18.8 Cg_endo -90.83 -51.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.943 2.429 . . . . 6.65 111.564 169.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -154.59 57.96 0.69 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.644 -0.707 . . . . 7.99 110.079 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.513 HG22 ' HG ' ' A' ' 8' ' ' LEU . 3.3 m -81.23 73.5 8.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.496 0.665 . . . . 4.26 110.585 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ptm -84.33 51.94 2.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.314 -0.857 . . . . 3.84 111.168 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 6' ' ' THR . 81.1 mt -80.97 60.38 4.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.305 0.574 . . . . 0.8 110.436 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 14.1 ptt180 -126.74 160.2 60.0 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.616 -0.72 . . . . 3.09 109.285 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HB2' HD11 ' A' ' 87' ' ' LEU . 56.7 Cg_endo -65.79 178.6 2.19 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.446 2.097 . . . . 0.47 111.984 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.539 ' HD3' HG23 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -137.31 132.5 33.75 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.108 -0.33 . . . . 2.37 110.108 175.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HG ' HD11 ' A' ' 109' ' ' LEU . 3.7 mt -92.82 109.9 21.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.08 -0.509 . . . . 1.32 109.843 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 17.9 m -91.19 116.64 28.97 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.966 -0.753 . . . . 0.4 108.966 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 116.7 33.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.517 -0.92 . . . . 0.35 108.517 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 46' ' ' ALA . 22.9 ptp -140.21 134.13 30.7 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.148 -0.478 . . . . 0.88 110.195 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 17.9 pttp -110.9 156.28 21.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.266 0.555 . . . . 2.58 110.583 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.574 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.8 ttmt -59.11 111.85 1.48 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.85 -1.068 . . . . 0.92 112.163 -171.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 19' ' ' PRO . . . -110.53 -107.16 3.0 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.414 -0.812 . . . . 1.28 111.256 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 18' ' ' GLY . 27.7 Cg_exo -62.33 95.33 0.14 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.088 2.525 . . . . 2.23 112.126 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.0 t 72.53 -52.17 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.461 0.705 . . . . 2.87 112.139 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.574 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -179.69 78.25 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 1.93 111.885 -175.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 71.04 -63.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.342 0.657 . . . . 1.82 110.913 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.12 69.31 0.67 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.158 -0.544 . . . . 0.43 112.982 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -156.43 150.99 25.69 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.783 0.325 . . . . 0.4 110.192 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 45.1 t-20 -102.26 129.33 48.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.894 0.378 . . . . 2.18 109.982 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 35' ' ' GLN . 1.7 tm? -100.84 129.33 46.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.168 -0.679 . . . . 1.52 109.168 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -153.18 167.04 30.63 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 115.852 1.797 . . . . 1.34 115.852 -167.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.643 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 70.5 m 87.39 12.61 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 113.209 -1.814 . . . . 2.3 112.487 169.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 70' ' ' HIS . 1.7 p-10 -129.67 163.26 26.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.173 0.511 . . . . 3.48 110.928 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -166.26 -25.75 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.945 -1.025 . . . . 4.54 109.054 170.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -150.04 19.51 0.88 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.645 -0.707 . . . . 3.49 110.281 174.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -126.18 135.4 27.09 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.932 -0.396 . . . . 3.0 109.932 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 154.08 68.44 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.408 2.072 . . . . 2.24 111.003 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 105.88 2.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.429 -0.891 . . . . 1.29 110.984 -173.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.695 ' HB3' HD11 ' A' ' 26' ' ' LEU . 16.4 mm-40 -100.4 140.51 34.55 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.523 -0.547 . . . . 1.5 109.523 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.643 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 50.3 m-85 -117.53 144.48 45.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.197 -1.001 . . . . 0.87 110.104 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.5 HG13 HD11 ' A' ' 51' ' ' LEU . 45.0 mm -81.56 115.3 23.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.541 -0.54 . . . . 0.39 109.541 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 2.1 tmm_? -77.25 -49.31 15.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.234 -0.654 . . . . 2.83 109.234 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.2 p -159.68 150.47 19.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.057 -0.974 . . . . 1.26 109.824 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.11 122.03 63.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.065 -0.717 . . . . 0.37 109.065 173.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.8 m-20 -67.42 133.02 93.02 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.589 . . . . 2.28 110.436 -174.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 35.5 Cg_exo -59.71 145.2 98.78 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.672 2.248 . . . . 1.17 112.033 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 34.4 m-20 74.54 15.59 3.34 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.997 0.81 . . . . 2.4 111.657 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.5 p -95.09 155.22 39.23 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.752 0.31 . . . . 0.57 110.238 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.68 -27.5 81.27 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.772 2.315 . . . . 0.65 111.182 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' HA ' ' HE2' ' A' ' 15' ' ' MET . . . -65.24 -48.81 71.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.732 -0.667 . . . . 0.36 110.114 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.909 -0.587 . . . . 2.01 110.272 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.52 -29.42 69.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.47 111.784 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 74.6 p -73.68 -12.15 60.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.046 0.451 . . . . 0.4 110.875 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.34 51.06 1.36 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.62 112.441 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.5 HD11 HG13 ' A' ' 37' ' ' ILE . 23.1 tp -100.83 142.62 32.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.0 0.429 . . . . 0.65 110.759 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.515 ' HG2' ' H ' ' A' ' 54' ' ' GLN . 32.4 ttm180 -121.63 144.23 48.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 4.38 109.805 175.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.71 26.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.144 0.497 . . . . 1.44 111.5 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -139.95 19.75 2.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.641 . . . . 3.06 109.271 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -104.27 157.85 16.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.341 -0.845 . . . . 1.02 111.305 -176.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -115.89 133.08 56.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.604 -0.725 . . . . 1.57 109.874 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' HA ' HG12 ' A' ' 88' ' ' VAL . 65.5 mt -76.63 124.43 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.296 -0.411 . . . . 0.68 110.465 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -106.65 -46.0 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.87 110.523 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 43.1 mt-10 -127.07 146.23 50.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.89 110.465 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' HG12 ' A' ' 63' ' ' VAL . 85.9 t -131.48 118.93 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.22 -0.446 . . . . 0.66 109.841 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 57.23 27.43 13.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.377 -0.374 . . . . 1.17 111.582 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.5 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 92.6 6.75 63.81 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.785 -0.722 . . . . 0.66 114.219 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 60' ' ' VAL . 12.1 p -115.41 135.07 56.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.784 0.792 . . . . 1.17 110.092 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.426 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 46.1 t -80.74 136.63 36.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.508 -0.769 . . . . 1.68 111.225 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.486 ' SD ' HG22 ' A' ' 73' ' ' VAL . 23.1 mmt -106.94 53.3 0.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.695 -0.684 . . . . 0.81 110.479 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.09 -56.77 4.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.86 -0.609 . . . . 3.75 110.309 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.72 1.47 39.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 1.47 111.794 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.2 146.6 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.178 0.513 . . . . 3.36 110.875 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -98.97 -179.46 4.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.661 -0.699 . . . . 2.89 110.644 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.549 ' HB2' ' OD2' ' A' ' 29' ' ' ASP . 40.7 t60 -55.57 -43.87 76.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.401 . . . . 1.42 110.773 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -37.85 95.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.734 -0.746 . . . . 0.72 112.21 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -65.44 -47.51 75.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.987 0.422 . . . . 2.03 110.876 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.486 HG22 ' SD ' ' A' ' 65' ' ' MET . 25.2 t -70.23 -47.14 68.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 1.08 110.983 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.83 -36.47 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 0.72 110.636 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.2 t -65.31 -47.0 78.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.187 -0.46 . . . . 0.66 110.093 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 -44.59 93.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.218 -0.446 . . . . 0.42 111.651 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.423 HG23 HG21 ' A' ' 84' ' ' THR . 70.3 mt -58.94 -43.26 88.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.288 0.566 . . . . 0.69 110.605 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -74.42 -30.08 61.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.516 -0.765 . . . . 3.09 111.342 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.15 9.94 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.65 111.727 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.1 -0.8 86.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.6 111.798 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.37 -101.5 2.49 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 111.129 -0.788 . . . . 1.1 111.129 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.497 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 6.0 t70 -128.86 -15.96 4.24 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.988 -0.285 . . . . 2.12 110.664 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 10.2 mt-10 -119.3 144.34 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 2.11 108.481 174.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 77' ' ' ILE . 13.3 t -135.34 148.82 49.57 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.094 0.473 . . . . 0.32 110.395 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HB3' HD22 ' A' ' 12' ' ' LEU . 97.8 mttt -111.67 117.46 32.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 1.63 109.856 175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.8 mt -106.68 129.98 54.49 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.16 -0.473 . . . . 0.28 109.797 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 10' ' ' PRO . 41.5 tp -104.8 115.31 30.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.284 -0.636 . . . . 0.51 109.284 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.0 m -127.48 160.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.107 -0.497 . . . . 0.33 110.861 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.88 138.77 53.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.862 -0.608 . . . . 0.42 110.644 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -76.22 166.38 23.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.605 . . . . 1.92 110.078 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 44.8 ttt180 -56.2 -48.01 77.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 4.16 110.259 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.62 -33.69 76.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.761 -0.654 . . . . 2.68 110.372 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.4 m -70.63 -51.8 25.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.302 -0.863 . . . . 0.47 111.122 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.87 -30.72 68.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 1.18 111.393 -172.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 26.4 mm-40 -62.02 -35.27 78.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.005 0.431 . . . . 1.94 110.126 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -67.83 -45.7 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.73 109.926 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -62.54 -36.91 84.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.44 111.498 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -59.66 -49.65 76.93 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.54 0.21 . . . . 1.92 111.257 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ptmt -71.89 -26.48 62.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.419 -0.355 . . . . 2.04 111.048 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 26.8 m -81.19 -8.4 59.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.273 -0.421 . . . . 1.39 111.242 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 58.53 39.63 24.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.338 -0.846 . . . . 4.09 111.046 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.448 HG11 ' CG ' ' A' ' 114' ' ' PRO . 7.3 p -132.87 145.25 34.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 1.42 110.924 -176.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 63.9 mt -80.51 131.75 60.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 1.33 110.572 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 103' ' ' ILE . 22.4 Cg_exo -63.7 136.65 54.8 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.472 2.115 . . . . 0.53 110.619 173.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 48.9 m -157.57 163.66 38.11 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.124 -0.23 . . . . 1.42 110.677 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.5 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 50.8 mt-30 -56.89 -28.78 62.32 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.7 0.625 . . . . 1.66 111.983 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 105' ' ' SER . 9.3 pt-20 -57.99 -29.97 65.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.114 0.483 . . . . 2.82 111.061 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.427 ' CD2' ' HD3' ' A' ' 114' ' ' PRO . 35.9 m80 -82.97 -13.68 55.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.884 -0.598 . . . . 0.53 110.98 -177.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.501 HD11 HD13 ' A' ' 87' ' ' LEU . 66.8 mt -73.73 -53.77 9.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.897 -0.592 . . . . 1.24 110.087 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.51 48.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.454 -0.794 . . . . 3.7 110.258 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.18 -168.53 38.36 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.755 -0.736 . . . . 1.12 111.959 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -87.94 174.54 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.048 2.499 . . . . 1.31 112.783 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 9' ' ' ARG . 48.1 mt -88.43 138.23 30.3 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.586 -0.734 . . . . 1.11 109.737 175.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.448 ' CG ' HG11 ' A' ' 102' ' ' VAL . 48.0 Cg_endo -68.23 127.41 15.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.808 2.338 . . . . 1.15 112.578 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 27.3 m -125.96 144.97 50.39 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.293 -0.867 . . . . 2.98 109.662 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 13.3 Cg_exo -70.4 72.64 1.74 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.922 2.415 . . . . 4.23 112.038 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -145.92 142.17 28.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.785 -0.45 . . . . 7.33 109.785 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.0 p -72.88 89.22 1.38 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 8.78 111.652 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.97 156.21 22.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.769 -0.65 . . . . 9.34 110.385 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.57 157.16 49.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.078 -0.582 . . . . 11.55 112.392 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.72 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.106 0.479 . . . . 13.92 111.46 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 57.8 mt -84.55 86.08 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.686 -0.857 . . . . 16.21 108.686 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -73.54 122.66 22.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.33 -0.85 . . . . 18.82 110.978 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -118.58 57.12 0.87 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.172 -0.922 . . . . 20.83 109.655 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -61.93 -59.31 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.773 -1.103 . . . . 22.5 110.669 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -102.53 106.17 16.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 23.99 110.113 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.2 t -130.78 120.71 24.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.829 -0.623 . . . . 25.0 109.919 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.708 -0.663 . . . . 27.52 109.465 179.471 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 112.035 -0.426 . . . . 11.87 112.035 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.9 mt 71.17 110.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.329 0.585 . . . . 9.86 110.75 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 16.2 t70 -85.51 135.63 38.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.828 -0.624 . . . . 6.96 109.567 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 3' ' ' ASP . 32.5 Cg_exo -59.62 -16.87 38.93 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.391 2.727 . . . . 6.65 112.784 -178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 8' ' ' LEU . 18.6 p90 -136.38 -152.76 0.46 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.917 -1.142 . . . . 7.99 107.917 172.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.541 HG22 ' HG3' ' A' ' 7' ' ' MET . 23.1 m 71.73 129.46 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 4.26 111.661 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 6' ' ' THR . 85.1 mtp 66.58 11.82 8.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.439 -0.8 . . . . 3.84 111.415 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 5' ' ' PHE . 65.9 mt -93.63 64.38 3.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.997 0.904 . . . . 0.8 109.038 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 110' ' ' ASN . 74.1 mtt180 -117.7 146.49 38.86 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.43 -1.259 . . . . 3.09 109.481 -173.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 87' ' ' LEU . 48.0 Cg_endo -66.93 159.25 52.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.378 2.052 . . . . 0.47 110.996 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HG3' HG23 ' A' ' 88' ' ' VAL . 6.3 ptp85 -114.92 129.55 56.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.209 -0.45 . . . . 2.37 110.304 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.451 -0.574 . . . . 1.32 109.451 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 21.4 m -93.85 116.18 28.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.535 -0.543 . . . . 0.4 109.535 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 85' ' ' LYS . 25.5 m -108.57 116.95 32.94 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.661 -0.866 . . . . 0.35 108.661 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.419 ' HE3' HD12 ' A' ' 86' ' ' LEU . 25.3 ptp -133.55 134.01 42.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.142 0.496 . . . . 0.88 111.201 -172.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -107.07 141.42 38.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.246 -0.888 . . . . 2.58 109.997 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 39.0 mttm -59.79 107.86 0.67 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.695 -0.684 . . . . 0.92 111.427 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 19' ' ' PRO . . . -104.41 -119.64 4.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.922 -1.036 . . . . 1.28 112.366 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 18' ' ' GLY . 43.1 Cg_exo -57.52 -58.01 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.079 2.519 . . . . 2.23 113.066 -176.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -121.37 36.4 4.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 2.87 111.425 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 55.63 84.4 0.04 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.249 -0.501 . . . . 1.93 112.736 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 8.7 m-85 67.32 -149.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.801 -0.444 . . . . 1.82 109.801 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.91 73.34 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.391 -0.909 . . . . 0.43 112.516 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -152.77 158.91 42.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.4 110.539 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -113.91 133.4 55.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.834 -0.621 . . . . 2.18 109.561 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 35' ' ' GLN . 3.1 tm? -109.23 129.38 55.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.024 -0.362 . . . . 1.52 110.024 -176.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.811 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.91 140.13 53.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.123 0.487 . . . . 1.34 110.292 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -126.36 142.57 51.48 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.972 -0.558 . . . . 2.3 110.066 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 8.6 t70 -92.26 141.27 28.74 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.67 -0.863 . . . . 3.48 108.67 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.36 -9.79 23.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 4.54 110.965 -175.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 t -97.53 -44.02 6.99 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.186 -0.672 . . . . 3.49 109.186 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 22.2 pttm -117.43 114.22 38.37 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.636 . . . . 3.0 109.889 176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -55.7 140.23 84.11 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.012 2.475 . . . . 2.24 113.193 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.82 135.47 2.9 Favored Glycine 0 C--N 1.312 -0.752 0 CA-C-N 114.618 -1.174 . . . . 1.29 112.115 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.435 ' HB3' HD21 ' A' ' 26' ' ' LEU . 2.6 mp0 -101.28 128.3 47.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.805 -0.443 . . . . 1.5 109.805 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.636 ' HB2' ' CD2' ' A' ' 27' ' ' HIS . 56.0 m-85 -122.08 142.31 50.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.926 -0.398 . . . . 0.87 109.926 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.534 HG13 HD11 ' A' ' 51' ' ' LEU . 43.7 mm -72.29 109.41 4.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.199 0.523 . . . . 0.39 110.029 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.811 ' HB2' ' HB3' ' A' ' 27' ' ' HIS . 29.1 tpt180 -66.81 -42.88 85.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.256 -0.883 . . . . 2.83 110.233 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.3 t -170.51 158.23 6.28 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.489 -0.778 . . . . 1.26 109.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.05 134.4 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.076 -0.713 . . . . 0.37 109.076 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.44 125.02 91.51 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.104 -0.498 . . . . 2.28 109.932 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 Cg_endo -61.38 134.82 53.92 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.756 2.304 . . . . 1.17 112.771 -176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 2.4 m-20 73.16 20.23 3.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.442 -0.799 . . . . 2.4 112.194 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 97.2 p -97.48 160.4 28.86 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.873 -0.417 . . . . 0.57 109.873 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 19.6 Cg_endo -60.06 -24.25 76.04 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.336 2.024 . . . . 0.65 111.999 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.91 -40.97 75.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.36 110.35 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -69.89 -39.38 76.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.201 -0.454 . . . . 2.01 110.249 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -19.85 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.47 111.79 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.472 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 53.5 p -75.45 -12.89 60.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.4 110.529 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.83 -1.0 30.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.686 . . . . 0.62 112.29 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 37' ' ' ILE . 30.9 tp -74.82 131.15 40.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.891 0.377 . . . . 0.65 110.466 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -132.77 -172.58 2.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.002 -0.544 . . . . 4.38 110.271 177.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.36 154.46 19.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.515 -0.311 . . . . 1.44 111.342 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 69.6 18.82 7.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.694 -0.685 . . . . 3.06 111.235 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -90.57 150.21 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 1.02 109.784 175.135 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' NH1' HG22 ' A' ' 58' ' ' VAL . 8.0 tmm_? -120.53 129.1 53.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.534 -0.543 . . . . 1.57 109.534 -176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' HG12 ' A' ' 88' ' ' VAL . 54.9 mt -76.26 136.67 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.68 111.406 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.511 HG22 ' NH1' ' A' ' 56' ' ' ARG . 3.4 t -115.1 -50.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.481 -0.782 . . . . 0.87 110.098 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 31.2 mt-10 -128.88 149.07 50.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.939 -0.573 . . . . 0.89 110.48 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -130.35 120.65 49.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.66 110.004 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 60.35 27.61 17.19 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.949 0.5 . . . . 1.17 111.447 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 1.01 82.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.66 112.32 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.86 121.62 55.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.13 -0.322 . . . . 1.17 110.13 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 48.8 t -70.23 135.27 48.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.983 0.421 . . . . 1.68 110.813 -178.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.754 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 23.8 mmt -112.67 64.39 0.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.596 0.712 . . . . 0.81 110.333 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -93.44 99.19 11.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.01 -0.995 . . . . 3.75 110.875 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.19 4.33 81.4 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 1.47 112.474 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.754 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 32.5 mmtp -58.77 156.61 10.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.621 0.724 . . . . 3.36 112.819 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -80.93 162.39 23.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.483 -1.235 . . . . 2.89 109.969 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -59.16 -38.9 80.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.924 0.392 . . . . 1.42 110.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.42 -41.2 91.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.751 -0.738 . . . . 0.72 113.099 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.51 -41.08 89.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.718 0.259 . . . . 2.03 111.215 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.1 m -69.41 -41.89 80.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.377 -0.374 . . . . 1.08 111.383 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.53 -38.09 78.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.973 0.416 . . . . 0.72 110.344 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -66.33 -35.85 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.759 -0.655 . . . . 0.66 110.51 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.49 98.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 0.42 111.567 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 HD21 ' A' ' 86' ' ' LEU . 62.9 mt -59.06 -42.26 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.295 0.569 . . . . 0.69 110.628 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -74.14 -30.28 62.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.682 -0.69 . . . . 3.09 110.706 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.44 -8.91 57.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.868 -0.605 . . . . 0.65 111.446 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.09 -30.85 78.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.76 -0.734 . . . . 0.6 111.683 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.65 -101.04 1.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.071 -0.585 . . . . 1.1 112.132 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.64 -18.06 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.998 0.428 . . . . 2.12 110.083 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.61 44.84 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.429 -0.582 . . . . 2.11 109.429 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.438 HG21 HG23 ' A' ' 77' ' ' ILE . 15.1 t -140.32 149.37 42.67 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.262 -0.426 . . . . 0.32 110.142 -177.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 14' ' ' THR . 59.9 mttp -116.26 116.89 28.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.185 -0.461 . . . . 1.63 109.989 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 77' ' ' ILE . 87.1 mt -108.3 126.87 53.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.105 -0.498 . . . . 0.28 109.995 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 10' ' ' PRO . 31.0 tp -103.25 115.71 31.09 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.093 -0.706 . . . . 0.51 109.093 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.4 m -127.39 164.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.767 -0.651 . . . . 0.33 110.089 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -127.74 142.06 44.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.086 -0.507 . . . . 0.42 111.14 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.21 168.74 17.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.23 -0.895 . . . . 1.92 109.48 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 91' ' ' ARG . 6.5 ttp180 -56.58 -47.55 79.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.268 0.556 . . . . 4.16 110.155 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.09 -35.92 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.438 -0.801 . . . . 2.68 110.981 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 m -72.16 -49.95 31.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.47 111.497 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.63 -46.75 88.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.109 0.48 . . . . 1.18 110.301 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -63.01 -34.63 77.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.913 -0.585 . . . . 1.94 111.269 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.81 -47.37 78.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.984 0.421 . . . . 0.73 110.438 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HD2' HG13 ' A' ' 102' ' ' VAL . 43.1 m-85 -65.1 -35.9 82.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.1 -0.5 . . . . 0.44 111.393 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -57.9 -49.1 77.88 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.505 0.187 . . . . 1.92 111.505 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -71.01 -22.17 62.19 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.202 0.525 . . . . 2.04 110.812 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 116' ' ' PRO . 85.9 m -84.81 -14.45 48.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.018 -0.537 . . . . 1.39 110.817 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 57.63 33.97 23.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.418 -0.81 . . . . 4.09 111.372 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.458 HG11 ' HG2' ' A' ' 114' ' ' PRO . 11.4 p -128.49 146.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.017 -0.538 . . . . 1.42 109.953 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.2 mt -87.23 132.06 42.52 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 1.33 111.322 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.04 143.37 84.56 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.783 2.322 . . . . 0.53 110.942 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.9 m -156.01 163.04 40.2 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.82 -0.352 . . . . 1.42 110.481 -173.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.45 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 22.7 mt-30 -55.66 -29.01 58.56 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.679 0.612 . . . . 1.66 110.904 174.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.54 -29.76 66.58 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.939 -0.573 . . . . 2.82 111.839 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -87.24 -13.88 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.361 -0.381 . . . . 0.53 111.798 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 73.2 mt -58.3 106.74 0.41 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.48 -0.327 . . . . 1.24 110.932 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.48 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 83.6 m-20 59.61 18.25 6.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.153 -0.476 . . . . 3.7 111.638 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.2 179.3 23.01 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.445 -0.662 . . . . 1.12 111.445 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.5 131.9 29.43 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.423 2.082 . . . . 1.31 111.886 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.3 mt -78.88 132.34 64.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.728 -0.471 . . . . 1.11 109.728 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HG2' HG11 ' A' ' 102' ' ' VAL . 30.4 Cg_endo -64.47 149.45 89.97 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 123.416 2.744 . . . . 1.15 113.02 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 p -128.77 83.29 66.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 122.002 0.906 . . . . 2.98 109.969 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 100' ' ' CYS . 3.0 Cg_endo -87.58 5.65 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.445 2.763 . . . . 4.23 112.068 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 63.88 -69.11 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.596 -1.184 . . . . 7.33 112.01 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 m 58.95 59.61 2.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.876 0.846 . . . . 8.78 110.213 -178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -94.78 -21.15 18.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.428 -0.806 . . . . 9.34 109.593 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.74 149.55 28.6 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.87 -0.681 . . . . 11.55 111.969 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -73.52 106.69 5.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.804 0.335 . . . . 13.92 110.339 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.73 109.12 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 16.21 110.446 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -126.89 87.71 2.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.445 . . . . 18.82 110.343 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -101.79 130.09 48.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.217 0.532 . . . . 20.83 110.737 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.11 155.55 18.56 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.696 -0.684 . . . . 22.5 110.756 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -115.22 66.61 0.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.941 -0.572 . . . . 23.99 110.417 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.3 p -81.34 90.77 6.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.381 0.61 . . . . 25.0 109.86 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.537 -0.756 . . . . 27.52 110.808 -175.16 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.952 0 N-CA-C 111.816 -0.513 . . . . 11.87 111.816 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.6 pt -114.61 36.36 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 9.86 109.637 176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.56 116.53 65.03 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.193 -0.912 . . . . 6.96 110.636 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.06 -26.46 30.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.838 2.359 . . . . 6.65 111.622 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -95.64 71.49 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 7.99 110.271 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -124.95 160.29 29.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 4.26 111.117 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.6 ptm -92.14 21.39 5.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 3.84 111.596 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.8 mt -109.25 41.05 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.348 0.594 . . . . 0.8 110.62 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -112.45 145.98 34.02 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.427 -0.806 . . . . 3.09 109.26 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.527 ' HB2' HD11 ' A' ' 87' ' ' LEU . 32.8 Cg_endo -65.06 160.28 42.47 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.21 1.94 . . . . 0.47 111.552 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -107.23 130.33 54.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.599 -0.728 . . . . 2.37 109.904 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.6 tp -106.23 109.4 21.32 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.536 -0.542 . . . . 1.32 109.536 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.2 m -96.26 117.5 30.91 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.743 -0.662 . . . . 0.4 109.841 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -111.06 116.87 31.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.407 -0.961 . . . . 0.35 108.407 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.652 ' HE3' HD12 ' A' ' 86' ' ' LEU . 22.8 ptp -132.88 133.54 43.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.942 0.401 . . . . 0.88 110.652 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.972 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 6.8 ttmt -108.78 137.38 46.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.233 0.54 . . . . 2.58 110.459 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.645 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 6.5 ttmt -54.88 125.65 21.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.407 -1.27 . . . . 0.92 112.045 -173.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.91 -153.0 28.68 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.792 -0.64 . . . . 1.28 111.637 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.21 -33.99 58.26 Favored 'Trans proline' 0 CA--C 1.527 0.159 0 C-N-CA 122.912 2.408 . . . . 2.23 112.663 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.9 m -119.49 38.23 3.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.129 0.49 . . . . 2.87 110.868 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.645 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 80.34 -108.91 2.85 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.325 -0.941 . . . . 1.93 111.869 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 73.0 m-85 -130.82 -155.0 0.67 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.835 -0.802 . . . . 1.82 108.835 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.86 73.35 0.22 Allowed Glycine 0 C--O 1.228 -0.265 0 C-N-CA 119.639 -1.267 . . . . 0.43 113.467 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -157.28 152.01 25.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.849 0.325 . . . . 0.4 110.701 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' OD1' ' HD3' ' A' ' 38' ' ' ARG . 3.0 t-20 -112.03 145.42 39.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.462 -0.569 . . . . 2.18 109.462 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -102.36 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.375 0.607 . . . . 1.52 112.579 -172.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -107.82 121.5 44.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 1.34 110.022 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -105.76 92.45 4.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.792 -0.818 . . . . 2.3 108.792 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.69 131.97 34.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.562 0.696 . . . . 3.48 111.982 -170.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 26.4 pttt -96.46 44.81 1.06 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.941 -1.027 . . . . 4.54 111.032 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.7 p -162.59 -57.54 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.321 -0.854 . . . . 3.49 109.804 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -101.57 131.11 23.36 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 3.0 110.162 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.95 155.04 30.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.668 2.245 . . . . 2.24 113.233 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.24 158.25 24.06 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.235 -0.893 . . . . 1.29 111.848 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -93.21 127.37 38.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.026 0.441 . . . . 1.5 110.315 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 56' ' ' ARG . 51.6 m-85 -106.55 158.22 17.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 0.87 109.129 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.802 HG13 ' HG ' ' A' ' 51' ' ' LEU . 10.8 mm -80.35 110.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.973 -0.751 . . . . 0.39 108.973 175.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 27' ' ' HIS . 79.7 ttt180 -67.48 -46.72 72.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.431 0.634 . . . . 2.83 109.905 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.9 p -167.59 131.64 1.79 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.932 -1.031 . . . . 1.26 108.881 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -95.01 127.99 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.314 -0.624 . . . . 0.37 109.314 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -69.2 115.52 32.86 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.275 -0.639 . . . . 2.28 109.275 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.72 147.53 94.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.591 2.194 . . . . 1.17 111.689 -178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 63.95 52.87 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.895 0.855 . . . . 2.4 110.031 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.616 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 78.4 p -142.95 167.9 14.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.57 110.113 176.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 44' ' ' SER . 9.3 Cg_endo -54.19 -36.04 84.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.65 111.862 175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.486 ' HA ' ' HE1' ' A' ' 15' ' ' MET . . . -67.42 -48.52 67.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.36 110.757 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.53 -38.54 90.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.254 -0.43 . . . . 2.01 110.152 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.78 79.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.47 111.589 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.8 p -72.8 -14.73 61.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.07 0.462 . . . . 0.4 110.933 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.92 38.46 4.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.096 -0.573 . . . . 0.62 113.047 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.802 ' HG ' HG13 ' A' ' 37' ' ' ILE . 13.0 tp -84.25 113.9 21.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 0.65 109.839 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD2' ' OD1' ' A' ' 55' ' ' ASP . 40.7 ttm105 -94.0 137.95 32.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.74 0.305 . . . . 4.38 110.579 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HA ' ' HB ' ' A' ' 37' ' ' ILE . . . -82.34 35.81 0.45 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.509 0.559 . . . . 1.44 112.509 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -143.65 -0.98 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 3.06 110.341 172.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.589 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 29.4 m-20 -98.04 153.78 18.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.184 -0.462 . . . . 1.02 110.957 -168.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 26.5 ttm105 -99.68 133.86 43.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.854 -0.612 . . . . 1.57 110.704 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.5 mt -73.42 122.72 26.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.1 -0.704 . . . . 0.68 109.1 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.4 t -105.69 -46.5 8.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.0 -0.545 . . . . 0.87 110.431 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 37.0 mt-10 -128.47 142.44 51.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.329 -0.396 . . . . 0.89 110.627 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.95 118.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.828 -0.624 . . . . 0.66 109.417 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 62.79 19.34 11.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.381 0.426 . . . . 1.17 110.781 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.29 4.55 66.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.837 -0.697 . . . . 0.66 112.425 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.26 115.52 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.037 -0.357 . . . . 1.17 110.037 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.558 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 49.8 t -74.79 130.16 38.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.26 0.552 . . . . 1.68 110.526 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.508 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 24.4 mmt -97.3 51.14 1.09 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.599 0.714 . . . . 0.81 111.079 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -77.2 105.67 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.103 -0.953 . . . . 3.75 110.355 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.94 -2.49 87.72 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 1.47 112.712 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 34.1 mmtp -66.53 160.68 24.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.238 0.542 . . . . 3.36 111.353 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.1 175.51 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.506 -0.77 . . . . 2.89 110.281 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 8.1 t60 -53.77 -43.4 69.18 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.444 0.465 . . . . 1.42 111.516 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.76 -41.84 88.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.714 -0.755 . . . . 0.72 113.178 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.95 -40.26 97.12 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.964 0.411 . . . . 2.03 110.655 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 77' ' ' ILE . 48.9 t -70.4 -47.04 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.898 -0.592 . . . . 1.08 110.788 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' HA ' HD12 ' A' ' 77' ' ' ILE . 89.9 t -68.29 -40.69 82.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.72 111.369 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.1 t -61.49 -38.93 89.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 0.66 110.397 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.9 92.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.497 -0.32 . . . . 0.42 111.138 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.527 HG23 HG21 ' A' ' 84' ' ' THR . 66.9 mt -58.76 -45.6 91.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.509 0.671 . . . . 0.69 110.162 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.54 -25.42 59.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.257 -0.883 . . . . 3.09 111.306 -178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.16 3.75 41.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.147 -0.479 . . . . 0.65 111.187 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.87 9.06 54.61 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.985 -0.626 . . . . 0.6 112.315 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.49 -120.13 5.92 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.772 -0.727 . . . . 1.1 111.517 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.564 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 9.3 t70 -107.49 -31.58 8.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.028 0.442 . . . . 2.12 110.275 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.972 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -121.13 139.66 53.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.242 -0.435 . . . . 2.11 110.273 175.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.527 HG21 HG23 ' A' ' 77' ' ' ILE . 9.1 t -130.66 150.06 52.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.805 -0.634 . . . . 0.32 111.19 -170.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -108.57 118.53 37.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.586 -0.734 . . . . 1.63 110.793 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.652 HD12 ' HE3' ' A' ' 15' ' ' MET . 80.2 mt -109.9 131.22 55.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.05 -0.523 . . . . 0.28 109.845 176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 10' ' ' PRO . 32.9 tp -104.19 119.6 39.31 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.604 -0.517 . . . . 0.51 109.604 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 27.3 m -126.64 153.33 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.173 0.511 . . . . 0.33 111.621 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.44 134.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.759 -0.655 . . . . 0.42 110.288 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.16 171.45 14.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.713 -0.477 . . . . 1.92 109.713 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 91' ' ' ARG . 34.2 ttm180 -52.44 -47.9 66.11 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.296 0.373 . . . . 4.16 111.615 -176.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.08 -42.32 76.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 2.68 110.622 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 89.5 m -64.92 -46.59 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.762 -0.653 . . . . 0.47 111.086 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -62.66 -47.27 84.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 1.18 110.976 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 10.2 mm-40 -60.02 -33.67 72.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.543 -0.299 . . . . 1.94 110.478 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.805 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 87.8 t80 -63.28 -48.33 78.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.73 110.497 176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 104' ' ' PRO . 34.2 m-85 -66.27 -38.14 87.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.831 0.348 . . . . 0.44 111.47 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -61.91 -48.53 80.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 1.92 111.618 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.805 ' HE2' ' HA ' ' A' ' 96' ' ' PHE . 61.5 pttt -70.76 -15.56 62.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 2.04 111.445 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.49 ' HB3' HG12 ' A' ' 102' ' ' VAL . 42.4 t -93.19 -7.83 44.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 1.39 110.196 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 59.35 29.45 19.01 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.281 -0.872 . . . . 4.09 111.21 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 100' ' ' CYS . 12.2 p -115.58 152.41 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 1.42 109.901 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.34 130.97 41.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.858 0.361 . . . . 1.33 110.983 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 47.3 Cg_endo -71.99 135.42 25.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.423 2.082 . . . . 0.53 111.244 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.0 t -158.43 173.92 15.91 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.295 -0.261 . . . . 1.42 110.295 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.474 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 43.8 mt-30 -55.89 -30.57 61.78 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.322 0.389 . . . . 1.66 111.636 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -59.79 -29.49 68.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 2.82 110.929 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.429 ' CD2' ' HD3' ' A' ' 114' ' ' PRO . 42.5 m80 -86.04 -13.67 46.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.892 -0.594 . . . . 0.53 111.561 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 86.7 mt -56.66 -73.59 0.06 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.885 0.374 . . . . 1.24 111.35 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -101.21 16.83 24.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.249 0.547 . . . . 3.7 110.044 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.51 -175.36 23.25 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.454 -0.793 . . . . 1.12 111.58 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.53 147.94 9.87 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 1.31 112.466 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 mt -79.37 135.15 57.63 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.009 -0.542 . . . . 1.11 110.072 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 108' ' ' HIS . 59.5 Cg_endo -71.07 160.81 48.08 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.239 2.626 . . . . 1.15 113.238 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 15.4 m -91.39 140.45 25.52 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.209 -0.905 . . . . 2.98 108.802 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 25.3 Cg_exo -64.66 65.48 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.477 2.785 . . . . 4.23 114.326 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -96.76 93.89 6.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.584 -0.895 . . . . 7.33 108.584 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 t -59.18 112.33 1.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.351 0.596 . . . . 8.78 111.426 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -143.94 134.3 24.58 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.162 -0.681 . . . . 9.34 109.162 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -102.88 117.4 5.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.643 -0.789 . . . . 11.55 112.259 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.83 34.07 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.363 0.601 . . . . 13.92 110.618 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 43.0 mm -98.41 -15.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 16.21 110.628 -175.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -67.19 -24.47 65.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.056 0.455 . . . . 18.82 110.549 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -81.49 -0.11 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 20.83 110.712 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.71 -0.48 57.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.647 0.737 . . . . 22.5 109.226 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 126' ' ' ASN . 12.2 m120 -116.41 -173.17 2.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.198 -0.91 . . . . 23.99 109.548 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.5 m -63.66 -53.32 53.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.819 0.342 . . . . 25.0 110.131 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.778 -0.63 . . . . 27.52 109.445 176.822 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.845 0 N-CA-C 112.29 -0.324 . . . . 11.87 112.29 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.3 tp -148.97 135.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.058 0.456 . . . . 9.86 110.386 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' OD2' ' HB ' ' A' ' 6' ' ' THR . 3.6 p-10 -91.91 111.82 51.71 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.923 -0.58 . . . . 6.96 109.451 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 3' ' ' ASP . 15.3 Cg_endo -56.13 -41.5 76.08 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.114 3.209 . . . . 6.65 113.703 -170.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -121.08 102.6 8.43 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.686 -0.487 . . . . 7.99 109.686 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.47 ' HB ' ' OD2' ' A' ' 3' ' ' ASP . 14.8 t -127.07 163.45 23.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.617 -0.72 . . . . 4.26 110.877 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -108.96 29.1 7.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.062 -0.517 . . . . 3.84 110.766 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' HG ' ' OG1' ' A' ' 6' ' ' THR . 90.0 mt -76.48 71.97 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.391 0.615 . . . . 0.8 111.091 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -122.0 146.02 45.24 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.617 -0.72 . . . . 3.09 109.801 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HB2' HD11 ' A' ' 87' ' ' LEU . 39.9 Cg_endo -68.32 173.57 9.44 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.488 2.125 . . . . 0.47 111.696 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.426 HH22 ' HB3' ' A' ' 52' ' ' ARG . 24.3 ptt-85 -134.3 132.51 39.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.849 0.356 . . . . 2.37 110.372 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.4 tp -95.32 113.22 24.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.928 -0.578 . . . . 1.32 109.879 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.6 m -96.79 118.86 34.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.981 -0.554 . . . . 0.4 109.902 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.851 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.2 m -109.73 117.51 34.09 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.126 -0.694 . . . . 0.35 109.126 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.0 ptp -128.89 133.7 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.88 111.259 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -107.67 143.6 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.238 -0.892 . . . . 2.58 110.018 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.432 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 77.0 mttt -56.8 126.23 26.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.373 -0.831 . . . . 0.92 111.25 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -124.3 1.62 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.451 -1.249 . . . . 1.28 111.011 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.18 -48.32 1.84 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.662 2.241 . . . . 2.23 112.365 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -118.86 -34.19 4.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 2.87 111.491 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . -174.61 -143.51 4.47 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.796 -0.716 . . . . 1.93 112.227 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.672 ' O ' ' HB2' ' A' ' 44' ' ' SER . 32.7 m-85 -99.24 -44.35 6.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.649 0.261 . . . . 1.82 110.894 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.68 69.25 0.9 Allowed Glycine 0 C--O 1.227 -0.292 0 C-N-CA 121.105 -0.569 . . . . 0.43 113.213 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -156.89 153.75 28.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.432 -0.581 . . . . 0.4 109.432 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.437 HD22 ' HD2' ' A' ' 38' ' ' ARG . 60.9 t30 -101.96 126.31 48.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.478 -0.564 . . . . 2.18 109.478 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.511 HD11 ' HG3' ' A' ' 35' ' ' GLN . 2.0 tm? -99.22 123.28 43.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.441 -0.577 . . . . 1.52 109.441 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.684 ' CB ' ' HB2' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -126.92 122.52 34.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.524 -0.762 . . . . 1.34 111.256 -171.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.0 m -112.05 170.91 7.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.65 -0.704 . . . . 2.3 110.266 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 32' ' ' LYS . 13.1 t70 -121.21 152.88 38.3 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.214 -0.662 . . . . 3.48 109.214 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.14 -7.09 40.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.258 -0.428 . . . . 4.54 111.121 -174.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.9 m -116.39 -45.89 2.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 3.49 110.645 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 24.8 pttm -105.32 127.8 27.87 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.431 . . . . 3.0 110.354 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 16.9 Cg_exo -68.62 169.24 17.81 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.931 2.421 . . . . 2.24 112.602 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.23 136.94 9.25 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.374 -0.83 . . . . 1.29 112.18 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HG3' HD11 ' A' ' 26' ' ' LEU . 1.6 mp0 -93.72 128.43 39.92 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.555 -0.535 . . . . 1.5 109.555 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.31 147.66 37.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.87 110.204 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.95 106.65 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.091 -0.707 . . . . 0.39 109.091 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.684 ' HB2' ' CB ' ' A' ' 27' ' ' HIS . 4.3 tmt_? -66.11 -42.39 89.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.941 -0.762 . . . . 2.83 108.941 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 p -174.48 154.87 2.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.736 -1.12 . . . . 1.26 109.56 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.0 p -109.93 127.41 66.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.664 -0.495 . . . . 0.37 109.664 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -65.18 128.36 93.71 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.045 -0.525 . . . . 2.28 109.973 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.51 144.9 98.22 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.477 2.118 . . . . 1.17 112.251 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.15 54.49 1.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.466 -0.788 . . . . 2.4 109.628 -177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 22' ' ' TYR . 91.9 p -131.79 150.8 77.24 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.454 -0.794 . . . . 0.57 111.086 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 18.5 Cg_endo -62.31 -24.14 75.7 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.65 111.629 172.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.87 77.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.146 0.498 . . . . 0.36 109.904 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.63 -32.0 73.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 2.01 110.08 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.32 -32.01 68.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.009 -0.541 . . . . 0.47 111.686 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.2 p -72.65 -13.23 61.32 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.037 0.446 . . . . 0.4 110.697 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.07 26.44 6.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.741 -0.742 . . . . 0.62 112.709 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 tp -77.41 158.3 30.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.051 -0.351 . . . . 0.65 110.051 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 39.5 ttm180 -158.04 160.92 37.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.811 -0.811 . . . . 4.38 108.811 -173.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' GLN . . . -83.45 152.41 24.99 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.129 -0.228 . . . . 1.44 110.88 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 25.1 mt-30 80.92 1.2 1.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.114 0.884 . . . . 3.06 112.175 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.63 ' OD2' ' HB3' ' A' ' 52' ' ' ARG . 33.2 m-20 -84.05 146.34 27.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.868 0.366 . . . . 1.02 110.49 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.4 ttp-105 -106.44 136.88 45.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.501 -0.555 . . . . 1.57 109.501 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.11 123.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.804 -0.443 . . . . 0.68 109.804 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.705 HG11 ' HG2' ' A' ' 104' ' ' PRO . 47.0 t -99.93 -49.91 10.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.674 -0.694 . . . . 0.87 110.117 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 64' ' ' CYS . 23.2 mt-10 -126.45 142.87 51.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.89 110.425 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 118.62 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.103 -0.498 . . . . 0.66 109.711 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.2 30.12 19.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.956 0.408 . . . . 1.17 110.966 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.97 -3.68 73.89 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.891 -0.671 . . . . 0.66 113.96 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.46 129.26 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 117.791 0.795 . . . . 1.17 111.237 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.7 p -71.0 137.15 48.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.004 -0.998 . . . . 1.68 112.028 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.762 ' HB3' HG22 ' A' ' 73' ' ' VAL . 24.1 mmt -115.0 11.46 16.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.81 111.048 -177.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 103' ' ' ILE . 72.8 mm-40 -59.42 -45.62 91.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 3.75 111.3 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.05 2.0 74.87 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.688 -0.768 . . . . 1.47 112.633 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 73.6 mmtt -90.72 179.53 5.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.208 -0.293 . . . . 3.36 110.208 -177.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -111.98 174.47 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.666 -0.243 . . . . 2.89 111.537 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -54.21 -43.93 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 1.42 111.415 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.86 -30.78 76.63 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.92 -0.657 . . . . 0.72 113.066 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.17 -46.1 62.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.936 0.398 . . . . 2.03 110.808 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 65' ' ' MET . 25.1 t -62.57 -46.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.828 -0.624 . . . . 1.08 111.049 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.05 -39.2 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.72 111.183 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.4 t -68.44 -38.82 81.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.324 -0.398 . . . . 0.66 110.646 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.68 85.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.42 111.658 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.95 -43.17 91.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.191 0.519 . . . . 0.69 110.432 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.4 -34.53 70.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 3.09 110.592 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.74 -15.51 63.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.796 -0.638 . . . . 0.65 111.415 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.4 80.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 0.6 111.725 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.23 -111.7 4.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.978 -0.63 . . . . 1.1 112.211 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 -8.34 35.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.664 0.269 . . . . 2.12 110.706 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.44 162.4 40.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.428 -0.351 . . . . 2.11 110.757 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.4 t -150.35 149.36 29.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.331 -0.395 . . . . 0.32 110.3 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.851 ' HG2' HG23 ' A' ' 14' ' ' THR . 26.9 mttm -115.15 117.46 30.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.713 -0.477 . . . . 1.63 109.713 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -107.89 129.73 55.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.857 0.36 . . . . 0.28 110.302 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.502 HD23 ' HG3' ' A' ' 59' ' ' GLU . 37.5 tp -103.7 116.62 32.67 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.19 -0.67 . . . . 0.51 109.19 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 16.7 m -127.52 161.83 34.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.005 -0.543 . . . . 0.33 110.756 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 10' ' ' PRO . 8.5 m -133.87 133.35 56.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.746 -0.661 . . . . 0.42 110.78 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.4 154.09 41.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 1.92 109.183 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 70.5 ttt180 -52.72 -41.61 64.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.251 0.463 . . . . 4.16 112.251 -170.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.34 -34.84 72.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.29 0.567 . . . . 2.68 110.72 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.7 m -79.45 -41.83 26.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.332 -0.849 . . . . 0.47 110.19 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 25.9 t0 -65.87 -39.01 90.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.206 -0.906 . . . . 1.18 111.689 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 5.1 mm-40 -63.58 -36.34 83.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.992 0.425 . . . . 1.94 110.061 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.16 -41.34 86.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 0.73 110.45 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HD1' HG13 ' A' ' 102' ' ' VAL . 28.3 m-85 -65.76 -37.39 86.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.276 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 94' ' ' ASP . 44.4 mttp -62.95 -49.89 72.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.323 . . . . 1.92 111.266 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.86 -25.82 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 2.04 111.167 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.486 ' HB3' HG12 ' A' ' 102' ' ' VAL . 36.3 t -87.62 -11.87 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.045 0.45 . . . . 1.39 110.676 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 61.96 35.54 16.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.366 -0.834 . . . . 4.09 111.334 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 100' ' ' CYS . 10.0 p -128.56 142.47 43.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.241 -0.436 . . . . 1.42 110.263 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 103' ' ' ILE . 3.0 mp -85.85 126.48 65.72 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.024 -0.534 . . . . 1.33 110.734 -176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.705 ' HG2' HG11 ' A' ' 58' ' ' VAL . 22.8 Cg_endo -63.42 146.4 93.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.75 2.3 . . . . 0.53 111.617 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.5 p -157.67 173.04 17.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.639 -0.255 . . . . 1.42 111.353 -174.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.511 ' HA ' ' HG ' ' A' ' 109' ' ' LEU . 51.8 mt-30 -60.12 -28.83 68.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.442 0.464 . . . . 1.66 110.703 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -58.47 -30.08 66.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.24 0.543 . . . . 2.82 111.118 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -85.88 -14.56 44.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.53 111.319 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 96.2 mt -63.09 107.64 1.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 1.24 110.443 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 60.41 24.79 14.34 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.96 -0.564 . . . . 3.7 110.494 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.74 174.17 15.13 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.915 -0.66 . . . . 1.12 111.973 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.87 136.39 38.31 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.902 2.401 . . . . 1.31 111.906 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 37.5 mt -80.96 161.3 63.76 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 109.269 -0.641 . . . . 1.11 109.269 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 77.7 Cg_exo -45.59 154.64 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.75 2.967 . . . . 1.15 114.446 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 114' ' ' PRO . 90.1 t 79.28 123.06 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 114.645 -1.161 . . . . 2.98 111.386 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 6.8 Cg_exo -73.62 89.44 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.127 2.551 . . . . 4.23 111.235 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -73.63 -18.39 61.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.915 -0.584 . . . . 7.33 110.871 -175.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.4 t -140.79 31.78 1.82 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.135 0.493 . . . . 8.78 110.154 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 65.87 -79.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.359 -0.837 . . . . 9.34 110.782 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.87 -63.67 4.21 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.08 -0.581 . . . . 11.55 112.832 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -81.57 74.19 8.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 13.92 110.865 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 11.1 pt -141.24 101.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.255 -0.884 . . . . 16.21 109.515 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.427 HE21 ' HG3' ' A' ' 124' ' ' LYS . 23.9 tt0 -128.1 -73.01 0.6 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.228 -0.442 . . . . 18.82 110.649 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HG3' HE21 ' A' ' 123' ' ' GLN . 28.2 mtpp -105.49 68.38 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.083 0.468 . . . . 20.83 110.793 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -90.19 137.41 32.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.634 -0.712 . . . . 22.5 109.845 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.22 -32.56 26.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.641 . . . . 23.99 110.37 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.1 t -170.2 -67.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 25.0 109.36 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.827 -0.606 . . . . 27.52 109.638 177.546 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.084 -0.806 . . . . 11.87 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.5 tt -84.05 78.99 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.564 1.173 . . . . 9.86 108.752 173.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -68.97 139.39 90.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.107 -1.406 . . . . 6.96 111.373 -170.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.74 -31.64 92.14 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.279 2.653 . . . . 6.65 112.096 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' MET . 25.9 p90 -117.82 -152.09 0.5 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.558 -1.275 . . . . 7.99 107.558 171.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 HH21 ' A' ' 9' ' ' ARG . 27.1 m 71.61 -12.65 0.62 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.577 0.703 . . . . 4.26 111.192 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 5' ' ' PHE . 91.8 mmm -92.96 -3.22 54.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.927 -0.579 . . . . 3.84 110.277 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.8 mt -80.04 68.52 6.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.828 -0.805 . . . . 0.8 108.828 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.484 HH21 HG22 ' A' ' 6' ' ' THR . 10.5 ptp180 -126.61 156.74 72.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.953 -1.022 . . . . 3.09 109.322 -174.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HB2' HD11 ' A' ' 87' ' ' LEU . 38.5 Cg_endo -65.49 165.97 21.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.138 1.892 . . . . 0.47 111.203 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.671 HH12 ' HB3' ' A' ' 90' ' ' ASP . 8.7 ptp85 -121.28 131.95 54.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.872 0.367 . . . . 2.37 110.157 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.5 tp -98.24 111.03 23.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.218 0.533 . . . . 1.32 109.83 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 22.3 m -98.92 117.59 33.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.544 -0.753 . . . . 0.4 109.799 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -105.75 117.61 34.46 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.297 -0.631 . . . . 0.35 109.297 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.62 142.49 51.48 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 0.88 111.072 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 83' ' ' GLU . 37.1 ttpt -114.77 140.18 49.11 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.817 -0.629 . . . . 2.58 109.622 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.691 ' HG2' ' HA2' ' A' ' 21' ' ' GLY . 5.6 ttmt -58.4 105.82 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.779 -0.452 . . . . 0.92 109.779 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.35 -134.37 7.0 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 1.28 113.257 -172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.11 -53.74 2.82 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.291 2.66 . . . . 2.23 112.843 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -116.87 33.31 5.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.091 -0.504 . . . . 2.87 110.663 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.691 ' HA2' ' HG2' ' A' ' 17' ' ' LYS . . . 90.58 -120.07 5.79 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.581 -0.819 . . . . 1.93 111.389 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.526 ' HA ' ' HG2' ' A' ' 45' ' ' PRO . 52.7 m-85 -121.08 172.95 7.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.82 109.283 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.28 73.75 0.41 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.159 -1.019 . . . . 0.43 112.816 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -155.43 144.91 21.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.731 0.301 . . . . 0.4 110.203 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 7.2 t-20 -103.57 141.04 36.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.207 -0.664 . . . . 2.18 109.207 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.9 tp -102.28 151.3 22.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.09 0.472 . . . . 1.52 111.535 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -108.82 122.27 46.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.782 -0.645 . . . . 1.34 110.287 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.5 p -135.31 92.92 2.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.196 0.522 . . . . 2.3 109.862 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.66 150.41 24.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.728 -0.669 . . . . 3.48 110.902 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.07 8.73 38.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 4.54 109.46 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 m -107.93 -47.89 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.269 -0.878 . . . . 3.49 110.507 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -126.78 134.77 26.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 3.0 110.675 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 159.87 46.07 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.79 2.327 . . . . 2.24 112.304 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 157.88 17.83 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.116 -0.794 . . . . 1.29 111.116 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.595 ' HG3' HG21 ' A' ' 73' ' ' VAL . 26.7 mm-40 -111.32 128.85 56.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.009 0.433 . . . . 1.5 110.448 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 57.8 m-85 -115.86 158.32 23.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.87 109.492 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG13 HD11 ' A' ' 51' ' ' LEU . 50.5 mm -87.28 106.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.553 -0.536 . . . . 0.39 109.553 176.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 25' ' ' ASN . 25.2 ttt180 -65.24 -50.09 67.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.874 -0.603 . . . . 2.83 110.014 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 p -160.87 133.92 6.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 1.26 109.878 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 p -104.66 132.83 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.356 -0.609 . . . . 0.37 109.356 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.73 134.52 72.19 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 109.489 -0.56 . . . . 2.28 109.489 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 52.6 Cg_exo -53.48 136.34 63.46 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.25 2.633 . . . . 1.17 113.126 -177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p30 44.19 38.51 2.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.29 1.036 . . . . 2.4 112.825 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.501 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 92.0 p -93.69 165.68 17.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.692 -0.855 . . . . 0.57 108.692 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HG2' ' HA ' ' A' ' 22' ' ' TYR . 10.4 Cg_endo -54.92 -30.31 68.2 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.789 1.659 . . . . 0.65 111.488 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -46.01 67.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.814 -0.63 . . . . 0.36 110.615 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 34.0 tt0 -70.03 -34.33 73.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.742 0.306 . . . . 2.01 110.384 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -24.89 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.47 111.959 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.437 ' OG ' ' HB3' ' A' ' 13' ' ' CYS . 82.9 p -75.83 -13.28 60.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.228 0.537 . . . . 0.4 110.718 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.43 37.41 4.04 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.603 -0.726 . . . . 0.62 111.874 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 37' ' ' ILE . 17.4 tp -83.97 148.26 26.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.197 -0.298 . . . . 0.65 110.197 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HD3' ' OD1' ' A' ' 55' ' ' ASP . 62.3 ttt-85 -128.95 151.42 49.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 4.38 110.364 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.6 133.02 44.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.437 -0.347 . . . . 1.44 111.37 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 12.9 mm-40 65.87 29.57 10.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.341 -0.845 . . . . 3.06 111.599 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.561 ' OD1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -88.71 136.17 33.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.105 -0.702 . . . . 1.02 109.105 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.3 129.2 36.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.706 -0.225 . . . . 1.57 110.626 -177.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.442 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 52.5 mt -82.87 123.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.68 109.779 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.554 HG11 ' HG2' ' A' ' 104' ' ' PRO . 6.5 t -106.05 -35.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.245 -0.434 . . . . 0.87 110.614 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 36.0 mt-10 -136.48 143.02 43.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.291 -0.413 . . . . 0.89 111.221 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG12 ' ND2' ' A' ' 61' ' ' ASN . 49.3 t -122.17 109.06 23.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.045 -0.724 . . . . 0.66 109.045 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.53 ' ND2' HG12 ' A' ' 60' ' ' VAL . 10.4 p30 46.47 43.18 11.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.958 0.885 . . . . 1.17 111.579 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 106' ' ' GLN . . . 94.26 -4.46 70.49 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.782 -1.099 . . . . 0.66 114.19 174.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.4 t -98.33 119.54 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 117.522 0.661 . . . . 1.17 110.471 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.0 p -67.92 130.55 43.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.384 -0.825 . . . . 1.68 111.061 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.522 ' SD ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mmt -117.2 45.28 1.92 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.989 -0.55 . . . . 0.81 111.971 -174.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -90.95 -47.73 7.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.137 0.494 . . . . 3.75 110.62 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.2 18.37 57.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 1.47 112.187 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HG3' ' SD ' ' A' ' 65' ' ' MET . 72.2 mmtt -100.37 173.83 6.4 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.176 -0.305 . . . . 3.36 110.176 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -112.85 178.49 4.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.591 -0.277 . . . . 2.89 111.169 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.439 ' O ' HG23 ' A' ' 74' ' ' VAL . 55.2 t-80 -54.88 -43.65 73.36 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.469 -0.332 . . . . 1.42 111.141 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.45 -38.23 95.5 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.013 -0.613 . . . . 0.72 112.831 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.68 -44.26 96.71 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.952 0.406 . . . . 2.03 110.714 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.595 HG21 ' HG3' ' A' ' 35' ' ' GLN . 48.6 t -69.88 -46.81 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.763 -0.653 . . . . 1.08 111.047 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.2 t -63.96 -38.12 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.429 -0.35 . . . . 0.72 110.903 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.1 t -65.65 -36.04 82.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.051 -0.351 . . . . 0.66 110.051 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.39 -34.52 78.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.42 110.856 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.557 HG23 HG21 ' A' ' 84' ' ' THR . 29.0 mm -57.47 -45.42 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.7 0.762 . . . . 0.69 109.548 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -75.26 -31.07 60.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.862 -1.063 . . . . 3.09 111.119 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.28 -18.79 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.65 111.637 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.03 -17.48 79.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.809 -0.71 . . . . 0.6 112.252 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.47 -114.74 3.45 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.744 -0.741 . . . . 1.1 111.628 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.644 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 34.3 m-20 -110.04 -9.28 14.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.164 0.507 . . . . 2.12 110.25 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 1.8 pm0 -139.16 142.53 37.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.946 -0.57 . . . . 2.11 110.153 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.557 HG21 HG23 ' A' ' 77' ' ' ILE . 10.2 t -133.01 151.17 52.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.435 -0.348 . . . . 0.32 110.624 -174.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -111.07 118.0 34.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.257 -0.646 . . . . 1.63 109.257 176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.85 135.07 47.94 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.916 0.389 . . . . 0.28 110.1 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 10' ' ' PRO . 26.4 tp -104.92 115.77 30.85 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.915 -0.772 . . . . 0.51 108.915 176.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' A' ' 11' ' ' ARG . 13.2 m -127.46 158.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.33 111.374 -176.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 147.66 30.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.42 110.402 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.671 ' HB3' HH12 ' A' ' 11' ' ' ARG . 21.3 p30 -92.47 176.94 6.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.965 -0.561 . . . . 1.92 110.298 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 54.4 ttp180 -54.72 -48.64 72.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.214 0.45 . . . . 4.16 112.214 -174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' HG2' ' OD1' ' A' ' 90' ' ' ASP . 1.8 pm0 -65.65 -42.76 91.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.843 0.354 . . . . 2.68 111.675 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -68.36 -44.67 74.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.07 -0.513 . . . . 0.47 110.772 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -60.86 -47.25 87.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.928 -0.578 . . . . 1.18 111.09 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 40.3 mt-10 -64.77 -32.85 74.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.605 -0.27 . . . . 1.94 110.64 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -64.24 -48.43 75.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.375 -0.375 . . . . 0.73 110.793 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CD2' HG13 ' A' ' 102' ' ' VAL . 30.4 m-85 -66.96 -38.74 86.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.642 -0.254 . . . . 0.44 111.495 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 95' ' ' GLU . 40.6 mtmt -63.85 -47.27 81.39 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.801 0.297 . . . . 1.92 111.801 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 95' ' ' GLU . 19.9 ptmt -65.79 -18.96 65.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.375 0.607 . . . . 2.04 110.537 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.477 ' HB2' HG12 ' A' ' 102' ' ' VAL . 92.4 m -94.04 -9.97 35.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.583 -0.735 . . . . 1.39 111.079 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.16 26.92 12.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.346 -0.843 . . . . 4.09 111.39 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 97' ' ' PHE . 7.7 p -109.41 141.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.436 -0.579 . . . . 1.42 109.436 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 37.3 mm -87.26 123.12 70.43 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.158 -0.474 . . . . 1.33 110.434 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.554 ' HG2' HG11 ' A' ' 58' ' ' VAL . 18.6 Cg_endo -60.49 135.66 62.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.197 1.931 . . . . 0.53 110.678 174.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 m -154.69 166.31 33.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.086 -0.339 . . . . 1.42 110.086 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 62' ' ' GLY . 48.3 mt-30 -62.06 -30.37 70.94 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.491 0.494 . . . . 1.66 112.288 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.7 -29.35 70.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 2.82 110.484 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.69 -14.93 60.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.994 -0.548 . . . . 0.53 111.366 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 106' ' ' GLN . 91.8 mt -62.25 -46.59 88.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.096 0.474 . . . . 1.24 110.362 177.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -128.61 75.99 1.67 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.619 -0.719 . . . . 3.7 110.1 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.43 176.08 46.75 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.52 -0.764 . . . . 1.12 111.312 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -74.98 111.08 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.556 2.171 . . . . 1.31 112.642 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.53 135.89 85.88 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 116.192 -0.458 . . . . 1.11 110.458 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.93 136.58 30.21 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.611 2.208 . . . . 1.15 112.444 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.04 125.21 2.02 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.649 -0.705 . . . . 2.98 110.526 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -84.04 118.52 2.36 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.585 2.19 . . . . 4.23 111.969 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -103.35 -46.59 4.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.061 0.458 . . . . 7.33 109.79 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.9 m -80.12 115.0 19.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.692 -0.686 . . . . 8.78 110.515 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.35 48.72 1.44 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.472 . . . . 9.34 110.998 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.5 -41.08 5.53 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.909 -0.662 . . . . 11.55 113.018 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.36 8.02 35.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.285 0.564 . . . . 13.92 111.104 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 47.1 mt -108.55 82.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.502 -0.925 . . . . 16.21 108.502 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -97.78 61.93 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.95 -0.568 . . . . 18.82 112.237 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.03 -3.02 20.49 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.471 -0.937 . . . . 20.83 108.471 167.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -71.89 148.5 46.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.547 -1.206 . . . . 22.5 110.638 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -128.7 -59.51 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 23.99 110.202 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.2 t -178.29 -47.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 . . . . . 0 C--O 1.245 0.851 0 CA-C-N 114.846 -1.07 . . . . 27.52 109.16 175.796 . . . . . . . . 0 0 . 1 stop_ save_